OBO_ID (LABEL):	CHEBI_27300 (vitamin D)

IGNORANCE CATEGORY:	alternative_options_controversy

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
BMJ_2010_Apr_29_340_c1640	4/2010	S17-BMJ_2010_Apr_29_340_c1640	['this latitudinal gradient SEEMS environmentally RELATED BECAUSE the risk ASSOCIATED with latitude alters if People move after Birth.45a strong environmental CANDIDATE is the level of ambient regional ultraviolet radiation, acting EITHER directly OR through the generation of Vitamin D.6higher exposure to ultraviolet radiation,7higher Vitamin D intake,8and also higher Serum Vitamin D concentrations9seem to be ASSOCIATED with a reduced risk of onset of multiple sclerosis.']	[('ANOMALY_CURIOUS_FINDING', 26), ('SUPERFICIAL_RELATIONSHIP', 48), ('PROBABLE_UNDERSTANDING', 56), ('SUPERFICIAL_RELATIONSHIP', 73), ('INCOMPLETE_EVIDENCE', 157), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 230), ('SUPERFICIAL_RELATIONSHIP', 411)]	7	[('NCBITaxon_10088', 'Mus <genus>', 108, 'people'), ('GO_0007567', 'parturition', 126, 'birth'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 335, 'vitamin D'), ('UBERON_0001977', 'blood serum', 369, 'serum'), ('CHEBI_27300', 'vitamin D', 375, 'vitamin D')]
BMJ_2010_Apr_29_340_c1640	4/2010	S18-BMJ_2010_Apr_29_340_c1640	['this EVIDENCE comes from both case-control and cohort studies and INDICATES that age of operation for such a PROTECTIVE EFFECT MIGHT include both childhood and early Adulthood.67891011\nexposure to ultraviolet radiation in early Life has NOT YET been formally examined but MIGHT be LINKED to excess risk of multiple sclerosis at Birth through seasonal deficiency in maternal Vitamin D concentrations.12A study of half siblings with multiple sclerosis has ALSO SHOWN that risk CAN be maternally MEDIATED.13pregnancy is a vulnerable time for Vitamin d deficiency BECAUSE of increased physiological needs and reduced maternal outdoor activity.14experimental data on Animal Fetal Development INDICATE that Cerebral White Matter is responsive to Vitamin D and that Oligodendrocytes in the Brain and Spinal Cord have Vitamin D Receptors.1516furthermore, maternal Vitamin D depletion alters Neurogenesis in the developing Rat Brain,17with subsequent altered Gene Expression in Adult Life.18a RECENT Genetic STUDY in Humans has FURTHER IMPLICATED Vitamin D as a strong environmental CANDIDATE by SHOWING direct functional INTERACTION with the major locus that determines susceptibility to multiple sclerosis.19ALTHOUGH Human EVIDENCE pertaining to fetal development HAS BEEN DIFFICULT to obtain, the body of RELATED EVIDENCE to date has led SOME to RECOMMEND Antenatal supplementation with Vitamin D to prevent multiple sclerosis.14\nAS an indicator of POSSIBLE Perinatal environmental exposures, such as ultraviolet radiation, individual studies in the northern hemisphere have examined month of Birth and risk of multiple sclerosis with VARIED results.2021222324a large RECENT pooled analysis of Births in the northern hemisphere, HOWEVER, SHOWED an excess of multiple sclerosis among People Born in may and a relative deficit among those Born in november; these results were stronger in familial cases and SUGGESTED INTERACTIONS between Genes and environment that are RELATED to climate and that MIGHT act during Gestation or shortly after Birth.12we EXAMINED month of Birth and risk of multiple sclerosis in australia.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 109), ('SUPERFICIAL_RELATIONSHIP', 120), ('INCOMPLETE_EVIDENCE', 127), ('FULL_UNKNOWN', 237), ('INCOMPLETE_EVIDENCE', 272), ('SUPERFICIAL_RELATIONSHIP', 281), ('INCOMPLETE_EVIDENCE', 399), ('INCOMPLETE_EVIDENCE', 454), ('INCOMPLETE_EVIDENCE', 475), ('SUPERFICIAL_RELATIONSHIP', 493), ('PROBABLE_UNDERSTANDING', 560), ('INCOMPLETE_EVIDENCE', 687), ('INCOMPLETE_EVIDENCE', 984), ('INCOMPLETE_EVIDENCE', 1019), ('SUPERFICIAL_RELATIONSHIP', 1027), ('INCOMPLETE_EVIDENCE', 1074), ('INCOMPLETE_EVIDENCE', 1087), ('SUPERFICIAL_RELATIONSHIP', 1113), ('ANOMALY_CURIOUS_FINDING', 1199), ('ANOMALY_CURIOUS_FINDING', 1199), ('INCOMPLETE_EVIDENCE', 1216), ('INCOMPLETE_EVIDENCE', 1257), ('DIFFICULT_TASK', 1266), ('INCOMPLETE_EVIDENCE', 1299), ('SUPERFICIAL_RELATIONSHIP', 1299), ('INCOMPLETE_EVIDENCE', 1332), ('FUTURE_WORK', 1340), ('PROBABLE_UNDERSTANDING', 1424), ('INCOMPLETE_EVIDENCE', 1443), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1629), ('INCOMPLETE_EVIDENCE', 1662), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1723), ('INCOMPLETE_EVIDENCE', 1732), ('INCOMPLETE_EVIDENCE', 1899), ('SUPERFICIAL_RELATIONSHIP', 1909), ('SUPERFICIAL_RELATIONSHIP', 1961), ('INCOMPLETE_EVIDENCE', 1989), ('QUESTION_ANSWERED_BY_THIS_WORK', 2044)]	40	[('UBERON_0000113', 'post-juvenile adult stage', 166, 'adulthood'), ('UBERON_0000104', 'life cycle', 228, 'life'), ('GO_0007567', 'parturition', 328, 'birth'), ('CHEBI_27300', 'vitamin D', 374, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 539, 'vitamin'), ('NCBITaxon_33208', 'Metazoa', 662, 'animal'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 669, 'fetal development'), ('UBERON_0002437', 'cerebral hemisphere white matter', 701, 'cerebral white matter'), ('CHEBI_27300', 'vitamin D', 740, 'vitamin D'), ('CL_0000128', 'oligodendrocyte', 759, 'oligodendrocytes'), ('UBERON_0000955', 'brain', 783, 'brain'), ('UBERON_0002240', 'spinal cord', 793, 'spinal cord'), ('CHEBI_27300', 'vitamin D', 810, 'vitamin D'), ('PR_000001708', 'sphingosine 1-phosphate receptor 3', 810, 'vitamin D receptors'), ('CHEBI_27300', 'vitamin D', 856, 'vitamin D'), ('GO_0022008', 'neurogenesis', 883, 'neurogenesis'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 914, 'rat'), ('UBERON_0000955', 'brain', 918, 'brain'), ('GO_0010467', 'gene expression', 950, 'gene expression'), ('SO_0000704', 'gene', 950, 'gene'), ('UBERON_0000113', 'post-juvenile adult stage', 969, 'adult life'), ('SO_0000704', 'gene', 991, 'genetic'), ('NCBITaxon_9606', 'Homo sapiens', 1008, 'humans'), ('CHEBI_27300', 'vitamin D', 1038, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 1210, 'human'), ('GO_0007567', 'parturition', 1350, 'antenatal'), ('CHEBI_27300', 'vitamin D', 1381, 'vitamin D'), ('GO_0036268', 'swimming', 1452, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1452, 'perinatal'), ('GO_0007567', 'parturition', 1587, 'birth'), ('GO_0007567', 'parturition', 1688, 'births'), ('NCBITaxon_10088', 'Mus <genus>', 1777, 'people'), ('GO_0007567', 'parturition', 1784, 'born'), ('GO_0007567', 'parturition', 1831, 'born'), ('SO_0000704', 'gene', 1930, 'genes'), ('GO_0007565', 'female pregnancy', 2006, 'gestation'), ('GO_0007567', 'parturition', 2033, 'birth'), ('GO_0007567', 'parturition', 2062, 'birth')]
BMJ_2010_Apr_29_340_c1640	4/2010	S84-BMJ_2010_Apr_29_340_c1640	['we could not examine the Vitamin D status of the fetus directly but INSTEAD chose the ambient ultraviolet radiation level experienced by the mother during Gestation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 68)]	1	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007565', 'female pregnancy', 155, 'gestation')]
BMJ_2010_Apr_29_340_c1640	4/2010	S100-BMJ_2010_Apr_29_340_c1640	['the first trimester is also a sensitive period with regard to Prenatal Thymocyte differentiation, with Animal STUDIES SHOWING that chemicals such as Dioxin CAN alter this process, disrupt the development of central tolerance, and LEAD TO increased auto-reactive Peripheral T Cells.49FURTHERMORE, indirect EFFECTS of Vitamin D SHOULD BE CONSIDERED.']	[('INCOMPLETE_EVIDENCE', 110), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 156), ('SUPERFICIAL_RELATIONSHIP', 230), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 281), ('SUPERFICIAL_RELATIONSHIP', 305), ('FUTURE_WORK', 326), ('FUTURE_WORK', 336)]	8	[('GO_0007565', 'female pregnancy', 62, 'prenatal'), ('CL_0000893', 'thymocyte', 71, 'thymocyte'), ('NCBITaxon_33208', 'Metazoa', 103, 'animal'), ('CHEBI_4553', 'dihydroanhydropodorhizol', 149, 'dioxin'), ('CL_0000111', 'peripheral neuron', 262, 'peripheral T cells'), ('CHEBI_27300', 'vitamin D', 316, 'vitamin D')]
PMC1281283	10/2005	S153-PMC1281283	['HOWEVER, fish also contain Nutrients such as iron, Vitamin E, Selenium, and Long-Chain N-3 polyunsaturated Fatty Acids that MAY benefit Brain development (clarkson and strain 2003;national research council 2000;neuringer et al.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 124)]	2	[('CHEBI_33284', 'nutrient', 27, 'nutrients'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin E'), ('CHEBI_27568', 'selenium atom', 62, 'selenium'), ('CHEBI_32805', 'cis-aconitic acid', 76, 'long-chain n-3'), ('CHEBI_35366', 'fatty acid', 107, 'fatty acids'), ('UBERON_0000955', 'brain', 136, 'brain')]
PMC1448690	4/2006	S301-PMC1448690	['in an investigation of WHETHER reduction in childhood infections OR change in diet COULD explain increases in asthma and atopic disease, seaton and devereux [178] FOUND that low intake of Vitamin C was ASSOCIATED with a sevenfold increase in the risk of bronchial hyper-reactivity; by CONTRAST, those with the lowest intake of saturated fats had a tenfold lower risk.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 163), ('SUPERFICIAL_RELATIONSHIP', 202), ('ANOMALY_CURIOUS_FINDING', 285)]	5	[('CHEBI_27300', 'vitamin D', 188, 'vitamin C')]
PMC1481554	4/2006	S34-PMC1481554	['d (Cholecalciferol)ε250 iu250 iu5 μg* Calcium 300 mg250 mg1000–1300 mg* Biotin 030 μg- chromium 025 μg29–30 μg* manganese 05 mg2 mg* Molybdenum 025 μg50 μg Selenium 025 μg60 μg pill size smalllarge\n* adequate intake\n** applies only to pregvit®\nψvit a – 1 international unit (iu) of Retinol is equivalent to 0.3 μg Retinol (750 μg of Retinol is 2,500 iu of Retinol)\n2 μg of supplemental β-Carotene is equivalent to 1 μg Retinol3 (page 92 & 565)\nξvit e – 1 international unite (iu) is equivalent to 0.67 μg of Α-Tocopherol (15 mg is equivalent to 22,388 iu)\nHOWEVER, DIFFERENT conversion factors are used for DIFFERENT forms of Vitamin E\nε vit d – 1 iu is equivalent to 0.025 μg of Cholecalciferol (5 μg is equivalent to 200 iu)\n*** please note : since the completion of this study a new formulation of materna was introduced containing 27 mg of elemental iron.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 556), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 565), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 607)]	3	[('CHEBI_52550', 'theopalauamide', 3, 'cholecalciferol'), ('CHEBI_31341', 'calcium dihydroxide', 38, 'Calcium'), ('CHEBI_15956', 'biotin', 72, 'Biotin'), ('UBERON_0002150', 'superior cerebellar peduncle', 133, 'Molybdenum'), ('CHEBI_27568', 'selenium atom', 156, 'Selenium'), ('CHEBI_26536', 'retinoic acid', 282, 'retinol'), ('CHEBI_26536', 'retinoic acid', 314, 'retinol'), ('CHEBI_26536', 'retinoic acid', 333, 'retinol'), ('CHEBI_26536', 'retinoic acid', 356, 'retinol'), ('CHEBI_23042', 'carotene', 388, 'carotene'), ('CHEBI_69514', 'rubinaphthin A methyl ester', 419, 'retinol3'), ('CHEBI_27725', 'butin', 508, 'α-tocopherol'), ('CHEBI_27300', 'vitamin D', 626, 'vitamin E'), ('CHEBI_52550', 'theopalauamide', 680, 'cholecalciferol')]
PMC2151954	10/2007	S175-PMC2151954	['for example, low maternal Vitamin D levels HAVE BEEN ASSOCIATED with altered Birth anthropometry, with SOME STUDIES FINDING an ASSOCIATION between Vitamin D deficiency and larger Birth weight and length [29], WHILE others HAVE SHOWN an ASSOCIATION between lower maternal Vitamin D levels and shorter Gestation and smaller Knee-Heel length (a component of Birth length) [22].']	[('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 127), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 209), ('INCOMPLETE_EVIDENCE', 222), ('SUPERFICIAL_RELATIONSHIP', 236)]	8	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007567', 'parturition', 77, 'birth'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0007567', 'parturition', 179, 'birth'), ('CHEBI_27300', 'vitamin D', 271, 'vitamin D'), ('GO_0007565', 'female pregnancy', 300, 'gestation'), ('UBERON_0001485', 'knee joint', 322, 'knee-heel'), ('GO_0007567', 'parturition', 355, 'birth')]
PMC2290997	4/2008	S16-PMC2290997	['ALTHOUGH most of the health-promoting benefits of sun exposure are THOUGHT TO occur through Vitamin D Photosynthesis, there MAY BE OTHER health benefits that have gone largely OVERLOOKED in the DEBATE over HOW much sun is NEEDED for good health [see “other sun-dependent pathways,” p. a165].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 124), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('INCOMPLETE_EVIDENCE', 176), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 194), ('EXPLICIT_QUESTION', 206), ('IMPORTANT_CONSIDERATION', 222)]	8	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0006654', 'phosphatidic acid biosynthetic process', 102, 'photosynthesis')]
PMC2290997	4/2008	S32-PMC2290997	['in the july 2000 issue of the journal of Human Evolution , california academy of sciences anthropologists nina jablonski and george chaplin wrote that BECAUSE dark skin REQUIRES about five to six times more solar exposure than pale skin for equivalent Vitamin D Photosynthesis, and because the intensity of uvb radiation declines with increasing latitude, one could surmise that skin lightening was an evolutionary adaptation that allowed for optimal survival in low-uvr climes, ASSUMING a traditional diet and outdoor lifestyle.']	[('PROBABLE_UNDERSTANDING', 151), ('IMPORTANT_CONSIDERATION', 169), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 479)]	3	[('NCBITaxon_10088', 'Mus <genus>', 41, 'Human'), ('GO_0006983', 'ER overload response', 47, 'Evolution'), ('CHEBI_27300', 'vitamin D', 252, 'vitamin D'), ('GO_0006654', 'phosphatidic acid biosynthetic process', 262, 'photosynthesis')]
PMC2290997	4/2008	S45-PMC2290997	['NEVERTHELESS, a meta-analysis published in the february 2008 international journal of epidemiology FOUND that high Vitamin D levels reduce the RISK of active tb (i.e., tb showing clinical symptoms) by 32%.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 99), ('IMPORTANT_CONSIDERATION', 143)]	3	[('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC2290997	4/2008	S72-PMC2290997	['for example, there is substantial THOUGH not DEFINITIVE EVIDENCE that high levels of Vitamin D EITHER from diet or from uvr exposure MAY decrease the risk of developing multiple sclerosis (ms).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 45), ('INCOMPLETE_EVIDENCE', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('INCOMPLETE_EVIDENCE', 133)]	5	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC2290997	4/2008	S74-PMC2290997	['STILL to be resolved, HOWEVER, is the QUESTION of WHAT levels of Vitamin D are OPTIMAL for preventing the disease—and WHETHER the statistical ASSOCIATIONS REFLECT DIFFERENT Gene pools RATHER than DIFFERENT levels of 25(Oh)D. (INTERESTINGLY, holick REPORTED in the august 1988 issue of the journal of clinical endocrinology & Metabolism that no previtamin d3formed when Human skin was exposed to sunlight on cloudless days in boston, at 42.2°n, from november through february or in edmonton, at 52°n, from october through march.)']	[('IMPORTANT_CONSIDERATION', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('EXPLICIT_QUESTION', 38), ('EXPLICIT_QUESTION', 50), ('IMPORTANT_CONSIDERATION', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 118), ('EXPLICIT_QUESTION', 118), ('SUPERFICIAL_RELATIONSHIP', 142), ('SUPERFICIAL_RELATIONSHIP', 155), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 163), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 184), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 196), ('ANOMALY_CURIOUS_FINDING', 226), ('INCOMPLETE_EVIDENCE', 248)]	14	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('SO_0000704', 'gene', 173, 'gene'), ('CHEBI_71657', 'versiconol acetate', 216, '25(OH)D'), ('GO_0008152', 'metabolic process', 325, 'Metabolism'), ('NCBITaxon_9606', 'Homo sapiens', 369, 'human')]
PMC2290997	4/2008	S76-PMC2290997	['“NEVERTHELESS, considering the SAFETY of Vitamin D EVEN in high doses, there is NO CLEAR contraindication, and BECAUSE Vitamin D deficiency is very PREVALENT, especially among ms patients, taking Vitamin D supplements and getting moderate sun exposure is more LIKELY to be beneficial than not.”\nas with ms, there APPEARS TO be a latitudinal gradient for type 1 diabetes, with a higher incidence at higher latitudes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 1), ('IMPORTANT_CONSIDERATION', 31), ('ANOMALY_CURIOUS_FINDING', 51), ('FULL_UNKNOWN', 80), ('PROBABLE_UNDERSTANDING', 111), ('IMPORTANT_CONSIDERATION', 148), ('PROBABLE_UNDERSTANDING', 260), ('ANOMALY_CURIOUS_FINDING', 313)]	8	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin D')]
PMC2290997	4/2008	S79-PMC2290997	['and a finnish study published 3 november 2001 in the lancet SHOWED that children who received 2,000 iu Vitamin D per day from 1 year of age on had an 80% decreased risk of developing type 1 diabetes later in Life, WHEREAS children who were Vitamin D deficient had a fourfold increased risk.']	[('INCOMPLETE_EVIDENCE', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 214)]	2	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('UBERON_0000104', 'life cycle', 208, 'life'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D')]
PMC2290997	4/2008	S80-PMC2290997	['researchers are now seeking to understand HOW much uvr/Vitamin D is NEEDED to lower the risk of diabetes and WHETHER this is a FACTOR ONLY in high-risk groups.']	[('EXPLICIT_QUESTION', 42), ('FUTURE_WORK', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 109), ('EXPLICIT_QUESTION', 109), ('SUPERFICIAL_RELATIONSHIP', 127), ('INCOMPLETE_EVIDENCE', 134)]	6	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC2290997	4/2008	S83-PMC2290997	['SOME STUDIES have DEMONSTRATED high prevalence of low Vitamin D levels in People with type 2 diabetes, ALTHOUGH it is NOT CLEAR WHETHER this is a cause of the disease or an EFFECT of another causative FACTOR—for example, lower levels of physical activity (in this case, outdoor activity in particular).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 18), ('ANOMALY_CURIOUS_FINDING', 103), ('FULL_UNKNOWN', 118), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 128), ('SUPERFICIAL_RELATIONSHIP', 173), ('SUPERFICIAL_RELATIONSHIP', 201)]	7	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 74, 'people')]
PMC2290997	4/2008	S101-PMC2290997	['NEVERTHELESS, given the epidemiologic backdrop DESCRIBED above, there are now CALLS to rethink sun exposure policy OR to promote Vitamin D supplementation in HIGHER-RISK populations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 47), ('IMPORTANT_CONSIDERATION', 78), ('IMPORTANT_CONSIDERATION', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115), ('IMPORTANT_CONSIDERATION', 158)]	6	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D')]
PMC2290997	4/2008	S132-PMC2290997	['furthermore, brief, repeated exposures are more efficient at producing Vitamin D. “longer sun exposures cause further sun damage to skin and increase the risk of photo-Aging and skin cancer, BUT do not increase Vitamin D Production,” she explains.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 191)]	1	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 79, 'D'), ('GO_0007568', 'aging', 168, 'aging'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D'), ('GO_0071611', 'granulocyte colony-stimulating factor production', 211, 'vitamin D production')]
PMC2290997	4/2008	S160-PMC2290997	['OTHER sun-dependent pathways\nthe sun MAY BE BEST KNOWN for boosting Production Of Vitamin D, BUT there are many OTHER uvr-MEDIATED EFFECTS independent of this pathway.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 44), ('PROBABLE_UNDERSTANDING', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('SUPERFICIAL_RELATIONSHIP', 122), ('SUPERFICIAL_RELATIONSHIP', 131)]	8	[('GO_0018240', 'protein S-linked glycosylation via cysteine', 68, 'production of vitamin D'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
PMC2290997	4/2008	S192-PMC2290997	['in short, there is no real specificity for ambient uvr.”\nresearchers also ASSESS history of time in the sun at various ages, history of sunburns, dietary and supplemental Vitamin D intake, and OTHER PROXY measures.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 193), ('SUPERFICIAL_RELATIONSHIP', 199)]	3	[('CHEBI_27300', 'vitamin D', 171, 'vitamin D')]
PMC2290997	4/2008	S193-PMC2290997	['NONETHELESS, says lucas, “there are DRAWBACKS to INFERRING that a RELATIONSHIP with any PROXY for the exposure of interest is a RELATIONSHIP with personal uv dose or Vitamin D status.” on the bright side, she adds, our ability to ACCURATELY gauge an Individual’s uv dose history HAS BEEN ENHANCED with the use of silicone rubber casts of the Back of subjects’ Hands.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 36), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 66), ('SUPERFICIAL_RELATIONSHIP', 88), ('SUPERFICIAL_RELATIONSHIP', 128), ('SUPERFICIAL_RELATIONSHIP', 230), ('INCOMPLETE_EVIDENCE', 279), ('FUTURE_WORK', 288)]	9	[('CHEBI_27300', 'vitamin D', 166, 'vitamin D'), ('NCBITaxon_1', 'root', 250, 'individual'), ('UBERON_0001137', 'dorsum', 342, 'back'), ('UBERON_0002398', 'manus', 360, 'hands')]
PMC2396486	6/2008	S133-PMC2396486	['combined with OTHER experimental findings, THE CURRENT STUDY LENDS FURTHER CREDIBILITY to the NOTION that developmental Vitamin D deficiency IMPACTS adversely on normal Brain Development[30].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 43), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 94), ('SUPERFICIAL_RELATIONSHIP', 141)]	5	[('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('GO_0007420', 'brain development', 169, 'brain development'), ('UBERON_0000955', 'brain', 169, 'brain')]
PMC2581757	11/2008	S4-PMC2581757	['THUS, we conclude that the use of Vitamins C and e SHOULD BE CONSIDERED for the Control of certain IMPORTANT biochemical indices during the development of Preeclampsia; HOWEVER, FURTHER STUDIES ARE NEEDED to develop methods for the PREVENTION of Preeclampsia in women at high RISK.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 51), ('FUTURE_WORK', 61), ('IMPORTANT_CONSIDERATION', 61), ('IMPORTANT_CONSIDERATION', 99), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 169), ('FUTURE_WORK', 178), ('FUTURE_WORK', 186), ('SUPERFICIAL_RELATIONSHIP', 232), ('IMPORTANT_CONSIDERATION', 276)]	10	[('CHEBI_27300', 'vitamin D', 34, 'vitamins C'), ('PR_000004900', 'complement C3', 43, 'C'), ('GO_0065007', 'biological regulation', 80, 'control'), ('GO_0007128', 'meiotic prophase I', 155, 'preeclampsia'), ('GO_0007128', 'meiotic prophase I', 246, 'preeclampsia')]
PMC2581757	11/2008	S13-PMC2581757	['HOWEVER, in a recent review, antioxidant therapy HAS BEEN SUGGESTED and that the prophylactic supplementation of Vitamins C and E to Pregnant women is ASSOCIATED with reduced incidence of preeclampsia and decreased Placental and Endothelial dysfunction [9].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 151)]	3	[('CHEBI_27300', 'vitamin D', 113, 'vitamins C'), ('PR_000004900', 'complement C3', 122, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 128, 'E'), ('GO_0007565', 'female pregnancy', 133, 'pregnant'), ('UBERON_0001987', 'placenta', 215, 'placental'), ('UBERON_0001986', 'endothelium', 229, 'endothelial')]
PMC2581757	11/2008	S16-PMC2581757	['THUS, decreased Plasma levels of Vitamin E COULD BE a CONTRIBUTORY FACTOR of hypertension in preeclampsia, BUT OTHER STUDIES have not demonstrated significant differences in Plasma Vitamin E levels between normal and Preeclamptic women [13].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 54), ('SUPERFICIAL_RELATIONSHIP', 67), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 107), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('INCOMPLETE_EVIDENCE', 117)]	7	[('UBERON_0001969', 'blood plasma', 16, 'plasma'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin E'), ('UBERON_0001969', 'blood plasma', 174, 'plasma'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin E'), ('GO_0007565', 'female pregnancy', 217, 'preeclamptic')]
PMC2581757	11/2008	S17-PMC2581757	['moreover, SOME results are at VARIANCE with the PREVAILING OPINION, SINCE increased Plasma levels of Vitamin E among women with Preeclampsia as compared to those in normotensive pregnant women HAVE BEEN REPORTED [14].']	[('INCOMPLETE_EVIDENCE', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 48), ('INCOMPLETE_EVIDENCE', 59), ('PROBABLE_UNDERSTANDING', 68), ('INCOMPLETE_EVIDENCE', 193)]	8	[('UBERON_0001969', 'blood plasma', 84, 'plasma'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin E'), ('GO_0007128', 'meiotic prophase I', 128, 'preeclampsia')]
PMC2581757	11/2008	S36-PMC2581757	['in VIEW of the CONTRADICTORY REPORTS and the SERIOUSNESS of preeclampsia, the PRESENT STUDY included the determination of the activities of catalase, sod, Gpx and Grx in the Blood of normal and Preeclamptic women with and without vitamin treatment, along-with the contents of mda, Gsh, gssg, gssg/Gsh, no and Uric Acid, TO collectively EVALUATE the ROLES of Vitamins C and e in the Regulation of these factors.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 15), ('INCOMPLETE_EVIDENCE', 29), ('IMPORTANT_CONSIDERATION', 45), ('QUESTION_ANSWERED_BY_THIS_WORK', 78), ('QUESTION_ANSWERED_BY_THIS_WORK', 320), ('QUESTION_ANSWERED_BY_THIS_WORK', 336), ('SUPERFICIAL_RELATIONSHIP', 349)]	8	[('PR_000008210', 'glutathione peroxidase 1', 155, 'GPx'), ('PR_000008290', 'eukaryotic peptide chain release factor GTP-binding subunit ERF3A', 163, 'GRx'), ('UBERON_0000178', 'blood', 174, 'blood'), ('GO_0007565', 'female pregnancy', 194, 'preeclamptic'), ('CHEBI_16856', 'glutathione', 281, 'GSH'), ('CHEBI_16856', 'glutathione', 297, 'GSH'), ('CHEBI_27226', 'uric acid', 309, 'uric acid'), ('CHEBI_27300', 'vitamin D', 358, 'vitamins C'), ('GO_0065007', 'biological regulation', 382, 'regulation')]
PMC2581757	11/2008	S170-PMC2581757	['from our results we INFER the positive EFFECT of Vitamins C and E on retaining sod activity during Preeclampsia.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 20), ('SUPERFICIAL_RELATIONSHIP', 39)]	2	[('CHEBI_27300', 'vitamin D', 49, 'vitamins C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 64, 'E'), ('GO_0007128', 'meiotic prophase I', 99, 'preeclampsia')]
PMC2581757	11/2008	S198-PMC2581757	['the activities of antioxidant enzymes were also INFLUENCED by the use of Vitamins C and E. the reduction of sod activity during the development of Preeclampsia was controlled as a CONSEQUENCE of Vitamin consumption: the decrease was FOUND TO BE 14% WHEREAS it was 23% in patients who had not used Vitamins C and E. the most prominent EFFECT of the use of these Vitamins was FOUND TO BE ASSOCIATED with the activity of Glutathione reductase.']	[('SUPERFICIAL_RELATIONSHIP', 48), ('PROBABLE_UNDERSTANDING', 180), ('ANOMALY_CURIOUS_FINDING', 233), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 249), ('SUPERFICIAL_RELATIONSHIP', 334), ('ANOMALY_CURIOUS_FINDING', 374), ('SUPERFICIAL_RELATIONSHIP', 386)]	7	[('CHEBI_27300', 'vitamin D', 73, 'vitamins C'), ('PR_000004900', 'complement C3', 82, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 88, 'E'), ('GO_0007128', 'meiotic prophase I', 147, 'preeclampsia'), ('CHEBI_33229', 'vitamin (role)', 195, 'vitamin'), ('CHEBI_27300', 'vitamin D', 297, 'vitamins C'), ('PR_000004900', 'complement C3', 306, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 312, 'E'), ('CHEBI_33277', 'gamma-tocotrienol', 361, 'vitamins'), ('CHEBI_16856', 'glutathione', 418, 'glutathione')]
PMC2582131	11/2008	S14-PMC2582131	['HOWEVER, the ubiquitous distribution of Intracellular Vitamin D Receptor across diverse Tissues[1]and the EMERGING epidemiological EVIDENCE DOCUMENTING INCREASED RISKS of hypertension[2],[3], Cardiovascular disease[4]–[7], and selected cancers[1],[8]ASSOCIATED with Vitamin D deficiency underscore the pleiotropic actions of Vitamin D. evidence is also accumulating for a ROLE of Vitamin D in maintaining normal Glucose Homeostasis.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 106), ('INCOMPLETE_EVIDENCE', 140), ('IMPORTANT_CONSIDERATION', 152), ('SUPERFICIAL_RELATIONSHIP', 250), ('SUPERFICIAL_RELATIONSHIP', 372)]	6	[('GO_0005622', 'intracellular anatomical structure', 40, 'intracellular'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 54, 'vitamin D receptor'), ('UBERON_0000479', 'tissue', 88, 'tissues'), ('UBERON_0004535', 'cardiovascular system', 192, 'cardiovascular'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 325, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 380, 'vitamin D'), ('CHEBI_17234', 'glucose', 412, 'glucose'), ('GO_0042593', 'glucose homeostasis', 412, 'glucose homeostasis')]
PMC2582131	11/2008	S21-PMC2582131	['data on the ROLE of Vitamin D in Glucose Homeostasis during Pregnancy and the development of Gestational Diabetes Mellitus (gdm) are SCANT and findings are INCONSISTENT.']	[('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 133), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 156)]	3	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_17234', 'glucose', 33, 'glucose'), ('GO_0042593', 'glucose homeostasis', 33, 'glucose homeostasis'), ('GO_0007565', 'female pregnancy', 60, 'pregnancy'), ('GO_0035193', 'larval central nervous system remodeling', 93, 'gestational diabetes mellitus')]
PMC2582131	11/2008	S85-PMC2582131	['the biologically active form of Vitamin D is 1,25-[Oh] D. HOWEVER, 25-[Oh] D is REGARDED AS the BEST INDICATOR of Vitamin D status in the body because it is the substrate for the Renal and Nonrenal Production Of 1,25-[Oh] D and has a longer biological half-life and higher concentrations in circulation than 1,25-[Oh] D. Plasma 25-[Oh] D REFLECTS Vitamin D from both endogenous and exogenous sources.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 58), ('PROBABLE_UNDERSTANDING', 80), ('PROBABLE_UNDERSTANDING', 89), ('IMPORTANT_CONSIDERATION', 96), ('SUPERFICIAL_RELATIONSHIP', 101), ('PROBABLE_UNDERSTANDING', 338), ('SUPERFICIAL_RELATIONSHIP', 338)]	7	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_34300', '2-naphthoyl-CoA', 47, '25-[OH] D'), ('CHEBI_34300', '2-naphthoyl-CoA', 67, '25-[OH] D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0006260', 'DNA replication', 179, 'renal ...'), ('UBERON_0002113', 'kidney', 179, 'renal'), ('UBERON_0000970', 'eye', 189, 'nonrenal'), ('GO_0030164', 'protein denaturation', 198, 'production of ... OH] D'), ('CHEBI_84441', '13(S)-HOTrE', 212, '1,25-[OH] D'), ('CHEBI_34300', '2-naphthoyl-CoA', 310, '25-[OH] D'), ('UBERON_0001969', 'blood plasma', 321, 'Plasma'), ('CHEBI_34300', '2-naphthoyl-CoA', 328, '25-[OH] D'), ('CHEBI_27300', 'vitamin D', 347, 'vitamin D')]
PMC2582131	11/2008	S89-PMC2582131	['first, Vitamin D MAY directly OR indirectly Modulate Pancreatic Β-Cell function and secretion by binding its circulating active form, 1,25-[Oh]D, to Β-Cell Vitamin D receptor and Regulating the balance between the Extracellular and Intracellular Β-Cell calcium pools[12],[30].']	[('INCOMPLETE_EVIDENCE', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30)]	2	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D'), ('GO_0065007', 'biological regulation', 44, 'modulate'), ('CL_0000173', 'pancreatic D cell', 53, 'pancreatic β-cell'), ('UBERON_0001264', 'pancreas', 53, 'pancreatic'), ('CHEBI_84441', '13(S)-HOTrE', 134, '1,25-[OH]D'), ('CL_0000623', 'natural killer cell', 149, 'β-cell'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('GO_0065007', 'biological regulation', 179, 'regulating'), ('GO_0005576', 'extracellular region', 214, 'extracellular'), ('GO_0005622', 'intracellular anatomical structure', 232, 'intracellular'), ('CL_0000623', 'natural killer cell', 246, 'β-cell')]
PMC2582131	11/2008	S92-PMC2582131	['lastly, IT IS POSSIBLE that the OBSERVED inverse ASSOCIATION of Plasma 25-[Oh] D with gdm risk REFLECTS the IMPACT of other components of major endogenous and exogenous sources of Vitamin D on Glucose Homeostasis through OTHER pathways.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 49), ('SUPERFICIAL_RELATIONSHIP', 95), ('SUPERFICIAL_RELATIONSHIP', 108), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221)]	6	[('UBERON_0001969', 'blood plasma', 64, 'plasma'), ('CHEBI_34300', '2-naphthoyl-CoA', 71, '25-[OH] D'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('CHEBI_17234', 'glucose', 193, 'glucose'), ('GO_0042593', 'glucose homeostasis', 193, 'glucose homeostasis')]
PMC2582131	11/2008	S118-PMC2582131	['HOWEVER, DUE TO the PREDISPOSITION of asian, black, and hispanic women for Insulin resistance and Vitamin D deficiency, IT IS POSSIBLE that adequate Vitamin D status MAY BE even more IMPORTANT in these populations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 120), ('INCOMPLETE_EVIDENCE', 166), ('IMPORTANT_CONSIDERATION', 183)]	6	[('PR_000045358', 'insulin family protein', 75, 'insulin'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC2582131	11/2008	S125-PMC2582131	['intervention studies[14],[40]–[44]assessing the EFFECT of Vitamin D and Calcium supplements on Glucose Metabolism among non-Pregnant Individuals have yielded MIXED results, which is AT LEAST PARTLY DUE TO VARIATIONS in the dose of supplementation and the duration of follow up.']	[('SUPERFICIAL_RELATIONSHIP', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158), ('PROBABLE_UNDERSTANDING', 182), ('INCOMPLETE_EVIDENCE', 191), ('PROBLEM_COMPLICATION', 198), ('DIFFICULT_TASK', 205)]	6	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 72, 'calcium'), ('CHEBI_17234', 'glucose', 95, 'glucose'), ('GO_0006006', 'glucose metabolic process', 95, 'glucose metabolism'), ('GO_0007565', 'female pregnancy', 124, 'pregnant'), ('NCBITaxon_1', 'root', 133, 'individuals')]
PMC2582131	11/2008	S127-PMC2582131	['IF CONFIRMED, our data RAISE the POSSIBILITY that treating Vitamin D deficiency in Pregnancy, via supplementation OR lifestyle measures, CAN CONTRIBUTE to the PREVENTION of gdm.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 3), ('EXPLICIT_QUESTION', 23), ('INCOMPLETE_EVIDENCE', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114), ('INCOMPLETE_EVIDENCE', 137), ('SUPERFICIAL_RELATIONSHIP', 141), ('SUPERFICIAL_RELATIONSHIP', 159)]	8	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'pregnancy')]
PMC2606998	6/2007	S73-PMC2606998	['when ASSUMING a 20% UNDERREPORTING before Pregnancy, the RECOMMENDATION for Vitamin\u2009E and iron intake was met, but Intake of Folate, Selenium and Vitamin\u2009D remained below ri for non-Pregnant women.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('PROBLEM_COMPLICATION', 20), ('FUTURE_WORK', 57)]	3	[('GO_0007565', 'female pregnancy', 42, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin E'), ('GO_0007631', 'feeding behavior', 115, 'intake'), ('CHEBI_30863', '5-azaorotic acid', 125, 'folate'), ('CHEBI_27568', 'selenium atom', 133, 'selenium'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('GO_0007565', 'female pregnancy', 182, 'pregnant')]
PMC2606998	6/2007	S126-PMC2606998	['by increasing Intake of Foods with high densities of, for example, Folate and Vitamin\u2009D, RATHER than increasing energy intake in general.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 89)]	1	[('GO_0007631', 'feeding behavior', 14, 'intake'), ('CHEBI_33290', 'food', 24, 'foods'), ('CHEBI_30863', '5-azaorotic acid', 67, 'folate'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC2642759	1/2009	S311-PMC2642759	["[87] evaluated WHETHER combined Antenatal Corticosteroid and Vitamin K administration has a BENEFIT, over and above that of Corticosteroid OR Vitamin K used alone, in reducing the frequency and the degree of Periventricular-Intraventricular haemorrhage (pivh) in premature newborns of less than 35 weeks' Gestation."]	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 15), ('IMPORTANT_CONSIDERATION', 92)]	2	[('GO_0007567', 'parturition', 32, 'antenatal'), ('CHEBI_36916', 'cation', 42, 'corticosteroid'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin K'), ('CHEBI_36916', 'cation', 124, 'corticosteroid'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin K'), ('UBERON_0002281', 'vestibular membrane of cochlear duct', 208, 'periventricular'), ('UBERON_0006250', 'infundibular recess of 3rd ventricle', 224, 'intraventricular'), ('GO_0007565', 'female pregnancy', 305, 'gestation')]
PMC2679409	5/2009	S497-PMC2679409	['conclusion\nthe existence of a cochrane review on the subject and several strong rcts allow us to rate the level of evidence as grade c [96], BUT the AVAILABLE EVIDENCE SUGGESTS no ROLE of Vitamin A in PREVENTING stillbirths.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('INCOMPLETE_EVIDENCE', 149), ('INCOMPLETE_EVIDENCE', 168), ('SUPERFICIAL_RELATIONSHIP', 180), ('SUPERFICIAL_RELATIONSHIP', 201)]	5	[('CHEBI_27300', 'vitamin D', 188, 'vitamin A')]
PMC2685863	5/2009	S14-PMC2685863	['WHEREAS the institute of medicine RECOMMENDS 200 international units of Vitamin D per day (iu/day) for People under age 50, including Pregnant and Lactating women and infants, hollis wrote in the december 2007 issue of the journal of bone and Mineral research that as much as 6,000 iu/day MIGHT be NEEDED to maintain adequate Blood levels of the Vitamin in these populations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 34), ('INCOMPLETE_EVIDENCE', 289), ('FUTURE_WORK', 298), ('IMPORTANT_CONSIDERATION', 298)]	5	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 103, 'people'), ('GO_0007565', 'female pregnancy', 134, 'pregnant'), ('GO_0007594', 'puparial adhesion', 147, 'lactating'), ('CHEBI_46662', 'mineral', 243, 'Mineral'), ('UBERON_0000178', 'blood', 326, 'blood'), ('CHEBI_33229', 'vitamin (role)', 346, 'vitamin')]
PMC2685863	5/2009	S17-PMC2685863	['“many obstetricians are oblivious to their patients’ Vitamin D status and FALSELY ASSUME that the miniscule amount of Vitamin D contained in Prenatal Vitamins will meet the needs of their patients,” hollis says.']	[('PROBLEM_COMPLICATION', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82)]	2	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0007565', 'female pregnancy', 141, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 150, 'vitamins')]
PMC2716336	7/2009	S135-PMC2716336	['HOWEVER, the study population Consumed less Retinol, total Vitamin E and zinc, SOME of which MAY BE EXPLAINED by the lower intake of meat.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 93), ('PROBABLE_UNDERSTANDING', 100)]	4	[('GO_0007631', 'feeding behavior', 30, 'consumed'), ('CHEBI_26536', 'retinoic acid', 44, 'retinol'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin E')]
PMC2716336	7/2009	S161-PMC2716336	['we FOUND that 34% of our subjects failed to meet the ear for Vitamin C, UNLIKE the relatively high percentage of inadequate intake of OTHER Nutrients such as riboflavin, Folate.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 72), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 134)]	3	[('CHEBI_27300', 'vitamin D', 61, 'vitamin C'), ('CHEBI_33284', 'nutrient', 140, 'nutrients'), ('CHEBI_30863', '5-azaorotic acid', 170, 'folate')]
PMC2716336	7/2009	S162-PMC2716336	['HOWEVER, because Vitamin C is Water-soluble and heat labile, RECOMMENDATIONS MUST STRESS the IMPORTANCE of the retention of Vitamin C during Food Preparation and cooking.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 61), ('IMPORTANT_CONSIDERATION', 77), ('IMPORTANT_CONSIDERATION', 93)]	4	[('CHEBI_27300', 'vitamin D', 17, 'vitamin C'), ('CHEBI_15377', 'water', 30, 'water'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin C'), ('CHEBI_33290', 'food', 141, 'food'), ('GO_0007631', 'feeding behavior', 141, 'food preparation')]
PMC2716336	7/2009	S166-PMC2716336	['HOWEVER, significant differences were FOUND in calcium, iron, zinc, riboflavin and Vitamin C intakes across the various subgroups of household wealth.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 38)]	3	[('CHEBI_27300', 'vitamin D', 83, 'vitamin C')]
PMC2722583	1/2009	S122-PMC2722583	['for example, the fact that Prenatal Folate supplementation substantially reduces the risk of Neural Tube defect ONLY IF it is taken Preconceptually is WELL KNOWN BUT improving Vitamin A status before Pregnancy HAS also BEEN SHOWN to have a dramatic and AS YET UNEXPLAINED EFFECT on maternal morbidity and mortality (west et al 1999).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('INCOMPLETE_EVIDENCE', 151), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 162), ('INCOMPLETE_EVIDENCE', 210), ('INCOMPLETE_EVIDENCE', 224), ('INCOMPLETE_EVIDENCE', 253), ('INCOMPLETE_EVIDENCE', 260), ('SUPERFICIAL_RELATIONSHIP', 272)]	8	[('GO_0007565', 'female pregnancy', 27, 'prenatal'), ('CHEBI_30863', '5-azaorotic acid', 36, 'folate'), ('UBERON_0001049', 'neural tube', 93, 'neural tube'), ('GO_0007608', 'sensory perception of smell', 132, 'preconceptually'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin A'), ('GO_0007565', 'female pregnancy', 200, 'pregnancy')]
PMC2779500	11/2009	S39-PMC2779500	['among their OTHER benefits, certain Micronutrients have antioxidant properties: Carotenoids and Vitamins A, C, and e [5].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 12)]	1	[('CHEBI_33839', 'macromolecule', 36, 'micronutrients'), ('CHEBI_50815', 'norgestimate', 80, 'carotenoids'), ('CHEBI_27300', 'vitamin D', 96, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 105, 'A'), ('PR_000004900', 'complement C3', 108, 'C')]
PMC2779500	11/2009	S327-PMC2779500	['this outcome is ANECDOTAL and highly DEPENDENT upon the amount of Vitamin C absorbed; HOWEVER, it ILLUSTRATES the POTENTIAL sensitivity of clinical results to the details of measurement timing.']	[('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('INCOMPLETE_EVIDENCE', 98), ('INCOMPLETE_EVIDENCE', 114)]	5	[('CHEBI_27300', 'vitamin D', 66, 'vitamin C')]
PMC2798111	12/2010	S20-PMC2798111	['the revised statement by the american academy of pediatrics [26] brings forth the QUESTION of WHETHER OR NOT Vitamin D-only preparations are as effective as the time-honored use of infant multivitamin preparations in achieving adequate Vitamin D status in breastfed infants.']	[('EXPLICIT_QUESTION', 82), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 94)]	2	[('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 236, 'vitamin D')]
PMC2798111	12/2010	S23-PMC2798111	['as part of an ongoing Vitamin D supplementation trial of fully Lactating women and their infants, we SOUGHT TO DETERMINE WHETHER a dosing regimen that utilizes an oil emulsion of one drop per day to Deliver 400\u2009iu/day is effective in raising infant 25(Oh)D levels from baseline.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 101), ('QUESTION_ANSWERED_BY_THIS_WORK', 108), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 63, 'lactating'), ('GO_0007567', 'parturition', 199, 'deliver'), ('CHEBI_71657', 'versiconol acetate', 249, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 249, '25(OH)D')]
PMC2798111	12/2010	S95-PMC2798111	['WHILE not powered to assess SAFETY at this juncture, it is IMPORTANT TO NOTE that, thus FAR, there HAVE BEEN no increased rates of infection in the infants or adverse health EFFECTS that COULD BE ATTRIBUTED to Vitamin D supplementation in this cohort.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 28), ('IMPORTANT_CONSIDERATION', 59), ('ANOMALY_CURIOUS_FINDING', 88), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 174), ('INCOMPLETE_EVIDENCE', 187), ('SUPERFICIAL_RELATIONSHIP', 196)]	8	[('CHEBI_27300', 'vitamin D', 210, 'vitamin D')]
PMC2798111	12/2010	S105-PMC2798111	['WHILE prescription of a Vitamin or medication and changes in Blood levels of that vitamin or medication, in this case, Vitamin D does NOT prove direct causality, the change in circulating 25(Oh)D status was INDEPENDENT of season.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 134), ('SUPERFICIAL_RELATIONSHIP', 207)]	3	[('CHEBI_33229', 'vitamin (role)', 24, 'vitamin'), ('UBERON_0000178', 'blood', 61, 'blood'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 188, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 188, '25(OH ... D')]
PMC2821652	2/2010	S20-PMC2821652	['with respect to the more Polar Metabolites of Vitamin D, a SIMILAR (BUT lesser) RELATIONSHIP is OBSERVED between mother and fetus [11].']	[('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 59), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 96)]	5	[('CHEBI_37173', 'silanol', 25, 'polar'), ('CHEBI_25212', 'metabolite', 31, 'metabolites'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC2821652	2/2010	S23-PMC2821652	['THUS, in the Human fetus, Vitamin D Metabolism in all LIKELIHOOD begins with 25(Oh)D. as a result, the nutritional Vitamin D status of the Human fetus/neonate is totally DEPENDENT on the Vitamin D stores of the mother [11]; THUS, IF the mother is hypovitaminotic D, her fetus will experience depleted Vitamin D exposure throughout Gestation [14].']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 54), ('SUPERFICIAL_RELATIONSHIP', 170), ('PROBABLE_UNDERSTANDING', 224), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 230)]	5	[('NCBITaxon_9606', 'Homo sapiens', 13, 'human'), ('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 26, 'vitamin D metabolism'), ('CHEBI_71657', 'versiconol acetate', 77, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 139, 'human'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 263, 'D'), ('CHEBI_27300', 'vitamin D', 301, 'vitamin D'), ('GO_0007565', 'female pregnancy', 331, 'gestation')]
PMC2821652	2/2010	S34-PMC2821652	['WHILE rickets HAS BEEN traditionally THOUGHT TO be the main sequelae of Vitamin D deficiency, numerous OTHER long-latency disease states (such as multiple sclerosis [23–25], rheumatoid arthritis [26–29], type 1 and 2 diabetes [30–34], Cardiovascular disease [35,36], various cancers [37–43], and systemic lupus erythematosus [44], to name BUT a few) as well as acute infections such as Upper Respiratory illnesses [45] and tuberculosis [46,47] are now LINKED with Vitamin D deficiency that are EXPLAINED by alterations in Immune function [47–49].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 339), ('SUPERFICIAL_RELATIONSHIP', 452), ('PROBABLE_UNDERSTANDING', 494)]	7	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 235, 'cardiovascular'), ('UBERON_0001154', 'vermiform appendix', 386, 'upper respiratory'), ('CHEBI_27300', 'vitamin D', 464, 'vitamin D'), ('UBERON_0002405', 'immune system', 522, 'immune')]
PMC2821652	2/2010	S74-PMC2821652	['WHILE there is a MODEL in existence which calculates the predicted change in Serum 25(Oh)D for different doses of Vitamin D supplement, this model was developed using data from men [64], and its applicability to a population of Pregnant females is debatable.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 17)]	2	[('UBERON_0001977', 'blood serum', 77, 'serum'), ('CHEBI_71657', 'versiconol acetate', 83, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 83, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0007565', 'female pregnancy', 228, 'pregnant')]
PMC2821652	2/2010	S77-PMC2821652	["in developing a definition of adherence by Serum 25(Oh)D levels, SEVERAL ASSUMPTIONS were made a priori about WHAT types of PATTERNS of 25(Oh)D levels would be exhibited by adherent and nonadherent patients BASED ON CURRENT KNOWLEDGE about the Metabolism Of Vitamin D.\nassumption 1\nBASED ON KNOWN pharmacokinetics of Vitamin D [64], adherent patients' 25(Oh)D levels would be expected to rise over time, eventually reaching a steady state after 2 months of therapy; nonadherent patients' 25(Oh)D levels would be expected to be erratic and to exhibit variable PATTERNS that would differ significantly from adherent patients' 25(Oh)D levels over the same dosing interval."]	[('INCOMPLETE_EVIDENCE', 65), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 73), ('EXPLICIT_QUESTION', 110), ('SUPERFICIAL_RELATIONSHIP', 124), ('INCOMPLETE_EVIDENCE', 207), ('PROBABLE_UNDERSTANDING', 207), ('SUPERFICIAL_RELATIONSHIP', 207), ('INCOMPLETE_EVIDENCE', 216), ('PROBABLE_UNDERSTANDING', 282), ('SUPERFICIAL_RELATIONSHIP', 282), ('INCOMPLETE_EVIDENCE', 291), ('SUPERFICIAL_RELATIONSHIP', 559)]	12	[('UBERON_0001977', 'blood serum', 43, 'serum'), ('CHEBI_71657', 'versiconol acetate', 49, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 49, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 136, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 142, 'D'), ('GO_0019458', 'methionine catabolic process via 2-oxobutanoate', 244, 'metabolism of vitamin D'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 317, 'vitamin'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 325, 'D'), ('CHEBI_71657', 'versiconol acetate', 352, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 358, 'D'), ('CHEBI_71657', 'versiconol acetate', 488, '25(OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 488, '25'), ('PR_000011614', 'opioid growth factor receptor', 491, 'OH'), ('PR_000006444', 'diacylglycerol kinase delta', 494, 'D'), ('CHEBI_71657', 'versiconol acetate', 624, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 624, '25(OH ... D')]
PMC2821652	2/2010	S119-PMC2821652	['in THIS TRIAL, we SOUGHT TO DETERMINE WHETHER there was a significant ASSOCIATION between adherence to Vitamin D supplementation as measured by pill count and assessment of a NOVEL measure of adherence BASED UPON Serum levels of Vitamin D Metabolites in a Pregnant population.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 38), ('SUPERFICIAL_RELATIONSHIP', 70), ('FULL_UNKNOWN', 175), ('QUESTION_ANSWERED_BY_THIS_WORK', 202), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 208)]	8	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('UBERON_0001977', 'blood serum', 213, 'serum'), ('CHEBI_27300', 'vitamin D', 229, 'vitamin D'), ('CHEBI_25212', 'metabolite', 239, 'metabolites'), ('GO_0007565', 'female pregnancy', 256, 'pregnant')]
PMC2821652	2/2010	S125-PMC2821652	['our analytic technique, HOWEVER, is UNIQUE in that it utilizes the pharmacokinetics of Vitamin D Metabolism to PREDICT adherence, and the data are then compared to pill counts.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('ANOMALY_CURIOUS_FINDING', 36), ('SUPERFICIAL_RELATIONSHIP', 111)]	3	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0008152', 'metabolic process', 97, 'metabolism')]
PMC2841444	2/2010	S11-PMC2841444	['the following are SUPPORTED by moderate- to high-quality evidence and STRONGLY RECOMMENDED for lmics:\n• two INTERVENTIONS PREVENT Preterm Births—smoking cessation and Progesterone\n• eight INTERVENTIONS PREVENT stillbirths—balanced protein energy supplementation, screening and treatment of syphilis, intermittant presumptive treatment for malaria during Pregnancy, Insecticide-treated mosquito nets, Birth preparedness, emergency obstetric care, cesarean section for breech presentation, and elective induction for post-term Delivery\n• eleven INTERVENTIONS improve survival of Preterm newborns—prophylactic Steroids in Preterm labor, Antibiotics for prom, Vitamin K supplementation at Delivery, case management of neonatal sepsis and pneumonia, delayed Cord clamping, room air (vs. 100% oxygen) for resuscitation, hospital-based kangaroo mother care, early breastfeeding, thermal care, and Surfactant therapy and application of continued distending pressure to the Lungs for Respiratory Distress syndrome\n\nconclusion\nthe research paradigm for discovery science and intervention development MUST BE BALANCED to address PREVENTION as well as improve morbidity and mortality in all settings.']	[('INCOMPLETE_EVIDENCE', 18), ('PROBABLE_UNDERSTANDING', 70), ('FUTURE_WORK', 79), ('SUPERFICIAL_RELATIONSHIP', 108), ('SUPERFICIAL_RELATIONSHIP', 122), ('SUPERFICIAL_RELATIONSHIP', 188), ('SUPERFICIAL_RELATIONSHIP', 202), ('SUPERFICIAL_RELATIONSHIP', 543), ('IMPORTANT_CONSIDERATION', 1090), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1098), ('SUPERFICIAL_RELATIONSHIP', 1118)]	11	[('GO_0007565', 'female pregnancy', 130, 'preterm births'), ('CHEBI_17026', 'progesterone', 167, 'progesterone'), ('GO_0007565', 'female pregnancy', 354, 'pregnancy'), ('CHEBI_24852', 'insecticide', 365, 'insecticide'), ('GO_0007567', 'parturition', 400, 'birth'), ('GO_0007567', 'parturition', 525, 'delivery'), ('GO_0007565', 'female pregnancy', 577, 'preterm'), ('CHEBI_35341', 'steroid', 607, 'steroids'), ('GO_0007565', 'female pregnancy', 619, 'preterm'), ('CHEBI_33282', 'antibacterial agent', 634, 'antibiotics'), ('CHEBI_27300', 'vitamin D', 656, 'vitamin K'), ('GO_0007567', 'parturition', 685, 'delivery'), ('UBERON_0002240', 'spinal cord', 753, 'cord'), ('CHEBI_35195', 'surfactant', 890, 'surfactant'), ('UBERON_0002048', 'lung', 965, 'lungs'), ('UBERON_0003495', 'respiratory system arteriole', 975, 'respiratory distress')]
PMC2841444	2/2010	S503-PMC2841444	['DUE TO ethical REASONS RECENT RCTS DID NOT include a placebo group, but compared DIFFERENT treatment modes, using Vitamin K status as the primary outcome.']	[('PROBLEM_COMPLICATION', 0), ('PROBABLE_UNDERSTANDING', 15), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81)]	5	[('CHEBI_27300', 'vitamin D', 114, 'vitamin K')]
PMC2872349	4/2010	S94-PMC2872349	['in developing populations, OFTEN the Nutrient in short supply is Calcium RATHER than Vitamin D: children of mothers, in a mother-offspring cohort study in pune, india [42], who had a higher frequency of Intake of Calcium-rich Foods during Pregnancy had higher total and Lumbar Spine bmc and areal bmd, INDEPENDENT of parental size and bone composition.']	[('PROBABLE_UNDERSTANDING', 27), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 73), ('SUPERFICIAL_RELATIONSHIP', 302)]	3	[('CHEBI_33284', 'nutrient', 37, 'nutrient'), ('CHEBI_22313', 'alkaline earth metal atom', 65, 'calcium'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007631', 'feeding behavior', 203, 'intake'), ('CHEBI_22313', 'alkaline earth metal atom', 213, 'calcium'), ('CHEBI_33290', 'food', 226, 'foods'), ('GO_0007565', 'female pregnancy', 239, 'pregnancy'), ('UBERON_0006074', 'lumbar region of vertebral column', 270, 'lumbar spine')]
PMC2872349	4/2010	S144-PMC2872349	['the maternal Vitamin D in osteoporosis study (mavidos) is a randomized controlled trial TO INVESTIGATE WHETHER supplementation of Vitamin D during Pregnancy serves to optimize offspring Skeletal Development, and commenced recruitment in 2008.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103)]	2	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007565', 'female pregnancy', 147, 'pregnancy'), ('GO_0001501', 'skeletal system development', 186, 'skeletal development'), ('UBERON_0004288', 'skeleton', 186, 'skeletal')]
PMC2873552	4/2010	S129-PMC2873552	['additional CIRCUMSTANTIAL EVIDENCE encouraged us to integrate this "Vitamin D HYPOTHESIS" and population-specific selection.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 78)]	3	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC2873552	4/2010	S137-PMC2873552	['these results are SUGGESTIVE that Vitamin D MIGHT have been INVOLVED in the alteration of risk of disease and abnormal development and CONSEQUENTLY in the Genetic adaptation of modern Humans, BUT validation from FURTHER STUDY IS NECESSARY.']	[('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 60), ('PROBABLE_UNDERSTANDING', 135), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 192), ('FUTURE_WORK', 212), ('FUTURE_WORK', 226), ('FUTURE_WORK', 229)]	8	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('SO_0000704', 'gene', 155, 'genetic'), ('NCBITaxon_9606', 'Homo sapiens', 184, 'humans')]
PMC2874518	6/2010	S111-PMC2874518	['women in our cohort were receiving adequate amounts of these Micronutrients from their diet alone, as assessed by the 24-hour dietary Recall (table 2), confirming the inverse Supplement HYPOTHESIS, that women who least NEED Supplements are most LIKELY to take them.22\nOTHER STUDIES have SUGGESTED POTENTIAL adverse EFFECTS of SOME Supplements, specifically those containing antioxidant Vitamins such as Vitamins C and E, on Pregnancy outcome when taken by women with adequate dietary Micronutrient intake.']	[('INCOMPLETE_EVIDENCE', 186), ('IMPORTANT_CONSIDERATION', 219), ('PROBABLE_UNDERSTANDING', 245), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 268), ('INCOMPLETE_EVIDENCE', 268), ('INCOMPLETE_EVIDENCE', 287), ('INCOMPLETE_EVIDENCE', 297), ('SUPERFICIAL_RELATIONSHIP', 315), ('INCOMPLETE_EVIDENCE', 326)]	9	[('CHEBI_33839', 'macromolecule', 61, 'micronutrients'), ('GO_0060033', 'anatomical structure regression', 134, 'recall'), ('CHEBI_16158', 'steroid sulfate', 175, 'supplement'), ('CHEBI_33341', 'titanium atom', 224, 'supplements'), ('CHEBI_33341', 'titanium atom', 331, 'supplements'), ('CHEBI_33277', 'gamma-tocotrienol', 386, 'vitamins'), ('CHEBI_27300', 'vitamin D', 403, 'vitamins C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 418, 'E'), ('GO_0007565', 'female pregnancy', 424, 'pregnancy'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 484, 'micronutrient')]
PMC2889879	5/2010	S36-PMC2889879	['HOWEVER, TO OUR KNOWLEDGE, NO STUDY has investigated the ASSOCIATION between dietary Intake of fish, Omega-3 and Omega-6 Pufa or Vitamin D and the risk of having positive psychotic symptoms in the general Adult population.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 9), ('FULL_UNKNOWN', 27), ('SUPERFICIAL_RELATIONSHIP', 57)]	4	[('GO_0007631', 'feeding behavior', 85, 'intake'), ('CHEBI_79370', 'ibho#10', 101, 'omega-3'), ('CHEBI_82670', 'ELQ-271', 113, 'omega-6 PUFA'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('UBERON_0007023', 'adult organism', 205, 'adult')]
PMC2889879	5/2010	S95-PMC2889879	['we DECIDED not to include dietary Vitamin D ESTIMATES in the final multivariate MODELS AS fish is a rich source of Vitamin D and COULD account for SOME of the EFFECT of fish on our outcome.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 3), ('INCOMPLETE_EVIDENCE', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 80), ('PROBABLE_UNDERSTANDING', 87), ('INCOMPLETE_EVIDENCE', 129), ('INCOMPLETE_EVIDENCE', 147), ('SUPERFICIAL_RELATIONSHIP', 159)]	7	[('CHEBI_28384', 'vitamin K', 34, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC2889879	5/2010	S125-PMC2889879	['HOWEVER, NONE of these covariates change the ESTIMATES substantially, and was THEREFORE not included in the final multivariate MODEL\ncsum of Eicosapentaenoic Acid (Epa), Docosahexaenoic Acid (Dha) and Docosapentaenoic Acid\ndadjusted for age, total energy intake and dietary intake of Vitamin B12, Alcohol and dietary intake of fat other than Eicosapentaenoic Acid, Docosahexaenoic Acid and Docosapentaenoic Acid\nesum of Arachidonic And Linoleic Acids\nfadjusted for age, total energy intake and dietary intake of Vitamin B12, Alcohol and dietary intake of other than Omega-6 Fatty Acids\ngsum of Eicosapentaenoic Acid (Epa), Docosahexaenoic Acid (Dha), Docosapentaenoic Acid and Α-Linolenic Acid\nhadjusted for age, total energy intake and dietary Intake of Vitamin B12, Alcohol and dietary intake of other than Omega-3 Fatty Acids\nthe intake of Vitamin D was significantly ASSOCIATED with a decreased relative risk of both the middle and high levels of psychotic-like symptoms (table4).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 45), ('PROBABLE_UNDERSTANDING', 78), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 871)]	6	[('CHEBI_36003', 'decenoic acid', 141, 'eicosapentaenoic acid'), ('CHEBI_34733', 'EPN', 164, 'EPA'), ('CHEBI_36003', 'decenoic acid', 170, 'docosahexaenoic acid'), ('CHEBI_17874', 'dihydrozeatin', 192, 'DHA'), ('CHEBI_61205', 'docosatetraenoic acid', 201, 'docosapentaenoic acid'), ('CHEBI_33279', 'vitamin D5', 284, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 284, 'vitamin B12'), ('CHEBI_30879', 'alcohol', 297, 'alcohol'), ('CHEBI_36003', 'decenoic acid', 342, 'eicosapentaenoic acid'), ('CHEBI_36003', 'decenoic acid', 365, 'docosahexaenoic acid'), ('CHEBI_61205', 'docosatetraenoic acid', 390, 'docosapentaenoic acid'), ('CHEBI_36431', 'angelic acid', 420, 'arachidonic and'), ('CHEBI_25048', 'linolenic acid', 436, 'linoleic acids'), ('CHEBI_33279', 'vitamin D5', 512, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 512, 'vitamin B12'), ('CHEBI_30879', 'alcohol', 525, 'alcohol'), ('CHEBI_75862', 'alpha-D-rhamnofuranose', 566, 'omega-6 fatty acids'), ('CHEBI_36003', 'decenoic acid', 594, 'eicosapentaenoic acid'), ('CHEBI_34733', 'EPN', 617, 'EPA'), ('CHEBI_36003', 'decenoic acid', 623, 'docosahexaenoic acid'), ('CHEBI_17874', 'dihydrozeatin', 645, 'DHA'), ('CHEBI_61205', 'docosatetraenoic acid', 651, 'docosapentaenoic acid'), ('CHEBI_86354', '2-hydroxyacrylic acid', 677, 'α-linolenic acid'), ('GO_0007631', 'feeding behavior', 745, 'intake'), ('CHEBI_33279', 'vitamin D5', 755, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 755, 'vitamin B12'), ('CHEBI_30879', 'alcohol', 768, 'alcohol'), ('CHEBI_75862', 'alpha-D-rhamnofuranose', 809, 'omega-3 fatty acids'), ('CHEBI_27300', 'vitamin D', 843, 'vitamin D')]
PMC2889879	5/2010	S138-PMC2889879	['HOWEVER, a SMALL pilot STUDY of maternal Vitamin D levels in archived Prenatal Sera, SHOWED no decrease in Prenatal Vitamin D in subjects who later developed schizophrenia [33].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 85)]	3	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'prenatal'), ('UBERON_0001977', 'blood serum', 79, 'sera'), ('GO_0007565', 'female pregnancy', 107, 'prenatal'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC2889879	5/2010	S141-PMC2889879	['our results of a PROTECTIVE EFFECT of Vitamin D intake MUST BE CONSIDERED AS ROUGH, SINCE we ONLY measure the dietary intake of Vitamin D. a more complete picture of the Vitamin D status COULD have been supplied through Vitamin D levels in Blood; HOWEVER, NO biological samples are AVAILABLE.']	[('SUPERFICIAL_RELATIONSHIP', 17), ('SUPERFICIAL_RELATIONSHIP', 28), ('IMPORTANT_CONSIDERATION', 55), ('IMPORTANT_CONSIDERATION', 63), ('PROBABLE_UNDERSTANDING', 74), ('INCOMPLETE_EVIDENCE', 77), ('PROBLEM_COMPLICATION', 84), ('INCOMPLETE_EVIDENCE', 93), ('INCOMPLETE_EVIDENCE', 187), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 247), ('FULL_UNKNOWN', 256)]	11	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('UBERON_0000178', 'blood', 240, 'blood')]
PMC2889879	5/2010	S142-PMC2889879	['the absorption of dietary Vitamin D is GENERALLY high at all stages of Life [34], BUT Serum levels also depend on the endogenous Production Of Vitamin D due to sun exposure which is subject to seasonal VARIATIONS.']	[('PROBABLE_UNDERSTANDING', 39), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('DIFFICULT_TASK', 202)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('UBERON_0000104', 'life cycle', 71, 'life'), ('UBERON_0001977', 'blood serum', 86, 'serum'), ('GO_0018240', 'protein S-linked glycosylation via cysteine', 129, 'production of vitamin D'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D')]
PMC2889879	5/2010	S146-PMC2889879	['our results of the PROTECTIVE EFFECT of fatty fish COULD IN PART be due to the content of Vitamin D. WHILE the epidemiological EVIDENCE LINKING low Prenatal Vitamin D and schizophrenia REMAINS INCONCLUSIVE, Rodent MODELS have provided COMPELLING EVIDENCE about the ROLE of Vitamin D deficiency for Brain Development like larger lateral volumes [36], subtle Memory dysfunction and altered attention processing [37] which have IMPLICATIONS for neuropsychiatric disorders.']	[('SUPERFICIAL_RELATIONSHIP', 19), ('SUPERFICIAL_RELATIONSHIP', 30), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 101), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 136), ('INCOMPLETE_EVIDENCE', 185), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 193), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 214), ('INCOMPLETE_EVIDENCE', 235), ('SUPERFICIAL_RELATIONSHIP', 265), ('IMPORTANT_CONSIDERATION', 425)]	13	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0007565', 'female pregnancy', 148, 'prenatal'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 207, 'rodent'), ('CHEBI_27300', 'vitamin D', 273, 'vitamin D'), ('GO_0007420', 'brain development', 298, 'brain development'), ('UBERON_0000955', 'brain', 298, 'brain'), ('GO_0007613', 'memory', 357, 'memory')]
PMC2889879	5/2010	S182-PMC2889879	['it is RELEVANT TO NOTE that in sweden low-fat dairy products and Margarines are fortified with Vitamin D. OTHERWISE the dietary intake of Vitamin D WOULD BE lower.']	[('IMPORTANT_CONSIDERATION', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 106), ('FUTURE_PREDICTION', 148)]	3	[('CHEBI_25140', 'maltodextrin', 65, 'margarines'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D')]
PMC2889879	5/2010	S191-PMC2889879	['MISCLASSIFICATION of fish and Pufa or Vitamin D Intake due to measurement ERROR ASSOCIATED with the Food frequency questionnaire is UNAVOIDABLE, BUT GIVEN the study design LIKELY non-differential, and THUS attenuating any TRUE ASSOCIATION.']	[('PROBLEM_COMPLICATION', 0), ('PROBLEM_COMPLICATION', 74), ('SUPERFICIAL_RELATIONSHIP', 80), ('PROBLEM_COMPLICATION', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 145), ('PROBABLE_UNDERSTANDING', 149), ('PROBABLE_UNDERSTANDING', 172), ('PROBABLE_UNDERSTANDING', 201), ('PROBABLE_UNDERSTANDING', 222), ('SUPERFICIAL_RELATIONSHIP', 227)]	10	[('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 30, 'PUFA'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0007631', 'feeding behavior', 48, 'intake'), ('CHEBI_33290', 'food', 100, 'food')]
PMC2889879	5/2010	S197-PMC2889879	['BUT, adjustment for multivitamin supplement intake, containing Vitamin D, did not change the ESTIMATES.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 93)]	2	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC2913107	8/2010	S0-PMC2913107	['on the aetiology of autism\ni have SUGGESTED that the primary environmental TRIGGER for autism is not vaccinations, Toxins or infections, BUT Gestational and early childhood Vitamin D deficiency (1,2).']	[('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137)]	3	[('CHEBI_27026', 'toxin', 115, 'toxins'), ('GO_0007565', 'female pregnancy', 141, 'gestational'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D')]
PMC2913107	8/2010	S1-PMC2913107	['subsequently, the title of an article in scientific american RECENTLY ASKED, ‘WHAT IF Vitamin D deficiency is a cause of autism?’ (3) since then, an ARTICLE on Vitamin D and autism in acta paediatrica (4) and the accompanying COMMENTARY (5) have added to the ACCELERATING SUSPICION that Vitamin D deficiency – EITHER during Pregnancy OR early childhood – MAY BE an environmental TRIGGER for the Genetic disease of autism.']	[('INCOMPLETE_EVIDENCE', 61), ('EXPLICIT_QUESTION', 70), ('EXPLICIT_QUESTION', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('EXPLICIT_QUESTION', 127), ('INCOMPLETE_EVIDENCE', 149), ('INCOMPLETE_EVIDENCE', 226), ('IMPORTANT_CONSIDERATION', 259), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 272), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 310), ('INCOMPLETE_EVIDENCE', 355), ('SUPERFICIAL_RELATIONSHIP', 379)]	12	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin D'), ('GO_0007565', 'female pregnancy', 324, 'pregnancy'), ('SO_0000704', 'gene', 395, 'genetic')]
PMC2913107	8/2010	S10-PMC2913107	['FOR THIS REASON, in 2007, the canadian paediatric society CAUTIONED Pregnant women they MAY REQUIRE NOT 400 iu/day BUT 2000 iu/day, or more, to PREVENT Gestational Vitamin D deficiency (9).']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 58), ('INCOMPLETE_EVIDENCE', 88), ('IMPORTANT_CONSIDERATION', 92), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 100), ('SUPERFICIAL_RELATIONSHIP', 144)]	6	[('GO_0007565', 'female pregnancy', 68, 'pregnant'), ('GO_0007565', 'female pregnancy', 152, 'gestational'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D')]
PMC2913107	8/2010	S15-PMC2913107	['even more INTRIGUING, BOTH PAPERS REPORT that the mental condition in rickets IMPROVED with Vitamin D.\nANOTHER of the MYSTERIES of autism is the APPARENT INCREASED INCIDENCE of autism in the children of richer college-educated parents, ESPECIALLY women, a FINDING announced a few months ago (12).']	[('ANOMALY_CURIOUS_FINDING', 10), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('FULL_UNKNOWN', 118), ('ANOMALY_CURIOUS_FINDING', 145), ('IMPORTANT_CONSIDERATION', 154), ('ANOMALY_CURIOUS_FINDING', 236), ('INCOMPLETE_EVIDENCE', 256)]	11	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC2913107	8/2010	S19-PMC2913107	['IF the Vitamin D THEORY is TRUE, autism SHOULD BE MORE COMMON in richer well-educated mothers, who are more LIKELY THAN other mothers to practice sun avoidance and use sunblock (1,2).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 17), ('PROBABLE_UNDERSTANDING', 27), ('FUTURE_PREDICTION', 40), ('PROBABLE_UNDERSTANDING', 50), ('PROBABLE_UNDERSTANDING', 108), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115)]	7	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D')]
PMC2913107	8/2010	S37-PMC2913107	['WHILE the Omega-3 and mercury content of fish is WELL KNOWN, LESS WELL KNOWN is THE FACT THAT fish is one of the few Foods with SIGNIFICANT amounts of Vitamin D, which, as referenced earlier, PROTECTS the Genome from damage by Toxins.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 49), ('INCOMPLETE_EVIDENCE', 61), ('ANOMALY_CURIOUS_FINDING', 80), ('IMPORTANT_CONSIDERATION', 128), ('SUPERFICIAL_RELATIONSHIP', 192)]	6	[('CHEBI_79370', 'ibho#10', 10, 'omega-3'), ('CHEBI_33290', 'food', 117, 'foods'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('SO_0001026', 'genome', 205, 'genome'), ('CHEBI_27026', 'toxin', 227, 'toxins')]
PMC2913107	8/2010	S42-PMC2913107	['i AGREE WITH dr eyles’ comment that the Vitamin D THEORY is ‘HIGHLY PARSIMONIOUS.’ indeed, it was love of parsimony that led me to first HYPOTHESIZE that Vitamin D is intimately INVOLVED in the pathology and epidemiology of both autism and influenza (21).']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 50), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 61), ('INCOMPLETE_EVIDENCE', 137), ('SUPERFICIAL_RELATIONSHIP', 178)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC2913107	8/2010	S44-PMC2913107	['OBVIOUSLY, ANOTHER, and more PARSIMONIOUS EXPLANATION, is that Vitamin D is INVOLVED in all three.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 29), ('PROBABLE_UNDERSTANDING', 42), ('SUPERFICIAL_RELATIONSHIP', 76)]	5	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC2913107	8/2010	S48-PMC2913107	['IF this THEORY is TRUE, the PATH TOWARDS EFFECTIVE PREVENTION – and PERHAPS a treatment EFFECT IF ADEQUATE physiological doses of Vitamin D are given – is so SIMPLE, so SAFE, so INEXPENSIVE, so READILY AVAILABLE and so easy, that it DEFIES IMAGINATION.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('PROBABLE_UNDERSTANDING', 18), ('FUTURE_WORK', 28), ('SUPERFICIAL_RELATIONSHIP', 41), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 68), ('SUPERFICIAL_RELATIONSHIP', 88), ('IMPORTANT_CONSIDERATION', 95), ('IMPORTANT_CONSIDERATION', 98), ('IMPORTANT_CONSIDERATION', 158), ('IMPORTANT_CONSIDERATION', 169), ('IMPORTANT_CONSIDERATION', 178), ('IMPORTANT_CONSIDERATION', 194), ('ANOMALY_CURIOUS_FINDING', 233)]	15	[('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC2913107	8/2010	S49-PMC2913107	['seventeen Vitamin D EXPERTS RECENTLY STATED, ‘IN OUR OPINION, children with chronic illnesses such as autism, diabetes and/or frequent infections SHOULD BE supplemented with higher doses of sunshine or Vitamin D3, doses ADEQUATE to maintain their 25(Oh)D levels in the mid-normal of the reference range [65 ng/ml (162 nmol/l)] – and SHOULD BE so supplemented year round.’ (22)\nfinally, IF TRUE, a DARKER SIDE of the THEORY EMERGES.']	[('PROBABLE_UNDERSTANDING', 20), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 46), ('IMPORTANT_CONSIDERATION', 146), ('IMPORTANT_CONSIDERATION', 220), ('IMPORTANT_CONSIDERATION', 333), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 386), ('PROBABLE_UNDERSTANDING', 389), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 397), ('INCOMPLETE_EVIDENCE', 416), ('INCOMPLETE_EVIDENCE', 423)]	12	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 202, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 202, 'vitamin D3'), ('CHEBI_71657', 'versiconol acetate', 247, '25(OH)D')]
PMC2963768	10/2010	S2-PMC2963768	['HOWEVER, LIMITED INFORMATION is available on the Vitamin D status of young infants in this region.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9)]	2	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC2963768	10/2010	S13-PMC2963768	['HOWEVER, SINCE Vitamin D status has become READILY estimable BASED on Serum/Plasma 25-Hydroxyvitamin D concentration [25(Oh)D] (2), epidemiologic RESEARCH aimed at identifying PREVIOUSLY-UNCHARACTERIZED AT-risk populations and characterizing NOVEL disease ASSOCIATIONS with Vitamin D status HAS BEEN greatly facilitated.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('PROBABLE_UNDERSTANDING', 43), ('QUESTION_ANSWERED_BY_THIS_WORK', 61), ('FUTURE_WORK', 146), ('INCOMPLETE_EVIDENCE', 176), ('INCOMPLETE_EVIDENCE', 187), ('IMPORTANT_CONSIDERATION', 203), ('FULL_UNKNOWN', 242), ('SUPERFICIAL_RELATIONSHIP', 256), ('INCOMPLETE_EVIDENCE', 291)]	11	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0001977', 'blood serum', 70, 'serum'), ('UBERON_0001969', 'blood plasma', 76, 'plasma'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 83, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 118, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D')]
PMC2963768	10/2010	S51-PMC2963768	['given that the DETERMINANTS of Vitamin D status MAY DIFFER across age-groups, associational analyses were repeated among participants aged less than six months.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 52)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC2963768	10/2010	S84-PMC2963768	['applying a very CONSERVATIVE definition of Vitamin D deficiency [25(Oh)D <25 nmol/l], we ESTIMATED that ABOUT one-third of infants aged 1-6 months MAY BE Vitamin D-deficient.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('INCOMPLETE_EVIDENCE', 89), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 147)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 65, '25(OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 65, '25'), ('PR_000006444', 'diacylglycerol kinase delta', 71, 'D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC2963768	10/2010	S106-PMC2963768	['HOWEVER, these age-DEPENDENT DIFFERENCES MAY HAVE BEEN CONFOUNDED by seasonal timing of Gestation—a younger age IMPLIED that the third trimester COINCIDED with the expected seasonal nadir of Vitamin D Synthesis, when maternal Vitamin D stores MIGHT be relatively depleted and, THUS, when transfer of Vitamin D Metabolites to the foetus MAY have been minimized.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 29), ('INCOMPLETE_EVIDENCE', 41), ('INCOMPLETE_EVIDENCE', 45), ('DIFFICULT_TASK', 55), ('SUPERFICIAL_RELATIONSHIP', 112), ('SUPERFICIAL_RELATIONSHIP', 145), ('INCOMPLETE_EVIDENCE', 243), ('PROBABLE_UNDERSTANDING', 277), ('INCOMPLETE_EVIDENCE', 336)]	11	[('GO_0007565', 'female pregnancy', 88, 'gestation'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 191, 'vitamin D synthesis'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 300, 'vitamin D'), ('CHEBI_25212', 'metabolite', 310, 'metabolites')]
PMC2963768	10/2010	S117-PMC2963768	['SINCE the concentration of Vitamin D Metabolites in Breastmilk is determined by maternal Vitamin D status, maternal Vitamin D deficiency during Lactation MAY cause ongoing deficits in Postnatal infants’ Vitamin D intake (42); YET, maternal FACTORS CANNOT ENTIRELY ACCOUNT for the persistence of low 25(Oh)D among toddlers (table 1) who experience direct exposure to sun and should BE unaffected by the conservative clothing practices of their mothers.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 154), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 226), ('ANOMALY_CURIOUS_FINDING', 226), ('SUPERFICIAL_RELATIONSHIP', 240), ('INCOMPLETE_EVIDENCE', 248), ('IMPORTANT_CONSIDERATION', 264), ('ANOMALY_CURIOUS_FINDING', 381)]	9	[('CHEBI_26871', 'terpene alkaloid', 27, 'vitamin D metabolites'), ('UBERON_0001348', 'brown adipose tissue', 52, 'breastmilk'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007595', 'lactation', 144, 'lactation'), ('GO_0007567', 'parturition', 184, 'postnatal'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 299, '25(OH)D')]
PMC2963768	10/2010	S118-PMC2963768	['THEREFORE, much remains to be learnt about the DETERMINANTS of Vitamin D status throughout infancy and childhood, PARTICULARLY where 25(Oh)D APPEARS DISCREPANT from that which would be expected BASED ON latitude.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 47), ('IMPORTANT_CONSIDERATION', 114), ('ANOMALY_CURIOUS_FINDING', 141), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 149), ('SUPERFICIAL_RELATIONSHIP', 194)]	6	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 133, '25(OH)D')]
PMC2963768	10/2010	S125-PMC2963768	['Vitamin D Receptor, 24-hydroxylase\nDESPITE the current enthusiasm for Vitamin D supplementation in the usa (22), the EFFECTS of Vitamin D deficits during early infancy are STILL NOT FULLY UNDERSTOOD, and meaningful inflection points in 25(Oh)D-outcome RELATIONSHIPS have NOT BEEN ESTABLISHED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('ANOMALY_CURIOUS_FINDING', 35), ('SUPERFICIAL_RELATIONSHIP', 117), ('FULL_UNKNOWN', 172), ('IMPORTANT_CONSIDERATION', 172), ('INCOMPLETE_EVIDENCE', 178), ('SUPERFICIAL_RELATIONSHIP', 252), ('FULL_UNKNOWN', 271), ('ANOMALY_CURIOUS_FINDING', 275)]	9	[('CHEBI_27300', 'vitamin D', 0, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 0, 'vitamin D receptor'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 236, '25(OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 236, '25'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 239, 'OH ... D')]
PMC2963768	10/2010	S134-PMC2963768	['SOME investigators have played down the ROLE of Vitamin D in rickets in bangladesh (10,52), INSTEAD blaming dietary calcium deficits or OTHER Mineral deficiencies or excesses, e.g.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 136)]	4	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('CHEBI_46662', 'mineral', 142, 'mineral')]
PMC2963768	10/2010	S137-PMC2963768	["a PLAUSIBLE HYPOTHESIS is that Vitamin D deficiency ACTS SYNERGISTICALLY with OTHER causes of INADEQUATE bone mineralization and that an Individual's 25(Oh)D concentration below which clinical signs emerge DEPENDS ON the severity and multiplicity of OTHER Genetic and environmental FACTORS."]	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 52), ('SUPERFICIAL_RELATIONSHIP', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 78), ('IMPORTANT_CONSIDERATION', 94), ('SUPERFICIAL_RELATIONSHIP', 206), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 250), ('SUPERFICIAL_RELATIONSHIP', 282)]	9	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('NCBITaxon_1', 'root', 137, 'individual'), ('CHEBI_71657', 'versiconol acetate', 150, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 150, '25 ... OH ... D'), ('SO_0000704', 'gene', 256, 'genetic')]
PMC2963768	10/2010	S142-PMC2963768	['OTHER POSTULATED CONSEQUENCES of Antenatal or infant Vitamin D deficiency include growth faltering (59,60), type 1 diabetes (61), and asthma (62).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('PROBLEM_COMPLICATION', 17)]	3	[('GO_0007567', 'parturition', 33, 'antenatal'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC2963768	10/2010	S143-PMC2963768	['HOWEVER, rigorous studies of the broad health benefits of interventions to improve the Antenatal or Postnatal Vitamin D status in south asian mothers and infants have YET to be REPORTED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 167), ('INCOMPLETE_EVIDENCE', 177)]	3	[('GO_0007567', 'parturition', 87, 'antenatal'), ('GO_0007567', 'parturition', 100, 'postnatal'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC2963768	10/2010	S146-PMC2963768	['selection of control was necessarily non-random from the perspective of age and gender and, thus, UNFORTUNATELY led to an over-representation of boys; however, there is UNLIKELY to be a gender DIFFERENTIAL in Vitamin D status during early infancy (63).']	[('IMPORTANT_CONSIDERATION', 98), ('PROBABLE_UNDERSTANDING', 169), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 193)]	3	[('CHEBI_27300', 'vitamin D', 209, 'vitamin D')]
PMC2996405	11/2010	S0-PMC2996405	['schizophrenia and Vitamin D RELATED Genes COULD have been subject to latitude-driven adaptation\n\nabstract\n\nbackground\nmany natural phenomena are directly OR indirectly RELATED to latitude.']	[('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 42), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 154), ('SUPERFICIAL_RELATIONSHIP', 168)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('SO_0000704', 'gene', 36, 'genes')]
PMC2996405	11/2010	S30-PMC2996405	['the clinal gradation of skin colouration is CORRELATED with uv radiation levels and represents a compromising Solution to the CONFLICTING physiological REQUIREMENTS of Photoprotection and Vitamin D uv-dependent synthesis [13].']	[('SUPERFICIAL_RELATIONSHIP', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 126), ('IMPORTANT_CONSIDERATION', 152)]	3	[('CHEBI_75958', 'solution', 110, 'solution'), ('GO_0006909', 'phagocytosis', 168, 'photoprotection'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D')]
PMC2996405	11/2010	S109-PMC2996405	['we checked WHETHER OR NOT in these 9 Genes belonged Snps, selected by our procedure, that were PREVIOUSLY studied in RELATIONSHIP to either schizophrenia or Vitamin D RELATED phenotypes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('INCOMPLETE_EVIDENCE', 95), ('SUPERFICIAL_RELATIONSHIP', 117), ('SUPERFICIAL_RELATIONSHIP', 167)]	4	[('SO_0000704', 'gene', 37, 'genes'), ('SO_0000694', 'SNP', 52, 'SNPs'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
PMC2996405	11/2010	S152-PMC2996405	['this adaptation process was compulsory, SINCE Pelvic deformities due to Vitamin D deficiency COULD PREVENT normal Childbirth, BUT it is REASONABLE to SUGGEST that also OTHER molecular mechanisms apart from depigmentation COULD HAVE been subject to selective pressure in order to increase the levels of Vitamin D in the body.']	[('PROBABLE_UNDERSTANDING', 40), ('PROBLEM_COMPLICATION', 40), ('INCOMPLETE_EVIDENCE', 93), ('SUPERFICIAL_RELATIONSHIP', 99), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 126), ('PROBABLE_UNDERSTANDING', 136), ('INCOMPLETE_EVIDENCE', 150), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 168), ('INCOMPLETE_EVIDENCE', 221), ('IMPORTANT_CONSIDERATION', 227)]	10	[('UBERON_0002108', 'small intestine', 46, 'pelvic'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007623', 'circadian rhythm', 114, 'childbirth'), ('CHEBI_27300', 'vitamin D', 302, 'vitamin D')]
PMC2996405	11/2010	S155-PMC2996405	['this result MAY SUGGEST that Vitamin D related Genes COULD have been subject, AT LEAST IN PART, to a latitude-DEPENDENT adaptation, SUPPORTING the HYPOTHESIS that selection also ACTED on OTHER mechanisms different from depigmentation.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 53), ('PROBABLE_UNDERSTANDING', 78), ('SUPERFICIAL_RELATIONSHIP', 110), ('INCOMPLETE_EVIDENCE', 132), ('INCOMPLETE_EVIDENCE', 147), ('SUPERFICIAL_RELATIONSHIP', 178), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 187)]	9	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('SO_0000704', 'gene', 47, 'genes')]
PMC2996405	11/2010	S156-PMC2996405	['ON THE OTHER HAND, the RELATIONSHIP between Vitamin D and schizophrenia is WELL ESTABLISHED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 23), ('PROBABLE_UNDERSTANDING', 75), ('INCOMPLETE_EVIDENCE', 80)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC2996405	11/2010	S157-PMC2996405	['Vitamin D receptors were FOUND in most Tissues OTHER than those classically INVOLVED in the Vitamin D action (bone, Gut, Kidney, etc.).']	[('INCOMPLETE_EVIDENCE', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('SUPERFICIAL_RELATIONSHIP', 76)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0000479', 'tissue', 39, 'tissues'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('UBERON_0001555', 'digestive tract', 116, 'gut'), ('UBERON_0002113', 'kidney', 121, 'kidney')]
PMC2996405	11/2010	S163-PMC2996405	['DESPITE the consistence of this RELATIONSHIP, TO OUR KNOWLEDGE studies CONNECTING schizophrenia and Vitamin D at a molecular level are NOT YET AVAILABLE.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 32), ('PROBABLE_UNDERSTANDING', 46), ('SUPERFICIAL_RELATIONSHIP', 71), ('FULL_UNKNOWN', 135), ('FUTURE_WORK', 139)]	7	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC2996405	11/2010	S212-PMC2996405	['as STATED, latitude acts directly OR indirectly, on a WIDE VARIETY of phenomena, THEREFORE it is expected that its EFFECTS are not limited just to Vitamin D and Neural Development.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 54), ('PROBABLE_UNDERSTANDING', 81), ('SUPERFICIAL_RELATIONSHIP', 115)]	5	[('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0007399', 'nervous system development', 161, 'neural development')]
PMC3004407	12/2010	S16-PMC3004407	['RATHER, Vitamin D is now seen as a preprohormone whose active Metabolites act not only to ensure Calcium Homeostasis and bone health [5] but also act as mediators of Immune function in general [6,7], and specific to Pregnancy, play a ROLE in Immune tolerance, Insulin resistance, and Preeclampsia [8–12].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 234)]	2	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('CHEBI_25212', 'metabolite', 62, 'metabolites'), ('GO_0055073', 'cadmium ion homeostasis', 97, 'calcium homeostasis'), ('UBERON_0002405', 'immune system', 166, 'immune'), ('GO_0007565', 'female pregnancy', 216, 'pregnancy'), ('UBERON_0002405', 'immune system', 242, 'immune'), ('PR_000045358', 'insulin family protein', 260, 'insulin'), ('GO_0007128', 'meiotic prophase I', 284, 'preeclampsia')]
PMC3004407	12/2010	S147-PMC3004407	['this is concerning in that the EFFECTS of Vitamin D deficiency among Pregnancy women are not limited to the women: IF a mother has Vitamin D insufficiency, or worse, deficiency, her fetus is developing in a hypovitaminotic state.']	[('SUPERFICIAL_RELATIONSHIP', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0007565', 'female pregnancy', 69, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC3032617	5/2010	S17-PMC3032617	['HOWEVER, Plasma concentrations fall to around 11µmol/l EVEN when dietary Vitamin C is between 10 and 20mg/day [6].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 55)]	3	[('UBERON_0001969', 'blood plasma', 9, 'plasma'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin C')]
PMC3032617	5/2010	S27-PMC3032617	['ON THE OTHER HAND, Oxalate is an end product of Ascorbate Catabolism and plays an IMPORTANT ROLE in Kidney Stone Formation, so excessive daily amounts of Vitamin C such as Intakes higher than 1g/day are shown to produce hyperoxaluria [1].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 82), ('SUPERFICIAL_RELATIONSHIP', 92)]	3	[('CHEBI_16162', 'o-orsellinate', 19, 'oxalate'), ('CHEBI_22651', 'ascorbate', 48, 'ascorbate'), ('GO_0009056', 'catabolic process', 58, 'catabolism'), ('GO_0016255', 'attachment of GPI anchor to protein', 100, 'kidney'), ('UBERON_0003460', 'arm bone', 100, 'kidney stone'), ('GO_0009057', 'macromolecule catabolic process', 113, 'formation'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin C'), ('GO_0007631', 'feeding behavior', 172, 'intakes')]
PMC3032617	5/2010	S30-PMC3032617	['SEVERAL randomized placebo controlled STUDIES have ATTEMPTED to repeat pauling’s experience with INCONSISTENT and variable results which to date can not provide a definite conclusion around the real extent of overall health BENEFIT brought in by Vitamin C high daily intake [16-18].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 38), ('DIFFICULT_TASK', 51), ('INCOMPLETE_EVIDENCE', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 97), ('IMPORTANT_CONSIDERATION', 224)]	6	[('CHEBI_27300', 'vitamin D', 246, 'vitamin C')]
PMC3032617	5/2010	S60-PMC3032617	['we HYPOTHESIZED to record at least 30% of women not hospitalized during Pregnancy in the control group in consideration of the fact they were supplemented regularly throughout their Pregnancy with Ferrous, Folic Acid and b-Complex for anemia prevention, also followed-up every month, ON THE OTHER SIDE at least a 50% of women not hospitalized in the group of women supplemented with Vitamin C in a 1:1 randomized ratio.']	[('INCOMPLETE_EVIDENCE', 3), ('DIFFICULT_TASK', 223), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 284)]	3	[('GO_0007565', 'female pregnancy', 72, 'pregnancy'), ('GO_0007565', 'female pregnancy', 182, 'pregnancy'), ('CHEBI_15378', 'hydron', 197, 'ferrous'), ('CHEBI_30751', 'formic acid', 206, 'folic acid'), ('CHEBI_34652', 'compactin diol lactone', 223, 'complex'), ('GO_0032991', 'protein-containing complex', 223, 'complex'), ('CHEBI_27300', 'vitamin D', 383, 'vitamin C')]
PMC3032617	5/2010	S102-PMC3032617	['INTERESTINGLY, ALTHOUGH the average weight gain was normal in the two groups during Pregnancy without any significant statistical difference, this was FOUND lower in the Vitamin C group COMPARED TO controls, and this COULD SUGGEST the POSSIBILITY of a better Fatty Acid Catabolism provided by high dose Vitamin C intake which IS KNOWN to enhance Carnitine synthesis, a fundamental long chain Fatty Acid transporter to the Mitochondrial site for energy production in form of atp, also, Ascorbic Acid is INVOLVED in the biosynthetic pathway of Thyroid hormones which are known regulators of the basal Metabolism.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 15), ('INCOMPLETE_EVIDENCE', 151), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 186), ('INCOMPLETE_EVIDENCE', 217), ('INCOMPLETE_EVIDENCE', 223), ('INCOMPLETE_EVIDENCE', 235), ('INCOMPLETE_EVIDENCE', 326), ('SUPERFICIAL_RELATIONSHIP', 502)]	9	[('GO_0007565', 'female pregnancy', 84, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin C'), ('CHEBI_35366', 'fatty acid', 259, 'fatty acid'), ('GO_0009062', 'fatty acid catabolic process', 259, 'fatty acid catabolism'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin C'), ('CHEBI_17126', 'carnitine', 346, 'carnitine'), ('GO_0015915', 'fatty-acyl group transport', 392, 'fatty acid'), ('GO_0005739', 'mitochondrion', 422, 'mitochondrial'), ('CHEBI_22652', 'ascorbic acid', 485, 'ascorbic acid'), ('CHEBI_9437', 'temoporfin', 542, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 542, 'thyroid'), ('GO_0008152', 'metabolic process', 599, 'metabolism')]
PMC3032617	5/2010	S112-PMC3032617	['the choice of dosing the Vitamin C supplement 400mg daily matured after reviewing the medical literature were it was HIGHLIGHTED that at doses exceeding 1g daily the PROBABILITY of side-effects such as diarrhea and Renal colic increased greatly [1,3,13,14] on the OTHER side doses up to 500 mg daily are advised by the official statement of the linus pauling’s institute to the general population, this led us to choose this dose as the SAFEST.']	[('INCOMPLETE_EVIDENCE', 117), ('PROBABLE_UNDERSTANDING', 166), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 264), ('IMPORTANT_CONSIDERATION', 437)]	4	[('CHEBI_27300', 'vitamin D', 25, 'vitamin C'), ('UBERON_0002113', 'kidney', 215, 'renal')]
PMC3034879	12/2010	S10-PMC3034879	['DESPITE DISCREPANT S-25-Ohd at baseline (median 36.3 vs. 52.5\xa0nmol/l, p \u2009<\u20090.001), the values at 14\xa0months were SIMILAR (63 vs. 66\xa0nmol/l, p \u2009=\u20090.58) in low d and high d. Serum 25-ohd increased more in low D ( p \u2009<\u20090.001) DESPITE SIMILAR total intake of Vitamin D (mean 12.3\xa0μg/day).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 8), ('SUPERFICIAL_RELATIONSHIP', 112), ('ANOMALY_CURIOUS_FINDING', 222), ('SUPERFICIAL_RELATIONSHIP', 230)]	5	[('CHEBI_16786', 'vestitone', 19, 'S-'), ('1', 'A1BG (human)', 20, '-'), ('CHEBI_72765', 'verruculogen', 21, '25-OHD'), ('UBERON_0001977', 'blood serum', 171, 'Serum'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 206, 'D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D')]
PMC3034879	12/2010	S30-PMC3034879	['the first was to follow WHETHER the Vitamin D-ASSOCIATED Skeletal EFFECTS observed at Birth persist during the first year of Life, and the second was TO EVALUATE the IMPACT of Postnatal Vitamin D status on bone growth and development in early infancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('SUPERFICIAL_RELATIONSHIP', 46), ('SUPERFICIAL_RELATIONSHIP', 66), ('QUESTION_ANSWERED_BY_THIS_WORK', 150), ('SUPERFICIAL_RELATIONSHIP', 166)]	5	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0004288', 'skeleton', 57, 'skeletal'), ('GO_0007567', 'parturition', 86, 'birth'), ('UBERON_0000104', 'life cycle', 125, 'life'), ('GO_0007567', 'parturition', 176, 'postnatal'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D')]
PMC3034879	12/2010	S180-PMC3034879	['HOWEVER, the number of d3users was very low ( n \u2009=\u200912), which MEANS that FURTHER comparison between DIFFERENT forms of Vitamin D is not justified.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 62), ('FUTURE_WORK', 73), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 100)]	4	[('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
PMC3034879	12/2010	S185-PMC3034879	['the study SHOWS that fetal Vitamin D status, RATHER than Postnatal Vitamin D status, AFFECTS bone growth during the first year.']	[('INCOMPLETE_EVIDENCE', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 45), ('SUPERFICIAL_RELATIONSHIP', 85)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007567', 'parturition', 57, 'postnatal'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC3034879	12/2010	S186-PMC3034879	['ON THE OTHER HAND, S-25-Ohd REFLECTS relatively short-term accumulation of dietary Vitamin D and solar exposure [41], WHEREAS observing DIFFERENCES in bone VARIABLES takes more time.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 118), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 136), ('SUPERFICIAL_RELATIONSHIP', 156)]	5	[('CHEBI_86929', 'S b G-5,5-G b S A CH2', 19, 'S-25-OHD'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
PMC3034879	12/2010	S198-PMC3034879	['HOWEVER, the strength of THIS STUDY was a prospective study design with Antenatal Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 25)]	2	[('GO_0007567', 'parturition', 72, 'antenatal'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
PMC3061267	2/2011	S5-PMC3061267	['it is UNCLEAR WHETHER maternal Vitamin A supplementation will LEAD TO improved health outcomes for mother OR child.']	[('FULL_UNKNOWN', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('SUPERFICIAL_RELATIONSHIP', 62)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin A')]
PMC3061267	2/2011	S40-PMC3061267	['WHILE DEFICIENCIES of several Nutrients besides iron CAN cause anemia, and SOME Nutrients like Vitamin A are OFTEN LINKED to iron status, a RECENT review FOUND no greater IMPACT of a multimicronutrient supplement on iron status THAN supplementing with iron alone [17].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 6), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 75), ('PROBABLE_UNDERSTANDING', 109), ('SUPERFICIAL_RELATIONSHIP', 115), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 154), ('SUPERFICIAL_RELATIONSHIP', 171), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 228)]	10	[('CHEBI_33284', 'nutrient', 30, 'nutrients'), ('CHEBI_33284', 'nutrient', 80, 'nutrients'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin A')]
PMC3061267	2/2011	S50-PMC3061267	['LATER trials within less Vitamin A deficient populations in bangladesh [23] and ghana [24] FAILED TO FIND any IMPACT.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 91), ('DIFFICULT_TASK', 91), ('SUPERFICIAL_RELATIONSHIP', 110)]	5	[('CHEBI_27300', 'vitamin D', 25, 'vitamin A')]
PMC3075531	7/2010	S8-PMC3075531	['also, OUR STUDY SHOWED significant DISCREPANCY between the two groups ACCORDING TO the rate of deficiency, insufficiency and normal range of Vitamin D categories (p=0.021).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('INCOMPLETE_EVIDENCE', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('SUPERFICIAL_RELATIONSHIP', 70)]	4	[('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC3075531	7/2010	S10-PMC3075531	['introduction\nmultiple sclerosis (ms) is a chronic PROBABLY with Autoimmune basis and UNCERTAIN etiology characterized by Demyelinative and inflammatory physiopathology causing Axonal damages.12this disease AFFECTS females more than males with ordinary 10 years Relapsing-remitting course and secondary progressive phase.2on histological basis, T Helper Cells type 1 (th1) is the MOST RESPONSIBLE cause for pathologies SEEN in ms.1–3there are multiple RISK FACTORS for ms in a COMPLEX RELATIONSHIP with each other from Genetic ones to environmental FACTORS BUT exact mechanism leading to ms has REMAINED UNCLEAR yet.45from GUESSED environmental RISK FACTORS for ms, past infection with Ebv, smoking and low Serum level of Vitamin D are more favorable.67the MOST IMPORTANT Vitamin in calcium and Phosphor Homeostasis is Vitamin D. this Vitamin has PROPOSED POTENTIAL power for Modulating Immune System.48this is achieved via enhancing the Phagocytic function of Monocytes9And decreasing the secretion of Il-6, Il-12, Tnf-Α and Pge2 by Monocytes.10also, immature or semi mature Apc’S cannot mature in presence of 1,25 (Oh)2D.8MANY STUDIES SHOWED a ROLE of paracrine function and Nerve Growth Factor Synthesis Of Vitamin D in Cns and also, SHOWED that deficiency of this Vitamin in Pregnancy Period CAN cause Neural System disorder in Animal cases.811–14then, Vitamin D has a near RELATION with ms and the results of DIFFERENT studies can be summarized as follows: first, the EFFECT of latitude via exposure to sun light and Serum level of Vitamin D on ms prevalence, that increases with distance from equator, with ONLY one EXCEPTION in norway.23815second, vander et al.']	[('PROBABLE_UNDERSTANDING', 50), ('FULL_UNKNOWN', 85), ('SUPERFICIAL_RELATIONSHIP', 206), ('PROBABLE_UNDERSTANDING', 379), ('PROBABLE_UNDERSTANDING', 384), ('INCOMPLETE_EVIDENCE', 418), ('SUPERFICIAL_RELATIONSHIP', 451), ('DIFFICULT_TASK', 476), ('SUPERFICIAL_RELATIONSHIP', 484), ('SUPERFICIAL_RELATIONSHIP', 548), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 556), ('INCOMPLETE_EVIDENCE', 594), ('FULL_UNKNOWN', 603), ('INCOMPLETE_EVIDENCE', 622), ('SUPERFICIAL_RELATIONSHIP', 644), ('PROBABLE_UNDERSTANDING', 756), ('IMPORTANT_CONSIDERATION', 761), ('INCOMPLETE_EVIDENCE', 846), ('INCOMPLETE_EVIDENCE', 855), ('INCOMPLETE_EVIDENCE', 1123), ('INCOMPLETE_EVIDENCE', 1136), ('SUPERFICIAL_RELATIONSHIP', 1145), ('INCOMPLETE_EVIDENCE', 1236), ('INCOMPLETE_EVIDENCE', 1295), ('SUPERFICIAL_RELATIONSHIP', 1377), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1413), ('SUPERFICIAL_RELATIONSHIP', 1472), ('ANOMALY_CURIOUS_FINDING', 1612), ('ANOMALY_CURIOUS_FINDING', 1621)]	29	[('UBERON_0001442', 'skeleton of manus', 64, 'autoimmune'), ('GO_0006188', 'IMP biosynthetic process', 121, 'demyelinative'), ('GO_0030424', 'axon', 176, 'axonal'), ('GO_0065007', 'biological regulation', 261, 'relapsing'), ('CL_0000545', 'T-helper 1 cell', 344, 'T helper cells'), ('SO_0000704', 'gene', 518, 'genetic'), ('NCBITaxon_10088', 'Mus <genus>', 685, 'EBV'), ('UBERON_0001977', 'blood serum', 706, 'serum'), ('CHEBI_27300', 'vitamin D', 721, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 771, 'vitamin'), ('CHEBI_30215', 'muonide', 794, 'phosphor'), ('GO_0042592', 'homeostatic process', 803, 'homeostasis'), ('CHEBI_27300', 'vitamin D', 818, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 834, 'vitamin'), ('GO_0065007', 'biological regulation', 875, 'modulating'), ('UBERON_0002405', 'immune system', 886, 'immune system'), ('GO_0006909', 'phagocytosis', 937, 'phagocytic'), ('CL_0002198', 'oncocyte', 960, 'monocytes9and'), ('PR_000001470', 'interleukin-28B', 1002, 'IL-6'), ('PR_000001470', 'interleukin-28B', 1008, 'IL-12'), ('PR_000000134', 'tumor necrosis factor alpha', 1015, 'TNF-α'), ('PR_000012560', 'peroxisomal membrane protein PEX14', 1025, 'PGE2'), ('CL_0000576', 'monocyte', 1033, 'monocytes'), ('PR_000004122', 'adenomatous polyposis coli protein', 1075, 'APC'), ('PR_000011000', 'N-alpha-acetyltransferase 60', 1079, 's'), ('CHEBI_82784', 'PVP38-Ag NP', 1110, '1,25 (OH)2D'), ('UBERON_0001021', 'nerve', 1176, 'nerve'), ('GO_0040007', 'growth', 1182, 'growth factor'), ('GO_0030474', 'spindle pole body duplication', 1196, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 1209, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 1222, 'CNS'), ('CHEBI_33229', 'vitamin (role)', 1267, 'vitamin'), ('GO_0007565', 'female pregnancy', 1278, 'pregnancy'), ('UBERON_0018298', 'stylocone', 1278, 'pregnancy period'), ('UBERON_0023879', 'neural system', 1305, 'neural system'), ('NCBITaxon_33208', 'Metazoa', 1331, 'animal'), ('CHEBI_27300', 'vitamin D', 1356, 'vitamin D'), ('UBERON_0001977', 'blood serum', 1521, 'serum'), ('CHEBI_27300', 'vitamin D', 1536, 'vitamin D')]
PMC3075531	7/2010	S11-PMC3075531	['SHOWED that sun exposure in Childhood period PREVENTS from ms.16third, it SEEMS low risk of ms in white population is ASSOCIATED with high Serum level of vitamin d or high oral Intake via supplements or oily fish in SOME STUDIES.217–19fourth, it HAVE BEEN SHOWN that Vitamin D CAN be a PROTECTIVE agent against experimental Autoimmune encephalitis in Mice (like ms in Humans).48finally, some scientists administered 100-1700 iu/day Vitamin D supplements in ms patients and OBSERVED the reduction of relapses.20–22the CANDIDATE for estimating Serum level of Vitamin D is 25-Hydroxy Vitamin D, BECAUSE of its prolonged half-Life.823–25it is used to assess an Individual’s overall Vitamin D nutritional status, BECAUSE its formation, UNLIKE that of 1, 25-Dihydroxy Vitamin D, is not tightly Regulated and it has a relatively long half-life (20-60 days).']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 45), ('ANOMALY_CURIOUS_FINDING', 74), ('SUPERFICIAL_RELATIONSHIP', 118), ('INCOMPLETE_EVIDENCE', 216), ('INCOMPLETE_EVIDENCE', 246), ('INCOMPLETE_EVIDENCE', 277), ('SUPERFICIAL_RELATIONSHIP', 286), ('INCOMPLETE_EVIDENCE', 473), ('INCOMPLETE_EVIDENCE', 517), ('PROBABLE_UNDERSTANDING', 592), ('PROBABLE_UNDERSTANDING', 708), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 731)]	13	[('UBERON_0013628', 'pollical pad', 28, 'childhood'), ('UBERON_0001977', 'blood serum', 139, 'serum'), ('GO_0007631', 'feeding behavior', 177, 'intake'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 324, 'autoimmune'), ('NCBITaxon_10088', 'Mus <genus>', 351, 'mice'), ('NCBITaxon_9606', 'Homo sapiens', 368, 'humans'), ('CHEBI_27300', 'vitamin D', 432, 'vitamin D'), ('UBERON_0001977', 'blood serum', 542, 'serum'), ('CHEBI_27300', 'vitamin D', 557, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 570, '25-hydroxy vitamin D'), ('UBERON_0000104', 'life cycle', 622, 'life'), ('NCBITaxon_1', 'root', 657, 'individual'), ('CHEBI_27300', 'vitamin D', 678, 'vitamin D'), ('CHEBI_43176', 'hydroxy group', 752, 'dihydroxy'), ('CHEBI_27300', 'vitamin D', 762, 'vitamin D'), ('GO_0065007', 'biological regulation', 788, 'regulated')]
PMC3075531	7/2010	S12-PMC3075531	['there are DIFFERENCES in OPTIMAL level of 25-Hydroxy Vitamin D BUT nowadays internationally ACCEPTED normal range is between 75 nmol/l and 200 nmol/l, and we CONSIDER Serum level below 75 nmol/l and below 2 nmol/l as insufficiency and deficiency, respectively.42325even it SEEMS to achieve the prevention of Autoimmune diseases, the Serum level of Vitamin D MUST BE higher than the level required to reduce osteoporosis (higher than 75 nmol/l).4in attention to high prevalence of ms in iran and especially in isfahan which is ABOUT 43.5/100,0002627and GIVEN that iran is located in an latitude of 32° 50’ and longitude of 51° 43’ with enough sun exposure and BECAUSE nobody INVESTIGATED the RELATIONSHIP between Vitamin D, AS an environmental agent, and ms disease in iran before, we DECIDED to compare the Serum level of 25-Hydroxy Vitamin D in ms patients and healthy control group in isfahan region.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('IMPORTANT_CONSIDERATION', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63), ('INCOMPLETE_EVIDENCE', 92), ('INCOMPLETE_EVIDENCE', 158), ('ANOMALY_CURIOUS_FINDING', 273), ('IMPORTANT_CONSIDERATION', 358), ('INCOMPLETE_EVIDENCE', 526), ('PROBABLE_UNDERSTANDING', 552), ('PROBABLE_UNDERSTANDING', 659), ('QUESTION_ANSWERED_BY_THIS_WORK', 674), ('SUPERFICIAL_RELATIONSHIP', 691), ('PROBABLE_UNDERSTANDING', 723), ('QUESTION_ANSWERED_BY_THIS_WORK', 784)]	14	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 42, '25-hydroxy vitamin D'), ('UBERON_0001977', 'blood serum', 167, 'serum'), ('UBERON_0001442', 'skeleton of manus', 308, 'autoimmune'), ('UBERON_0001977', 'blood serum', 333, 'serum'), ('CHEBI_27300', 'vitamin D', 348, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 712, 'vitamin D'), ('UBERON_0001977', 'blood serum', 807, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 822, '25-hydroxy vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 841, 'D')]
PMC3075531	7/2010	S43-PMC3075531	['relative to sun exposure, diet is a POOR source of Colecalciferol, providing ONLY 40-400 iu per Food serving,12WHEREAS whole-body uvb exposure for 20 min for a light-skinned Person during the summer months will produce AT LEAST 10,000 iu.713HOWEVER, increased skin pigmentation, age, use of sunscreen, built environment, and environmental FACTORS that reduce the strength of uvb reaching the earth’s surface (e.g., winter season, high latitude, pollution, cloud cover, and Ozone levels) all CONTRIBUTE to reduce skin Colecalciferol production to the point at which diet MIGHT become the primary source.7–14BECAUSE Melanin Pigment in Human skin absorbs uvb,28black People have lower 25 Hydroxyvitamin D concentrations than white People, and are OFTEN Vitamin D deficient.21HOWEVER, the risk of ms in black People is lower than in white People (BECAUSE of Genetic differences).28analyses of the RELATION between Vitamin D status and ms risk are THEREFORE BETTER done separately within each race/ethnic group.']	[('IMPORTANT_CONSIDERATION', 36), ('ANOMALY_CURIOUS_FINDING', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('PROBABLE_UNDERSTANDING', 219), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 241), ('SUPERFICIAL_RELATIONSHIP', 339), ('SUPERFICIAL_RELATIONSHIP', 491), ('INCOMPLETE_EVIDENCE', 570), ('PROBABLE_UNDERSTANDING', 606), ('PROBABLE_UNDERSTANDING', 744), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 772), ('PROBABLE_UNDERSTANDING', 843), ('SUPERFICIAL_RELATIONSHIP', 893), ('PROBABLE_UNDERSTANDING', 943), ('IMPORTANT_CONSIDERATION', 953)]	15	[('CHEBI_50553', 'mancude carbobicyclic parent', 51, 'colecalciferol'), ('CHEBI_33290', 'food', 96, 'food'), ('NCBITaxon_10088', 'Mus <genus>', 174, 'person'), ('CHEBI_25812', 'ozone', 473, 'ozone'), ('CHEBI_50553', 'mancude carbobicyclic parent', 517, 'colecalciferol'), ('CHEBI_25179', 'melanins', 614, 'melanin'), ('CHEBI_26130', 'biological pigment', 622, 'pigment'), ('NCBITaxon_9606', 'Homo sapiens', 633, 'human'), ('NCBITaxon_10088', 'Mus <genus>', 664, 'people'), ('CHEBI_67828', 'rel-(3aR,4S,6aS,7R,9aR,10aS)-10a-Hydroxy-7-isopropyl-1,4,9a-trimethyl-4,5,6,6a,7,8,9,9a,10,10a-decahydro-3aH-dicyclopenta[a,d]cycloocten-3-one', 682, '25 hydroxyvitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 728, 'people'), ('CHEBI_27300', 'vitamin D', 750, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 805, 'people'), ('NCBITaxon_10088', 'Mus <genus>', 835, 'people'), ('SO_0000704', 'gene', 854, 'genetic'), ('CHEBI_27300', 'vitamin D', 910, 'vitamin D')]
PMC3075531	7/2010	S58-PMC3075531	['THEREFORE, Genetic variations in Vitamin-D-related Genes MIGHT also AFFECT ms risk, EITHER directly OR by modifying the EFFECTS of Vitamin D.40\nour IMPLICATIONS for FUTURE RESEARCH and ms prevention and ACCORDING TO the basis of the results of the ONLY longitudinal study of Serum 25-Hydroxyvitamin D and ms onset,18and ASSUM-ING that these results are unbiased and Vitamin D is TRULY PROTECTIVE against ms, over 70% of ms cases in the usa and europe COULD BE PREVENTED by increasing the Serum 25-Hydroxyvitamin D concentration of adolescents and young Adults to above 100 nmol/l.4142these concentrations are commonly FOUND ONLY in Individuals with outdoor lifestyles in sunny regions, BUT COULD BE reached in MOST People by taking 1000-4000 iu Colecalciferol daily.8254344ALTHOUGH these doses are LARGELY CONSIDERED SAFE and POTENTIALLY beneficial for other outcomes,819CONFIRMATION of SAFETY and efficacy in a LARGE randomized TRIAL is NEEDED before making general RECOMMENDATIONS.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 84), ('SUPERFICIAL_RELATIONSHIP', 120), ('IMPORTANT_CONSIDERATION', 148), ('FUTURE_WORK', 165), ('INCOMPLETE_EVIDENCE', 203), ('INCOMPLETE_EVIDENCE', 248), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 320), ('PROBABLE_UNDERSTANDING', 379), ('SUPERFICIAL_RELATIONSHIP', 385), ('INCOMPLETE_EVIDENCE', 451), ('SUPERFICIAL_RELATIONSHIP', 460), ('INCOMPLETE_EVIDENCE', 618), ('ANOMALY_CURIOUS_FINDING', 624), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 686), ('INCOMPLETE_EVIDENCE', 690), ('PROBABLE_UNDERSTANDING', 710), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 773), ('INCOMPLETE_EVIDENCE', 798), ('INCOMPLETE_EVIDENCE', 806), ('IMPORTANT_CONSIDERATION', 817), ('INCOMPLETE_EVIDENCE', 826), ('INCOMPLETE_EVIDENCE', 871), ('IMPORTANT_CONSIDERATION', 887), ('INCOMPLETE_EVIDENCE', 912), ('FUTURE_WORK', 938), ('FUTURE_WORK', 967)]	29	[('SO_0000704', 'gene', 11, 'genetic'), ('CHEBI_83326', 'tedizolid phosphate', 33, 'vitamin-D'), ('SO_0000704', 'gene', 51, 'genes'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('UBERON_0001977', 'blood serum', 275, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 281, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 366, 'vitamin D'), ('UBERON_0001977', 'blood serum', 488, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 494, '25-hydroxyvitamin D'), ('UBERON_0007023', 'adult organism', 553, 'adults'), ('NCBITaxon_1', 'root', 632, 'individuals'), ('NCBITaxon_10088', 'Mus <genus>', 715, 'people'), ('CHEBI_50553', 'mancude carbobicyclic parent', 745, 'colecalciferol')]
PMC3075531	7/2010	S59-PMC3075531	['one option WOULD BE a national or multinational study based on randomization of school districts or other suitable units in regions of low sunlight intensity, PERHAPS including multiple outcomes that MIGHT be AFFECTED by Vitamin D, such as diabetes, obesity, Respiratory infections, and asthma.4546ALTERNATIVELY, high-risk first-degree relatives of individu-als with ms COULD BE targeted in a smaller trial,47ALTHOUGH randomization and compliance COULD BE more CHALLENGING.']	[('FUTURE_WORK', 11), ('INCOMPLETE_EVIDENCE', 159), ('INCOMPLETE_EVIDENCE', 200), ('SUPERFICIAL_RELATIONSHIP', 209), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 298), ('FUTURE_WORK', 370), ('ANOMALY_CURIOUS_FINDING', 409), ('FUTURE_WORK', 447), ('DIFFICULT_TASK', 461)]	9	[('CHEBI_27300', 'vitamin D', 221, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 259, 'respiratory')]
PMC3075531	7/2010	S62-PMC3075531	['WHEREAS FUTURE observational epidemiological studies and Genetic and molecular INVESTIGATIONS WILL be useful to strengthen and refine the HYPOTHESIS, it MIGHT be NECESSARY to do a LARGE randomized TRIAL to establish the SAFETY and efficacy NEEDED to promote large-scale Vitamin D supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 8), ('FUTURE_WORK', 79), ('FUTURE_PREDICTION', 94), ('INCOMPLETE_EVIDENCE', 138), ('INCOMPLETE_EVIDENCE', 153), ('IMPORTANT_CONSIDERATION', 162), ('FUTURE_WORK', 180), ('IMPORTANT_CONSIDERATION', 220), ('FUTURE_WORK', 240)]	10	[('SO_0000704', 'gene', 57, 'genetic'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D')]
PMC3099599	5/2011	S211-PMC3099599	['HOWEVER, Vitamin D deficiency (vdd) and its bony manifestation, rickets, CAN lead to deformation of the weakened Skull during Birth resulting in psdh, and CONTRIBUTE to bony FINDINGS that SEEMINGLY CONFIRM the child abuse etiology.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 155), ('INCOMPLETE_EVIDENCE', 174), ('ANOMALY_CURIOUS_FINDING', 188), ('INCOMPLETE_EVIDENCE', 198)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0003129', 'skull', 113, 'skull'), ('GO_0007567', 'parturition', 126, 'birth')]
PMC3099599	5/2011	S217-PMC3099599	['the radiographic findings are transient (figure 9) but MAY NEVERTHELESS be interpreted as abusive, without clinical correlation, Vitamin D testing, meaningful differential diagnosis or corroborative history of violence.64\n\nconfusion between Central Nervous System infection and Shaken baby syndrome\nfever, irritability, Meningeal signs, elevated white counts and tense fontanelles suggest central Nervous System infection.']	[('INCOMPLETE_EVIDENCE', 55), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 59)]	2	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 241, 'Central Nervous System'), ('PR_000014863', 'single Ig IL-1-related receptor', 278, 'Shaken'), ('UBERON_0002360', 'meninx', 320, 'meningeal'), ('UBERON_0001016', 'nervous system', 397, 'nervous system')]
PMC3103150	3/2011	S16-PMC3103150	['this IMPLIES that babies Born to mothers with Vitamin D deficiency are very LIKELY to develop Vitamin D deficiency UNLESS supplemented from outside or adequately exposed to sunlight which is OFTEN NOT PRACTICAL during early Infancy.']	[('PROBABLE_UNDERSTANDING', 5), ('PROBABLE_UNDERSTANDING', 76), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115), ('PROBABLE_UNDERSTANDING', 191), ('DIFFICULT_TASK', 197)]	5	[('GO_0007567', 'parturition', 25, 'born'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('UBERON_0000023', 'wing', 224, 'infancy')]
PMC3103150	3/2011	S115-PMC3103150	['ALTERNATIVE EXPLANATION can be that these infants accrued lower stores of Vitamin D in utero as the latter half of Pregnancy was in winter season.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 12)]	2	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'pregnancy')]
PMC3103150	3/2011	S124-PMC3103150	['HOWEVER, for any given infant, it is DIFFICULT to determine reliably the amount of sunlight exposure sufficient to maintain normal Vitamin D status, as it is influenced by many factors such as clothing, skin pigmentation, sunscreen use, weather conditions, latitude, air pollution, time of the day and time of the year31.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('DIFFICULT_TASK', 37)]	2	[('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC3107676	4/2011	S106-PMC3107676	['in the first month of Pregnancy, between 40 and 41% (DEPENDING ON the type of Nitrosatable Drug taken) of participants who took Nitrosatable Drugs did not take any Supplements with Vitamin C; the proportion of nonusers dropped to 12.3% by the third month of Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 53)]	1	[('GO_0007565', 'female pregnancy', 22, 'pregnancy'), ('CHEBI_7587', 'nitroalkane', 78, 'nitrosatable'), ('CHEBI_23888', 'drug', 91, 'drug'), ('CHEBI_7587', 'nitroalkane', 128, 'nitrosatable'), ('CHEBI_23888', 'drug', 141, 'drugs'), ('CHEBI_33341', 'titanium atom', 164, 'supplements'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin C'), ('GO_0007565', 'female pregnancy', 258, 'pregnancy')]
PMC3169551	9/2011	S133-PMC3169551	['ALTHOUGH vitamin a capsules were less costly than iron per person (usd0.12/person/year COMPARED TO usd0.36), delivery costs for Vitamin A were higher: usd1.83 COMPARED TO usd0.40.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 87), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 159)]	3	[('CHEBI_27300', 'vitamin D', 128, 'vitamin A')]
PMC3171895	9/2011	S145-PMC3171895	['a CONSIDERABLE INTEREST exists regarding PREVENTION of Maternal and Perinatal Morbidity with Vitamins C and E. HOWEVER, the most RECENT meta-analysis of ten trials (6533 women) published in 2008 of antioxidant supplementation (including Vitamin C and e but also OTHER supplements such as Lycopene) SHOWED no difference in the relative risk (rr) of Preeclampsia (rr 0.73, 95% ci 0.51 to 1.06), Preterm Birth (before 37 weeks) (rr 1.10, 95% ci 0.99 to 1.22), sga infants (rr 0.83, 95% ci 0.62 to 1.11), or any baby death (rr 1.12, 95% ci 0.81 to 1.53) [7].']	[('ANOMALY_CURIOUS_FINDING', 2), ('ANOMALY_CURIOUS_FINDING', 15), ('IMPORTANT_CONSIDERATION', 15), ('SUPERFICIAL_RELATIONSHIP', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('INCOMPLETE_EVIDENCE', 129), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 262), ('INCOMPLETE_EVIDENCE', 298)]	8	[('GO_0007618', 'mating', 55, 'maternal ...'), ('GO_0019230', 'proprioception', 68, 'perinatal morbidity'), ('UBERON_0012101', 'perinatal stage', 68, 'perinatal'), ('CHEBI_27300', 'vitamin D', 93, 'vitamins C'), ('PR_000004900', 'complement C3', 102, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 108, 'E'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin C'), ('CHEBI_15948', 'lycopene', 288, 'lycopene'), ('GO_0007128', 'meiotic prophase I', 348, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 393, 'preterm'), ('GO_0007567', 'parturition', 401, 'birth')]
PMC3171895	9/2011	S148-PMC3171895	['ANOTHER RECENT multicentre placebo-controlled TRIAL of Vitamin C and E in women with type-1 diabetes in Pregnancy (Dapit) also REPORTED no differences in the rates of Preeclampsia between supplemented or placebo groups [133].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 46), ('INCOMPLETE_EVIDENCE', 127)]	4	[('CHEBI_27300', 'vitamin D', 55, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 69, 'E'), ('GO_0007565', 'female pregnancy', 104, 'pregnancy'), ('CHEBI_73285', "3-iodo-4-aminobenzyl-5'-N-methylcarboxamidoadenosine", 115, 'DAPIT'), ('GO_0007128', 'meiotic prophase I', 167, 'preeclampsia')]
PMC3235789	12/2011	S24-PMC3235789	['another us cohort study among nonpregnant women FOUND an ASSOCIATION between bv and the high total dietary intake of fat (aor 1.5, 95% ci: 1.1–2.4) and the low dietary Intake of Folate (aor 0.4, 95% ci: 0.2–0.8), Vitamin E (aor 0.4, 95% ci: 0.2–0.8), and Calcium (aor 0.4, 95% ci: 0.3–0.7), WHEREAS no relationship with dietary Vitamin D intake was observed [31].']	[('INCOMPLETE_EVIDENCE', 48), ('SUPERFICIAL_RELATIONSHIP', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 291)]	3	[('GO_0007631', 'feeding behavior', 168, 'intake'), ('CHEBI_30863', '5-azaorotic acid', 178, 'folate'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin E'), ('CHEBI_22313', 'alkaline earth metal atom', 255, 'calcium'), ('CHEBI_27300', 'vitamin D', 328, 'vitamin D')]
PMC3235789	12/2011	S108-PMC3235789	['circulating levels of 25-Oh-D are a direct REFLECTION of total body Vitamin D status, which DEPENDS upon access to Vitamin D EITHER through exposure to sunlight or dietary intake.']	[('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 92), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 125)]	3	[('CHEBI_46744', 'DDT-2,3-dihydrodiol', 22, '25-OH-D'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC3235789	12/2011	S115-PMC3235789	['THUS, in addition to the myriad OTHER health REASONS for addressing the POOR UNDERLYING Vitamin D and Folate status of us women [48,49], decreasing the susceptibility of women of Reproductive age to bv MAY provide further RATIONALE.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('PROBABLE_UNDERSTANDING', 45), ('IMPORTANT_CONSIDERATION', 72), ('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 202), ('PROBABLE_UNDERSTANDING', 222)]	7	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 102, 'folate'), ('GO_0000003', 'reproduction', 179, 'reproductive')]
PMC3257641	3/2010	S4-PMC3257641	['the EVIDENCE to date SUPPORTS that women SHOULD BE monitored and treated for Vitamin D deficiency during Pregnancy BUT OPTIMAL and upper limit Serum 25(Oh)D levels during Pregnancy are NOT KNOWN.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 21), ('FUTURE_WORK', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115), ('IMPORTANT_CONSIDERATION', 119), ('FULL_UNKNOWN', 185)]	6	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0007565', 'female pregnancy', 105, 'pregnancy'), ('UBERON_0001977', 'blood serum', 143, 'serum'), ('CHEBI_71657', 'versiconol acetate', 149, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 149, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 171, 'pregnancy')]
PMC3257641	3/2010	S7-PMC3257641	['with regard to terminology, we use Vitamin D when referring to Cholecalciferol or Ergocalciferol (BUT ‘Vitamin D3’ or ‘Vitamin D2’ where reference is made specifically to only a single form of Calciferol); 25(Oh)D to refer to 25 Hydroxycalciferol (including both 25(Oh)D2And 25(Oh)d3), and 1,25(Oh)2D, the active form of the hormone, to include both 1,25(Oh)2D2And 1,25(Oh)2D3.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 98)]	1	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('CHEBI_52550', 'theopalauamide', 63, 'cholecalciferol'), ('CHEBI_4910', 'etomidate', 82, 'ergocalciferol'), ('CHEBI_33279', 'vitamin D5', 103, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 103, 'vitamin D3'), ('CHEBI_28934', 'vitamin D2', 119, 'vitamin D2'), ('PR_000017299', 'VIP peptides', 119, 'vitamin D2'), ('CHEBI_28623', 'campesterol', 193, 'calciferol'), ('CHEBI_71657', 'versiconol acetate', 206, '25(OH)D'), ('CHEBI_65819', 'eckol', 226, '25 hydroxycalciferol'), ('CHEBI_76948', 'ent-manool', 263, '25(OH)D2and'), ('CHEBI_63056', 'zinc cation', 275, '25(OH'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 292, '25(OH)2D'), ('CHEBI_76948', 'ent-manool', 352, '25(OH)2D2and'), ('CHEBI_73394', 'Ala-Ser', 367, '25(OH)2D3')]
PMC3257641	3/2010	S13-PMC3257641	['dietary Vitamin D MAY BE in the form of Vitamin D2(Ergocalciferol), derived from Plants, OR Vitamin D3, sourced from fatty fish such as salmon, Sardines and mackerel and, to a certain extent, Egg Yolks [3].']	[('INCOMPLETE_EVIDENCE', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 89)]	2	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('CHEBI_28934', 'vitamin D2', 40, 'vitamin D2'), ('PR_000017299', 'VIP peptides', 40, 'vitamin D2'), ('CHEBI_4910', 'etomidate', 51, 'ergocalciferol'), ('NCBITaxon_10088', 'Mus <genus>', 81, 'plants'), ('CHEBI_33279', 'vitamin D5', 92, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 92, 'vitamin D3'), ('UBERON_2000442', 'supraneural bone', 144, 'sardines'), ('UBERON_0005079', 'eggshell', 192, 'egg yolks')]
PMC3257641	3/2010	S42-PMC3257641	['as for OTHER population groups, Pregnant women living at high latitude and low altitude, with dark skin pigmentation or skin USUALLY covered by clothing will be at increased risk of Vitamin D deficiency [31,32], UNLESS dietary intake is high (table 1).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 7), ('INCOMPLETE_EVIDENCE', 125), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 212)]	3	[('GO_0007565', 'female pregnancy', 32, 'pregnant'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D')]
PMC3257641	3/2010	S45-PMC3257641	['NEVERTHELESS, low Vitamin D status is also PREVALENT in Pregnant caucasian populations, PARTICULARLY those not receiving supplementation (table 2).nutrients-02-00389-t002_table 2\n\ncaption (table-wrap): table 2\n\nthe prevalence of a low Vitamin D status in Pregnancy.referenceyearcountrypopulationstage Of Pregnancydefinition% n/n[127]1997iraniran women attending largest tehran hospitaldelivery<25 nmol/l80% (40/50)[128]1997-2001usaafrican american–90% receiving Prenatal Vitamins4-21 week Gestation<37.5 nmol/l44.9% (89/194)[128]1997-2001usawhite–90% receiving Prenatal Vitamins4-21 week Gestation<37.5 nmol/l2% (4/199)[128]1997-2001usaafrican–american37-42 weeks<37.5 nmol/l29.2% (54/185)[128]1997-2001usawhite37-42 weeks<37.5 nmol/l5% (10/199)[128]1997-2001usaturkish12 week Gestation<25 nmol/l83.5% (66/79)[128]1997-2001usamoroccan12 week Gestation<25 nmol/l81.2% (56/69)[128]1997-2001usaother non-western12 week Gestation<25 nmol/l59% (62/105)[129]1999irelandcaucasians in ulster–on supplements (54–55on)12 weeks<25 nmol/l4.5% (1/22)[129]1999irelandno supplements12 weeks<25 nmol/l44.2% (34/77)[129]1999irelandsupplements20 weeks<25 nmol/l22.7% (5/22)[129]1999irelandno supplements20 weeks<25 nmol/l50.6% (39/77)[129]1999irelandsupplements35 weeks<25 nmol/l0% (0/22)[129]1999irelandno supplements35 weeks<25 nmol/l20.8% (16/77)[32]1999-2000australiaveiled &/or dark skinned women attending Antenatal clinicduring Antenatal care, when a routine Blood test was ordered<22.5 nmol/l80.5% (66/82)[130]1999-2000united arab emirateskuwaitdelivery<25 nmol/l40% (86/214)[131]2002indiaattendees of queen mary’s hosptal, lucknow (26.8on) northern india – urbandelivery–full term, live<22.5 nmol/l84.3% (118/140)[131]2002indiaattendees of queen mary’s hosptal, lucknow (26.8on) northern india–urbanrural<56.3 nmol/l84%(56/67)[132]2005-2006indiaresidents of barabanki district, 26.8onsecond trimester<50 nmol/l74.1% (103/139)\n\n4.1.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 43), ('ANOMALY_CURIOUS_FINDING', 88), ('IMPORTANT_CONSIDERATION', 88)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0007565', 'female pregnancy', 56, 'pregnant'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin D'), ('GO_0007565', 'female pregnancy', 255, 'pregnancy'), ('GO_0007308', 'oocyte construction', 301, 'of PregnancyDefinition'), ('GO_0007565', 'female pregnancy', 462, 'prenatal'), ('CHEBI_38749', 'dihydroxyflavanone', 471, 'vitamins4'), ('GO_0007565', 'female pregnancy', 489, 'gestation'), ('GO_0007565', 'female pregnancy', 561, 'prenatal'), ('CHEBI_38749', 'dihydroxyflavanone', 570, 'vitamins4'), ('GO_0007565', 'female pregnancy', 588, 'gestation'), ('GO_0007565', 'female pregnancy', 777, 'gestation'), ('GO_0007565', 'female pregnancy', 842, 'gestation'), ('GO_0007565', 'female pregnancy', 916, 'gestation'), ('GO_0007567', 'parturition', 1394, 'antenatal'), ('GO_0007567', 'parturition', 1417, 'antenatal'), ('UBERON_0000178', 'blood', 1448, 'blood')]
PMC3257641	3/2010	S48-PMC3257641	['a NUMBER OF STUDIES within non-Pregnant Adult populations have examined 25(Oh)D levels in RELATION to DIFFERENT dosages, preparations or dosing intervals of oral Vitamin D (reviewed in[33]).']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102)]	3	[('GO_0007565', 'female pregnancy', 31, 'pregnant'), ('UBERON_0007023', 'adult organism', 40, 'adult'), ('CHEBI_71657', 'versiconol acetate', 72, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 72, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D')]
PMC3257641	3/2010	S63-PMC3257641	['HOWEVER, the ASSOCIATION between Vitamin D deficiency and defective Reproduction MAY BE the result of hypocalcaemia RATHER than a Vitamin D EFFECT per se , AS the infertile female Vdr null Mice developed normal fertility when Fed a Calcium rich diet [48].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116), ('SUPERFICIAL_RELATIONSHIP', 140), ('PROBABLE_UNDERSTANDING', 156)]	6	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0000003', 'reproduction', 68, 'reproduction'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 180, 'VDR'), ('NCBITaxon_10088', 'Mus <genus>', 189, 'mice'), ('GO_0007631', 'feeding behavior', 226, 'fed'), ('CHEBI_22313', 'alkaline earth metal atom', 232, 'calcium')]
PMC3257641	3/2010	S75-PMC3257641	['ONGOING RESEARCH is examining the ROLE of 1,25(Oh)2D in decreasing the risk of infections during Pregnancy and WHETHER Vitamin D status alters the risk of developing adverse outcomes following such infections.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111)]	3	[('CHEBI_82784', 'PVP38-Ag NP', 42, '1,25(OH)2D'), ('GO_0007565', 'female pregnancy', 97, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
PMC3257641	3/2010	S78-PMC3257641	['HOWEVER, it is NOT CLEAR that the Vitamin D REQUIREMENTS of these largely nocturnal Animals REFLECT Human NEEDS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FULL_UNKNOWN', 15), ('IMPORTANT_CONSIDERATION', 44), ('SUPERFICIAL_RELATIONSHIP', 92), ('IMPORTANT_CONSIDERATION', 106)]	5	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 84, 'animals'), ('NCBITaxon_9606', 'Homo sapiens', 100, 'human')]
PMC3257641	3/2010	S92-PMC3257641	['Birth weight\nOBSERVATIONAL STUDIES of Vitamin D status during Pregnancy and physical characteristics of the offspring are FEW and provide CONFLICTING results.']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 138)]	3	[('GO_0007567', 'parturition', 0, 'Birth'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0007565', 'female pregnancy', 62, 'pregnancy')]
PMC3257641	3/2010	S93-PMC3257641	['ONE STUDY FOUND Pregnancies of mothers with low Vitamin D status were shorter (by 0.7 week; 95% ci −1.3, −0.1) [60], and the babies had poorer Intrauterine long bone growth [60], WHILE in OTHER studies, offspring had lower Birth weight [61,62,63].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 179), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 188)]	4	[('GO_0007565', 'female pregnancy', 16, 'pregnancies'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0022293', 'reproductive gland secretion', 143, 'intrauterine'), ('GO_0007567', 'parturition', 223, 'birth')]
PMC3257641	3/2010	S94-PMC3257641	['HOWEVER ANOTHER STUDY FOUND THE OPPOSITE, with babies of Vitamin D deficient mothers being both heavier and longer, compared to the offspring of Vitamin D-sufficient mothers [64].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28)]	4	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
PMC3257641	3/2010	S98-PMC3257641	['the media REPORTED on a reduction in both Preterm Birth and small-for-dates babies, with Vitamin D supplementation [41], BUT formal publication of the FINDINGS had not occurred at the time of writing this review, THUS these reports cannot BE formally evaluated.']	[('INCOMPLETE_EVIDENCE', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('INCOMPLETE_EVIDENCE', 151), ('PROBABLE_UNDERSTANDING', 213), ('ANOMALY_CURIOUS_FINDING', 239)]	5	[('GO_0007565', 'female pregnancy', 42, 'preterm'), ('GO_0007567', 'parturition', 50, 'birth'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC3257641	3/2010	S106-PMC3257641	['NEVERTHELESS, in two studies in Pigs, Vitamin D administration to two sows at doses that achieved Serum 25(Oh)D levels, APPROXIMATING RECOMMENDED Human levels, was ASSOCIATED with Coronary lesions in offspring at six weeks [74,75].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 120), ('FUTURE_WORK', 134), ('SUPERFICIAL_RELATIONSHIP', 164)]	4	[('NCBITaxon_10088', 'Mus <genus>', 32, 'pigs'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0001977', 'blood serum', 98, 'serum'), ('CHEBI_71657', 'versiconol acetate', 104, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 104, '25(OH ... D'), ('NCBITaxon_9606', 'Homo sapiens', 146, 'human'), ('UBERON_0005985', 'coronary vessel', 180, 'coronary')]
PMC3257641	3/2010	S121-PMC3257641	['low Vitamin D intake during Pregnancy HAS BEEN ASSOCIATED with an increased risk of asthma, eczema or hay fever [92,93], WHILE winter Birth was ASSOCIATED with higher Ige levels and lower Il-10 than summer Birth [57].']	[('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 47), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('ANOMALY_CURIOUS_FINDING', 121), ('SUPERFICIAL_RELATIONSHIP', 144)]	5	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('GO_0007565', 'female pregnancy', 28, 'pregnancy'), ('GO_0007567', 'parturition', 134, 'birth'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 167, 'IgE'), ('PR_000001470', 'interleukin-28B', 188, 'IL-10'), ('GO_0007567', 'parturition', 206, 'birth')]
PMC3257641	3/2010	S132-PMC3257641	['this is a DIFFICULT BUT IMPORTANT AREA to research [101,102,103,104], with Animal work indicting transient Prenatal Vitamin D deficiency is ASSOCIATED with subtle alterations in Learning and Memory functions in Adult Rats [105].']	[('DIFFICULT_TASK', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 20), ('IMPORTANT_CONSIDERATION', 24), ('FUTURE_WORK', 34), ('SUPERFICIAL_RELATIONSHIP', 140)]	5	[('NCBITaxon_33208', 'Metazoa', 75, 'animal'), ('GO_0007565', 'female pregnancy', 107, 'prenatal'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007612', 'learning', 178, 'learning'), ('GO_0007613', 'memory', 191, 'memory'), ('UBERON_0007023', 'adult organism', 211, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 217, 'rats')]
PMC3257641	3/2010	S139-PMC3257641	['OTHER CANDIDATE diseases that REQUIRE FURTHER RESEARCH with regard to the POTENTIAL ROLE of Prenatal Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('FUTURE_WORK', 30), ('IMPORTANT_CONSIDERATION', 30), ('FUTURE_WORK', 38), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 84)]	7	[('GO_0007565', 'female pregnancy', 92, 'prenatal'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC3257641	3/2010	S140-PMC3257641	['seasonal PATTERNS of Birth in Adults [114] and children [115] with Brain tumors and epilepsy [116] HAVE BEEN NOTED and COULD BE evidence of an EFFECT of low Vitamin D status, BUT this is far from CONCLUSIVE.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('INCOMPLETE_EVIDENCE', 99), ('ANOMALY_CURIOUS_FINDING', 109), ('INCOMPLETE_EVIDENCE', 119), ('SUPERFICIAL_RELATIONSHIP', 143), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 175), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 196)]	7	[('GO_0007567', 'parturition', 21, 'birth'), ('UBERON_0007023', 'adult organism', 30, 'adults'), ('UBERON_0000955', 'brain', 67, 'brain'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
PMC3257641	3/2010	S141-PMC3257641	['a TENTATIVE LINK between Vitamin D status and autism HAS BEEN POSTULATED, arising MAINLY from the FINDINGS of population level studies [117,118].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 2), ('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 62), ('PROBABLE_UNDERSTANDING', 82), ('INCOMPLETE_EVIDENCE', 98)]	7	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D')]
PMC3257641	3/2010	S153-PMC3257641	['HOWEVER, the MAJORITY of POTENTIAL adverse offspring health outcomes pertain to low Prenatal Vitamin D status and the EVOLVING EVIDENCE has provided greater IMPETUS for PUBLIC HEALTH EFFORTS to ensure mothers are not frankly Vitamin D deficient (<25 nmol/l) in Pregnancy, ALTHOUGH the value of treating relative Vitamin D insufficiency in Pregnancy is NOT clearly ESTABLISHED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 13), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 118), ('IMPORTANT_CONSIDERATION', 157), ('IMPORTANT_CONSIDERATION', 169), ('FUTURE_WORK', 183), ('ANOMALY_CURIOUS_FINDING', 272), ('FULL_UNKNOWN', 352)]	9	[('GO_0007565', 'female pregnancy', 84, 'prenatal'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D'), ('GO_0007565', 'female pregnancy', 261, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 312, 'vitamin D'), ('GO_0007565', 'female pregnancy', 339, 'pregnancy')]
PMC3257641	3/2010	S162-PMC3257641	['in this situation, the timing of low Vitamin D’s EFFECT over the Life Course will HAVE TO BE carefully determined, using specific Life Course analytic techniques [125], TO ASSESS WHETHER any low Prenatal Vitamin D status is INDEPENDENTLY ASSOCIATED with health outcomes INDEPENDENTLY of the mother’s Vitamin D status before Pregnancy and the offspring’s Vitamin D status during Postnatal Life.']	[('SUPERFICIAL_RELATIONSHIP', 49), ('IMPORTANT_CONSIDERATION', 82), ('QUESTION_ANSWERED_BY_THIS_WORK', 169), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 179), ('SUPERFICIAL_RELATIONSHIP', 224), ('SUPERFICIAL_RELATIONSHIP', 238), ('SUPERFICIAL_RELATIONSHIP', 270)]	7	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('UBERON_0001281', 'hepatic sinusoid', 65, 'life course'), ('UBERON_0001281', 'hepatic sinusoid', 130, 'life course'), ('GO_0007565', 'female pregnancy', 195, 'prenatal'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 300, 'vitamin D'), ('GO_0007565', 'female pregnancy', 324, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 354, 'vitamin D'), ('GO_0007567', 'parturition', 378, 'postnatal'), ('UBERON_0000104', 'life cycle', 388, 'life')]
PMC3271033	1/2012	S14-PMC3271033	['Serum 25-Hydroxyvitamin D (25(Oh)D) is ACCEPTED as the BEST MARKER of Vitamin D status ALTHOUGH it MAY serve PRIMARILY as a MARKER of exposure RATHER than clinical outcomes [2].there are FEW DATA that CORRELATE Serum 25(Oh)D levels with functional outcomes in newborns and small infants.']	[('INCOMPLETE_EVIDENCE', 39), ('IMPORTANT_CONSIDERATION', 55), ('SUPERFICIAL_RELATIONSHIP', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 87), ('INCOMPLETE_EVIDENCE', 99), ('PROBABLE_UNDERSTANDING', 109), ('SUPERFICIAL_RELATIONSHIP', 124), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 143), ('INCOMPLETE_EVIDENCE', 187), ('SUPERFICIAL_RELATIONSHIP', 201)]	10	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 6, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 27, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('UBERON_0001977', 'blood serum', 211, 'serum'), ('CHEBI_71657', 'versiconol acetate', 217, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 217, '25(OH)D')]
PMC3271033	1/2012	S20-PMC3271033	['HOWEVER, the RELATIONSHIP between Vitamin D status and bone-related outcomes in supplemented infants provides INFORMATION about the EFFECTS of these Cord levels and Vitamin D supplementation in early Infancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 110), ('SUPERFICIAL_RELATIONSHIP', 132)]	4	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 149, 'cord'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D'), ('UBERON_0000023', 'wing', 200, 'infancy')]
PMC3271033	1/2012	S131-PMC3271033	['it HAS BEEN SUGGESTED BUT is NOT PROVEN that early Life calcium absorption is PRIMARILY non-Vitamin D DEPENDENT [2].']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('INCOMPLETE_EVIDENCE', 29), ('PROBABLE_UNDERSTANDING', 78), ('SUPERFICIAL_RELATIONSHIP', 102)]	5	[('UBERON_0000104', 'life cycle', 51, 'life'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC3271033	1/2012	S132-PMC3271033	['HOWEVER, it is LIKELY that by three months of age, Vitamin D has a KEY ROLE in calcium absorption, especially in Breast-Fed infants with a relatively low Calcium Intake COMPARED TO formula-Fed infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 15), ('IMPORTANT_CONSIDERATION', 67), ('SUPERFICIAL_RELATIONSHIP', 71), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 169)]	5	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007567', 'parturition', 113, 'breast'), ('UBERON_0000310', 'breast', 113, 'breast'), ('GO_0007631', 'feeding behavior', 120, 'fed'), ('CHEBI_22313', 'alkaline earth metal atom', 154, 'calcium'), ('GO_0007631', 'feeding behavior', 162, 'intake'), ('GO_0007631', 'feeding behavior', 189, 'fed')]
PMC3271033	1/2012	S138-PMC3271033	['high doses of Vitamin D in early Life) with or without monitoring of 25(Oh)D levels or WHETHER the 400 iu/day dose is adequate.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 87)]	1	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('UBERON_0000104', 'life cycle', 33, 'life'), ('CHEBI_71657', 'versiconol acetate', 69, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 75, 'D')]
PMC3271033	1/2012	S140-PMC3271033	['HOWEVER, it APPEARS that, AT LEAST in a southern us setting, 400 iu/day is adequate for infants REGARDLESS OF Vitamin D status at Birth.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 12), ('PROBABLE_UNDERSTANDING', 26), ('INCOMPLETE_EVIDENCE', 96)]	4	[('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('GO_0007567', 'parturition', 130, 'birth')]
PMC3271033	1/2012	S141-PMC3271033	['we CANNOT RULE OUT the POSSIBILITY that a SMALL NUMBER OF infants WILL be hypocalcemic in the first weeks of Life with this approach, BUT, this APPEARS TO BE UNCOMMON and MAY BE more RELATED to pth function than Vitamin D. further RESEARCH IS NEEDED relative to the etiology of symptomatic hypocalcemia in the first weeks of life.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 3), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 42), ('INCOMPLETE_EVIDENCE', 48), ('FUTURE_PREDICTION', 66), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 134), ('ANOMALY_CURIOUS_FINDING', 144), ('INCOMPLETE_EVIDENCE', 158), ('INCOMPLETE_EVIDENCE', 171), ('SUPERFICIAL_RELATIONSHIP', 183), ('FUTURE_WORK', 231)]	11	[('UBERON_0000104', 'life cycle', 109, 'life'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D')]
PMC3271033	1/2012	S146-PMC3271033	['HOWEVER, the FINDINGS in OUR STUDY APPEAR MEANINGFUL in that the provision of Vitamin D at a dose of 400 iu/day LED TO mean values that were above 30 ng/ml REGARDLESS OF starting value or ethnicity.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('ANOMALY_CURIOUS_FINDING', 35), ('PROBABLE_UNDERSTANDING', 42), ('SUPERFICIAL_RELATIONSHIP', 112), ('INCOMPLETE_EVIDENCE', 156)]	7	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC3277098	12/2011	S25-PMC3277098	['WHILE the incidence of rickets has been largely reduced in western countries through the use of dietary supplementation and uv exposure [12], the same societies continue to experience a high prevalence of sub-clinical Vitamin D deficiency or insufficiency [13] that is LIKELY RELATED to indoor lifestyle habits with limited sun exposure.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 269), ('SUPERFICIAL_RELATIONSHIP', 276)]	4	[('CHEBI_27300', 'vitamin D', 218, 'vitamin D')]
PMC3277098	12/2011	S35-PMC3277098	['this RAISES the QUESTION of WHETHER Vitamin D status in utero and early Life has EFFECTS on Immune function and development of allergic disease.']	[('EXPLICIT_QUESTION', 5), ('EXPLICIT_QUESTION', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('SUPERFICIAL_RELATIONSHIP', 81)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0000104', 'life cycle', 72, 'life'), ('UBERON_0002405', 'immune system', 92, 'immune')]
PMC3277098	12/2011	S43-PMC3277098	['HOWEVER, just as with the epidemiological ASSOCIATIONS, the EFFECTS of Vitamin D on Th2 Cells HAVE also BEEN CONTRADICTORY, with REPORTS of both enhancement and inhibition [29,30].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 42), ('SUPERFICIAL_RELATIONSHIP', 60), ('INCOMPLETE_EVIDENCE', 94), ('ANOMALY_CURIOUS_FINDING', 104), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 109), ('INCOMPLETE_EVIDENCE', 129)]	7	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CL_0000546', 'T-helper 2 cell', 84, 'Th2 cells')]
PMC3277098	12/2011	S50-PMC3277098	['to date, the MAJORITY of research HAS BEEN conducted using cells sourced from peripheral Blood; HOWEVER SOME authors have PROPOSED that Gut-associated lymphoid Tissue MAY be of RELEVANCE, particularly in regard to oral Vitamin D Intake and Food Allergen sensitization [33].']	[('PROBABLE_UNDERSTANDING', 13), ('INCOMPLETE_EVIDENCE', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 96), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 122), ('INCOMPLETE_EVIDENCE', 167), ('IMPORTANT_CONSIDERATION', 177)]	7	[('UBERON_0000178', 'blood', 89, 'blood'), ('UBERON_0001555', 'digestive tract', 136, 'gut'), ('UBERON_0000479', 'tissue', 160, 'tissue'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin D'), ('GO_0007631', 'feeding behavior', 229, 'intake'), ('CHEBI_33290', 'food', 240, 'food'), ('CHEBI_50904', 'allergen', 245, 'allergen')]
PMC3277098	12/2011	S59-PMC3277098	['the “Vitamin D/microbiome HYPOTHESIS” has PROPONENTS on BOTH SIDES, with vassallo and camargo [35] ARGUING that deficiency is causative, WHILE wjst [17] SUGGESTS that the introduction of Vitamin D supplementation COINCIDES with the rise in allergic disease.']	[('INCOMPLETE_EVIDENCE', 26), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 56), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137), ('INCOMPLETE_EVIDENCE', 153), ('SUPERFICIAL_RELATIONSHIP', 213)]	7	[('CHEBI_27300', 'vitamin D', 5, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin D')]
PMC3277098	12/2011	S60-PMC3277098	['this line of argument HIGHLIGHTS that the potency and pharmacokinetics of endogenous and exogenous Vitamin D MAY BE DIFFERENT and that Serum 25(Oh)D, sun exposure and oral Intake SHOULD BE CONSIDERED INDEPENDENTLY of one another.']	[('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 109), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116), ('FUTURE_WORK', 179), ('FUTURE_WORK', 189), ('SUPERFICIAL_RELATIONSHIP', 200)]	6	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('UBERON_0001977', 'blood serum', 135, 'serum'), ('CHEBI_71657', 'versiconol acetate', 141, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 141, '25(OH ... D'), ('GO_0007631', 'feeding behavior', 172, 'intake')]
PMC3277098	12/2011	S101-PMC3277098	['functional consequences of vdr polymorphisms MAY, THEREFORE, vary with the availability of Vitamin D to Tissues and become apparent, OR exaggerated, in an environment of Vitamin d deficiency, such as observed in the case of several infectious diseases [45,46].']	[('INCOMPLETE_EVIDENCE', 45), ('PROBABLE_UNDERSTANDING', 50), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 133)]	3	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('UBERON_0000479', 'tissue', 104, 'tissues'), ('CHEBI_33229', 'vitamin (role)', 170, 'vitamin')]
PMC3277098	12/2011	S111-PMC3277098	['in japan, a MAJOR source of dietary Vitamin D is fish which is a rich source of N-3 Fatty Acids, WHEREAS OTHER countries such as the us rely heavily on Vitamin D fortified Milk [51] which is relatively high in saturated, and low in polyunsaturated, Fatty Acids [52].']	[('IMPORTANT_CONSIDERATION', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 97), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 105)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_35418', 'N-acetylneuraminate', 80, 'n-3 fatty acids'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D'), ('UBERON_0001913', 'milk', 172, 'milk'), ('CHEBI_35366', 'fatty acid', 249, 'fatty acids')]
PMC3277098	12/2011	S113-PMC3277098	['WHILE Vitamin D MAY BE ASSOCIATED with the development of wheeze through OTHER mechanisms (seesection 4.3) these REPORTS of wheeze are NOT NECESSARILY RELATED to a true th2-dominant allergic response.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 73), ('INCOMPLETE_EVIDENCE', 113), ('INCOMPLETE_EVIDENCE', 135), ('SUPERFICIAL_RELATIONSHIP', 151)]	7	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D')]
PMC3277098	12/2011	S120-PMC3277098	['HOWEVER, there was no association between maternal Vitamin D and eczema RISK at 3 years.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 72)]	3	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC3277098	12/2011	S181-PMC3277098	['[64] FOUND that lower Serum 25(Oh)D (of ≤37.5 nmol/l) was ASSOCIATED with both Peanut (or 2.39; 95% ci 1.29–4.45, p = 0.005) and shrimp (or 3.08; 95% ci 1.16–8.19, p = 0.02) sensitization, HOWEVER, OTHER studies of Food allergy are LARGELY LIMITED TO epidemiological data without serological measures of Vitamin D [69,70,71,72].']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 58), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 189), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 198), ('INCOMPLETE_EVIDENCE', 232), ('INCOMPLETE_EVIDENCE', 240)]	6	[('UBERON_0001977', 'blood serum', 22, 'serum'), ('CHEBI_71657', 'versiconol acetate', 28, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 28, '25(OH)D'), ('NCBITaxon_10088', 'Mus <genus>', 79, 'peanut'), ('CHEBI_33290', 'food', 215, 'food'), ('CHEBI_27300', 'vitamin D', 304, 'vitamin D')]
PMC3277098	12/2011	S184-PMC3277098	['this data has the advantage of focussing on the Early Life Period and MAY THEREFORE provide INSIGHT into the aetiological ROLE of Vitamin D. DESPITE the OBSERVED PROTECTIVE ASSOCIATION of Serum 25(Oh)D and allergy, it has been NOTED that the widespread practice of supplementation COINCIDED with the rise in allergic disease [35].']	[('INCOMPLETE_EVIDENCE', 70), ('PROBABLE_UNDERSTANDING', 74), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('ANOMALY_CURIOUS_FINDING', 141), ('INCOMPLETE_EVIDENCE', 153), ('SUPERFICIAL_RELATIONSHIP', 162), ('SUPERFICIAL_RELATIONSHIP', 173), ('ANOMALY_CURIOUS_FINDING', 227), ('SUPERFICIAL_RELATIONSHIP', 281)]	11	[('UBERON_0019248', 'early embryo', 48, 'early life period'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('UBERON_0001977', 'blood serum', 188, 'serum'), ('CHEBI_71657', 'versiconol acetate', 194, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 194, '25(OH)D')]
PMC3277098	12/2011	S185-PMC3277098	['SUPPORTING this observation are SEVERAL STUDIES which FOUND Vitamin D supplementation to be ASSOCIATED with an INCREASED RISK of atopic dermatitis [73], allergic rhinitis [35,74], asthma, sensitisation [69,74] and Food allergy [70], HOWEVER NONE of these papers are SUPPORTED by biological measures of Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 92), ('IMPORTANT_CONSIDERATION', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 233), ('INCOMPLETE_EVIDENCE', 241), ('INCOMPLETE_EVIDENCE', 266)]	8	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_33290', 'food', 214, 'food'), ('CHEBI_27300', 'vitamin D', 302, 'vitamin D')]
PMC3277098	12/2011	S189-PMC3277098	['HOWEVER, OTHER authors investigating infant Intakes in this lower dose range (closer to aap recommendations) HAVE ALSO SHOWN that atopic manifestations (particularly atopic dermatitis) were more prevalent in children with “high” (>13.1 μg/day) versus “low” (≤13.1 μg/day) intake of Vitamin D [73].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('IMPORTANT_CONSIDERATION', 109), ('INCOMPLETE_EVIDENCE', 114)]	4	[('GO_0007631', 'feeding behavior', 44, 'intakes'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin D')]
PMC3277098	12/2011	S194-PMC3277098	['there is also SOME EVIDENCE that the EFFECT of supplementation MAY depend ON WHETHER Vitamin D is administered in a fat- OR Water-soluble form.']	[('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 63), ('ANOMALY_CURIOUS_FINDING', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121)]	6	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_15377', 'water', 124, 'water')]
PMC3277098	12/2011	S197-PMC3277098	['these CONTRASTING results HIGHLIGHT THE NEED for randomised controlled trials (rct) to provide clearer picture of ROLE of Vitamin D during infancy in Regulation of Allergic disease, including uptake, Metabolism and Immunomodulation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 36), ('FUTURE_WORK', 40), ('SUPERFICIAL_RELATIONSHIP', 114), ('SUPERFICIAL_RELATIONSHIP', 150)]	6	[('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('GO_0065007', 'biological regulation', 150, 'regulation'), ('GO_0040011', 'locomotion', 164, 'allergic'), ('GO_0008152', 'metabolic process', 200, 'metabolism'), ('GO_0050900', 'leukocyte migration', 215, 'immunomodulation')]
PMC3277098	12/2011	S198-PMC3277098	['IN SUMMARY, the CONTRARY epidemiological OBSERVATIONS between Serum status (GENERALLY PROTECTIVE) and Oral exposure (supplementation increasing allergy risk in MANY STUDIES) HIGHLIGHT the uncertainty surrounding Vitamin D in Allergy Development and precludes population RECOMMENDATIONS.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('INCOMPLETE_EVIDENCE', 41), ('PROBABLE_UNDERSTANDING', 76), ('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 160), ('INCOMPLETE_EVIDENCE', 174), ('FUTURE_WORK', 270)]	8	[('UBERON_0001977', 'blood serum', 62, 'serum'), ('UBERON_0000165', 'mouth', 102, 'oral'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('GO_0060021', 'roof of mouth development', 225, 'allergy development')]
PMC3277098	12/2011	S201-PMC3277098	['FUTURE RESEARCH MUST accurately account for the DIFFERENT sources of Vitamin D, stage of Immune Development and Genetic FACTORS in order to understand the immunological consequences of changing Vitamin d status through supplementation or lifestyle changes.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 48), ('SUPERFICIAL_RELATIONSHIP', 120)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0001822', 'kidney development', 89, 'immune development'), ('UBERON_0002405', 'immune system', 89, 'immune'), ('SO_0000704', 'gene', 112, 'genetic'), ('CHEBI_33229', 'vitamin (role)', 194, 'vitamin')]
PMC3278486	1/2012	S137-PMC3278486	["comparison with other studies\nour finding of no benefit, BUT a POSSIBLE adverse EFFECT from Folic Acid supplementation on cancer incidence is IN LINE WITH REPORTED results of studies on other Nutrient supplements, including Vitamin E, Β-Carotene (Vitamin-A precursor) or Selenium; all SHOWING no or an adverse EFFECT of supplementation in controlled clinical trials on cancer development.4243a RECENT meta-analysis of Folic Acid supplements by clarke and coworkers, in the ‘b-Vitamin treatment trialists' collaboration’3with individual patient data, FOUND no increased cancer risk in any subgroups."]	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 57), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 142), ('INCOMPLETE_EVIDENCE', 155), ('INCOMPLETE_EVIDENCE', 285), ('SUPERFICIAL_RELATIONSHIP', 310), ('INCOMPLETE_EVIDENCE', 394), ('INCOMPLETE_EVIDENCE', 550)]	9	[('CHEBI_30751', 'formic acid', 92, 'folic acid'), ('CHEBI_33284', 'nutrient', 192, 'nutrient'), ('CHEBI_27300', 'vitamin D', 224, 'vitamin E'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 235, 'β-carotene'), ('CHEBI_83326', 'tedizolid phosphate', 247, 'vitamin-A'), ('CHEBI_27568', 'selenium atom', 271, 'selenium'), ('CHEBI_30751', 'formic acid', 418, 'folic acid'), ('CHEBI_33229', 'vitamin (role)', 476, 'Vitamin')]
PMC3296991	2/2012	S10-PMC3296991	['HOWEVER, the behavior of these BIOMARKERS in the fetus and their RELATIONSHIP with Vitamin D status and neonatal bone mineralization are POORLY characterized.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 31), ('SUPERFICIAL_RELATIONSHIP', 65), ('PROBLEM_COMPLICATION', 137)]	4	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
PMC3296991	2/2012	S21-PMC3296991	['HOWEVER, there are gaps in the understanding of WHETHER AND HOW Vitamin D INFLUENCES fetal Bone Development and WHETHER markers of bone turnover in Cord Blood PREDICT bone Mineral content.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 48), ('EXPLICIT_QUESTION', 48), ('EXPLICIT_QUESTION', 60), ('SUPERFICIAL_RELATIONSHIP', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('EXPLICIT_QUESTION', 112), ('SUPERFICIAL_RELATIONSHIP', 159)]	8	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0048539', 'bone marrow development', 91, 'bone development'), ('UBERON_0002240', 'spinal cord', 148, 'cord'), ('UBERON_0000178', 'blood', 153, 'blood'), ('CHEBI_46662', 'mineral', 172, 'mineral')]
PMC3296991	2/2012	S98-PMC3296991	['FURTHER RESEARCH is NECESSARY to CONSIDER the behavior of OTHER BIOMARKERS in RELATIONSHIP to Vitamin D status and their POTENTIAL CONTRIBUTION to PREDICTION of neonatal wbbmc.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 20), ('FUTURE_WORK', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 58), ('SUPERFICIAL_RELATIONSHIP', 64), ('SUPERFICIAL_RELATIONSHIP', 78), ('INCOMPLETE_EVIDENCE', 121), ('SUPERFICIAL_RELATIONSHIP', 131), ('SUPERFICIAL_RELATIONSHIP', 147)]	9	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC3309463	6/2011	S43-PMC3309463	['it HAS BEEN PROPOSED that developmental Vitamin D deficiency MAY CONTRIBUTE to the increased risk of schizophrenia in dark-skinned migrants and those living in crowded urban settings.28both dark skin and urban residence are ASSOCIATED with an INCREASED risk of hypovitaminosis D.29developmental Vitamin D deficiency MAY also UNDERLIE the well-replicated season of birth EFFECT FOUND in schizophrenia (those Born in winter and spring have a small but significant increased risk of schizophrenia).30vitamin D is a potent pro-differentiation agent and CAN INFLUENCE Brain functioning via many DIFFERENT pathways.31the Vitamin D receptor and the enzyme required for the manufacture of the hormonally active form of Vitamin D have BEEN IDENTIFIED in the Human Brain,32AND THERE IS EVIDENCE from Rodent MODELS DEMONSTRATING that transient Prenatal Vitamin D deficiency results in persistent changes in Adult Brain structure, neurochemistry and behavior.33our species has evolved in settings where Vitamin D is abundant, and migration to colder climates and urban-related lifestyle factors have left modern Humans at increased risk of hypovitaminosis D.\ninspired by the conceptual framework described above, we PROPOSE that the absence of adequate Vitamin D levels during development deprives the Organism of expected instructions from the environment.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 224), ('IMPORTANT_CONSIDERATION', 243), ('INCOMPLETE_EVIDENCE', 316), ('SUPERFICIAL_RELATIONSHIP', 325), ('SUPERFICIAL_RELATIONSHIP', 370), ('INCOMPLETE_EVIDENCE', 377), ('INCOMPLETE_EVIDENCE', 549), ('SUPERFICIAL_RELATIONSHIP', 553), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 590), ('ANOMALY_CURIOUS_FINDING', 726), ('INCOMPLETE_EVIDENCE', 731), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 761), ('INCOMPLETE_EVIDENCE', 767), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 797), ('INCOMPLETE_EVIDENCE', 797), ('INCOMPLETE_EVIDENCE', 804), ('INCOMPLETE_EVIDENCE', 1204)]	21	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 277, 'D'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D'), ('GO_0007567', 'parturition', 407, 'born'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 505, 'D'), ('UBERON_0000955', 'brain', 563, 'brain'), ('CHEBI_27300', 'vitamin D', 615, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 711, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 749, 'human'), ('UBERON_0000955', 'brain', 755, 'brain'), ('NCBITaxon_33208', 'Metazoa', 790, 'rodent'), ('GO_0007565', 'female pregnancy', 833, 'prenatal'), ('CHEBI_27300', 'vitamin D', 842, 'vitamin D'), ('UBERON_0007023', 'adult organism', 896, 'adult'), ('UBERON_0000955', 'brain', 902, 'brain'), ('CHEBI_27300', 'vitamin D', 991, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 1100, 'humans'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1144, 'D'), ('CHEBI_27300', 'vitamin D', 1241, 'vitamin D'), ('NCBITaxon_1', 'root', 1290, 'organism')]
PMC3309463	6/2011	S45-PMC3309463	['we SPECULATE that Prenatal Vitamin D deficiency would be one of many DIFFERENT exposures that COULD decanalize Brain Development and lead TO an increased susceptibility to schizophrenia.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 69), ('INCOMPLETE_EVIDENCE', 94), ('QUESTION_ANSWERED_BY_THIS_WORK', 138)]	4	[('GO_0007565', 'female pregnancy', 18, 'prenatal'), ('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007420', 'brain development', 111, 'brain development'), ('UBERON_0000955', 'brain', 111, 'brain')]
PMC3309463	6/2011	S51-PMC3309463	['IF cryptic variation is exposed by environmental exposures, such as Vitamin D deficiency, stress or cannabis use, then Allelic EFFECTS should BE larger in populations where these exposures are prevalent.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 127), ('ANOMALY_CURIOUS_FINDING', 142)]	3	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('SO_0001023', 'allele', 119, 'allelic')]
PMC3319623	4/2012	S63-PMC3319623	['SIMILAR mechanisms MAY apply to bad and rdd, BUT the EVIDENCE for Vitamin D in these disorders is much LESS STRONG and OTHER FACTORS such as maternal infections and fluctuations in diet MAY also play an IMPORTANT ROLE.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 45), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 103), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 119), ('SUPERFICIAL_RELATIONSHIP', 125), ('INCOMPLETE_EVIDENCE', 186), ('IMPORTANT_CONSIDERATION', 203), ('SUPERFICIAL_RELATIONSHIP', 213)]	11	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC3338544	4/2012	S170-PMC3338544	['such DIFFERENCES HIGHLIGHT the IMPORTANCE of species and strain selection in studies of altered Vitamin D Signalling and Brain Development.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('INCOMPLETE_EVIDENCE', 17), ('IMPORTANT_CONSIDERATION', 31)]	3	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('GO_0048371', 'lateral mesodermal cell differentiation', 96, 'vitamin D signalling'), ('GO_0007420', 'brain development', 121, 'brain development'), ('UBERON_0000955', 'brain', 121, 'brain')]
PMC3347007	4/2012	S9-PMC3347007	['the need for Vitamin D CAN be fulfilled by exposing skin to sunlight; however, in northern latitudes the sun exposure only synthesizes Vitamin D from april to october [1] and Vitamin D MUST BE obtained from OTHER sources during the winter period.']	[('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 185), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 207)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D')]
PMC3347007	4/2012	S20-PMC3347007	['OTHER SUGGESTED CONSEQUENCES of Vitamin D deficiency during Pregnancy are increased risks of: schizophrenia, type 1 diabetes, multiple sclerosis, Heart disease, cancer, and small for Gestational age diagnosis [10,11,12,13].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('PROBLEM_COMPLICATION', 16)]	3	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007565', 'female pregnancy', 60, 'pregnancy'), ('UBERON_0000948', 'heart', 146, 'heart'), ('GO_0007565', 'female pregnancy', 183, 'gestational')]
PMC3347007	4/2012	S21-PMC3347007	['the definition of optimal Vitamin D status and optimal intake level of Vitamin D HAVE BEEN subject to much DEBATE, and RECOMMENDATIONS VARY between countries.']	[('INCOMPLETE_EVIDENCE', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 107), ('FUTURE_WORK', 119), ('DIFFICULT_TASK', 135)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC3347007	4/2012	S95-PMC3347007	['we wanted TO EXAMINE WHETHER the women with sufficient total Vitamin D intake DIFFERED from the women with insufficient total Vitamin D intake (table 4).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 21), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 78)]	3	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
PMC3347007	4/2012	S100-PMC3347007	['single women had lower odds ratio (or) for sufficient total Vitamin D intake than married/coupled women, HOWEVER, this RELATION was not statistically significant.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 105), ('ANOMALY_CURIOUS_FINDING', 105), ('SUPERFICIAL_RELATIONSHIP', 119)]	3	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC3347007	4/2012	S149-PMC3347007	['multiparous women were found to be less LIKELY to have sufficient total Vitamin D intakes COMPARED TO nulliparous women.']	[('PROBABLE_UNDERSTANDING', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90)]	2	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC3347007	4/2012	S166-PMC3347007	['it is QUESTIONABLE WHETHER this ASSOCIATION is random OR IF it REFLECTS a seasonal variation in dietary Vitamin D intake OR in the AWARENESS of the IMPORTANCE of Vitamin D supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('SUPERFICIAL_RELATIONSHIP', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 57), ('SUPERFICIAL_RELATIONSHIP', 63), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('IMPORTANT_CONSIDERATION', 131), ('IMPORTANT_CONSIDERATION', 148)]	8	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D')]
PMC3347007	4/2012	S178-PMC3347007	['IT IS POSSIBLE that null value IMPUTATION has caused an UNDERESTIMATION of Vitamin D supplementation, BUT since the ESTIMATED use of Vitamin D supplements is SIMILAR TO the one SEEN in norway [17], and lower than the one in finland [27], we do not think this ISSUE is RELEVANT.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 31), ('PROBLEM_COMPLICATION', 56), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 158), ('INCOMPLETE_EVIDENCE', 177), ('PROBLEM_COMPLICATION', 259), ('IMPORTANT_CONSIDERATION', 268)]	9	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D')]
PMC3347007	4/2012	S183-PMC3347007	['HOWEVER, we BELIEVE that the DETERMINANTS of Vitamin D intake SEEN in THIS STUDY MAY adequately reflect the ones of the background population.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 62), ('QUESTION_ANSWERED_BY_THIS_WORK', 70), ('INCOMPLETE_EVIDENCE', 81)]	6	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC3347028	3/2012	S0-PMC3347028	['Vitamin D and its ROLE during Pregnancy in attaining optimal health of mother and fetus\n\nabstract\nDESPITE its discovery a hundred years ago, Vitamin D has emerged as one of the most CONTROVERSIAL Nutrients and prohormones of the 21st century.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('ANOMALY_CURIOUS_FINDING', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 30, 'Pregnancy'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('CHEBI_33284', 'nutrient', 196, 'nutrients')]
PMC3347028	3/2012	S2-PMC3347028	['there are clear indicators from in vitro and Animal in vivo studies that POINT to Vitamin D’s INDISPUTABLE ROLE in both Innate and Adaptive Immunity; HOWEVER, the translation of THESE FINDINGS to clinical practice, including the Care of the Pregnant woman, has not occurred.']	[('INCOMPLETE_EVIDENCE', 73), ('IMPORTANT_CONSIDERATION', 94), ('SUPERFICIAL_RELATIONSHIP', 107), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 150), ('INCOMPLETE_EVIDENCE', 178)]	5	[('NCBITaxon_33208', 'Metazoa', 45, 'animal'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0007631', 'feeding behavior', 120, 'innate ...'), ('GO_0051866', 'general adaptation syndrome', 131, 'adaptive immunity'), ('GO_0007567', 'parturition', 229, 'care'), ('GO_0007565', 'female pregnancy', 241, 'pregnant')]
PMC3347028	3/2012	S23-PMC3347028	['WHILE certain Plants are capable of making both forms of Vitamin D, the major form made by Plants is Vitamin D2Following ultraviolet b exposure of the provitamin D2Ergosterol [4,5].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('NCBITaxon_10088', 'Mus <genus>', 14, 'plants'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 91, 'plants'), ('CHEBI_83390', 'pentachlorobenzenes', 101, 'vitamin D2following'), ('PR_000006490', 'solute carrier family 49 member 4', 109, 'D2following'), ('CHEBI_1646', '3-Oxooctanoyl-[acp]', 162, 'D2ergosterol')]
PMC3347028	3/2012	S25-PMC3347028	['(for the purposes of this review, UNLESS otherwise mentioned, when Vitamin D and its Metabolites are stated without a subscript, both families of Vitamin D—cholecalciferols and ergocalciferols are described.)']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 34)]	1	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 75, 'D'), ('CHEBI_25212', 'metabolite', 85, 'metabolites'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 154, 'D')]
PMC3347028	3/2012	S30-PMC3347028	['it is IMPORTANT TO NOTE that UNLIKE OTHER Steroid hormones in the body whose main substrate is Cholesterol, Vitamin D Synthesis requires the 7-Dehydrocholesterol precursor and sunlight at a specific wavelength and angle.']	[('IMPORTANT_CONSIDERATION', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 36)]	3	[('CHEBI_35341', 'steroid', 42, 'steroid'), ('CHEBI_16113', 'cholesterol', 95, 'cholesterol'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('GO_0031151', 'histone methyltransferase activity (H3-K79 specific)', 116, 'D synthesis'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 141, '7-dehydrocholesterol')]
PMC3347028	3/2012	S32-PMC3347028	['a western diet, HOWEVER, provides less than 200 iu (5 μg) Vitamin D/day, a point that was reestablished in our two recently completed Vitamin D clinical trial during Pregnancy [6].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 16)]	1	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0007565', 'female pregnancy', 166, 'pregnancy')]
PMC3347028	3/2012	S36-PMC3347028	['general Vitamin D Metabolism\nIN ORDER TO understand the DIFFERENCES between the nonpregnant and Pregnant states and their EFFECTS on Vitamin D Metabolism, it is ESSENTIAL to understand the nonpregnant state first.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 56), ('SUPERFICIAL_RELATIONSHIP', 122), ('IMPORTANT_CONSIDERATION', 161)]	4	[('CHEBI_28384', 'vitamin K', 8, 'Vitamin D'), ('GO_0046443', 'FAD metabolic process', 8, 'Vitamin D Metabolism'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 8, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 96, 'pregnant'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 133, 'vitamin D metabolism'), ('PR_000006444', 'diacylglycerol kinase delta', 141, 'D')]
PMC3347028	3/2012	S40-PMC3347028	['WHILE there APPEARS TO BE a DIFFERENTIAL conversion rate of the two forms of Vitamin D to 25(Oh)D [8], the conversion of either form is DEPENDENT on a functional Liver and the activity of 25-hydroxylase.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('SUPERFICIAL_RELATIONSHIP', 136)]	4	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 90, '25(OH)D'), ('UBERON_0002107', 'liver', 162, 'liver')]
PMC3347028	3/2012	S58-PMC3347028	['DESPITE these OBSERVATIONS, it was CONCLUDED that the condition of Vitamin D deficiency LED TO weakness and malnutrition and was not a direct EFFECT of Vitamin D on the Immune System.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 88), ('SUPERFICIAL_RELATIONSHIP', 142)]	6	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D'), ('UBERON_0002405', 'immune system', 169, 'immune system')]
PMC3347028	3/2012	S97-PMC3347028	['WHILE okonofua, et al, SUGGEST that normalization of maternal calcium and pth would be useful endpoints in determining the success of Vitamin D supplementation during Pregnancy, more RECENT STUDIES SUGGEST that BECAUSE pth threshold ESTIMATES cannot be precisely defined, total circulating 25(Oh)D ALONE is a BETTER measure of maternal Vitamin D status [60,64,65].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 183), ('INCOMPLETE_EVIDENCE', 198), ('PROBLEM_COMPLICATION', 211), ('INCOMPLETE_EVIDENCE', 233), ('ANOMALY_CURIOUS_FINDING', 298), ('INCOMPLETE_EVIDENCE', 298), ('INCOMPLETE_EVIDENCE', 309)]	9	[('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0007565', 'female pregnancy', 167, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 290, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 336, 'vitamin D')]
PMC3347028	3/2012	S109-PMC3347028	['throughout Gestation, IF a woman is Vitamin D deficient, it APPEARS to IMPACT fetal bone health more than maternal [66,67,68].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('ANOMALY_CURIOUS_FINDING', 60), ('SUPERFICIAL_RELATIONSHIP', 71)]	3	[('GO_0007565', 'female pregnancy', 11, 'gestation'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
PMC3347028	3/2012	S110-PMC3347028	['in addition, BASED on rickets and osteoporosis data, it APPEARS that bone health, which is LINKED with Renal production of 1,25(Oh)2D and Calcium Metabolism is maintained at significantly lower levels of circulating Vitamin D concentrations COMPARED to OTHER health factors such as Immune function, which is dependent on delivery of 25(Oh)D to cells of the target Tissue.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('ANOMALY_CURIOUS_FINDING', 56), ('SUPERFICIAL_RELATIONSHIP', 91), ('ANOMALY_CURIOUS_FINDING', 241), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 253)]	5	[('UBERON_0002113', 'kidney', 103, 'renal'), ('CHEBI_37958', 'dye', 123, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 125, '25(OH)2D'), ('CHEBI_22313', 'alkaline earth metal atom', 138, 'calcium'), ('GO_0018884', 'carbazole metabolic process', 138, 'calcium metabolism'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D'), ('UBERON_0002405', 'immune system', 282, 'immune'), ('CHEBI_71657', 'versiconol acetate', 333, '25(OH)D'), ('UBERON_0000479', 'tissue', 364, 'tissue')]
PMC3347028	3/2012	S115-PMC3347028	['using the RECENTLY revised institute of medicine’s (iom) 2010 criterion for Vitamin D deficiency of total circulating 25(Oh)D < 20 ng/ml (50 nmol/l) [72], approximately 70% of the african american COMPARED TO 35% of caucasian women in the rhode island study had evidence of Vitamin D deficiency during winter, with slight improvement during summer months compared to winter months in both groups.']	[('INCOMPLETE_EVIDENCE', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 197)]	2	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 118, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 118, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D')]
PMC3347028	3/2012	S125-PMC3347028	['YET, it was THOUGHT for the MOST PART that Vitamin D deficiency was RARE and COULD BE avoided through some sunlight exposure and a daily Vitamin D intake of 200 iu (5 μg) [80].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 12), ('PROBABLE_UNDERSTANDING', 28), ('PROBABLE_UNDERSTANDING', 28), ('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 77)]	7	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC3347028	3/2012	S146-PMC3347028	['such readily observable fetal and neonatal Skeletal EFFECTS of profound Vitamin D deficiency are easily understood in terms of cause and effect, BUT the more subtle EFFECTS of deficiency on the developing Immune System, for example, and subsequent infection risk or Immune dysfunction are more DIFFICULT to understand [19,84,97,98,99].']	[('SUPERFICIAL_RELATIONSHIP', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 145), ('SUPERFICIAL_RELATIONSHIP', 165), ('DIFFICULT_TASK', 294)]	4	[('UBERON_0004288', 'skeleton', 43, 'skeletal'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0002405', 'immune system', 205, 'immune system'), ('UBERON_0002405', 'immune system', 266, 'immune')]
PMC3347028	3/2012	S155-PMC3347028	['mcgrath and others continue to investigate WHETHER there are lasting EFFECTS of fetal and early infancy Vitamin D deficiency on later Adult disease processes such as Anatomical changes of the Brain, schizophrenia, multiple sclerosis, certain cancers, Cardiovascular disease, and various other Autoimmune diseases such as diabetes and lupus [106,107,108,109,110,111,112,113,114,115,116,117,118,119,120,121].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 43), ('SUPERFICIAL_RELATIONSHIP', 69)]	2	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('UBERON_0007023', 'adult organism', 134, 'adult'), ('UBERON_0001062', 'anatomical entity', 166, 'anatomical'), ('UBERON_0000955', 'brain', 192, 'brain'), ('UBERON_0004535', 'cardiovascular system', 251, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 293, 'autoimmune')]
PMC3347028	3/2012	S157-PMC3347028	['the FEW STUDIES that HAVE BEEN conducted have FOCUSED more on discernible neonatal EFFECTS of Vitamin D during Pregnancy, RATHER than the long-latency and later health EFFECTS.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 21), ('QUESTION_ANSWERED_BY_THIS_WORK', 46), ('SUPERFICIAL_RELATIONSHIP', 83), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('SUPERFICIAL_RELATIONSHIP', 168)]	6	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('GO_0007565', 'female pregnancy', 111, 'pregnancy')]
PMC3347028	3/2012	S161-PMC3347028	['WHILE there are numerous epidemiological studies that bear EVIDENCE of the ASSOCIATION between Vitamin D deficiency and altered health, definitive proof in terms of randomized controlled trials is often LACKING.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 75), ('FULL_UNKNOWN', 203)]	4	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC3347028	3/2012	S163-PMC3347028	['WHILE we await the results of numerous clinical trials now underway TO determine IF there is a discernible EFFECT of Vitamin D in altering RISK for various disease states to understand the ROLE of Vitamin D in health, it is IMPORTANT not TO discount the MOUNTING EVIDENCE from laboratory studies and prospective observation trials [103,104,105] that Vitamin D—as a preprohormone—is ESSENTIAL in maintaining the Immune System with PROFOUND IMPLICATIONS [19,138,139,140].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('SUPERFICIAL_RELATIONSHIP', 107), ('IMPORTANT_CONSIDERATION', 139), ('SUPERFICIAL_RELATIONSHIP', 189), ('IMPORTANT_CONSIDERATION', 224), ('QUESTION_ANSWERED_BY_THIS_WORK', 238), ('INCOMPLETE_EVIDENCE', 254), ('IMPORTANT_CONSIDERATION', 382), ('IMPORTANT_CONSIDERATION', 430), ('IMPORTANT_CONSIDERATION', 439)]	12	[('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 350, 'vitamin D'), ('UBERON_0002405', 'immune system', 411, 'immune system')]
PMC3347028	3/2012	S174-PMC3347028	['one does not become Vitamin D toxic from sunlight exposure; HOWEVER, in comparison, People have become toxic from Ingesting too much oral Vitamin D. in an Adult, it APPEARS that the upper limit of tolerability of Vitamin D is a daily consumption of thousands of international units of Vitamin D—above 10,000 iu/day [142,143].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 60), ('ANOMALY_CURIOUS_FINDING', 165)]	2	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 84, 'people'), ('GO_0007567', 'parturition', 114, 'ingesting'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('UBERON_0007023', 'adult organism', 155, 'adult'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 285, 'vitamin D')]
PMC3347028	3/2012	S177-PMC3347028	['in addition, WHAT amount of sunlight is sufficient to achieve optimal Vitamin D status varies DEPENDING ON a host of FACTORS such as the time of day, the time of year, the latitude, degree of skin pigmentation, type and extend of clothing, body surface area exposed and one’s body mass index (bmi) [146].']	[('EXPLICIT_QUESTION', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 94), ('SUPERFICIAL_RELATIONSHIP', 117)]	3	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC3347028	3/2012	S180-PMC3347028	['SINCE the modern diet supplies less than 10% of one’s total Vitamin D REQUIREMENTS, IF judicious sunlight exposure is not an option, then the only alternative for the Pregnant woman is Vitamin D supplementation.']	[('PROBLEM_COMPLICATION', 0), ('IMPORTANT_CONSIDERATION', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 84)]	3	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 167, 'pregnant'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
PMC3347028	3/2012	S216-PMC3347028	['having a higher 25(Oh)D concentration was ASSOCIATED with improved health outcomes in both studies, BUT WHETHER improved Vitamin D status is a MARKER of some OTHER parameter or a direct EFFECT of Vitamin D supplementation REMAINS UNCLEAR at this time.']	[('SUPERFICIAL_RELATIONSHIP', 42), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 104), ('SUPERFICIAL_RELATIONSHIP', 143), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158), ('SUPERFICIAL_RELATIONSHIP', 186), ('FULL_UNKNOWN', 222)]	7	[('CHEBI_71657', 'versiconol acetate', 16, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin D')]
PMC3347028	3/2012	S217-PMC3347028	['studies specifically designed and powered to answer the QUESTION of WHETHER OR NOT Vitamin D supplementation LEADS TO improved health outcomes—lower RISK of Preterm Birth, preeclampsia, and infection REMAIN to be done.']	[('EXPLICIT_QUESTION', 56), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('SUPERFICIAL_RELATIONSHIP', 109), ('IMPORTANT_CONSIDERATION', 149), ('INCOMPLETE_EVIDENCE', 200)]	5	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0007565', 'female pregnancy', 157, 'preterm birth')]
PMC3347028	3/2012	S218-PMC3347028	['we can conservatively say that WHILE we do not understand completely the ROLE of 1,25(Oh)2D during Pregnancy, achieving OPTIMAL production can be done SAFELY with 4000 iu Vitamin D3/day, which APPEARS TO BE the amount of Vitamin D that would be conservatively generated by the body with adequate sunlight exposure over the duration of Gestation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('SUPERFICIAL_RELATIONSHIP', 73), ('IMPORTANT_CONSIDERATION', 120), ('IMPORTANT_CONSIDERATION', 151), ('ANOMALY_CURIOUS_FINDING', 193)]	5	[('CHEBI_37958', 'dye', 81, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 83, '25(OH)2D'), ('GO_0007565', 'female pregnancy', 99, 'pregnancy'), ('CHEBI_33279', 'vitamin D5', 171, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 171, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin D'), ('GO_0007565', 'female pregnancy', 335, 'gestation')]
PMC3347028	3/2012	S226-PMC3347028	['the health effects data from Vitamin D supplementation trials THUS FAR, WHILE TANTALIZING, are NOT CONCLUSIVE in SHOWING definitive “proof” for Vitamin D AS a POTENTIAL CANDIDATE in the reduction of comorbidities of Pregnancy, YET one CANNOT DISMISS the strong CORRELATION between reduced RISK with increased Serum 25(Oh)D concentrations.']	[('INCOMPLETE_EVIDENCE', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 72), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('INCOMPLETE_EVIDENCE', 113), ('PROBABLE_UNDERSTANDING', 154), ('INCOMPLETE_EVIDENCE', 159), ('INCOMPLETE_EVIDENCE', 169), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 227), ('ANOMALY_CURIOUS_FINDING', 227), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 235), ('SUPERFICIAL_RELATIONSHIP', 261), ('IMPORTANT_CONSIDERATION', 289)]	13	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('GO_0007565', 'female pregnancy', 216, 'pregnancy'), ('UBERON_0001977', 'blood serum', 309, 'serum'), ('CHEBI_71657', 'versiconol acetate', 315, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 315, '25(OH)D')]
PMC3347028	3/2012	S231-PMC3347028	['IF so, does substrate sufficiency—EITHER through adequate sunlight exposure OR Vitamin D supplementation—saturate such EFFECTS, making them clinically irrelevant?']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('SUPERFICIAL_RELATIONSHIP', 119), ('EXPLICIT_QUESTION', 161)]	4	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC3347028	3/2012	S239-PMC3347028	['what is clear, HOWEVER, is that Vitamin D deficiency during Pregnancy is RAMPANT throughout the world, including countries such as the united states and great britain.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 15), ('IMPORTANT_CONSIDERATION', 73)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007565', 'female pregnancy', 60, 'pregnancy')]
PMC3347028	3/2012	S240-PMC3347028	['WHILE there REMAINS much to be DISCOVERED and learned about Vitamin D’s EFFECT on the mother and her developing fetus, there is enough EVIDENCE TO SUPPORT the PREMISE that deficiency is not healthful for either the mother or fetus.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 72), ('INCOMPLETE_EVIDENCE', 135), ('INCOMPLETE_EVIDENCE', 159)]	6	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC3348565	4/2012	S18-PMC3348565	['HOWEVER, the risk of repeated pneumonia in the subsequent 3 months was 13% (relative risk [rr] 0·78, 95% ci 0·64–0·94; p=0·01) lower in the Vitamin D3Compared with the placebo group.3OTHER more RECENT STUDIES assessing different outcomes in children or Adults have CONFLICTING findings on the effectiveness of Vitamin D.\nthere is GROWING EVIDENCE of the Vitamin D parancrine system enhancing Innate Immunity:4the activation of toll-like receptors on Monocytes and Macrophages by Microbial pathogens results in increased Expression of Cyp27B1 and Vitamin D Receptor ( vdr ) Genes within these cells.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 183), ('INCOMPLETE_EVIDENCE', 194), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 265), ('INCOMPLETE_EVIDENCE', 330)]	6	[('CHEBI_59884', 'XDP(3-)', 140, 'vitamin D3compared'), ('UBERON_0007023', 'adult organism', 253, 'adults'), ('CHEBI_27300', 'vitamin D', 310, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 354, 'vitamin D'), ('GO_0045087', 'innate immune response', 392, 'innate immunity'), ('CL_0000576', 'monocyte', 450, 'monocytes'), ('CL_0000235', 'macrophage', 464, 'macrophages'), ('NCBITaxon_10088', 'Mus <genus>', 479, 'microbial'), ('GO_0010467', 'gene expression', 520, 'expression'), ('PR_000006101', 'cytochrome P450 1A1', 534, 'CYP27B1'), ('CHEBI_27300', 'vitamin D', 546, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 546, 'vitamin D receptor'), ('SO_0000704', 'gene', 573, 'genes')]
PMC3348565	4/2012	S22-PMC3348565	['there is DEBATE between investigators regarding concentrations that RELATE to optimum stores of Vitamin D in the body.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('SUPERFICIAL_RELATIONSHIP', 68)]	2	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D')]
PMC3348565	4/2012	S96-PMC3348565	['on intention-to-treat analysis, the incidence of the first episode of pneumonia was greater in the Vitamin D rather than the placebo group, ALTHOUGH this difference was not statistically significant (table 2).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 140)]	1	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
PMC3348565	4/2012	S121-PMC3348565	['ALTHOUGH this is PROBABLY TRUE, a sufficient Serum concentrations for the immunological EFFECTS of Vitamin D is UNKNOWN and COULD BE higher or lower than that of the Skeletal system accepted concentrations.6THE NEED for a steady state is currently highly SPECULATIVE and RELATES to Vitamin D2Supplementation for negative cancer22and bone outcomes.23\nour findings are AT ODDS with SMALLER case-control hospital STUDIES that show an enhanced rate of Vitamin D deficiency or rickets in children with pneumonia and the INCREASING EVIDENCE SUGGESTING that Calcitriol, the biologically active Metabolite of Vitamin D, has an IMPORTANT ROLE in the Human Immune System.4a systematic review of the ROLE of Vitamin D supplementation in infectious diseases had MIXED findings, CONCLUDING that more rigorously designed clinical trials ARE NEEDED (panel).25NO STUDIES report the EFFECT of Vitamin D on radiologically confirmed pneumonias.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 17), ('PROBABLE_UNDERSTANDING', 26), ('SUPERFICIAL_RELATIONSHIP', 88), ('FULL_UNKNOWN', 112), ('INCOMPLETE_EVIDENCE', 124), ('INCOMPLETE_EVIDENCE', 207), ('INCOMPLETE_EVIDENCE', 255), ('SUPERFICIAL_RELATIONSHIP', 271), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 367), ('INCOMPLETE_EVIDENCE', 380), ('INCOMPLETE_EVIDENCE', 515), ('INCOMPLETE_EVIDENCE', 535), ('IMPORTANT_CONSIDERATION', 619), ('SUPERFICIAL_RELATIONSHIP', 629), ('SUPERFICIAL_RELATIONSHIP', 689), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 750), ('PROBABLE_UNDERSTANDING', 766), ('FUTURE_WORK', 823), ('INCOMPLETE_EVIDENCE', 844), ('SUPERFICIAL_RELATIONSHIP', 866)]	21	[('UBERON_0001977', 'blood serum', 45, 'serum'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('UBERON_0004288', 'skeleton', 166, 'skeletal'), ('CHEBI_52910', 'delta-lactam ring', 282, 'vitamin D2supplementation'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 282, 'vitamin D2supplementation'), ('CHEBI_27300', 'vitamin D', 448, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 551, 'calcitriol'), ('CHEBI_39382', 'flufenoxuron', 587, 'metabolite'), ('CHEBI_27300', 'vitamin D', 601, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 641, 'human'), ('UBERON_0002405', 'immune system', 647, 'immune system'), ('CHEBI_27300', 'vitamin D', 697, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 876, 'vitamin D')]
PMC3348565	4/2012	S127-PMC3348565	['AS IN our studies, these INCONSISTENT findings POINT to the existence of COMPLICATED pathways for the function of Vitamin D in disease processes, or simply that the correct effective dose of Vitamin D supplementation NEEDS to be BETTER defined.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('INCOMPLETE_EVIDENCE', 47), ('DIFFICULT_TASK', 73), ('FUTURE_WORK', 217), ('INCOMPLETE_EVIDENCE', 229)]	6	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D')]
PMC3348565	4/2012	S130-PMC3348565	['these SPECULATIONS RELATE two studies in which supplementation of a single large dose (300\u200800033or 500\u200800023iu) of Vitamin D for reducing fractures in elderly women led to an increase in fractures, plus similar DISCREPANCIES in Prostate cancer research with Vitamin D.22our findings and particularly the slightly higher repeat episodes of pneumonia in the vitamin d group COULD BE DUE TO such fluctuations IF the HYPOTHESIS is TRUE.']	[('INCOMPLETE_EVIDENCE', 6), ('SUPERFICIAL_RELATIONSHIP', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 211), ('INCOMPLETE_EVIDENCE', 372), ('PROBLEM_COMPLICATION', 381), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 406), ('INCOMPLETE_EVIDENCE', 413), ('PROBABLE_UNDERSTANDING', 427)]	8	[('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('UBERON_0002367', 'prostate gland', 228, 'prostate'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D')]
PMC3348565	4/2012	S133-PMC3348565	['FURTHER QUESTIONS arise with respect to the previous treatment trial in the same region of kabul, which showed that a single high-dose supplementation with 100\u2008000 iu Vitamin D3Given orally to young children, along with Antibiotic treatment at the time of diagnosis, reduced repeat episodes of pneumonia in the subsequent 3 months.3the INCONSISTENT results COULD BE RELATED to the evidence that stimulation of toll-like receptors on Macrophages and Monocytes by Bacterial Antigens is IMPORTANT in up-regulation of Cyp27B1 and the Vitamin D receptor,5which are CRUCIAL in Production Of Cathelicidins in Vitamin-D-depleted Individuals.']	[('FUTURE_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 336), ('INCOMPLETE_EVIDENCE', 357), ('SUPERFICIAL_RELATIONSHIP', 366), ('IMPORTANT_CONSIDERATION', 484), ('IMPORTANT_CONSIDERATION', 560)]	6	[('CHEBI_67916', '2alpha,3beta,23-trihydroxylup-20(29)-en-28-oic acid', 167, 'vitamin D3given'), ('PR_000001177', 'D(2) dopamine receptor', 175, 'D3given'), ('CHEBI_33282', 'antibacterial agent', 220, 'antibiotic'), ('CL_0000235', 'macrophage', 433, 'macrophages'), ('CL_0000576', 'monocyte', 449, 'monocytes'), ('CHEBI_22695', 'base', 462, 'bacterial'), ('CHEBI_59132', 'antigen', 472, 'antigens'), ('PR_000006101', 'cytochrome P450 1A1', 514, 'CYP27B1'), ('CHEBI_27300', 'vitamin D', 530, 'vitamin D'), ('GO_0030154', 'cell differentiation', 571, 'production of cathelicidins'), ('CHEBI_83326', 'tedizolid phosphate', 602, 'vitamin-D'), ('NCBITaxon_1', 'root', 621, 'individuals')]
PMC3348565	4/2012	S138-PMC3348565	['ALTHOUGH Vitamin D overload is a theoretical POSSIBILITY, 100\u2008000 iu of Vitamin D3Has BEEN shown to provide the best protection against Vitamin D deficiency without overload or side-effects in high-risk infants aged 0–9 months with normal baseline ranges of Vitamin D.16furthermore, single intramuscular injection of three times this dose (300\u2008000 iu) was safe in treating nutritional rickets in 6–30-month-old children residing in lower socioeconomic regions of sunny istanbul.35higher than RECOMMENDED doses of daily supplementation of Vitamin D (500–1000 iu per day, adding up to 120\u2008000 iu over 3 months) plus additional milk fortified with Vitamin D, HAS BEEN shown not to induce an overload,13including in infants starting with normal ranges of Vitamin D, EVEN when supplementation continued during the summer (in france) and when mothers had Antenatal Vitamin D supplementation.36it is IMPORTANT to note that in our study, where community supplementation was in a population with known high rates of Vitamin D deficiency, 1% of children tested had a Calcifediol concentration greater than 375 nmol/l—THOUGHT UNDESIRABLY high.6ALTHOUGH these did not produce any clinical signs and symptoms, these measurements raise a NEED for CAUTION with doses for population supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 82), ('FUTURE_WORK', 492), ('INCOMPLETE_EVIDENCE', 656), ('ANOMALY_CURIOUS_FINDING', 762), ('IMPORTANT_CONSIDERATION', 893), ('INCOMPLETE_EVIDENCE', 1107), ('PROBLEM_COMPLICATION', 1115), ('ANOMALY_CURIOUS_FINDING', 1133), ('FUTURE_WORK', 1224), ('IMPORTANT_CONSIDERATION', 1233)]	12	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_35646', 'galanthan', 72, 'vitamin D3has'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 72, 'vitamin D3has'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 538, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 645, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 751, 'vitamin D'), ('GO_0007567', 'parturition', 849, 'antenatal'), ('CHEBI_27300', 'vitamin D', 859, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1007, 'vitamin D'), ('CHEBI_22975', 'cadinane sesquiterpenoid', 1057, 'calcifediol')]
PMC3355895	1/2011	S50-PMC3355895	['the Regulation of this process is AS YET UNKNOWN, but at least one of the Isoforms of Pmca HAS BEEN shown to be Regulated by 1,25(Oh)-Vitamin D (kip and strehler,2004), and in SOME Animals, BUT NOT OTHERS, 1,25(Oh)2-Vitamin D APPEARS necessary for maintenance of the maternofetal calcium gradient (lester,1986).']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 34), ('FULL_UNKNOWN', 37), ('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 176), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 190), ('ANOMALY_CURIOUS_FINDING', 226)]	7	[('GO_0065007', 'biological regulation', 4, 'regulation'), ('SO_0001060', 'sequence_variant', 74, 'isoforms'), ('PR_000012924', 'bifunctional polynucleotide phosphatase/kinase', 86, 'PMCA'), ('GO_0065007', 'biological regulation', 112, 'regulated'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 130, 'OH)-'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 181, 'animals'), ('CHEBI_75874', 'para-terphenyl', 206, '1,25(OH)2-'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D')]
PMC3355895	1/2011	S171-PMC3355895	['1,25(oh)-Vitamin D HAS BEEN SHOWN to Regulate OTHER Pmca Isoforms (kip and strehler,2004) and is THEREFORE a POTENTIAL CANDIDATE.']	[('INCOMPLETE_EVIDENCE', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 46), ('PROBABLE_UNDERSTANDING', 97), ('INCOMPLETE_EVIDENCE', 109), ('INCOMPLETE_EVIDENCE', 119)]	5	[('CHEBI_37958', 'dye', 0, '1,'), ('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0065007', 'biological regulation', 37, 'regulate'), ('PR_000012924', 'bifunctional polynucleotide phosphatase/kinase', 52, 'PMCA'), ('SO_0001060', 'sequence_variant', 57, 'isoforms')]
PMC3356951	4/2012	S26-PMC3356951	['Vitamin D that comes from the skin or diet is biologically inert and REQUIRES its first hydroxylation in the Liver by the Vitamin D-25-hydroxylase (25-ohase) to 25(Oh)D.[311] HOWEVER, 25(Oh)D requires a further hydroxylation in the Kidneys by the 25(Oh)D-1-Ohase (Cyp27B1) to form the biologically active form of Vitamin D 1,25(Oh)2D.']	[('IMPORTANT_CONSIDERATION', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 175), ('ANOMALY_CURIOUS_FINDING', 175)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('UBERON_0002107', 'liver', 109, 'liver'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 161, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 184, '25(OH)D'), ('UBERON_0002113', 'kidney', 232, 'kidneys'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 250, 'OH)D'), ('CHEBI_32906', 'gibberellin A24', 257, 'OHase'), ('PR_000006101', 'cytochrome P450 1A1', 264, 'CYP27B1'), ('CHEBI_27300', 'vitamin D', 313, 'vitamin D'), ('CHEBI_17996', 'chloride', 324, ','), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 325, '25(OH)2D')]
PMC3356951	4/2012	S88-PMC3356951	['[68] another example of Extrarenal Regulation of 1α-hydroxylase is that the increased Production Of 1,25(Oh)2D by Keratinocytes in wounds[69] THEREFORE provides a good ESTIMATE of Vitamin D status, BUT Regulation of 1α-hydroxylase activity SHOULD also BE CONSIDERED.']	[('SUPERFICIAL_RELATIONSHIP', 35), ('PROBABLE_UNDERSTANDING', 142), ('INCOMPLETE_EVIDENCE', 168), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 198), ('FUTURE_WORK', 240), ('ANOMALY_CURIOUS_FINDING', 252), ('FUTURE_WORK', 255)]	7	[('UBERON_0001691', 'external ear', 24, 'extrarenal'), ('GO_0065007', 'biological regulation', 35, 'regulation'), ('GO_0034205', 'amyloid-beta formation', 86, 'production of ... 2D'), ('CHEBI_82784', 'PVP38-Ag NP', 100, '1,25(OH)2D'), ('CL_0000312', 'keratinocyte', 114, 'keratinocytes'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('GO_0065007', 'biological regulation', 202, 'regulation')]
PMC3356951	4/2012	S101-PMC3356951	['[71] a definitive conclusion cannot yet be made about the ASSOCIATION between Vitamin D concentration and cancer RISK, BUT results from MANY STUDIES are promising.']	[('SUPERFICIAL_RELATIONSHIP', 58), ('IMPORTANT_CONSIDERATION', 113), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 119), ('INCOMPLETE_EVIDENCE', 136)]	4	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC3356951	4/2012	S116-PMC3356951	['[90] a CORRELATION between Vitamin D and the risk diabetes CAN be RULED in from the results.']	[('SUPERFICIAL_RELATIONSHIP', 7), ('INCOMPLETE_EVIDENCE', 59), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 66)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
PMC3356951	4/2012	S165-PMC3356951	['it is the FIRST of the new Vitamin D analogs to be approved for secondary hyperparathyroidism and DIFFERS from Calcitriol in that it lacks the exocyclic carbon 19 and has a Vitamin D2Side Chain INSTEAD of a Vitamin D3Side Chain.']	[('INCOMPLETE_EVIDENCE', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 194)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 111, 'calcitriol'), ('CHEBI_66361', 'Viridamide A', 173, 'vitamin D2side chain'), ('CHEBI_66361', 'Viridamide A', 207, 'vitamin D3side chain')]
PMC3376765	6/2012	S144-PMC3376765	['BECAUSE the KEY comparisons we make in our rct are between daily supplements with iron versus iron and zinc or between weekly iron supplements with iron versus iron and zinc, Vitamin B-12 is not a factor in INTERPRETING these DIFFERENCES.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 12), ('PROBABLE_UNDERSTANDING', 207), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 226)]	4	[('CHEBI_27300', 'vitamin D', 175, 'vitamin B')]
PMC3385441	2/2012	S269-PMC3385441	['caption (table-wrap): table 3\n\nchallenges to developing comprehensive fish Consumption ADVICE.viewpoint and challengesexamplestoxicological hazards: fish contaminants (e.g., mehg, Pcbs, Pesticides)multiple co-occurring contaminantssynergistic adverse EFFECTS on Neurodevelopment with Joint mehg and pcb exposureadvisories for single contaminantfarmed salmon low in mehg but can be high in pcbstoxicant levels vary within and across speciestilefish Mehg: high in gulf of mexico but low in atlanticvariable susceptibility to toxicitiesprenatal exposure: increased susceptibility to Mehg neurotoxicityconfounding by nutritional BENEFITSUNDERESTIMATION of hazard from mehg if CONFOUNDED by n‑3 lcpufasnutritional BENEFITS: fish Nutrients (e.g., n‑3 lcpufas, Vitamin D, Iodine, Selenium)multiple co-occurring nutrientsfor Neurodevelopment, fish intake more CONSISTENTLY beneficial than n‑3 lcpufa supplementsanutrient levels vary within and across specieshealth benefits associated with high n‑3 lcpufa fishaconfounding by contaminant riskunderestimation of benefit from n‑3 lcpufas if CONFOUNDED by Mehgincreased fish intake (for most populations) RECOMMENDED by nutrition GUIDELINESAVAILABLE fish insufficient to meet demand EVEN without greater intakeenvironmental sustainability: overfishing, habitat destruction, aquaculturemodern harvesting can deplete fish stocks, other aquatic wildlife, and habitatsfishing trawls plough the Seafloor, removing most, if not all, aquatic Life and structures in their pathwild fish stocks insufficient to meet projected GLOBAL demandapproximately 90% of large predatory fish stocks (e.g., bluefin Tuna, atlantic salmon) are already depletedaquaculture CAN adversely AFFECT wild fish and ecosystems; CONTAMINANTSFARMED salmon can escape and outcompete wild fish and MAY have higher Pcb levelseconomic INFLUENCES: consumer choice, industry stakeholders, fisheries managementeconomic ASSUMPTION of improved consumer welfare with more information not necessarily TRUE for fish choiceu.s.']	[('FUTURE_WORK', 87), ('SUPERFICIAL_RELATIONSHIP', 251), ('IMPORTANT_CONSIDERATION', 625), ('DIFFICULT_TASK', 672), ('IMPORTANT_CONSIDERATION', 709), ('PROBABLE_UNDERSTANDING', 852), ('DIFFICULT_TASK', 1081), ('FUTURE_WORK', 1144), ('PROBABLE_UNDERSTANDING', 1169), ('ANOMALY_CURIOUS_FINDING', 1222), ('IMPORTANT_CONSIDERATION', 1555), ('INCOMPLETE_EVIDENCE', 1687), ('SUPERFICIAL_RELATIONSHIP', 1701), ('IMPORTANT_CONSIDERATION', 1734), ('INCOMPLETE_EVIDENCE', 1800), ('SUPERFICIAL_RELATIONSHIP', 1835), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1916), ('PROBABLE_UNDERSTANDING', 1994)]	18	[('GO_0007631', 'feeding behavior', 75, 'consumption'), ('CHEBI_26199', 'polyprenol', 180, 'PCBs'), ('CHEBI_35392', 'glucarate(1-)', 186, 'pesticides'), ('GO_0007399', 'nervous system development', 262, 'neurodevelopment'), ('UBERON_0004905', 'articulation', 284, 'joint'), ('CHEBI_82056', 'Mebenil', 448, 'MeHg'), ('CHEBI_82056', 'Mebenil', 580, 'MeHg'), ('CHEBI_33284', 'nutrient', 724, 'nutrients'), ('CHEBI_27300', 'vitamin D', 754, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 765, 'iodine'), ('CHEBI_27568', 'selenium atom', 773, 'selenium'), ('GO_0007399', 'nervous system development', 817, 'neurodevelopment'), ('CHEBI_82492', 'N-Methylolacrylamide', 1095, 'MeHgIncreased'), ('UBERON_0001273', 'ilium', 1429, 'seafloor'), ('UBERON_0000104', 'life cycle', 1474, 'life'), ('NCBITaxon_10088', 'Mus <genus>', 1632, 'tuna'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 1816, 'PCB')]
PMC3395583	7/2012	S1-PMC3395583	["we AIMED TO INVESTIGATE WHETHER season of Birth INFLUENCES the risk of rheumatoid arthritis, crohn's disease, ulcerative colitis and systemic lupus erythematosus in addition to multiple sclerosis, and TO EXPLORE the CORRELATION between the risk of id and predicted ultraviolet b (uvb) light exposure and Vitamin D status during Gestation."]	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('SUPERFICIAL_RELATIONSHIP', 48), ('QUESTION_ANSWERED_BY_THIS_WORK', 201), ('SUPERFICIAL_RELATIONSHIP', 216)]	6	[('GO_0007567', 'parturition', 42, 'birth'), ('CHEBI_27300', 'vitamin D', 304, 'vitamin D'), ('GO_0007565', 'female pregnancy', 328, 'gestation')]
PMC3395583	7/2012	S21-PMC3395583	['DESPITE these DIFFERENCES, an abnormal Activation Of the Immune System is a common thread LINKING these conditions and several OBSERVATIONS INDICATE that similar Genetic pathways and environmental agents, such as Vitamin D deficiency, smoking behaviour and various infections, are INVOLVED in the pathogenesis of these disorders [18-20,22-25].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('SUPERFICIAL_RELATIONSHIP', 90), ('INCOMPLETE_EVIDENCE', 127), ('INCOMPLETE_EVIDENCE', 140), ('SUPERFICIAL_RELATIONSHIP', 281)]	7	[('GO_0000103', 'sulfate assimilation', 39, 'activation of ... immune system'), ('UBERON_0002405', 'immune system', 57, 'immune system'), ('SO_0000704', 'gene', 162, 'genetic'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D')]
PMC3395583	7/2012	S24-PMC3395583	['since all these conditions HAVE BEEN LINKED to Vitamin D deficiency [23,24], we also TESTED WHETHER the risk of disease by month of Birth follows the same seasonal distribution of predicted ultraviolet b (uvb) light radiation and 25-Hydroxyvitamin D (25-Oh-D) levels during Gestation.']	[('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 37), ('QUESTION_ANSWERED_BY_THIS_WORK', 85), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92)]	4	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007567', 'parturition', 132, 'birth'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 230, '25-hydroxyvitamin D'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 251, '25-OH-D'), ('GO_0007565', 'female pregnancy', 274, 'gestation')]
PMC3395583	7/2012	S56-PMC3395583	['we next INVESTIGATED WHETHER the monthly risk of id inversely CORRELATED with PREDICTED Gestational Uvb exposure and Vitamin D status during different Trimesters of Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 21), ('SUPERFICIAL_RELATIONSHIP', 62), ('SUPERFICIAL_RELATIONSHIP', 78)]	4	[('GO_0007565', 'female pregnancy', 88, 'gestational'), ('CHEBI_37043', "pyrimidine 2'-deoxyribonucleoside 5'-triphosphate", 100, 'UVB'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('GO_0043033', 'isoamylase complex', 151, 'trimesters'), ('GO_0007565', 'female pregnancy', 165, 'pregnancy')]
PMC3395583	7/2012	S85-PMC3395583	['furthermore, the seasonal variation of 25-Oh-D levels WAS NOT INVESTIGATED AND NO other STUDIES have tried to answer the same QUESTION in id OTHER than ms. we FOUND that the risk of id was inversely ASSOCIATED with PREDICTED second trimester Uvb exposure and third trimester Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 54), ('FULL_UNKNOWN', 58), ('QUESTION_ANSWERED_BY_THIS_WORK', 62), ('EXPLICIT_QUESTION', 126), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('INCOMPLETE_EVIDENCE', 159), ('SUPERFICIAL_RELATIONSHIP', 199), ('SUPERFICIAL_RELATIONSHIP', 215)]	8	[('CHEBI_46744', 'DDT-2,3-dihydrodiol', 39, '25-OH-D'), ('CHEBI_37043', "pyrimidine 2'-deoxyribonucleoside 5'-triphosphate", 242, 'UVB'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D')]
PMC3395583	7/2012	S101-PMC3395583	['it is IMPORTANT TO NOTE that our uvb and Vitamin D CORRELATION analysis DOES NOT prove causation and that, ALTHOUGH the Vitamin D HYPOTHESIS is SUPPORTED by both epidemiological and functional OBSERVATIONS, seasonality dominates many features of the global environment and OTHER seasonal factors MAY play a ROLE in determining the risk of id.']	[('IMPORTANT_CONSIDERATION', 6), ('SUPERFICIAL_RELATIONSHIP', 51), ('ANOMALY_CURIOUS_FINDING', 72), ('ANOMALY_CURIOUS_FINDING', 107), ('INCOMPLETE_EVIDENCE', 130), ('INCOMPLETE_EVIDENCE', 144), ('INCOMPLETE_EVIDENCE', 193), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 273), ('INCOMPLETE_EVIDENCE', 296), ('SUPERFICIAL_RELATIONSHIP', 307)]	10	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC3407995	7/2012	S16-PMC3407995	['titles and abstracts were reviewed and reports were selected for inclusion in the review if they were systematic reviews, meta-analyses, randomised controlled trials, cohort studies, cross-sectional or case-control studies and IF they reported BENEFITS and/or harms ASSOCIATED with maternal supplementation with Dha, Vitamin D, Folic Acid or Iodine during Pregnancy and/or Lactation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 227), ('IMPORTANT_CONSIDERATION', 244), ('SUPERFICIAL_RELATIONSHIP', 266)]	3	[('CHEBI_17874', 'dihydrozeatin', 312, 'DHA'), ('CHEBI_27300', 'vitamin D', 317, 'vitamin D'), ('CHEBI_30751', 'formic acid', 328, 'folic acid'), ('CHEBI_24859', 'iodine atom', 342, 'iodine'), ('GO_0007565', 'female pregnancy', 356, 'pregnancy'), ('GO_0007595', 'lactation', 373, 'lactation')]
PMC3407995	7/2012	S83-PMC3407995	['there are very few dietary sources of Vitamin D. oily fish such as herring, Mackerel, pilchards, sardines and Tuna are rich sources BUT their Consumption in some countries is low.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 132)]	1	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('NCBITaxon_40674', 'Mammalia', 76, 'mackerel'), ('NCBITaxon_10088', 'Mus <genus>', 110, 'tuna'), ('GO_0007631', 'feeding behavior', 142, 'consumption')]
PMC3407995	7/2012	S84-PMC3407995	['the only OTHER useful sources are Eggs, fortified Margarines (REQUIRED in some countries by law to contain Vitamin D) and SOME fortified yoghurts and breakfast cereals.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('IMPORTANT_CONSIDERATION', 62), ('INCOMPLETE_EVIDENCE', 122)]	3	[('CL_0000025', 'egg cell', 34, 'eggs'), ('CHEBI_25140', 'maltodextrin', 50, 'margarines'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]
PMC3407995	7/2012	S85-PMC3407995	['HOWEVER, a recent global review of Vitamin D status HAS SHOWN that its Intake is OFTEN TOO low TO sustain healthy circulating 25(Oh)D in countries without mandatory staple Food fortification and is EVEN too low in countries that do fortify due to low Milk Consumption, vegetarianism, non-supplement use and low fish Intake [46].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 52), ('PROBABLE_UNDERSTANDING', 81), ('DIFFICULT_TASK', 87), ('ANOMALY_CURIOUS_FINDING', 198)]	5	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007631', 'feeding behavior', 71, 'intake'), ('CHEBI_71657', 'versiconol acetate', 126, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 126, '25(OH ... D'), ('CHEBI_33290', 'food', 172, 'food'), ('UBERON_0001913', 'milk', 251, 'milk'), ('GO_0007631', 'feeding behavior', 256, 'consumption'), ('GO_0007631', 'feeding behavior', 316, 'intake')]
PMC3407995	7/2012	S100-PMC3407995	['THEREFORE at its worst, Vitamin D deficiency CAN be Life threatening to the newborn, WHILE lesser deficiency CAN weaken Skull Bones risking Brain injury during Birth and can CONTRIBUTE to a multitude of future health PROBLEMS.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 85), ('INCOMPLETE_EVIDENCE', 109), ('SUPERFICIAL_RELATIONSHIP', 174), ('IMPORTANT_CONSIDERATION', 217)]	6	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('UBERON_0000104', 'life cycle', 52, 'life'), ('UBERON_0003215', 'alveolus', 120, 'skull bones'), ('UBERON_0000955', 'brain', 140, 'brain'), ('GO_0007567', 'parturition', 160, 'birth')]
PMC3407995	7/2012	S253-PMC3407995	['a STUDY in black and white Pregnant women residing in the northern united states FOUND that approximately 29% of black Pregnant women and 5% of white Pregnant women had Vitamin D deficiency (Serum 25(Oh)D less than 37.5 nmol/l); WHEREAS 54% of black women and 47% of white women had Vitamin D insufficiency (defined as Serum 25(Oh)D levels 37.5 to 80 nmol/l) [122].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 229)]	3	[('GO_0007565', 'female pregnancy', 27, 'pregnant'), ('GO_0007565', 'female pregnancy', 119, 'pregnant'), ('GO_0007565', 'female pregnancy', 150, 'pregnant'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D'), ('UBERON_0001977', 'blood serum', 191, 'serum'), ('CHEBI_71657', 'versiconol acetate', 197, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 197, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D'), ('UBERON_0001977', 'blood serum', 319, 'serum'), ('CHEBI_71657', 'versiconol acetate', 325, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 325, '25 ... OH ... D')]
PMC3407995	7/2012	S256-PMC3407995	['seasonal variation increases the risk of Vitamin D deficiency in Pregnancy, with greater prevalence of Vitamin D deficiency during the winter months COMPARED TO the summer months [139].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 149)]	1	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC3407995	7/2012	S261-PMC3407995	['maternal Vitamin D status early in Pregnancy was ASSOCIATED with risk of low Birth weight and small-for-Gestational age infants in ONE STUDY, WHEREAS another study FOUND this RELATION ONLY among white women [141].']	[('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 131), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 142), ('INCOMPLETE_EVIDENCE', 164), ('SUPERFICIAL_RELATIONSHIP', 175), ('ANOMALY_CURIOUS_FINDING', 184), ('INCOMPLETE_EVIDENCE', 184)]	7	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 35, 'pregnancy'), ('GO_0007567', 'parturition', 77, 'birth'), ('GO_0007565', 'female pregnancy', 104, 'gestational')]
PMC3407995	7/2012	S290-PMC3407995	['HOWEVER, because Vitamin D intake is highly CORRELATED with the Intake of Long Chain N -3 Fatty Acids in the norwegian diet, the authors cautioned that further RESEARCH IS NEEDED to disentangle the separate EFFECTS of these Nutrients.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 44), ('FUTURE_WORK', 160), ('SUPERFICIAL_RELATIONSHIP', 207)]	4	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0007631', 'feeding behavior', 64, 'intake'), ('CHEBI_25098', 'lyxoside', 74, 'long chain n -3 fatty acids'), ('CHEBI_33284', 'nutrient', 224, 'nutrients')]
PMC3407995	7/2012	S303-PMC3407995	['HOWEVER, one SHOULD CONSIDER the COMPLEX nature of Vitamin D EFFECTS SINCE EITHER deficiency OR excess MAY BE harmful [53].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 13), ('FUTURE_WORK', 20), ('DIFFICULT_TASK', 33), ('SUPERFICIAL_RELATIONSHIP', 61), ('PROBABLE_UNDERSTANDING', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93), ('INCOMPLETE_EVIDENCE', 103)]	9	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC3407995	7/2012	S432-PMC3407995	['Vitamin D\ncurrently there are NO CONSISTENT RECOMMENDATIONS amongst or EVEN within countries for Vitamin D intake during Pregnancy and Lactation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('FUTURE_WORK', 44), ('ANOMALY_CURIOUS_FINDING', 71)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('GO_0007565', 'female pregnancy', 121, 'pregnancy'), ('GO_0007595', 'lactation', 135, 'lactation')]
PMC3407995	7/2012	S436-PMC3407995	['a RECENT cochrane review ASSESSED the EFFECTS and SAFETY of Vitamin D supplementation in Pregnancy and EXAMINED WHETHER supplementation with Vitamin D alone OR in combination with Calcium and other Vitamins and Minerals given to women during Pregnancy COULD SAFELY improve Pregnancy outcomes [175].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 38), ('IMPORTANT_CONSIDERATION', 50), ('QUESTION_ANSWERED_BY_THIS_WORK', 103), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('INCOMPLETE_EVIDENCE', 252), ('IMPORTANT_CONSIDERATION', 258)]	8	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 180, 'calcium'), ('CHEBI_33277', 'gamma-tocotrienol', 198, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 211, 'minerals'), ('GO_0007565', 'female pregnancy', 242, 'pregnancy'), ('GO_0007565', 'female pregnancy', 273, 'pregnancy')]
PMC3407995	7/2012	S438-PMC3407995	['data from four trials involving 414 women CONSISTENTLY SHOWED that women who received Vitamin D supplements during Pregnancy had higher concentrations of Vitamin D in Serum at term than those women who received no intervention or a placebo; HOWEVER the magnitude of the response was highly heterogenous.']	[('PROBABLE_UNDERSTANDING', 42), ('INCOMPLETE_EVIDENCE', 55), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 241)]	3	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('UBERON_0001977', 'blood serum', 167, 'serum')]
PMC3407995	7/2012	S449-PMC3407995	['the authors CONCLUDED that Vitamin D supplementation of 4000 iu/day for Pregnant women is SAFE and MOST EFFECTIVE in achieving sufficiency in all women and their neonates regardless of race, WHEREAS the current ESTIMATED average REQUIREMENT is comparatively ineffective at achieving adequate circulating 25(Oh)D concentrations, especially in african americans [179].']	[('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 90), ('PROBABLE_UNDERSTANDING', 99), ('SUPERFICIAL_RELATIONSHIP', 104), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 191), ('INCOMPLETE_EVIDENCE', 211), ('IMPORTANT_CONSIDERATION', 229)]	7	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 72, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 304, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 304, '25(OH)D')]
PMC3407995	7/2012	S480-PMC3407995	['HOWEVER, common dietary DEFICIENCIES within many populations of particular Nutrients including dha, Vitamin D, Folic Acid, and Iodine, that all play CRITICAL ROLES at various developmental stages, HAVE BEEN SHOWN to CONTRIBUTE to functional abnormalities, many of which have lasting EFFECTS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 24), ('IMPORTANT_CONSIDERATION', 149), ('SUPERFICIAL_RELATIONSHIP', 158), ('INCOMPLETE_EVIDENCE', 197), ('SUPERFICIAL_RELATIONSHIP', 216), ('SUPERFICIAL_RELATIONSHIP', 283)]	7	[('CHEBI_33284', 'nutrient', 75, 'nutrients'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('CHEBI_30751', 'formic acid', 111, 'folic acid'), ('CHEBI_24859', 'iodine atom', 127, 'iodine')]
PMC3409554	7/2012	S111-PMC3409554	['CONSEQUENTLY, Ferrous Iron supplements SHOULD BE taken between meals, preferably with fruit juice containing Vitamin C [38], which enhances absorption, WHEREAS Milk, coffee, and tea inhibit absorption.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 39), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 152)]	3	[('CHEBI_5014', 'fenvalerate', 14, 'ferrous iron'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin C'), ('UBERON_0001913', 'milk', 160, 'milk')]
PMC3411795	8/2012	S13-PMC3411795	['in particular those Animal MODELS that HAVE BEEN developed specifically to address KNOWN epidemiological risk factors for schizophrenia, such as Prenatal Vitamin D deficiency or Prenatal infection, reveal very early changes in Da Development[9],[10],[11],[12].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 27), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 83)]	4	[('NCBITaxon_33208', 'Metazoa', 20, 'animal'), ('GO_0007565', 'female pregnancy', 145, 'prenatal'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('GO_0007565', 'female pregnancy', 178, 'prenatal'), ('GO_0060539', 'diaphragm development', 227, 'DA development')]
PMC3415261	7/2012	S38-PMC3415261	['for example, the selection of the Animal model for studying Vitamin A supplementation is CRUCIAL because the Carotenoids are very differently absorbed DEPENDING ON the selected MODEL [7].']	[('IMPORTANT_CONSIDERATION', 89), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 151), ('INCOMPLETE_EVIDENCE', 177)]	3	[('NCBITaxon_33208', 'Metazoa', 34, 'animal'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin A'), ('CHEBI_50815', 'norgestimate', 109, 'carotenoids')]
PMC3424155	8/2012	S165-PMC3424155	['HOWEVER, Vitamin D insufficiency is STILL UNDER-RECOGNIZED and UNDER-TREATED, DESPITE its prevalence.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 36), ('IMPORTANT_CONSIDERATION', 42), ('IMPORTANT_CONSIDERATION', 63), ('ANOMALY_CURIOUS_FINDING', 78)]	5	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
PMC3424155	8/2012	S208-PMC3424155	['the MAJOR AIM of the study was TO INVESTIGATE Glomerular Development and Renal structure at Birth, 10 days and Adulthood in Mice Born to mothers Fed a diet restricted in Vitamin D. ALTHOUGH, we EXAMINED OTHER variables, such as body mass and 24 h Urine, the PRESENT STUDY was NOT DESIGNED TO investigate Renal functional and Metabolic CONSEQUENCES BUT RATHER was DESIGNED TO answer the QUESTION of WHETHER there were structural, Glomerular alterations or transgenerational EFFECTS.']	[('IMPORTANT_CONSIDERATION', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('QUESTION_ANSWERED_BY_THIS_WORK', 194), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 203), ('QUESTION_ANSWERED_BY_THIS_WORK', 258), ('INCOMPLETE_EVIDENCE', 276), ('IMPORTANT_CONSIDERATION', 335), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 348), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 352), ('QUESTION_ANSWERED_BY_THIS_WORK', 363), ('EXPLICIT_QUESTION', 386), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 398), ('SUPERFICIAL_RELATIONSHIP', 473)]	15	[('GO_0032835', 'glomerulus development', 46, 'glomerular development'), ('UBERON_0000074', 'renal glomerulus', 46, 'glomerular'), ('UBERON_0002113', 'kidney', 73, 'renal'), ('GO_0007567', 'parturition', 92, 'birth'), ('UBERON_0000113', 'post-juvenile adult stage', 111, 'adulthood'), ('NCBITaxon_10088', 'Mus <genus>', 124, 'mice'), ('GO_0007567', 'parturition', 129, 'born'), ('GO_0007631', 'feeding behavior', 145, 'fed'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('UBERON_0001088', 'urine', 247, 'urine'), ('UBERON_0002113', 'kidney', 304, 'renal'), ('GO_0008152', 'metabolic process', 325, 'metabolic'), ('UBERON_0000074', 'renal glomerulus', 429, 'glomerular')]
PMC3427192	4/2012	S15-PMC3427192	['vdrs are Expressed on a variety of Airway Immune Cells, where they function as classic Nuclear Steroid Hormone receptors and ultimately Regulate the transcription of numerous Genes associated with inflammation and Immunomodulation.27vitamin d also plays an IMPORTANT ROLE in Respiratory infection by facilitating Toll-Like Receptor Signaling through increased Synthesis of Human Cathelicidin Antimicrobial peptide,28-30which is cleaved to generate the active Cationic peptide, Ll-37.31,32vitamin D also exerts direct EFFECTS on target cells independent of Gene transcription33and MAY THEREFORE be of relevance to Airway inflammatory disorders.34while Vitamin D can suppress il-1735and Il-4-mediated Expression of Il-13,35,36it CAN also shift the th1/th2 balance toward th2 dominance.37THESE CONTRADICTORY actions MAY BE DUE to the direct actions of Vitamin D on cd4+T Cells to promote an Il-10-secreting T-Regulatory population.38\n\nBiosynthesis Of Vitamin D\nBiosynthesis Of Vitamin D begins PRIMARILY with absorption of solar ultravoilet-b (uvb) radiation and secondarily via Consumption of Vitamin D-rich and fortified foods, such as oily fish, fortified grains and dairy products.26following exposure to uvb radiation, 7-Dehydrocholesterol within the skin is converted to Previtamin D3( fig.']	[('IMPORTANT_CONSIDERATION', 257), ('SUPERFICIAL_RELATIONSHIP', 267), ('SUPERFICIAL_RELATIONSHIP', 517), ('INCOMPLETE_EVIDENCE', 580), ('PROBABLE_UNDERSTANDING', 584), ('INCOMPLETE_EVIDENCE', 727), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 783), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 791), ('INCOMPLETE_EVIDENCE', 813), ('IMPORTANT_CONSIDERATION', 820), ('PROBABLE_UNDERSTANDING', 991)]	11	[('GO_0010467', 'gene expression', 9, 'expressed'), ('UBERON_0001005', 'respiratory airway', 35, 'airway'), ('CL_0000738', 'leukocyte', 42, 'immune cells'), ('UBERON_0002405', 'immune system', 42, 'immune'), ('GO_0005634', 'nucleus', 87, 'nuclear'), ('CHEBI_26764', 'steroid hormone', 95, 'steroid hormone'), ('GO_0065007', 'biological regulation', 136, 'regulate'), ('SO_0000704', 'gene', 175, 'genes'), ('GO_0050900', 'leukocyte migration', 214, 'immunomodulation'), ('UBERON_0001004', 'respiratory system', 275, 'respiratory'), ('GO_0002770', 'T cell inhibitory signaling pathway', 313, 'Toll-like receptor signaling'), ('GO_0009057', 'macromolecule catabolic process', 360, 'synthesis'), ('NCBITaxon_9606', 'Homo sapiens', 373, 'human'), ('PR_000006009', 'alpha-catulin', 379, 'cathelicidin'), ('CHEBI_65381', 'albizoside C', 392, 'antimicrobial'), ('CHEBI_36916', 'cation', 459, 'cationic'), ('PR_000009809', 'leukocyte immunoglobulin-like receptor subfamily B member 2', 477, 'LL-37'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 496, 'D'), ('SO_0000704', 'gene', 556, 'gene'), ('UBERON_0001005', 'respiratory airway', 613, 'airway'), ('CHEBI_27300', 'vitamin D', 651, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 685, 'IL-4'), ('GO_0010467', 'gene expression', 699, 'expression'), ('PR_000001470', 'interleukin-28B', 713, 'IL-13'), ('CHEBI_27300', 'vitamin D', 849, 'vitamin D'), ('CL_0000084', 'T cell', 866, 'T cells'), ('PR_000001470', 'interleukin-28B', 888, 'IL-10'), ('CL_0000895', 'naive thymus-derived CD4-positive, alpha-beta T cell', 904, 'T'), ('CL_0000232', 'erythrocyte', 906, 'regulatory'), ('GO_0065007', 'biological regulation', 906, 'regulatory'), ('GO_0033593', 'BRCA2-MAGE-D1 complex', 932, 'Biosynthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 948, 'vitamin D'), ('GO_0033593', 'BRCA2-MAGE-D1 complex', 958, 'Biosynthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 974, 'vitamin D'), ('GO_0007631', 'feeding behavior', 1076, 'consumption'), ('CHEBI_27300', 'vitamin D', 1091, 'vitamin D'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 1221, '7-dehydrocholesterol'), ('PR_000014709', 'neuroserpin', 1274, 'previtamin D3')]
PMC3427192	4/2012	S18-PMC3427192	['1,25(Oh)2D3, also referred to as Calcitriol, is then transported throughout the body via the Blood to various cells types that Express vdrs, where Gene Expression is induced.24,39BECAUSE the MAJORITY of Vitamin D Metabolism occurs in this skin, several FACTORS ARE THOUGHT TO INFLUENCE Vitamin D skin Metabolism, including age, body fat, the level of skin Melanin, and OTHER variables such as latitude, the amount and degree of sun exposure, and use of sunscreen products with uv protection.40these FACTORS HAVE BEEN PREVIOUSLY ASSOCIATED with Vitamin D deficiency in epidemiologic studies.41-43\n\ncaption (fig): figure 2.']	[('PROBABLE_UNDERSTANDING', 177), ('PROBABLE_UNDERSTANDING', 191), ('SUPERFICIAL_RELATIONSHIP', 253), ('INCOMPLETE_EVIDENCE', 261), ('INCOMPLETE_EVIDENCE', 265), ('SUPERFICIAL_RELATIONSHIP', 276), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 369), ('SUPERFICIAL_RELATIONSHIP', 499), ('INCOMPLETE_EVIDENCE', 507), ('INCOMPLETE_EVIDENCE', 517), ('SUPERFICIAL_RELATIONSHIP', 528)]	11	[('CHEBI_37958', 'dye', 0, '1,'), ('CHEBI_73394', 'Ala-Ser', 2, '25(OH)2D3'), ('CHEBI_17823', 'calcitriol', 33, 'calcitriol'), ('UBERON_0000178', 'blood', 93, 'blood'), ('GO_0010467', 'gene expression', 127, 'express'), ('GO_0010467', 'gene expression', 147, 'gene expression'), ('SO_0000704', 'gene', 147, 'gene'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 203, 'vitamin D metabolism'), ('CHEBI_27300', 'vitamin D', 286, 'vitamin D'), ('GO_0008152', 'metabolic process', 301, 'metabolism'), ('CHEBI_25179', 'melanins', 356, 'melanin'), ('CHEBI_27300', 'vitamin D', 544, 'vitamin D')]
PMC3427192	4/2012	S19-PMC3427192	['Biosynthesis Of Vitamin D.\n\nVitamin D THRESHOLDS\nSerum concentrations of 25(Oh)D are CONSIDERED to be a BIOMARKER and INDICATOR of Vitamin D status.44,45ALTHOUGH Vitamin D insufficiency HAS TRADITIONALLY BEEN defined as a Serum 25(Oh)D concentration of 20 to 29 ng/ml,46a panel of experts from the institute of medicine RECENTLY SUGGESTED that Vitamin D INSUFFICIENCY be redefined AS a Serum 25(Oh)D concentration less than 20 ng/ml.47this RECOMMENDATION was based ON INCONCLUSIVE evidence for the threshold of 29 ng/ml and EVIDENCE for adverse Skeletal EFFECTS at thresholds less than 20 ng/ml.47HOWEVER, this revised definition of Vitamin D insufficiency has generated significant CONTROVERSY48,49AND THUS there is presently NO universally ACCEPTED definition for “optimal” 25(Oh)d concentrations INDEPENDENT of Musculoskeletal health.']	[('PROBABLE_UNDERSTANDING', 38), ('INCOMPLETE_EVIDENCE', 85), ('SUPERFICIAL_RELATIONSHIP', 104), ('SUPERFICIAL_RELATIONSHIP', 118), ('ANOMALY_CURIOUS_FINDING', 151), ('IMPORTANT_CONSIDERATION', 186), ('INCOMPLETE_EVIDENCE', 190), ('PROBABLE_UNDERSTANDING', 190), ('INCOMPLETE_EVIDENCE', 320), ('INCOMPLETE_EVIDENCE', 329), ('IMPORTANT_CONSIDERATION', 354), ('PROBABLE_UNDERSTANDING', 381), ('FUTURE_WORK', 440), ('ANOMALY_CURIOUS_FINDING', 465), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 468), ('INCOMPLETE_EVIDENCE', 524), ('SUPERFICIAL_RELATIONSHIP', 554), ('ANOMALY_CURIOUS_FINDING', 595), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 683), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 697), ('PROBABLE_UNDERSTANDING', 703), ('INCOMPLETE_EVIDENCE', 727), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 742), ('INCOMPLETE_EVIDENCE', 742), ('SUPERFICIAL_RELATIONSHIP', 799)]	25	[('GO_0033593', 'BRCA2-MAGE-D1 complex', 0, 'Biosynthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 28, 'Vitamin D'), ('UBERON_0001977', 'blood serum', 49, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 73, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('UBERON_0001977', 'blood serum', 222, 'serum'), ('CHEBI_71657', 'versiconol acetate', 228, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 228, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 344, 'vitamin D'), ('UBERON_0001977', 'blood serum', 386, 'serum'), ('CHEBI_71657', 'versiconol acetate', 392, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 392, '25(OH)D'), ('UBERON_0004288', 'skeleton', 545, 'skeletal'), ('CHEBI_27300', 'vitamin D', 633, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 776, '25(OH)'), ('UBERON_0002204', 'musculoskeletal system', 814, 'musculoskeletal')]
PMC3427192	4/2012	S21-PMC3427192	['INSTEAD, a number of environmental exposures MAY also alter the rate of Asthma Development.50-54of these modifiable environmental exposures, the ROLE of diet in asthma is of PARTICULAR INTEREST13,55since RECENT STUDIES SUGGEST that the Development Of Asthma in children MAY BE DUE to in utero exposure to Nutrients from the mother’s diet.56given the ROLE of Vitamin D in inflammation and Immunomodulation, SEVERAL STUDIES have focused on in utero Vitamin D exposure and subsequent asthma in children.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 145), ('ANOMALY_CURIOUS_FINDING', 174), ('ANOMALY_CURIOUS_FINDING', 185), ('INCOMPLETE_EVIDENCE', 204), ('INCOMPLETE_EVIDENCE', 219), ('INCOMPLETE_EVIDENCE', 270), ('IMPORTANT_CONSIDERATION', 277), ('SUPERFICIAL_RELATIONSHIP', 350), ('INCOMPLETE_EVIDENCE', 406)]	11	[('GO_0035801', 'adrenal cortex development', 72, 'asthma development'), ('GO_0009602', 'detection of symbiont', 236, 'development of asthma'), ('CHEBI_33284', 'nutrient', 305, 'nutrients'), ('CHEBI_27300', 'vitamin D', 358, 'vitamin D'), ('GO_0050900', 'leukocyte migration', 388, 'immunomodulation'), ('CHEBI_27300', 'vitamin D', 447, 'vitamin D')]
PMC3427192	4/2012	S22-PMC3427192	['WHILE SOME STUDIES quantified maternal dietary Intake of Vitamin D during the final Trimester of Pregnancy, others measured Vitamin D levels within the Plasma and whole Blood of Pregnant women (table 1).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6)]	2	[('GO_0007631', 'feeding behavior', 47, 'intake'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 84, 'trimester'), ('GO_0007565', 'female pregnancy', 97, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 152, 'plasma'), ('UBERON_0000178', 'blood', 169, 'blood'), ('GO_0007565', 'female pregnancy', 178, 'pregnant')]
PMC3427192	4/2012	S23-PMC3427192	['SEVERAL of THESE STUDIES NOTED an inverse RELATIONSHIP between maternal Vitamin D intake and the RISK of subsequent wheezing in young infants and preschool children.58,61,62,64HOWEVER, Vitamin D intakes varied CONSIDERABLY between geographic locations, from 548 iu/day in the united states58and 260 iu/day in finland62to 248 and 137 iu/day in japan64and scotland,61respectively.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 11), ('ANOMALY_CURIOUS_FINDING', 25), ('SUPERFICIAL_RELATIONSHIP', 42), ('IMPORTANT_CONSIDERATION', 97), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 174), ('ANOMALY_CURIOUS_FINDING', 210)]	7	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
PMC3427192	4/2012	S24-PMC3427192	['it is also IMPORTANT TO NOTE that ASSOCIATIONS between Prenatal Vitamin D exposure, wheezing and subsequent asthma have NOT BEEN CONSISTENT across studies.']	[('IMPORTANT_CONSIDERATION', 11), ('SUPERFICIAL_RELATIONSHIP', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 120)]	3	[('GO_0007565', 'female pregnancy', 55, 'prenatal'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC3427192	4/2012	S25-PMC3427192	['WHEREAS devereux et al.61did observe a negative ASSOCIATION between Vitamin D intake and wheezing in preschool children, no associations between Vitamin D intake and asthma were noted in children 5 y of age.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 48)]	2	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
PMC3427192	4/2012	S28-PMC3427192	['studies of Vitamin D exposure in early Life and Respiratory outcomesauthoryearcountrystudy designsample sizeage of children at assessmentdetermination of Vitamin D statusassociation between Vitamin D and Respiratory outcomesbelderbos572011netherlandsprospective cohort156 neonatesbirth to 1 ymaternal Food-frequency questionnaire and Cord Blood 25(Oh)Dlower 25(Oh)D concentrations ASSOCIATED with an increased risk of Respiratory syncytial Virus infectioncamargo582007united statesprospective cohort1194 mother-child dyads3 ymaternal Food-frequency questionnairehighest quartile of Vitamin D intake during Pregnancy ASSOCIATED with a lower risk of recurrent wheezingcamargo592011new zealandprospective cohort922 newbornsbirth to 5 ycord Blood 25(Oh)Dhigher 25(Oh)D ASSOCIATED with a decreased risk of Respiratory infection and wheezing BUT NO associations with childhood asthma NOTEDCARROLL602011CANADACROSS-sectional340 mother-infant dyads5–29 weeksmaternal whole Blood 25(Oh)Dincreasing maternal 25(Oh)D ASSOCIATED with decreased odds of asthma in mothers BUT no associations with infantile wheezing noteddevereux612007scotlandprospective cohort2000 Pregnant women, 1212 children5 ymaternal Food-frequency questionnairehighest and lowest maternal Vitamin D intakes ASSOCIATED with lower risk of wheezingerkkola622009finlandprospective cohort1669 mother-child dyads5 ymaternal Food-frequency questionnairehigher maternal Vitamin D intake ASSOCIATED with lower risk of asthma and allergic rhinitisgale632008ukprospective cohort466 mothers and 178 children9 mo and 9 ymaternal Serum 25(Oh)Dmaternal Vitamin D levels > 75 nmol/l ASSOCIATED with increased risk of atopic dermatitis and asthmamiyake642010japanprospective cohort763 mother-child dyads16–24 momaternal Food-frequency questionnairehigher maternal Vitamin D intake ASSOCIATED with a decreased risk of wheeze and atopic dermatitismorales652012spainprospective cohort1724 children12 mo, 4–6 ymaternal plasma 25(Oh)Dincreased maternal 25(Oh)D ASSOCIATED with a decreased risk of lower Respiratory infections BUT NOT wheezing or asthmarothers662011united statesprospective cohort219 childrenbirth to 5 ycord Blood 25(Oh)Dboth low and high Cord Blood 25(Oh)D ASSOCIATED with increased Aeroallergen sensitization BUT NOT with allergic rhinitis or asthma\nin other Birth cohort studies where 25(Oh)D concentrations were measured in the Plasma and whole Blood of Pregnant women, median 25(Oh)D concentrations ranged from APPROXIMATELY 20 to 29.5 ng/ml.60,63,65a 50% decrease in the odds of maternal asthma was FURTHER OBSERVED with every 35 nmol/l increase in 25(Oh)D levels, SUGGESTING a POSSIBLE LINK between Vitamin D status and asthma during Pregnancy.60HOWEVER, similar to the studies of maternal Vitamin D intake, NO CONSISTENT RELATIONSHIPS between 25(Oh)D concentrations and Respiratory symptoms during childhood HAVE BEEN observed.']	[('SUPERFICIAL_RELATIONSHIP', 381), ('SUPERFICIAL_RELATIONSHIP', 616), ('SUPERFICIAL_RELATIONSHIP', 765), ('ANOMALY_CURIOUS_FINDING', 836), ('ANOMALY_CURIOUS_FINDING', 878), ('SUPERFICIAL_RELATIONSHIP', 1006), ('ANOMALY_CURIOUS_FINDING', 1058), ('SUPERFICIAL_RELATIONSHIP', 1267), ('SUPERFICIAL_RELATIONSHIP', 1439), ('SUPERFICIAL_RELATIONSHIP', 1627), ('SUPERFICIAL_RELATIONSHIP', 1824), ('SUPERFICIAL_RELATIONSHIP', 1999), ('ANOMALY_CURIOUS_FINDING', 2064), ('SUPERFICIAL_RELATIONSHIP', 2213), ('ANOMALY_CURIOUS_FINDING', 2266), ('INCOMPLETE_EVIDENCE', 2471), ('INCOMPLETE_EVIDENCE', 2560), ('INCOMPLETE_EVIDENCE', 2568), ('INCOMPLETE_EVIDENCE', 2626), ('INCOMPLETE_EVIDENCE', 2639), ('SUPERFICIAL_RELATIONSHIP', 2648), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2706), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2770), ('SUPERFICIAL_RELATIONSHIP', 2784), ('INCOMPLETE_EVIDENCE', 2871)]	25	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('UBERON_0000104', 'life cycle', 39, 'life'), ('UBERON_0001004', 'respiratory system', 48, 'respiratory'), ('CHEBI_28384', 'vitamin K', 154, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 204, 'respiratory'), ('CHEBI_33290', 'food', 301, 'food'), ('UBERON_0002240', 'spinal cord', 334, 'cord'), ('UBERON_0000178', 'blood', 339, 'blood'), ('CHEBI_78858', '(R)-2-methylpyrrolidine', 345, '25(OH)DLower'), ('CHEBI_71657', 'versiconol acetate', 358, '25(OH)D'), ('UBERON_0001004', 'respiratory system', 418, 'respiratory'), ('NCBITaxon_1', 'root', 440, 'virus'), ('CHEBI_33290', 'food', 534, 'food'), ('CHEBI_27300', 'vitamin D', 582, 'vitamin D'), ('GO_0007565', 'female pregnancy', 606, 'pregnancy'), ('UBERON_0000178', 'blood', 737, 'blood'), ('CHEBI_72842', '9-oxo-ODE', 743, '25(OH)DHigher'), ('CHEBI_71657', 'versiconol acetate', 757, '25(OH)D'), ('UBERON_0001004', 'respiratory system', 801, 'respiratory'), ('UBERON_0000178', 'blood', 965, 'blood'), ('CHEBI_74350', 'N-diazoacetylnorleucine methyl ester', 971, '25(OH)DIncreasing'), ('PR_000011614', 'opioid growth factor receptor', 974, 'OH'), ('PR_000006449', 'diacylglycerol kinase kappa', 977, 'DIncreasing'), ('CHEBI_71657', 'versiconol acetate', 998, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 998, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 1152, 'pregnant'), ('CHEBI_33290', 'food', 1193, 'food'), ('CHEBI_27300', 'vitamin D', 1249, 'vitamin D'), ('CHEBI_33290', 'food', 1378, 'food'), ('CHEBI_27300', 'vitamin D', 1422, 'vitamin D'), ('UBERON_0001977', 'blood serum', 1576, 'serum'), ('CHEBI_51469', 'butyllithium', 1582, '25(OH)DMaternal'), ('CHEBI_27300', 'vitamin D', 1598, 'vitamin D'), ('CHEBI_33290', 'food', 1763, 'food'), ('CHEBI_27300', 'vitamin D', 1807, 'vitamin D'), ('CHEBI_86378', '(25R)-3beta-hydroxycholest-5-en-26-oic acid', 1965, '25(OH)DIncreased'), ('PR_000011040', 'nuclear receptor coactivator 1', 1967, '(OH'), ('CHEBI_71657', 'versiconol acetate', 1991, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 1991, '25(OH ... D'), ('UBERON_0001004', 'respiratory system', 2041, 'respiratory'), ('UBERON_0000178', 'blood', 2163, 'blood'), ('CHEBI_73803', 'Ala-Asp', 2169, '25(OH)DBoth'), ('UBERON_0002240', 'spinal cord', 2194, 'cord'), ('UBERON_0000178', 'blood', 2199, 'blood'), ('CHEBI_71657', 'versiconol acetate', 2205, '25(OH)D'), ('CHEBI_2500', 'Aescin', 2239, 'aeroallergen'), ('GO_0007567', 'parturition', 2316, 'birth'), ('CHEBI_71657', 'versiconol acetate', 2343, '25(OH)D'), ('UBERON_0001969', 'blood plasma', 2387, 'plasma'), ('UBERON_0000178', 'blood', 2404, 'blood'), ('GO_0007565', 'female pregnancy', 2413, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 2436, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 2610, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 2616, 'D'), ('CHEBI_27300', 'vitamin D', 2661, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2696, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 2752, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 2806, '25(OH)D'), ('UBERON_0001004', 'respiratory system', 2833, 'respiratory')]
PMC3427192	4/2012	S32-PMC3427192	['HOWEVER, in THESE STUDIES, there were no associations between Cord-Blood 25(Oh)D concentrations and subsequent asthma at 5 y of age.59,66\ncollectively, these studies SUGGEST that the benefits of Vitamin D during early Life MAY BE LIMITED to its EFFECTS on Respiratory infections and Viral-induced wheezing and not asthma per se.17HOWEVER, ALTHOUGH Vitamin D MAY have IMPORTANT ROLES in Immune Regulation during early Life, excessive Vitamin D exposure MAY also be ASSOCIATED with adverse health outcomes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 166), ('INCOMPLETE_EVIDENCE', 223), ('INCOMPLETE_EVIDENCE', 230), ('SUPERFICIAL_RELATIONSHIP', 245), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 328), ('ANOMALY_CURIOUS_FINDING', 339), ('INCOMPLETE_EVIDENCE', 358), ('IMPORTANT_CONSIDERATION', 367), ('SUPERFICIAL_RELATIONSHIP', 377), ('INCOMPLETE_EVIDENCE', 452), ('SUPERFICIAL_RELATIONSHIP', 464)]	13	[('UBERON_0002240', 'spinal cord', 62, 'cord'), ('UBERON_0000178', 'blood', 67, 'blood'), ('CHEBI_71657', 'versiconol acetate', 73, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 73, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin D'), ('UBERON_0000104', 'life cycle', 218, 'life'), ('UBERON_0001004', 'respiratory system', 256, 'respiratory'), ('NCBITaxon_1', 'root', 283, 'viral'), ('CHEBI_27300', 'vitamin D', 348, 'vitamin D'), ('GO_0002521', 'leukocyte differentiation', 386, 'immune regulation'), ('UBERON_0002405', 'immune system', 386, 'immune'), ('UBERON_0000104', 'life cycle', 417, 'life'), ('CHEBI_27300', 'vitamin D', 433, 'vitamin D')]
PMC3427192	4/2012	S35-PMC3427192	['HOWEVER, it is IMPORTANT TO NOTE that a large percentage of children were lost to follow-up, and THUS the resulting sample of mothers had higher concentrations of 25(Oh)D and were older, less LIKELY to smoke during Pregnancy, and more educated.63therefore WHILE there MAY BE therapeutic window for vitamin D supplementation in early Life, FURTHER STUDIES ARE NEEDED to more clearly understand the RISKS of high Vitamin D intake and bioavailability during the early childhood years.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 15), ('PROBABLE_UNDERSTANDING', 97), ('PROBABLE_UNDERSTANDING', 192), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 256), ('INCOMPLETE_EVIDENCE', 268), ('FUTURE_WORK', 339), ('FUTURE_WORK', 347), ('IMPORTANT_CONSIDERATION', 397)]	9	[('CHEBI_71657', 'versiconol acetate', 163, '25(OH)D'), ('GO_0007565', 'female pregnancy', 215, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 306, 'D'), ('UBERON_0000104', 'life cycle', 333, 'life'), ('CHEBI_27300', 'vitamin D', 411, 'vitamin D')]
PMC3427192	4/2012	S40-PMC3427192	['HOWEVER, 25(Oh)D concentrations in the non-asthmatic group were significantly higher than PREVIOUSLY-REPORTED average values in african american children.21the childhood asthma management program study, which consisted of a racially diverse population, also FOUND that 24% of Vitamin D deficient subjects were african american, compared with only 7% in the Vitamin D sufficient group.69the FACTORS responsible for the racial DISPARITY in Vitamin D status are UNCLEAR and WARRANT FURTHER STUDY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 90), ('INCOMPLETE_EVIDENCE', 101), ('INCOMPLETE_EVIDENCE', 258), ('SUPERFICIAL_RELATIONSHIP', 390), ('IMPORTANT_CONSIDERATION', 425), ('FULL_UNKNOWN', 459), ('FUTURE_WORK', 471), ('FUTURE_WORK', 479)]	10	[('CHEBI_71657', 'versiconol acetate', 9, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 357, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 438, 'vitamin D')]
PMC3427192	4/2012	S45-PMC3427192	['WHILE these studies SHOW INTRIGUING ASSOCIATIONS between Vitamin D insufficiency (or deficiency) and asthma Control, the cross-sectional nature of the 25(Oh)D measurement and outcome assessment prevents causal INTERPRETATION.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 20), ('ANOMALY_CURIOUS_FINDING', 25), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 210)]	5	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0065007', 'biological regulation', 108, 'control'), ('CHEBI_71657', 'versiconol acetate', 151, '25(OH)D')]
PMC3427192	4/2012	S55-PMC3427192	['furthermore, in those subjects with current asthma, lower 25(Oh)D concentrations were ASSOCIATED with increased odds of asthma exacerbations and healthcare utilization in the preceding year.81OTHER STUDIES have also NOTED ASSOCIATIONS between decreased Serum 25(Oh)D concentrations and decreased Lung function, increased Airway hyperresponsiveness to Methacholine, and blunted Glucocorticoid responsiveness.80,82,84HOWEVER, in a RECENT case-control STUDY of obese subjects with and without asthma, no associations between Vitamin D status and asthma prevalence were NOTED.83the cross-sectional nature of these studies SHOULD again BE EMPHASIZED SINCE causation CANNOT BE determined DUE TO potential CONFOUNDING of the study results.']	[('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 190), ('ANOMALY_CURIOUS_FINDING', 216), ('SUPERFICIAL_RELATIONSHIP', 222), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 413), ('INCOMPLETE_EVIDENCE', 429), ('ANOMALY_CURIOUS_FINDING', 566), ('FUTURE_WORK', 618), ('ANOMALY_CURIOUS_FINDING', 631), ('IMPORTANT_CONSIDERATION', 634), ('PROBLEM_COMPLICATION', 645), ('DIFFICULT_TASK', 661), ('PROBLEM_COMPLICATION', 682), ('PROBLEM_COMPLICATION', 699)]	14	[('CHEBI_71657', 'versiconol acetate', 58, '25(OH)D'), ('UBERON_0001977', 'blood serum', 253, 'serum'), ('CHEBI_71657', 'versiconol acetate', 259, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 259, '25 ... OH ... D'), ('UBERON_0002048', 'lung', 296, 'lung'), ('UBERON_0001005', 'respiratory airway', 321, 'airway'), ('CHEBI_6805', 'methacycline', 351, 'methacholine'), ('CHEBI_24261', 'glucocorticoid', 377, 'glucocorticoid'), ('CHEBI_27300', 'vitamin D', 522, 'vitamin D')]
PMC3427192	4/2012	S68-PMC3427192	['WHILE several observational STUDIES and a handful of SMALL clinical trials SUGGEST that Vitamin D MAY BE beneficial in asthma and wheezing disorders resulting from Respiratory Viral infections, findings are NOT CONSISTENT.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 75), ('INCOMPLETE_EVIDENCE', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 207), ('INCOMPLETE_EVIDENCE', 211)]	7	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 164, 'respiratory'), ('NCBITaxon_1', 'root', 176, 'viral')]
PMC3427192	4/2012	S69-PMC3427192	['these studies also DIFFER significantly in terms of the populations studied, the timing of the Vitamin D intake assessments and the 25(Oh)D sampling, the 25(Oh)D THRESHOLDS used for determining insufficiency, and the Respiratory outcomes of interest.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('PROBABLE_UNDERSTANDING', 162)]	2	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 132, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 154, '25(OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 154, '25'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 157, 'OH ... D'), ('UBERON_0001004', 'respiratory system', 217, 'respiratory')]
PMC3427250	8/2012	S15-PMC3427250	['the ubiquitous presence of Vitamin D receptors in most Tissues, including the Placenta, SUGGESTS that Vitamin D MAY have OTHER ROLES as well.']	[('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 112), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('SUPERFICIAL_RELATIONSHIP', 127)]	4	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('UBERON_0000479', 'tissue', 55, 'tissues'), ('UBERON_0001987', 'placenta', 78, 'placenta'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC3427250	8/2012	S27-PMC3427250	['the cut-off points used to define Vitamin D insufficiency and deficiency are NOT WELL ESTABLISHED and REMAIN CONTROVERSIAL.']	[('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 102), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 109)]	3	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D')]
PMC3427250	8/2012	S32-PMC3427250	['the adequacy of the current Vitamin D dietary RECOMMENDATIONS to reach an optimal Vitamin D status during Pregnancy HAS BEEN QUESTIONED[24].']	[('FUTURE_WORK', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116)]	2	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0007565', 'female pregnancy', 106, 'pregnancy')]
PMC3427250	8/2012	S90-PMC3427250	['ON THE OTHER HAND risk of severe Vitamin D deficiency decreased for women who reported Alcohol Consumption during Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0)]	2	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_30879', 'alcohol', 87, 'alcohol'), ('GO_0007631', 'feeding behavior', 95, 'consumption'), ('GO_0007565', 'female pregnancy', 114, 'pregnancy')]
PMC3427250	8/2012	S119-PMC3427250	['HOWEVER, the Vitamin D content of multivitamins for Pregnant women in belgium is ONLY 400 iu INDICATING EVEN this RECOMMENDATION is not followed as Pregnant women only take one Multivitamin pill a day.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 81), ('INCOMPLETE_EVIDENCE', 93), ('ANOMALY_CURIOUS_FINDING', 104), ('FUTURE_WORK', 114)]	5	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'pregnant'), ('GO_0007565', 'female pregnancy', 148, 'pregnant'), ('CHEBI_7025', 'mupirocin', 177, 'multivitamin')]
PMC3427250	8/2012	S121-PMC3427250	['this ASSUMPTION is based on the fact that the main risk factors ASSOCIATED with Vitamin D deficiency (sun exposure and/or ethnicity) are common to many european countries.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('SUPERFICIAL_RELATIONSHIP', 64)]	2	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
PMC3427250	8/2012	S133-PMC3427250	['WHILE several observational studies POINT to CORRELATIONS between Vitamin D insufficiency and maternal and neonatal ill health, EXPERIMENTAL EVIDENCE from supplementation clinical trials IS NEEDED to inform health policy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 128), ('FUTURE_WORK', 187)]	5	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC3432839	8/2012	S24-PMC3432839	['HOWEVER, they MAY BE an INDICATOR of increased risk of arthritis in Adulthood, SINCE it HAS BEEN SHOWN that children with Limb pains are more LIKELY to have parents and/or grandparents with a history of arthritis COMPARED TO the general population.1among SMALL STUDIES of selected groups of children, recurrent Limb pains HAVE BEEN REPORTED to be PARTICULARLY PREVALENT in obese children,4and in those with some Vitamin D deficiency,5THOUGH this WAS NOT FOUND in a SMALL STUDY in new mexico.6other POSSIBILITIES HAVE BEEN summarised by evans and scutter.7\nAdult arthritis HAS long BEEN CONSIDERED to be a condition that COULD BE ameliorated or prevented by dietary manipulation, with SUGGESTIONS of different components of the diet being IMPORTANT—particularly Ω-3 Fatty Acids.8TO OUR KNOWLEDGE the ONLY specific dietary factor that has BEEN CONSIDERED in regard to childhood Limb pain concerns a study of 532 greek children aged 4–12.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 24), ('PROBABLE_UNDERSTANDING', 79), ('INCOMPLETE_EVIDENCE', 88), ('PROBABLE_UNDERSTANDING', 142), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 213), ('INCOMPLETE_EVIDENCE', 255), ('INCOMPLETE_EVIDENCE', 322), ('INCOMPLETE_EVIDENCE', 332), ('ANOMALY_CURIOUS_FINDING', 347), ('IMPORTANT_CONSIDERATION', 360), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 433), ('INCOMPLETE_EVIDENCE', 446), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 454), ('INCOMPLETE_EVIDENCE', 465), ('INCOMPLETE_EVIDENCE', 498), ('INCOMPLETE_EVIDENCE', 512), ('INCOMPLETE_EVIDENCE', 572), ('INCOMPLETE_EVIDENCE', 586), ('INCOMPLETE_EVIDENCE', 620), ('INCOMPLETE_EVIDENCE', 684), ('IMPORTANT_CONSIDERATION', 738), ('PROBABLE_UNDERSTANDING', 777), ('INCOMPLETE_EVIDENCE', 799), ('ANOMALY_CURIOUS_FINDING', 837), ('INCOMPLETE_EVIDENCE', 842)]	27	[('UBERON_0000113', 'post-juvenile adult stage', 68, 'adulthood'), ('UBERON_0002101', 'limb', 122, 'limb'), ('UBERON_0002101', 'limb', 311, 'limb'), ('CHEBI_27300', 'vitamin D', 412, 'vitamin D'), ('UBERON_0007023', 'adult organism', 556, 'Adult'), ('CHEBI_18320', '1,4-dithiothreitol', 761, 'ω-3'), ('CHEBI_35366', 'fatty acid', 765, 'fatty acids'), ('UBERON_0002101', 'limb', 876, 'limb')]
PMC3465343	10/2012	S38-PMC3465343	['excess dietary Vitamin A, ON THE OTHER HAND, HAS BEEN SHOWN to cause Teratogenesis, but toxicity from Food sources is RARE.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 26), ('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 118)]	3	[('CHEBI_27300', 'vitamin D', 15, 'vitamin A'), ('GO_0031649', 'heat generation', 69, 'teratogenesis'), ('CHEBI_33290', 'food', 102, 'food')]
PMC3465343	10/2012	S67-PMC3465343	['vad induced Skeletal abnormalities in neonatal Rats\nbecause Vitamin A is REQUIRED for Skeletal Development during Embryo Development, we also exmined the OTHER Skeletal System of neonatal Rats by the same anteroposterior radiography.']	[('IMPORTANT_CONSIDERATION', 73), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 154)]	2	[('UBERON_0004288', 'skeleton', 12, 'skeletal'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 47, 'rats'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin A'), ('GO_0001501', 'skeletal system development', 86, 'skeletal development'), ('UBERON_0004288', 'skeleton', 86, 'skeletal'), ('GO_0009790', 'embryo development', 114, 'embryo development'), ('UBERON_0000922', 'embryo', 114, 'embryo'), ('UBERON_0001434', 'skeletal system', 160, 'skeletal system'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 188, 'rats')]
PMC3465343	10/2012	S129-PMC3465343	['HOWEVER, the RELATIONSHIP between the congenital Spinal deformities and Vitamin A deficiency has been poorly understood.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13)]	2	[('UBERON_0001130', 'vertebral column', 49, 'spinal'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin A')]
PMC3465343	10/2012	S139-PMC3465343	['excess dietary Vitamin A, ON THE OTHER HAND, HAS BEEN SHOWN to also cause Teratogenesis.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 26), ('INCOMPLETE_EVIDENCE', 45)]	2	[('CHEBI_27300', 'vitamin D', 15, 'vitamin A'), ('GO_0031649', 'heat generation', 74, 'teratogenesis')]
PMC3465343	10/2012	S175-PMC3465343	['HOWEVER, in OUR STUDY, we used the modified ain-93g diet without any source of Vitamin A and the mean Serum Retinol concentration in the Adult females in the vad group was 0.51±0.57 µmol/l, which was significantly lower than that of the control group (p<0.01).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 12)]	2	[('CHEBI_27300', 'vitamin D', 79, 'vitamin A'), ('UBERON_0001977', 'blood serum', 102, 'serum'), ('CHEBI_26536', 'retinoic acid', 108, 'retinol'), ('UBERON_0007023', 'adult organism', 137, 'adult')]
PMC3465343	10/2012	S190-PMC3465343	['moreover, EFFECTS of partial INSTEAD of absolute deprivation of Vitamin A on Spine malformation SHOULD also BE examined.']	[('SUPERFICIAL_RELATIONSHIP', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 29), ('FUTURE_WORK', 96), ('ANOMALY_CURIOUS_FINDING', 108)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin A'), ('UBERON_0001013', 'adipose tissue', 77, 'spine')]
PMC3470091	9/2012	S20-PMC3470091	['THEREFORE, Vitamin D supplementation in high doses HAS BEEN RECOMMENDED, and oral doses of 20000 or 40000 iu were ASSOCIATED with positive outcomes.6,14moreover, higher oral dose of (6400 iu per day) to Lactating mothers significantly increased Vitamin D status in mothers as well as the Vitamin D content and antirachitic activity of their Milk.14THEREFORE, high doses of Vitamin D, EITHER orally OR through injection, HAS RECENTLY BEEN RECOMMENDED.15-24\na single dose of Vitamin D, administered parenterally, WOULD BE more EFFECTIVE, BECAUSE it is not associated with the NONCOMPLIANCE ASSOCIATED with an oral dose.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 51), ('FUTURE_WORK', 60), ('SUPERFICIAL_RELATIONSHIP', 114), ('PROBABLE_UNDERSTANDING', 348), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 384), ('INCOMPLETE_EVIDENCE', 420), ('FUTURE_WORK', 438), ('FUTURE_PREDICTION', 511), ('SUPERFICIAL_RELATIONSHIP', 525), ('PROBLEM_COMPLICATION', 536), ('PROBLEM_COMPLICATION', 574), ('SUPERFICIAL_RELATIONSHIP', 588)]	13	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 203, 'lactating'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 288, 'vitamin D'), ('UBERON_0001913', 'milk', 341, 'milk'), ('CHEBI_27300', 'vitamin D', 373, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 473, 'vitamin D')]
PMC3470091	9/2012	S87-PMC3470091	['moreover, ANOTHER STUDY,18SHOWED that a single dose of 200,000 iu of Vitamin D in the healthy youths was ASSOCIATED with a peak in Vitamin D concentration after two weeks of treatment, BUT lower than that of OUR STUDY at three months after treatment.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 185), ('QUESTION_ANSWERED_BY_THIS_WORK', 208)]	5	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC3471827	10/2012	S130-PMC3471827	['the malformations ASSOCIATED with ttp knockdown are DIFFERENT from those caused by parental diet-induced Vitamin E deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 52)]	2	[('CHEBI_27300', 'vitamin D', 105, 'vitamin E')]
PMC3471827	10/2012	S132-PMC3471827	['loss of ttp, HOWEVER, precludes the specific trafficking and localization of Vitamin E, mimicking an absolute deficient state REGARDLESS OF the ubiquitous Yolk Sac supply.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('INCOMPLETE_EVIDENCE', 126)]	2	[('CHEBI_27300', 'vitamin D', 77, 'vitamin E'), ('UBERON_0001040', 'yolk sac', 155, 'yolk sac')]
PMC3471827	10/2012	S133-PMC3471827	['furthermore, in our PREVIOUS STUDIES Vitamin E deficiency was imposed by parental diet, WHILE ttp knockdown was performed using Embryos from fish Fed commercial lab diets.']	[('INCOMPLETE_EVIDENCE', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 88)]	2	[('CHEBI_27300', 'vitamin D', 37, 'vitamin E'), ('UBERON_0000922', 'embryo', 128, 'embryos'), ('GO_0007631', 'feeding behavior', 146, 'fed')]
PMC3472720	8/2012	S22-PMC3472720	['we wondered IF the second generation (f2) had any persisting alterations in Immune function RELATED to the Vitamin D status of the Pregnant f0female Mice.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('SUPERFICIAL_RELATIONSHIP', 92)]	2	[('UBERON_0002405', 'immune system', 76, 'immune'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('GO_0007565', 'female pregnancy', 131, 'pregnant'), ('NCBITaxon_10088', 'Mus <genus>', 149, 'mice')]
PMC3472720	8/2012	S29-PMC3472720	['PARADOXICALLY, we OBSERVED that the Vitamin D deficiency AFFECTING the f0pregnant Mice induced a precocious and more SEVERE eae in the f2generation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 57), ('IMPORTANT_CONSIDERATION', 117)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 82, 'mice')]
PMC3472720	8/2012	S31-PMC3472720	['the QUESTION we have ADDRESSED was WHETHER one’s parents’ season of Birth (AS a PROXY-measure of developmental Vitamin D status) COULD BE an additional RISK FACTOR for ms patients?']	[('EXPLICIT_QUESTION', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('EXPLICIT_QUESTION', 35), ('PROBABLE_UNDERSTANDING', 75), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 152), ('EXPLICIT_QUESTION', 179)]	9	[('GO_0007567', 'parturition', 68, 'birth'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 119, 'D')]
PMC3472720	8/2012	S53-PMC3472720	['NONETHELESS, to date, NOT a single study has yet DEMONSTRATED a Pirna- or a Mirna-ASSOCIATED action of Vitamin D on the Immune or the Nervous system.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 22), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 82)]	5	[('SO_0001035', 'piRNA', 64, 'piRNA'), ('SO_0000276', 'miRNA', 76, 'miRNA'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('UBERON_0002405', 'immune system', 120, 'immune'), ('UBERON_0001016', 'nervous system', 134, 'nervous')]
PMC3472720	8/2012	S56-PMC3472720	['additionally, we SHOULD perform a transgenerational study in order to assess WHETHER the f2generation is positively AFFECTED by a high dose of Vitamin D delivered to the f0generation.']	[('FUTURE_WORK', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('SUPERFICIAL_RELATIONSHIP', 116)]	3	[('CHEBI_27300', 'vitamin D', 143, 'vitamin D')]
PMC3472720	8/2012	S105-PMC3472720	['conclusions\nwe SHOW HERE for the FIRST TIME that a maternal Vitamin D deficiency induces inverted transgenerational EFFECTS on the Immune System of offspring: the f2generation is more sensitive to Myelin peptide immunization WHILE, as PREVIOUSLY DEMONSTRATED, the f1generation is less sensitive.']	[('INCOMPLETE_EVIDENCE', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 116), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 225), ('INCOMPLETE_EVIDENCE', 235)]	6	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0002405', 'immune system', 131, 'immune system'), ('UBERON_0000345', 'myelin', 197, 'myelin')]
PMC3472720	8/2012	S107-PMC3472720	['eae symptoms in the f2generation are equally increased IF it is either the f1mother or the f1father that has been Vitamin D-deprived during Embryogenesis.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 55)]	1	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0009790', 'embryo development', 140, 'embryogenesis')]
PMC3472720	8/2012	S112-PMC3472720	['HOWEVER, we FOUND that parents developing in a supposedly Vitamin D rich environment ( i.e.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12)]	2	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC3475131	6/2012	S111-PMC3475131	['[21] all included a single rct (suharno 1993 [40]) which DEMONSTRATED higher mean haemoglobin concentrations and lower prevalence of anaemia at Birth for women who had received a combination of Vitamin A and Iron, COMPARED TO women who received Vitamin A or iron alone.']	[('INCOMPLETE_EVIDENCE', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 214)]	2	[('GO_0007567', 'parturition', 144, 'birth'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin A'), ('CHEBI_24870', 'ion', 208, 'iron'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin A')]
PMC3476426	8/2012	S11-PMC3476426	['HOWEVER, FUTURE STUDIES looking at a POTENTIAL ROLE of Vitamin D in the pathophysiology and treatment of autism ARE WARRANTED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 9), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 47), ('FUTURE_WORK', 112)]	5	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC3476426	8/2012	S50-PMC3476426	['ACCORDING TO current recommendations, Serum 25-Hydroxy Vitamin D levels < 30 and < 10 ng/ml were DEFINED AS Vitamin D insufficiency and Vitamin D deficiency, respectively, WHILE levels > 30 ng/ml were defined as Vitamin D sufficiency [25].']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 97), ('PROBABLE_UNDERSTANDING', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 172)]	4	[('UBERON_0001977', 'blood serum', 38, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 44, '25-hydroxy vitamin D'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D')]
PMC3476426	8/2012	S145-PMC3476426	['basic, Genetic, and epidemiological studies INDICATE a POTENTIAL ROLE of Vitamin D in the PREVENTION of Autoimmune diseases, BUT randomized and controlled TRIALS ARE NECESSARY to establish the clinical efficacy of Vitamin D supplementation in ill or at-RISK subjects [48].']	[('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 55), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 125), ('FUTURE_WORK', 155), ('FUTURE_WORK', 166), ('IMPORTANT_CONSIDERATION', 166), ('IMPORTANT_CONSIDERATION', 253)]	9	[('SO_0000704', 'gene', 7, 'genetic'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 104, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]
PMC3476426	8/2012	S150-PMC3476426	['HOWEVER, FUTURE STUDIES looking at a POTENTIAL ROLE of Vitamin D in the pathophysiology and treatment of autism ARE WARRANTED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 9), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 47), ('FUTURE_WORK', 112)]	5	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC3485340	10/2012	S165-PMC3485340	['by up-regulating Expression of the Vitamin C transporter Svct2 protein or OTHER PROTECTIVE mechanisms, to increase Postnatal Vitc uptake and retention in the Brain ensuring a rapid repletion once an adequate vitc supply is provided.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 74), ('SUPERFICIAL_RELATIONSHIP', 80)]	2	[('GO_0010467', 'gene expression', 17, 'expression'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin C'), ('PR_000004900', 'complement C3', 43, 'C'), ('PR_000015393', 'suppressor of cytokine signaling 2', 57, 'SVCT2'), ('GO_0007567', 'parturition', 115, 'postnatal'), ('GO_0007601', 'visual perception', 125, 'VitC'), ('UBERON_0000955', 'brain', 158, 'brain')]
PMC3501517	11/2012	S15-PMC3501517	["Vitamin D3Is further hydrolyzed by the Liver to create 25-Hydroxyvitamin D3(25[Oh]D3), which REFLECTS the body's store of Vitamin D. additional conversion of 25[Oh]D3To the more biologically active 1α,25-Hydroxyvitamin D3(1α,25[Oh]D3) occurs primarily in the Kidney[5], BUT, is also observed in OTHER cell types such as Macrophages[6], Respiratory Epithelial Cells[7], and others[8],[9]."]	[('SUPERFICIAL_RELATIONSHIP', 93), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 270), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 295)]	3	[('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D3is'), ('UBERON_0002107', 'liver', 39, 'liver'), ('CHEBI_63991', '15-epi-lipoxin B4', 55, '25-hydroxyvitamin D3'), ('PR_000001177', 'D(2) dopamine receptor', 73, 'D3'), ('CHEBI_63218', 'pramipexole(2+)', 76, '25[OH]D3'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('CHEBI_86960', 'veratrone acetate', 158, '25[OH]D3to'), ('CHEBI_17996', 'chloride', 200, ','), ('CHEBI_63991', '15-epi-lipoxin B4', 201, '25-hydroxyvitamin D3'), ('CHEBI_63218', 'pramipexole(2+)', 225, '25[OH]D3'), ('UBERON_0002113', 'kidney', 259, 'kidney'), ('CL_0000235', 'macrophage', 320, 'macrophages'), ('CL_0002368', 'respiratory epithelial cell', 336, 'respiratory epithelial cells'), ('UBERON_0004802', 'respiratory tract epithelium', 336, 'respiratory epithelial')]
PMC3501517	11/2012	S21-PMC3501517	['Neutrophils also Express the Vitamin D receptor[21]; HOWEVER, beyond the fact that patients with rickets have impaired Neutrophil Chemotaxis[22], little else is known about Vitamin D Regulation Of Neutrophil Function.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 53), ('SUPERFICIAL_RELATIONSHIP', 183)]	2	[('CL_0000775', 'neutrophil', 0, 'Neutrophils'), ('GO_0010467', 'gene expression', 17, 'express'), ('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 37, 'D'), ('CL_0000775', 'neutrophil', 119, 'neutrophil'), ('GO_0007567', 'parturition', 119, 'neutrophil'), ('GO_0006935', 'chemotaxis', 130, 'chemotaxis'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('GO_1902530', 'positive regulation of protein linear polyubiquitination', 183, 'regulation of neutrophil function'), ('CL_0000775', 'neutrophil', 197, 'neutrophil')]
PMC3501517	11/2012	S190-PMC3501517	['these data CONTRAST WITH OTHER published STUDIES that demonstrate a POSSIBLE PROTECTIVE ROLE of Vitamin D supplementation during Lung injury.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('INCOMPLETE_EVIDENCE', 41), ('INCOMPLETE_EVIDENCE', 68), ('SUPERFICIAL_RELATIONSHIP', 77), ('SUPERFICIAL_RELATIONSHIP', 88)]	6	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('UBERON_0002048', 'lung', 129, 'lung')]
PMC3501517	11/2012	S192-PMC3501517	['no benefit of Vitamin D supplementation was observed when Lung injury was evaluated by light microscopy; HOWEVER, some statistically significant differences were observed with transmission Electron microscopy (tem).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 105)]	1	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('UBERON_0002048', 'lung', 58, 'lung'), ('CHEBI_10545', 'electron', 189, 'electron')]
PMC3501517	11/2012	S194-PMC3501517	['these data SUGGEST that SOME PROTECTIVE BENEFIT MAY BE derived from Vitamin D supplementation in the setting of radiation-induced Lung injury; HOWEVER, the POTENTIAL physiological relevance of these differences is DIFFICULT to ascertain given the absence of systematic sampling or the LACK OF DATA on the magnitude of the differences.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 29), ('IMPORTANT_CONSIDERATION', 40), ('INCOMPLETE_EVIDENCE', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 143), ('INCOMPLETE_EVIDENCE', 156), ('DIFFICULT_TASK', 214), ('INCOMPLETE_EVIDENCE', 285)]	9	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0002048', 'lung', 130, 'lung')]
PMC3501517	11/2012	S197-PMC3501517	['Il-8 Production MAY BE suppressed by Vitamin D, DEPENDING ON the cell type[39],[40].']	[('INCOMPLETE_EVIDENCE', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 48)]	2	[('GO_0032637', 'interleukin-8 production', 0, 'IL-8 production'), ('PR_000001470', 'interleukin-28B', 0, 'IL-8'), ('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC3501517	11/2012	S201-PMC3501517	['ALTERNATIVELY, DIFFERENCES MAY again reflect the DIFFERENCE of supplementation above a normal level VERSUS chronic Vitamin D deficiency.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 15), ('INCOMPLETE_EVIDENCE', 27), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 49), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 100)]	5	[('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC3501517	11/2012	S214-PMC3501517	['we chose this MODEL because we were primarily interested in HOW Vitamin D level AFFECTED inflammatory response and resolution of inflammation RATHER than bacterial or Viral clearance.']	[('INCOMPLETE_EVIDENCE', 14), ('EXPLICIT_QUESTION', 60), ('SUPERFICIAL_RELATIONSHIP', 80), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 142)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('NCBITaxon_1', 'root', 167, 'viral')]
PMC3501517	11/2012	S217-PMC3501517	['THEREFORE, WHILE Vitamin D MAY not play a ROLE in the acute inflammatory Response or resolution of inflammation, it MAY STILL be IMPORTANT in Controlling infections in the Lung.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 116), ('IMPORTANT_CONSIDERATION', 120), ('IMPORTANT_CONSIDERATION', 129)]	7	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0060033', 'anatomical structure regression', 73, 'response'), ('GO_0065007', 'biological regulation', 142, 'controlling'), ('UBERON_0002048', 'lung', 172, 'lung')]
PMC3501517	11/2012	S218-PMC3501517	['WHETHER Vitamin D Modulates Neutrophil function with infectious pneumonia REMAINS UNKNOWN.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('EXPLICIT_QUESTION', 0), ('FULL_UNKNOWN', 74)]	3	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0065007', 'biological regulation', 18, 'modulates'), ('CL_0000775', 'neutrophil', 28, 'neutrophil')]
PMC3501517	11/2012	S220-PMC3501517	['IN CONTRAST, a RECENT STUDY REPORTED that balb/c Vitamin D deficient Mice had smaller Lung volumes than Vitamin D sufficient Mice as well as higher elastance[44].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 28)]	3	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 69, 'mice'), ('UBERON_0002048', 'lung', 86, 'lung'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 125, 'mice')]
PMC3501517	11/2012	S222-PMC3501517	['additionally, in the prior study, the breeders were Vitamin D deficient; WHEREAS, ours were only placed in a Vitamin deficient environment once they were already visibly Pregnant.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 73)]	1	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 109, 'vitamin'), ('GO_0007565', 'female pregnancy', 170, 'pregnant')]
PMC3501517	11/2012	S223-PMC3501517	['the DIFFERENCES that the OTHER group saw MAY BE more the result of maternal and early Gestational Vitamin D deficiency and its EFFECTS on Fetal Lung Development.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 127)]	4	[('GO_0007565', 'female pregnancy', 86, 'gestational'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0007631', 'feeding behavior', 138, 'fetal'), ('GO_0030324', 'lung development', 144, 'lung development'), ('UBERON_0002048', 'lung', 144, 'lung')]
PMC3501517	11/2012	S226-PMC3501517	['THEREFORE, an UNANSWERED QUESTION is IF Vitamin D augmentation CAN be PROTECTIVE in our Lps MODEL for ali.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 14), ('ANOMALY_CURIOUS_FINDING', 14), ('ANOMALY_CURIOUS_FINDING', 14), ('EXPLICIT_QUESTION', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 37), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 92)]	9	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_16412', 'lipopolysaccharide', 88, 'LPS')]
PMC3501517	11/2012	S232-PMC3501517	['HOWEVER, the IMPACT of these DIFFERENCES on overall clinical RELEVANCE of Vitamin D deficiency is LIKELY minimal.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 29), ('IMPORTANT_CONSIDERATION', 61), ('PROBABLE_UNDERSTANDING', 98)]	5	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC3509518	11/2012	S131-PMC3509518	['we could not confirm PREVIOUS FINDINGS that reduced maternal Vitamin E intakes were ASSOCIATED with increased risk of developing childhood wheeze [9,10,11,12] DESPITE the fact that almost 50% of Pregnant mothers did not meet the rdi when intakes from diet alone were TAKEN INTO ACCOUNT, and 20% of the mothers did not meet the rdi when total Vitamin E intakes were analysed [18].']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 84), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 159), ('ANOMALY_CURIOUS_FINDING', 159), ('IMPORTANT_CONSIDERATION', 267)]	6	[('CHEBI_27300', 'vitamin D', 61, 'vitamin E'), ('GO_0007565', 'female pregnancy', 195, 'pregnant'), ('CHEBI_27300', 'vitamin D', 342, 'vitamin E')]
PMC3515553	12/2012	S15-PMC3515553	['DESPITE the IMPORTANCE of Vitamin B-12 to Neuronal Development and the dependency of the developing foetus and infant on maternal Vitamin B-12 status, it is UNKNOWN WHETHER variation in maternal Pregnancy Vitamin B-12, across the normal range, INFLUENCES offspring Neurodevelopment.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 12), ('FULL_UNKNOWN', 157), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 165), ('SUPERFICIAL_RELATIONSHIP', 244)]	5	[('CHEBI_27300', 'vitamin D', 26, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 26, 'vitamin B-12'), ('CL_0000540', 'neuron', 42, 'neuronal'), ('GO_0007399', 'nervous system development', 42, 'neuronal development'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 130, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 195, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 205, 'vitamin B-12'), ('GO_0007399', 'nervous system development', 265, 'neurodevelopment')]
PMC3515553	12/2012	S18-PMC3515553	['ONE WAY to avoid PROBLEMS of residual CONFOUNDING in OBSERVATIONAL epidemiology is to use Genetic variants that are KNOWN to be reliably RELATED to the modifiable risk factor of interest (here maternal Vitamin B-12) as PROXIES IN ORDER TO determine the causal EFFECT of the risk factor[9],[10].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 17), ('PROBLEM_COMPLICATION', 38), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 137), ('SUPERFICIAL_RELATIONSHIP', 219), ('QUESTION_ANSWERED_BY_THIS_WORK', 227), ('QUESTION_ANSWERED_BY_THIS_WORK', 236), ('SUPERFICIAL_RELATIONSHIP', 260)]	10	[('SO_0000704', 'gene', 90, 'genetic'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 202, 'vitamin B-12')]
PMC3515553	12/2012	S134-PMC3515553	['conditioning on offspring genotype made this ASSOCIATION SOMEWHAT stronger, giving SUPPORT to the HYPOTHESIS that offspring iq score MAY BE INFLUENCED by maternal Vitamin B-12 status during the Intra-Uterine or Perinatal Period RATHER than REFLECT post-Natal offspring exposure to dietary Vitamin B-12.']	[('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 98), ('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 140), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 228), ('SUPERFICIAL_RELATIONSHIP', 240)]	8	[('CHEBI_27300', 'vitamin D', 163, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 163, 'vitamin B-12'), ('UBERON_0001273', 'ilium', 194, 'intra'), ('UBERON_0000995', 'uterus', 200, 'uterine'), ('GO_0036268', 'swimming', 211, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 211, 'perinatal period'), ('GO_0007567', 'parturition', 253, 'natal'), ('CHEBI_27300', 'vitamin D', 289, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 289, 'vitamin B-12')]
PMC3515553	12/2012	S151-PMC3515553	['HOWEVER, the MAJORITY of the children with Cord Blood Vitamin B-12 measures in OUR STUDY were not Vitamin B-12 deficient.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 79)]	3	[('UBERON_0009472', 'axilla', 43, 'cord blood'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 54, 'vitamin B-12'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 98, 'vitamin B-12')]
PMC3515553	12/2012	S156-PMC3515553	['two studies conducted in india, that measured Vitamin B-12 concentration, REPORTED CONTRADICTORY results, POSSIBLY DUE TO DIFFERING levels of Vitamin B-12 deficiency between the populations[6],[8].']	[('INCOMPLETE_EVIDENCE', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('INCOMPLETE_EVIDENCE', 106), ('PROBABLE_UNDERSTANDING', 115), ('PROBLEM_COMPLICATION', 115), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122)]	6	[('CHEBI_27300', 'vitamin D', 46, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 46, 'vitamin B-12'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 142, 'vitamin B-12')]
PMC3515553	12/2012	S169-PMC3515553	['the differences in CONFOUNDERS between sample subsets and the overall alspac sample are UNLIKELY to AFFECT the ASSOCIATION between genotypes and Cord Blood Vitamin B-12 or genotypes and iq because, as EXPECTED, there was no association between genotypes and POTENTIAL CONFOUNDERS, OTHER than what MAY have arisen by chance DUE TO performing a large number of tests on the data.']	[('PROBLEM_COMPLICATION', 19), ('PROBABLE_UNDERSTANDING', 88), ('SUPERFICIAL_RELATIONSHIP', 100), ('SUPERFICIAL_RELATIONSHIP', 111), ('INCOMPLETE_EVIDENCE', 201), ('INCOMPLETE_EVIDENCE', 258), ('PROBLEM_COMPLICATION', 268), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 281), ('INCOMPLETE_EVIDENCE', 297), ('PROBLEM_COMPLICATION', 323)]	10	[('UBERON_0002240', 'spinal cord', 145, 'cord'), ('UBERON_0000178', 'blood', 150, 'blood'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 156, 'vitamin B-12')]
PMC3515553	12/2012	S170-PMC3515553	['conclusions\nIN SUMMARY, we have FOUND that children Born to mothers with a higher dietary intake of Vitamin B-12 had a slightly higher iq than OTHER children, and that those with mothers carrying PUTATIVE Vitamin B-12-increasing Alleles were more LIKELY to have a higher iq than those Born to mothers without these Alleles.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 143), ('PROBABLE_UNDERSTANDING', 196), ('PROBABLE_UNDERSTANDING', 247)]	5	[('GO_0007567', 'parturition', 52, 'born'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 100, 'vitamin B-12'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 205, 'vitamin B-12'), ('SO_0001023', 'allele', 229, 'alleles'), ('GO_0007567', 'parturition', 285, 'born'), ('SO_0001023', 'allele', 315, 'alleles')]
PMC3515553	12/2012	S171-PMC3515553	['NONETHELESS, the fact that our OBSERVATIONAL ASSOCIATION of maternal dietary Intake attenuated NOTICEABLY with adjustment for CONFOUNDING FACTORS and that the Genetic ASSOCIATIONS are not very strong SUGGESTS that maternal Vitamin B-12 MAY not have an IMPORTANT causal EFFECT on offspring iq.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 45), ('ANOMALY_CURIOUS_FINDING', 95), ('PROBLEM_COMPLICATION', 126), ('SUPERFICIAL_RELATIONSHIP', 167), ('INCOMPLETE_EVIDENCE', 200), ('INCOMPLETE_EVIDENCE', 236), ('IMPORTANT_CONSIDERATION', 252), ('SUPERFICIAL_RELATIONSHIP', 269)]	10	[('GO_0007631', 'feeding behavior', 77, 'intake'), ('SO_0000704', 'gene', 159, 'genetic'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 223, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 233, '12')]
PMC3521768	12/2012	S32-PMC3521768	['DESPITE the existence of MANY rcts and OBSERVATIONAL studies which evaluated the EFFECT of Prenatal zinc and Vitamin A status on Birthweight, THE CURRENT STUDY is WORTH documentable as it HAS BEEN conducted in area with high prevalence of zinc and Vitamin A deficiencies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 81), ('QUESTION_ANSWERED_BY_THIS_WORK', 142), ('ANOMALY_CURIOUS_FINDING', 163), ('INCOMPLETE_EVIDENCE', 188)]	8	[('GO_0007565', 'female pregnancy', 91, 'prenatal'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin A'), ('GO_0007596', 'blood coagulation', 129, 'birthweight'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin A')]
PMC3521768	12/2012	S66-PMC3521768	['apart from the main independent variables (Prenatal Vitamin A and zinc statuses), OTHER independent variables of interest were maternal Literacy (ability to Read and write), maternal employment, household wealth index, agro-ecological zone, antenatal care (anc) follow up, Blood pressure during Pregnancy, type of staple diet, distance from the nearby health facility, maternal thinness (maternal mid-upper Arm circumference (muac) less than 220 mm), maternal stunting (maternal height less than 145 cm), elevated crp (crp greater or equal to 5 mg/dl), newborn sex, maternal age and primiparity.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 82)]	1	[('GO_0007565', 'female pregnancy', 43, 'prenatal'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin A'), ('GO_0007612', 'learning', 136, 'literacy'), ('GO_0006281', 'DNA repair', 157, 'read'), ('UBERON_0000178', 'blood', 273, 'blood'), ('GO_0007565', 'female pregnancy', 295, 'pregnancy'), ('UBERON_0002362', 'arachnoid mater', 407, 'Arm')]
PMC3521768	12/2012	S169-PMC3521768	['OBSERVATIONAL studies on the RELATIONSHIP between maternal Vitamin A and Birthweight in apparently health subjects concluded DIVERGENTLY.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 125)]	3	[('CHEBI_27300', 'vitamin D', 59, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 67, 'A'), ('GO_0007596', 'blood coagulation', 73, 'birthweight')]
PMC3532199	11/2012	S25-PMC3532199	['a NUMBER OF SUBSEQUENT STUDIES reviewed by czeizel [9] and munger [10] have CONTINUED to SUGGEST that Folic Acid and/or OTHER Micronutrients or vitamins, including Vitamin A and Vitamin B6, MAY BE IMPORTANT in the etiology of clefts as well.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 12), ('FUTURE_WORK', 76), ('INCOMPLETE_EVIDENCE', 89), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 120), ('INCOMPLETE_EVIDENCE', 190), ('IMPORTANT_CONSIDERATION', 197)]	7	[('CHEBI_30751', 'formic acid', 102, 'folic acid'), ('CHEBI_33839', 'macromolecule', 126, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin A'), ('CHEBI_33237', 'vitamin D4', 178, 'vitamin B6')]
PMC3534399	10/2012	S169-PMC3534399	['a single trial (in hiv-infected mothers) has investigated a LIMITED range of T-Cell subsets in Pregnancy, but not in the offspring, and FOUND that limited mmn supplementation (Vitamins B, c and e), BUT NOT Vitamin A alone, increased cd4+ and cd8+ counts [25].']	[('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 136), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 198), ('ANOMALY_CURIOUS_FINDING', 202)]	4	[('CL_0000084', 'T cell', 77, 'T-cell'), ('GO_0007565', 'female pregnancy', 95, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 176, 'vitamins B'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin A')]
PMC3552819	12/2012	S12-PMC3552819	['there is considerable SPECULATION regarding the POTENTIAL EFFECTS of Vitamin D on both Skeletal and Extra-Skeletal aspects of Reproductive physiology and Fetal Development, YET it REMAINS UNKNOWN WHETHER there are benefits to improving maternal Antenatal Vitamin D status beyond the correction of SEVERE deficiency [2,3].']	[('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 48), ('SUPERFICIAL_RELATIONSHIP', 58), ('ANOMALY_CURIOUS_FINDING', 173), ('FULL_UNKNOWN', 180), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 196), ('IMPORTANT_CONSIDERATION', 297)]	7	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('UBERON_0004288', 'skeleton', 87, 'skeletal'), ('UBERON_0001431', 'distal carpal bone 2', 100, 'extra-skeletal'), ('GO_0000003', 'reproduction', 126, 'reproductive'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 154, 'fetal development'), ('GO_0007567', 'parturition', 245, 'antenatal'), ('CHEBI_27300', 'vitamin D', 255, 'vitamin D')]
PMC3552819	12/2012	S13-PMC3552819	['clinical trials employing Vitamin D dose regimens that SAFELY optimize maternal-fetal Vitamin D status will enable testing of these HYPOTHESES [4].']	[('IMPORTANT_CONSIDERATION', 55), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC3552819	12/2012	S14-PMC3552819	['HOWEVER, VERY FEW STUDIES have rigorously addressed Vitamin D supplementation during Pregnancy, and the single-dose Vitamin D3 Pregnancy trials published to date have provided LITTLE insight into pharmacokinetics or SAFETY [5,6].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 9), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 176), ('IMPORTANT_CONSIDERATION', 216)]	5	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('GO_0007565', 'female pregnancy', 85, 'pregnancy'), ('CHEBI_33279', 'vitamin D5', 116, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 116, 'vitamin D3'), ('GO_0007565', 'female pregnancy', 127, 'pregnancy')]
PMC3552819	12/2012	S16-PMC3552819	['the pharmacokinetics of oral Vitamin D3 are CONVENTIONALLY described with respect to its EFFECT on the Serum concentration of the predominant circulating Metabolite, 25-Hydroxyvitamin D ([25(Oh)D]), which is a WELL-ESTABLISHED BIOMARKER of systemic Vitamin D status [9].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 44), ('SUPERFICIAL_RELATIONSHIP', 89), ('PROBABLE_UNDERSTANDING', 210), ('SUPERFICIAL_RELATIONSHIP', 227)]	4	[('CHEBI_33279', 'vitamin D5', 29, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 29, 'vitamin D3'), ('UBERON_0001977', 'blood serum', 103, 'serum'), ('CHEBI_39382', 'flufenoxuron', 154, 'metabolite'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 166, '25-hydroxyvitamin D'), ('CHEBI_33010', 'chromide(1-)', 190, '(OH)D'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D')]
PMC3552819	12/2012	S26-PMC3552819	['HOWEVER, to enhance the assessment of 25(Oh)D response and SAFETY during the first week of follow-up, an additional cohort of participants who continued to receive weekly Vitamin D doses beginning on day 7 (“weekly-dose group”) contributed biochemical data to the present analysis for the first 7 days after the 70,000 iu dose (i.e., up to the time preceding their 2nd dose).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 59)]	2	[('CHEBI_71657', 'versiconol acetate', 38, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 38, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D')]
PMC3552819	12/2012	S54-PMC3552819	['participants in the “weekly dose” groups were similarly randomized to one of two schedules (c or d); HOWEVER, the analysis of single-dose pharmacokinetics ONLY included those specimens collected up to and including day 7, preceding administration of the 2nd Vitamin D dose.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 101), ('INCOMPLETE_EVIDENCE', 155)]	2	[('CHEBI_27300', 'vitamin D', 258, 'vitamin D')]
PMC3552819	12/2012	S64-PMC3552819	['the reference range for albumin-adjusted Serum calcium was set at 2.10 – 2.60 mmol/l, the upper limit of which was a CONSERVATIVE THRESHOLD relative to those used by: the local laboratory in dhaka (2.62 mmol/l), the us institute of medicine (iom) 1997 dietary reference intakes (dris) for Vitamin D (2.75 mmol/l) [15], and the iom revised 2011 Vitamin D dris (2.63 mmol/l) [1].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 117), ('PROBABLE_UNDERSTANDING', 130)]	2	[('UBERON_0001977', 'blood serum', 41, 'serum'), ('CHEBI_27300', 'vitamin D', 289, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 344, 'vitamin D')]
PMC3552819	12/2012	S189-PMC3552819	['MANY participants DEMONSTRATED a rapid rise in [25(Oh)D] during the first week, which is SIMILAR TO the response to an acute dose of ultraviolet radiation exposure [25]; BUT distinct from the more gradual EFFECTS of OTHER forms of exogenous Vitamin D Intake (e.g., oral D2 Ingestion [10]).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 89), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('SUPERFICIAL_RELATIONSHIP', 205), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 216)]	6	[('CHEBI_71657', 'versiconol acetate', 48, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 48, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 241, 'vitamin D'), ('GO_0007631', 'feeding behavior', 251, 'intake'), ('CHEBI_37987', 'Cy3 dye', 270, 'D2'), ('PR_000002019', 'MHC class II histocompatibility antigen beta chain DRB1', 270, 'D2'), ('GO_0007631', 'feeding behavior', 273, 'ingestion')]
PMC3552819	12/2012	S222-PMC3552819	['HOWEVER, the unpredictability of the 25(Oh)D response at the individual level, PREVIOUS REPORTS of adverse EFFECTS of large single doses [23], and the THEORETICAL DISADVANTAGES of excessive fluctuations in Vitamin D status [29] SUGGEST that the use of large single or infrequent intermittent doses of Vitamin D3 MAY BE physiologically DISADVANTAGEOUS DESPITE its practical APPEAL.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 107), ('INCOMPLETE_EVIDENCE', 151), ('IMPORTANT_CONSIDERATION', 163), ('INCOMPLETE_EVIDENCE', 228), ('INCOMPLETE_EVIDENCE', 312), ('IMPORTANT_CONSIDERATION', 335), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 351), ('ANOMALY_CURIOUS_FINDING', 351), ('IMPORTANT_CONSIDERATION', 373)]	12	[('CHEBI_71657', 'versiconol acetate', 37, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 301, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 301, 'vitamin D3')]
PMC3599191	1/2013	S118-PMC3599191	['EVEN the lack of OTHER micro-Nutrients such as Selenium, Vitamins E, d and c, zinc and Folic Acid is RESPONSIBLE for the onset of disorders AFFECTING the Respiratory System in the offspring [46].']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 17), ('PROBABLE_UNDERSTANDING', 101), ('SUPERFICIAL_RELATIONSHIP', 140)]	4	[('CHEBI_33284', 'nutrient', 29, 'nutrients'), ('CHEBI_27568', 'selenium atom', 47, 'selenium'), ('CHEBI_27300', 'vitamin D', 57, 'vitamins E'), ('CHEBI_30751', 'formic acid', 87, 'folic acid'), ('UBERON_0001004', 'respiratory system', 154, 'respiratory system')]
PMC3599191	1/2013	S199-PMC3599191	['Intake Of Vitamin D during Pregnancy, EITHER through the diet OR through supplements, has a protective ROLE against asthma and atopic dermatitis.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 62), ('SUPERFICIAL_RELATIONSHIP', 103)]	3	[('GO_0060384', 'innervation', 0, 'Intake of'), ('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('GO_0007565', 'female pregnancy', 27, 'pregnancy')]
PMC3613945	2/2013	S0-PMC3613945	['common variants of the Vitamin D Binding Protein Gene and adverse health outcomes\n\nabstract\nthe Vitamin D Binding protein (dbp) is the MAJOR Plasma carrier for Vitamin D and its Metabolites, BUT it is also an actin scavenger, and is the precursor to the immunomodulatory protein, gc-maf.']	[('IMPORTANT_CONSIDERATION', 135), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 191)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 23, 'vitamin D binding protein'), ('SO_0000704', 'gene', 49, 'gene'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('PR_000017299', 'VIP peptides', 96, 'vitamin D binding'), ('UBERON_0001969', 'blood plasma', 141, 'plasma'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('CHEBI_25212', 'metabolite', 178, 'metabolites')]
PMC3613945	2/2013	S2-PMC3613945	['they are common enough to generate population-wide constitutive DIFFERENCES in Vitamin D status, based on assay of the Serum Metabolite, 25-Hydroxyvitamin D (25Ohd).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 64)]	1	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('UBERON_0001977', 'blood serum', 119, 'serum'), ('CHEBI_39382', 'flufenoxuron', 125, 'metabolite'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 137, '25-hydroxyvitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 158, '25OHD')]
PMC3613945	2/2013	S3-PMC3613945	['WHETHER these variants also INFLUENCE the ROLE of Vitamin D in an Immunologic milieu is NOT KNOWN.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('EXPLICIT_QUESTION', 0), ('SUPERFICIAL_RELATIONSHIP', 28), ('SUPERFICIAL_RELATIONSHIP', 42), ('FULL_UNKNOWN', 88)]	5	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('UBERON_0000913', 'interstitial fluid', 66, 'immunologic')]
PMC3613945	2/2013	S5-PMC3613945	['indeed, dbp and Vitamin D MAY JOINTLY OR INDEPENDENTLY CONTRIBUTE to a variety of adverse health outcomes unrelated to classical notions of their function in bone and Mineral Metabolism.']	[('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 38), ('SUPERFICIAL_RELATIONSHIP', 41), ('SUPERFICIAL_RELATIONSHIP', 55)]	5	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_46662', 'mineral', 167, 'mineral'), ('GO_0008152', 'metabolic process', 175, 'metabolism')]
PMC3613945	2/2013	S50-PMC3613945	['WHILE these common polymorphisms are ASSOCIATED with dbp status, others have DEMONSTRATED ASSOCIATION between genotype and Serum Vitamin D Metabolite levels.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 90)]	4	[('UBERON_0001977', 'blood serum', 123, 'serum'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('CHEBI_39382', 'flufenoxuron', 139, 'metabolite')]
PMC3613945	2/2013	S63-PMC3613945	['IN CONTRAST, the ROLE of Vitamin D and dbp in Innate Immunity HAS BEEN appreciated ONLY more RECENTLY, EITHER through its INVOLVEMENT in the Vitamin D transport pathway OR by independent mechanisms51.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 17), ('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 93), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('SUPERFICIAL_RELATIONSHIP', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 169)]	8	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0045087', 'innate immune response', 46, 'innate immunity'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC3613945	2/2013	S163-PMC3613945	['a RECENT prospective STUDY examining more than 6100 elderly caucasians FOUND no association between dbp phenotype and osteoporosis; HOWEVER, a 33% increased risk of fracture was detected in gc1s carriers homozygous for polymorphisms in the 3′ Untranslated Region (Utr) of the Vitamin D Receptor ( vdr ) in haploblock 5 compared with non-carriers ( p \u2009=\u20090.005)88.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 71), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('ANOMALY_CURIOUS_FINDING', 132)]	4	[('SO_0000205', 'three_prime_UTR', 240, '3′ untranslated region'), ('GO_0006309', 'apoptotic DNA fragmentation', 243, 'untranslated'), ('SO_0000203', 'UTR', 264, 'UTR'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 276, 'vitamin D receptor')]
PMC3613945	2/2013	S184-PMC3613945	['ecological studies INDICATE that Vitamin D deficiency is ASSOCIATED with asthma and asthma RELATED phenotypes101–105, BUT SOME STUDIES CONTRADICT these FINDINGS reporting a positive ASSOCIATION106,107, WHEREAS others SHOW no association108.']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 57), ('SUPERFICIAL_RELATIONSHIP', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 118), ('INCOMPLETE_EVIDENCE', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135), ('INCOMPLETE_EVIDENCE', 135), ('INCOMPLETE_EVIDENCE', 152), ('SUPERFICIAL_RELATIONSHIP', 182), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 202), ('INCOMPLETE_EVIDENCE', 217)]	11	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC3613945	2/2013	S188-PMC3613945	['overall EVIDENCE SUGGESTS that Vitamin D PROTECTS against asthma, BUT the precise nature of this RELATIONSHIP is AMBIGUOUS and INCONSISTENT findings are LIKELY a function of epidemiological context.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 66), ('SUPERFICIAL_RELATIONSHIP', 97), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('PROBABLE_UNDERSTANDING', 153)]	8	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC3613945	2/2013	S208-PMC3613945	['the UNDERLYING mechanism by which Vitamin D status AFFECTS cancer RISK is UNKNOWN, HOWEVER, 1,25(Oh)2D3Has BEEN SHOWN to Modulate Cell Proliferation and Differentiation Of both normal and malignant Cells.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 51), ('IMPORTANT_CONSIDERATION', 66), ('FULL_UNKNOWN', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('ANOMALY_CURIOUS_FINDING', 83), ('INCOMPLETE_EVIDENCE', 107)]	7	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_76957', 'N-2-hydroxytetracosenoylsphingosine', 92, '1,25(OH)2D3has'), ('GO_0065007', 'biological regulation', 121, 'modulate'), ('GO_0008283', 'cell proliferation', 130, 'cell proliferation'), ('GO_0030154', 'cell differentiation', 153, 'differentiation of ... cells')]
PMC3613945	2/2013	S210-PMC3613945	['Breast cancer\necological case-control studies INDICATE an inverse CORRELATION between Vitamin D status and Breast cancer RISK, HOWEVER, the RELATIONSHIP is LESS CLEAR in longitudinal studies150,151.']	[('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 121), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('ANOMALY_CURIOUS_FINDING', 127), ('SUPERFICIAL_RELATIONSHIP', 140), ('FULL_UNKNOWN', 156)]	7	[('UBERON_0000310', 'breast', 0, 'Breast'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0000310', 'breast', 107, 'breast')]
PMC3613945	2/2013	S214-PMC3613945	['ALTERNATIVELY, the active Metabolite of Vitamin D, Calcitriol, HAS BEEN SHOWN to inhibit Cell Proliferation and Differentiation and promote Apoptosis of Breast tumor Tissue155–158.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 63)]	2	[('CHEBI_39382', 'flufenoxuron', 26, 'metabolite'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 51, 'calcitriol'), ('GO_0030154', 'cell differentiation', 89, 'cell proliferation ... differentiation'), ('GO_0006915', 'apoptotic process', 140, 'apoptosis'), ('UBERON_0000310', 'breast', 153, 'breast'), ('UBERON_0003605', 'eye skin gland', 166, 'tissue155')]
PMC3613945	2/2013	S249-PMC3613945	['schizophrenia\na NUMBER OF HYPOTHESES HAVE BEEN put FORTH to explain the etiology of schizophrenia, BUT several lines of OBSERVATIONAL EVIDENCE SUGGEST that Vitamin D MAY BE a risk Factor183.']	[('INCOMPLETE_EVIDENCE', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 26), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99), ('INCOMPLETE_EVIDENCE', 120), ('INCOMPLETE_EVIDENCE', 143), ('INCOMPLETE_EVIDENCE', 166)]	9	[('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('PR_000007391', 'F-box only protein 17', 180, 'factor183')]
PMC3613945	2/2013	S314-PMC3613945	['conclusion\nthere is GROWING EVIDENCE that dbp plays a ROLE in Immune modulation, EITHER directly through gc-maf, OR indirectly by INFLUENCING Serum levels of Vitamin D. it is TEMPTING to SPECULATE that dbp operates as a molecular switch between pro- and anti-inflammation and intervention STRATEGIES designed to modify this switch MAY be IMPORTANT in the Control and prevention Of chronic and Infectious Diseases.']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 54), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('SUPERFICIAL_RELATIONSHIP', 130), ('INCOMPLETE_EVIDENCE', 175), ('INCOMPLETE_EVIDENCE', 187), ('FUTURE_WORK', 289), ('INCOMPLETE_EVIDENCE', 331), ('IMPORTANT_CONSIDERATION', 338)]	9	[('UBERON_0002405', 'immune system', 62, 'immune'), ('UBERON_0001977', 'blood serum', 142, 'serum'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('GO_0001715', 'ectodermal cell fate specification', 355, 'control ... of ... infectious diseases')]
PMC3616124	4/2013	S186-PMC3616124	['first, Cardiovascular disease studies SUGGEST that Vitamin E alone has DIFFERENT EFFECTS from Vitamin C and E combined[18],[19],[27].']	[('INCOMPLETE_EVIDENCE', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71), ('SUPERFICIAL_RELATIONSHIP', 81)]	3	[('UBERON_0004535', 'cardiovascular system', 7, 'cardiovascular'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 108, 'E')]
PMC3616124	4/2013	S189-PMC3616124	['HOWEVER, the pro-oxidant EFFECTS of Vitamin C[28]combined with the reduced antioxidant capacity of Hp 2-2 MAY have CONTRIBUTED to accelerated Coronary Artery narrowing in diabetic Hp 2-2 post-menopausal women taking Vitamins C and E[21].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 106), ('SUPERFICIAL_RELATIONSHIP', 115)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin C'), ('PR_000008793', 'heat shock factor protein 4', 99, 'Hp 2-2'), ('UBERON_0005985', 'coronary vessel', 142, 'coronary'), ('UBERON_0001637', 'artery', 151, 'artery'), ('PR_000008443', 'huntingtin-associated protein 1', 180, 'Hp 2'), ('CHEBI_27300', 'vitamin D', 216, 'vitamins C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 231, 'E')]
PMC3616124	4/2013	S192-PMC3616124	['THEREFORE, we cannot determine WHETHER Vitamin E OR C alone would have been efficacious.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31)]	2	[('CHEBI_27300', 'vitamin D', 39, 'vitamin E'), ('CHEBI_18245', 'carboxylato group', 52, 'C')]
PMC3616124	4/2013	S203-PMC3616124	['conclusions\nIN CONTRAST TO our HYPOTHESIS, our secondary analysis of a large rct INDICATES that hp phenotype does not influence preeclampsia risk, or identify a subset of nulligravidas for whom Vitamins C and E would reduce Preeclampsia RISK in white, black or hispanic women.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 81), ('IMPORTANT_CONSIDERATION', 237)]	4	[('CHEBI_27300', 'vitamin D', 194, 'vitamins C'), ('PR_000004900', 'complement C3', 203, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 209, 'E'), ('GO_0007128', 'meiotic prophase I', 224, 'preeclampsia')]
PMC3629265	4/2013	S1-PMC3629265	['DESPITE this long history, Vitamin D deficiency REMAINS a significant health CONCERN.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 48), ('IMPORTANT_CONSIDERATION', 77)]	4	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
PMC3629265	4/2013	S12-PMC3629265	['HOWEVER, it was not until the early 1900s that Vitamin D deficiency was recognised as the UNDERLYING cause, and that the IMPORTANCE of sunlight to maintain adequate vitamin d levels was appreciated.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 90), ('IMPORTANT_CONSIDERATION', 121)]	3	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC3629265	4/2013	S80-PMC3629265	['in this study, >30% of aboriginal women had Vitamin D levels <37.5 nmol/l COMPARED TO 18.6% of caucasian women (29).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 74)]	1	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC3629265	4/2013	S86-PMC3629265	['WHILE our 6 infants had numerous RISK FACTORS for Vitamin D deficiency, they were not Breast Fed, which was the most CONSISTENT FINDING in PREVIOUS reports (13,15–19).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 33), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 139)]	5	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007567', 'parturition', 86, 'breast'), ('GO_0007631', 'feeding behavior', 93, 'fed')]
PMC3629265	4/2013	S89-PMC3629265	['this RAISES the QUESTION of WHETHER 400 iu of Vitamin D per litre of formula is SUFFICIENT.']	[('EXPLICIT_QUESTION', 5), ('EXPLICIT_QUESTION', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('EXPLICIT_QUESTION', 28), ('IMPORTANT_CONSIDERATION', 80)]	5	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC3635901	4/2013	S35-PMC3635901	['this ROLE of Vitamin D SEEMS to be so IMPORTANT that ads show seasonality (due TO DIFFERENT levels of uv exposure), and EVEN the month of Birth MAY INFLUENCE the risk of onset of an ad, as SHOWN by disanto et al .']	[('SUPERFICIAL_RELATIONSHIP', 5), ('ANOMALY_CURIOUS_FINDING', 23), ('IMPORTANT_CONSIDERATION', 38), ('QUESTION_ANSWERED_BY_THIS_WORK', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('ANOMALY_CURIOUS_FINDING', 120), ('INCOMPLETE_EVIDENCE', 144), ('SUPERFICIAL_RELATIONSHIP', 148), ('INCOMPLETE_EVIDENCE', 189)]	9	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007567', 'parturition', 138, 'birth')]
PMC3635901	4/2013	S43-PMC3635901	['People can be exposed to such elements through diet (for example, Vitamin D), and OTHER sources.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 82)]	1	[('NCBITaxon_10088', 'Mus <genus>', 0, 'People'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC3641012	4/2013	S13-PMC3641012	['HOWEVER, the EFFECTS of Vitamin D on maternal, Placental or Fetal Tissues are UNCERTAIN [2], and the extent to which health outcomes are responsive to changes in maternal-fetal Vitamin D status REMAINS UNKNOWN [2,6,7].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('FULL_UNKNOWN', 78), ('FULL_UNKNOWN', 194)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('UBERON_0001987', 'placenta', 47, 'placental'), ('UBERON_0000922', 'embryo', 60, 'fetal'), ('UBERON_0000479', 'tissue', 66, 'tissues'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D')]
PMC3641012	4/2013	S14-PMC3641012	['CURRENTLY, there is INSUFFICIENT EVIDENCE to EITHER SUPPORT OR REFUTE the benefits of any given supplemental Vitamin D dose during Pregnancy [8,9].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 45), ('INCOMPLETE_EVIDENCE', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63)]	5	[('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('GO_0007565', 'female pregnancy', 131, 'pregnancy')]
PMC3641012	4/2013	S18-PMC3641012	['uncertainty surrounding Vitamin D REQUIREMENTS in Pregnancy has LED TO DIVERGENT dose RECOMMENDATIONS; for example, the unicef Antenatal Micronutrient formulation contains 200\xa0iu/day [11], the canadian paediatric society has SUGGESTED 2000\xa0iu/day [12], and hollis et al.']	[('IMPORTANT_CONSIDERATION', 34), ('SUPERFICIAL_RELATIONSHIP', 64), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71), ('FUTURE_WORK', 86), ('INCOMPLETE_EVIDENCE', 225)]	5	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0007565', 'female pregnancy', 50, 'pregnancy'), ('GO_0007567', 'parturition', 127, 'antenatal'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 137, 'micronutrient')]
PMC3641012	4/2013	S20-PMC3641012	['SIMILARLY, the 25(Oh)D THRESHOLD to define Vitamin D sufficiency is DEBATED; the iom set 50\xa0nmol/l as a lower limit of sufficiency [7], YET OTHER expert bodies such as the american academy of pediatrics have SUGGESTED that Pregnant women attain Serum 25(Oh)D >80\xa0nmol/l [14].']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 136), ('ANOMALY_CURIOUS_FINDING', 136), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 140), ('INCOMPLETE_EVIDENCE', 208)]	7	[('CHEBI_71657', 'versiconol acetate', 15, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0007565', 'female pregnancy', 223, 'pregnant'), ('UBERON_0001977', 'blood serum', 245, 'serum'), ('CHEBI_71657', 'versiconol acetate', 251, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 251, '25(OH)D')]
PMC3641012	4/2013	S226-PMC3641012	['in comparison to the lc-ms/ms method used HERE, the immunoassay used in the pilot study (diasorin liaison total) MAY have UNDER-estimated 25(Oh)D because of raised dbp concentrations in Pregnancy [29] OR relative imprecision at the higher 25(Oh)D range attained in the Vitamin D group [30,31].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 42), ('INCOMPLETE_EVIDENCE', 113), ('IMPORTANT_CONSIDERATION', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 201)]	4	[('CHEBI_71657', 'versiconol acetate', 138, '25(OH)D'), ('GO_0007565', 'female pregnancy', 186, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 239, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 269, 'vitamin D')]
PMC3641012	4/2013	S237-PMC3641012	['HOWEVER, like hollis et al., we did not encounter any EVIDENCE of Vitamin D toxicity.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 54)]	2	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC3641012	4/2013	S238-PMC3641012	['Vitamin D DID NOT affect average Urinary Calcium Excretion, YET we did see a SMALL but significant increase in the mean adj-ca in the Vitamin D group COMPARED TO the placebo group.']	[('INCOMPLETE_EVIDENCE', 10), ('ANOMALY_CURIOUS_FINDING', 60), ('INCOMPLETE_EVIDENCE', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 150)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0001088', 'urine', 33, 'urinary'), ('CHEBI_22313', 'alkaline earth metal atom', 41, 'calcium'), ('GO_0036161', 'calcitonin secretion', 41, 'calcium excretion'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC3641012	4/2013	S243-PMC3641012	['third, a positive ASSOCIATION between adj-ca and 25(Oh)D was apparent in the range of 25(Oh)D below 100\xa0nmol/l BUT not above 100\xa0nmol/l; evidence of POSSIBLE harm would be more CONSISTENT with the OPPOSITE FINDING of a Serum calcium that was tightly Controlled (i.e., unassociated with 25(Oh)D) within the lower range of 25(Oh)D, but deflected upward at higher 25(Oh)D. all maternal uncorrected and adj-ca values were below the threshold for hypercalcemia used by the iom in the 1997 Vitamin D dris (2.75\xa0mmol/l) [10] and the 2010 revision (2.63\xa0mmol/l) [7].']	[('SUPERFICIAL_RELATIONSHIP', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('INCOMPLETE_EVIDENCE', 149), ('INCOMPLETE_EVIDENCE', 177), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 197), ('INCOMPLETE_EVIDENCE', 206)]	6	[('CHEBI_71657', 'versiconol acetate', 49, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 86, '25(OH)D'), ('UBERON_0001977', 'blood serum', 219, 'serum'), ('GO_0065007', 'biological regulation', 250, 'controlled'), ('CHEBI_71657', 'versiconol acetate', 286, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 321, '25(OH)D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 364, 'OH)D'), ('CHEBI_27300', 'vitamin D', 484, 'vitamin D')]
PMC3641012	4/2013	S244-PMC3641012	['we set a conservative upper limit of reference range for trial monitoring (2.60\xa0mmol/l), which was crossed by one participant in the Vitamin D group; HOWEVER, this was not logically attributable to Vitamin D toxicity based on normal repeat Serum calcium, normal ca:cr, and a 25(Oh)d that was well within the range considered to be non-hypercalcemic [37].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 150)]	1	[('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('UBERON_0001977', 'blood serum', 240, 'serum'), ('CHEBI_63056', 'zinc cation', 275, '25(OH')]
PMC3641012	4/2013	S250-PMC3641012	['in addition, enrolment was not conducted throughout the entire season, but RATHER occurred during a period in which Vitamin D status was declining from its summer peak.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 75)]	1	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC3651971	5/2013	S24-PMC3651971	['introduction\nrisk for Cognitive and motor impairment begins in the Womb, where nutritional restrictions on Embryofetal Tissue growth, differentiation, development and Maturation MAY disturb growth, maturation and function of the Central Nervous System.1neural myelination and Synaptogenesis are underway before 24\u2005weeks’ Gestational age, Neural Tube Formation and Cell Migration are complete before the third Trimester of Pregnancy, and basic structures of the Brain formed before Birth.2as complex structures and functions extend as a cascade, disruptions to nascent systems by nutritional and OTHER insults CAN be amplified with age.3\nEmbryofetal Development is sensitive to Gestational deficiency in Vitamin A,4most EVIDENT in Animals by gross anomalies in Organ and Tissue Morphogenesis, development, structure and function.5–7Retinoic Acid, the oxidised Metabolite and transcriptional ligand of Vitamin A, Regulates the Expression of hox Genes that are essential in Neural Tube Formation,8the Development Of Neurons, and in Synaptic Signalling that UNDERLIES Learning and Memory.9–13developing neural Tissue in the Mouse is ESPECIALLY sensitive to variation in Retinoic Acid exposure near Parturition, a time analogous to the second Trimester of Human Gestation, when deficiency can induce behavioural problems and mild structural damage within the Limbic Cortex.14\nchronic dietary Vitamin A deficiency is common among Pregnant women in poor countries,1516leading TO concern that it MAY have adverse consequences for Cognitive and Motor Development Of the Fetus.']	[('INCOMPLETE_EVIDENCE', 178), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 595), ('INCOMPLETE_EVIDENCE', 609), ('PROBABLE_UNDERSTANDING', 719), ('SUPERFICIAL_RELATIONSHIP', 1054), ('ANOMALY_CURIOUS_FINDING', 1129), ('QUESTION_ANSWERED_BY_THIS_WORK', 1469), ('INCOMPLETE_EVIDENCE', 1488)]	8	[('GO_0050890', 'cognition', 22, 'cognitive'), ('UBERON_0002396', 'vomer', 67, 'womb'), ('UBERON_0000922', 'embryo', 107, 'embryofetal'), ('UBERON_0000479', 'tissue', 119, 'tissue'), ('GO_0007618', 'mating', 167, 'maturation'), ('UBERON_0001017', 'central nervous system', 229, 'central nervous system'), ('GO_0007416', 'synapse assembly', 276, 'synaptogenesis'), ('GO_0007565', 'female pregnancy', 321, 'gestational'), ('GO_0042136', 'neurotransmitter biosynthetic process', 338, 'neural tube formation'), ('UBERON_0001049', 'neural tube', 338, 'neural tube'), ('GO_0016477', 'cell migration', 364, 'cell migration'), ('GO_0009294', 'DNA mediated transformation', 409, 'trimester'), ('GO_0007565', 'female pregnancy', 422, 'pregnancy'), ('UBERON_0000955', 'brain', 461, 'brain'), ('GO_0007567', 'parturition', 481, 'birth'), ('GO_0009790', 'embryo development', 637, 'Embryofetal development'), ('UBERON_0000922', 'embryo', 637, 'Embryofetal'), ('GO_0007565', 'female pregnancy', 677, 'gestational'), ('CHEBI_27300', 'vitamin D', 703, 'vitamin A'), ('NCBITaxon_33208', 'Metazoa', 730, 'animals'), ('UBERON_0000062', 'organ', 760, 'organ'), ('GO_0048729', 'tissue morphogenesis', 770, 'tissue morphogenesis'), ('UBERON_0000479', 'tissue', 770, 'tissue'), ('CHEBI_52071', 'dextran', 828, '5'), ('CHEBI_24115', 'fuconate', 830, '7Retinoic acid'), ('CHEBI_39382', 'flufenoxuron', 859, 'metabolite'), ('CHEBI_27300', 'vitamin D', 900, 'vitamin A'), ('GO_0065007', 'biological regulation', 911, 'regulates'), ('GO_0010467', 'gene expression', 925, 'expression'), ('SO_0000704', 'gene', 943, 'genes'), ('GO_0042136', 'neurotransmitter biosynthetic process', 971, 'neural tube formation'), ('UBERON_0001049', 'neural tube', 971, 'neural tube'), ('GO_0046697', 'decidualization', 998, 'development of neurons'), ('CL_0000540', 'neuron', 1013, 'neurons'), ('GO_0045202', 'synapse', 1029, 'synaptic'), ('GO_0099536', 'synaptic signaling', 1029, 'synaptic signalling'), ('GO_0007612', 'learning', 1064, 'learning'), ('GO_0007613', 'memory', 1077, 'memory'), ('UBERON_0000479', 'tissue', 1106, 'tissue'), ('NCBITaxon_10088', 'Mus <genus>', 1120, 'mouse'), ('CHEBI_26536', 'retinoic acid', 1166, 'retinoic acid'), ('GO_0019230', 'proprioception', 1194, 'parturition'), ('GO_0009294', 'DNA mediated transformation', 1238, 'trimester'), ('NCBITaxon_9606', 'Homo sapiens', 1251, 'human'), ('GO_0007565', 'female pregnancy', 1257, 'gestation'), ('UBERON_0016542', 'limbic cortex', 1354, 'limbic cortex'), ('CHEBI_27300', 'vitamin D', 1387, 'vitamin A'), ('GO_0007565', 'female pregnancy', 1424, 'pregnant'), ('GO_0050890', 'cognition', 1522, 'cognitive ...'), ('GO_0048870', 'cell motility', 1536, 'motor development of ... fetus')]
PMC3651971	5/2013	S26-PMC3651971	['in a study of healthy chinese mothers and newborns, a positive RELATIONSHIP was OBSERVED between Cord Blood Retinol level and motor skill achievements by age 2.17in indonesia, newborn Vitamin A supplementation resulted in modest improvement in Motor Development scores after 3\u2005years,18while Vitamin A supplementation to hiv-positive tanzanian women exerted no detectable changes in infant Psychomotor Development.19there REMAINS, HOWEVER, a NEED FOR ADDITIONAL causal data on early Life Vitamin A exposure and Neurocognitive and motor function.']	[('SUPERFICIAL_RELATIONSHIP', 63), ('INCOMPLETE_EVIDENCE', 80), ('INCOMPLETE_EVIDENCE', 421), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 430), ('FUTURE_WORK', 441)]	5	[('UBERON_0002240', 'spinal cord', 97, 'cord'), ('UBERON_0000178', 'blood', 102, 'blood'), ('CHEBI_26536', 'retinoic acid', 108, 'retinol'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin A'), ('GO_0009653', 'anatomical structure morphogenesis', 244, 'motor development'), ('CHEBI_27300', 'vitamin D', 291, 'vitamin A'), ('GO_0030324', 'lung development', 389, 'psychomotor development'), ('UBERON_0000104', 'life cycle', 482, 'life'), ('CHEBI_27300', 'vitamin D', 487, 'vitamin A'), ('GO_0050905', 'neuromuscular process', 510, 'neurocognitive')]
PMC3651971	5/2013	S88-PMC3651971	['this TREND, HOWEVER, was ONLY evident in the Vitamin A group (among whom the percentages were 84.6 vs 52.9, respectively, p<0.01; data not shown).']	[('INCOMPLETE_EVIDENCE', 5), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 25)]	3	[('CHEBI_27300', 'vitamin D', 45, 'vitamin A')]
PMC3651971	5/2013	S143-PMC3651971	['there are also a host of OTHER nutritional INFLUENCES on Cognitive Development, SOME of which MIGHT obscure the RELATIONSHIP between early Vitamin A deficiency and developmental outcomes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('SUPERFICIAL_RELATIONSHIP', 43), ('INCOMPLETE_EVIDENCE', 80), ('INCOMPLETE_EVIDENCE', 94), ('SUPERFICIAL_RELATIONSHIP', 112)]	5	[('GO_0050787', 'detoxification of mercury ion', 57, 'cognitive development'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin A')]
PMC3651971	5/2013	S151-PMC3651971	['ANOTHER POSSIBLE EXPLANATION for the LACK OF difference between groups is that unit and mabc are INSUFFICIENTLY PRECISE to pick up on subtle differences in Vitamin A nutriture.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('PROBABLE_UNDERSTANDING', 17), ('INCOMPLETE_EVIDENCE', 37), ('PROBLEM_COMPLICATION', 97)]	5	[('CHEBI_27300', 'vitamin D', 156, 'vitamin A')]
PMC3659910	1/2013	S13-PMC3659910	['CONCERNS about Vitamin D have RESURFACED in medical and scientific literature OWING TO its multiple EFFECTS on Human health.']	[('IMPORTANT_CONSIDERATION', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('PROBABLE_UNDERSTANDING', 78), ('SUPERFICIAL_RELATIONSHIP', 100)]	4	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 111, 'human')]
PMC3659910	1/2013	S44-PMC3659910	['the REQUIREMENT for Vitamin D in maintaining normal Calcium Metabolism throughout Pregnancy and Lactation in mothers, fetuses and newborn infants is STILL CONTROVERSIAL.']	[('IMPORTANT_CONSIDERATION', 4), ('IMPORTANT_CONSIDERATION', 149), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 155)]	3	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0018884', 'carbazole metabolic process', 52, 'calcium metabolism'), ('GO_0007565', 'female pregnancy', 82, 'pregnancy'), ('GO_0007595', 'lactation', 96, 'lactation')]
PMC3659910	1/2013	S45-PMC3659910	['IT IS CLEAR, HOWEVER, that Vitamin D REQUIREMENTS are increased in mothers during Pregnancy and Lactation.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('IMPORTANT_CONSIDERATION', 37)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'pregnancy'), ('GO_0007595', 'lactation', 96, 'lactation')]
PMC3659910	1/2013	S52-PMC3659910	['ALTHOUGH transplacental Transport has NOT BEEN STUDIED in Humans, Vitamin D passage from the mother to the fetus WOULD BE facilitated by Serum concentrations of 1,25(Oh) 2D being higher in the maternal compared to the fetal Circulations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FULL_UNKNOWN', 38), ('FUTURE_PREDICTION', 113)]	3	[('GO_0006809', 'nitric oxide biosynthetic process', 24, 'transport'), ('NCBITaxon_9606', 'Homo sapiens', 58, 'humans'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('UBERON_0001977', 'blood serum', 137, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 166, 'OH) 2D'), ('UBERON_0002595', 'orbital sulcus', 224, 'circulations')]
PMC3659910	1/2013	S61-PMC3659910	['in the united states staple Foods like milk, breakfast cereals and margarines are artificially fortified with Vitamin D.[14] AT PRESENT, the number and variety of Vitamin D fortified foods available on the market DIFFERS significantly between countries and is ATTRIBUTED to the country-specific policies on Food fortification which are NOT YET unified.']	[('INCOMPLETE_EVIDENCE', 125), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 213), ('SUPERFICIAL_RELATIONSHIP', 260), ('FUTURE_WORK', 336)]	4	[('CHEBI_33290', 'food', 28, 'foods'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D'), ('CHEBI_33290', 'food', 307, 'food')]
PMC3659910	1/2013	S79-PMC3659910	['[18] this RECOMMENDATION MAY BE CONTROVERSIAL BECAUSE very high doses of Vitamin D HAVE long BEEN BELIEVED to cause Birth defects.']	[('FUTURE_WORK', 10), ('INCOMPLETE_EVIDENCE', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('PROBABLE_UNDERSTANDING', 46), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 98)]	6	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007567', 'parturition', 116, 'birth')]
PMC3659910	1/2013	S93-PMC3659910	['HOWEVER, hypervitaminosis D has NEVER OCCURRED when physiologic amounts of Vitamin D are Ingested.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 32)]	2	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 26, 'D'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0007631', 'feeding behavior', 89, 'ingested')]
PMC3659910	1/2013	S97-PMC3659910	['RECENT work EMPHASIZES the IMPORTANCE of NON-CLASSICAL ROLES of Vitamin D in Pregnancy and the Placenta.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 12), ('IMPORTANT_CONSIDERATION', 27), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 41), ('SUPERFICIAL_RELATIONSHIP', 55)]	5	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy'), ('UBERON_0001987', 'placenta', 95, 'placenta')]
PMC3659910	1/2013	S122-PMC3659910	['CONVERSELY, Vitamin D deficiency results in proximal muscle weakness and decreased Lower Extremity muscle function PERHAPS CONTRIBUTING TO the RISK for cesarean section.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 123), ('IMPORTANT_CONSIDERATION', 143)]	4	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('UBERON_0002103', 'hindlimb', 83, 'lower extremity')]
PMC3659910	1/2013	S131-PMC3659910	['RESEARCH has FOUND direct CONNECTIONS between Vitamin D and the Genes KNOWN to be INVOLVED in ms, BUT exact pathology and WHETHER Vitamin D supplements during Pregnancy OR childhood can lessen the likelihood of the child developing ms later in Life is NOT KNOWN.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 82), ('ANOMALY_CURIOUS_FINDING', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('FULL_UNKNOWN', 252)]	8	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('SO_0000704', 'gene', 64, 'genes'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007565', 'female pregnancy', 159, 'pregnancy'), ('UBERON_0000104', 'life cycle', 244, 'life')]
PMC3659910	1/2013	S132-PMC3659910	['while there is INTEREST in the ROLE of Vitamin D in the PREVENTION of multiple sclerosis, following epidemiological STUDIES DEMONSTRATING an ASSOCIATION between Vitamin D supplementation and reduced PREVALENCE of the disease, FUTURE RESEARCH, including randomized controlled trials in Pregnant or nonpregnant Individuals, is AWAITED TO CONFIRM OR REFUTE such BENEFIT.']	[('IMPORTANT_CONSIDERATION', 15), ('SUPERFICIAL_RELATIONSHIP', 31), ('SUPERFICIAL_RELATIONSHIP', 56), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 124), ('SUPERFICIAL_RELATIONSHIP', 141), ('IMPORTANT_CONSIDERATION', 199), ('FUTURE_WORK', 226), ('FUTURE_WORK', 325), ('FUTURE_WORK', 333), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 344), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 347), ('IMPORTANT_CONSIDERATION', 359)]	13	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D'), ('GO_0007565', 'female pregnancy', 285, 'pregnant'), ('NCBITaxon_1', 'root', 309, 'individuals')]
PMC3659910	1/2013	S138-PMC3659910	['OTHER SUGGESTS Vitamin D supplementation of 400 iu/day to Breast Fed infants is the MOST secure way of PREVENTING rickets in infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('PROBABLE_UNDERSTANDING', 84), ('SUPERFICIAL_RELATIONSHIP', 103)]	4	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0007567', 'parturition', 58, 'breast fed')]
PMC3659910	1/2013	S157-PMC3659910	['one approach is to CONSIDER Serum testing in patients at high RISK for Vitamin D deficiency BUT treating without testing those at lower RISK.']	[('FUTURE_WORK', 19), ('IMPORTANT_CONSIDERATION', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('IMPORTANT_CONSIDERATION', 136)]	4	[('UBERON_0001977', 'blood serum', 28, 'serum'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC3659910	1/2013	S161-PMC3659910	['[44] ALTHOUGH 1,25(Oh) 2D is the active circulating form of Vitamin D, measuring this level is NOT HELPFUL BECAUSE it is quickly and tightly Regulated by the Kidney.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('DIFFICULT_TASK', 95), ('PROBLEM_COMPLICATION', 107)]	3	[('CHEBI_37983', 'sulfur-35 atom', 14, '1'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 16, '25(OH) 2D'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 68, 'D'), ('GO_0065007', 'biological regulation', 141, 'regulated'), ('UBERON_0002113', 'kidney', 158, 'kidney')]
PMC3659910	1/2013	S166-PMC3659910	['[44] CONTROVERSY exists regarding the optimum concentration of Serum 25-Hydroxyvitamin D for DEFINING Vitamin D deficiency, ESPECIALLY in Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('INCOMPLETE_EVIDENCE', 93), ('IMPORTANT_CONSIDERATION', 124)]	3	[('UBERON_0001977', 'blood serum', 63, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 69, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0007565', 'female pregnancy', 138, 'pregnancy')]
PMC3659910	1/2013	S173-PMC3659910	['HOWEVER this RECOMMENDED level, which was LARGELY ARBITRARILY set, SEEMS TO BE LESS HELPFUL to improve the nutritional Vitamin D status of Pregnant women.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 13), ('INCOMPLETE_EVIDENCE', 42), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 50), ('ANOMALY_CURIOUS_FINDING', 67), ('FUTURE_PREDICTION', 73), ('IMPORTANT_CONSIDERATION', 79)]	7	[('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('GO_0007565', 'female pregnancy', 139, 'pregnant')]
PMC3659910	1/2013	S185-PMC3659910	['HOWEVER, getting 25(Oh) D levels consistently above 75 nmol/l (30 ng/ml) MAY REQUIRE AT LEAST 1500-2000 iu/day of Vitamin D. if a mother is Vitamin D deficient, Breast Milk is not a good source of Vitamin D, so infants need to be given Vitamin D supplementation until they are weaned.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 73), ('FUTURE_WORK', 77), ('PROBABLE_UNDERSTANDING', 85)]	4	[('CHEBI_71657', 'versiconol acetate', 17, '25(OH) D'), ('PR_000006444', 'diacylglycerol kinase delta', 24, 'D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('UBERON_0000310', 'breast', 161, 'breast'), ('UBERON_0001913', 'milk', 168, 'milk'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 236, 'vitamin D')]
PMC3659910	1/2013	S189-PMC3659910	['the current LACK OF EVIDENCE of benefit for women at lower RISK of Vitamin D deficiency points to the NEED FOR FURTHER RESEARCH into Vitamin D supplementation in Pregnant women with clinical neonatal and infant end-points under SCRUTINY.']	[('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 59), ('FUTURE_WORK', 102), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 228)]	4	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('GO_0007565', 'female pregnancy', 162, 'pregnant')]
PMC3660294	5/2013	S198-PMC3660294	['WHILE more than 20% of breastfeeding mothers in this study did not provide Vitamin D supplements to their infants, ABOUT half of exclusively breastfeeding mothers in another national survey gave their infants Vitamin D supplements [24].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 115)]	2	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D')]
PMC3662163	3/2013	S162-PMC3662163	['besides that, all Vitamins -except Folic Acid- were included in their study WHEREAS we excluded Vitamin D users.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 76)]	1	[('CHEBI_33277', 'gamma-tocotrienol', 18, 'vitamins'), ('CHEBI_30751', 'formic acid', 35, 'folic acid'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D')]
PMC3668200	5/2013	S10-PMC3668200	['HOWEVER, measuring 1,25-Oh2-D levels AS a PREDICTOR of Vitamin D status CAN LEAD TO ERRONEOUS CONCLUSIONS BECAUSE, compared with 25(Oh)D levels, 1,25-Oh2-D levels CAN be normal or EVEN elevated DESPITE Vitamin D deficiency due to secondary hyperparathyroidism.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 37), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 72), ('PROBABLE_UNDERSTANDING', 76), ('QUESTION_ANSWERED_BY_THIS_WORK', 81), ('PROBLEM_COMPLICATION', 84), ('PROBLEM_COMPLICATION', 84), ('PROBABLE_UNDERSTANDING', 94), ('PROBABLE_UNDERSTANDING', 106), ('PROBLEM_COMPLICATION', 106), ('INCOMPLETE_EVIDENCE', 163), ('ANOMALY_CURIOUS_FINDING', 180), ('ANOMALY_CURIOUS_FINDING', 194)]	14	[('CHEBI_78731', '9(R)-HPETE', 21, '25-OH2-D'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_63056', 'zinc cation', 129, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 135, 'D'), ('CHEBI_78731', '9(R)-HPETE', 147, '25-OH2-D'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D')]
PMC3668200	5/2013	S29-PMC3668200	['ON the CONTRARY, Vitamin D content of the Breast Milk does not meet the REQUIRED daily amount for the infants DESPITE adequate dietary supplementation of Vitamin D12), because this supplementing does not substantially increase the Vitamin D concentration in Human milk13).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 7), ('IMPORTANT_CONSIDERATION', 72), ('ANOMALY_CURIOUS_FINDING', 110)]	4	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0001348', 'brown adipose tissue', 42, 'breast milk'), ('CHEBI_33279', 'vitamin D5', 154, 'vitamin D12'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 258, 'human')]
PMC3668200	5/2013	S41-PMC3668200	['THEREFORE, daily supplementation with 400 iu of Vitamin D during the last Trimester of Pregnancy HAS BEEN practiced, ALBEIT with MINIMAL EFFECT on circulating 25(Oh)D concentrations in the mother and infant at term.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 97), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 117), ('ANOMALY_CURIOUS_FINDING', 117), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 137)]	6	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 74, 'trimester'), ('GO_0007565', 'female pregnancy', 87, 'pregnancy'), ('CHEBI_30778', 'gallic acid', 159, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 165, 'D')]
PMC3668200	5/2013	S42-PMC3668200	['NEVERTHELESS, it is NOTEWORTHY that infants Born to unsupplemented Vitamin D-deficient mothers were LIKELY to have early Vitamin D deficiency compared with those whose mothers were supplemented with Vitamin D during Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 20), ('PROBABLE_UNDERSTANDING', 100)]	3	[('GO_0007567', 'parturition', 44, 'born'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('GO_0007565', 'female pregnancy', 216, 'pregnancy')]
PMC3668200	5/2013	S45-PMC3668200	['the authors DID NOT TAKE into CONSIDERATION the height profiles of the newborns EVEN IF Minerals and Vitamin D are key FACTORS of bony growth.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 30), ('ANOMALY_CURIOUS_FINDING', 80), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 85), ('SUPERFICIAL_RELATIONSHIP', 119)]	5	[('CHEBI_46751', 'quinolizidine', 88, 'minerals'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC3672018	5/2013	S1-PMC3672018	['HOWEVER, the IMPORTANCE of maternal Vitamin D status on offspring health later in Life has not been widely studied.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 13)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0000104', 'life cycle', 82, 'life')]
PMC3672018	5/2013	S8-PMC3672018	['also, OTHER health outcomes can subsequently be studied to generate multiple health research OPPORTUNITIES involving Vitamin D. finally, the results of the study will justify the DEBATE of danish health authorities whether to resume Vitamin D supplementation policies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('FUTURE_WORK', 93), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 179)]	3	[('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 233, 'vitamin D')]
PMC3672018	5/2013	S23-PMC3672018	['Animal Tissues consumed as Food provide additional sources of this hormone-like vitamin, WHILE Plant foods MAY provide the less potent form of Vitamin D: Ergocalciferol (Vitamin D2) [7].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 89), ('INCOMPLETE_EVIDENCE', 107)]	2	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('UBERON_0000479', 'tissue', 7, 'tissues'), ('CHEBI_33290', 'food', 27, 'food'), ('NCBITaxon_33208', 'Metazoa', 95, 'plant'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('CHEBI_4910', 'etomidate', 154, 'ergocalciferol'), ('CHEBI_28934', 'vitamin D2', 170, 'vitamin D2'), ('PR_000017299', 'VIP peptides', 170, 'vitamin D2')]
PMC3672018	5/2013	S24-PMC3672018	['ALTHOUGH adequate exposure to uvb sunlight is PARAMOUNT to an ample supply of Vitamin D, Oral Intake, augmented by both fortification and supplementation, is NECESSARY to maintain baseline stores in populations at high latitudes were the sun can only drive dermal Synthesis Of Vitamin D from april to october [8].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 46), ('IMPORTANT_CONSIDERATION', 158)]	4	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0000165', 'mouth', 89, 'oral'), ('GO_0007631', 'feeding behavior', 94, 'intake'), ('GO_0030474', 'spindle pole body duplication', 264, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 277, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 285, 'D')]
PMC3672018	5/2013	S41-PMC3672018	['ALTHOUGH mechanisms RELATING low Perinatal Vitamin D to later obesity are NOT WELL KNOWN, PROPOSED mediators include epigenetic changes leading to initiation of Adipogenesis, or induction of permanent functional changes in Hypothalamic Appetite Regulation [17,18].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 20), ('FULL_UNKNOWN', 74), ('FUTURE_WORK', 78), ('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 245)]	7	[('GO_0036268', 'swimming', 33, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 33, 'perinatal'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0060612', 'adipose tissue development', 161, 'adipogenesis'), ('UBERON_0001898', 'hypothalamus', 223, 'hypothalamic'), ('GO_0034205', 'amyloid-beta formation', 236, 'appetite regulation')]
PMC3672018	5/2013	S56-PMC3672018	['the Vitamin D fortification of low fat milk was not mandatory and THEREFORE not all low fat Milk distributed in denmark in the time period was fortified with Vitamin D. UNFORTUNATELY, there are no national statistics INDICATING the proportion of Milk Consumed that was fortified with Vitamin D. NEVERTHELESS, the two well-defined time periods of Vitamin D fortification provide a natural framework for comparing the EFFECTS of early exposure to Vitamin D on the Development Of Diseases later in Life amongst exposed and non-exposed adjacent Birth cohorts (figure\xa01).']	[('PROBABLE_UNDERSTANDING', 66), ('IMPORTANT_CONSIDERATION', 169), ('INCOMPLETE_EVIDENCE', 217), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 295), ('SUPERFICIAL_RELATIONSHIP', 416)]	5	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('UBERON_0001913', 'milk', 92, 'milk'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('UBERON_0001913', 'milk', 246, 'milk'), ('GO_0007631', 'feeding behavior', 251, 'consumed'), ('CHEBI_27300', 'vitamin D', 284, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 346, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 445, 'vitamin D'), ('GO_0009603', 'detection of symbiotic fungus', 462, 'development of diseases'), ('UBERON_0000104', 'life cycle', 495, 'life'), ('GO_0007567', 'parturition', 541, 'birth')]
PMC3672018	5/2013	S94-PMC3672018	['the HYPOTHESIS is that Individuals Born 1–2\u2009years after commencement of mandatory fortification (1961) and thus exposed to extra Vitamin D during Fetal Development and for the next 24–25\u2009years until 1985 (where fortification was ended), ALTHOUGH unexposed thereafter, will have a lower lifetime risk of developing the aforementioned disease entities COMPARED TO Individuals Born 1\u2009–2\u2009years before fortification.']	[('INCOMPLETE_EVIDENCE', 4), ('ANOMALY_CURIOUS_FINDING', 237), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 350)]	3	[('NCBITaxon_1', 'root', 23, 'individuals'), ('GO_0007567', 'parturition', 35, 'born'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 146, 'fetal development'), ('NCBITaxon_1', 'root', 362, 'individuals'), ('GO_0007567', 'parturition', 374, 'born')]
PMC3672018	5/2013	S96-PMC3672018	['LIKEWISE, Individuals Born 1–2\u2009years after mandatory fortification terminated in 1985, and who were unexposed to Vitamin D both during Fetal Development and subsequently, will have a higher risk of later developing the diseases COMPARED TO those exposed during fetal Life.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 228)]	2	[('NCBITaxon_1', 'root', 10, 'individuals'), ('GO_0007567', 'parturition', 22, 'born'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 135, 'fetal development'), ('UBERON_0000104', 'life cycle', 267, 'life')]
PMC3672018	5/2013	S100-PMC3672018	['WHETHER OR NOT exposure to Vitamin D fortification in different Gestational trimesters is IMPORTANT will be examined.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 90)]	2	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'gestational')]
PMC3672018	5/2013	S101-PMC3672018	['for instance, INFLUENCE of low Vitamin D on obesity and Adipose Tissues MAY BE particularly IMPORTANT for children whose third Gestation periods occur during winter, WHILE INFLUENCE of low Vitamin D on Autoimmune diseases MAY BE particularly IMPORTANT for children whose first Gestational trimester occurs during winter.']	[('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 72), ('IMPORTANT_CONSIDERATION', 92), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 166), ('SUPERFICIAL_RELATIONSHIP', 172), ('INCOMPLETE_EVIDENCE', 222), ('IMPORTANT_CONSIDERATION', 242)]	7	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('UBERON_0001013', 'adipose tissue', 56, 'adipose tissues'), ('GO_0007565', 'female pregnancy', 127, 'gestation'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 202, 'autoimmune'), ('GO_0007565', 'female pregnancy', 277, 'gestational')]
PMC3672018	5/2013	S146-PMC3672018	['HOWEVER, Vitamin D fortification is especially beneficial when Vitamin D status is low [9], e.g.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC3672018	5/2013	S153-PMC3672018	['in CONTRARY, the Individuals in the database are unselected in RELATION to Vitamin D exposure as well as to later disease occurrence.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 3), ('SUPERFICIAL_RELATIONSHIP', 63)]	2	[('NCBITaxon_1', 'root', 17, 'individuals'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC3672018	5/2013	S160-PMC3672018	['moreover, there MIGHT be regional and urban/rural DIFFERENCES in Vitamin D intake.']	[('INCOMPLETE_EVIDENCE', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 50)]	2	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC3672018	5/2013	S165-PMC3672018	['implications\nUNLIKE many OTHER nutritional deficiencies, low Vitamin D status is PREVALENT among industrialized populations, and, ACCORDING TO danish health authorities, about half of all adults have Vitamin D insufficiency (below 50\u2009nmol/l) [32].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('IMPORTANT_CONSIDERATION', 81), ('INCOMPLETE_EVIDENCE', 130)]	4	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D')]
PMC3672018	5/2013	S166-PMC3672018	['adequate exposure to uvb sunlight is PARAMOUNT IMPORTANCE for supply of Vitamin D, BUT Oral Intake, augmented by fortification and supplementation, is NECESSARY to maintain baseline stores, particularly in winter when sunlight is limited [8,33,34].']	[('IMPORTANT_CONSIDERATION', 37), ('IMPORTANT_CONSIDERATION', 47), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('IMPORTANT_CONSIDERATION', 151)]	4	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0000165', 'mouth', 87, 'oral'), ('GO_0007631', 'feeding behavior', 92, 'intake')]
PMC3672018	5/2013	S167-PMC3672018	['THUS, AS IT IS CLEAR that Vitamin D status of danes NEEDS to be improved, the danish health authorities currently DEBATE, WHETHER to resume Vitamin D fortification of Food [35].']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 6), ('FUTURE_WORK', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('EXPLICIT_QUESTION', 122)]	6	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('CHEBI_33290', 'food', 167, 'food')]
PMC3672018	5/2013	S170-PMC3672018	['the results will also provide solid quantitative justification WHETHER to resume Vitamin D fortification.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 63)]	1	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC3672018	5/2013	S180-PMC3672018	['besides IMPLICATIONS for research in the field, it MAY also inform the current DEBATE in denmark on WHETHER to resume Vitamin D Food fortification.']	[('IMPORTANT_CONSIDERATION', 8), ('INCOMPLETE_EVIDENCE', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 100), ('EXPLICIT_QUESTION', 100)]	5	[('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_33290', 'food', 128, 'food')]
PMC3679329	6/2013	S79-PMC3679329	['a population based cohort study of Adults in the us DEMONSTRATED that supplement users, COMPARED TO non-users, GENERALLY had higher average Intakes of Foods which are IMPORTANT sources of Vitamin C and Carotenoids (i.e., fruits and certain vegetables) [12].']	[('INCOMPLETE_EVIDENCE', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 88), ('PROBABLE_UNDERSTANDING', 111), ('IMPORTANT_CONSIDERATION', 167)]	4	[('UBERON_0007023', 'adult organism', 35, 'adults'), ('GO_0007631', 'feeding behavior', 140, 'intakes'), ('CHEBI_33290', 'food', 151, 'foods'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin C'), ('CHEBI_50815', 'norgestimate', 202, 'carotenoids')]
PMC3685533	6/2013	S23-PMC3685533	['HOWEVER, most Pregnant women are Vitamin D deficient or insufficient with a consequential deficiency or insufficiency in their neonates [5-8].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('GO_0007565', 'female pregnancy', 14, 'pregnant'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC3685533	6/2013	S27-PMC3685533	['moreover, SOME STUDIES INDICATE that ethnic DIFFERENCES play a ROLE in the circulating levels of Serum Vitamin D [13-15].']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 44), ('SUPERFICIAL_RELATIONSHIP', 63)]	4	[('UBERON_0001977', 'blood serum', 97, 'serum'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC3685533	6/2013	S32-PMC3685533	['DISCORDANT data are present with respect to the ROLE of Vitamin D supplementation during Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 48)]	2	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy')]
PMC3685533	6/2013	S35-PMC3685533	['IN ORDER TO understand the DIFFERENCES in Vitamin D levels depending on skin colour and ethnic differences, we evaluated 25Ohd levels at Birth in Cord Blood and in the first three days of Life from ethnically diverse infants Born within our hospital.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 27)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 121, '25OHD'), ('GO_0007567', 'parturition', 137, 'birth'), ('UBERON_0002240', 'spinal cord', 146, 'cord'), ('UBERON_0000178', 'blood', 151, 'blood'), ('UBERON_0000104', 'life cycle', 188, 'life'), ('GO_0007567', 'parturition', 225, 'born')]
PMC3685533	6/2013	S107-PMC3685533	['analyzing data by mothers according to their country of origin, 25Ohd Cord Blood levels were higher in neonates Born from italian mothers than from north african or african mothers, WHILE after Birth Vitamin D Serum levels were higher in italian newborns ONLY when compared with north african.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 182), ('ANOMALY_CURIOUS_FINDING', 255), ('INCOMPLETE_EVIDENCE', 255)]	3	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 64, '25OHD'), ('UBERON_0002240', 'spinal cord', 70, 'cord'), ('UBERON_0000178', 'blood', 75, 'blood'), ('GO_0007567', 'parturition', 112, 'born'), ('GO_0007567', 'parturition', 194, 'birth'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('UBERON_0001977', 'blood serum', 210, 'serum')]
PMC3685533	6/2013	S123-PMC3685533	['Cord Blood Vitamin D levels were higher in fs than lob or mbb REGARDLESS of supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 62)]	1	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('CHEBI_27300', 'vitamin D', 11, 'vitamin D')]
PMC3685533	6/2013	S126-PMC3685533	['ALTHOUGH SEVERAL STUDIES are AVAILABLE on Vitamin D supplementation during Pregnancy, its APPROPRIATE dose is NOT CLEAR [19-21].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 29), ('IMPORTANT_CONSIDERATION', 90), ('FULL_UNKNOWN', 110)]	5	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0007565', 'female pregnancy', 75, 'pregnancy')]
PMC3685533	6/2013	S132-PMC3685533	['moreover, Vitamin D is INFLUENCED by seasonability and the study was conducted in a single season; HOWEVER, the data was collected in summer when better Vitamin D levels are DEMONSTRATED by literature [1].']	[('SUPERFICIAL_RELATIONSHIP', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99), ('INCOMPLETE_EVIDENCE', 174)]	3	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC3691177	6/2013	S14-PMC3691177	['dietary intake of Vitamin D makes a relatively small CONTRIBUTION to overall Vitamin D status, and APPARENT EFFECTS of Vitamin D intake MAY BE CONFOUNDED by OTHER CORRELATED nutrients.']	[('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 108), ('INCOMPLETE_EVIDENCE', 136), ('DIFFICULT_TASK', 143), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 157), ('SUPERFICIAL_RELATIONSHIP', 163)]	7	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
PMC3691177	6/2013	S21-PMC3691177	['Vitamin D insufficiency is NEVERTHELESS very common during Pregnancy[15]–[17], and it HAS BEEN PROPOSED that Prenatal Vitamin D supplementation MAY PREVENT childhood wheezing and asthma[18].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 27), ('INCOMPLETE_EVIDENCE', 86), ('INCOMPLETE_EVIDENCE', 95), ('INCOMPLETE_EVIDENCE', 144), ('SUPERFICIAL_RELATIONSHIP', 148)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 59, 'pregnancy'), ('GO_0007565', 'female pregnancy', 109, 'prenatal'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
PMC3691177	6/2013	S22-PMC3691177	['we assessed children whose mothers had taken part in a randomised controlled trial of Prenatal Vitamin D supplementation, TO DETERMINE WHETHER supplementation PREVENTED wheezing or allergic disease in the first 3 years of Life[19].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135), ('SUPERFICIAL_RELATIONSHIP', 159)]	3	[('GO_0007565', 'female pregnancy', 86, 'prenatal'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('UBERON_0000104', 'life cycle', 222, 'life')]
PMC3691177	6/2013	S74-PMC3691177	['as PREVIOUSLY reported[19], median Cord 25(Oh)D levels at Delivery were significantly higher in supplemented children COMPARED TO the control group [control 17 nmol/l (interquartile range (iqr) 14–22); daily dose 26 nmol/l (iqr 17–45); p<0.001; bolus dose 25 nmol/l (iqr 18–34); p<0.001)].10.1371/journal.pone.0066627.g001\n\ncaption (fig): figure 1\nrecruitment and follow up of study participants.10.1371/journal.pone.0066627.t001\n\ncaption (table-wrap): table 1\ncharacteristics of study participants followed up at age three years.controldaily Vitamin dbolus vitamin dcombined Vitamin D(n\u200a=\u200a50)(n\u200a=\u200a56)(n\u200a=\u200a52)(n\u200a=\u200a108)baseline maternal 25(Oh)D <25 nmol/l, n/n (%)24/50 (48)25/56 (45)22/52 (42)47/108 (44)male sex, n/n (%)27/50 (54)32/56 (57)26/52 (50)58/108 (55)Birth weight (g), mean (sd)3268 (585)3321 (525)3290 (467)3307 (497)ethnicity, n (%)asian12 (24)15 (27)13 (25)28 (26)middle eastern13 (26)14 (25)14 (26)28 (26)black12 (24)14 (25)13 (25)27 (25)white13 (26)13 (23)12 (24)25 (23)ga at Delivery (weeks), mean (sd)40 (1)39 (2)40 (1)39 (2)nulliparous mother, n/n (%)23/50 (46)20/56 (36)21/52 (40)41/108 (38)Vaginal Delivery, n/n (%)29/50 (58)35/56 (63)28/52 (54)63/108 (58)maternal smoking during Pregnancy, n/n (%)2/48 (4)3/55 (5)0/46 (0)3/101 (3)presence of household smokers, n/n (%)16/48 (33)15/55 (27)17/46 (37)32/101 (32)number of children in household, mean (sd)2 (1)2 (1)2 (1)2 (1)age mother left full time education, mean (sd)20 (3)20 (4)21 (4)21 (4)child in nursery, n/n (%)27/48 (56)36/55 (65)20/45 (44)57/101 (56)Cat or Dog in household, n/n (%)4/48 (8)5/54 (9)4/46 (9)9/100 (9)maternal fitzpatrick skin score grade 3–6, n/n (%)28/44 (64)33/49 (67)28/43 (65)61/92 (66)maternal regular vitamin intake at three years, n/n (%)9/46 (20)16/53 (30)16/45 (36)32/98 (33)at least one parent with allergic disease, n/n (%)23/45 (51)35/53 (66)21/45 (47)56/98 (57)exclusively Breast-Fed for 4 months, n/n (%)22/48 (46)20/54 (37)23/44 (52)43/98 (44)any child vitamin supplementation, n/n (%)30/48 (63)34/55 (62)30/46 (65)64/101 (63)completed immunizations to date, n/n (%)48/49 (98)54/55 (98)43/47 (91)97/102 (95)age at time of assessment (months), median (iqr)37.9 (36.9, 39.9)37.1 (36.5, 38.8)37.4 (36.5, 39.5)37.3 (36.5, 39.0)child fitzpatrick skin score grade 3–6, n (%)29/42 (69)34/48 (71)29/43 (67)63/91 (69)child bmi z score age 3, mean (sd)0.51 (1.48)0.35 (1.15)0.62 (1.15)0.47 (1.15)child outdoors >1 hour/day, n/n (%)32/48 (67)34/53 (64)33/45 (73)67/98 (68)child tv/computer >2 hours/day, n/n (%)24/48 (50)18/53 (34)17/45 (38)35/98 (36)child 25(Oh)D (nmol/l) age 3, median (iqr)42 (27, 68)35 (21, 66)42 (30, 93)41 (26, 72)\ndata shown are for all participants analysed.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 118)]	2	[('UBERON_0002240', 'spinal cord', 35, 'cord'), ('CHEBI_71657', 'versiconol acetate', 40, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 40, '25(OH ... D'), ('GO_0007567', 'parturition', 58, 'delivery'), ('CHEBI_33229', 'vitamin (role)', 543, 'vitamin'), ('CHEBI_27300', 'vitamin D', 576, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 636, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 636, '25(OH ... D'), ('GO_0007567', 'parturition', 762, 'Birth'), ('GO_0007567', 'parturition', 992, 'delivery'), ('GO_0007567', 'parturition', 1111, 'Vaginal'), ('UBERON_0000970', 'eye', 1111, 'Vaginal'), ('GO_0007567', 'parturition', 1119, 'delivery'), ('GO_0007565', 'female pregnancy', 1201, 'pregnancy'), ('NCBITaxon_10088', 'Mus <genus>', 1529, 'Cat'), ('NCBITaxon_33208', 'Metazoa', 1536, 'dog'), ('GO_0007567', 'parturition', 1880, 'breast'), ('UBERON_0000310', 'breast', 1880, 'breast'), ('GO_0007631', 'feeding behavior', 1887, 'fed'), ('CHEBI_71657', 'versiconol acetate', 2555, '25(OH)D'), ('PR_000011614', 'opioid growth factor receptor', 2558, 'OH)D')]
PMC3691177	6/2013	S109-PMC3691177	['our results SUGGEST that the MOST LIKELY EXPLANATION for the FINDING of decreased wheezing risk in offspring of mothers with a higher Vitamin D intake during Pregnancy in observational studies[1]–[4], is CONFOUNDING by OTHER dietary or lifestyle factors ASSOCIATED with Vitamin D intake.']	[('INCOMPLETE_EVIDENCE', 12), ('PROBABLE_UNDERSTANDING', 29), ('PROBABLE_UNDERSTANDING', 34), ('PROBABLE_UNDERSTANDING', 41), ('INCOMPLETE_EVIDENCE', 61), ('PROBLEM_COMPLICATION', 204), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 219), ('SUPERFICIAL_RELATIONSHIP', 254)]	8	[('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0007565', 'female pregnancy', 158, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D')]
PMC3691177	6/2013	S117-PMC3691177	['the 95% confidence interval for our primary outcome measure was 0.49 to 1.50, so we are UNABLE TO confidently exclude EFFECTS of Prenatal vitamin D supplementation on RISK of wheezing, or on the development of atopy especially in mothers treated with daily Vitamin D. third, we DID NOT assess Vitamin D receptor polymorphisms or OTHER POTENTIALLY IMPORTANT genotypic variations.']	[('DIFFICULT_TASK', 88), ('SUPERFICIAL_RELATIONSHIP', 118), ('IMPORTANT_CONSIDERATION', 167), ('INCOMPLETE_EVIDENCE', 278), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 329), ('INCOMPLETE_EVIDENCE', 335), ('IMPORTANT_CONSIDERATION', 347)]	7	[('GO_0007565', 'female pregnancy', 129, 'prenatal'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 146, 'D'), ('CHEBI_27300', 'vitamin D', 257, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 293, 'vitamin D')]
PMC3691177	6/2013	S137-PMC3691177	['ALTHOUGH THESE FINDINGS cannot automatically be generalised to OTHER populations of Pregnant women, one MIGHT expect Prenatal Vitamin D supplementation to SHOW its clearest clinical EFFECTS in a deficient population such as this.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 155), ('SUPERFICIAL_RELATIONSHIP', 182)]	7	[('GO_0007565', 'female pregnancy', 84, 'pregnant'), ('GO_0007565', 'female pregnancy', 117, 'prenatal'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
PMC3695234	7/2013	S17-PMC3695234	['ANOTHER STUDY REPORTED regional DIFFERENCES in the number of prescriptions of epipens within the united states; the highest rates were FOUND in new england, and the lowest in the southern states.2THESE results MAY provide IMPORTANT etiologic CLUES and INDICATE the POTENTIAL ROLE of Vitamin D in atopic disease susceptibility.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('INCOMPLETE_EVIDENCE', 135), ('PROBABLE_UNDERSTANDING', 195), ('PROBABLE_UNDERSTANDING', 195), ('INCOMPLETE_EVIDENCE', 210), ('IMPORTANT_CONSIDERATION', 222), ('INCOMPLETE_EVIDENCE', 242), ('INCOMPLETE_EVIDENCE', 252), ('INCOMPLETE_EVIDENCE', 265), ('SUPERFICIAL_RELATIONSHIP', 275)]	12	[('CHEBI_27300', 'vitamin D', 283, 'vitamin D')]
PMC3695234	7/2013	S20-PMC3695234	['a GROWING body of LITERATURE has LINKED decreased Serum Vitamin D levels with allergic diseases, PARTICULARLY ad.2-4HOWEVER, large-scale prospective and randomized studies are LACKING.']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 33), ('IMPORTANT_CONSIDERATION', 97), ('IMPORTANT_CONSIDERATION', 114), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115), ('FULL_UNKNOWN', 176)]	6	[('UBERON_0001977', 'blood serum', 50, 'serum'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D')]
PMC3695234	7/2013	S21-PMC3695234	['THUS, the available data highlights the NEED FOR FURTHER ANALYSIS of the ASSOCIATIONS between Vitamin D and atopic diseases in DIFFERENT populations.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 40), ('INCOMPLETE_EVIDENCE', 40), ('FUTURE_WORK', 49), ('SUPERFICIAL_RELATIONSHIP', 73), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127)]	6	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC3695234	7/2013	S57-PMC3695234	['the 1,25(Oh)2D3Molecule induces Antimicrobial peptide Gene Expression in isolated Human Keratinocytes, Monocytes, Neutrophils, and Human cell lines.9tlr activation of Human Macrophages up-regulates the Expression of the Vitamin D receptor and Vitamin D-1-hydroxylase Genes, leading to the induction of the Cathelicidin.10these data SUGGEST a LINK between tlrs and Vitamin D-mediated Innate Immunity, INDICATING that a DIFFERENCE in the ability of Human populations to produce Vitamin D MAY contributes to susceptibility to Microbial infection.']	[('INCOMPLETE_EVIDENCE', 332), ('SUPERFICIAL_RELATIONSHIP', 342), ('INCOMPLETE_EVIDENCE', 400), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 418), ('INCOMPLETE_EVIDENCE', 486)]	5	[('CHEBI_84221', '1-ethyl-2-propylcyclohexane', 4, '1,25(OH)2D3molecule'), ('CHEBI_65381', 'albizoside C', 32, 'antimicrobial'), ('GO_0010467', 'gene expression', 54, 'gene expression'), ('SO_0000704', 'gene', 54, 'gene'), ('NCBITaxon_9606', 'Homo sapiens', 82, 'human'), ('CL_0000312', 'keratinocyte', 88, 'keratinocytes'), ('CL_0000576', 'monocyte', 103, 'monocytes'), ('CL_0000775', 'neutrophil', 114, 'neutrophils'), ('NCBITaxon_9606', 'Homo sapiens', 131, 'human'), ('NCBITaxon_9606', 'Homo sapiens', 167, 'human'), ('CL_0000235', 'macrophage', 173, 'macrophages'), ('GO_0010467', 'gene expression', 202, 'expression'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 228, 'D'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D'), ('SO_0000704', 'gene', 267, 'genes'), ('PR_000006009', 'alpha-catulin', 306, 'cathelicidin'), ('CHEBI_27300', 'vitamin D', 364, 'vitamin D'), ('GO_0045087', 'innate immune response', 383, 'innate immunity'), ('NCBITaxon_9606', 'Homo sapiens', 447, 'human'), ('CHEBI_27300', 'vitamin D', 476, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 523, 'microbial')]
PMC3695234	7/2013	S60-PMC3695234	['supplementation with oral Vitamin D in 14 atopic subjects with moderate-to-severe atopic dermatitis for 21 days resulted in a significant increase in Cathelicidin Expression in ad-lesional skin.11ANOTHER pilot STUDY of winter-time onset or exacerbation of ad also SHOWED a favorable IMPACT of Vitamin D supplementation.12HOWEVER, there are CONFLICTING data surrounding the EFFECT of Vitamin D on the development of allergic Skin disease.']	[('INCOMPLETE_EVIDENCE', 194), ('INCOMPLETE_EVIDENCE', 264), ('SUPERFICIAL_RELATIONSHIP', 283), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 319), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 340), ('SUPERFICIAL_RELATIONSHIP', 373)]	6	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('PR_000006009', 'alpha-catulin', 150, 'cathelicidin'), ('GO_0010467', 'gene expression', 163, 'expression'), ('CHEBI_27300', 'vitamin D', 293, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 383, 'vitamin D'), ('GO_0036331', 'avascular cornea development in camera-type eye', 424, 'skin')]
PMC3695234	7/2013	S69-PMC3695234	['ACCORDING TO ANOTHER POINT OF VIEW, strict restriction of the offending Food Allergen provides an ALTERNATIVE EXPLANATION for Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('INCOMPLETE_EVIDENCE', 21), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('PROBABLE_UNDERSTANDING', 110)]	5	[('CHEBI_33290', 'food', 72, 'food'), ('CHEBI_50904', 'allergen', 77, 'allergen'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
PMC3702245	6/2013	S1-PMC3702245	['WHILE Vitamin D is IMPORTANT for Calcium and Phosphorus Homeostasis and for bone health, it also plays IMPORTANT ROLES in many OTHER physiologic functions in the body.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 19), ('IMPORTANT_CONSIDERATION', 103), ('SUPERFICIAL_RELATIONSHIP', 113), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127)]	5	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 33, 'calcium'), ('CHEBI_35885', 'secondary phosphine', 45, 'phosphorus'), ('GO_0042592', 'homeostatic process', 56, 'homeostasis')]
PMC3702245	6/2013	S6-PMC3702245	['in addition, it is now known to be INVOLVED in Immunomodulation, Cell Proliferation, and Cell Differentiation, and in other physiologic functions in diverse Tissues and Organs, including the Brain, Pancreas, and Heart.6despite the REPORTED high prevalence of Vitamin D deficiency and its POSSIBLE consequences, the criteria for defining an optimal level in the body, and HENCE the amount of Vitamin D intake REQUIRED to maintain adequate levels, is CONTROVERSIAL.3,7,8this overview addresses the CURRENT INFORMATION about Vitamin D function, the GLOBAL BURDEN and POTENTIAL consequences of low Vitamin D status in Pregnancy, and current STRATEGIES to optimize Vitamin D status in Pregnant mothers and their offspring.']	[('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 231), ('INCOMPLETE_EVIDENCE', 288), ('PROBABLE_UNDERSTANDING', 371), ('IMPORTANT_CONSIDERATION', 408), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 449), ('INCOMPLETE_EVIDENCE', 496), ('IMPORTANT_CONSIDERATION', 546), ('INCOMPLETE_EVIDENCE', 564), ('FUTURE_WORK', 637)]	10	[('GO_0050900', 'leukocyte migration', 47, 'immunomodulation'), ('GO_0008283', 'cell proliferation', 65, 'cell proliferation'), ('GO_0030154', 'cell differentiation', 89, 'cell differentiation'), ('UBERON_0000479', 'tissue', 157, 'tissues'), ('UBERON_0000062', 'organ', 169, 'organs'), ('UBERON_0000955', 'brain', 191, 'brain'), ('UBERON_0001264', 'pancreas', 198, 'pancreas'), ('UBERON_0000948', 'heart', 212, 'heart'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 391, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 522, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 594, 'vitamin D'), ('GO_0007565', 'female pregnancy', 614, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 660, 'vitamin D'), ('GO_0007565', 'female pregnancy', 680, 'pregnant')]
PMC3702245	6/2013	S13-PMC3702245	['HOWEVER, sustained Vitamin D deficiency results in rickets in children and osteomalacia in Adults.28the COMMONLY evaluated BIOMARKERS of Vitamin D nutrition include Serum 25(Oh)D concentrations, the inverse RELATIONSHIP between 25(Oh)D and Parathyroid hormone, Intestinal calcium absorption, and assessment of Skeletal integrity.29WHILE there is an inverse RELATIONSHIP between Serum Parathyroid hormone and 25(Oh)D in nonpregnant states, this RELATIONSHIP HAS BEEN SHOWN in RECENT STUDIES to be weak during Pregnancy,6,18,30,31INDICATING that Serum Parathyroid hormone MAY BE a LESS RELIABLE BIOMARKER of maternal Vitamin D status during Pregnancy than Serum 25(Oh)d.32the maternal 25(Oh)D level does not vary significantly during Pregnancy unless there is a change in Vitamin D intake or Endogenous Synthesis.2,33,34HOWEVER, Serum 1,25(Oh)2D levels increase by 100%–200% starting in the first trimester in both the mother and the fetus.35–37the increase in maternal 1,25(Oh)2D, which originates mostly from the Kidneys, accounts for increased Intestinal calcium absorption during Pregnancy.38,39the increase in fetal 1,25(Oh)2D level SEEMS to BE RELATED to synthesis in Placental and Fetal Tissues.39,40\nan IMPORTANT aspect of Vitamin D nutrition in Pregnancy is that the Vitamin D status of the infant at Birth and in early infancy DEPENDS ON the vitamin d status of the mother during Pregnancy.41vitamin D stores in the infant start with transplacental Transfer of 25(Oh)D in early Pregnancy from mother to fetus.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 104), ('SUPERFICIAL_RELATIONSHIP', 123), ('SUPERFICIAL_RELATIONSHIP', 207), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 329), ('SUPERFICIAL_RELATIONSHIP', 357), ('SUPERFICIAL_RELATIONSHIP', 444), ('INCOMPLETE_EVIDENCE', 457), ('INCOMPLETE_EVIDENCE', 475), ('INCOMPLETE_EVIDENCE', 526), ('INCOMPLETE_EVIDENCE', 570), ('INCOMPLETE_EVIDENCE', 579), ('IMPORTANT_CONSIDERATION', 584), ('SUPERFICIAL_RELATIONSHIP', 593), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 816), ('ANOMALY_CURIOUS_FINDING', 1136), ('ANOMALY_CURIOUS_FINDING', 1145), ('SUPERFICIAL_RELATIONSHIP', 1148), ('IMPORTANT_CONSIDERATION', 1209), ('SUPERFICIAL_RELATIONSHIP', 1335)]	20	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('UBERON_0007023', 'adult organism', 91, 'adults'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('UBERON_0001977', 'blood serum', 165, 'serum'), ('CHEBI_30778', 'gallic acid', 171, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 177, 'D'), ('CHEBI_71657', 'versiconol acetate', 228, '25(OH)D'), ('UBERON_0001132', 'parathyroid gland', 240, 'parathyroid'), ('UBERON_0000160', 'intestine', 261, 'intestinal'), ('UBERON_0004288', 'skeleton', 310, 'skeletal'), ('UBERON_0001977', 'blood serum', 378, 'serum'), ('UBERON_0001132', 'parathyroid gland', 384, 'parathyroid'), ('CHEBI_71657', 'versiconol acetate', 408, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 411, 'OH ... D'), ('GO_0007565', 'female pregnancy', 508, 'pregnancy'), ('UBERON_0001977', 'blood serum', 544, 'serum'), ('UBERON_0001132', 'parathyroid gland', 550, 'parathyroid'), ('CHEBI_27300', 'vitamin D', 615, 'vitamin D'), ('GO_0007565', 'female pregnancy', 639, 'pregnancy'), ('UBERON_0001977', 'blood serum', 654, 'serum'), ('CHEBI_30778', 'gallic acid', 660, '25(OH)'), ('CHEBI_71657', 'versiconol acetate', 683, '25(OH)D'), ('GO_0007565', 'female pregnancy', 732, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 770, 'vitamin D'), ('GO_0042400', 'ectoine catabolic process', 790, 'endogenous synthesis'), ('UBERON_0001977', 'blood serum', 827, 'serum'), ('CHEBI_37958', 'dye', 833, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 835, '25(OH)2D'), ('CHEBI_37958', 'dye', 968, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 970, '25(OH)2D'), ('UBERON_0002113', 'kidney', 1013, 'kidneys'), ('UBERON_0000160', 'intestine', 1045, 'intestinal'), ('GO_0007565', 'female pregnancy', 1082, 'pregnancy'), ('CHEBI_37958', 'dye', 1119, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 1121, '25(OH)2D'), ('UBERON_0001987', 'placenta', 1172, 'placental'), ('UBERON_0005291', 'embryonic tissue', 1186, 'fetal tissues'), ('CHEBI_27300', 'vitamin D', 1229, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1252, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1274, 'vitamin D'), ('GO_0007567', 'parturition', 1308, 'birth'), ('GO_0007565', 'female pregnancy', 1388, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1408, 'D'), ('GO_0006412', 'translation', 1457, 'transfer'), ('CHEBI_71657', 'versiconol acetate', 1469, '25(OH)D'), ('GO_0007565', 'female pregnancy', 1486, 'pregnancy')]
PMC3702245	6/2013	S16-PMC3702245	['high prevalence of low Vitamin D intake in Pregnancy\nthe Vitamin D status in Adults, including Pregnant women, is based currently on measurement of Serum 25(Oh)D concentrations, BUT WHAT constitutes the “normal” OR “optimal” level is CONTROVERSIAL.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 178), ('EXPLICIT_QUESTION', 182), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 212), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 234)]	4	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0007565', 'female pregnancy', 43, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('UBERON_0007023', 'adult organism', 77, 'adults'), ('GO_0007565', 'female pregnancy', 95, 'pregnant'), ('UBERON_0001977', 'blood serum', 148, 'serum'), ('CHEBI_63056', 'zinc cation', 154, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 160, 'D')]
PMC3702245	6/2013	S17-PMC3702245	['the institute of medicine in the us in its RECENT report RECOMMENDS that a Serum 25(Oh)D concentration of 50 nmol/l (20 ng/ml) is adequate for calcium absorption and bone health in Adults, including Pregnant women, in the us and canada.7HOWEVER, new clinical guidelines from the endocrine society RECOMMEND maintaining a Serum 25(Oh)D concentration >75 nmol/l (30 ng/ml) in order to maximize calcium absorption and bone health, and for POTENTIAL Extraskeletal benefits noted in observational studies.8many RECENT STUDIES13,15–17,48–57that evaluated Vitamin D nutrition during Pregnancy in different geographic locations REPORTED wide VARIATION in Vitamin D status depending on latitude, season, sunlight exposure behavior, and Vitamin D intake (table 1).']	[('INCOMPLETE_EVIDENCE', 43), ('FUTURE_WORK', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 236), ('FUTURE_WORK', 297), ('INCOMPLETE_EVIDENCE', 436), ('INCOMPLETE_EVIDENCE', 506), ('INCOMPLETE_EVIDENCE', 620), ('DIFFICULT_TASK', 634)]	8	[('UBERON_0001977', 'blood serum', 75, 'serum'), ('CHEBI_71657', 'versiconol acetate', 81, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 81, '25(OH)D'), ('UBERON_0007023', 'adult organism', 181, 'adults'), ('GO_0007565', 'female pregnancy', 199, 'pregnant'), ('UBERON_0001977', 'blood serum', 321, 'serum'), ('CHEBI_71657', 'versiconol acetate', 327, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 327, '25(OH)D'), ('UBERON_0001431', 'distal carpal bone 2', 446, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 549, 'vitamin D'), ('GO_0007565', 'female pregnancy', 576, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 647, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 727, 'vitamin D')]
PMC3702245	6/2013	S19-PMC3702245	['there is a high prevalence of Vitamin D deficiency [Serum 25(Oh) D <50 nmol/l], and as shown intable 1, most women studied (>80%) have Serum 25(Oh)D concentrations <75 nmol/l, which are CONSIDERED “INSUFFICIENT”.8mean Serum 25(Oh)D concentrations are highest and the prevalence of Vitamin D deficiency is lowest in sun-enriched populations,51,57WHILE the lowest mean Serum 25(Oh)d and the highest prevalence of Vitamin D deficiency are REPORTED in sunshine-deprived populations.16,17,50,55,56the high prevalence of low Vitamin D ASSOCIATED with sunshine deprivation and INADEQUATE corrective Vitamin D intake SHOULD RAISE PUBLIC HEALTH CONCERN about the INCREASED RISK of adverse health EFFECTS of low Vitamin D status for the mother and fetus and poor Vitamin D nutrition in the infant at Birth.']	[('INCOMPLETE_EVIDENCE', 186), ('PROBLEM_COMPLICATION', 198), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 343), ('INCOMPLETE_EVIDENCE', 436), ('SUPERFICIAL_RELATIONSHIP', 529), ('IMPORTANT_CONSIDERATION', 570), ('FUTURE_WORK', 609), ('IMPORTANT_CONSIDERATION', 616), ('IMPORTANT_CONSIDERATION', 622), ('IMPORTANT_CONSIDERATION', 654), ('SUPERFICIAL_RELATIONSHIP', 687)]	11	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0001977', 'blood serum', 52, 'serum'), ('CHEBI_71657', 'versiconol acetate', 58, '25(OH) D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 58, '25(OH) D'), ('UBERON_0001977', 'blood serum', 135, 'serum'), ('CHEBI_71657', 'versiconol acetate', 141, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 141, '25(OH)D'), ('UBERON_0001977', 'blood serum', 218, 'serum'), ('CHEBI_30778', 'gallic acid', 224, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 230, 'D'), ('CHEBI_27300', 'vitamin D', 281, 'vitamin D'), ('UBERON_0001977', 'blood serum', 367, 'serum'), ('CHEBI_30778', 'gallic acid', 373, '25(OH)'), ('CHEBI_27300', 'vitamin D', 411, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 519, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 592, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 702, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 753, 'vitamin D'), ('GO_0007567', 'parturition', 790, 'birth')]
PMC3702245	6/2013	S21-PMC3702245	['a Serum 25(Oh)D concentration <25 nmol/l (10 ng/ml), which is ASSOCIATED with INCREASED RISK of osteomalacia in Adults,7is common during Pregnancy, AS INDICATED by RECENT REPORTS from many parts of the world.1for example, Serum 25(Oh)D < 25 nmol/l during Pregnancy HAS BEEN REPORTED in 17%–18% of the caucasian population in the uk,48,4961% of a mixed population in new zealand,5432%–42% in the indian population,15,4559%–84% of a nonwestern population in the netherlands,1441% of the kuwaiti population,1680% of the iranian population,17and 75% of the arab population in the united arab emirates.1HOWEVER, there are LIMITED STUDIES on the ASSOCIATION between such low levels of Vitamin D status and Skeletal integrity in Pregnant women.']	[('SUPERFICIAL_RELATIONSHIP', 62), ('IMPORTANT_CONSIDERATION', 78), ('PROBABLE_UNDERSTANDING', 148), ('INCOMPLETE_EVIDENCE', 151), ('INCOMPLETE_EVIDENCE', 164), ('INCOMPLETE_EVIDENCE', 171), ('INCOMPLETE_EVIDENCE', 265), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 597), ('INCOMPLETE_EVIDENCE', 617), ('SUPERFICIAL_RELATIONSHIP', 640)]	10	[('UBERON_0001977', 'blood serum', 2, 'serum'), ('CHEBI_71657', 'versiconol acetate', 8, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 8, '25(OH)D'), ('UBERON_0007023', 'adult organism', 112, 'adults'), ('GO_0007565', 'female pregnancy', 137, 'pregnancy'), ('UBERON_0001977', 'blood serum', 222, 'serum'), ('CHEBI_71657', 'versiconol acetate', 228, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 228, '25(OH)D'), ('GO_0007565', 'female pregnancy', 255, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 679, 'vitamin D'), ('UBERON_0004288', 'skeleton', 700, 'skeletal'), ('GO_0007565', 'female pregnancy', 722, 'pregnant')]
PMC3702245	6/2013	S25-PMC3702245	['there is CONTROVERSY concerning the EFFECT of maternal Vitamin D deficiency on Skeletal Development Of the Fetus.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('SUPERFICIAL_RELATIONSHIP', 36)]	2	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0000901', 'translation repressor activity, non-nucleic acid binding', 79, 'skeletal development of ... fetus'), ('UBERON_0004288', 'skeleton', 79, 'skeletal')]
PMC3702245	6/2013	S26-PMC3702245	['from Animal studies and SOME Human data, it is SUGGESTED that mineralization of the Fetal Skeleton is independent of Vitamin D and, THEREFORE, maternal Vitamin D deficiency has little EFFECT on fetal Skeletal Development.59IN CONTRAST, SOME recent OBSERVATIONAL STUDIES SUGGEST that Vitamin D nutrition during Pregnancy MAY AFFECT fetal Bone Development.']	[('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 47), ('PROBABLE_UNDERSTANDING', 132), ('SUPERFICIAL_RELATIONSHIP', 184), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221), ('INCOMPLETE_EVIDENCE', 236), ('INCOMPLETE_EVIDENCE', 248), ('INCOMPLETE_EVIDENCE', 270), ('INCOMPLETE_EVIDENCE', 320), ('SUPERFICIAL_RELATIONSHIP', 324)]	10	[('NCBITaxon_33208', 'Metazoa', 5, 'animal'), ('NCBITaxon_9606', 'Homo sapiens', 29, 'human'), ('UBERON_0000922', 'embryo', 84, 'fetal'), ('UBERON_0004288', 'skeleton', 90, 'skeleton'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D'), ('GO_0001501', 'skeletal system development', 200, 'skeletal development'), ('UBERON_0004288', 'skeleton', 200, 'skeletal'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D'), ('GO_0007565', 'female pregnancy', 310, 'pregnancy'), ('GO_0048539', 'bone marrow development', 337, 'bone development')]
PMC3702245	6/2013	S27-PMC3702245	['high resolution three-dimensional ultrasound assessment in a study from the uk FOUND greater splaying of the distal Femoral Metaphysis in the fetus when maternal Serum 25(Oh)D was <50 nmol/l,60AND the authors SUGGESTED that this FINDING is SIMILAR TO radiologic features in Vitamin D-deficient rickets.']	[('INCOMPLETE_EVIDENCE', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 191), ('INCOMPLETE_EVIDENCE', 209), ('INCOMPLETE_EVIDENCE', 229), ('INCOMPLETE_EVIDENCE', 240)]	5	[('UBERON_0013751', 'metaphysis of radius', 116, 'femoral metaphysis'), ('UBERON_0001977', 'blood serum', 162, 'serum'), ('CHEBI_63056', 'zinc cation', 168, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 174, 'D'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D')]
PMC3702245	6/2013	S30-PMC3702245	['maternal 25(Oh)D concentrations during Pregnancy was SHOWN in ONE uk STUDY48TO AFFECT childhood bone mass at nine years of age, but this WAS NOT confirmed in a larger more RECENT STUDY from the uk.61in populations where Vitamin D deficiency is very SEVERE, maternal Vitamin D deficiency during Pregnancy HAS BEEN ASSOCIATED with neonatal craniotabes62and congenital rickets.63–65taken TOGETHER, the results from OBSERVATIONAL studies SUGGEST a POSSIBLE EFFECT of low maternal 25(Oh)D during Pregnancy on Fetal Bone Development, BUT the ASSOCIATION with lower childhood bone mass is UNPROVEN.']	[('INCOMPLETE_EVIDENCE', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 62), ('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 79), ('INCOMPLETE_EVIDENCE', 137), ('INCOMPLETE_EVIDENCE', 172), ('IMPORTANT_CONSIDERATION', 249), ('INCOMPLETE_EVIDENCE', 304), ('SUPERFICIAL_RELATIONSHIP', 313), ('INCOMPLETE_EVIDENCE', 385), ('INCOMPLETE_EVIDENCE', 412), ('INCOMPLETE_EVIDENCE', 434), ('INCOMPLETE_EVIDENCE', 444), ('SUPERFICIAL_RELATIONSHIP', 453), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 528), ('ANOMALY_CURIOUS_FINDING', 528), ('SUPERFICIAL_RELATIONSHIP', 536), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 582), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 582)]	19	[('CHEBI_71657', 'versiconol acetate', 9, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 9, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 39, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin D'), ('GO_0007565', 'female pregnancy', 294, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 476, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 479, 'OH ... D'), ('GO_0007565', 'female pregnancy', 491, 'pregnancy'), ('GO_0007631', 'feeding behavior', 504, 'fetal'), ('GO_0048539', 'bone marrow development', 510, 'bone development')]
PMC3702245	6/2013	S34-PMC3702245	['Fetal growth\nthe ASSOCIATION between Birth weight and maternal Vitamin D status or intake REMAINS INCONCLUSIVE.5while SOME OBSERVATIONAL68–71and interventional53,72,73studies FOUND improvement in Birth weight with maternal Vitamin D supplementation or improved Vitamin D status, several other observational studies31,74–76and SOME interventional studies18,33,77,78showed no improvement with higher Vitamin D status or supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 17), ('INCOMPLETE_EVIDENCE', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 123), ('INCOMPLETE_EVIDENCE', 175), ('INCOMPLETE_EVIDENCE', 326)]	7	[('GO_0008618', '7-methylguanosine metabolic process', 0, 'Fetal'), ('GO_0007567', 'parturition', 37, 'birth'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0007567', 'parturition', 196, 'birth'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 261, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 398, 'vitamin D')]
PMC3702245	6/2013	S38-PMC3702245	['the RELATIONSHIP between maternal Vitamin D status and small-for-Gestational age infants was found to be u-shaped in a study from pittsburgh in the us,81BUT this WAS NOT CONFIRMED in the above studies.68,80the REASONS for this DIFFERENCE are UNCLEAR.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 151), ('INCOMPLETE_EVIDENCE', 162), ('PROBABLE_UNDERSTANDING', 210), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 227), ('FULL_UNKNOWN', 242)]	6	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'gestational')]
PMC3702245	6/2013	S54-PMC3702245	['Monocytes cultured in Vitamin D-deficient Plasma (Serum 25(Oh)D < 30 nmol/l) SHOWED significantly decreased Tolllike Receptor-mediated Expression of Cathelicidin (p < 0.05) compared with those conditioned in Vitamin D-sufficient Plasma (Serum 25(Oh)D > 75 nmol/l).93CONSISTENT with these in vitro FINDINGS, OBSERVATIONAL clinical DATA FOUND an ASSOCIATION between Vitamin D status in Cord Blood and the RISK of Lower Respiratory Tract infection in the first year of Life.94the risk of Respiratory syncytial Virus bronchiolitis in the first year of Life is increased by six-fold (ci 1.6–24.9) in infants with Cord Blood 25(Oh)D < 50 nmol/l compared with infants with 25(Oh)D > 75 nmol/l.']	[('INCOMPLETE_EVIDENCE', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 264), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 264), ('INCOMPLETE_EVIDENCE', 297), ('INCOMPLETE_EVIDENCE', 307), ('FUTURE_WORK', 330), ('INCOMPLETE_EVIDENCE', 335), ('SUPERFICIAL_RELATIONSHIP', 344), ('IMPORTANT_CONSIDERATION', 403)]	9	[('CL_0000576', 'monocyte', 0, 'Monocytes'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 42, 'plasma'), ('UBERON_0001977', 'blood serum', 50, 'serum'), ('CHEBI_71657', 'versiconol acetate', 56, '25(OH)D'), ('PR_000001660', 'prostaglandin F2-alpha receptor', 108, 'tolllike receptor'), ('GO_0010467', 'gene expression', 135, 'expression'), ('PR_000006009', 'alpha-catulin', 149, 'cathelicidin'), ('CHEBI_27300', 'vitamin D', 208, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 229, 'plasma'), ('UBERON_0001977', 'blood serum', 237, 'serum'), ('CHEBI_71657', 'versiconol acetate', 243, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 243, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 364, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 384, 'cord'), ('UBERON_0000178', 'blood', 389, 'blood'), ('UBERON_0004905', 'articulation', 411, 'lower respiratory tract'), ('UBERON_0000104', 'life cycle', 466, 'life'), ('UBERON_0001004', 'respiratory system', 485, 'respiratory'), ('NCBITaxon_1', 'root', 507, 'virus'), ('UBERON_0000104', 'life cycle', 548, 'life'), ('UBERON_0002240', 'spinal cord', 608, 'cord'), ('UBERON_0000178', 'blood', 613, 'blood'), ('CHEBI_71657', 'versiconol acetate', 619, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 619, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 666, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 666, '25(OH)D')]
PMC3702245	6/2013	S56-PMC3702245	['IN CONTRAST, an OBSERVATIONAL study REPORTED an increased RISK of infantile eczema and pneumonia in ASSOCIATION with maternal Serum 25(Oh)D > 75 nmol/l in the last trimester.76HOWEVER, another RECENT STUDY with a larger sample size from the same institution DID NOT FIND an ASSOCIATION between maternal 25(Oh)d > 75 nmol/l in late Pregnancy and eczema or asthma at 12 months and three and six years of age.97there was no report on the ASSOCIATION between maternal Vitamin D status and Respiratory infections in the latter study.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 36), ('IMPORTANT_CONSIDERATION', 58), ('SUPERFICIAL_RELATIONSHIP', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 174), ('INCOMPLETE_EVIDENCE', 193), ('INCOMPLETE_EVIDENCE', 258), ('SUPERFICIAL_RELATIONSHIP', 274), ('SUPERFICIAL_RELATIONSHIP', 435)]	10	[('UBERON_0001977', 'blood serum', 126, 'serum'), ('CHEBI_71657', 'versiconol acetate', 132, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 132, '25(OH)D'), ('CHEBI_30778', 'gallic acid', 303, '25(OH)'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 303, '25(OH'), ('GO_0007565', 'female pregnancy', 331, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 464, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 485, 'respiratory')]
PMC3702245	6/2013	S57-PMC3702245	['regarding Neurocognitive Development, WHILE ONE STUDY FOUND no association between maternal Vitamin D status during Pregnancy and Neurocognitive function,76a RECENT larger-sized STUDY LINKED maternal Serum 25(Oh)D levels during Pregnancy with Language Development in the offspring.98the results of the above studies SUGGEST that childhood infections, atopy, and Neurocognitive development NEED TO BE included as outcomes of interest following Vitamin D supplementation in Pregnancy, and that clinical trials SHOULD include a RELEVANT group of subjects CONSIDERED to be replete for Vitamin D.\ntaken TOGETHER, the high prevalence of Vitamin D deficiency in Pregnancy and the POSSIBLE multiple POTENTIAL adverse EFFECTS on mother and offspring IDENTIFIED in SEVERAL epidemiologic STUDIES UNDERSCORE the URGENT NEED FOR large randomized controlled TRIALS to identify the amount of Vitamin D supplementation that optimizes Vitamin D status during Pregnancy, and to DETERMINE the EFFECT of supplementation on POTENTIAL adverse conditions ASSOCIATED with Vitamin D deficiency and any POSSIBLE Vitamin D excess.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 38), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 158), ('SUPERFICIAL_RELATIONSHIP', 184), ('INCOMPLETE_EVIDENCE', 316), ('FUTURE_WORK', 389), ('FUTURE_WORK', 508), ('IMPORTANT_CONSIDERATION', 525), ('IMPORTANT_CONSIDERATION', 552), ('INCOMPLETE_EVIDENCE', 598), ('INCOMPLETE_EVIDENCE', 673), ('INCOMPLETE_EVIDENCE', 691), ('SUPERFICIAL_RELATIONSHIP', 709), ('INCOMPLETE_EVIDENCE', 741), ('INCOMPLETE_EVIDENCE', 755), ('IMPORTANT_CONSIDERATION', 785), ('IMPORTANT_CONSIDERATION', 800), ('FUTURE_WORK', 807), ('INCOMPLETE_EVIDENCE', 807), ('FUTURE_WORK', 844), ('QUESTION_ANSWERED_BY_THIS_WORK', 960), ('SUPERFICIAL_RELATIONSHIP', 974), ('INCOMPLETE_EVIDENCE', 1003), ('SUPERFICIAL_RELATIONSHIP', 1032), ('INCOMPLETE_EVIDENCE', 1077)]	26	[('GO_0007399', 'nervous system development', 10, 'neurocognitive development'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 116, 'pregnancy'), ('GO_0050905', 'neuromuscular process', 130, 'neurocognitive'), ('UBERON_0001977', 'blood serum', 200, 'serum'), ('CHEBI_71657', 'versiconol acetate', 206, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 206, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 228, 'pregnancy'), ('GO_0060132', 'prolactin secreting cell development', 243, 'language development'), ('GO_0050905', 'neuromuscular process', 362, 'neurocognitive'), ('CHEBI_27300', 'vitamin D', 443, 'vitamin D'), ('GO_0007565', 'female pregnancy', 472, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 581, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 631, 'vitamin D'), ('GO_0007565', 'female pregnancy', 655, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 877, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 918, 'vitamin D'), ('GO_0007565', 'female pregnancy', 942, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1048, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1086, 'vitamin D')]
PMC3702245	6/2013	S60-PMC3702245	['HOWEVER, a committee of Vitamin D EXPERTS99AND the Endocrine society8recommend a target Serum concentration >75 nmol/l BASED ON the AVAILABLE EVIDENCE in order to achieve optimal benefits for Skeletal health as well as POTENTIAL nonskeletal BENEFITS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 34), ('INCOMPLETE_EVIDENCE', 119), ('PROBABLE_UNDERSTANDING', 119), ('SUPERFICIAL_RELATIONSHIP', 119), ('INCOMPLETE_EVIDENCE', 132), ('INCOMPLETE_EVIDENCE', 219), ('IMPORTANT_CONSIDERATION', 241)]	8	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('UBERON_0005063', 'left ventricular compact myocardium', 51, 'Endocrine'), ('UBERON_0001977', 'blood serum', 88, 'serum'), ('UBERON_0004288', 'skeleton', 192, 'skeletal')]
PMC3702245	6/2013	S62-PMC3702245	['these RECOMMENDATIONS are based MOSTLY ON STUDIES from the us and MAY not be applicable worldwide DUE TO DIFFERENCES in baseline Vitamin D status,100particularly in populations where severe Vitamin D deficiency is PREVALENT.']	[('FUTURE_WORK', 6), ('INCOMPLETE_EVIDENCE', 32), ('PROBABLE_UNDERSTANDING', 32), ('INCOMPLETE_EVIDENCE', 42), ('INCOMPLETE_EVIDENCE', 66), ('PROBLEM_COMPLICATION', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 105), ('IMPORTANT_CONSIDERATION', 214)]	8	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D')]
PMC3702245	6/2013	S71-PMC3702245	['as mentioned earlier, the criteria for defining WHAT constitutes “normal” Vitamin D status are CONTROVERSIAL.']	[('EXPLICIT_QUESTION', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95)]	2	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC3702245	6/2013	S72-PMC3702245	['the institute of MEDICINE7CONSIDERS a Serum 25(Oh)D concentration >50 nmol/l AS acceptable, WHILE the Endocrine society and Vitamin D EXPERTS RECOMMEND >75 nmol/l.8,99a RECENT STUDY among traditional populations in tanzania with type vi (dark) skin color living in a sun-abundant environment RECOMMENDED a mean Serum 25(Oh)D concentration of 115 nmol/l in nonpregnant Adults and 139 nmol/l in Pregnant women.57the question then is: WHAT Serum concentration of 25(Oh)D is “normal” in Adults, including during Pregnancy?']	[('INCOMPLETE_EVIDENCE', 17), ('PROBABLE_UNDERSTANDING', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('PROBABLE_UNDERSTANDING', 134), ('FUTURE_WORK', 142), ('INCOMPLETE_EVIDENCE', 169), ('FUTURE_WORK', 292), ('EXPLICIT_QUESTION', 432), ('EXPLICIT_QUESTION', 517)]	9	[('UBERON_0001977', 'blood serum', 38, 'serum'), ('CHEBI_71657', 'versiconol acetate', 44, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 44, '25(OH)D'), ('UBERON_0005063', 'left ventricular compact myocardium', 102, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('UBERON_0001977', 'blood serum', 311, 'serum'), ('CHEBI_71657', 'versiconol acetate', 317, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 317, '25(OH)D'), ('UBERON_0007023', 'adult organism', 368, 'adults'), ('GO_0007565', 'female pregnancy', 393, 'pregnant'), ('UBERON_0001977', 'blood serum', 437, 'serum'), ('CHEBI_71657', 'versiconol acetate', 460, '25(OH)D'), ('UBERON_0007023', 'adult organism', 483, 'adults'), ('GO_0007565', 'female pregnancy', 508, 'pregnancy')]
PMC3702245	6/2013	S73-PMC3702245	['WHILE the DEBATE and studies to identify OPTIMAL Serum 25(Oh)D concentration CONTINUE, it is PRUDENT to monitor Vitamin D status and develop STRATEGIES to ensure AT LEAST a minimum Serum 25(Oh)D concentration of 50 nmol/l in Pregnant women, especially in an environment where Vitamin D deficiency is endemic.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('IMPORTANT_CONSIDERATION', 41), ('FUTURE_WORK', 77), ('FUTURE_WORK', 93), ('IMPORTANT_CONSIDERATION', 93), ('FUTURE_WORK', 141), ('PROBABLE_UNDERSTANDING', 162)]	8	[('UBERON_0001977', 'blood serum', 49, 'serum'), ('CHEBI_71657', 'versiconol acetate', 55, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 55, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('UBERON_0001977', 'blood serum', 181, 'serum'), ('CHEBI_71657', 'versiconol acetate', 187, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 187, '25(OH)D'), ('GO_0007565', 'female pregnancy', 225, 'pregnant'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D')]
PMC3702245	6/2013	S75-PMC3702245	['because of CONTROVERSY surrounding Vitamin D REQUIREMENTS during Pregnancy, investigators from south carolina performed a comprehensive, large, randomized controlled study of Vitamin D supplementation in Pregnancy to achieve optimal Vitamin D status, DEFINED as a Serum 25(Oh)D concentration ≥80 nmol/l at Delivery.18BASED on the pharmacokinetics of Vitamin d, the authors INVESTIGATED the SAFETY and EFFECTIVENESS of high-dose Vitamin D supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('IMPORTANT_CONSIDERATION', 45), ('PROBABLE_UNDERSTANDING', 251), ('PROBABLE_UNDERSTANDING', 315), ('QUESTION_ANSWERED_BY_THIS_WORK', 373), ('IMPORTANT_CONSIDERATION', 390), ('SUPERFICIAL_RELATIONSHIP', 401)]	7	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('GO_0007565', 'female pregnancy', 204, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 233, 'vitamin D'), ('UBERON_0001977', 'blood serum', 264, 'serum'), ('CHEBI_71657', 'versiconol acetate', 270, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 270, '25(OH)D'), ('GO_0007567', 'parturition', 306, 'delivery'), ('CHEBI_33229', 'vitamin (role)', 350, 'vitamin'), ('CHEBI_27300', 'vitamin D', 428, 'vitamin D')]
PMC3702245	6/2013	S89-PMC3702245	['IF the institute of medicine’s target of a Serum 25(Oh)D concentration ≥50 nmol/l7was adopted for neonatal Vitamin D status, 79%, 58%, and 40%, respectively, of the infants of mothers on 4000, 2000, and 400 iu per day achieved adequate Vitamin D status ( p = 0.0001).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('UBERON_0001977', 'blood serum', 43, 'serum'), ('CHEBI_71657', 'versiconol acetate', 49, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 49, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 236, 'vitamin D')]
PMC3702245	6/2013	S92-PMC3702245	['the authors also FOUND that maternal Vitamin D supplementation with 4000 iu/day decreased the risk of combined comorbidities, including infection, Preterm Birth, Gestational diabetes, and pre-eclampsia,82and SUGGESTED that ADDITIONAL STUDIES with adequate power for assessment of OTHER endpoints WERE NEEDED.']	[('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 208), ('FUTURE_WORK', 223), ('FUTURE_WORK', 234), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 280), ('FUTURE_WORK', 296)]	6	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 147, 'preterm birth'), ('GO_0007565', 'female pregnancy', 162, 'gestational')]
PMC3702245	6/2013	S95-PMC3702245	['conclusion\nthe criteria for defining optimal Vitamin D intake during Pregnancy REMAIN CONTROVERSIAL.']	[('INCOMPLETE_EVIDENCE', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86)]	2	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007565', 'female pregnancy', 69, 'pregnancy')]
PMC3702339	6/2013	S15-PMC3702339	['the world health organization (who) defines Vitamin A deficiency (vad) AS Tissue concentrations of Vitamin A (Va) low enough to have adverse health consequences, EVEN IF there is no evidence of clinical deficiency (3).']	[('PROBABLE_UNDERSTANDING', 71), ('ANOMALY_CURIOUS_FINDING', 162), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 167)]	3	[('CHEBI_27300', 'vitamin D', 44, 'vitamin A'), ('UBERON_0000479', 'tissue', 74, 'tissue'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin A'), ('CHEBI_37958', 'dye', 110, 'VA')]
PMC3705146	5/2013	S36-PMC3705146	['BUT over the generations, lacking readily available Nutrients from the sea meant the resulting deficiency of Vitamin D from EITHER diet or the sun selected for an extremely fair skin type, which helped their descendents avoid rickets.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124)]	2	[('CHEBI_33284', 'nutrient', 52, 'nutrients'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D')]
PMC3705146	5/2013	S37-PMC3705146	['clearly, the relative lack of sunlight had an evolutionary IMPACT on Genes AFFECTING Vitamin D generation from sunlight, BUT WHAT EVIDENCE is there that it MIGHT also have selected for a change in the prevalence of a disease such as schizophrenia?']	[('SUPERFICIAL_RELATIONSHIP', 59), ('SUPERFICIAL_RELATIONSHIP', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('EXPLICIT_QUESTION', 125), ('INCOMPLETE_EVIDENCE', 130), ('INCOMPLETE_EVIDENCE', 156), ('EXPLICIT_QUESTION', 246)]	7	[('SO_0000704', 'gene', 69, 'genes'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC3705146	5/2013	S194-PMC3705146	['in CONTRAST TO most OTHER Animals, Humans have a large cutaneous surface area that is responds to sunlight by proportional (not step-wise) adjustments to sunlight intensity for both Vitamin D (chen et al.,2007) and Melanotropin Production (farooqui et al.,1993; chakraborty et al.,1996; hiramoto et al.,2003).']	[('ANOMALY_CURIOUS_FINDING', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 20)]	2	[('NCBITaxon_33208', 'Metazoa', 26, 'animals'), ('NCBITaxon_9606', 'Homo sapiens', 35, 'humans'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D'), ('GO_0034309', 'primary alcohol biosynthetic process', 215, 'melanotropin production')]
PMC3705146	5/2013	S219-PMC3705146	['it is WELL KNOWN that a lack of Vitamin D causes rickets, which would have had a negative IMPACT the ability to perform the physical work NECESSARY to survive in historical times, BUT more IMPORTANTLY, frequently caused fatal outcomes during Delivery BECAUSE of the improper configuration of Pelvis in SEVERE rickets (harrison,1966; cruickshank,1967; konje and ladipo,2000).']	[('INCOMPLETE_EVIDENCE', 6), ('SUPERFICIAL_RELATIONSHIP', 90), ('IMPORTANT_CONSIDERATION', 138), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 180), ('ANOMALY_CURIOUS_FINDING', 180), ('ANOMALY_CURIOUS_FINDING', 189), ('PROBLEM_COMPLICATION', 251), ('IMPORTANT_CONSIDERATION', 302)]	8	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007567', 'parturition', 242, 'delivery'), ('UBERON_0002355', 'pelvic region of trunk', 292, 'pelvis')]
PMC3705146	5/2013	S221-PMC3705146	['in such a manner, certain polymorphisms in melanotropin Genes MAY have become more prevalent in low-light environments IF they positively AFFECTED the natural Synthesis Of Vitamin D by reducing the Synthesis and Sequestration Of Melanin (valverde et al.,1995).']	[('INCOMPLETE_EVIDENCE', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 119), ('SUPERFICIAL_RELATIONSHIP', 138)]	3	[('SO_0000704', 'gene', 56, 'genes'), ('GO_0030474', 'spindle pole body duplication', 159, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D'), ('GO_0009057', 'macromolecule catabolic process', 198, 'synthesis'), ('GO_0098725', 'symmetric cell division', 212, 'sequestration of melanin'), ('CHEBI_25179', 'melanins', 229, 'melanin')]
PMC3705146	5/2013	S223-PMC3705146	['ALTHOUGH no Genetic associations between Vitamin-D receptors or enzymes INVOLVED in its formation or degradation HAVE yet BEEN IDENTIFIED for schizophrenia, that outcome does not NECESSARILY mean that Vitamin D is without effect in modifying the phenotypic plasticity that is obviously present in the disease.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 72), ('INCOMPLETE_EVIDENCE', 113), ('INCOMPLETE_EVIDENCE', 127), ('PROBABLE_UNDERSTANDING', 179)]	6	[('SO_0000704', 'gene', 12, 'genetic'), ('CHEBI_83326', 'tedizolid phosphate', 41, 'vitamin-D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 41, 'vitamin-D'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D')]
PMC3705146	5/2013	S226-PMC3705146	['HOWEVER, mcgrath and colleagues have ALSO SHOWN that the RELATIONSHIP between Vitamin D in Gestation and subsequent schizophrenia MAY BE COMPLEX, in that those with low maternal vitamin d are at INCREASED RISK of bearing offspring who become schizophrenic as are those with overly high Vitamin D (mcgrath et al.,2010a).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 57), ('INCOMPLETE_EVIDENCE', 130), ('DIFFICULT_TASK', 137), ('IMPORTANT_CONSIDERATION', 195)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('GO_0007565', 'female pregnancy', 91, 'gestation'), ('CHEBI_27300', 'vitamin D', 286, 'vitamin D')]
PMC3705146	5/2013	S239-PMC3705146	['OBVIOUSLY, two of the major light-responsive physiological systems that would be strongly AFFECTED in afro-caribbean immigrants to the u.k. would be uv-induced Vitamin D and the melanotropins.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 90)]	2	[('CHEBI_27300', 'vitamin D', 160, 'vitamin D')]
PMC3705320	3/2013	S14-PMC3705320	['HOWEVER, observational studies have SUGGESTED ASSOCIATIONS between Vitamin D status during Pregnancy and Postnatal infant health outcomes [3,4,5].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 46)]	3	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007565', 'female pregnancy', 91, 'pregnancy'), ('GO_0007567', 'parturition', 105, 'postnatal')]
PMC3705320	3/2013	S15-PMC3705320	['Serum 25-Hydroxyvitamin D concentration ([25(Oh)D]) ≥ 50 nmol/l is ASSOCIATED with Skeletal health benefits [1], BUT SOME data SUGGEST that IMPROVING Vitamin D status to attain Serum [25(Oh)D] ≥ 80 nmol/l MAY enhance a range of Vitamin D-related functions [6,7,8].']	[('SUPERFICIAL_RELATIONSHIP', 67), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 127), ('FUTURE_WORK', 140), ('INCOMPLETE_EVIDENCE', 205)]	6	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 6, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 42, '25(OH)D'), ('UBERON_0004288', 'skeleton', 83, 'skeletal'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D'), ('UBERON_0001977', 'blood serum', 177, 'serum'), ('CHEBI_71657', 'versiconol acetate', 184, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D')]
PMC3705320	3/2013	S180-PMC3705320	['HOWEVER, SINCE the ROLE of pth as a Vitamin D status BIOMARKER during Pregnancy is UNCLEAR [26], the clinical significance of the APPARENT dose-response EFFECT of Vitamin D on pth REQUIRES FURTHER STUDY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('SUPERFICIAL_RELATIONSHIP', 19), ('SUPERFICIAL_RELATIONSHIP', 53), ('FULL_UNKNOWN', 83), ('ANOMALY_CURIOUS_FINDING', 130), ('SUPERFICIAL_RELATIONSHIP', 153), ('IMPORTANT_CONSIDERATION', 180), ('FUTURE_WORK', 189)]	9	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC3705320	3/2013	S201-PMC3705320	['NONETHELESS, increases in the mean calcium concentration (within the normal range) and suppression of pth secretion among Pregnant women receiving the higher-dose regimen (70,000 iu initial dose followed by weekly doses of 35,000 iu) HIGHLIGHTED the physiological IMPACT of the intervention and the NEED to cautiously address POTENTIAL Pregnancy-specific sensitivities to Vitamin D supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 234), ('SUPERFICIAL_RELATIONSHIP', 264), ('FUTURE_WORK', 299), ('INCOMPLETE_EVIDENCE', 299), ('INCOMPLETE_EVIDENCE', 326)]	7	[('GO_0007565', 'female pregnancy', 122, 'pregnant'), ('GO_0007565', 'female pregnancy', 336, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 372, 'vitamin D')]
PMC3710934	7/2013	S378-PMC3710934	['ON THE OTHER HAND, dietary Heme Iron Intake was positively ASSOCIATED with Lung cancer when subjects were stratified by Vitamin C supplements Intake.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 59)]	3	[('CHEBI_36084', 'dihydroxybenzoate', 27, 'heme iron'), ('GO_0007631', 'feeding behavior', 37, 'intake'), ('UBERON_0002048', 'lung', 75, 'lung'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin C'), ('GO_0007631', 'feeding behavior', 142, 'intake')]
PMC3713405	7/2013	S40-PMC3713405	['• schizophrenia\nNeurodevelopmental disorder ASSOCIATED with altered Dopamine function both prior to and during disease onset\n• developmental Vitamin D (Dvd) deficiency\nASSOCIATED with INCREASED susceptibility to schizophrenia\n• Dvd Rat MODEL\nDvd-deficiency in the Rat LEADS to a pattern of altered developmental and Adult Dopaminergic function\n• Vitamin D and Dopamine\nearly Vitamin D signaling is intrinsically LINKED with the developing Dopamine system\n• Animal MODELS of schizophrenia\nmultiple Animal MODELS of schizophrenia SHOW alterations in Dopamine Development prior to post-adolescent alterations in behavior\n• Dopamine and schizophrenia\nALTHOUGH FOCUS REMAINS TIED to Dopamine as a common endpoint in schizophrenia, understanding common Dopaminergic origins MAY BE\n\nthe epidemiology of vitamin d and schizophrenia\nnumerous pieces of epidemiological EVIDENCE IMPLICATE low levels of maternal Vitamin D AS a POTENTIAL risk factor for schizophrenia.']	[('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 168), ('IMPORTANT_CONSIDERATION', 184), ('INCOMPLETE_EVIDENCE', 236), ('SUPERFICIAL_RELATIONSHIP', 268), ('SUPERFICIAL_RELATIONSHIP', 412), ('INCOMPLETE_EVIDENCE', 464), ('INCOMPLETE_EVIDENCE', 504), ('INCOMPLETE_EVIDENCE', 528), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 647), ('ANOMALY_CURIOUS_FINDING', 647), ('IMPORTANT_CONSIDERATION', 656), ('INCOMPLETE_EVIDENCE', 662), ('SUPERFICIAL_RELATIONSHIP', 670), ('INCOMPLETE_EVIDENCE', 768), ('INCOMPLETE_EVIDENCE', 859), ('SUPERFICIAL_RELATIONSHIP', 868), ('PROBABLE_UNDERSTANDING', 911), ('INCOMPLETE_EVIDENCE', 916)]	19	[('GO_0007285', 'primary spermatocyte growth', 16, 'Neurodevelopmental'), ('CHEBI_18243', 'dopamine', 68, 'dopamine'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 152, 'DVD'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 228, 'DVD'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 232, 'rat'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 242, 'DVD'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 264, 'rat'), ('UBERON_0007023', 'adult organism', 316, 'adult'), ('CHEBI_18243', 'dopamine', 322, 'dopaminergic'), ('CHEBI_28384', 'vitamin K', 346, 'Vitamin D'), ('CHEBI_18243', 'dopamine', 360, 'dopamine'), ('CHEBI_27300', 'vitamin D', 375, 'vitamin D'), ('CHEBI_18243', 'dopamine', 439, 'dopamine'), ('NCBITaxon_33208', 'Metazoa', 457, 'Animal'), ('NCBITaxon_33208', 'Metazoa', 497, 'animal'), ('CHEBI_18243', 'dopamine', 548, 'dopamine'), ('GO_0048597', 'post-embryonic camera-type eye morphogenesis', 548, 'dopamine development'), ('CHEBI_18243', 'dopamine', 620, 'Dopamine'), ('CHEBI_18243', 'dopamine', 678, 'dopamine'), ('CHEBI_18243', 'dopamine', 747, 'dopaminergic'), ('CHEBI_27300', 'vitamin D', 901, 'vitamin D')]
PMC3713405	7/2013	S51-PMC3713405	['to establish the biological PLAUSIBILITY of WHETHER Dvd deficiency COULD BE RELATED to schizophrenia, our group ESTABLISHED a Dvd-deficient Rat MODEL which HAS SHOWN that low Prenatal Vitamin D adversely AFFECTS Brain Development and Adult behavior, ESPECIALLY da development and da-RELATED behaviors.']	[('INCOMPLETE_EVIDENCE', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 44), ('INCOMPLETE_EVIDENCE', 67), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 112), ('INCOMPLETE_EVIDENCE', 144), ('INCOMPLETE_EVIDENCE', 156), ('SUPERFICIAL_RELATIONSHIP', 204), ('IMPORTANT_CONSIDERATION', 250), ('SUPERFICIAL_RELATIONSHIP', 283)]	10	[('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 52, 'DVD'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 126, 'DVD'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 140, 'rat'), ('GO_0007565', 'female pregnancy', 175, 'prenatal'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('GO_0007420', 'brain development', 212, 'brain development'), ('UBERON_0000955', 'brain', 212, 'brain'), ('UBERON_0007023', 'adult organism', 234, 'adult')]
PMC3713405	7/2013	S85-PMC3713405	['gross brain anatomy, mitosis and apoptosis\nthe initial absence of Vitamin D also AFFECTS OTHER, more general, aspects of Brain Development that do not directly RELATE to Da Neurons.']	[('SUPERFICIAL_RELATIONSHIP', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 89), ('SUPERFICIAL_RELATIONSHIP', 160)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007420', 'brain development', 121, 'brain development'), ('UBERON_0000955', 'brain', 121, 'brain'), ('CL_0000589', 'cochlear inner hair cell', 170, 'DA neurons')]
PMC3713405	7/2013	S92-PMC3713405	['CONVERSELY, the absence of Vitamin D in the Embryonic Brain results in increased levels of mitosis and decreased levels of Apoptosis (eyles et al., 2003;ko et al., 2004).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('UBERON_0000922', 'embryo', 44, 'embryonic'), ('UBERON_0000955', 'brain', 54, 'brain'), ('GO_0006915', 'apoptotic process', 123, 'apoptosis')]
PMC3713405	7/2013	S126-PMC3713405	['Vitamin D deficiency in the later portion of Gestation is REQUIRED to elicit this behavioral sensitivity WHEREAS Vitamin D deficiency during the early portion of Gestation has no IMPACT (o’loan et al., 2007).']	[('IMPORTANT_CONSIDERATION', 58), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 105), ('SUPERFICIAL_RELATIONSHIP', 179)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 45, 'gestation'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('GO_0007565', 'female pregnancy', 162, 'gestation')]
PMC3713405	7/2013	S141-PMC3713405	['HOWEVER, it is the COINCIDENT Expression of the vdr within developing Da Neurons (cui et al., 2013) and Projections in the Brain that SUGGEST an important ROLE for Vitamin D in the developing da system.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 19), ('INCOMPLETE_EVIDENCE', 134), ('SUPERFICIAL_RELATIONSHIP', 155)]	4	[('GO_0010467', 'gene expression', 30, 'expression'), ('CL_0000589', 'cochlear inner hair cell', 70, 'DA neurons'), ('GO_0042995', 'cell projection', 104, 'projections'), ('UBERON_0000955', 'brain', 123, 'brain'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D')]
PMC3717170	5/2013	S2-PMC3717170	['HOWEVER, the biological significance of the Expression of the vdr in different Tissues is not FULLY understood, and the ROLE of Vitamin D in Extraskeletal health HAS been a matter of DEBATE.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 94), ('SUPERFICIAL_RELATIONSHIP', 120), ('IMPORTANT_CONSIDERATION', 162), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 183)]	5	[('GO_0010467', 'gene expression', 44, 'expression'), ('UBERON_0000479', 'tissue', 79, 'tissues'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 141, 'extraskeletal')]
PMC3717170	5/2013	S6-PMC3717170	['WHETHER Ingested OR synthesized, Vitamin D is transported to the Liver, where it is hydroxylated at position 25 to form 25-Hydroxyvitamin D (25(Oh)d2or 25(Oh)D3), the major circulating form of Vitamin D. next, 25(Oh)D3Is transported to the Kidney, where it is hydroxylated at position 1 by the enzyme Cyp27B1 to form 1,25-Dihydroxyvitamin D (1,25(Oh)2D3), the most active form of Vitamin D, which is then transported to target Tissues, where it functions like a Steroid, binding to the Vitamin D receptor (vdr).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('GO_0007631', 'feeding behavior', 8, 'ingested'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0002107', 'liver', 65, 'liver'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 120, '25-hydroxyvitamin D'), ('CHEBI_63056', 'zinc cation', 141, '25(OH'), ('CHEBI_62946', 'ammonium sulfate', 152, '25(OH)D3'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('CHEBI_71667', '2,3,4-saturated fatty acid', 210, '25(OH)D3is'), ('UBERON_0002113', 'kidney', 240, 'kidney'), ('PR_000006101', 'cytochrome P450 1A1', 301, 'CYP27B1'), ('CHEBI_67472', '15-epi-lupulin B', 317, '1,25-dihydroxyvitamin D'), ('CHEBI_72779', '11-trans-LTE4', 342, '1,25(OH)2D3'), ('CHEBI_27300', 'vitamin D', 380, 'vitamin D'), ('UBERON_0000479', 'tissue', 427, 'tissues'), ('CHEBI_35341', 'steroid', 462, 'steroid'), ('CHEBI_27300', 'vitamin D', 486, 'vitamin D')]
PMC3717170	5/2013	S10-PMC3717170	['WHILE it was LONG HELD that Vitamin D ACTED only at the Intestine, Kidney, and Skeleton, and that its function was LIMITED to calcium Homeostasis, the POSSIBILITY of Extraskeletal EFFECTS HAS BEEN CONSIDERED for decades AS a result of the discovery of the vdr in Tissues that have no involvement in Calcium Homeostasis (e.g., skin, Placenta, Pancreas, Breast, Prostate and Colon cancer cells, and Activated T Cells).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 18), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 115), ('INCOMPLETE_EVIDENCE', 151), ('SUPERFICIAL_RELATIONSHIP', 180), ('INCOMPLETE_EVIDENCE', 188), ('INCOMPLETE_EVIDENCE', 197), ('PROBABLE_UNDERSTANDING', 220)]	10	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('UBERON_0000160', 'intestine', 56, 'intestine'), ('UBERON_0002113', 'kidney', 67, 'kidney'), ('UBERON_0004288', 'skeleton', 79, 'skeleton'), ('GO_0042592', 'homeostatic process', 134, 'homeostasis'), ('UBERON_0001431', 'distal carpal bone 2', 166, 'extraskeletal'), ('UBERON_0000479', 'tissue', 263, 'tissues'), ('GO_0055073', 'cadmium ion homeostasis', 299, 'calcium homeostasis'), ('UBERON_0001987', 'placenta', 332, 'placenta'), ('UBERON_0001264', 'pancreas', 342, 'pancreas'), ('UBERON_0000310', 'breast', 352, 'breast'), ('UBERON_0002367', 'prostate gland', 360, 'prostate'), ('UBERON_0001155', 'colon', 373, 'colon'), ('CL_0002129', 'regular atrial cardiac myocyte', 397, 'activated T cells')]
PMC3717170	5/2013	S12-PMC3717170	['on september 21, 2012, the abbott nutrition health institute and the sackler institute for nutrition science at the new york academy of sciences sponsored a conference, “Vitamin D: beyond bone,” that gathered researchers investigating Vitamin D in a WIDE range of Tissues and diseases.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 250)]	1	[('CHEBI_28384', 'vitamin K', 170, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin D'), ('UBERON_0000479', 'tissue', 264, 'tissues')]
PMC3717170	5/2013	S21-PMC3717170	['UNLIKE the ASSOCIATION between Vitamin D deficiency and rickets, causal LINKS between Vitamin D deficiency and specific Extraskeletal diseases have YET to be identified.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 11), ('SUPERFICIAL_RELATIONSHIP', 72), ('ANOMALY_CURIOUS_FINDING', 148)]	4	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 120, 'extraskeletal')]
PMC3717170	5/2013	S40-PMC3717170	['HOWEVER, it is IMPORTANT TO RECOGNIZE that similar antibacterial responses to Vitamin D HAVE also BEEN REPORTED for OTHER cell types within Tissues, such as the skin, Lungs, Gi Tract, and Placenta, that MAY broadly be termed barrier sites .']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 15), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 103), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116), ('INCOMPLETE_EVIDENCE', 203)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0000479', 'tissue', 140, 'tissues'), ('UBERON_0002048', 'lung', 167, 'lungs'), ('UBERON_0000993', 'oviduct', 174, 'GI tract'), ('UBERON_0001987', 'placenta', 188, 'placenta')]
PMC3717170	5/2013	S41-PMC3717170	['THUS, IT IS POSSIBLE that Vitamin D deficiency has a generalized DETRIMENTAL IMPACT on antibacterial responses and MAY THEREFORE play a ROLE in many types of infectious diseases.5an IMPORTANT NOTE by hewison is that current data SUGGEST that this particular Immune Response to Vitamin D is restricted to Primates, UNDERLINING a POTENTIAL ROLE for Vitamin D in the evolution of Primate Immunity, BUT also LIMITING the scope of FURTHER in vivo STUDIES to explore this activity.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 6), ('IMPORTANT_CONSIDERATION', 65), ('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 115), ('PROBABLE_UNDERSTANDING', 119), ('SUPERFICIAL_RELATIONSHIP', 136), ('IMPORTANT_CONSIDERATION', 182), ('IMPORTANT_CONSIDERATION', 192), ('INCOMPLETE_EVIDENCE', 229), ('PROBABLE_UNDERSTANDING', 314), ('INCOMPLETE_EVIDENCE', 328), ('SUPERFICIAL_RELATIONSHIP', 338), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 395), ('INCOMPLETE_EVIDENCE', 404), ('FUTURE_WORK', 426)]	16	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0006955', 'immune response', 258, 'immune response'), ('UBERON_0002405', 'immune system', 258, 'immune'), ('CHEBI_27300', 'vitamin D', 277, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 304, 'primates'), ('CHEBI_27300', 'vitamin D', 347, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 377, 'primate'), ('GO_0007566', 'embryo implantation', 385, 'immunity')]
PMC3717170	5/2013	S46-PMC3717170	['hewison STATED that it will be IMPORTANT to define WHETHER enhanced Vitamin D–mediated immunity prevents Immune disease OR WHETHER it CAN be used as therapy for these diseases.']	[('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 123), ('INCOMPLETE_EVIDENCE', 134)]	5	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0002405', 'immune system', 105, 'immune')]
PMC3717170	5/2013	S48-PMC3717170	['these and OTHER facets of Vitamin D and Immune function will be IMPORTANT research challenges for the Vitamin D community.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('IMPORTANT_CONSIDERATION', 64)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('UBERON_0002405', 'immune system', 40, 'immune'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC3717170	5/2013	S50-PMC3717170	['WHILE the Heart and Vasculature have ONLY RECENTLY been identified as POTENTIAL targets of Vitamin D action, a GROWING body of EVIDENCE SUGGESTS that the activated vdr plays an IMPORTANT ROLE in Regulating Cardiovascular function.8first, the vdr and the ligand-generating 25-Hydroxyvitamin D31-α-hydroxylase HAVE BEEN SHOWN to be present in Cardiac Myocytes, Cardiac Fibroblasts, Vascular Smooth Muscle Cells, and Vascular Endothelial Cells.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 42), ('INCOMPLETE_EVIDENCE', 70), ('INCOMPLETE_EVIDENCE', 111), ('INCOMPLETE_EVIDENCE', 136), ('IMPORTANT_CONSIDERATION', 177), ('SUPERFICIAL_RELATIONSHIP', 187), ('INCOMPLETE_EVIDENCE', 308)]	9	[('UBERON_0000948', 'heart', 10, 'heart'), ('UBERON_0002049', 'vasculature', 20, 'vasculature'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0065007', 'biological regulation', 195, 'regulating'), ('UBERON_0004535', 'cardiovascular system', 206, 'cardiovascular'), ('CHEBI_67376', 'dihydrooroxylin A', 272, '25-hydroxyvitamin'), ('PR_000002019', 'MHC class II histocompatibility antigen beta chain DRB1', 290, 'D31'), ('CL_0000746', 'cardiac muscle cell', 341, 'cardiac myocytes'), ('UBERON_0000948', 'heart', 341, 'cardiac'), ('CL_0002548', 'fibroblast of cardiac tissue', 359, 'cardiac fibroblasts'), ('UBERON_0000948', 'heart', 359, 'cardiac'), ('CL_0000359', 'vascular associated smooth muscle cell', 380, 'vascular smooth muscle cells'), ('UBERON_0001135', 'smooth muscle tissue', 389, 'smooth muscle'), ('CL_0000071', 'blood vessel endothelial cell', 414, 'vascular endothelial cells'), ('UBERON_0001986', 'endothelium', 423, 'endothelial')]
PMC3717170	5/2013	S73-PMC3717170	['YET, before such FINDINGS are fully EMBRACED, the mechanism(s) of action of Vitamin D and its PROTECTIVE EFFECT during Pregnancy MUST BE BETTER delineated.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 94), ('SUPERFICIAL_RELATIONSHIP', 105), ('IMPORTANT_CONSIDERATION', 129), ('INCOMPLETE_EVIDENCE', 137)]	8	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'pregnancy')]
PMC3717170	5/2013	S82-PMC3717170	['the EFFECTS of the hormonal form of Vitamin D, 1,25(Oh)2D3, on Apoptotic Cell Death are MEDIATED via multiple signaling pathways that involve common regulators and Effectors CONVERGING on cellular Ca2+.19,21sergeev and colleagues HAVE SHOWN that the CRITICAL characteristic of the apoptotic Ca2+signal is a sustained increase in the concentration of Intracellular Ca2+, reaching elevated BUT NOT cytotoxic levels.22HOWEVER, 1,25(Oh)2D3-Regulated, Ca2+-dependent apoptotic molecular targets HAVE NOT BEEN IDENTIFIED in Adipose Tissue.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 174), ('INCOMPLETE_EVIDENCE', 230), ('IMPORTANT_CONSIDERATION', 250), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 388), ('ANOMALY_CURIOUS_FINDING', 392), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 413), ('FULL_UNKNOWN', 490)]	9	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_72779', '11-trans-LTE4', 47, '1,25(OH)2D3'), ('CL_0000445', 'apoptosis fated cell', 63, 'apoptotic cell'), ('GO_0006915', 'apoptotic process', 63, 'apoptotic cell death'), ('CHEBI_35224', 'effector', 164, 'effectors'), ('CHEBI_29108', 'calcium(2+)', 197, 'Ca2+.'), ('CHEBI_29108', 'calcium(2+)', 291, 'Ca2+'), ('GO_0005622', 'intracellular anatomical structure', 350, 'intracellular'), ('CHEBI_3312', 'calcium dichloride', 364, 'Ca2+,'), ('CHEBI_17996', 'chloride', 425, ','), ('CHEBI_73394', 'Ala-Ser', 426, '25(OH)2D3'), ('GO_0065007', 'biological regulation', 436, 'regulated'), ('CHEBI_81233', 'Schizonepetoside B', 447, 'Ca2+-'), ('UBERON_0001013', 'adipose tissue', 518, 'adipose tissue')]
PMC3717170	5/2013	S85-PMC3717170	['the 1,25(Oh)2D3-induced increase in cellular Ca2+is also ASSOCIATED with reduced Lipid accumulation in mature Adipocytes.23in prelimary BUT ongoing STUDIES, a Murine diet-induced obesity (dio) MODEL is being used to evaluate the ROLE of Vitamin D in adiposity.']	[('SUPERFICIAL_RELATIONSHIP', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 136), ('INCOMPLETE_EVIDENCE', 148), ('INCOMPLETE_EVIDENCE', 193), ('SUPERFICIAL_RELATIONSHIP', 229)]	5	[('CHEBI_72779', '11-trans-LTE4', 4, '1,25(OH)2D3'), ('CHEBI_29108', 'calcium(2+)', 45, 'Ca2+'), ('CHEBI_18059', 'lipid', 81, 'lipid'), ('CL_0000136', 'fat cell', 110, 'adipocytes'), ('NCBITaxon_39107', 'Murinae', 159, 'murine'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D')]
PMC3717170	5/2013	S87-PMC3717170	['2; unpublished data) and improved MARKERS of adiposity and Vitamin D status (Plasma concentrations of Glucose, Insulin, adiponectin, 25(Oh)D3, 1,25(Oh)2D3, and pth), BUT an increased Plasma Ca2+.']	[('SUPERFICIAL_RELATIONSHIP', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 166)]	2	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 77, 'plasma'), ('CHEBI_17234', 'glucose', 102, 'glucose'), ('PR_000045358', 'insulin family protein', 111, 'insulin'), ('CHEBI_62946', 'ammonium sulfate', 133, '25(OH)D3'), ('CHEBI_73394', 'Ala-Ser', 145, '25(OH)2D3'), ('UBERON_0001969', 'blood plasma', 183, 'plasma'), ('CHEBI_29108', 'calcium(2+)', 190, 'Ca2+.')]
PMC3717170	5/2013	S104-PMC3717170	['and WHILE Vitamin D concentration HAS BEEN RELATED to Lung function in the general population, the RELATION between Lung function and Vitamin D concentration has YET to be investigated in copd patients ONLY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 99), ('ANOMALY_CURIOUS_FINDING', 162), ('INCOMPLETE_EVIDENCE', 202)]	6	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0002048', 'lung', 54, 'lung'), ('UBERON_0002048', 'lung', 116, 'lung'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC3717170	5/2013	S135-PMC3717170	['the EFFECT of Vitamin D MAY BE direct, as SUPPORTED by the Expression of the vdr and the local Production Of 1,25(Oh)2D3In Pancreatic Β Cells, OR indirect via its ROLE in Regulating Calcium Homeostasis and calcium Flux through Cell Membranes.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 42), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 143), ('SUPERFICIAL_RELATIONSHIP', 163)]	5	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0010467', 'gene expression', 59, 'expression'), ('GO_0008283', 'cell proliferation', 95, 'production of ...'), ('CHEBI_84175', '2-methylhexadecanoate', 109, '1,25(OH)2D3in'), ('GO_0006306', 'DNA methylation', 117, '2D3in'), ('UBERON_0001264', 'pancreas', 123, 'pancreatic'), ('CL_0000015', 'male germ cell', 134, 'β cells'), ('GO_0065007', 'biological regulation', 171, 'regulating'), ('GO_0055073', 'cadmium ion homeostasis', 182, 'calcium homeostasis'), ('GO_0006457', 'protein folding', 214, 'flux'), ('GO_0005886', 'plasma membrane', 227, 'cell membranes'), ('GO_0007613', 'memory', 232, 'membranes')]
PMC3717170	5/2013	S139-PMC3717170	['HOWEVER, pittas CAUTIONED that one SHOULD RESIST making inferences on the basis of OBSERVATIONAL studies BECAUSE of the POSSIBILITY of CONFOUNDING ISSUES, which MAY BE especially TRUE when assessing Vitamin D status, BECAUSE WHILE 25(Oh)D3Concentration is an excellent MARKER of good health many of the VARIABLES that CONTRIBUTE to 25(Oh)d3concentration (e.g., skin pigmentation, physical inactivity, Aging, unhealthy dietary patterns) are also RISK FACTORS for the development of diabetes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 16), ('INCOMPLETE_EVIDENCE', 16), ('FUTURE_WORK', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('INCOMPLETE_EVIDENCE', 83), ('PROBLEM_COMPLICATION', 105), ('INCOMPLETE_EVIDENCE', 120), ('PROBLEM_COMPLICATION', 135), ('PROBLEM_COMPLICATION', 147), ('INCOMPLETE_EVIDENCE', 161), ('PROBABLE_UNDERSTANDING', 179), ('PROBABLE_UNDERSTANDING', 217), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 225), ('SUPERFICIAL_RELATIONSHIP', 269), ('SUPERFICIAL_RELATIONSHIP', 303), ('SUPERFICIAL_RELATIONSHIP', 318), ('SUPERFICIAL_RELATIONSHIP', 445)]	18	[('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('CHEBI_74304', '(6Z,9Z,12Z,15Z,18Z,21Z)-3-oxotetracosahexaenoyl-CoA(4-)', 231, '25(OH)D3concentration'), ('CHEBI_30778', 'gallic acid', 332, '25(OH)'), ('GO_0007568', 'aging', 401, 'aging')]
PMC3717170	5/2013	S141-PMC3717170	['the results from SMALL clinical trials and post hoc analyses of larger trials on the EFFECT of Vitamin D supplementation on diabetes-related parameters HAVE BEEN INCONCLUSIVE, although Vitamin D APPEARS to have beneficial EFFECTS in Persons AT RISK for diabetes.36–39HOWEVER, no firm conclusions can be drawn from the available intervention studies BECAUSE of several LIMITATIONS: (1) NEARLY ALL studies were UNDERPOWERED; (2) the MINORITY of studies were designed specifically for Glycemic outcomes; (3) MOST STUDIES DID NOT REPORT use of diabetes medications at baseline or during the study; (4) SOME TRIALS used large infrequent doses of Vitamin D, which MAY BE Metabolized DIFFERENTLY compared to daily doses and MAY provide EITHER no benefit OR result in an UNFAVORABLE benefit/risk ratio.']	[('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 85), ('INCOMPLETE_EVIDENCE', 152), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 162), ('ANOMALY_CURIOUS_FINDING', 195), ('SUPERFICIAL_RELATIONSHIP', 222), ('IMPORTANT_CONSIDERATION', 241), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 265), ('PROBLEM_COMPLICATION', 349), ('INCOMPLETE_EVIDENCE', 368), ('PROBLEM_COMPLICATION', 368), ('PROBABLE_UNDERSTANDING', 385), ('PROBLEM_COMPLICATION', 409), ('INCOMPLETE_EVIDENCE', 431), ('INCOMPLETE_EVIDENCE', 505), ('INCOMPLETE_EVIDENCE', 518), ('INCOMPLETE_EVIDENCE', 598), ('INCOMPLETE_EVIDENCE', 658), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 677), ('INCOMPLETE_EVIDENCE', 717), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 729), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 747), ('IMPORTANT_CONSIDERATION', 763)]	23	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 233, 'persons'), ('GO_0006096', 'glycolytic process', 482, 'glycemic'), ('CHEBI_27300', 'vitamin D', 641, 'vitamin D'), ('GO_0008152', 'metabolic process', 665, 'metabolized')]
PMC3717170	5/2013	S142-PMC3717170	['pittas CONCLUDED that ALTHOUGH the OBSERVATION studies STRONGLY SUGGEST an IMPORTANT ROLE for Vitamin D in type 2 diabetes, and such a ROLE is biologically PLAUSIBLE, there is LACK OF EVIDENCE from intervention studies to SUPPORT the CONTENTION that type 2 diabetes CAN be improved or PREVENTED by raising 25(Oh)D3Concentration.']	[('INCOMPLETE_EVIDENCE', 7), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('ANOMALY_CURIOUS_FINDING', 22), ('INCOMPLETE_EVIDENCE', 35), ('PROBABLE_UNDERSTANDING', 55), ('INCOMPLETE_EVIDENCE', 64), ('IMPORTANT_CONSIDERATION', 75), ('SUPERFICIAL_RELATIONSHIP', 85), ('SUPERFICIAL_RELATIONSHIP', 135), ('INCOMPLETE_EVIDENCE', 156), ('INCOMPLETE_EVIDENCE', 176), ('INCOMPLETE_EVIDENCE', 222), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 234), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 234), ('INCOMPLETE_EVIDENCE', 266), ('SUPERFICIAL_RELATIONSHIP', 285)]	16	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('CHEBI_74304', '(6Z,9Z,12Z,15Z,18Z,21Z)-3-oxotetracosahexaenoyl-CoA(4-)', 306, '25(OH)D3concentration'), ('PR_000005058', 'extracellular calcium-sensing receptor', 306, '25(OH ... D3concentration')]
PMC3717170	5/2013	S143-PMC3717170	['on numerous earlier occasions, encouraging findings from observational studies were NOT CONFIRMED by well-designed clinical trials (e.g., hormone replacement therapy, β-Carotene, Vitamins C and E, and Folic Acid) and prevailing clinical practice was OVERTURNED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 84), ('IMPORTANT_CONSIDERATION', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 250)]	3	[('CHEBI_23042', 'carotene', 169, 'carotene'), ('CHEBI_27300', 'vitamin D', 179, 'vitamins C'), ('PR_000004900', 'complement C3', 188, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 194, 'E'), ('CHEBI_30751', 'formic acid', 201, 'folic acid')]
PMC3717170	5/2013	S144-PMC3717170	['THEREFORE, CONFIRMATION of a POTENTIAL beneficial EFFECT of Vitamin D in type 2 diabetes IS NEEDED in trials conducted in well-defined populations (e.g., pre-diabetes and early diabetes) SPECIFICALLY DESIGNED TO TEST the COMPELLING BUT YET UNPROVEN HYPOTHESIS that Vitamin D status is a direct CONTRIBUTOR to the pathogenesis of type 2 diabetes.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 50), ('FUTURE_WORK', 89), ('QUESTION_ANSWERED_BY_THIS_WORK', 187), ('QUESTION_ANSWERED_BY_THIS_WORK', 200), ('QUESTION_ANSWERED_BY_THIS_WORK', 209), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 232), ('ANOMALY_CURIOUS_FINDING', 236), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 240), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 294)]	14	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D')]
PMC3717170	5/2013	S164-PMC3717170	['indeed, beyond its ROLES in bone health and Calcium Homeostasis, Vitamin D AFFECTS many OTHER physiological domains that are CRITICALLY modified by Aging.']	[('SUPERFICIAL_RELATIONSHIP', 19), ('SUPERFICIAL_RELATIONSHIP', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 88), ('IMPORTANT_CONSIDERATION', 125)]	4	[('GO_0055073', 'cadmium ion homeostasis', 44, 'calcium homeostasis'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007568', 'aging', 148, 'aging')]
PMC3717170	5/2013	S165-PMC3717170	['UNFORTUNATELY, the QUESTION of WHETHER Vitamin D PREVENTS OR slows Aging cannot be easily tested.']	[('IMPORTANT_CONSIDERATION', 0), ('EXPLICIT_QUESTION', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('SUPERFICIAL_RELATIONSHIP', 49), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 58)]	5	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0007568', 'aging', 67, 'aging')]
PMC3717170	5/2013	S168-PMC3717170	['shifting attention from Aging to the Aging phenotype, the QUESTION of WHETHER Vitamin D AFFECTS major Aging phenotypes becomes more approachable.']	[('EXPLICIT_QUESTION', 58), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 70), ('EXPLICIT_QUESTION', 70), ('SUPERFICIAL_RELATIONSHIP', 88)]	4	[('GO_0007568', 'aging', 24, 'aging'), ('GO_0007568', 'aging', 37, 'aging'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('GO_0007568', 'aging', 102, 'aging')]
PMC3717170	5/2013	S173-PMC3717170	['HOWEVER, some recent DATA SUGGEST that low Vitamin D PREDICTS an accelerated increase in fat mass and incident obesity.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 21), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 53)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D')]
PMC3717170	5/2013	S184-PMC3717170	['WHETHER Vitamin D supplementation MAY positively IMPACT the Aging process REMAINS UNKNOWN and will REQUIRE FURTHER long-term intervention STUDIES.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 49), ('FULL_UNKNOWN', 74), ('FUTURE_WORK', 99), ('FUTURE_WORK', 107)]	6	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0007568', 'aging', 60, 'aging')]
PMC3717170	5/2013	S185-PMC3717170	['Vitamin D dietary reference intakes\ndaniel bikle (university of california and va medical center, san francisco) addressed the RECENT institute of medicine (iom) RECOMMENDATIONS for dietary Intake of Vitamin D and EVALUATED WHETHER they were sufficient in the context of EMERGING DATA about the ROLES of Vitamin D and the prevalence of deficiency.']	[('INCOMPLETE_EVIDENCE', 127), ('FUTURE_WORK', 162), ('QUESTION_ANSWERED_BY_THIS_WORK', 214), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 224), ('INCOMPLETE_EVIDENCE', 271), ('SUPERFICIAL_RELATIONSHIP', 295)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007631', 'feeding behavior', 190, 'intake'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 304, 'vitamin D')]
PMC3717170	5/2013	S186-PMC3717170	['RECOMMENDATIONS for the appropriate amount of Vitamin D to be taken for OPTIMAL health—BE it for Musculoskeletal strength OR for the numerous nonskeletal presumptive benefits of Vitamin D—remain contentious.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 72), ('ANOMALY_CURIOUS_FINDING', 87), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0002204', 'musculoskeletal system', 97, 'musculoskeletal'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
PMC3717170	5/2013	S191-PMC3717170	['the iom EXPERT panel CONCLUDED that MOST americans (97.5%) had adequate levels of Vitamin D, BASED ON their CONCLUSION that a 25(Oh)d3of 20 ng/ml or greater was sufficient, RAISING the QUESTION of WHETHER supplementation was EVEN NEEDED.']	[('PROBABLE_UNDERSTANDING', 8), ('INCOMPLETE_EVIDENCE', 21), ('PROBABLE_UNDERSTANDING', 36), ('INCOMPLETE_EVIDENCE', 93), ('PROBABLE_UNDERSTANDING', 93), ('INCOMPLETE_EVIDENCE', 108), ('IMPORTANT_CONSIDERATION', 173), ('EXPLICIT_QUESTION', 185), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 197), ('EXPLICIT_QUESTION', 197), ('ANOMALY_CURIOUS_FINDING', 225), ('IMPORTANT_CONSIDERATION', 230)]	12	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 126, '25(OH)')]
PMC3717170	5/2013	S207-PMC3717170	['the scope of Vitamin D research and its therapeutic POSSIBILITIES, as presented by researchers across many different disciplines, generated enthusiasm TEMPERED with SOME SKEPTICISM.']	[('INCOMPLETE_EVIDENCE', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 151), ('INCOMPLETE_EVIDENCE', 165), ('IMPORTANT_CONSIDERATION', 170)]	4	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D')]
PMC3728489	7/2013	S312-PMC3728489	['it HAS BEEN PROPOSED, THOUGH NOT PROVEN, that low levels of Vitamin D during Pregnancy and infancy COULD increase the RISK of Neurodevelopmental disorders, and that supplementation COULD play a ROLE in prevention.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 99), ('IMPORTANT_CONSIDERATION', 118), ('INCOMPLETE_EVIDENCE', 181), ('SUPERFICIAL_RELATIONSHIP', 194)]	8	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy'), ('GO_0007399', 'nervous system development', 126, 'neurodevelopmental')]
PMC3728489	7/2013	S319-PMC3728489	['fish oil (that commonly contains Vitamin D) and OTHER omega 3 Fatty Acid supplements taken in infancy HAVE BEEN ASSOCIATED with improved Cognitive development, THOUGH this evidence is also far from definitive (auestad et al.,2003; karr et al.,2011; meldrum et al.,2012; luchtman and song,2013).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 48), ('INCOMPLETE_EVIDENCE', 102), ('SUPERFICIAL_RELATIONSHIP', 112), ('ANOMALY_CURIOUS_FINDING', 160)]	4	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_35366', 'fatty acid', 62, 'fatty acid'), ('GO_0050890', 'cognition', 137, 'cognitive')]
PMC3734354	7/2013	S43-PMC3734354	['WHILE many Nutrients have a ROLE to play in Brain Development, certain ones SEEM TO BE of particular IMPORTANCE during fetal and neonatal life: protein, iron, zinc, Selenium, Iodine, Folate, Vitamin A, Choline, and Long-Chain polyunsaturated Fatty Acids (lcpufas) (georgieff,2007).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 28), ('ANOMALY_CURIOUS_FINDING', 76), ('IMPORTANT_CONSIDERATION', 101)]	4	[('CHEBI_33284', 'nutrient', 11, 'nutrients'), ('GO_0007420', 'brain development', 44, 'brain development'), ('UBERON_0000955', 'brain', 44, 'brain'), ('CHEBI_27568', 'selenium atom', 165, 'selenium'), ('CHEBI_24859', 'iodine atom', 175, 'iodine'), ('CHEBI_30863', '5-azaorotic acid', 183, 'folate'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin A'), ('CHEBI_15354', 'choline', 202, 'choline'), ('CHEBI_28911', 'cob(III)alamin', 215, 'long-chain'), ('CHEBI_35366', 'fatty acid', 242, 'fatty acids')]
PMC3739737	8/2013	S20-PMC3739737	['WHILE there is now a considerable body of research examining the IMPACT of developmental Vitamin D (dvd) deficiency on Brain outcomes, there is relatively LITTLE KNOWN about the IMPACT of Adult Vitamin D (avd) deficiency on Rodent behaviour.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 65), ('FULL_UNKNOWN', 155), ('SUPERFICIAL_RELATIONSHIP', 178)]	4	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0000955', 'brain', 119, 'brain'), ('UBERON_0007023', 'adult organism', 188, 'adult'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 224, 'rodent')]
PMC3739737	8/2013	S120-PMC3739737	['IN CONTRAST TO behavioural features IDENTIFIED in Rats exposed to developmental Vitamin D deficiency, avd deficiency was not associated with altered responses to Mk-801[13]or Amphetamine[14].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 36)]	2	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 50, 'rats'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('PR_000000124', 'ribosomal protein S6 kinase beta-2', 162, 'MK-801'), ('CHEBI_2687', 'amsacrine', 175, 'amphetamine')]
PMC3739737	8/2013	S158-PMC3739737	['like Humans, rodents also gain Vitamin D from the diet but the main DIFFERENCE between rodents and Humans is the bioavailability of Vitamin D2And D3[34].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 68)]	1	[('NCBITaxon_9606', 'Homo sapiens', 5, 'humans'), ('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 99, 'humans'), ('CHEBI_83334', '12-HPE(8,10,14)TrE(1-)', 132, 'vitamin D2and D3'), ('PR_000027594', 'histone H3', 132, 'vitamin D2and D3')]
PMC3739737	8/2013	S161-PMC3739737	['WHILE low Vitamin D in the Adult Rodent is characterised by several behavioural and neurochemical changes in the balb/c Mouse[18], the phenotype of avd in the sprague-dawley Rat is essentially normal.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0007023', 'adult organism', 27, 'adult'), ('NCBITaxon_33208', 'Metazoa', 33, 'rodent'), ('NCBITaxon_10088', 'Mus <genus>', 120, 'mouse'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 174, 'rat')]
PMC3739737	8/2013	S163-PMC3739737	['RECENTLY, EVIDENCE has EMERGED from Animal MODELS to SUGGEST that Vitamin D insufficiency or deficiency MAY exacerbate the progression of an UNDERLYING Brain disorder.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 43), ('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 104), ('SUPERFICIAL_RELATIONSHIP', 141)]	8	[('NCBITaxon_33208', 'Metazoa', 36, 'animal'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('UBERON_0000955', 'brain', 152, 'brain')]
PMC3739737	8/2013	S171-PMC3739737	['IN CONTRAST, those on Vitamin D supplements had no change in pd outcomes over the year.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D')]
PMC3760821	9/2013	S34-PMC3760821	['the results of a large RECENTLY published prospective study has, HOWEVER, FOUND NO EVIDENCE of an association between the maternal Vitamin D status in Pregnancy and late childhood bone Mineral content (average age 10 yrs)[14].']	[('INCOMPLETE_EVIDENCE', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 65), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 80)]	4	[('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('GO_0007565', 'female pregnancy', 151, 'pregnancy'), ('CHEBI_46662', 'mineral', 185, 'mineral')]
PMC3760821	9/2013	S39-PMC3760821	['WHILE it HAS BEEN SPECULATED that Vitamin D deficiency MAY BE causal in the development of adiposity and, POTENTIALLY, its co-morbidities, a RECENT STUDY using Genetic Markers AS instrumental VARIABLES in bi-directional mendelian randomization analysis has PROVIDED EVIDENCE that a higher bmi leads to lower 25ohd and that the LIKELIHOOD of lower 25ohd increasing bmi is small[19].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 55), ('INCOMPLETE_EVIDENCE', 106), ('INCOMPLETE_EVIDENCE', 141), ('PROBABLE_UNDERSTANDING', 176), ('SUPERFICIAL_RELATIONSHIP', 192), ('PROBABLE_UNDERSTANDING', 257), ('INCOMPLETE_EVIDENCE', 266), ('PROBABLE_UNDERSTANDING', 327)]	11	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('SO_0001645', 'genetic_marker', 160, 'genetic markers')]
PMC3760821	9/2013	S44-PMC3760821	['there are numerous REPORTS SUPPORTING a ROLE for Vitamin D in promoting Insulin sensitivity and maintaining Glycaemic Control in t2dm, WHILE the EVIDENCE for a similar ROLE in t1dm is more LIMITED.']	[('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135), ('INCOMPLETE_EVIDENCE', 145), ('SUPERFICIAL_RELATIONSHIP', 168), ('INCOMPLETE_EVIDENCE', 189)]	7	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('PR_000045358', 'insulin family protein', 72, 'insulin'), ('GO_0051162', 'L-arabitol metabolic process', 108, 'glycaemic control')]
PMC3760821	9/2013	S159-PMC3760821	['THESE FINDINGS SUPPORT the CONTENTION that measurement of Vitamin D levels prior to, and during Pregnancy, SHOULD BE RECOMMENDED, and that Vitamin D supplementation be initiated when deficiency is CONFIRMED.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 27), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 27), ('FUTURE_WORK', 107), ('FUTURE_WORK', 117), ('INCOMPLETE_EVIDENCE', 197)]	7	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0007565', 'female pregnancy', 96, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC3760821	9/2013	S163-PMC3760821	['department of health GUIDELINES in the uk CURRENTLY RECOMMEND Pregnant women to supplement with 10 µg/day to protect against Vitamin D deficiency[29], but this is DISPUTED by SOME[30].']	[('PROBABLE_UNDERSTANDING', 21), ('INCOMPLETE_EVIDENCE', 42), ('FUTURE_WORK', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 163), ('INCOMPLETE_EVIDENCE', 175)]	5	[('GO_0007565', 'female pregnancy', 62, 'pregnant'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC3760821	9/2013	S172-PMC3760821	['WHILE josefson et al ., REPORTED an IMPACT of maternal age and neonatal adiposity, directly measured by air displacement plethysmography, on Cord Vitamin D levels, in the CURRENT STUDY, ALTHOUGH neonatal bmi sds was significantly negatively CORRELATED with Cord 25Ohd in subjects with t1dm, regression analysis INDICATED that maternal age at Delivery and SURROGATE measures of neonatal adiposity (Subscapular Skinfold, Triceps Skinfold, and sds bmi) did not impact significantly on Cord Blood 25Ohd.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 36), ('QUESTION_ANSWERED_BY_THIS_WORK', 171), ('INCOMPLETE_EVIDENCE', 179), ('ANOMALY_CURIOUS_FINDING', 186), ('SUPERFICIAL_RELATIONSHIP', 241), ('INCOMPLETE_EVIDENCE', 311), ('SUPERFICIAL_RELATIONSHIP', 355)]	9	[('UBERON_0002240', 'spinal cord', 141, 'cord'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 257, 'cord'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 262, '25OHD'), ('GO_0007567', 'parturition', 342, 'delivery'), ('UBERON_0007191', 'anterior paracentral gyrus', 397, 'subscapular skinfold'), ('UBERON_0005299', 'prepuce of clitoris', 419, 'triceps skinfold'), ('UBERON_0002240', 'spinal cord', 482, 'cord'), ('UBERON_0000178', 'blood', 487, 'blood'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 493, '25OHD')]
PMC3760821	9/2013	S183-PMC3760821	['HOWEVER, the low levels of Vitamin D FOUND in both the control and t1dm groups would APPEAR TO argue against the widespread use of augmented intake.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 37), ('ANOMALY_CURIOUS_FINDING', 85)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
PMC3760821	9/2013	S185-PMC3760821	['GIVEN the SAFETY of Vitamin D, the low cost of supplementation and its REQUIREMENT for OPTIMAL bone health (and POTENTIALLY other health outcomes) in both the mother and off-spring, the FINDINGS of THE CURRENT STUDY SUPPORT the case for determining Vitamin D status and, IF NECESSARY, administering Vitamin D in t1dm pregnancy.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 10), ('IMPORTANT_CONSIDERATION', 71), ('IMPORTANT_CONSIDERATION', 87), ('INCOMPLETE_EVIDENCE', 112), ('INCOMPLETE_EVIDENCE', 186), ('QUESTION_ANSWERED_BY_THIS_WORK', 198), ('INCOMPLETE_EVIDENCE', 216), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 271), ('IMPORTANT_CONSIDERATION', 274)]	10	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin D')]
PMC3773018	4/2013	S6-PMC3773018	['HOWEVER, in combination, persistence of low Vitamin D status at Birth and early childhood increased the risk of fs (or=2.03, 95%ci:1.02–4.04), PARTICULARLY among children carrying the c Allele of rs2243250 (or=3.23, 95%ci:1.37–7.60).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 143)]	3	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0007567', 'parturition', 64, 'birth'), ('SO_0001023', 'allele', 186, 'allele')]
PMC3773018	4/2013	S9-PMC3773018	['the Vitamin D HYPOTHESIS, one of several HYPOTHESES on the development Of Food Allergy, was first SUGGESTED in 2007(2), and the POTENTIAL mechanisms were later PROPOSED in detail by vassallo et al.']	[('INCOMPLETE_EVIDENCE', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 41), ('INCOMPLETE_EVIDENCE', 98), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 160)]	5	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('GO_0042067', 'establishment of ommatidial planar polarity', 71, 'of food allergy'), ('CHEBI_33290', 'food', 74, 'food')]
PMC3773018	4/2013	S19-PMC3773018	['HOWEVER, FINDINGS regarding the combined EFFECTS of Prenatal and Postnatal Vitamin D status on fs, two of the most CRITICAL periods for Immune System Development (19,20), are UNCLEAR.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 41), ('IMPORTANT_CONSIDERATION', 115), ('FULL_UNKNOWN', 175)]	5	[('GO_0007565', 'female pregnancy', 52, 'prenatal'), ('GO_0007567', 'parturition', 65, 'postnatal'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0002520', 'immune system development', 136, 'immune system development'), ('UBERON_0002405', 'immune system', 136, 'immune system')]
PMC3773018	4/2013	S65-PMC3773018	['toddlers’ patterns of physical activity (i.e., sun exposure) and dietary habits (i.e., supplementation) are more like their mothers’, WHILE infants obtain their Vitamin D mainly through fortified formula.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 134)]	1	[('CHEBI_27300', 'vitamin D', 161, 'vitamin D')]
PMC3773018	4/2013	S75-PMC3773018	['children who had very low Vitamin D status at Birth but had sufficient Vitamin D during their early Life had no risk or a lower RISK of fs; WHILE children who were exposed to persistently low Vitamin D both pre- and post-Natally had the highest risk of fa (table 3).']	[('IMPORTANT_CONSIDERATION', 128), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 140)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007567', 'parturition', 46, 'birth'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('UBERON_0000104', 'life cycle', 100, 'life'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D'), ('GO_0007567', 'parturition', 221, 'natally')]
PMC3773018	4/2013	S98-PMC3773018	['NEVERTHELESS, our data are valuable to the field given that there is a LACK OF longitudinal data on Vitamin D and allergic outcomes in early childhood.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 71)]	2	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC3773018	4/2013	S104-PMC3773018	['IF THESE FINDINGS are REPLICATED in OTHER independent studies, then more ATTENTION to Vitamin D nutrition SHOULD BE given to very young children in the toddler age range, and particularly to those with very low Cord Blood Vitamin D measures and specific genotypes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 36), ('FUTURE_WORK', 73), ('FUTURE_WORK', 106)]	6	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0009472', 'axilla', 211, 'cord blood'), ('CHEBI_27300', 'vitamin D', 222, 'vitamin D')]
PMC3798907	8/2013	S1-PMC3798907	['we INVESTIGATED WHETHER these ASSOCIATIONS REFLECT direct EFFECTS of Vitamin E by INVESTIGATING the EFFECTS of supplementing cbmc cultures with physiological concentrations of Vitamin E. cbmc from seventy neonates were cultured supplemented with either nothing, Α-Tocopherol or Ascorbic Acid.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('SUPERFICIAL_RELATIONSHIP', 30), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 58), ('QUESTION_ANSWERED_BY_THIS_WORK', 82), ('SUPERFICIAL_RELATIONSHIP', 100)]	7	[('CHEBI_27300', 'vitamin D', 69, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin E'), ('CHEBI_27725', 'butin', 262, 'α-tocopherol'), ('CHEBI_22652', 'ascorbic acid', 278, 'ascorbic acid')]
PMC3798907	8/2013	S17-PMC3798907	['ALTHOUGH keen to conduct such an intervention trial we considered it IMPORTANT to conduct PRELIMINARY work to justify/REFUTE the use of Vitamin E supplements for several reasons.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 69), ('INCOMPLETE_EVIDENCE', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 118)]	4	[('CHEBI_27300', 'vitamin D', 136, 'vitamin E')]
PMC3798907	8/2013	S21-PMC3798907	['these considerations RAISE the POSSIBILITY that the OBSERVED epidemiological ASSOCIATION between maternal Vitamin E intake during Pregnancy and cbmc responses MAY NOT be a direct ASSOCIATION BUT MERELY a consequence of CONFOUNDING by other Nutrients ASSOCIATED with Vitamin E.\nTO INVESTIGATE these ISSUES further, and to inform any intervention trial, we CONDUCTED an ex vivo study to test WHETHER the OBSERVED epidemiological ASSOCIATION between reduced maternal Vitamin E intake during Pregnancy and increased cbmc responses COULD BE EXPLAINED by a direct causal EFFECT.']	[('EXPLICIT_QUESTION', 21), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 159), ('ANOMALY_CURIOUS_FINDING', 163), ('SUPERFICIAL_RELATIONSHIP', 179), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 191), ('ANOMALY_CURIOUS_FINDING', 195), ('ANOMALY_CURIOUS_FINDING', 195), ('PROBLEM_COMPLICATION', 219), ('SUPERFICIAL_RELATIONSHIP', 250), ('QUESTION_ANSWERED_BY_THIS_WORK', 277), ('PROBLEM_COMPLICATION', 298), ('QUESTION_ANSWERED_BY_THIS_WORK', 355), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 390), ('INCOMPLETE_EVIDENCE', 402), ('SUPERFICIAL_RELATIONSHIP', 427), ('INCOMPLETE_EVIDENCE', 527), ('PROBABLE_UNDERSTANDING', 536), ('SUPERFICIAL_RELATIONSHIP', 565)]	21	[('CHEBI_27300', 'vitamin D', 106, 'vitamin E'), ('GO_0007565', 'female pregnancy', 130, 'pregnancy'), ('CHEBI_33284', 'nutrient', 240, 'nutrients'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 464, 'vitamin E'), ('GO_0007565', 'female pregnancy', 488, 'pregnancy')]
PMC3798907	8/2013	S22-PMC3798907	['the approach was TO DETERMINE WHETHER the in vitro addition of Vitamin E to cbmc cultures altered proliferative and th cytokine responses against a panel of Mitogenic, Antigenic and Allergenic T-Cell stimuli.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30)]	2	[('CHEBI_27300', 'vitamin D', 63, 'vitamin E'), ('CHEBI_59132', 'antigen', 157, 'mitogenic'), ('CHEBI_59132', 'antigen', 168, 'antigenic'), ('CHEBI_77514', '6-phenylundecane', 182, 'allergenic'), ('GO_0000380', 'alternative mRNA splicing, via spliceosome', 182, 'allergenic T-cell'), ('CL_0000084', 'T cell', 193, 'T-cell'), ('GO_0085026', 'tubovesicular membrane network', 193, 'T-cell')]
PMC3798907	8/2013	S23-PMC3798907	['the prime AIM was TO DETERMINE WHETHER the in vitro addition of Vitamin E to cbmc cultures at a physiological concentration observed in Cord Blood altered proliferative and th-cell cytokine responses in a manner predicted by the original observation studies [12,13].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin E'), ('UBERON_0002240', 'spinal cord', 136, 'cord'), ('UBERON_0000178', 'blood', 141, 'blood')]
PMC3798907	8/2013	S25-PMC3798907	['given the REPORTED age RELATED DIFFERENTIAL responsiveness of Vitamin E on Human Th-Cell Responses [4,8], a secondary AIM of the study was TO INVESTIGATE the in vitro EFFECTS of Vitamins E and C on Adult Peripheral Blood Mononuclear Cell (Pbmc) responses.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 118), ('QUESTION_ANSWERED_BY_THIS_WORK', 139), ('SUPERFICIAL_RELATIONSHIP', 167)]	6	[('CHEBI_27300', 'vitamin D', 62, 'vitamin E'), ('NCBITaxon_9606', 'Homo sapiens', 75, 'human'), ('CL_0000545', 'T-helper 1 cell', 81, 'Th-cell'), ('GO_0001783', 'B cell apoptotic process', 81, 'Th-cell responses'), ('CHEBI_27300', 'vitamin D', 178, 'vitamins E'), ('CHEBI_18245', 'carboxylato group', 193, 'C'), ('PR_000004900', 'complement C3', 193, 'C'), ('UBERON_0007023', 'adult organism', 198, 'adult'), ('CL_0000111', 'peripheral neuron', 204, 'peripheral blood mononuclear cell'), ('UBERON_0012101', 'perinatal stage', 204, 'peripheral blood'), ('GO_0031097', 'medial cortex', 221, 'mononuclear'), ('CL_0002246', 'peripheral blood stem cell', 239, 'PBMC')]
PMC3798907	8/2013	S68-PMC3798907	['Vitamin E supplementation of Adult pbmc\nwhen the EFFECTS of Vitamin E supplementation were tested on pbmc responses, UNLIKE the results for cbmc, there were no consistent trends or significant differences in Proliferation induced by the set of T-Cell stimuli (figure 2andtable 1).']	[('SUPERFICIAL_RELATIONSHIP', 49), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 117)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin E'), ('UBERON_0007023', 'adult organism', 29, 'Adult'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin E'), ('GO_0008283', 'cell proliferation', 208, 'proliferation'), ('CL_0000084', 'T cell', 244, 'T-cell')]
PMC3798907	8/2013	S73-PMC3798907	['UNLIKE Vitamin E supplementation, addition of Vitamin C was ASSOCIATED with a general TREND for increases in the Effector cytokines Ifn-Γ and Il-4, which was significant for both cytokines after ppd stimulation (Ifn-Γ: 26 of 43 cultures DEMONSTRATING an increase in Ifn-Γ, Il-4: 20 of 42 cultures), and for Il-4 in cultures responding to klh (21 of 41 cultures) or tg (20 of 46 cultures).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 60), ('INCOMPLETE_EVIDENCE', 86), ('INCOMPLETE_EVIDENCE', 237)]	4	[('CHEBI_27300', 'vitamin D', 7, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin C'), ('CHEBI_35224', 'effector', 113, 'effector'), ('PR_000008920', 'interferon alpha-7', 132, 'IFN-γ'), ('PR_000001470', 'interleukin-28B', 142, 'IL-4'), ('PR_000008920', 'interferon alpha-7', 212, 'IFN-γ'), ('PR_000008920', 'interferon alpha-7', 266, 'IFN-γ'), ('PR_000001470', 'interleukin-28B', 273, 'IL-4'), ('PR_000001470', 'interleukin-28B', 307, 'IL-4')]
PMC3798907	8/2013	S85-PMC3798907	['HOWEVER, as was the case for cbmc, in general, Vitamin C supplementation was ASSOCIATED with a TREND for an increase in cytokines characteristic of Th Effector Cells; Ifn-Γ and Il-4, which was significant for the Il-4 response to klh, (10 of 16 cultures) ALTHOUGH this trend was not universal and there was decreased Ifn-Γ after stimulation with con a (figure 4andtable 1).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 95), ('ANOMALY_CURIOUS_FINDING', 255)]	5	[('CHEBI_27300', 'vitamin D', 47, 'vitamin C'), ('CL_0000635', "Deiter's cell", 148, 'Th effector cells'), ('CHEBI_35224', 'effector', 151, 'effector'), ('PR_000008920', 'interferon alpha-7', 167, 'IFN-γ'), ('PR_000001470', 'interleukin-28B', 177, 'IL-4'), ('PR_000001470', 'interleukin-28B', 213, 'IL-4'), ('PR_000008920', 'interferon alpha-7', 317, 'IFN-γ')]
PMC3798907	8/2013	S86-PMC3798907	['Production Of the Regulatory Cytokine Il-10 TENDED to be lower after Vitamin C supplementation of pbmc, significantly so for con a, WHEREAS, UNLIKE cbmc, there was a TREND for Tgf-Β secretion to be increased.']	[('SUPERFICIAL_RELATIONSHIP', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('INCOMPLETE_EVIDENCE', 166)]	4	[('GO_0008283', 'cell proliferation', 0, 'Production of ...'), ('GO_0090106', 'pancreatic E cell fate commitment', 18, 'regulatory cytokine IL-'), ('PR_000001470', 'interleukin-28B', 38, 'IL-10'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin C'), ('PR_000000046', 'TGF-beta', 176, 'TGF-β')]
PMC3798907	8/2013	S94-PMC3798907	['IN CONTRAST, the pattern of EFFECTS of Vitamin E supplementation on pbmc responses was typified by increases in both th Effector and Regulatory cytokine responses.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 28)]	2	[('CHEBI_27300', 'vitamin D', 39, 'vitamin E'), ('CHEBI_35224', 'effector', 120, 'effector'), ('GO_0065007', 'biological regulation', 133, 'regulatory')]
PMC3798907	8/2013	S102-PMC3798907	['before embarking on a Vitamin E intervention study during Pregnancy we wanted TO TEST WHETHER in vitro Vitamin E supplementation COULD Modulate Neonatal Immune Responses, REASONING that the demonstration of a direct EFFECT would justify Vitamin E supplementation, WHEREAS FAILURE to demonstrate a direct EFFECT would justify ALTERNATIVE dietary STRATEGIES to increase Vitamin E intake.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('INCOMPLETE_EVIDENCE', 129), ('PROBABLE_UNDERSTANDING', 171), ('PROBABLE_UNDERSTANDING', 171), ('SUPERFICIAL_RELATIONSHIP', 216), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 264), ('PROBLEM_COMPLICATION', 272), ('SUPERFICIAL_RELATIONSHIP', 304), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 325), ('FUTURE_WORK', 345)]	11	[('CHEBI_27300', 'vitamin D', 22, 'vitamin E'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin E'), ('GO_0065007', 'biological regulation', 135, 'modulate'), ('GO_0007567', 'parturition', 144, 'neonatal'), ('GO_0006955', 'immune response', 153, 'immune responses'), ('UBERON_0002405', 'immune system', 153, 'immune'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 368, 'vitamin E')]
PMC3798907	8/2013	S106-PMC3798907	['HOWEVER, ALTHOUGH direct supplementation of cbmc with Vitamin E was ASSOCIATED with decreased proliferative responses to ppd, klh and hdm, there was an OPPOSITE EFFECT on Proliferation to the allergen tg.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 9), ('SUPERFICIAL_RELATIONSHIP', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 152), ('SUPERFICIAL_RELATIONSHIP', 161)]	6	[('CHEBI_27300', 'vitamin D', 54, 'vitamin E'), ('GO_0008283', 'cell proliferation', 171, 'proliferation')]
PMC3798907	8/2013	S109-PMC3798907	['a further POSSIBILITY raised by THE CURRENT STUDY is that isolated maternal Vitamin E supplementation during Pregnancy MAY have MIXED or EVEN adverse CONSEQUENCES for atopic sensitisation to different Allergens.']	[('INCOMPLETE_EVIDENCE', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('INCOMPLETE_EVIDENCE', 119), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 128), ('ANOMALY_CURIOUS_FINDING', 137), ('PROBLEM_COMPLICATION', 150)]	6	[('CHEBI_27300', 'vitamin D', 76, 'vitamin E'), ('GO_0007565', 'female pregnancy', 109, 'pregnancy'), ('CHEBI_33663', 'cyclic hydrocarbon', 201, 'allergens')]
PMC3798907	8/2013	S111-PMC3798907	['the DIFFERENTIAL EFFECTS of supplementation on hdm and tg responses EXCLUDES the POSSIBILITY that any suppressive EFFECTS of Vitamin E supplementation REPRESENT toxicity, which was also avoided by adding physiological concentrations representative of those measured in Cord Blood at Birth in the epidemiological study DEMONSTRATING an ASSOCIATION between Vitamin E and cbmc responses [18].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('SUPERFICIAL_RELATIONSHIP', 17), ('PROBABLE_UNDERSTANDING', 68), ('PROBABLE_UNDERSTANDING', 68), ('INCOMPLETE_EVIDENCE', 81), ('SUPERFICIAL_RELATIONSHIP', 114), ('PROBABLE_UNDERSTANDING', 151), ('INCOMPLETE_EVIDENCE', 318), ('SUPERFICIAL_RELATIONSHIP', 335)]	9	[('CHEBI_27300', 'vitamin D', 125, 'vitamin E'), ('UBERON_0002240', 'spinal cord', 269, 'cord'), ('UBERON_0000178', 'blood', 274, 'blood'), ('GO_0007567', 'parturition', 283, 'birth'), ('CHEBI_27300', 'vitamin D', 355, 'vitamin E')]
PMC3798907	8/2013	S114-PMC3798907	['this SEEMS an UNLIKELY EXPLANATION for the DIFFERENTIAL EFFECTS of Vitamin E supplementation on tg and hdm responses SEEN in the current work because, as in our original observational study, cbmc samples were collected throughout the year [12].']	[('ANOMALY_CURIOUS_FINDING', 5), ('PROBABLE_UNDERSTANDING', 14), ('PROBABLE_UNDERSTANDING', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 43), ('SUPERFICIAL_RELATIONSHIP', 56), ('INCOMPLETE_EVIDENCE', 117)]	6	[('CHEBI_27300', 'vitamin D', 67, 'vitamin E')]
PMC3798907	8/2013	S125-PMC3798907	['we FOUND NO CONVINCING evidence of differential responsiveness of cbmc and Adult Pbmc to Vitamin E supplementation; HOWEVER the dose of Vitamin E used in THE current study was CONSIDERABLY LESS than that REPORTED in PREVIOUS work [4].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116), ('QUESTION_ANSWERED_BY_THIS_WORK', 154), ('ANOMALY_CURIOUS_FINDING', 176), ('INCOMPLETE_EVIDENCE', 189), ('INCOMPLETE_EVIDENCE', 204), ('INCOMPLETE_EVIDENCE', 216)]	8	[('UBERON_0007023', 'adult organism', 75, 'adult'), ('UBERON_2005026', 'primary head sinus', 81, 'PBMC'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin E')]
PMC3798907	8/2013	S132-PMC3798907	['ONLY single doses of Mitogen and Allergens were used to stimulate the cbmc; HOWEVER these were identical to those used to identify the original ASSOCIATION between maternal Vitamin E Intake and cbmc responses in a general population [12].']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 76), ('SUPERFICIAL_RELATIONSHIP', 144)]	3	[('CHEBI_52290', 'mitogen', 21, 'mitogen'), ('CHEBI_33663', 'cyclic hydrocarbon', 33, 'allergens'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin E'), ('GO_0007631', 'feeding behavior', 183, 'intake')]
PMC3798907	8/2013	S135-PMC3798907	['the population studied in the CURRENT study (children Born by elective caesarean section) DIFFERED from the general population from which the original ASSOCIATION between Vitamin E and cbmc responses was drawn [12], HOWEVER cbmc responses in a general population were not associated with mode of delivery (unpublished observations from [12]).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90), ('SUPERFICIAL_RELATIONSHIP', 151), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 216)]	4	[('GO_0007567', 'parturition', 54, 'born'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin E')]
PMC3798907	8/2013	S138-PMC3798907	['HOWEVER, our original OBSERVATION was between maternal Vitamin E intake and cbmc responses, we FOUND no associations between cbmc responses and maternal (and Cord) Blood Ascorbate Tocopherol at 10 weeks Gestation or at Delivery [12].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 22), ('INCOMPLETE_EVIDENCE', 95)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin E'), ('UBERON_0002240', 'spinal cord', 158, 'cord'), ('UBERON_0000178', 'blood', 164, 'blood'), ('CHEBI_22651', 'ascorbate', 170, 'ascorbate'), ('CHEBI_27013', 'tocopherol', 180, 'tocopherol'), ('GO_0007565', 'female pregnancy', 203, 'gestation'), ('GO_0007567', 'parturition', 219, 'delivery')]
PMC3798907	8/2013	S139-PMC3798907	['a SMALL number ( n = 40) of Adult Pbmc samples were obtained to investigate a POSSIBLE age RELATED differential responsiveness to Vitamin E. consequently the concentrations of Ascorbate and Α-Tocopherol used to supplement these pbmc cultures, was the same as that used to supplement cbmc cultures, HOWEVER these levels are lower than those FOUND in the Plasma of healthy Adults, which COULD EXPLAIN the LACK OF EFFECTS SEEN in pbmc cultures.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 78), ('SUPERFICIAL_RELATIONSHIP', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 298), ('ANOMALY_CURIOUS_FINDING', 298), ('INCOMPLETE_EVIDENCE', 340), ('INCOMPLETE_EVIDENCE', 385), ('PROBABLE_UNDERSTANDING', 391), ('INCOMPLETE_EVIDENCE', 403), ('SUPERFICIAL_RELATIONSHIP', 411), ('INCOMPLETE_EVIDENCE', 419)]	11	[('UBERON_0007023', 'adult organism', 28, 'adult'), ('UBERON_2005026', 'primary head sinus', 34, 'PBMC'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin E'), ('CHEBI_22651', 'ascorbate', 176, 'ascorbate'), ('CHEBI_27725', 'butin', 190, 'α-tocopherol'), ('UBERON_0001969', 'blood plasma', 353, 'plasma'), ('UBERON_0007023', 'adult organism', 371, 'adults')]
PMC3798907	8/2013	S145-PMC3798907	['HOWEVER, such a shared property cannot provide an EXPLANATION where Vitamins E and C DIFFER in their EFFECTS on cbmc and pbmc responses.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 50), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 85), ('SUPERFICIAL_RELATIONSHIP', 101)]	4	[('CHEBI_27300', 'vitamin D', 68, 'vitamins E'), ('CHEBI_18245', 'carboxylato group', 83, 'C'), ('PR_000004900', 'complement C3', 83, 'C')]
PMC3798907	8/2013	S148-PMC3798907	['in THE CURRENT STUDY, the EFFECTS of in vitro Vitamin E supplementation on cbmc and pbmc Effector cytokine responses did DIFFER, BUT the EFFECTS of in vitro Vitamin C supplementation were broadly SIMILAR in neonates and Adults.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 26), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('ANOMALY_CURIOUS_FINDING', 129), ('SUPERFICIAL_RELATIONSHIP', 137), ('SUPERFICIAL_RELATIONSHIP', 196)]	6	[('CHEBI_27300', 'vitamin D', 46, 'vitamin E'), ('CHEBI_35224', 'effector', 89, 'effector'), ('CHEBI_33229', 'vitamin (role)', 157, 'vitamin'), ('CHEBI_18245', 'carboxylato group', 165, 'C'), ('UBERON_0007023', 'adult organism', 220, 'adults')]
PMC3809191	1/2013	S49-PMC3809191	['Dental problems and muscle cramps were SEEN more frequent in Vitamin D deficient Pregnant women COMPARED TO non-Vitamin D deficient Pregnant women (fig.']	[('INCOMPLETE_EVIDENCE', 39), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 96)]	2	[('UBERON_0001091', 'calcareous tooth', 0, 'Dental'), ('CHEBI_28384', 'vitamin K', 61, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 81, 'pregnant'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0007565', 'female pregnancy', 132, 'pregnant')]
PMC3809191	1/2013	S53-PMC3809191	['THIS EVIDENCE is CONSISTENT with low Vitamin D levels in either Pregnant or non-Pregnant Individuals in our country as in the rest of the world.11,12HOWEVER we did not FIND significant association of low levels of Serum 25 (Oh) D with elevated RISK for gdm EVEN after adjustment for conventional risk FACTORS for diabetes.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 147), ('INCOMPLETE_EVIDENCE', 168), ('IMPORTANT_CONSIDERATION', 244), ('ANOMALY_CURIOUS_FINDING', 257), ('SUPERFICIAL_RELATIONSHIP', 301)]	8	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'pregnant'), ('GO_0007565', 'female pregnancy', 80, 'pregnant'), ('NCBITaxon_1', 'root', 89, 'individuals'), ('UBERON_0001977', 'blood serum', 214, 'serum'), ('CHEBI_71657', 'versiconol acetate', 220, '25 (OH) D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 220, '25 (OH) D')]
PMC3809191	1/2013	S54-PMC3809191	['data RELATING Vitamin D status to gdm RISK are INCONSISTENT and LIMITED.']	[('SUPERFICIAL_RELATIONSHIP', 5), ('IMPORTANT_CONSIDERATION', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('INCOMPLETE_EVIDENCE', 64)]	4	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D')]
PMC3809191	1/2013	S55-PMC3809191	['in ONE cross-sectional STUDY, Serum 25(Oh) D levels during 24-28 weeks of Gestation were lower in gdm women than in nondiabetic Pregnant women.9in ANOTHER STUDY, maternal Serum 25 (Oh) D concentrations measured at the time of gdm screening test were significantly and inversely ASSOCIATED with fasting glucose, ALTHOUGH the ASSOCIATION of Vitamin D with gdm risk was not statistically significant.8our FINDINGS are also CONSISTENT with a study in an indian population, SHOWING no significant ASSOCIATION between 25 (Oh) D concentrations (at 30 weeks of Gestation) and gdm risk.6\ndeficiency of Vitamin D was shown to be ASSOCIATED with fetal and Brain growth deficiency and type 1 diabetes in children.13significantly reduced risk of type 1 Diabetes Mellitus Development was FOUND when high doses of Vitamin D supplementation (up to 2000 iu/d) were given during infancy in a Birth-cohort study.14\nVitamin D deficiency was also ASSOCIATED with INCREASED risk for Pregnancy complications and SERIOUS health PROBLEMS in the offspring.5,15-17higher risks of Preeclampsia and cesarean section ratios were shown in Pregnants with low levels of Vitamin D.16,17moreover supplementation of Vitamin D HAS BEEN DEMONSTRATED to decrease the RISK of Preeclampsia by 27% in a STUDY.18\n\ncaption (fig): fig.1\n\nthe correlation between Serum Vitamin D and pth levels\n\ncaption (fig): fig.2\n\nSerum Vitamin D levels in veiled and nonveiled Pregnant\n\ncaption (fig): fig.3\n\nVitamin D levels and the frequency of muscle cramps (x²=3.57, p=0.05).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 3), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 147), ('SUPERFICIAL_RELATIONSHIP', 278), ('ANOMALY_CURIOUS_FINDING', 311), ('SUPERFICIAL_RELATIONSHIP', 324), ('INCOMPLETE_EVIDENCE', 402), ('INCOMPLETE_EVIDENCE', 420), ('INCOMPLETE_EVIDENCE', 469), ('SUPERFICIAL_RELATIONSHIP', 492), ('SUPERFICIAL_RELATIONSHIP', 619), ('INCOMPLETE_EVIDENCE', 774), ('SUPERFICIAL_RELATIONSHIP', 926), ('IMPORTANT_CONSIDERATION', 942), ('IMPORTANT_CONSIDERATION', 989), ('IMPORTANT_CONSIDERATION', 1004), ('INCOMPLETE_EVIDENCE', 1190), ('IMPORTANT_CONSIDERATION', 1228), ('INCOMPLETE_EVIDENCE', 1261)]	19	[('UBERON_0001977', 'blood serum', 30, 'serum'), ('CHEBI_71657', 'versiconol acetate', 36, '25(OH) D'), ('PR_000008838', 'serine protease HTRA1', 36, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 74, 'gestation'), ('GO_0007565', 'female pregnancy', 128, 'pregnant'), ('UBERON_0001977', 'blood serum', 171, 'serum'), ('CHEBI_71657', 'versiconol acetate', 177, '25 (OH) D'), ('PR_000009880', 'Lon protease, mitochondrial', 177, '25 ... OH ... D'), ('CHEBI_28384', 'vitamin K', 339, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 339, 'Vitamin'), ('CHEBI_71657', 'versiconol acetate', 512, '25 (OH) D'), ('GO_0007565', 'female pregnancy', 553, 'gestation'), ('CHEBI_27300', 'vitamin D', 593, 'vitamin D'), ('UBERON_0000955', 'brain', 645, 'brain'), ('GO_1903709', 'uterine gland development', 740, 'diabetes mellitus development'), ('CHEBI_27300', 'vitamin D', 799, 'vitamin D'), ('GO_0007567', 'parturition', 874, 'birth'), ('CHEBI_28384', 'vitamin K', 896, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 961, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 1053, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 1108, 'pregnants'), ('CHEBI_28384', 'vitamin K', 1137, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 1180, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 1236, 'preeclampsia'), ('UBERON_0001977', 'blood serum', 1317, 'serum'), ('CHEBI_28384', 'vitamin K', 1323, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 1323, 'Vitamin D'), ('UBERON_0001977', 'blood serum', 1371, 'Serum'), ('CHEBI_28384', 'vitamin K', 1377, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 1377, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 1418, 'pregnant'), ('CHEBI_28384', 'vitamin K', 1450, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 1450, 'Vitamin D')]
PMC3809191	1/2013	S64-PMC3809191	['ALTHOUGH there is NO CONSENSUS for routine Vitamin D screening in Pregnancy, being ALERT about the vitamin\xa0d deficiency and its symptoms and optimising when NECESSARY by replacement and/or through taking lifestyle measures MAY BE RECOMMENDED to prevent the Birth of Vitamin D-deficient infants from Vitamin D-deficient mothers.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 18), ('IMPORTANT_CONSIDERATION', 83), ('IMPORTANT_CONSIDERATION', 157), ('INCOMPLETE_EVIDENCE', 223), ('FUTURE_WORK', 230)]	7	[('CHEBI_28384', 'vitamin K', 43, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 66, 'pregnancy'), ('GO_0007567', 'parturition', 257, 'birth'), ('CHEBI_28384', 'vitamin K', 266, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 266, 'Vitamin'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin D')]
PMC3814422	10/2013	S1-PMC3814422	['the epidemiological EVIDENCE TO SUPPORT these CLAIMS is CONFLICTING and MAY reflect chance FINDINGS and differences in HOW Vitamin D was assessed.']	[('INCOMPLETE_EVIDENCE', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 46), ('INCOMPLETE_EVIDENCE', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 56), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 91), ('EXPLICIT_QUESTION', 119)]	7	[('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC3814422	10/2013	S12-PMC3814422	['HOWEVER, an OPPOSING argument holds that the increasing PREVALENCE of asthma and atopy MAY BE PARTLY a consequence of the fortification of childhood Foods with Vitamin D and HENCE high Vitamin D status in early childhood3–7.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('IMPORTANT_CONSIDERATION', 56), ('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 94), ('PROBABLE_UNDERSTANDING', 174)]	6	[('CHEBI_33290', 'food', 149, 'foods'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
PMC3814422	10/2013	S14-PMC3814422	['HOWEVER, a MAJOR LIMITATION of these studies is that diet makes a relatively minor CONTRIBUTION to total Vitamin D status, which is derived largely from Photosynthesis in the skin.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 11), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 83)]	4	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0006654', 'phosphatidic acid biosynthetic process', 153, 'photosynthesis')]
PMC3814422	10/2013	S15-PMC3814422	['HENCE, the value of analysing dietary Vitamin D intake alone AS a means of EFFECTIVELY establishing the INFLUENCE of Vitamin D on outcomes HAS BEEN QUESTIONED as it leads to considerable MISCLASSIFICATION of total exposure.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 61), ('IMPORTANT_CONSIDERATION', 75), ('SUPERFICIAL_RELATIONSHIP', 104), ('INCOMPLETE_EVIDENCE', 139), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 148), ('PROBLEM_COMPLICATION', 187)]	7	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC3814422	10/2013	S47-PMC3814422	['potential confounders and mediators\nwe considered the following as POTENTIAL CONFOUNDERS BECAUSE of their KNOWN or POTENTIAL PLAUSIBLE ASSOCIATION with both maternal concentrations of Vitamin D and with childhood atopic and Lung function outcomes21,22: maternal FACTORS during Pregnancy [smoking, infections, anxiety score, Antibiotic use, Paracetamol use, body mass index (bmi) and Alcohol intake], OTHER maternal factors (educational level, housing tenure, financial difficulties, ethnicity, age, parity, history of asthma, eczema, rhinoconjunctivitis, migraine) and Postnatal FACTORS that MAY reflect a background socio-economic CONFOUNDING pathway originating prior to Birth (breastfeeding, day care, pets, exposure to damp/mould in home, environmental tobacco smoke exposure and number of younger siblings).']	[('INCOMPLETE_EVIDENCE', 67), ('PROBLEM_COMPLICATION', 77), ('PROBLEM_COMPLICATION', 89), ('INCOMPLETE_EVIDENCE', 106), ('INCOMPLETE_EVIDENCE', 115), ('INCOMPLETE_EVIDENCE', 125), ('SUPERFICIAL_RELATIONSHIP', 135), ('SUPERFICIAL_RELATIONSHIP', 262), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 400), ('SUPERFICIAL_RELATIONSHIP', 579), ('INCOMPLETE_EVIDENCE', 592), ('PROBLEM_COMPLICATION', 632)]	12	[('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('UBERON_0002048', 'lung', 224, 'lung'), ('GO_0007565', 'female pregnancy', 277, 'pregnancy'), ('CHEBI_33282', 'antibacterial agent', 324, 'antibiotic'), ('CHEBI_46195', 'paracetamol', 340, 'paracetamol'), ('CHEBI_30879', 'alcohol', 383, 'alcohol'), ('GO_0007567', 'parturition', 569, 'postnatal'), ('GO_0007567', 'parturition', 673, 'birth')]
PMC3814422	10/2013	S63-PMC3814422	['additional analyses\nTO TEST WHETHER ASSOCIATIONS were driven by a threshold effect of greater risk in those whose mothers had insufficient levels of Vitamin D, we EXAMINED ASSOCIATIONS of categories of 25(Oh)D levels (≥ 50 nmol/l; 27.5–49.99 nmol/l and < 27.5 nmol/l) with outcomes, we also repeated analyses using 75 nmol/l as a higher THRESHOLD for sufficiency as recommended in a more RECENT REVIEW23.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('SUPERFICIAL_RELATIONSHIP', 36), ('QUESTION_ANSWERED_BY_THIS_WORK', 163), ('SUPERFICIAL_RELATIONSHIP', 172), ('PROBABLE_UNDERSTANDING', 337), ('INCOMPLETE_EVIDENCE', 388)]	7	[('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 202, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 208, 'D')]
PMC3814422	10/2013	S118-PMC3814422	['HOWEVER, given the large sample size, and the range of Vitamin D values, we would have expected to see SOME EVIDENCE of qualitative TRENDS IF this were the case and none was present.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 132), ('SUPERFICIAL_RELATIONSHIP', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139)]	5	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC3814422	10/2013	S119-PMC3814422	['furthermore, from a PUBLIC HEALTH perspective Maternal Pregnancy Vitamin D as a risk FACTOR for future offspring atopy or Respiratory health would only be of MAJOR IMPORTANCE IF it was relevant to most of the population and not ONLY those members at the extremes.']	[('IMPORTANT_CONSIDERATION', 20), ('SUPERFICIAL_RELATIONSHIP', 85), ('IMPORTANT_CONSIDERATION', 158), ('IMPORTANT_CONSIDERATION', 164), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 175), ('ANOMALY_CURIOUS_FINDING', 228)]	6	[('GO_0007618', 'mating', 46, 'maternal'), ('GO_0007565', 'female pregnancy', 55, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 122, 'respiratory')]
PMC3814422	10/2013	S123-PMC3814422	['Serum 25(Oh)D HAS BEEN CRITICIZED as a PROXY for Vitamin D ASSOCIATIONS.']	[('INCOMPLETE_EVIDENCE', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 59)]	4	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 6, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC3814422	10/2013	S124-PMC3814422	['for instance, it HAS BEEN SUGGESTED that there is a NEED to DISTINGUISH between Serum 25(Oh)D and EFFECTS of Vitamin D supplementation, the former being a prohormone representing a physiological state that is only relevant at extremely high or low levels, and the latter representing the non-physiological action of interest4.']	[('INCOMPLETE_EVIDENCE', 17), ('FUTURE_WORK', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 60), ('SUPERFICIAL_RELATIONSHIP', 98)]	4	[('UBERON_0001977', 'blood serum', 80, 'serum'), ('CHEBI_71657', 'versiconol acetate', 86, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 86, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D')]
PMC3814422	10/2013	S133-PMC3814422	['HOWEVER, given that Vitamin D intake is a POOR PROXY for total Vitamin D status11, APPARENT ASSOCIATIONS with dietary Vitamin D MAY HAVE BEEN CONFOUNDED by OTHER dietary or non-dietary factors which had not been controlled for in those Birth cohort studies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 42), ('PROBLEM_COMPLICATION', 42), ('SUPERFICIAL_RELATIONSHIP', 47), ('ANOMALY_CURIOUS_FINDING', 83), ('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 132), ('DIFFICULT_TASK', 142), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 156)]	11	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0007567', 'parturition', 236, 'birth')]
PMC3814422	10/2013	S134-PMC3814422	['by way of analogy, in a study of Vitamin D and Adult Lung function we FOUND that, WHILST there were APPARENT ASSOCIATIONS with dietary Vitamin D intake, there was NO EVIDENCE for an association with Blood 25(Oh)D concentrations29.']	[('INCOMPLETE_EVIDENCE', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('ANOMALY_CURIOUS_FINDING', 82), ('ANOMALY_CURIOUS_FINDING', 100), ('SUPERFICIAL_RELATIONSHIP', 109), ('INCOMPLETE_EVIDENCE', 163)]	6	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0007023', 'adult organism', 47, 'adult'), ('UBERON_0002048', 'lung', 53, 'lung'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('UBERON_0000178', 'blood', 199, 'blood'), ('CHEBI_71657', 'versiconol acetate', 205, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 205, '25(OH)D')]
PMC3814422	10/2013	S137-PMC3814422	['ALTHOUGH Animal studies HAVE SHOWN that Vitamin D is INVOLVED in normal Fetal Lung Development31, OUR STUDY is IN GENERAL AGREEMENT with OTHER epidemiological STUDIES that have considered later offspring Lung function in the general population – two STUDIES HAVE REPORTED null ASSOCIATIONS of maternal 25(Oh)D13,32or dietary Vitamin D intake32with offspring Lung function.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 53), ('QUESTION_ANSWERED_BY_THIS_WORK', 98), ('INCOMPLETE_EVIDENCE', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137), ('INCOMPLETE_EVIDENCE', 159), ('INCOMPLETE_EVIDENCE', 250), ('INCOMPLETE_EVIDENCE', 258), ('SUPERFICIAL_RELATIONSHIP', 277)]	11	[('NCBITaxon_33208', 'Metazoa', 9, 'animal'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007631', 'feeding behavior', 72, 'fetal'), ('GO_0030324', 'lung development', 78, 'lung development31'), ('UBERON_0002048', 'lung', 78, 'lung'), ('UBERON_0002048', 'lung', 204, 'lung'), ('CHEBI_73281', '(2S)-versicolorone(1-)', 302, '25(OH)D13'), ('CHEBI_27300', 'vitamin D', 325, 'vitamin D'), ('UBERON_0002048', 'lung', 358, 'lung')]
PMC3814422	10/2013	S140-PMC3814422	['WHILST definitive evidence will ONLY come from randomized trials of Vitamin D supplementation during Pregnancy, which are currently underway (e.g.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 32)]	2	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('GO_0007565', 'female pregnancy', 101, 'pregnancy')]
PMC3820434	12/2012	S377-PMC3820434	['a POSSIBLE EXPLANATION MAY BE that upon Oral Consumption, circulating and Intracellular levels of Resveratrol in Humans are much lower than that of OTHER IMPORTANT Antioxidants, such as Vitamin C, Uric Acid, Vitamin E, and Glutathione.']	[('INCOMPLETE_EVIDENCE', 2), ('PROBABLE_UNDERSTANDING', 11), ('INCOMPLETE_EVIDENCE', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 148), ('IMPORTANT_CONSIDERATION', 154)]	5	[('UBERON_0000165', 'mouth', 40, 'oral'), ('GO_0007631', 'feeding behavior', 45, 'consumption'), ('GO_0005622', 'intracellular anatomical structure', 74, 'intracellular'), ('CHEBI_27881', 'resveratrol', 98, 'resveratrol'), ('NCBITaxon_9606', 'Homo sapiens', 113, 'humans'), ('CHEBI_60641', 'methyl 5-aminolevulinate hydrochloride', 164, 'antioxidants'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin C'), ('CHEBI_27226', 'uric acid', 197, 'uric acid'), ('CHEBI_27300', 'vitamin D', 208, 'vitamin E'), ('CHEBI_16856', 'glutathione', 223, 'glutathione')]
PMC3821254	4/2013	S80-PMC3821254	['WHETHER a single ingredient of drakshavaleha such as Vitamin C, Vitamin P, Folic Acid, Minerals, etc., was EFFECTIVE in the current research OR the result was a collective outcome is such DIFFICULT to conclude at this level.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 107), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('DIFFICULT_TASK', 188)]	4	[('CHEBI_27300', 'vitamin D', 53, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin P'), ('CHEBI_30751', 'formic acid', 75, 'folic acid'), ('CHEBI_46751', 'quinolizidine', 87, 'minerals')]
PMC3827489	10/2013	S20-PMC3827489	['IN LIGHT OF the near universal Expression of the vdr across Tissues, Vitamin D would be expected to play a ROLE in diseases OTHER than those of bone.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 107), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124)]	3	[('GO_0010467', 'gene expression', 31, 'expression'), ('UBERON_0000479', 'tissue', 60, 'tissues'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC3827489	10/2013	S27-PMC3827489	['diagnostic criteria of Vitamin D insufficiency or deficiency\nNO CONSENSUS on the definition of Vitamin D deficiency exists; HOWEVER, most clinicians and researchers agree on the following stratifications BASED ON the Serum concentration of 25(Oh)D: deficiency, <50.0 nmol/l or <20.0 ng/ml; insufficiency, 50.0-74.9 nmol/l or 20.0-29.9 ng/ml; and sufficiency, ≥75.0 nmol/l or ≥30.0 ng/ml1,6,16,17).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 61), ('INCOMPLETE_EVIDENCE', 61), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124), ('INCOMPLETE_EVIDENCE', 204), ('PROBABLE_UNDERSTANDING', 204)]	5	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('UBERON_0001977', 'blood serum', 217, 'serum'), ('CHEBI_71657', 'versiconol acetate', 240, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 240, '25(OH)D')]
PMC3827489	10/2013	S45-PMC3827489	['MOUNTING EVIDENCE also SUGGESTS that there are ethnic DIFFERENCES in Vitamin D levels20,21).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 54)]	3	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC3827489	10/2013	S47-PMC3827489	['low Vitamin D status in black Individuals MAY BE ATTRIBUTED MAINLY to decreased skin Synthesis Of Vitamin D due to greater skin pigmentation32)OR to the high prevalence of obesity in black populations25,33,34).']	[('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 49), ('PROBABLE_UNDERSTANDING', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 143)]	4	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('NCBITaxon_1', 'root', 30, 'individuals'), ('GO_0030474', 'spindle pole body duplication', 85, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC3827489	10/2013	S48-PMC3827489	['HOWEVER, there are NO epidemiologic DATA comparing asians with whites or blacks with regard to Serum Vitamin D levels.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FULL_UNKNOWN', 19)]	2	[('UBERON_0001977', 'blood serum', 95, 'serum'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC3827489	10/2013	S57-PMC3827489	['ONE STUDY REPORTED that IF the Vitamin D level was 30 ng/ml or less, there was a significant decrease in Intestinal calcium absorption36), which CORRELATED to increased circulating Parathyroid hormone (pth)37).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('SUPERFICIAL_RELATIONSHIP', 145)]	4	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('UBERON_0000160', 'intestine', 105, 'intestinal'), ('UBERON_0001132', 'parathyroid gland', 181, 'parathyroid')]
PMC3827489	10/2013	S65-PMC3827489	['THUS, the QUESTION has BEEN RAISED as to WHETHER Vitamin D status INFLUENCES the RISK of Respiratory Tract infections such as common Viral infections or Pulmonary tuberculosis in children.']	[('PROBABLE_UNDERSTANDING', 0), ('EXPLICIT_QUESTION', 10), ('ANOMALY_CURIOUS_FINDING', 23), ('EXPLICIT_QUESTION', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 41), ('EXPLICIT_QUESTION', 41), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 81)]	8	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000065', 'respiratory tract', 89, 'respiratory tract'), ('NCBITaxon_1', 'root', 133, 'viral'), ('UBERON_0002048', 'lung', 153, 'pulmonary')]
PMC3827489	10/2013	S68-PMC3827489	['SEVERAL STUDIES conducted in DIFFERENT ethnic groups have FOUND a close ASSOCIATION between Vitamin D deficiency and an INCREASED RISK of tuberculosis43-45).']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 29), ('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 72), ('IMPORTANT_CONSIDERATION', 120)]	5	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC3827489	10/2013	S70-PMC3827489	['IN CONTRAST, a cochrane review REPORTED that Vitamin D supplementation in patients diagnosed with tuberculosis did not alter the rates of Sputum smear Conversion in Adults or body weight in children47).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 31)]	2	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0007311', 'sputum', 138, 'sputum'), ('GO_0006936', 'muscle contraction', 151, 'conversion'), ('UBERON_0007023', 'adult organism', 165, 'adults')]
PMC3827489	10/2013	S79-PMC3827489	['SOME obesity-related health consequences HAVE BEEN CORRELATED with Vitamin D deficiency or insufficiency5,52-54), and RECENT reports have SUGGESTED that Vitamin D supplementation MAY reduce these RISKS, ALTHOUGH the data are INCONSISTENT55,56).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 138), ('INCOMPLETE_EVIDENCE', 179), ('IMPORTANT_CONSIDERATION', 196), ('ANOMALY_CURIOUS_FINDING', 203), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 225)]	9	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC3827489	10/2013	S93-PMC3827489	['IN CONTRAST, OTHER OBSERVATIONAL studies SHOWED no correlation between maternal Vitamin D status and infant Birth weight68,69).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 41)]	4	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007567', 'parturition', 108, 'birth')]
PMC3829803	11/2013	S32-PMC3829803	['a SURPRISING spin-OFF from these Vitamin A supplementation STUDIES was the re-discovery that Vitamin A ‘treatment’ CAN significantly decrease the morbidity and mortality ASSOCIATED with acute Mev infection [16]–[19].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 2), ('ANOMALY_CURIOUS_FINDING', 2), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 18), ('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 170)]	6	[('CHEBI_27300', 'vitamin D', 33, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 192, 'MeV')]
PMC3829803	11/2013	S164-PMC3829803	['HOWEVER, the EFFECTS of Vitamin A on Viral infections have been highly VARIABLE and at times, completely CONTRADICTORY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 105)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin A'), ('NCBITaxon_1', 'root', 37, 'viral')]
PMC3829803	11/2013	S175-PMC3829803	['in aggregate, these OBSERVATIONS SUGGEST that Vitamin A and its derivatives MAY play an IMPORTANT ROLE in Antiviral Responses BUT demonstrate clearly that mechanistic studies are ESSENTIAL to fully UNDERSTAND and exploit this POTENTIAL.']	[('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 76), ('IMPORTANT_CONSIDERATION', 88), ('SUPERFICIAL_RELATIONSHIP', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 126), ('IMPORTANT_CONSIDERATION', 179), ('FUTURE_WORK', 198), ('INCOMPLETE_EVIDENCE', 226)]	9	[('CHEBI_27300', 'vitamin D', 46, 'vitamin A'), ('GO_0002901', 'mature B cell apoptotic process', 106, 'antiviral responses')]
PMC3829803	11/2013	S249-PMC3829803	['HOWEVER, high doses of Vitamin A in children with Rsv infection have no benefit and MAY EVEN cause harm [74,88].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 84), ('ANOMALY_CURIOUS_FINDING', 88)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 50, 'RSV')]
PMC3873449	12/2013	S13-PMC3873449	['HOWEVER, neither prolonging the time of sunlight exposure nor Multivitamin supplements CAN effectively prevent Pregnant women from Vitamin D deficiency.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 87)]	2	[('CHEBI_7025', 'mupirocin', 62, 'multivitamin'), ('GO_0007565', 'female pregnancy', 111, 'pregnant'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC3873449	12/2013	S14-PMC3873449	['OTHER measures MIGHT have to be taken for Pregnant women to improve their Vitamin D status in winter.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 15)]	2	[('GO_0007565', 'female pregnancy', 42, 'pregnant'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC3873449	12/2013	S24-PMC3873449	['HOWEVER, data are CONFLICTED on the IMPACT of Vitamin D on the RISK of allergic conditions.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 18), ('SUPERFICIAL_RELATIONSHIP', 36), ('IMPORTANT_CONSIDERATION', 63)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC3873449	12/2013	S62-PMC3873449	['ALTHOUGH there HAS BEEN DEBATE over WHICH level of Serum 25(Oh)D REFLECTS optimum Vitamin D status, it is GENERALLY ACCEPTED that Serum 25(Oh)d level of < 30ng/ml(75nmol/l) is the cut-off value for insufficiency [15-17], which is ASSOCIATED with maximal suppression of Parathyroid hormone [18].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('EXPLICIT_QUESTION', 36), ('SUPERFICIAL_RELATIONSHIP', 65), ('PROBABLE_UNDERSTANDING', 106), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 230)]	9	[('UBERON_0001977', 'blood serum', 51, 'serum'), ('CHEBI_71657', 'versiconol acetate', 57, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('UBERON_0001977', 'blood serum', 130, 'serum'), ('CHEBI_63056', 'zinc cation', 136, '25(OH'), ('UBERON_0001132', 'parathyroid gland', 269, 'parathyroid')]
PMC3873449	12/2013	S108-PMC3873449	['TO DETERMINE WHETHER education levels IMPACT Vitamin D status, women were grouped by better educated women (with associate degree or higher) and less educated women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('SUPERFICIAL_RELATIONSHIP', 38)]	3	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC3873449	12/2013	S119-PMC3873449	['OTHER STUDIES have DEMONSTRATED that Vitamin D deficiency is common in Pregnant women in DIFFERENT countries, such as 31% in southern india [8], 19.5% in greece [20] and 5.7 % in iran [10].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 89)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 71, 'pregnant')]
PMC3873449	12/2013	S123-PMC3873449	['direct comparisons between studies are not possible DUE TO the use of DIFFERENT methods and INCONSISTENT definitions of Vitamin D deficiency.']	[('PROBLEM_COMPLICATION', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92)]	3	[('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC3873449	12/2013	S124-PMC3873449	['it SEEMS, HOWEVER, that all Pregnant women are at a high RISK of Vitamin D deficiency.']	[('ANOMALY_CURIOUS_FINDING', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('IMPORTANT_CONSIDERATION', 57)]	3	[('GO_0007565', 'female pregnancy', 28, 'pregnant'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC3873449	12/2013	S157-PMC3873449	['HOWEVER, the exposure level of 18–20 mj/cm2is not generally reached during the winter above latitude 40° and a caucasian Individual in a bathing suit outside on a sunny january day would not produce endogenous Vitamin D-3 [29].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('NCBITaxon_1', 'root', 121, 'individual'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 210, 'vitamin D-3')]
PMC3873449	12/2013	S168-PMC3873449	['THEREFORE OTHER EFFECTIVE measures MAY NEED to be taken to improve Vitamin D status in chinese Pregnant women.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('SUPERFICIAL_RELATIONSHIP', 16), ('INCOMPLETE_EVIDENCE', 35), ('FUTURE_WORK', 39)]	5	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007565', 'female pregnancy', 95, 'pregnant')]
PMC3873449	12/2013	S172-PMC3873449	['the Supplements in our study used were most commonly Pregnancy-specific multivitamins, containing relatively low doses of Vitamin D (between 5 and 12·5 μg/d), OBVIOUSLY, which does not effectively alter the outcome of high prevalence of Vitamin D deficiency.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 159)]	1	[('CHEBI_33341', 'titanium atom', 4, 'supplements'), ('GO_0007565', 'female pregnancy', 53, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D')]
PMC3873449	12/2013	S179-PMC3873449	['EITHER single (200,000 iu Vitamin D) OR daily (800 iu) dose of Vitamin D HAS BEEN effective at raising circulating 25(Oh)d concentrations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 73)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 115, '25(OH)')]
PMC3873449	12/2013	S180-PMC3873449	['HOWEVER, EVEN with supplementation, ONLY a SMALL percentage of women and babies were Vitamin D sufficient.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 9), ('ANOMALY_CURIOUS_FINDING', 36), ('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 43)]	6	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC3873449	12/2013	S182-PMC3873449	['HOWEVER, in Pregnant women, a study evaluating Plasma Vitamin D status HAS SHOWN that Vitamin D supplementation of <2000 iu/day is not EFFECTIVE in achieving sufficiency [42].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 71), ('SUPERFICIAL_RELATIONSHIP', 135)]	3	[('GO_0007565', 'female pregnancy', 12, 'pregnant'), ('UBERON_0001969', 'blood plasma', 47, 'plasma'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC3873449	12/2013	S188-PMC3873449	['HOWEVER, SINCE there is INSUFFICIENT DATA to evaluate the EFFECTIVENESS of Vitamin D supplementation during Pregnancy Vitamin D supplementation as routine Antenatal care is YET TO BE DETERMINED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 58), ('FULL_UNKNOWN', 173)]	5	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0007565', 'female pregnancy', 108, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0007567', 'parturition', 155, 'antenatal')]
PMC3873449	12/2013	S197-PMC3873449	['this SUGGESTS that education levels are MOST LIKELY to INFLUENCE women’s health awareness RATHER than directly AFFECT Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 5), ('PROBABLE_UNDERSTANDING', 40), ('PROBABLE_UNDERSTANDING', 45), ('SUPERFICIAL_RELATIONSHIP', 55), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90), ('SUPERFICIAL_RELATIONSHIP', 111)]	6	[('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
PMC3873449	12/2013	S213-PMC3873449	['IMPORTANTLY, we did have the INFORMATION on multivitamin supplement usage, which allowed us to SHOW that WHILE Pregnancy-specific multivitamin supplements improve the status in women at low risk of severe Vitamin D deficiency, it does not prevent women from Vitamin D deficiency in winter.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 105)]	4	[('GO_0007565', 'female pregnancy', 111, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D')]
PMC3882256	1/2014	S25-PMC3882256	['we EXAMINED WHETHER any observed ASSOCIATIONS were MEDIATED by Cord Blood ferritin levels, Gestational age, offspring’s birthweight, and dietary iron intake and explored WHETHER offspring sex and maternal Vitamin C intake moderate any ASSOCIATIONS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('SUPERFICIAL_RELATIONSHIP', 33), ('SUPERFICIAL_RELATIONSHIP', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('SUPERFICIAL_RELATIONSHIP', 235)]	6	[('UBERON_0002240', 'spinal cord', 63, 'cord'), ('UBERON_0000178', 'blood', 68, 'blood'), ('GO_0007565', 'female pregnancy', 91, 'gestational'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin C')]
PMC3888066	12/2012	S2-PMC3888066	['HOWEVER, Vitamin A deficiency HAS long BEEN KNOWN to be deleterious to the mother and fetus.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 44)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin A')]
PMC3888066	12/2012	S14-PMC3888066	['methodologies used in this study HAVE BEEN CRITICIZED, including aggregating Heart defects as Neural Crest defects, ESTIMATING missing information on Retinol supplementation and DEMONSTRATING the Vitamin A threshold of >10,000 iu/day.9SUBSEQUENT STUDIES have DISPUTED the 10,000 iu/day THRESHOLD BASED ON Non-Human Primate STUDIES and SMALL clinical trials in Humans.10\n\nEVIDENCE to SUPPORT the NOTION that a Toxin is responsible for SOME Neurodevelopmental disorders\na Toxin that MAY cause Neurodevelopmental disorders MUST BE able to cross NOT ONLY the Placenta, BUT ALSO the Blood Brain Barrier (bbb).']	[('INCOMPLETE_EVIDENCE', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 43), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 178), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 234), ('INCOMPLETE_EVIDENCE', 234), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 259), ('PROBABLE_UNDERSTANDING', 286), ('INCOMPLETE_EVIDENCE', 296), ('PROBABLE_UNDERSTANDING', 296), ('INCOMPLETE_EVIDENCE', 323), ('INCOMPLETE_EVIDENCE', 335), ('INCOMPLETE_EVIDENCE', 371), ('INCOMPLETE_EVIDENCE', 383), ('INCOMPLETE_EVIDENCE', 395), ('INCOMPLETE_EVIDENCE', 434), ('INCOMPLETE_EVIDENCE', 481), ('IMPORTANT_CONSIDERATION', 520), ('ANOMALY_CURIOUS_FINDING', 542)]	19	[('UBERON_0000948', 'heart', 77, 'heart'), ('UBERON_0002342', 'neural crest', 94, 'neural crest'), ('CHEBI_26536', 'retinoic acid', 150, 'retinol'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 305, 'non'), ('NCBITaxon_9606', 'Homo sapiens', 309, 'human'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 315, 'primate'), ('NCBITaxon_9606', 'Homo sapiens', 360, 'humans'), ('CHEBI_27026', 'toxin', 409, 'toxin'), ('GO_0007399', 'nervous system development', 439, 'neurodevelopmental'), ('CHEBI_27026', 'toxin', 470, 'toxin'), ('GO_0007399', 'nervous system development', 491, 'neurodevelopmental'), ('UBERON_0001987', 'placenta', 555, 'placenta'), ('UBERON_0000120', 'blood brain barrier', 578, 'blood brain barrier')]
PMC3888066	12/2012	S28-PMC3888066	['in addition, studying fetal Mice with knock out lesions for Comi and Retinol Binding Protein, kim et al “demonstrate UNEQUIVOCALLY that Beta Carotene CAN serve as an alternative Vitamin A source for the in situ Synthesis Of Retinoids in developing Tissues by the action of cmoi.”4\nthe equation for isomerization with 13-Trans Retinoic Acid as the energy-favored conformation is:isomerase13-cis\u2009Retinoic\u2009Acid↔13-Trans\u2009Retinoic\u2009Acid\nclearly, an increase in the concentration of 13-Trans Retinoic Acid will shift the equilibrium to the left, increasing Production Of Teratogenic 13-Cis Retinoic Acid.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 117), ('INCOMPLETE_EVIDENCE', 150)]	2	[('NCBITaxon_10088', 'Mus <genus>', 28, 'mice'), ('PR_000003266', 'collagen type II alpha chain', 60, 'COMI'), ('CHEBI_26536', 'retinoic acid', 69, 'retinol'), ('PR_000014009', 'regulating synaptic membrane exocytosis protein 1', 69, 'retinol binding protein'), ('CHEBI_51438', 'D-isoascorbic acid', 136, 'beta carotene'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin A'), ('GO_0010198', 'synergid death', 211, 'synthesis of retinoids'), ('CHEBI_26537', 'retinoid', 224, 'retinoids'), ('UBERON_0000479', 'tissue', 248, 'tissues'), ('CHEBI_38356', 'trans-hex-4-enoic acid', 317, '13-trans retinoic acid'), ('CHEBI_26536', 'retinoic acid', 394, 'retinoic acid'), ('CHEBI_38356', 'trans-hex-4-enoic acid', 408, '13-trans retinoic acid'), ('CHEBI_37983', 'sulfur-35 atom', 476, '13-'), ('CHEBI_64330', 'wybutoxosine', 479, 'trans retinoic acid'), ('GO_0007565', 'female pregnancy', 550, 'production of'), ('CHEBI_50905', 'teratogenic agent', 564, 'teratogenic'), ('GO_0006572', 'tyrosine catabolic process', 564, 'teratogenic ... retinoic acid'), ('CHEBI_61206', '2-hexenoic acid', 576, '13-cis retinoic acid')]
PMC3888066	12/2012	S37-PMC3888066	['some contain no Vitamin A, WHILE others contain as much as 5,000 iu of Retinol or 4,000 iu of Beta Carotene, a precursor of Vitamin A (table 3).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 27)]	1	[('CHEBI_27300', 'vitamin D', 16, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 71, 'retinol'), ('CHEBI_51438', 'D-isoascorbic acid', 94, 'beta carotene'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin A')]
PMC3888066	12/2012	S42-PMC3888066	['ON THE OTHER HAND, the amount of Vitamin A in free-range beef is 7 times greater than in grain-Fed Animals.36thus, IF free-range beef is Eaten on a regular basis in combination with other foods, Vitamins, and Beta Carotene, significant increases in Retinoic Acid COULD result.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115), ('INCOMPLETE_EVIDENCE', 263)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin A'), ('GO_0007631', 'feeding behavior', 95, 'fed'), ('NCBITaxon_33208', 'Metazoa', 99, 'animals'), ('GO_0036268', 'swimming', 137, 'eaten'), ('CHEBI_33277', 'gamma-tocotrienol', 195, 'vitamins'), ('CHEBI_51438', 'D-isoascorbic acid', 209, 'beta carotene'), ('CHEBI_26536', 'retinoic acid', 249, 'retinoic acid')]
PMC3888066	12/2012	S45-PMC3888066	['examples of non-fortified Foods that are high in Vitamin A or beta Carotene are listed intable 5.37\n\ncalculation of Vitamin A and beta Carotene intake during Pregnancy\nthe absorption, Metabolism, storage, and Excretion Of Beta Carotene and Retinol in the mother are NOT COMPLETELY UNDERSTOOD; HOWEVER, most investigators agree that consumption of these forms of Vitamin A is RELATED to maternal Serum levels.38–40in ONE STUDY, maternal diet INFLUENCED Cord levels of Beta Carotene, but not Vitamin A.41absorption Of Beta Carotene from raw carrots and a low fat diet is very low compared to carrot juice.42according to current literature, 6 μg of Ingested Beta Carotene convert to 1 Retinol equivalent, or 1 μg Retinol, but ratios have ranged from 3.3:1 to 26:1.43,44\nbased on the discussion above, it MAY BE apparent that Maternal Ingestion of non-Beta Carotene sources of Vitamin A in foods + fortified foods + nutritional supplements would not LIKELY elevate Retinoic Acid levels in the fetus to Teratogenic levels.']	[('INCOMPLETE_EVIDENCE', 266), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 293), ('SUPERFICIAL_RELATIONSHIP', 375), ('INCOMPLETE_EVIDENCE', 416), ('SUPERFICIAL_RELATIONSHIP', 441), ('INCOMPLETE_EVIDENCE', 801), ('PROBABLE_UNDERSTANDING', 946)]	7	[('CHEBI_33290', 'food', 26, 'foods'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin A'), ('CHEBI_23042', 'carotene', 67, 'carotene'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin A'), ('CHEBI_23042', 'carotene', 135, 'carotene'), ('GO_0007565', 'female pregnancy', 158, 'pregnancy'), ('GO_0008152', 'metabolic process', 184, 'metabolism'), ('GO_0007530', 'sex determination', 209, 'excretion of ... carotene'), ('CHEBI_51438', 'D-isoascorbic acid', 222, 'beta carotene'), ('CHEBI_26536', 'retinoic acid', 240, 'retinol'), ('GO_0060033', 'anatomical structure regression', 240, 'retinol'), ('CHEBI_27300', 'vitamin D', 362, 'vitamin A'), ('UBERON_0001977', 'blood serum', 395, 'serum'), ('UBERON_0002240', 'spinal cord', 452, 'cord'), ('CHEBI_51438', 'D-isoascorbic acid', 467, 'beta carotene'), ('CHEBI_27300', 'vitamin D', 490, 'vitamin A'), ('GO_0046311', 'prenylcysteine biosynthetic process', 513, 'of ... carotene'), ('CHEBI_51438', 'D-isoascorbic acid', 516, 'beta carotene'), ('GO_0007631', 'feeding behavior', 646, 'ingested'), ('CHEBI_51438', 'D-isoascorbic acid', 655, 'beta carotene'), ('CHEBI_26536', 'retinoic acid', 682, 'retinol'), ('CHEBI_26536', 'retinoic acid', 710, 'retinol'), ('GO_0007618', 'mating', 822, 'maternal'), ('GO_0007631', 'feeding behavior', 831, 'ingestion'), ('CHEBI_51438', 'D-isoascorbic acid', 848, 'beta carotene'), ('CHEBI_27300', 'vitamin D', 873, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 961, 'retinoic acid'), ('CHEBI_50905', 'teratogenic agent', 998, 'teratogenic'), ('GO_0031649', 'heat generation', 998, 'teratogenic')]
PMC3901983	1/2013	S109-PMC3901983	['HOWEVER, there are no RECOMMENDATIONS about supplementation of the Vitamin K [22].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 22)]	2	[('CHEBI_27300', 'vitamin D', 67, 'vitamin K')]
PMC3926113	1/2014	S0-PMC3926113	['Prenatal Vitamin C deficiency results in DIFFERENTIAL levels of oxidative stress during late Gestation in foetal guinea pig Brains\n\nabstract\nantioxidant defences are comparatively low during Foetal Development making the Brain PARTICULARLY susceptible to oxidative stress during antioxidant deficiencies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 41), ('ANOMALY_CURIOUS_FINDING', 227)]	2	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 9, 'vitamin C'), ('GO_0007565', 'female pregnancy', 93, 'gestation'), ('UBERON_0000955', 'brain', 124, 'brains'), ('GO_0060324', 'face development', 191, 'foetal development'), ('UBERON_0000955', 'brain', 221, 'brain')]
PMC3933171	3/2014	S12-PMC3933171	['introduction\nlow Vitamin D (vitd) status is a risk FACTOR for rickets and HAS BEEN ASSOCIATED with INCREASED prevalence of Respiratory infections and other adverse health outcomes in infants and children.12in response to the CONCERN about widespread childhood vitd deficiency, professional bodies have RECOMMENDED vitd intake of 400\u2005iu/ day for all infants.13the european society for paediatrics gastroenterology, hepatology and nutrition RECOMMENDS 800–1000\u2005iu/day for preterm infants.4based on BIOMARKERS of vitd status MOSTLY in adults, Serum 25-Hydroxyvitamin-D [25(Oh)D] concentration ≥50\u2005nmol/l was also RECOMMENDED.13HOWEVER, the functional benefit of this level is CONTROVERSIAL.']	[('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 83), ('IMPORTANT_CONSIDERATION', 99), ('IMPORTANT_CONSIDERATION', 225), ('FUTURE_WORK', 302), ('FUTURE_WORK', 439), ('SUPERFICIAL_RELATIONSHIP', 496), ('PROBABLE_UNDERSTANDING', 522), ('FUTURE_WORK', 610), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 622), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 673)]	12	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 123, 'respiratory'), ('UBERON_0001977', 'blood serum', 540, 'serum'), ('CHEBI_67320', 'majusculamide A', 546, '25-hydroxyvitamin-D'), ('CHEBI_71657', 'versiconol acetate', 567, '25(OH)D')]
PMC3953741	3/2014	S65-PMC3953741	['an experimental approach of conjugating the lipophilic Cation, Triphenylphosphonium, to an antioxidant such as Vitamin E or ubiquinone HAS BEEN SHOWN to permit the delivery of the antioxidant Moiety through the Mitochondrial Membrane.48,49WHEN this approach was DESCRIBED by murphy and smith in 2007,48it was their intention to employ the lipophilicity of Triphenylphosphonium to ensure diffusion of the antioxidant into the Mitochondria, where Ros neutralization is most useful in relegating oxidative stress.']	[('INCOMPLETE_EVIDENCE', 135), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 237), ('INCOMPLETE_EVIDENCE', 262)]	3	[('CHEBI_36916', 'cation', 55, 'cation'), ('CHEBI_44880', 'tetraphenylphosphonium', 63, 'triphenylphosphonium'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin E'), ('CHEBI_29357', 'methanediyl', 192, 'moiety'), ('GO_0031966', 'mitochondrial membrane', 211, 'mitochondrial membrane'), ('CHEBI_44880', 'tetraphenylphosphonium', 356, 'triphenylphosphonium'), ('GO_0005739', 'mitochondrion', 425, 'mitochondria'), ('CHEBI_8756', 'RNA (poly(A))', 445, 'ROS')]
PMC3973641	4/2014	S35-PMC3973641	['DESPITE these STUDIES, LITTLE IS KNOWN about the EFFECTS of Vitamin B deficiency in fetuses and neonates on their Methionine-Homocysteine Metabolism programming and subsequent consequences to the Brain.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('FULL_UNKNOWN', 23), ('SUPERFICIAL_RELATIONSHIP', 49)]	5	[('CHEBI_27300', 'vitamin D', 60, 'vitamin B'), ('GO_0006555', 'methionine metabolic process', 114, 'methionine- ... metabolism'), ('CHEBI_17088', 'monoacyl-sn-glycerol 3-phosphate', 125, 'homocysteine'), ('UBERON_0000955', 'brain', 196, 'brain')]
PMC3991049	11/2013	S2-PMC3991049	['the current GUIDELINES for Vitamin D intake during Pregnancy of 200–400 iu has LITTLE scientific SUPPORT and HAS BEEN RECENTLY CHALLENGED.']	[('IMPORTANT_CONSIDERATION', 12), ('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 97), ('INCOMPLETE_EVIDENCE', 109), ('INCOMPLETE_EVIDENCE', 118), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127)]	7	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 51, 'pregnancy')]
PMC3991049	11/2013	S21-PMC3991049	['a high prevalence of Vitamin D insufficiency was FOUND in Pregnant women in different studies with DIFFERENT ethnic and geographical backgrounds.4–8the average Prenatal Vitamins contain 400 iu of Vitamin D, which PARTIALLY EXPLAINS this high prevalence of Vitamin D insufficiency in Pregnant women.']	[('INCOMPLETE_EVIDENCE', 49), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99), ('INCOMPLETE_EVIDENCE', 213), ('PROBABLE_UNDERSTANDING', 223)]	4	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007565', 'female pregnancy', 58, 'pregnant'), ('GO_0007565', 'female pregnancy', 160, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 169, 'vitamins'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D'), ('GO_0007565', 'female pregnancy', 283, 'pregnant')]
PMC3991049	11/2013	S22-PMC3991049	['Vitamin D supplementation during Pregnancy REMAINS CONTROVERSIAL and the current RECOMMENDED REQUIREMENT for Vitamin D during Pregnancy (200–400 iu/d) has LITTLE scientific SUPPORT.']	[('INCOMPLETE_EVIDENCE', 43), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 51), ('FUTURE_WORK', 81), ('IMPORTANT_CONSIDERATION', 93), ('INCOMPLETE_EVIDENCE', 155), ('INCOMPLETE_EVIDENCE', 173)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('GO_0007565', 'female pregnancy', 126, 'pregnancy')]
PMC3991049	11/2013	S68-PMC3991049	['SEVERAL STUDIES have REPORTED ASSOCIATION between infant size and Vitamin D status.13,14reduced concentration of 25-Hydroxyvitamin D in mothers during late Pregnancy is ASSOCIATED with reduced Whole Body and Lumbar-Spine bone Mineral content in their children at the age of 9 years.15several studies HYPOTHESIZED that low Prenatal and Perinatal Vitamin D concentrations AFFECT the functional characteristics of various Tissues of the body, which leads to greater risk in later Life of multiple sclerosis, cancer, Insulin-dependent diabetes mellitus and schizophrenia.16,17\nthe current RECOMMENDED dose of Vitamin D during Pregnancy DIFFERS in DIFFERENT parts of the world.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 30), ('SUPERFICIAL_RELATIONSHIP', 169), ('INCOMPLETE_EVIDENCE', 300), ('SUPERFICIAL_RELATIONSHIP', 370), ('FUTURE_WORK', 585), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 632), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 643)]	9	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 113, '25-hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 156, 'pregnancy'), ('UBERON_0000468', 'multicellular organism', 193, 'whole body'), ('UBERON_0006074', 'lumbar region of vertebral column', 208, 'lumbar-spine'), ('CHEBI_46662', 'mineral', 226, 'mineral'), ('GO_0007565', 'female pregnancy', 322, 'prenatal'), ('GO_0036268', 'swimming', 335, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 335, 'perinatal'), ('CHEBI_27300', 'vitamin D', 345, 'vitamin D'), ('UBERON_0000479', 'tissue', 419, 'tissues'), ('UBERON_0000104', 'life cycle', 477, 'life'), ('PR_000045358', 'insulin family protein', 513, 'insulin'), ('CHEBI_27300', 'vitamin D', 605, 'vitamin D'), ('GO_0007565', 'female pregnancy', 622, 'pregnancy')]
PMC3991049	11/2013	S69-PMC3991049	['the RECOMMENDED daily intake of Vitamin D is 200 iu/day in the united states, australia, new zealand and canada.18–20in the uk, the daily recommended dose is 400 iu/day.21HISTORICALLY, Vitamin D supplementation during Pregnancy WAS THOUGHT TO be a risk factor for Supravalvular stenosis in infants, which was BASED ON a 1964 case report.22\nDIFFERENT STUDIES SUGGESTED that the daily use 1000 iu,23–272000 iu,284000 iu,29and 6400 iu30would HELP to eliminate Vitamin D insufficiency without apparent toxicity in Pregnant women and their infants.']	[('FUTURE_WORK', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 169), ('INCOMPLETE_EVIDENCE', 228), ('INCOMPLETE_EVIDENCE', 232), ('INCOMPLETE_EVIDENCE', 309), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 340), ('INCOMPLETE_EVIDENCE', 350), ('INCOMPLETE_EVIDENCE', 358), ('FUTURE_WORK', 439)]	9	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D'), ('GO_0007565', 'female pregnancy', 218, 'pregnancy'), ('UBERON_2000442', 'supraneural bone', 264, 'supravalvular'), ('CHEBI_27300', 'vitamin D', 457, 'vitamin D'), ('GO_0007565', 'female pregnancy', 510, 'pregnant')]
PMC4018592	4/2014	S22-PMC4018592	['[17] in a study in nepal, multiple Micronutrient supplementations during Pregnancy did NOT reduce early infant mortality;[18] HOWEVER, it led TO improved folate status and reduced the prevalence of riboflavin, Vitamin B6, Vitamin B12, Folate and Vitamin D deficiencies.']	[('ANOMALY_CURIOUS_FINDING', 87), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 126), ('QUESTION_ANSWERED_BY_THIS_WORK', 142)]	3	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 35, 'micronutrient'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('CHEBI_33237', 'vitamin D4', 210, 'vitamin B6'), ('CHEBI_33279', 'vitamin D5', 222, 'vitamin B12'), ('CHEBI_30863', '5-azaorotic acid', 235, 'folate'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin D')]
PMC4034700	5/2014	S137-PMC4034700	['HOWEVER, DESPITE encouraging in vitro DATA and cohort trials, clinical trials aimed to treat women AT RISK of Preeclampsia with Vitamins C and E (poston et al., 2006;rumbold et al., 2006) SHOWED no reduction in the incidence of the disease.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 9), ('FUTURE_WORK', 38), ('IMPORTANT_CONSIDERATION', 99), ('INCOMPLETE_EVIDENCE', 188)]	5	[('GO_0007128', 'meiotic prophase I', 110, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 128, 'vitamins C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 143, 'E')]
PMC4045304	2/2014	S2-PMC4045304	['several RECENT STUDIES have PUT FORWARD HYPOTHESES to EXPLAIN the mechanism of ASSOCIATION between both Folic Acid and Vitamin D and autism.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 40), ('PROBABLE_UNDERSTANDING', 54), ('SUPERFICIAL_RELATIONSHIP', 79)]	5	[('CHEBI_30751', 'formic acid', 104, 'folic acid'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
PMC4045304	2/2014	S4-PMC4045304	['there is also a GROWING body of RESEARCH that SUGGESTS that Vitamin D status EITHER in utero OR early in Life MAY BE a RISK for autism.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('INCOMPLETE_EVIDENCE', 110), ('IMPORTANT_CONSIDERATION', 119)]	6	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0000104', 'life cycle', 105, 'life')]
PMC4045304	2/2014	S5-PMC4045304	['in this communication, CONTROVERSIES regarding increase in ESTIMATE of prevalence, IMPLICATIONS of changes in definition, and POSSIBLE ASSOCIATION between SOME modifiable nutritional risk factors such as Folic Acid and Vitamin D and asd will be discussed.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('IMPORTANT_CONSIDERATION', 23), ('INCOMPLETE_EVIDENCE', 59), ('IMPORTANT_CONSIDERATION', 83), ('INCOMPLETE_EVIDENCE', 126), ('SUPERFICIAL_RELATIONSHIP', 135), ('INCOMPLETE_EVIDENCE', 155)]	7	[('CHEBI_5054', 'Fibrin', 204, 'folic'), ('CHEBI_37527', 'acid', 210, 'acid'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin D')]
PMC4045304	2/2014	S184-PMC4045304	['there is a GROWING body of RESEARCH that SUGGESTS that Vitamin D status EITHER in utero OR early in Life MAY BE a RISK of autism.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 72), ('INCOMPLETE_EVIDENCE', 105), ('IMPORTANT_CONSIDERATION', 114)]	6	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('UBERON_0000104', 'life cycle', 100, 'life')]
PMC4045304	2/2014	S187-PMC4045304	['grant and soles [72] used epidemiological data for seasonal variation of Birth rates and prevalence of infantile autism disease (iad) to examine WHETHER maternal Vitamin D deficiency was a RISK factor for iad for cohorts Born before 1985.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 145), ('SUPERFICIAL_RELATIONSHIP', 189)]	2	[('GO_0007567', 'parturition', 73, 'birth'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('GO_0007567', 'parturition', 221, 'born')]
PMC4045304	2/2014	S190-PMC4045304	['Vitamin D and autism hypotheses\nseveral HYPOTHESES HAVE BEEN PROPOSED and tested to EXPLAIN the ASSOCIATION between Vitamin D status of mother and/or autistic child.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 40), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 61), ('PROBABLE_UNDERSTANDING', 84), ('SUPERFICIAL_RELATIONSHIP', 96)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC4045304	2/2014	S193-PMC4045304	['OTHER mechanisms which MAY EXPLAIN the EFFECT of Vitamin D on autism symptoms are that Vitamin D MAY reduce the severity of autism through its anti-inflammatory actions, increasing T-Regulatory Cells, antiautoimmune effects, and upregulating Glutathione, a scavenger of oxidative byproducts [81–84].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 23), ('PROBABLE_UNDERSTANDING', 27), ('SUPERFICIAL_RELATIONSHIP', 39), ('INCOMPLETE_EVIDENCE', 97)]	5	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('CL_0000901', 'Tr1 cell', 181, 'T-regulatory cells'), ('GO_0065007', 'biological regulation', 183, 'regulatory'), ('CHEBI_16856', 'glutathione', 242, 'glutathione')]
PMC4045304	2/2014	S219-PMC4045304	["ANOTHER PROPOSED HYPOTHESIS for the ROLE of Vitamin D in development of autism HAS TO do with Vitamin D's function in the Dna Repair and maintenance [95]."]	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 36), ('IMPORTANT_CONSIDERATION', 79)]	5	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 94, 'Vitamin D'), ('GO_0006281', 'DNA repair', 122, 'DNA repair')]
PMC4045304	2/2014	S266-PMC4045304	['furthermore, OTHER modifiable, nutrition related RISK factors such as Folic Acid, Vitamin D, and maternal Metabolic syndrome MAY ACCOUNT FOR SOME proportion of increase in asd prevalence.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 125), ('PROBABLE_UNDERSTANDING', 129), ('INCOMPLETE_EVIDENCE', 141)]	5	[('CHEBI_30751', 'formic acid', 70, 'folic acid'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0008152', 'metabolic process', 106, 'metabolic')]
PMC4051754	6/2014	S35-PMC4051754	['Calcium, gamma-Glutamyl transpeptidase (ggt), Bilirubin, and Creatinine concentrations had a significant diet × time INTERACTION WHILE Vitamin A and Vitamin E concentrations TENDED to have a significant INTERACTION.']	[('SUPERFICIAL_RELATIONSHIP', 117), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 129), ('ANOMALY_CURIOUS_FINDING', 129), ('SUPERFICIAL_RELATIONSHIP', 174), ('SUPERFICIAL_RELATIONSHIP', 203)]	5	[('CHEBI_31341', 'calcium dihydroxide', 0, 'Calcium'), ('CHEBI_24322', 'glutamoyl group', 15, 'glutamyl'), ('CHEBI_16990', 'bilirubin IXalpha', 46, 'bilirubin'), ('CHEBI_16737', 'creatinine', 61, 'creatinine'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin E')]
PMC4071151	6/2014	S84-PMC4071151	['the precise pathogenesis of these conditions REMAINS UNKNOWN, BUT non-Genetic and non-infectious causes HAVE BEEN POSTULATED and include maternal Vitamin A deficiency [25].']	[('FULL_UNKNOWN', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 62), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 114)]	4	[('SO_0000704', 'gene', 70, 'genetic'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin A')]
PMC4072587	6/2014	S16-PMC4072587	['ALTHOUGH the current RECOMMENDED dietary intake of Vitamin D during Pregnancy ranges from 600 to 2000 international units (iu) per day[8], a standardised definition of Vitamin D deficiency during Pregnancy REMAINS CONTROVERSIAL[4],[9],[10],[11].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 21), ('INCOMPLETE_EVIDENCE', 206), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 214)]	5	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D'), ('GO_0007565', 'female pregnancy', 196, 'pregnancy')]
PMC4072587	6/2014	S23-PMC4072587	['Vitamin D insufficiency in vietnam HAS PREVIOUSLY been REPORTED to be as high as 46%[27],[28],[29], HOWEVER, there is LIMITED DATA on the BURDEN and CONSEQUENCES of Vitamin D deficiency during Pregnancy in this setting[17]and FEW STUDIES have followed Infants past the Neonatal Period.']	[('IMPORTANT_CONSIDERATION', 35), ('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 55), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 100), ('INCOMPLETE_EVIDENCE', 118), ('IMPORTANT_CONSIDERATION', 138), ('IMPORTANT_CONSIDERATION', 149), ('INCOMPLETE_EVIDENCE', 226)]	8	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D'), ('GO_0007565', 'female pregnancy', 193, 'pregnancy'), ('UBERON_0002397', 'maxilla', 252, 'infants'), ('UBERON_0007221', 'neonate stage', 269, 'neonatal period')]
PMC4072587	6/2014	S99-PMC4072587	['HOWEVER, lower language composite scores were SEEN in infants Born to women with Vitamin D deficiency (<37.5 nmol/l) compared to those Born to women who were Vitamin D replete (≥75 nmol/l) (md −3.48, 95% ci −5.52 to −1.44) (table 5).10.1371/journal.pone.0099005.t004\n\ncaption (table-wrap): table 4\ndevelopmental composite scores at 6 months of age ASSOCIATED with maternal Serum 25-Ohd concentration (nmol/l) at 32 weeks Gestation.unadjusted modeladjusted model 1adjusted model 2domainmean developmental composite score [sd]mean difference1,2(95% ci)p valuemean difference1,3(95% ci)p valuemean difference1,4(95% ci)p valuecognitive104.5 [10.1]−0.47 (−1.22 to 0.27)0.21−0.39 (−1.19 to 0.40)0.30−0.43 (−1.23 to 0.370.29language97.8 [7.6]−0.02 (−0.58 to 0.55)0.960.04 (−0.51 to 0.59)0.890.08 (−0.47 to 0.63)0.77motor110.9 [13.4]0.03 (−0.97 to 1.03)0.950.25 (−0.71 to 1.21)0.610.05 (−0.92 to 0.64)0.92socio-emotional79.6 [9.8]−0.12 (−0.85 to 0.61)0.75−0.06 (−0.81 to 0.70)0.88−0.14 (−0.92 to 0.64)0.71\nvalues are ESTIMATED mean difference for each outcome associated with a 25 nmol/l increase in Vitamin.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 348), ('INCOMPLETE_EVIDENCE', 1010)]	5	[('GO_0007567', 'parturition', 62, 'born'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007567', 'parturition', 135, 'born'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('UBERON_0001977', 'blood serum', 373, 'serum'), ('CHEBI_72765', 'verruculogen', 379, '25-OHD'), ('GO_0007565', 'female pregnancy', 421, 'gestation'), ('CHEBI_33229', 'vitamin (role)', 1093, 'vitamin')]
PMC4072587	6/2014	S124-PMC4072587	['RECENT RESEARCH SUGGESTS that Vitamin D deficiency during Pregnancy or early childhood MAY BE an environmental TRIGGER for autism spectrum disorder in infants Genetically predisposed to autism, EITHER through its EFFECT on Neuronal function and Brain Development, or through Gene interaction and Regulation.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 87), ('SUPERFICIAL_RELATIONSHIP', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 194), ('SUPERFICIAL_RELATIONSHIP', 213)]	6	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('SO_0000704', 'gene', 159, 'genetically'), ('CL_0000540', 'neuron', 223, 'neuronal'), ('GO_0007420', 'brain development', 245, 'brain development'), ('UBERON_0000955', 'brain', 245, 'brain'), ('SO_0000704', 'gene', 275, 'gene'), ('GO_0065007', 'biological regulation', 296, 'regulation')]
PMC4072587	6/2014	S127-PMC4072587	['SEVERAL STUDIES have FOUND an ASSOCIATION between maternal Vitamin D status and post-Natal growth, BUT results are INCONSISTENT and the majority are OBSERVATIONAL studies that HAVE been carried out in developed countries.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115), ('INCOMPLETE_EVIDENCE', 149), ('IMPORTANT_CONSIDERATION', 176)]	7	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007567', 'parturition', 85, 'natal')]
PMC4072587	6/2014	S144-PMC4072587	['there are no standardised definitions for Vitamin D thresholds in Pregnancy (deficiency, insufficiency and sufficiency), HOWEVER a RECENT meta-analysis defined insufficiency for Pregnancy outcomes as less than 75 vnmol/l, and insufficiency for Birth variables as less than 37.5 nmol/l[12].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('INCOMPLETE_EVIDENCE', 131)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0007565', 'female pregnancy', 66, 'pregnancy'), ('GO_0007565', 'female pregnancy', 178, 'pregnancy'), ('GO_0007567', 'parturition', 244, 'birth')]
PMC4072587	6/2014	S145-PMC4072587	['the REPORTED prevalence and definitions of Vitamin D insufficiency/deficiency in vietnamese women has VARIED in PREVIOUS STUDIES, ranging from 7% to 46%[27],[28],[29].']	[('INCOMPLETE_EVIDENCE', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102), ('INCOMPLETE_EVIDENCE', 112)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D')]
PMC4072587	6/2014	S148-PMC4072587	['SOME authors have also SUGGESTED that the cut off for sufficient Vitamin D levels during Pregnancy SHOULD BE as high as 100–150 nmo/l[10],[11], and THEREFORE the PROBLEM of Vitamin D deficiency in vietnam and OTHER south east asian countries MAY BE EVEN more widespread than PREVIOUSLY THOUGHT.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 23), ('FUTURE_WORK', 99), ('PROBABLE_UNDERSTANDING', 148), ('IMPORTANT_CONSIDERATION', 162), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 209), ('INCOMPLETE_EVIDENCE', 242), ('ANOMALY_CURIOUS_FINDING', 249), ('INCOMPLETE_EVIDENCE', 275), ('INCOMPLETE_EVIDENCE', 286)]	10	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D')]
PMC4072587	6/2014	S153-PMC4072587	['HOWEVER, SIMILAR FINDINGS in PREVIOUS STUDIES[24],[38],[41],[42],[43]and the INCREASING EVIDENCE for Vitamin D deficiency AS a POTENTIAL environmental risk FACTOR for autism[10],[25],[26]SUGGEST that these ASSOCIATIONS SHOULD NOT BE discounted.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 77), ('PROBABLE_UNDERSTANDING', 122), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 156), ('INCOMPLETE_EVIDENCE', 187), ('SUPERFICIAL_RELATIONSHIP', 206), ('FUTURE_WORK', 219)]	10	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC4074693	3/2014	S81-PMC4074693	['[151620] the most commonly used was Vitamin C then followed by multivitamins, this is CONTRARY TO OTHER STUDIES where multivitamin was the most commonly used followed by Vitamin C and others.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('INCOMPLETE_EVIDENCE', 98)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin C')]
PMC4113768	7/2014	S11-PMC4113768	['the existence of a u-shaped RELATIONSHIP between Vitamin D status and RISK of certain health outcomes was ANOTHER area of discussion.']	[('SUPERFICIAL_RELATIONSHIP', 28), ('IMPORTANT_CONSIDERATION', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 106)]	3	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC4113768	7/2014	S12-PMC4113768	['a third EMERGING theme, also RELATING to Vitamin D dose–response RELATIONSHIPS, was the POTENTIAL DIFFERENTIAL EFFECT of daily vs. intermittent bolus dosing on biological outcomes.']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 29), ('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('SUPERFICIAL_RELATIONSHIP', 111)]	6	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D')]
PMC4113768	7/2014	S17-PMC4113768	['sex-specific ASSOCIATIONS between 25-Hydroxy Vitamin D3And Serum Lipids in elderly german subjects without intake of Lipid-modifying Drugs\n\njungert, a.; neuhäuser-berthold, m.\nbackground: ALTHOUGH EMERGING EVIDENCE INDICATES an ASSOCIATION between Vitamin D and Serum Lipids, the data are STILL INCONSISTENT.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 188), ('ANOMALY_CURIOUS_FINDING', 188), ('INCOMPLETE_EVIDENCE', 197), ('INCOMPLETE_EVIDENCE', 215), ('SUPERFICIAL_RELATIONSHIP', 228), ('IMPORTANT_CONSIDERATION', 289), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 295)]	8	[('CHEBI_668', '1-Phenyl-5-heptene-1,3-diyne', 34, '25-Hydroxy Vitamin D3and'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 45, 'Vitamin D3and'), ('UBERON_0001977', 'blood serum', 59, 'Serum'), ('CHEBI_18059', 'lipid', 65, 'Lipids'), ('CHEBI_18059', 'lipid', 117, 'Lipid'), ('CHEBI_23888', 'drug', 133, 'Drugs'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin D'), ('UBERON_0001977', 'blood serum', 262, 'serum'), ('CHEBI_18059', 'lipid', 268, 'lipids')]
PMC4113768	7/2014	S148-PMC4113768	['2012, 67 , 1139-1144), NO PUBLISHED research has specifically examined WHETHER there is a LINK between Vitamin D and Sleep.']	[('INCOMPLETE_EVIDENCE', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71), ('EXPLICIT_QUESTION', 71), ('SUPERFICIAL_RELATIONSHIP', 90)]	4	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0030431', 'sleep', 117, 'sleep')]
PMC4113768	7/2014	S214-PMC4113768	['we THEREFORE AIMED TO DETERMINE WHETHER seasonal Vitamin D deficiency occurs in two healthy young Adult populations with moderate or dark skin pigmentation in cape town, WHETHER this had an EFFECT on the number and function of Circulating Blood Cells, their ability to Control to hiv-1 infection and WHETHER Vitamin D supplementation modifies the investigated responses.']	[('PROBABLE_UNDERSTANDING', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('SUPERFICIAL_RELATIONSHIP', 190), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 300)]	7	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0007023', 'adult organism', 98, 'adult'), ('CL_0000080', 'circulating cell', 227, 'circulating'), ('CL_0000081', 'blood cell', 239, 'blood cells'), ('UBERON_0000178', 'blood', 239, 'blood'), ('GO_0065007', 'biological regulation', 269, 'control'), ('CHEBI_27300', 'vitamin D', 308, 'vitamin D')]
PMC4113768	7/2014	S253-PMC4113768	['hiv progression, which is ASSOCIATED with excessive Immune Activation and impaired T-Cell Immunity, is also ASSOCIATED with low Serum Vitamin D level ALTHOUGH biological PLAUSIBILITY and causality have yet to be established.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('SUPERFICIAL_RELATIONSHIP', 108), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 150), ('ANOMALY_CURIOUS_FINDING', 150), ('INCOMPLETE_EVIDENCE', 170)]	5	[('GO_0060819', 'inactivation of X chromosome by genetic imprinting', 52, 'immune activation'), ('UBERON_0002405', 'immune system', 52, 'immune'), ('CL_0000084', 'T cell', 83, 'T-cell'), ('GO_0002456', 'T cell mediated immunity', 83, 'T-cell immunity'), ('GO_0005622', 'intracellular anatomical structure', 84, '-cell'), ('UBERON_0001977', 'blood serum', 128, 'serum'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC4113768	7/2014	S367-PMC4113768	['ALTHOUGH no children were taking vitamin supplements at the time of the study, the average Vitamin D level in african children who had ever been prescribed Vitadol-c was 34 nmol/l WHILST those who had never been prescribed Vitadol-c was 16 nmol/l.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 180)]	2	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('CHEBI_27355', 'xylulose phosphate', 156, 'vitadol'), ('CHEBI_27355', 'xylulose phosphate', 223, 'vitadol')]
PMC4113768	7/2014	S369-PMC4113768	['HOWEVER this window-shot IDENTIFIES ongoing cross cultural Vitamin D deficiency in our community.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 25)]	2	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D')]
PMC4113768	7/2014	S378-PMC4113768	['the national academies press : washington, dc, usa, 2011).we INVESTIGATED WHETHER DIFFERENT levels of habitual Calcium Intake INFLUENCED Serum 25(Oh)D and indices of Vitamin D activation and Catabolism during winter and in the context of both adequate and inadequate Vitamin D intakes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 61), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 74), ('EXPLICIT_QUESTION', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('SUPERFICIAL_RELATIONSHIP', 126)]	5	[('CHEBI_22313', 'alkaline earth metal atom', 111, 'calcium'), ('GO_0007631', 'feeding behavior', 119, 'intake'), ('UBERON_0001977', 'blood serum', 137, 'serum'), ('CHEBI_71657', 'versiconol acetate', 143, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 143, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D'), ('GO_0009056', 'catabolic process', 191, 'catabolism'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D')]
PMC4113768	7/2014	S443-PMC4113768	['IF Vitamin D status does indeed IMPACT on Neurodevelopment, seasonal variation in Lateral Ventricular diameter MIGHT be expected.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 32), ('INCOMPLETE_EVIDENCE', 111)]	3	[('CHEBI_27300', 'vitamin D', 3, 'vitamin D'), ('GO_0007399', 'nervous system development', 42, 'neurodevelopment'), ('UBERON_0004086', 'brain ventricle', 82, 'lateral ventricular')]
PMC4113768	7/2014	S476-PMC4113768	['overall reductions in Lung cancer RISKS in never-smokers in the women’s health initiative (1771 cases in 128,779 women) were seen with vitamin D intakes >400 iu/day (or = 0.37, 95% ci: 0.18–0.77); HOWEVER, rct data for the 12% of women given Vitamin D supplements SHOWED lower Lung cancer risk ONLY in those with low intakes of Retinol (or = 0.69, 95% ci, 0.5–0.96).']	[('IMPORTANT_CONSIDERATION', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 197), ('ANOMALY_CURIOUS_FINDING', 197), ('INCOMPLETE_EVIDENCE', 264), ('ANOMALY_CURIOUS_FINDING', 294), ('INCOMPLETE_EVIDENCE', 294)]	6	[('UBERON_0002048', 'lung', 22, 'lung'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 143, 'D'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin D'), ('UBERON_0002048', 'lung', 277, 'lung'), ('CHEBI_26536', 'retinoic acid', 328, 'retinol')]
PMC4113768	7/2014	S478-PMC4113768	['lower death rates from malignant melanoma are SEEN with higher Vitamin D intakes (or = 0.77, 95% ci, 0.64–0.93) BUT this benefit is smaller in those with high Retinol intakes (or = 0.99, 95% ci, 0.72–1.36).']	[('INCOMPLETE_EVIDENCE', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112)]	2	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_26536', 'retinoic acid', 159, 'retinol')]
PMC4113768	7/2014	S479-PMC4113768	['conclusions: (1) SINCE the use of supplements containing Vitamin A as well as Vitamin D is common, WHETHER in Cod Liver oil OR multi-vitamins, especially in developed countries, Vitamin A status is LIKELY to CONFOUND rcts of Vitamin D in westernized populations; (2) in particular, high Vitamin A Intakes COULD ACCOUNT for j or inverse u shaped curves for outcomes in rcts, AS COULD Gene polymorphisms increasing circulating Retinol/Retinoids; (3) CONVERSELY, poor Vitamin D status MAY BE expected to CONFOUND rcts of Vitamin A in developing countries; (4) as well as Vitamin A intakes, other lifestyle factors that are POTENTIAL CONFOUNDERS of the EFFECTS of Vitamin D SHOULD BE CONSIDERED in the PLANNING of FUTURE rcts of supplemental Vitamin D, including intakes of other Nutrients, tobacco usage, and also betel-chewing which MAY increase Catabolism Of Vitamin D and is a habit used by 10% of the world population.']	[('PROBABLE_UNDERSTANDING', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99), ('PROBABLE_UNDERSTANDING', 198), ('PROBLEM_COMPLICATION', 208), ('INCOMPLETE_EVIDENCE', 305), ('IMPORTANT_CONSIDERATION', 311), ('PROBABLE_UNDERSTANDING', 374), ('INCOMPLETE_EVIDENCE', 377), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 448), ('INCOMPLETE_EVIDENCE', 482), ('PROBLEM_COMPLICATION', 501), ('INCOMPLETE_EVIDENCE', 620), ('PROBLEM_COMPLICATION', 630), ('SUPERFICIAL_RELATIONSHIP', 649), ('FUTURE_WORK', 670), ('FUTURE_WORK', 680), ('FUTURE_WORK', 698), ('FUTURE_WORK', 710), ('INCOMPLETE_EVIDENCE', 831)]	19	[('CHEBI_27300', 'vitamin D', 57, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 110, 'cod'), ('UBERON_0002107', 'liver', 114, 'liver'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin A'), ('GO_0007631', 'feeding behavior', 297, 'intakes'), ('SO_0000704', 'gene', 383, 'gene'), ('CHEBI_26536', 'retinoic acid', 425, 'retinol'), ('CHEBI_26537', 'retinoid', 433, 'retinoids'), ('CHEBI_27300', 'vitamin D', 465, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 518, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 568, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 660, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 738, 'vitamin D'), ('CHEBI_33284', 'nutrient', 776, 'nutrients'), ('GO_0044851', 'hair cycle phase', 844, 'catabolism of vitamin D'), ('CHEBI_27300', 'vitamin D', 858, 'vitamin D')]
PMC4113768	7/2014	S580-PMC4113768	['AIM: the PRESENT STUDY EXAMINED IF exposure to Vitamin D from fortified Margarine and milk during Prenatal Life INFLUENCED Birth weight.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('SUPERFICIAL_RELATIONSHIP', 112)]	5	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_6784', 'mestranol', 72, 'margarine'), ('GO_0007565', 'female pregnancy', 98, 'prenatal'), ('UBERON_0000104', 'life cycle', 107, 'life'), ('GO_0007567', 'parturition', 123, 'birth')]
PMC4113768	7/2014	S587-PMC4113768	['conclusion: exposure to Vitamin D from fortified Margarine and milk during Prenatal Life altered Birth weight, but the ASSOCIATIONS were INCONSISTENT.']	[('SUPERFICIAL_RELATIONSHIP', 119), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137)]	2	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_6784', 'mestranol', 49, 'margarine'), ('GO_0007565', 'female pregnancy', 75, 'prenatal'), ('UBERON_0000104', 'life cycle', 84, 'life'), ('GO_0007567', 'parturition', 97, 'birth')]
PMC4113768	7/2014	S682-PMC4113768	['conclusions: frequent use of high-dose oral Vitamin D APPEARS TO HAVE resulted in a high overall Vitamin D status in older new zealanders, which is in STARK CONTRAST TO the relatively low status REPORTED PREVIOUSLY.']	[('ANOMALY_CURIOUS_FINDING', 54), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 151), ('INCOMPLETE_EVIDENCE', 195), ('INCOMPLETE_EVIDENCE', 204)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D')]
PMC4113768	7/2014	S782-PMC4113768	['RANDOMIZED controlled trials of Vitamin D supplementation MAY BE WARRANTED for infants with low 25(Oh)D during the initial months of Life, BUT careful selection of the regimen with close monitoring of safety for those who reach high 25(Oh)D levels will be NECESSARY.']	[('FUTURE_WORK', 0), ('INCOMPLETE_EVIDENCE', 58), ('FUTURE_WORK', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139), ('IMPORTANT_CONSIDERATION', 256)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 96, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 102, 'D'), ('UBERON_0000104', 'life cycle', 133, 'life'), ('CHEBI_71657', 'versiconol acetate', 233, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 233, '25(OH ... D')]
PMC4113768	7/2014	S808-PMC4113768	['we THEREFORE AIMED TO ESTABLISH WHETHER maternal Vitamin D and Vitamin D-binding protein (dbp) levels MIGHT RELATE to the Expression of amino acid transporters in Human Placenta.']	[('PROBABLE_UNDERSTANDING', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('INCOMPLETE_EVIDENCE', 102), ('SUPERFICIAL_RELATIONSHIP', 108)]	6	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0010467', 'gene expression', 122, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 163, 'human'), ('UBERON_0001987', 'placenta', 169, 'placenta')]
PMC4113768	7/2014	S817-PMC4113768	['the CORRELATIONS between dbp levels and several amino acid transporters SUGGEST that Vitamin D Delivery MAY BE IMPORTANT for Placental function, but FURTHER WORK is now REQUIRED to establish WHETHER these ASSOCIATIONS are causal.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 104), ('IMPORTANT_CONSIDERATION', 111), ('FUTURE_WORK', 149), ('IMPORTANT_CONSIDERATION', 169), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 191), ('SUPERFICIAL_RELATIONSHIP', 205)]	8	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007567', 'parturition', 95, 'delivery'), ('UBERON_0001987', 'placenta', 125, 'placental')]
PMC4113768	7/2014	S850-PMC4113768	['background: the ROLE of Vitamin D in bone Metabolism is WELL KNOWN BUT its’ actions on muscle are INCOMPLETELY understood.']	[('SUPERFICIAL_RELATIONSHIP', 16), ('INCOMPLETE_EVIDENCE', 56), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 67), ('INCOMPLETE_EVIDENCE', 98)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0008152', 'metabolic process', 42, 'metabolism')]
PMC4113768	7/2014	S870-PMC4113768	['IN CONTRAST TO observational studies that SHOW a beneficial EFFECT of Vitamin D on grip strength, there was no significant increase seen in grip strength in any of the included studies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 60)]	3	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC4113768	7/2014	S877-PMC4113768	['the results of this review are at ODDS with findings from SOME observational studies, which have SUGGESTED that Vitamin D status AFFECTS Hand-grip strength.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 97), ('SUPERFICIAL_RELATIONSHIP', 129)]	4	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('UBERON_0002398', 'manus', 137, 'hand')]
PMC4113768	7/2014	S904-PMC4113768	['objective: to ascertain WHETHER Vitamin D deficiency is LINKED to Dental health.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('SUPERFICIAL_RELATIONSHIP', 56)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('UBERON_0001091', 'calcareous tooth', 66, 'dental')]
PMC4113768	7/2014	S1036-PMC4113768	['HOWEVER, a stronger reduction in the risk of pre-term Birth by single preparation Vitamin D was seen in Pregnancies complicated with maternal infection (0.39, 0.29–0.52, p = 6.8e−12), compared to Prematurity following an infection-free Pregnancy (0.46, 0.41–0.52, p = 7.6e−39).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('GO_0007567', 'parturition', 54, 'birth'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0007565', 'female pregnancy', 104, 'pregnancies'), ('GO_0007565', 'female pregnancy', 196, 'prematurity'), ('GO_0007565', 'female pregnancy', 236, 'pregnancy')]
PMC4113768	7/2014	S1038-PMC4113768	['these data SUGGEST that the RELATED EFFECTS are strong and CONSISTENT across DIFFERENT types of infections, HIGHLIGHTING THE NEED to PREVENT Vitamin D deficiency in Pregnant mothers.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 28), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 59), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('IMPORTANT_CONSIDERATION', 108), ('INCOMPLETE_EVIDENCE', 108), ('INCOMPLETE_EVIDENCE', 121), ('FUTURE_WORK', 125), ('SUPERFICIAL_RELATIONSHIP', 133)]	11	[('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('GO_0007565', 'female pregnancy', 165, 'pregnant')]
PMC4113768	7/2014	S1045-PMC4113768	['HOWEVER randomized controlled trials in children and adolescents did not show significant EFFECTS on total body bone Mineral density after Vitamin D supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 90)]	2	[('CHEBI_46662', 'mineral', 117, 'mineral'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC4113768	7/2014	S1051-PMC4113768	['for β-ctx ALONE no significant association with 25(Oh) Vitamin D was observed (−0.58 ng/l, p = 0.84), WHEREAS the β-ctx to Osteocalcin ratio was inversely ASSOCIATED with 25(Oh) Vitamin D levels (−1.1% change, p = 0.003).']	[('ANOMALY_CURIOUS_FINDING', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102), ('SUPERFICIAL_RELATIONSHIP', 155)]	3	[('CHEBI_30778', 'gallic acid', 48, '25(OH)'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('PR_000011634', 'oxidized low-density lipoprotein receptor 1', 123, 'osteocalcin'), ('CHEBI_30778', 'gallic acid', 171, '25(OH)'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
PMC4113768	7/2014	S1152-PMC4113768	['it adds to SIMILAR FINDINGS from OTHER regions of the world, INDICATING Vitamin D deficiency in the population and especially in Individuals with asd.']	[('INCOMPLETE_EVIDENCE', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 33), ('INCOMPLETE_EVIDENCE', 61)]	3	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('NCBITaxon_1', 'root', 129, 'individuals')]
PMC4113768	7/2014	S1172-PMC4113768	['studies FOUND INCONSISTENT results regarding the RELATIONSHIP of Vitamin D status and bone Mineral density (bmd) and quantitative ultrasound measurements (qus).']	[('INCOMPLETE_EVIDENCE', 8), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('SUPERFICIAL_RELATIONSHIP', 49)]	3	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_46662', 'mineral', 91, 'mineral')]
PMC4113768	7/2014	S1173-PMC4113768	['THIS STUDY has two AIMS: (1) TO EXAMINE the ASSOCIATION between Vitamin D status and qus and bmd; and (2) TO EXAMINE WHETHER gender, age, physical activity or body mass index (bmi) MODIFY these ASSOCIATIONS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('SUPERFICIAL_RELATIONSHIP', 44), ('QUESTION_ANSWERED_BY_THIS_WORK', 106), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 117), ('SUPERFICIAL_RELATIONSHIP', 181), ('SUPERFICIAL_RELATIONSHIP', 194)]	8	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC4113768	7/2014	S1176-PMC4113768	['multiple linear regression was used TO ASSESS WHETHER Vitamin D status was RELATED to qus and bmd and WHETHER age (below vs. above the median age), gender, bmi (≤26.5 vs.>26.5 kg/m2) or physical activity (low vs. high) MODIFIED these RELATIONSHIPS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 36), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 46), ('SUPERFICIAL_RELATIONSHIP', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102), ('SUPERFICIAL_RELATIONSHIP', 219), ('SUPERFICIAL_RELATIONSHIP', 234)]	6	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
PMC4113768	7/2014	S1178-PMC4113768	['low Vitamin D status (<25 nmol/l) was significantly ASSOCIATED with lower bua as COMPARED TO the reference group (≥50 nmol/l); this ASSOCIATION was modified by bmi ( p< 0.1).']	[('SUPERFICIAL_RELATIONSHIP', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('SUPERFICIAL_RELATIONSHIP', 132)]	3	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D')]
PMC4113768	7/2014	S1203-PMC4113768	['conclusions: pth is the MOST LIKELY MARKER to be outside the reference range (raised) IF the patient is Vitamin D deficient BUT the literature SUGGESTS the RELATIONSHIP between 25Ohd and pth MAY BE COMPLICATED by Glomerular filtration rate.']	[('PROBABLE_UNDERSTANDING', 24), ('PROBABLE_UNDERSTANDING', 29), ('SUPERFICIAL_RELATIONSHIP', 36), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124), ('INCOMPLETE_EVIDENCE', 143), ('SUPERFICIAL_RELATIONSHIP', 156), ('INCOMPLETE_EVIDENCE', 191), ('DIFFICULT_TASK', 198)]	9	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 177, '25OHD'), ('UBERON_0000074', 'renal glomerulus', 213, 'glomerular')]
PMC4113768	7/2014	S1265-PMC4113768	['we wanted to study WHETHER intervention with high dose Vitamin D would improve muscular strength OR balance in Postmenopausal women.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 19)]	1	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0007595', 'lactation', 111, 'postmenopausal')]
PMC4113768	7/2014	S1285-PMC4113768	['a RECENT meta-analysis SHOWED INCONSISTENT EFFECTS of Vitamin D supplementation on bone Mineral density of healthy children.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('SUPERFICIAL_RELATIONSHIP', 43)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_46662', 'mineral', 88, 'mineral')]
PMC4113768	7/2014	S1301-PMC4113768	['; wood, a.d.\nbackground: variation in Vitamin D binding protein (Vdbp) MAY EXPLAIN the INCONSISTENCIES between studies of Vitamin D; EITHER ( a ) through a mechanism by which the circulating half-life of 25-Hydroxy Vitamin D [25(Oh)D] MAY BE extended or ( b ) BECAUSE non-Vdbp bound or free Metabolites of Vitamin D MAY BETTER REFLECT biological activity.']	[('INCOMPLETE_EVIDENCE', 71), ('PROBABLE_UNDERSTANDING', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 87), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 133), ('INCOMPLETE_EVIDENCE', 235), ('PROBABLE_UNDERSTANDING', 260), ('INCOMPLETE_EVIDENCE', 316), ('INCOMPLETE_EVIDENCE', 320), ('SUPERFICIAL_RELATIONSHIP', 327)]	9	[('CHEBI_28384', 'vitamin K', 38, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 38, 'Vitamin D'), ('PR_000017279', 'testis-specific basic protein Y 1', 65, 'VDBP'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 204, '25-hydroxy vitamin D'), ('CHEBI_71657', 'versiconol acetate', 226, '25(OH)D'), ('PR_000017279', 'testis-specific basic protein Y 1', 272, 'VDBP'), ('CHEBI_25212', 'metabolite', 291, 'metabolites'), ('CHEBI_27300', 'vitamin D', 306, 'vitamin D')]
PMC4113768	7/2014	S1321-PMC4113768	['IN CONTRAST, both Vitamin D doses caused a rapid increase in 25(Oh)D, reaching a plateau of 65[20] nmol/l for 400 iu, and 76[19] nmol/l for 1000 iu Vitamin D. we REPORTED that 1000 iu Vitamin D3But not 400 iu attenuated bone mineral density loss, WHEREAS the increase in 25(Oh)D for the 1000 iu dose was ONLY 25% above that for the 400 iu dose (2).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 162), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 247), ('ANOMALY_CURIOUS_FINDING', 247), ('ANOMALY_CURIOUS_FINDING', 304), ('INCOMPLETE_EVIDENCE', 304)]	6	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 61, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('CHEBI_82668', 'DH335(1+)', 184, 'vitamin D3but'), ('PR_000017209', 'utrophin', 184, 'vitamin D3but'), ('CHEBI_71657', 'versiconol acetate', 271, '25(OH)D')]
PMC4113768	7/2014	S1345-PMC4113768	['it is our IMPRESSION that quality of Life in MOST cancer patients was good after Vitamin D supplementation, and in those who died this was right up until their final stage.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('PROBABLE_UNDERSTANDING', 45)]	2	[('UBERON_0000104', 'life cycle', 37, 'life'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC4113768	7/2014	S1348-PMC4113768	['in the absence of any known negative EFFECTS of Vitamin D supplementation and WHILE waiting for conclusive trials it COULD BE beneficial for many cancer patients to be tested and treated for Vitamin D deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 78), ('INCOMPLETE_EVIDENCE', 117)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D')]
PMC4113768	7/2014	S1375-PMC4113768	['HOWEVER the mechanism is UNCLEAR, with studies examining the RELATIONSHIP between Vitamin D and Insulin resistance showing CONFLICTING results.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FULL_UNKNOWN', 25), ('SUPERFICIAL_RELATIONSHIP', 61), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 123)]	4	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('PR_000045358', 'insulin family protein', 96, 'insulin')]
PMC4113768	7/2014	S1386-PMC4113768	['robust randomised controlled TRIALS ARE NEEDED to determine WHETHER improving Vitamin D status has a positive EFFECT on Insulin resistance OR OTHER pathophysiological indicators of dm including Beta-Cell function.']	[('FUTURE_WORK', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 60), ('SUPERFICIAL_RELATIONSHIP', 110), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 142)]	5	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('PR_000045358', 'insulin family protein', 120, 'insulin'), ('CL_0000349', 'extraembryonic cell', 194, 'beta-cell')]
PMC4113768	7/2014	S1407-PMC4113768	['to COMPLICATE the picture, Genetic DIFFERENCES in the Vitamin D receptor (vdr) MAY also be of IMPORTANCE.']	[('DIFFICULT_TASK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('INCOMPLETE_EVIDENCE', 79), ('IMPORTANT_CONSIDERATION', 94)]	4	[('SO_0000704', 'gene', 27, 'genetic'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
PMC4113768	7/2014	S1445-PMC4113768	['suboptimal Vitamin D status APPEARS TO increase an Individual’s RISK of developing cvd, ALTHOUGH the OPTIMAL level REQUIRED is UNCLEAR and the results of intervention studies REMAIN HETEROGENEOUS and INCONCLUSIVE.']	[('ANOMALY_CURIOUS_FINDING', 28), ('IMPORTANT_CONSIDERATION', 64), ('ANOMALY_CURIOUS_FINDING', 88), ('IMPORTANT_CONSIDERATION', 101), ('IMPORTANT_CONSIDERATION', 115), ('FULL_UNKNOWN', 127), ('INCOMPLETE_EVIDENCE', 175), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182), ('DIFFICULT_TASK', 182), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 200)]	10	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('NCBITaxon_1', 'root', 51, 'individual')]
PMC4113768	7/2014	S1448-PMC4113768	['THIS STUDY INVESTIGATED WHETHER Vitamin D status PREDICTS ed and OTHER cvd MARKERS in Ageing men.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('SUPERFICIAL_RELATIONSHIP', 49), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 65), ('SUPERFICIAL_RELATIONSHIP', 75)]	6	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007568', 'aging', 86, 'ageing')]
PMC4113768	7/2014	S1460-PMC4113768	['this study SUPPORTS a POTENTIAL ROLE for Vitamin D in cvd development, HOWEVER FURTHER RESEARCH IS REQUIRED to establish causality.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71), ('FUTURE_WORK', 79), ('IMPORTANT_CONSIDERATION', 99)]	6	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D')]
PMC4113768	7/2014	S1461-PMC4113768	['there is a NEED for randomised controlled Human intervention trials to investigate WHETHER improving Vitamin D status in men ameliorates vasculogenic ed and reduces the RISK of cvd.']	[('FUTURE_WORK', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('IMPORTANT_CONSIDERATION', 169)]	3	[('NCBITaxon_9606', 'Homo sapiens', 42, 'human'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC4113768	7/2014	S1533-PMC4113768	['carriers of a high grs of Cyp2R1 (rs10741657 and rs10766197) and gc (rs4588 and rs842999) were more PRONE to be Vitamin D insufficient COMPARED TO carriers of low grs.']	[('PROBABLE_UNDERSTANDING', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135)]	2	[('PR_000006110', 'cytochrome P450 27, mitochondrial', 26, 'CYP2R1'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
PMC4113768	7/2014	S1535-PMC4113768	['IMPORTANTLY, it is SEEMED that low risk carriers with adequate S-25(Oh)D concentrations achieved EVEN higher S-25(Oh)D concentrations with increasing Vitamin D intake WHEREAS high risk carriers did NOT.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 19), ('PROBABLE_UNDERSTANDING', 19), ('ANOMALY_CURIOUS_FINDING', 97), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 167), ('ANOMALY_CURIOUS_FINDING', 198)]	6	[('CHEBI_82715', 'PH 797804', 63, 's-25(OH)D'), ('CHEBI_82715', 'PH 797804', 109, 's-25(OH)D'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D')]
PMC4113768	7/2014	S1540-PMC4113768	['background: Vitamin D IS KNOWN to AFFECT Immune function; HOWEVER it is UNCERTAIN IF Vitamin D CAN alter the Immune Response towards the persistent herpesviruses, Ebv and Cmv.']	[('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 58), ('FULL_UNKNOWN', 72), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('INCOMPLETE_EVIDENCE', 95)]	6	[('CHEBI_28384', 'vitamin K', 12, 'Vitamin D'), ('UBERON_0002405', 'immune system', 41, 'immune'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0006955', 'immune response', 109, 'immune response'), ('UBERON_0002405', 'immune system', 109, 'immune'), ('NCBITaxon_10088', 'Mus <genus>', 163, 'EBV'), ('NCBITaxon_10088', 'Mus <genus>', 171, 'CMV')]
PMC4113768	7/2014	S1544-PMC4113768	['we INVESTIGATE for the FIRST TIME WHETHER Vitamin D levels MAY alter cmv serology in a cohort of non-white Adults resident in the uk.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('INCOMPLETE_EVIDENCE', 59)]	4	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0007023', 'adult organism', 107, 'adults')]
PMC4113768	7/2014	S1559-PMC4113768	['HOWEVER, when the previously defined covariates (age, ethnicity, cosinor terms) were added to the linear regression model, Vitamin D CEASED to be a significant PREDICTOR of Cmv Antibody titre.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 133), ('SUPERFICIAL_RELATIONSHIP', 160)]	3	[('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 173, 'CMV'), ('GO_0042571', 'immunoglobulin complex, circulating', 177, 'antibody')]
PMC4113768	7/2014	S1571-PMC4113768	['there is also EVIDENCE that Vitamin D plays an IMPORTANT ROLE in OTHER aspects of health, including infection and immunity.']	[('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 47), ('SUPERFICIAL_RELATIONSHIP', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 65)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D')]
PMC4113768	7/2014	S1598-PMC4113768	['it is STILL UNCLEAR WHETHER the altered 25(Oh)D levels SEEN AFFECT the active Vitamin D Metabolite 1,25(Oh)2D and health outcomes (such as bone mineralization).']	[('FULL_UNKNOWN', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 20), ('INCOMPLETE_EVIDENCE', 55), ('SUPERFICIAL_RELATIONSHIP', 60)]	4	[('CHEBI_71657', 'versiconol acetate', 40, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_39382', 'flufenoxuron', 88, 'metabolite'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 101, '25(OH)2D')]
PMC4113768	7/2014	S1614-PMC4113768	['HOWEVER, Vitamin D deficiency (<50 nmol/l) APPEARS to amplify bmd loss in the hip in those not on tdf.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 43)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
PMC4113768	7/2014	S1641-PMC4113768	['background: meta-analysis of clinical trials of Vitamin D supplementation for the PREVENTION of acute Respiratory infection (ari) SHOWS a PROTECTIVE EFFECT in the general population, BUT there is CONTROVERSY regarding the OPTIMAL dosing regimen.']	[('SUPERFICIAL_RELATIONSHIP', 82), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 138), ('SUPERFICIAL_RELATIONSHIP', 149), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 183), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 196), ('IMPORTANT_CONSIDERATION', 222)]	7	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 102, 'respiratory')]
PMC4113768	7/2014	S1642-PMC4113768	['low-dose Vitamin D supplementation is already RECOMMENDED in older Adults for PREVENTION of fractures and falls, but clinical trials investigating WHETHER higher doses COULD provide additional protection against ari are LACKING.']	[('FUTURE_WORK', 46), ('SUPERFICIAL_RELATIONSHIP', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 147), ('INCOMPLETE_EVIDENCE', 168), ('FULL_UNKNOWN', 220)]	5	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0007023', 'adult organism', 67, 'adults')]
PMC4113768	7/2014	S1693-PMC4113768	['BUT MANY STUDIES in india PROVED Vitamin D deficiency in healthy subjects.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 26), ('PROBABLE_UNDERSTANDING', 26)]	4	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC4113768	7/2014	S1702-PMC4113768	['conclusion: subjects that had Vitamin D deficiency not showed any significant clinical sign of any disease so this situation of Vitamin D deficiency COULD BE ignore at early stage that MAY lead to SOME drastic health EFFECTS in later stages that MAY BE OTHER then bone disorders.']	[('INCOMPLETE_EVIDENCE', 149), ('INCOMPLETE_EVIDENCE', 185), ('INCOMPLETE_EVIDENCE', 197), ('SUPERFICIAL_RELATIONSHIP', 217), ('INCOMPLETE_EVIDENCE', 246), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 253)]	6	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC4113768	7/2014	S1793-PMC4113768	['the AIM of the PRESENT STUDY was to follow up the study participants INVESTIGATING WHETHER the EFFECT of Vitamin D is restricted to the Prenatal period OR can also be SEEN in one or two year old infants INDEPENDENTLY from the maternal status during Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('SUPERFICIAL_RELATIONSHIP', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 152), ('INCOMPLETE_EVIDENCE', 167), ('SUPERFICIAL_RELATIONSHIP', 203)]	8	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0007565', 'female pregnancy', 136, 'prenatal'), ('GO_0007565', 'female pregnancy', 249, 'pregnancy')]
PMC4113768	7/2014	S1801-PMC4113768	['HOWEVER, 25(Oh)D3Levels at year one SHOWED an INDEPENDENT TREND: due to the general rickets prophylaxis within the first year (87% of the children were supplemented with Vitamin D at least during the first 3 months), absolute 25(Oh)D3Was generally higher with almost no variations due to seasonal sunlight exposure.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 58)]	5	[('CHEBI_51924', 'ethyl 2-cyanoacetoacetate', 9, '25(OH)D3levels'), ('PR_000006775', 'cytoplasmic dynein 2 heavy chain 1', 15, 'D3levels'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('CHEBI_73386', 'Ala-Val-Asp-Ser', 226, '25(OH)D3was'), ('PR_000012979', 'DNA-directed DNA/RNA polymerase mu', 232, 'D3was')]
PMC4113768	7/2014	S1805-PMC4113768	['conclusions: OUR STUDY DEMONSTRATES that in east germany region (latitude: 51.3667) the Vitamin D status of one year old children is sufficient DUE to a general rickets prophylaxis, WHEREAS levels of two years old infants drop back to levels similar SEEN for Pregnant mothers.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('INCOMPLETE_EVIDENCE', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('IMPORTANT_CONSIDERATION', 144), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182), ('INCOMPLETE_EVIDENCE', 250)]	6	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('GO_0007565', 'female pregnancy', 259, 'pregnant')]
PMC4113768	7/2014	S1806-PMC4113768	['HOWEVER, according TO allergic outcomes our data RATHER POINT to a promoting THAN a protecting EFFECT of Vitamin D.\n\n2.82.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 49), ('INCOMPLETE_EVIDENCE', 56), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('SUPERFICIAL_RELATIONSHIP', 95)]	6	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC4113768	7/2014	S1845-PMC4113768	['IN CONTRAST, there was NO EVIDENCE to SUGGEST a similar ASSOCIATION amongst the children Born while the Vitamin D fortification policy was in place.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 56)]	4	[('GO_0007567', 'parturition', 89, 'born'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D')]
PMC4113768	7/2014	S1850-PMC4113768	['HOWEVER, in RECENT YEARS, it HAS BEEN SHOWN that the ROLE of Vitamin D goes beyond Calcium Homeostasis and Skeletal health.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 53)]	4	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('GO_0050817', 'coagulation', 83, 'calcium'), ('GO_0042592', 'homeostatic process', 91, 'homeostasis'), ('UBERON_0004288', 'skeleton', 107, 'skeletal')]
PMC4113768	7/2014	S1852-PMC4113768	['moreover, it HAS BEEN RECOGNIZED that Vitamin D has a WIDE RANGE of biological functions, including Cell Differentiation, inhibition of cell growth and Regulation Of Gene Expression.']	[('INCOMPLETE_EVIDENCE', 13), ('PROBABLE_UNDERSTANDING', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 54)]	3	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0030154', 'cell differentiation', 100, 'cell differentiation'), ('GO_0010468', 'regulation of gene expression', 152, 'regulation of gene expression'), ('SO_0000704', 'gene', 166, 'gene')]
PMC4113768	7/2014	S1868-PMC4113768	['WHILST Food fortification is a sustainable solution for the PREVENTION of Vitamin D deficiency, the Food industry NEEDS to determine SUITABLE means of carriage IF it is to maximise the effectiveness of fortification.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 60), ('FUTURE_WORK', 114), ('IMPORTANT_CONSIDERATION', 133), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 160)]	5	[('CHEBI_33290', 'food', 7, 'food'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_33290', 'food', 100, 'food')]
PMC4113768	7/2014	S1906-PMC4113768	['results: in both SCENARIOS and subgroups, replacing Cows’ Milk with gum LED TO a significant increase in Vitamin D intakes (+278% to +356%).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 17), ('SUPERFICIAL_RELATIONSHIP', 72)]	2	[('NCBITaxon_33208', 'Metazoa', 52, 'cows'), ('UBERON_0001913', 'milk', 58, 'milk'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC4113768	7/2014	S1983-PMC4113768	['RECENT EVIDENCE SUGGESTS that Vitamin D MAY have a WIDE RANGE of PROTECTIVE EFFECT on Human health.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 51), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 76)]	6	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 86, 'human')]
PMC4113768	7/2014	S2024-PMC4113768	['HOWEVER, a causal RELATIONSHIP between Vitamin D status and cardiovascular disease (cvd) risk factors, such as hypertension or an atherogenic Lipid profile, has NOT BEEN ESTABLISHED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 18), ('FULL_UNKNOWN', 161)]	3	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_18059', 'lipid', 142, 'lipid')]
PMC4113768	7/2014	S2064-PMC4113768	['we OBSERVED a higher prevalence of dyspnea in children with pneumonia and Vitamin D deficiency COMPARED TO subjects with Vitamin D levels ≥20 ng/ml (85.6% vs. 14.3%, p = 0.01).']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95)]	2	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC4113768	7/2014	S2071-PMC4113768	['a WIDE RANGE of non-Skeletal conditions HAVE BEEN ASSOCIATED with Vitamin D deficiency, BUT EVIDENCE for a causal LINK is INCONCLUSIVE and INCONSISTENT.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 2), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 50), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 88), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 114), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139)]	8	[('UBERON_0004288', 'skeleton', 20, 'skeletal'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC4113768	7/2014	S2097-PMC4113768	['background: ACCUMULATING EVIDENCE SUGGESTS that Vitamin D deficiency MAY BE a risk FACTOR for Cardiovascular disease BUT its ASSOCIATION with the risk of stroke is UNCERTAIN.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 83), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 117), ('SUPERFICIAL_RELATIONSHIP', 125), ('FULL_UNKNOWN', 164)]	7	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 94, 'cardiovascular')]
PMC4113768	7/2014	S2159-PMC4113768	['IN CONTRAST, a GROWING NUMBER OF SMALL randomised trials testing the EFFECT of Vitamin D supplementation on Blood pressure have REPORTED MIXED results.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 69), ('INCOMPLETE_EVIDENCE', 128), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137)]	7	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('UBERON_0000178', 'blood', 108, 'blood')]
PMC4113768	7/2014	S2182-PMC4113768	['we TESTED WHETHER high-dose intermittent oral Vitamin D therapy COULD reduce Blood pressure and Left Ventricular mass in patients with hypertension resistant to conventional treatment.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('INCOMPLETE_EVIDENCE', 64)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0000178', 'blood', 77, 'blood'), ('UBERON_0002084', 'heart left ventricle', 96, 'left ventricular')]
PMC4113768	7/2014	S2197-PMC4113768	['we TESTED WHETHER high-dose intermittent oral Vitamin D therapy COULD improve MARKERS of vascular health and fatigue in patients with chronic fatigue syndrome.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 78)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC4113768	7/2014	S2210-PMC4113768	['increased Food allergy with Vitamin D: a randomized, double-blind, placebo-controlled trial\n\nurashima, m.; norizoe, c.; akiyama, n.; segawa, t.; tachimoto, h.; mezawa, h.; ida, h.\nbackground: to elucidate WHETHER maternal Vitamin D supplementation during Lactation improves infantile eczema and other subsequent allergic disorders, a randomized, double-blind, placebo-controlled trial was performed.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 205)]	1	[('CHEBI_33290', 'food', 10, 'Food'), ('CHEBI_28384', 'vitamin K', 28, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 222, 'vitamin D'), ('GO_0007595', 'lactation', 255, 'lactation')]
PMC4113768	7/2014	S2216-PMC4113768	['conclusions: these results SUGGEST that Vitamin D supplementation MAY not decrease the severity of infantile eczema at three months of age, but MAY RATHER increase the risk of later Food allergy up to two years of age.']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 144), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 148)]	4	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_33290', 'food', 182, 'food')]
PMC4113768	7/2014	S2272-PMC4113768	['background: ACCUMULATING EVIDENCE has stipulated a strong CORRELATION between Vitamin D (vitd) deficiency and Cardiovascular disease (cvd) HOWEVER a mechanistic LINK is missing.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 58), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139), ('ANOMALY_CURIOUS_FINDING', 139), ('SUPERFICIAL_RELATIONSHIP', 161)]	5	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 110, 'cardiovascular')]
PMC4113768	7/2014	S2294-PMC4113768	['conclusion: nearly 4 out of 5 Premenopausal saudi women shoppers harbor Vitamin D deficiency and this is INFLUENCED not by sun exposure, BUT by age and Milk consumption.']	[('SUPERFICIAL_RELATIONSHIP', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137)]	2	[('GO_0043277', 'apoptotic cell clearance', 30, 'premenopausal'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0001913', 'milk', 152, 'milk')]
PMC4113768	7/2014	S2295-PMC4113768	['IT IS CLEAR that general female public FACES an IMMINENT THREAT of Vitamin D deficiency-RELATED diseases UNLESS aggressive public AWARENESS is conducted.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 39), ('IMPORTANT_CONSIDERATION', 48), ('IMPORTANT_CONSIDERATION', 57), ('SUPERFICIAL_RELATIONSHIP', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 105), ('IMPORTANT_CONSIDERATION', 130)]	7	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC4113768	7/2014	S2323-PMC4113768	['the Metformin group SHOWED the highest change in circulating Vitamin D levels both at 6 months (62.6%) and 12 months (50.6%) as COMPARED TO baseline ( p< 0.001).']	[('INCOMPLETE_EVIDENCE', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 128)]	2	[('CHEBI_6801', 'metformin', 4, 'metformin'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC4113768	7/2014	S2345-PMC4113768	['; al-othman, a.; yakout, s.; al-saleh, y.; fouda, m.; sabico, s.\nbackground: WHILE moderate to severe Vitamin D deficiency is prevalent in saudi arabia, Skeletal EFFECTS ASSOCIATED with this deficiency are not common in this population.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('SUPERFICIAL_RELATIONSHIP', 162), ('SUPERFICIAL_RELATIONSHIP', 170)]	3	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('UBERON_0004288', 'skeleton', 153, 'skeletal')]
PMC4113768	7/2014	S2366-PMC4113768	['conclusion: seasonal differences in Serum 25(Oh) Vitamin D levels in saudi arabia are COUNTERINTUITIVE, with circulating levels being higher during the winter RATHER than the summer season.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 159)]	2	[('UBERON_0001977', 'blood serum', 36, 'serum'), ('CHEBI_30778', 'gallic acid', 42, '25(OH)'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC4113768	7/2014	S2386-PMC4113768	['ANOTHER implication MIGHT BE that Serum 25-Ohd measurements during summertime SHOULD BE repeated during wintertime, OR that a higher threshold for Vitamin D deficiency ( i.e.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 20), ('FUTURE_WORK', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116)]	4	[('UBERON_0001977', 'blood serum', 34, 'serum'), ('CHEBI_72765', 'verruculogen', 40, '25-OHD'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D')]
PMC4113768	7/2014	S2393-PMC4113768	['background: we performed a systematic review TO EXPLORE WHETHER (1) low maternal circulating 25(Oh)-Vitamin D (25(Oh)D) during Pregnancy is ASSOCIATED with impairment of offspring health; and (2) maternal supplementation with Vitamin D in Pregnancy MIGHT ameliorate these EFFECTS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 56), ('SUPERFICIAL_RELATIONSHIP', 140), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 272)]	5	[('CHEBI_63056', 'zinc cation', 93, '25(OH'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 111, '25(OH)D'), ('GO_0007565', 'female pregnancy', 127, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('GO_0007565', 'female pregnancy', 239, 'pregnancy')]
PMC4113768	7/2014	S2447-PMC4113768	['; macdonald, h.m.\nbackground: it HAS BEEN ASSUMED that most of the population in the uk obtain sufficient Vitamin D from casual exposure to summer sunlight.']	[('INCOMPLETE_EVIDENCE', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('PROBABLE_UNDERSTANDING', 42)]	3	[('CHEBI_27300', 'vitamin D', 106, 'vitamin D')]
PMC4113768	7/2014	S2448-PMC4113768	['HOWEVER it is BECOMING CLEAR that subgroups of the population are AT RISK of Vitamin D deficiency because of INADEQUATE sunlight exposure.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 14), ('IMPORTANT_CONSIDERATION', 66), ('IMPORTANT_CONSIDERATION', 109)]	4	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D')]
PMC4113768	7/2014	S2469-PMC4113768	['Vitamin D and tuberculosis in Adults in selected districts in the provinces baghlan, bamyan and badakhshan, afghanistan\n\nsarin, p.; manaseki-holland, s.; duffy, j.c.\nbackground: EVIDENCE for an ASSOCIATION between Vitamin D and tuberculosis (tb) is INCONSISTENT and NO previous STUDIES HAVE BEEN conducted in afghanistan.']	[('INCOMPLETE_EVIDENCE', 178), ('SUPERFICIAL_RELATIONSHIP', 194), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 249), ('FULL_UNKNOWN', 266), ('INCOMPLETE_EVIDENCE', 278), ('INCOMPLETE_EVIDENCE', 286)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin'), ('UBERON_0007023', 'adult organism', 30, 'Adults'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]
PMC4113768	7/2014	S2523-PMC4113768	['the dose response RELATIONSHIP between Vitamin D supplementation and Plasma 25(Oh)D levels IS THOUGHT TO be biphasic (exponential at low intakes and linear at high), HOWEVER this is NOT WELL DOCUMENTED for supplementation levels that exceed 2000 iu per day for large populations of healthy Individuals.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('INCOMPLETE_EVIDENCE', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 166), ('INCOMPLETE_EVIDENCE', 182)]	4	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 69, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 76, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 76, '25(OH ... D'), ('NCBITaxon_1', 'root', 290, 'individuals')]
PMC4113768	7/2014	S2593-PMC4113768	['THUS, OUR STUDY AIMED TO ASSESS IF Intake of Foods fortified with Vitamin D during Gestation had an EFFECT on the RISK of t1d later in Life.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('SUPERFICIAL_RELATIONSHIP', 100), ('IMPORTANT_CONSIDERATION', 114)]	7	[('GO_0007631', 'feeding behavior', 35, 'intake'), ('CHEBI_33290', 'food', 45, 'foods'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'gestation'), ('UBERON_0000104', 'life cycle', 135, 'life')]
PMC4113768	7/2014	S2663-PMC4113768	['HOWEVER, there is uncertainty as to WHETHER low Vitamin D status is a TRUE cause of these outcomes, OR simply a MARKER of OTHER lifestyle VARIABLES.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 36), ('PROBABLE_UNDERSTANDING', 70), ('SUPERFICIAL_RELATIONSHIP', 112), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('SUPERFICIAL_RELATIONSHIP', 138)]	6	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
PMC4113768	7/2014	S2666-PMC4113768	['THIS STUDY AIMED TO DETERMINE IF long-term high-dose Vitamin D over 18 months lowered bp.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30)]	4	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC4113768	7/2014	S2722-PMC4113768	['conclusions: our results SHOW the WIDE RANGE of Vitamin D supplement regimes used by members of the public that have resulted in them having high to toxic levels of 25Ohd.']	[('INCOMPLETE_EVIDENCE', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34)]	2	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 165, '25OHD')]
PMC4113768	7/2014	S2813-PMC4113768	['as OTHER FACTORS in today’s modern lifestyles (e.g., sunscreen/Cosmetic use, indoor occupations, lack of outdoor activities) further limit such synthesis during the summer months, the general population is becoming increasingly reliant on dietary sources of Vitamin D to maintain adequate Vitamin D status (gillie, o. mol.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 3), ('SUPERFICIAL_RELATIONSHIP', 9)]	2	[('GO_0007620', 'copulation', 63, 'cosmetic'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 289, 'vitamin D')]
PMC4113768	7/2014	S2828-PMC4113768	['REPORTED Vitamin D intakes, HOWEVER, were SIMILAR between the sexes after adjusting for energy intake.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('ANOMALY_CURIOUS_FINDING', 28), ('SUPERFICIAL_RELATIONSHIP', 42)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
PMC4113768	7/2014	S2930-PMC4113768	['conclusions: in CONCLUSION THIS STUDY INDICATES that Vitamin D deficiency promotes the development of dysplasia, increases Proliferation and inflammation, which is LIKELY promote the development of frank squamous Cell carcinoma, WHEREAS sufficiency retards this development.']	[('INCOMPLETE_EVIDENCE', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('INCOMPLETE_EVIDENCE', 38), ('PROBABLE_UNDERSTANDING', 164), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 229)]	5	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('GO_0008283', 'cell proliferation', 123, 'proliferation'), ('CL_0000573', 'retinal cone cell', 213, 'cell')]
PMC4113768	7/2014	S3066-PMC4113768	['RISK FACTORS for Cardiovascular disease HAVE also BEEN ASSOCIATED with low Serum (25(Oh)D. we AIMED TO INVESTIGATE WHETHER high-dose Vitamin D supplementation CAN improve Glucose Metabolism in a population with impaired fasting Glucose and/or impaired Glucose tolerance.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 55), ('QUESTION_ANSWERED_BY_THIS_WORK', 94), ('QUESTION_ANSWERED_BY_THIS_WORK', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115), ('INCOMPLETE_EVIDENCE', 159)]	7	[('UBERON_0004535', 'cardiovascular system', 17, 'cardiovascular'), ('UBERON_0001977', 'blood serum', 75, 'serum'), ('CHEBI_71657', 'versiconol acetate', 82, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('CHEBI_17234', 'glucose', 171, 'glucose'), ('GO_0006006', 'glucose metabolic process', 171, 'glucose metabolism'), ('CHEBI_17234', 'glucose', 228, 'glucose'), ('CHEBI_17234', 'glucose', 252, 'glucose')]
PMC4113768	7/2014	S3130-PMC4113768	['conclusions: THESE FINDINGS CONTRAST WITH OTHER RECENT STUDIES which SHOWED clear ASSOCIATIONS between Ige levels and Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 82)]	6	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 103, 'IgE'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
PMC4113768	7/2014	S3135-PMC4113768	['background: there is CONTROVERSY surrounding the designation of Vitamin D adequacy as defined by circulating levels of the Metabolite 25-Hydroxy Vitamin D [25(Oh)d].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 21)]	1	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_39382', 'flufenoxuron', 123, 'metabolite'), ('CHEBI_43141', '3-hydroxypropoxy group', 134, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 156, '25(OH)')]
PMC4113768	7/2014	S3136-PMC4113768	['DEPENDING ON the cutoff chosen, dietary intakes of Vitamin D MAY OR MAY NOT provide sufficient IMPACT upon Vitamin D status, in improving levels of 25(Oh)d. purpose: we SOUGHT TO EXAMINE WHETHER a supplemental dose of 10 mcg (400 iu) as found in fortified foods OR as a supplement, has a measurable IMPACT on Vitamin D status, as defined by improving status from below to above 50 nmol/l, or from less than 30 nmol/l to above 30 nmol/l.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 61), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 65), ('INCOMPLETE_EVIDENCE', 68), ('SUPERFICIAL_RELATIONSHIP', 95), ('QUESTION_ANSWERED_BY_THIS_WORK', 169), ('QUESTION_ANSWERED_BY_THIS_WORK', 176), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 187), ('SUPERFICIAL_RELATIONSHIP', 299)]	9	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('CHEBI_63056', 'zinc cation', 148, '25(OH'), ('CHEBI_27300', 'vitamin D', 309, 'vitamin D')]
PMC4113768	7/2014	S3147-PMC4113768	['Serum Vitamin D concentrations are ASSOCIATED with markers of Intestinal BUT NOT systemic inflammation in crohn’s disease in remission\n\nraftery, t.; smith, s.; o’morain, c.; mahmud, n.; healy, m.; cox, g.; mcnamara, d.; o’sullivan, m.\nbackground: there are ESTABLISHED ASSOCIATIONS between Vitamin D (vitd) status and crohn’s disease (cd).']	[('SUPERFICIAL_RELATIONSHIP', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 73), ('INCOMPLETE_EVIDENCE', 257), ('SUPERFICIAL_RELATIONSHIP', 269)]	4	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_28384', 'vitamin K', 6, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 6, 'Vitamin D'), ('UBERON_0000160', 'intestine', 62, 'Intestinal'), ('CHEBI_27300', 'vitamin D', 290, 'vitamin D')]
PMC4113768	7/2014	S3194-PMC4113768	['; pearce, s.; rasvi, s.; jagger, c.\nbackground: DESPITE RECENT concerns about the high prevalence of low Vitamin D status in much of the british Adult and pediatric population, there is a dearth of data on Vitamin D status and its PREDICTORS in very old Adults, a sub-group of the population which is at INCREASED RISK of POOR Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 48), ('ANOMALY_CURIOUS_FINDING', 48), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 231), ('IMPORTANT_CONSIDERATION', 304), ('IMPORTANT_CONSIDERATION', 322)]	6	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('UBERON_0007023', 'adult organism', 145, 'adult'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('UBERON_0007023', 'adult organism', 254, 'adults'), ('CHEBI_27300', 'vitamin D', 327, 'vitamin D')]
PMC4113768	7/2014	S3248-PMC4113768	['Prenatal Vitamin D deficiency in a Rat pup MODEL HAS BEEN ASSOCIATED with Ventriculomegaly and Brain overgrowth and abnormal behaviour WHILE a FEW STUDIES have DEMONSTRATED an ASSOCIATION between Prenatal Vitamin D deficiency and lower Birthweight.']	[('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 58), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135), ('INCOMPLETE_EVIDENCE', 143), ('INCOMPLETE_EVIDENCE', 160), ('SUPERFICIAL_RELATIONSHIP', 176)]	7	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 35, 'rat'), ('UBERON_0001137', 'dorsum', 74, 'ventriculomegaly'), ('UBERON_0000955', 'brain', 95, 'brain'), ('GO_0007565', 'female pregnancy', 196, 'prenatal'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D'), ('GO_0007596', 'blood coagulation', 236, 'birthweight')]
PMC4113768	7/2014	S3303-PMC4113768	['HOWEVER, rcts in iran, where the mean Serum 25(Oh)D levels TEND to be low, IN PART DUE TO sun avoidance during the hot summers, have FOUND beneficial EFFECTS of Vitamin D supplementation on cvd RISK FACTORS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 59), ('INCOMPLETE_EVIDENCE', 75), ('PROBLEM_COMPLICATION', 83), ('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 150), ('SUPERFICIAL_RELATIONSHIP', 194)]	7	[('UBERON_0001977', 'blood serum', 38, 'serum'), ('CHEBI_71657', 'versiconol acetate', 44, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 44, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D')]
PMC4113768	7/2014	S3323-PMC4113768	['HOWEVER, cold temperature is also a risk FACTOR for seasonal diseases and outcome, making it DIFFICULT to separate the EFFECTS of solar uvb/Vitamin D from those of temperature.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 41), ('DIFFICULT_TASK', 93), ('SUPERFICIAL_RELATIONSHIP', 119)]	4	[('CHEBI_27300', 'vitamin D', 140, 'vitamin D')]
PMC4113768	7/2014	S3331-PMC4113768	['1965; 58: 295–300) CAN be used to assess WHETHER Vitamin D is casually LINKED to reduced risk of the disease OR adverse health outcome.']	[('INCOMPLETE_EVIDENCE', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 41), ('SUPERFICIAL_RELATIONSHIP', 71)]	3	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC4113768	7/2014	S3332-PMC4113768	['WHILE a FEW Vitamin D randomized controlled trials have SUPPORTED the ecological and observational STUDIES, MANY were NOT DESIGNED and/or conducted properly.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 56), ('INCOMPLETE_EVIDENCE', 99), ('INCOMPLETE_EVIDENCE', 108), ('INCOMPLETE_EVIDENCE', 118)]	6	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D')]
PMC4129499	8/2014	S105-PMC4129499	['THESE FINDINGS encompass EITHER of two main disease-provoking mechanisms: a Cns disorder that is being detected peripherally [e.g., Serotonin and its Metabolites, Sulfate (54), low Platelet levels of Gamma-Aminobutyric Acid (Gaba) (55), low Oxytocin (which AFFECTS social affiliation) (56), and low Vitamin D levels (57,58)] or a systemic abnormality that has repercussions in the Brain (59).']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('SUPERFICIAL_RELATIONSHIP', 257)]	3	[('UBERON_0001017', 'central nervous system', 76, 'CNS'), ('CHEBI_28790', 'serotonin', 132, 'serotonin'), ('CHEBI_25212', 'metabolite', 150, 'metabolites'), ('CHEBI_16189', 'sulfate', 163, 'sulfate'), ('CL_0000233', 'platelet', 181, 'platelet'), ('CHEBI_16865', 'gamma-aminobutyric acid', 200, 'gamma-aminobutyric acid'), ('CHEBI_16865', 'gamma-aminobutyric acid', 225, 'GABA'), ('CHEBI_7872', 'oxytocin', 241, 'oxytocin'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin D'), ('UBERON_0000955', 'brain', 381, 'brain')]
PMC4155147	4/2007	S79-PMC4155147	['the recommended dosage originally on the package was one tablet “every three hours.” HOWEVER, it was RECENTLY changed to add “up to three times per day as NECESSARY,” BECAUSE the 15,000 units of Vitamin A from three tablets is enough to cause POSSIBLE Liver damage, dizziness, and blurred Vision.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 85), ('INCOMPLETE_EVIDENCE', 101), ('IMPORTANT_CONSIDERATION', 155), ('PROBABLE_UNDERSTANDING', 167), ('INCOMPLETE_EVIDENCE', 243)]	5	[('CHEBI_27300', 'vitamin D', 195, 'vitamin A'), ('UBERON_0002107', 'liver', 252, 'liver'), ('GO_0007601', 'visual perception', 289, 'vision')]
PMC4161853	8/2014	S218-PMC4161853	['AS SEVERE malnutrition is one of the risk FACTORS to develop malaria-ibi co-infection, it is IMPORTANT TO evaluate the IMPACT of Vitamin A administration in the clinical management of children with malaria and ibi-co-infection in africa, EITHER as a therapeutic and/OR prophylactic measure, ESPECIALLY due to recent EVIDENCE of the positive IMPACT of Vitamin A and zinc supplementation on malaria morbidity in a study conducted in ghana [121,122].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 3), ('SUPERFICIAL_RELATIONSHIP', 42), ('IMPORTANT_CONSIDERATION', 93), ('QUESTION_ANSWERED_BY_THIS_WORK', 103), ('SUPERFICIAL_RELATIONSHIP', 119), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 238), ('IMPORTANT_CONSIDERATION', 291), ('INCOMPLETE_EVIDENCE', 316), ('SUPERFICIAL_RELATIONSHIP', 341)]	10	[('CHEBI_27300', 'vitamin D', 129, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 351, 'vitamin A')]
PMC4161853	8/2014	S219-PMC4161853	['HOWEVER, in Man, the ROLE of Vitamin A in malaria pathogenesis is multifaceted, and p. falciparum clearly BENEFITS from normal to high Vitamin A Hepatic stores, POSSIBLY depending on scavenged Vitamin A Metabolites to destabilize host Rbc Membranes facilitating invasion [123].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 21), ('IMPORTANT_CONSIDERATION', 106), ('INCOMPLETE_EVIDENCE', 161)]	4	[('NCBITaxon_40674', 'Mammalia', 12, 'man'), ('CHEBI_27300', 'vitamin D', 29, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin A'), ('UBERON_0002107', 'liver', 145, 'hepatic'), ('CHEBI_26871', 'terpene alkaloid', 193, 'vitamin A metabolites'), ('CL_0000232', 'erythrocyte', 235, 'RBC'), ('GO_0016020', 'membrane', 239, 'membranes')]
PMC4169453	9/2014	S2-PMC4169453	['THIS STUDY EVALUATED WHETHER Vitamin D supplementation during Lactation enhances the maternal and infant’s Vitamin D status, bone mass and body composition.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 21)]	3	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0007595', 'lactation', 62, 'lactation'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]
PMC4169453	9/2014	S11-PMC4169453	['conclusions\nVitamin D supplementation at a dose of 400 iu/d was not sufficient to maintain 25(Oh)D >20 ng/ml in nursing women, WHILE 1200 iu/d APPEARED more EFFECTIVE, but had no effect on Breastfed offspring Vitamin D status, or changes in the bone mass and the body composition OBSERVED in both during breastfeeding.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('ANOMALY_CURIOUS_FINDING', 127), ('ANOMALY_CURIOUS_FINDING', 143), ('SUPERFICIAL_RELATIONSHIP', 157), ('INCOMPLETE_EVIDENCE', 280)]	5	[('CHEBI_28384', 'vitamin K', 12, 'Vitamin D'), ('CHEBI_71657', 'versiconol acetate', 91, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 91, '25(OH)D'), ('GO_0007567', 'parturition', 189, 'breastfed'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D')]
PMC4169453	9/2014	S19-PMC4169453	['HOWEVER, the OPTIMAL Vitamin D intake as well as OPTIMAL 25(Oh)D level for Lactating women (BASED ON ESTIMATED maternal NEEDS) STILL REMAINS NOT fully ESTABLISHED, or AT LEAST not accepted worldwide.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 13), ('IMPORTANT_CONSIDERATION', 49), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 101), ('IMPORTANT_CONSIDERATION', 120), ('IMPORTANT_CONSIDERATION', 127), ('FULL_UNKNOWN', 133), ('PROBABLE_UNDERSTANDING', 167)]	10	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 57, '25(OH)D'), ('GO_0007594', 'puparial adhesion', 75, 'lactating')]
PMC4169453	9/2014	S20-PMC4169453	['the RECOMMENDED Vitamin D intake VARIES from 400 iu/d to 2000 iu/d[7],[12]–[16], BUT supplementation using less than 1000 iu/d MAY BE INADEQUATE for maintaining an “optimal” 25(Oh)D level[17].']	[('FUTURE_WORK', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('INCOMPLETE_EVIDENCE', 127), ('IMPORTANT_CONSIDERATION', 134), ('PROBLEM_COMPLICATION', 134)]	6	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 174, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 180, 'D')]
PMC4169453	9/2014	S28-PMC4169453	['we HYPOTHESIZED that maternal Vitamin D supplementation during Lactation at a dose of 1200 iu/d, BUT NOT 400 iu/d, is more beneficial for both breastfeeding mothers and Breastfed infants, when Vitamin D status, bone mass and body composition are controlled for.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 97)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007595', 'lactation', 63, 'lactation'), ('GO_0007567', 'parturition', 169, 'breastfed'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D')]
PMC4169453	9/2014	S68-PMC4169453	['Serum 25(Oh)D <20 ng/ml DEFINED the Vitamin D deficiency state, WHEREAS ≥30 ng/ml REFLECTED Vitamin D sufficiency[7].']	[('PROBABLE_UNDERSTANDING', 24), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 64), ('SUPERFICIAL_RELATIONSHIP', 82)]	3	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 6, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 6, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC4169453	9/2014	S83-PMC4169453	['because Vitamin D concentration in Human Milk VARIES[27], a concentration of 4 iu/100 ml was arbitrarily chosen for further calculation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 46)]	1	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 35, 'human'), ('UBERON_0001913', 'milk', 41, 'milk')]
PMC4169453	9/2014	S89-PMC4169453	['it was BASED ON an ASSUMPTION that each 400 iu/d of Vitamin D MAY increase 25(Ohd) level by 2.8–4.8 ng/ml (mean ∼4 ng/ml) and the standard deviation of 25(Oh)D measurements was 8[28],[29].']	[('PROBABLE_UNDERSTANDING', 7), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('INCOMPLETE_EVIDENCE', 62)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_18009', 'NADP(+)', 75, '25(OHD'), ('CHEBI_71657', 'versiconol acetate', 152, '25(OH)D')]
PMC4169453	9/2014	S126-PMC4169453	['the EFFECT of group (Vitamin D dose) x time INTERACTION ( p \u200a=\u200a0.0004) and the EFFECT of time (p<0.0001) on maternal Serum 25(Oh)D level were statistically significant, BUT the EFFECT of group (Vitamin D dose) was not ( p \u200a=\u200a0.25).']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 169), ('SUPERFICIAL_RELATIONSHIP', 177)]	5	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0001977', 'blood serum', 117, 'serum'), ('CHEBI_71657', 'versiconol acetate', 123, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 123, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D')]
PMC4169453	9/2014	S131-PMC4169453	['ON THE OTHER HAND, the prevalence of Vitamin D sufficiency (≥30 ng/ml) was comparable across the intervention groups (400 iu/d vs. 1200 iu/d) during Vitamin D supplementation, at v3 (22.4% vs. 22.8%; p \u200a=\u200a0.95) and v6 (13.4% vs.24.9%; p \u200a=\u200a0.1) (fig.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC4169453	9/2014	S135-PMC4169453	['the EFFECT of group (Vitamin D dose) x time INTERACTION ( p \u200a=\u200a0.12) and the EFFECT of group ( p \u200a=\u200a0.45) on infants’ Serum 25(Oh)D levels was not statistically significant, WHILE the EFFECT of time was statistically significant ( p<0.0001) (fig.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 174), ('ANOMALY_CURIOUS_FINDING', 174), ('SUPERFICIAL_RELATIONSHIP', 184)]	6	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0001977', 'blood serum', 118, 'serum'), ('CHEBI_71657', 'versiconol acetate', 124, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 124, '25(OH)D')]
PMC4169453	9/2014	S181-PMC4169453	['HOWEVER, a Vitamin D daily dose of 1200 iu APPEARED too low to replenish Vitamin D deficiency/insufficiency states in all breastfeeding mothers from the study group.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 43)]	2	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC4169453	9/2014	S183-PMC4169453	['in CONSEQUENCE, fundamental QUESTIONS of: a) HOW much Vitamin D is enough to reach and maintain OPTIMAL 25(Oh)D level, and b) what is the OPTIMAL range for 25(Oh)D levels, REMAIN an ISSUE of DEBATE[32],[33].']	[('PROBABLE_UNDERSTANDING', 3), ('EXPLICIT_QUESTION', 28), ('EXPLICIT_QUESTION', 45), ('IMPORTANT_CONSIDERATION', 96), ('IMPORTANT_CONSIDERATION', 138), ('INCOMPLETE_EVIDENCE', 172), ('PROBLEM_COMPLICATION', 182), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 191)]	8	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 104, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 106, '(OH ... D'), ('CHEBI_71657', 'versiconol acetate', 156, '25(OH)D')]
PMC4169453	9/2014	S189-PMC4169453	['DESPITE the AFOREMENTIONED CONTROVERSIES, the improvement in Vitamin D status in studied groups was achieved without any evidence of hypervitaminosis D, such as elevated 25(Oh)d, hypercalcemia, or increased hypercalciuria.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 27)]	4	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 150, 'D'), ('CHEBI_30778', 'gallic acid', 170, '25(OH)')]
PMC4169453	9/2014	S194-PMC4169453	['HOWEVER, when the prevalence of Vitamin D deficiency in intervention groups was considered, the clinical EFFECT of the higher dose was much more distinct.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 105)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D')]
PMC4169453	9/2014	S206-PMC4169453	['NEVERTHELESS, we SHOULD KEEP IN MIND that each 400 iu/d of Vitamin D MAY increase Serum 25(Oh)D level by 2.8 ng/ml[17].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 17), ('IMPORTANT_CONSIDERATION', 24), ('INCOMPLETE_EVIDENCE', 69)]	4	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('UBERON_0001977', 'blood serum', 82, 'serum'), ('CHEBI_71657', 'versiconol acetate', 88, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 88, '25(OH)D')]
PMC4169453	9/2014	S210-PMC4169453	['INTERESTINGLY, the fish Intake was not associated with Serum 25(Oh)D level in that study, DESPITE fish being CONSIDERED a rich source of Vitamin D. ON THE OTHER HAND, a mean skin synthesis of Vitamin D was 200–650 iu/d at the summer peak, but it accounted for ONLY 10–25% of total basal Vitamin D input[37].']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 90), ('INCOMPLETE_EVIDENCE', 109), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 148), ('ANOMALY_CURIOUS_FINDING', 260)]	5	[('GO_0007631', 'feeding behavior', 24, 'intake'), ('UBERON_0001977', 'blood serum', 55, 'serum'), ('CHEBI_74268', "N(1)-methylguanosine 5'-monophosphate", 61, '25(OH)d'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 61, '25(OH)d'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin D')]
PMC4169453	9/2014	S212-PMC4169453	['ANOTHER INTERESTING OBSERVATION RELATES to pth as a functional MARKER of Vitamin D status in Adults, children and infants but not necessarily in neonates[44]–[47].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 8), ('ANOMALY_CURIOUS_FINDING', 20), ('SUPERFICIAL_RELATIONSHIP', 32), ('SUPERFICIAL_RELATIONSHIP', 63)]	5	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0007023', 'adult organism', 93, 'adults')]
PMC4169453	9/2014	S217-PMC4169453	['ON THE OTHER HAND, stable and comparable pth concentrations were REPORTED by greer in infants supplemented with Vitamin D or receiving a placebo, DESPITE significantly lower 25(Oh)D levels in the placebo group[45].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 65), ('ANOMALY_CURIOUS_FINDING', 146)]	3	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 177, 'OH)D')]
PMC4169453	9/2014	S221-PMC4169453	['keeping IN MIND the diminutive DIFFERENCES in 25(Oh)D levels among the study groups, we ASSUMED that the Vitamin D status in nursing women had no IMPACT on bone mass and body composition.']	[('IMPORTANT_CONSIDERATION', 8), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('PROBABLE_UNDERSTANDING', 88), ('SUPERFICIAL_RELATIONSHIP', 146)]	4	[('CHEBI_71657', 'versiconol acetate', 46, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 52, 'D'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC4169453	9/2014	S223-PMC4169453	['the INFLUENCE of Vitamin D status and bone mass in nursing women MIGHT BE evaluated FURTHER BUT higher Vitamin D doses are NECESSARY.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 65), ('ANOMALY_CURIOUS_FINDING', 71), ('FUTURE_WORK', 84), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('IMPORTANT_CONSIDERATION', 123)]	6	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC4169453	9/2014	S229-PMC4169453	['Animal data demonstrate that, INSTEAD of Vitamin D, Calcitriol, or the Vitamin D receptor, the increase in Intestinal calcium absorption is LIKELY due to the Pregnancy-RELATED increase in Duodenal Expression of the calcium transporter Gene Trpv6 [53].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('PROBABLE_UNDERSTANDING', 140), ('SUPERFICIAL_RELATIONSHIP', 168)]	3	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 52, 'calcitriol'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('UBERON_0000160', 'intestine', 107, 'intestinal'), ('GO_0007565', 'female pregnancy', 158, 'pregnancy'), ('UBERON_0001245', 'anus', 188, 'duodenal'), ('GO_0010467', 'gene expression', 197, 'expression'), ('SO_0000704', 'gene', 235, 'gene'), ('PR_000016580', 'tropomyosin beta chain', 240, 'Trpv6')]
PMC4169453	9/2014	S230-PMC4169453	['IF the same mechanism exists in Humans, increasing the Vitamin D intake of Lactating women CAN be PRESUMED to have no beneficial effect on bone Mineral content and density.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 91), ('PROBABLE_UNDERSTANDING', 98)]	3	[('NCBITaxon_9606', 'Homo sapiens', 32, 'humans'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 75, 'lactating'), ('CHEBI_46662', 'mineral', 144, 'mineral')]
PMC4169453	9/2014	S238-PMC4169453	['HOWEVER, diet is not an IMPORTANT source of Vitamin D in poland[5].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 24)]	2	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC4171568	9/2014	S136-PMC4171568	['research using Animal MODELS HAS SHOWN that low Prenatal Vitamin D alters Brain Development [103].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('INCOMPLETE_EVIDENCE', 29)]	2	[('NCBITaxon_33208', 'Metazoa', 15, 'animal'), ('GO_0007565', 'female pregnancy', 48, 'prenatal'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007420', 'brain development', 74, 'brain development'), ('UBERON_0000955', 'brain', 74, 'brain')]
PMC4171568	9/2014	S141-PMC4171568	['HOWEVER, THERE IS EVIDENCE that high doses of Vitamin D are NOT NECESSARILY PROTECTIVE; in 424 matched pairs from a population-based cohort, a bi-modal RELATIONSHIP APPEARED in which the participants with the lowest and highest levels of Vitamin D had increased risk of schizophrenia.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 60), ('SUPERFICIAL_RELATIONSHIP', 76), ('SUPERFICIAL_RELATIONSHIP', 152), ('ANOMALY_CURIOUS_FINDING', 165)]	6	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 238, 'vitamin D')]
PMC4188019	1/2010	S69-PMC4188019	['NO CONSENSUS exists on the RECOMMENDED intake and supplementation of 25-Oh Vitamin D during Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 27)]	2	[('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 69, '25-OH'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0007565', 'female pregnancy', 92, 'pregnancy')]
PMC4193194	10/2014	S178-PMC4193194	['as with OTHER oxidative stress Metabolites, levels of antioxidant enzymes and Compounds, such as catalase, Superoxide dismutase (sod) and Vitamin E HAVE BEEN found to be variable in pe studies compared to normal Pregnancies (bilodeau,2014).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 8), ('INCOMPLETE_EVIDENCE', 148)]	2	[('CHEBI_25212', 'metabolite', 31, 'metabolites'), ('CHEBI_36357', 'polyatomic entity', 78, 'compounds'), ('CHEBI_18421', 'superoxide', 107, 'superoxide'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin E'), ('GO_0007565', 'female pregnancy', 212, 'pregnancies')]
PMC4193194	10/2014	S187-PMC4193194	['the study, called combined antioxidants and Preeclampsia prediction studies (capps), had the OBJECTIVE of determining WHETHER Vitamin C and E COULD reduce the frequency of Pregnancy related hypertension.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 93), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 118), ('INCOMPLETE_EVIDENCE', 142)]	3	[('GO_0007128', 'meiotic prophase I', 44, 'Preeclampsia'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 140, 'E'), ('GO_0007565', 'female pregnancy', 172, 'pregnancy')]
PMC4193194	10/2014	S190-PMC4193194	['ALIGNED with this FINDINGS, the cochrane collaboration initiative have CONCLUDED on its latest review on Antioxidants for preventing pe that evidence from trials reviewed does NOT SUPPORT the use of Vitamin C and E during Pregnancy for the PREVENTION of Preeclampsia and other outcomes (rumbold et al.,2008; salles et al.,2012).']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 71), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 176), ('SUPERFICIAL_RELATIONSHIP', 240)]	5	[('CHEBI_60641', 'methyl 5-aminolevulinate hydrochloride', 105, 'antioxidants'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 213, 'E'), ('GO_0007565', 'female pregnancy', 222, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 254, 'preeclampsia')]
PMC4210909	10/2014	S91-PMC4210909	['iron status CAN also be AFFECTED by the intake of OTHER Nutrients that MAY inhibit (e.g., calcium, phytates) OR promote (e.g., Vitamin C) iron absorption [43].']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 24), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 50), ('INCOMPLETE_EVIDENCE', 71), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 109)]	5	[('CHEBI_33284', 'nutrient', 56, 'nutrients'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin C')]
PMC4216020	10/2014	S72-PMC4216020	['a larger prospective study, HOWEVER, DID NOT demonstrate an ASSOCIATED RISK between maternal smoking and jia.92\nOTHER Perinatal exposures and Pregnancy-related FACTORS HAVE BEEN investigated.47,92an australian study that reviewed 262 cases and matched controls IDENTIFIED a TREND towards a PROTECTIVE EFFECT with Prenatal Nutritional Supplements.47the mothers of children that eventually developed jia were less LIKELY to receive supplementation with Prenatal multivitamins (24.9% versus 30.8%), Vitamin D (3.3% versus 7.8%), Fish Oil (2.9% versus 6.4%), Calcium (10.2% versus 14.9%), Iron (35.4% versus 40.3%), and Folate (61.4% versus 64.8%) while Pregnant compared to controls.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 60), ('IMPORTANT_CONSIDERATION', 71), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('SUPERFICIAL_RELATIONSHIP', 160), ('INCOMPLETE_EVIDENCE', 168), ('INCOMPLETE_EVIDENCE', 261), ('INCOMPLETE_EVIDENCE', 274), ('SUPERFICIAL_RELATIONSHIP', 290), ('SUPERFICIAL_RELATIONSHIP', 301), ('PROBABLE_UNDERSTANDING', 412)]	12	[('GO_0036268', 'swimming', 118, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 118, 'perinatal'), ('GO_0007565', 'female pregnancy', 142, 'pregnancy'), ('GO_0007565', 'female pregnancy', 313, 'prenatal'), ('CHEBI_7495', 'nefazodone hydrochloride', 322, 'nutritional'), ('CHEBI_33341', 'titanium atom', 334, 'supplements'), ('GO_0007565', 'female pregnancy', 451, 'prenatal'), ('CHEBI_27300', 'vitamin D', 496, 'vitamin D'), ('CHEBI_34766', 'Furamizole', 526, 'fish oil'), ('CHEBI_22313', 'alkaline earth metal atom', 555, 'calcium'), ('CHEBI_24870', 'ion', 585, 'iron'), ('CHEBI_30863', '5-azaorotic acid', 616, 'folate'), ('GO_0007565', 'female pregnancy', 650, 'pregnant')]
PMC4221707	11/2014	S18-PMC4221707	['in a swedish survey on diet intake conducted in 2010 to 2011, Childbearing-aged women had lower than recommended intake of fruit, berries, vegetables, and whole grain products, BUT a higher than RECOMMENDED intake of fatty foods and Sugar and lower than RECOMMENDED intake of Folate, Vitamin D, and iron [7].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 177), ('FUTURE_WORK', 195), ('FUTURE_WORK', 254)]	3	[('GO_0007129', 'homologous chromosome pairing at meiosis', 62, 'childbearing'), ('CHEBI_24870', 'ion', 233, 'sugar'), ('CHEBI_30863', '5-azaorotic acid', 276, 'folate'), ('CHEBI_27300', 'vitamin D', 284, 'vitamin D')]
PMC4221707	11/2014	S134-PMC4221707	['mean daily Intake (amounts/day) of whole grain, Sucrose, total fat, saturated fat, monounsaturated fat, polyunsaturated fat, Iodine, calcium, Vitamin D, Folate, and Vitamin B12 from Foods did not differ between the Pregnant and referent women REGARDLESS OF standardization by the residual method or not, WHEREAS iron Intake from Foods TENDED to be lower in the Pregnant women (table\xa02).']	[('INCOMPLETE_EVIDENCE', 243), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 304), ('SUPERFICIAL_RELATIONSHIP', 335)]	3	[('GO_0007631', 'feeding behavior', 11, 'intake'), ('CHEBI_17992', 'sucrose', 48, 'sucrose'), ('CHEBI_24859', 'iodine atom', 125, 'iodine'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 153, 'folate'), ('CHEBI_33279', 'vitamin D5', 165, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 165, 'vitamin B12'), ('CHEBI_33290', 'food', 182, 'foods'), ('GO_0007565', 'female pregnancy', 215, 'pregnant'), ('GO_0007631', 'feeding behavior', 317, 'intake'), ('CHEBI_33290', 'food', 329, 'foods'), ('GO_0007565', 'female pregnancy', 361, 'pregnant')]
PMC4221707	11/2014	S137-PMC4221707	['addition from Supplements LED TO significantly higher estimated intake of Vitamin D and Folate and borderline significantly higher intake of Calcium and Vitamin B12 in the Pregnant than referent women, WHEREAS ESTIMATED Intake of iron supplement EVENED out the difference in Intakes from Foods only (table\xa02).']	[('SUPERFICIAL_RELATIONSHIP', 26), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 202), ('INCOMPLETE_EVIDENCE', 210), ('ANOMALY_CURIOUS_FINDING', 246)]	4	[('CHEBI_33341', 'titanium atom', 14, 'supplements'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 88, 'folate'), ('CHEBI_22313', 'alkaline earth metal atom', 141, 'calcium'), ('CHEBI_33279', 'vitamin D5', 153, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 153, 'vitamin B12'), ('GO_0007565', 'female pregnancy', 172, 'pregnant'), ('GO_0007631', 'feeding behavior', 220, 'intake'), ('GO_0007631', 'feeding behavior', 275, 'intakes'), ('CHEBI_33290', 'food', 288, 'foods')]
PMC4231606	10/2013	S16-PMC4231606	['conclusion\nchildren with s-ecc APPEAR to have relatively POOR nutritional health COMPARED TO caries-free controls, and were significantly more LIKELY to have low Vitamin D, calcium, and albumin concentrations and elevated pth levels.']	[('ANOMALY_CURIOUS_FINDING', 31), ('IMPORTANT_CONSIDERATION', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('PROBABLE_UNDERSTANDING', 143)]	4	[('CHEBI_27300', 'vitamin D', 162, 'vitamin D')]
PMC4231606	10/2013	S80-PMC4231606	['the EXCEPTION were regular Milk drinkers (≥ 5 servings weekly), who had significantly higher mean Vitamin D levels THAN non-regular milk drinkers (76.6\u2009±\u200930.3\xa0nmol/l vs. 63.2\u2009±\u200927.0, p\u2009=\u20090.042).']	[('ANOMALY_CURIOUS_FINDING', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115)]	2	[('UBERON_0001913', 'milk', 27, 'milk'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC4231606	10/2013	S112-PMC4231606	['discussion\nthe PURPOSE of THIS STUDY was TO DETERMINE WHETHER children with s-ecc have different nutritional profiles THAN their caries-free peers, specifically Vitamin D, calcium and albumin status.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 41), ('EXPLICIT_QUESTION', 54), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 118)]	5	[('CHEBI_27300', 'vitamin D', 161, 'vitamin D')]
PMC4231606	10/2013	S113-PMC4231606	['WHILE HISTORICAL EVIDENCE SUGGESTS that Vitamin D supplementation CAN PREVENT caries onset and progression, much of this RESEARCH has been OVERLOOKED [18,29,30].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 121), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139)]	8	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC4251419	12/2014	S1-PMC4251419	['the active form of Vitamin D has an IMPORTANT ROLE in Calcium Metabolism and in bone mineralisation, BUT the EVIDENCE for OTHER health outcomes is MIXED, with the strongest EFFECTS SEEN in the weakest epidemiological study designs.']	[('IMPORTANT_CONSIDERATION', 36), ('SUPERFICIAL_RELATIONSHIP', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 101), ('INCOMPLETE_EVIDENCE', 109), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 147), ('SUPERFICIAL_RELATIONSHIP', 173), ('INCOMPLETE_EVIDENCE', 181)]	8	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0018884', 'carbazole metabolic process', 54, 'calcium metabolism')]
PMC4251419	12/2014	S6-PMC4251419	['over the last 10-15 years, INCREASED RISK of a WIDE RANGE of health outcomes HAS BEEN LINKED to Vitamin D deficiency, ALTHOUGH in many cases the LINKS REMAIN rather weak.']	[('IMPORTANT_CONSIDERATION', 27), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 86), ('ANOMALY_CURIOUS_FINDING', 118), ('SUPERFICIAL_RELATIONSHIP', 145), ('INCOMPLETE_EVIDENCE', 151)]	7	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D')]
PMC4251419	12/2014	S23-PMC4251419	['HOWEVER, for AT LEAST some of the Immune-RELATED diseases, it is DIFFICULT to determine WHETHER low sun exposure OR Vitamin D cause, OR are caused by, the disease.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 13), ('SUPERFICIAL_RELATIONSHIP', 41), ('DIFFICULT_TASK', 65), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 88)]	5	[('UBERON_0002405', 'immune system', 34, 'immune'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC4251419	12/2014	S27-PMC4251419	['DESPITE these relatively COHERENT FINDINGS from ecologic and OBSERVATIONAL studies, and PLAUSIBLE biological mechanisms, trials of Vitamin D supplementation for the PREVENTION of Immune-related diseases have LARGELY returned null results [17].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 165), ('INCOMPLETE_EVIDENCE', 208)]	8	[('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('UBERON_0002405', 'immune system', 179, 'immune')]
PMC4251419	12/2014	S30-PMC4251419	['NEVERTHELESS, there is not yet COMPELLING EVIDENCE from these studies that Vitamin D supplementation ameliorates any Immune-related disease.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 31)]	2	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('UBERON_0002405', 'immune system', 117, 'immune')]
PMC4251419	12/2014	S33-PMC4251419	['the amount of 1,25(Oh)2D produced MAY depend on the ability of Immune Cells to Express Cyp27B1 and OTHER enzymatic machinery of the Vitamin D pathway, including the Cyp24A1 deactivation enzyme.']	[('INCOMPLETE_EVIDENCE', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99)]	2	[('CHEBI_37958', 'dye', 14, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 16, '25(OH)2D'), ('CL_0000738', 'leukocyte', 63, 'immune cells'), ('UBERON_0002405', 'immune system', 63, 'immune'), ('GO_0010467', 'gene expression', 79, 'express'), ('PR_000006101', 'cytochrome P450 1A1', 87, 'CYP27B1'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('PR_000006101', 'cytochrome P450 1A1', 165, 'CYP24A1')]
PMC4251419	12/2014	S65-PMC4251419	['HOWEVER, the level of Vitamin D binding protein, and its affinity to 25(Oh)D, CAN also restrict the availability of 25(Oh)d to Dendritic Cells and POSSIBLY other cells [35].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 78), ('INCOMPLETE_EVIDENCE', 147)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 69, '25(OH)D'), ('CHEBI_30778', 'gallic acid', 116, '25(OH)'), ('CL_0000451', 'dendritic cell', 127, 'dendritic cells')]
PMC4251419	12/2014	S71-PMC4251419	['YET, DESPITE PLAUSIBLE immunological pathways whereby Vitamin D (through stimulation of tregsand dampening of T Helper Type 1 over-reactivity) COULD diminish the risk of multiple sclerosis or disease activity, Vitamin D supplementation trials HAVE SHOWN immunological [42] and radiological [43], BUT NOT CLINICAL, benefit for People with multiple sclerosis.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('ANOMALY_CURIOUS_FINDING', 5), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 143), ('INCOMPLETE_EVIDENCE', 243), ('FULL_UNKNOWN', 296), ('ANOMALY_CURIOUS_FINDING', 300)]	9	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CL_0002061', 'T-helper 9 cell', 110, 'T helper'), ('PR_000016293', 'protein-glutamine gamma-glutamyltransferase 2', 110, 'T helper type 1'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 326, 'people')]
PMC4251419	12/2014	S72-PMC4251419	['it is CHALLENGING to DIFFERENTIATE between Vitamin D-DEPENDENT and INDEPENDENT pathways in the EFFECT of sun exposure on disease risk.']	[('DIFFICULT_TASK', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 21), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 67), ('SUPERFICIAL_RELATIONSHIP', 95)]	5	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D')]
PMC4251419	12/2014	S79-PMC4251419	['additionally, WHILE increased sun exposure during childhood was inversely ASSOCIATED with risk of multiple sclerosis, there was no decreased risk associated with intake of Vitamin D supplements during childhood [40].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('ANOMALY_CURIOUS_FINDING', 14), ('SUPERFICIAL_RELATIONSHIP', 74)]	3	[('CHEBI_27300', 'vitamin D', 172, 'vitamin D')]
PMC4251419	12/2014	S86-PMC4251419	['ALTHOUGH childhood Vitamin D levels and sun exposure APPEAR TO BE IMPORTANT DETERMINANTS of the risk of disease onset, higher 25(Oh)D levels early in the disease course MAY PREDICT the rate of disease progression in multiple sclerosis [53].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 53), ('IMPORTANT_CONSIDERATION', 66), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 169), ('SUPERFICIAL_RELATIONSHIP', 173)]	7	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 126, '25(OH)D')]
PMC4251419	12/2014	S101-PMC4251419	['ALTERNATIVELY, microbiome changes, like those induced following the use of Probiotics, MAY Regulate the responsiveness of Immune Cells to Vitamin D by enhancing the Expression of the Vitamin D receptor (vdr) THUS reducing Tissue inflammation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 87), ('PROBABLE_UNDERSTANDING', 208)]	3	[('CHEBI_26346', 'prostaglandins J', 75, 'probiotics'), ('GO_0065007', 'biological regulation', 91, 'regulate'), ('CL_0000738', 'leukocyte', 122, 'immune cells'), ('UBERON_0002405', 'immune system', 122, 'immune'), ('GO_0007567', 'parturition', 129, 'cells'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('GO_0010467', 'gene expression', 165, 'expression'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D'), ('UBERON_0000479', 'tissue', 222, 'tissue')]
PMC4251419	12/2014	S130-PMC4251419	['in addition, with respect to an ability of supplemental Vitamin D to alter the course of Autoimmune diseases, there is DEBATE about the VALIDITY of biochemical OR cellular markers from Blood AS TRULY representative of disease status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 119), ('IMPORTANT_CONSIDERATION', 136), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 160), ('PROBABLE_UNDERSTANDING', 191), ('PROBABLE_UNDERSTANDING', 194)]	5	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 89, 'autoimmune'), ('UBERON_0000178', 'blood', 185, 'blood')]
PMC4251419	12/2014	S137-PMC4251419	['HOWEVER, SEVERAL STUDIES SUGGEST that low Vitamin D status or low levels of ambient uvr during the in utero period [49], or during childhood [40], are ASSOCIATED with increased risk of Immune-related disorders.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 151)]	4	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0002405', 'immune system', 185, 'immune')]
PMC4251419	12/2014	S145-PMC4251419	['TRADITIONALLY the level of total 25(Oh)D HAS BEEN CONSIDERED the best ESTIMATE of Vitamin D status, BUT RECENT STUDIES have SUGGESTED that the “bioavailable” (albumin-bound and free) 25(Oh)D concentration MAY BE more RELEVANT to health and disease [83].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 41), ('INCOMPLETE_EVIDENCE', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 100), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 124), ('INCOMPLETE_EVIDENCE', 205), ('SUPERFICIAL_RELATIONSHIP', 217)]	8	[('CHEBI_71657', 'versiconol acetate', 33, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 39, 'D'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 183, '25(OH)D')]
PMC4251419	12/2014	S149-PMC4251419	['most RECENT Vitamin D supplementation TRIALS use Vitamin D3, SUGGESTING that any DIFFERENCES between d2and d3do NOT ACCOUNT for the DIFFERENT findings from OBSERVATIONAL and Vitamin D supplementation trials.']	[('INCOMPLETE_EVIDENCE', 5), ('FUTURE_WORK', 38), ('INCOMPLETE_EVIDENCE', 61), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('ANOMALY_CURIOUS_FINDING', 112), ('IMPORTANT_CONSIDERATION', 116), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('INCOMPLETE_EVIDENCE', 156)]	8	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 49, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 49, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D')]
PMC4251419	12/2014	S155-PMC4251419	['SIMILARLY, in ONE rct of high-dose Vitamin D supplementation there was an INCREASED RISK of falls and fractures [93].']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('IMPORTANT_CONSIDERATION', 74)]	3	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
PMC4251419	12/2014	S156-PMC4251419	['it is LIKELY that there is a loss of study power and a risk of harm IF participants in Vitamin D supplementation trials already have adequate 25(Oh)d levels at baseline [91].']	[('PROBABLE_UNDERSTANDING', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68)]	2	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 142, '25(OH)')]
PMC4251419	12/2014	S159-PMC4251419	['this DISCREPANCY in timing MAY CONTRIBUTE to the failure of Vitamin D supplementation trials to decrease the RISK of disease onset.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 31), ('IMPORTANT_CONSIDERATION', 109)]	4	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC4251419	12/2014	S161-PMC4251419	['EFFECTS MAY not be direct, but COULD work through alterations in the microbiome, OR be ONLY PARTLY Vitamin D-MEDIATED, with exposure to uvr itself also IMPORTANT.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 109), ('IMPORTANT_CONSIDERATION', 152)]	8	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
PMC4256222	12/2014	S0-PMC4256222	['maternal Vitamin D status and offspring bone fractures: prospective study over two decades in aarhus city, denmark\n\nabstract\n\nbackground\nstudies investigating the ASSOCIATION between maternal Vitamin D status and offspring bone mass measured by dual-energy x-ray absorptiometry (dxa) during childhood HAVE SHOWN CONFLICTING results.']	[('SUPERFICIAL_RELATIONSHIP', 163), ('INCOMPLETE_EVIDENCE', 301), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 312)]	3	[('CHEBI_28384', 'vitamin K', 9, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D')]
PMC4256222	12/2014	S18-PMC4256222	['DIFFERENT LINES of EVIDENCE also SUGGEST that maternal Vitamin D status MAY IMPACT offspring bone health in the short as well as the long term, BUT the studies have shown CONFLICTING results[5]–[9].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 72), ('SUPERFICIAL_RELATIONSHIP', 76), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 144), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 171)]	8	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC4256222	12/2014	S25-PMC4256222	['in a prospective cohort with follow up over two decades, we therefore EXAMINED WHETHER the risk of bone fractures during the first 18 years of Life was ASSOCIATED with the maternal status of Vitamin D in Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 79), ('SUPERFICIAL_RELATIONSHIP', 152)]	3	[('UBERON_0000104', 'life cycle', 143, 'life'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('GO_0007565', 'female pregnancy', 204, 'pregnancy')]
PMC4256222	12/2014	S97-PMC4256222	['HOWEVER, in sensitivity analyses we FOUND a borderline significant inverse ASSOCIATION (p\u200a=\u200a0.054) between Vitamin D status in Pregnancy and offspring Forearm fractures.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 75)]	3	[('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('GO_0007565', 'female pregnancy', 127, 'pregnancy'), ('UBERON_0002386', 'forelimb zeugopod', 151, 'forearm')]
PMC4256222	12/2014	S99-PMC4256222	['adjustment for Vitamin D status did not attenuate this ASSOCIATION as would be expected if the ASSOCIATION were DUE TO seasonal variation in Vitamin D status, RATHER it was strengthened upon adjustment.']	[('SUPERFICIAL_RELATIONSHIP', 55), ('SUPERFICIAL_RELATIONSHIP', 95), ('PROBLEM_COMPLICATION', 112), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 159)]	4	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC4256222	12/2014	S103-PMC4256222	['HOWEVER, IF our results are reliable, there MIGHT be OTHER aspects UNDERLYING a seasonal variation during Pregnancy on bone fracture risk later in Life INDEPENDENTLY of Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('INCOMPLETE_EVIDENCE', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 53), ('SUPERFICIAL_RELATIONSHIP', 67), ('SUPERFICIAL_RELATIONSHIP', 152)]	6	[('GO_0007565', 'female pregnancy', 106, 'pregnancy'), ('UBERON_0000104', 'life cycle', 147, 'life'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC4256222	12/2014	S106-PMC4256222	['the PRESENT STUDY is TO OUR KNOWLEDGE the FIRST to INVESTIGATE WHETHER maternal Vitamin D status PREDICTS offspring bone fractures.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('PROBABLE_UNDERSTANDING', 21), ('INCOMPLETE_EVIDENCE', 42), ('QUESTION_ANSWERED_BY_THIS_WORK', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63), ('EXPLICIT_QUESTION', 63), ('SUPERFICIAL_RELATIONSHIP', 97)]	7	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
PMC4256222	12/2014	S110-PMC4256222	['[6]were UNABLE TO detect any RELEVANT ASSOCIATION between maternal Vitamin D status and bmc and bmd shortly after Birth, ALTHOUGH they did indeed find a positive CORRELATION between maternal Vitamin D status and fetal Femur volume measured by three-dimensional ultrasound.']	[('DIFFICULT_TASK', 8), ('IMPORTANT_CONSIDERATION', 29), ('SUPERFICIAL_RELATIONSHIP', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('ANOMALY_CURIOUS_FINDING', 121), ('SUPERFICIAL_RELATIONSHIP', 162)]	6	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007567', 'parturition', 114, 'birth'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('UBERON_0000981', 'femur', 218, 'femur')]
PMC4256222	12/2014	S121-PMC4256222	['IF a TRUE UNDERLYING beneficial EFFECT of maternal Vitamin D status on offspring bone health exists and is LIMITED to very low levels, we MAY not be able to detect such a RELATIONSHIP in our data, where ONLY 6.3% of the study population had a Vitamin D status below 25 nmol/l and 25.5% had a status below 50 nmol/l.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 5), ('SUPERFICIAL_RELATIONSHIP', 10), ('SUPERFICIAL_RELATIONSHIP', 32), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 138), ('SUPERFICIAL_RELATIONSHIP', 171), ('ANOMALY_CURIOUS_FINDING', 203), ('INCOMPLETE_EVIDENCE', 203)]	9	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D')]
PMC4256222	12/2014	S124-PMC4256222	['CONSISTENT with temporal TRENDS, there were also fewer Vitamin D deficient mothers in our study sample COMPARED TO two later danish studies, which measured Vitamin D in pregnant women[32]and in a general population sample[33]approximately 10 years later.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103)]	4	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D')]
PMC4256222	12/2014	S137-PMC4256222	['furthermore, OBSERVATIONS HAVE SHOWN that infant Vitamin D deficiency CAN be eliminated as early as 9 months Postpartum, IF Vitamin D drops with 10 µg of Vitamin D per day are given as RECOMMENDED[34].']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('FUTURE_WORK', 185)]	5	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007565', 'female pregnancy', 109, 'postpartum'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC4256222	12/2014	S140-PMC4256222	['in this context, a POTENTIAL negative IMPACT of maternal Vitamin D deficiency MAY have been BLURRED in our data, SINCE data are lacking on POTENTIALLY IMPORTANT CONFOUNDERS.']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('PROBABLE_UNDERSTANDING', 113), ('PROBLEM_COMPLICATION', 113), ('INCOMPLETE_EVIDENCE', 139), ('IMPORTANT_CONSIDERATION', 151), ('PROBLEM_COMPLICATION', 161)]	9	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC4256222	12/2014	S141-PMC4256222	['ON THE OTHER HAND, in the RECENT alspac STUDY[8]it WAS SHOWN that offspring level of physical activity and dietary Vitamin D intake were not associated with maternal Vitamin D status[10].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 51)]	4	[('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D')]
PMC4256222	12/2014	S142-PMC4256222	['IF this also is the case in the dafo88 cohort, physical activity level and childhood Vitamin D intake COULD did NOT act as CONFOUNDERS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 102), ('ANOMALY_CURIOUS_FINDING', 112), ('PROBLEM_COMPLICATION', 123)]	4	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC4256222	12/2014	S145-PMC4256222	['FURTHER STUDIES on this subject ARE NEEDED, BUT such STUDIES MUST BE conducted in study populations large enough to allow for INVESTIGATION of seasonal variation, subdivision of fractures and further stratification of study participants by Vitamin D status.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('FUTURE_WORK', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 44), ('FUTURE_WORK', 53), ('IMPORTANT_CONSIDERATION', 61), ('ANOMALY_CURIOUS_FINDING', 66), ('FUTURE_WORK', 126)]	8	[('CHEBI_27300', 'vitamin D', 240, 'vitamin D')]
PMC4258799	11/2014	S310-PMC4258799	['HOWEVER, subsequent observational studies in men with POOR Sperm dna integrity showed that supplementation with both Vitamins E and C resulted in fewer Spermatozoa with fragmented dna [107,108], as well as higher Implantation and clinical Pregnancy rates [108].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 54)]	2	[('CL_0000019', 'sperm', 59, 'sperm'), ('CHEBI_27300', 'vitamin D', 117, 'vitamins E'), ('CHEBI_18245', 'carboxylato group', 132, 'C'), ('CL_0000019', 'sperm', 152, 'spermatozoa'), ('GO_0007566', 'embryo implantation', 213, 'implantation'), ('GO_0007565', 'female pregnancy', 239, 'pregnancy')]
PMC4258799	11/2014	S315-PMC4258799	['HOWEVER, smaller prospective studies SHOWED that oral Vitamin C supplementation in women, EITHER undergoing ivf-et treatment [123] or with Luteal phase defects [124], LEAD TO increased Pregnancy rates.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90), ('SUPERFICIAL_RELATIONSHIP', 167)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin C'), ('GO_0007565', 'female pregnancy', 139, 'luteal'), ('GO_0007565', 'female pregnancy', 185, 'pregnancy')]
PMC4263713	12/2014	S2-PMC4263713	['the PRESENT STUDY AIMS TO TEST WHETHER Vitamin A supplementation CAN restore Lymphocyte pools in Vitamin A-deficient Rats and thereby improve the function of their Intestinal Mucosa; furthermore, the study AIMED TO IDENTIFY the BEST time frame for Vitamin A supplementation.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('INCOMPLETE_EVIDENCE', 65), ('QUESTION_ANSWERED_BY_THIS_WORK', 206), ('QUESTION_ANSWERED_BY_THIS_WORK', 212), ('IMPORTANT_CONSIDERATION', 228)]	8	[('CHEBI_27300', 'vitamin D', 39, 'vitamin A'), ('CL_0000542', 'lymphocyte', 77, 'lymphocyte'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin A'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 117, 'rats'), ('UBERON_0001242', 'intestinal mucosa', 164, 'intestinal mucosa'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin A')]
PMC4275593	9/2014	S187-PMC4275593	['the mrc trial launched just as the long-running public CONTROVERSY over CLAIMS that large doses of Vitamin C could cure cancer was about to reach its climax (richards, 1991).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 55), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 72)]	2	[('CHEBI_27300', 'vitamin D', 99, 'vitamin C')]
PMC4277121	12/2015	S255-PMC4277121	['CONVERSELY, when treatments with Minocycline and Vitamin E were started at earlier ages – 7 months and 4 months, respectively – and maintained for several months, both PREVENTED neurodegeneration at 10 months.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 168)]	2	[('CHEBI_50694', 'minocycline', 33, 'minocycline'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin E')]
PMC4289064	1/2015	S88-PMC4289064	['we also TESTED the INFLUENCE of uncertainty in the CONTRIBUTION of pollinators to crop yields on our results for Vitamin A Intake in children and FOUND that WHILE the specific values for the proportion of the population at risk of Nutrient deficiency changed slightly if we used the minimum, midpoint, or maximum percent yield due to pollinators of the categories defined by klein et al.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('SUPERFICIAL_RELATIONSHIP', 19), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 146), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 157)]	5	[('CHEBI_27300', 'vitamin D', 113, 'vitamin A'), ('GO_0007631', 'feeding behavior', 123, 'intake'), ('CHEBI_33284', 'nutrient', 231, 'nutrient')]
PMC4289064	1/2015	S133-PMC4289064	['“other” refers to oils, flavorings, drinks, candy, honey, and other items that do not fit into other Food groups.10.1371/journal.pone.0114805.t001\n\ncaption (table-wrap): table 1\naverage proportion of total Nutrient Intake by percent yield due to pollinators and country for children 1 to 3 years old.% yield due to pollinatorsenergyvitamin acalciumfolateironzinc bangladesh 00.740.380.550.480.620.6850.050.190.080.140.080.07250.080.100.130.170.110.10650.040.090.090.120.070.04950.080.250.160.100.120.12total1.001.001.001.001.001.00 mozambique 00.570.290.540.300.370.4950.140.130.190.290.200.16250.130.020.160.240.250.19650.140.270.080.150.120.13950.020.300.040.020.050.03total1.001.001.001.001.001.00 uganda 00.680.490.530.400.520.5550.140.090.140.300.130.16250.100.090.240.140.210.17650.040.020.010.080.020.05950.040.320.070.080.120.07total1.001.001.001.001.001.00 zambia 00.480.380.410.300.510.5150.170.110.170.350.210.24250.060.020.140.100.080.10650.120.210.130.180.070.03950.070.270.110.050.110.101000.090.000.040.020.030.02total1.001.001.001.001.001.00\nBASED ON these results, we HYPOTHESIZED that pollinators would be most IMPORTANT for nutritional health ASSOCIATED with Vitamin A, BUT less IMPORTANT for nutritional health ASSOCIATED with all other Nutrients.']	[('PROBABLE_UNDERSTANDING', 1058), ('INCOMPLETE_EVIDENCE', 1085), ('IMPORTANT_CONSIDERATION', 1129), ('SUPERFICIAL_RELATIONSHIP', 1162), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1189), ('IMPORTANT_CONSIDERATION', 1198), ('SUPERFICIAL_RELATIONSHIP', 1231)]	7	[('CHEBI_33290', 'food', 101, 'food'), ('CHEBI_33284', 'nutrient', 206, 'nutrient'), ('GO_0007631', 'feeding behavior', 215, 'intake'), ('CHEBI_27300', 'vitamin D', 1178, 'vitamin A'), ('CHEBI_33284', 'nutrient', 1257, 'nutrients')]
PMC4289064	1/2015	S141-PMC4289064	['these results SUPPORTED our HYPOTHESIS that the risk of Vitamin A deficiency is more sensitive to pollinator removal than that of OTHER Nutrients.10.1371/journal.pone.0114805.g005\n\ncaption (fig): figure 5\ncumulative distributions of Vitamin A Intakes for the full Pollination scenario (blue) and Pollinator removal scenario (pink) for children 1 to 3 years old.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 130)]	3	[('CHEBI_27300', 'vitamin D', 56, 'vitamin A'), ('CHEBI_33284', 'nutrient', 136, 'nutrients'), ('CHEBI_27300', 'vitamin D', 233, 'vitamin A'), ('GO_0007631', 'feeding behavior', 243, 'intakes'), ('GO_0009856', 'pollination', 264, 'pollination'), ('GO_0051008', 'Hsp27 protein binding', 296, 'pollinator')]
PMC4289064	1/2015	S154-PMC4289064	['WHILE the risk of Nutrient deficiency did not change substantially for most Nutrients when pollinators were removed, the increased risk we ESTIMATED for Vitamin A carries concerning PUBLIC HEALTH IMPLICATIONS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 139), ('IMPORTANT_CONSIDERATION', 182), ('IMPORTANT_CONSIDERATION', 196)]	5	[('CHEBI_33284', 'nutrient', 18, 'nutrient'), ('CHEBI_33284', 'nutrient', 76, 'nutrients'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin A')]
PMC4289064	1/2015	S160-PMC4289064	['in zambia, ON THE OTHER HAND, children received much of their Vitamin A from pollinator-dependent fruits and vegetables, but had daily Vitamin A intakes well above the ear.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11)]	1	[('CHEBI_27300', 'vitamin D', 62, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin A')]
PMC4289064	1/2015	S165-PMC4289064	['the wide DIFFERENCES we find among populations for Vitamin A (table 2) SUGGEST that global data on crop and Nutrient Production (e.g.,[10]) are INSUFFICIENT for predicting the EFFECTS of pollinator declines on Human health.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('INCOMPLETE_EVIDENCE', 71), ('PROBLEM_COMPLICATION', 144), ('SUPERFICIAL_RELATIONSHIP', 176)]	4	[('CHEBI_27300', 'vitamin D', 51, 'vitamin A'), ('CHEBI_33284', 'nutrient', 108, 'nutrient'), ('GO_0007128', 'meiotic prophase I', 117, 'production'), ('NCBITaxon_9606', 'Homo sapiens', 210, 'human')]
PMC4292819	1/2015	S277-PMC4292819	['HOWEVER, as fish and shellfish are IMPORTANT CONTRIBUTORS of Fatty Acids, Vitamin D, proteins, and minerals, it is ADVISABLE that women of child-Bearing age receive proper GUIDANCE to choose the right types of fish from nonpolluted waters.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 35), ('SUPERFICIAL_RELATIONSHIP', 45), ('FUTURE_WORK', 115), ('IMPORTANT_CONSIDERATION', 115), ('FUTURE_WORK', 172)]	6	[('CHEBI_35366', 'fatty acid', 61, 'fatty acids'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007567', 'parturition', 145, 'bearing')]
PMC4302429	1/2015	S163-PMC4302429	['a central feature of many of these NON-CLASSICAL actions of Vitamin D is RELATED to the synthesis of active 1,25(Oh)2D in a cell-specific manner: enzyme 25Ohd-1α-hydroxylase (encoded by the Gene Cyp27B1 ) is Expressed by many Extrarenal Tissues, including the Immune System [14,34].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('SUPERFICIAL_RELATIONSHIP', 73)]	2	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_82784', 'PVP38-Ag NP', 108, '1,25(OH)2D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 153, '25OHD'), ('SO_0000704', 'gene', 190, 'gene'), ('PR_000006101', 'cytochrome P450 1A1', 195, 'CYP27B1'), ('GO_0010467', 'gene expression', 208, 'expressed'), ('UBERON_0005292', 'extraembryonic tissue', 226, 'extrarenal tissues'), ('UBERON_0002405', 'immune system', 260, 'immune system')]
PMC4302429	1/2015	S175-PMC4302429	['we THEREFORE ASKED WHETHER Vitamin D MIGHT Modulate the course of and survival from infection after bacterial meningoencephalitis and WHETHER Vitamin D COULD POTENTIALLY be used therapeutically to alleviate Cns pathology.']	[('PROBABLE_UNDERSTANDING', 3), ('EXPLICIT_QUESTION', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('INCOMPLETE_EVIDENCE', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 134), ('EXPLICIT_QUESTION', 134), ('INCOMPLETE_EVIDENCE', 152), ('INCOMPLETE_EVIDENCE', 158)]	9	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0065007', 'biological regulation', 43, 'modulate'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 207, 'CNS')]
PMC4302429	1/2015	S185-PMC4302429	['one REASON for the mild Antimicrobial properties of Vitamin D3 in the present in-vivo MODEL MIGHT be that, UNLIKE the Human Cathelicidin Gene, the Mouse Gene does not contain a Vitamin D response element, and is not induced directly by 1,25(Oh)2D [16].']	[('PROBABLE_UNDERSTANDING', 4), ('INCOMPLETE_EVIDENCE', 86), ('INCOMPLETE_EVIDENCE', 92), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 107)]	4	[('CHEBI_65381', 'albizoside C', 24, 'antimicrobial'), ('CHEBI_33279', 'vitamin D5', 52, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 52, 'vitamin D3'), ('NCBITaxon_9606', 'Homo sapiens', 118, 'human'), ('PR_000006009', 'alpha-catulin', 124, 'cathelicidin'), ('SO_0000704', 'gene', 137, 'gene'), ('NCBITaxon_10088', 'Mus <genus>', 147, 'mouse'), ('SO_0000704', 'gene', 153, 'gene'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D'), ('CHEBI_37958', 'dye', 236, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 238, '25(OH)2D')]
PMC4302429	1/2015	S186-PMC4302429	['PRESUMABLY, in addition to Cathelicidin, OTHER Immune Mediators are INVOLVED in the Vitamin D-dependent Immune pathways.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 41), ('SUPERFICIAL_RELATIONSHIP', 68)]	4	[('CHEBI_3364', 'Canthiumine', 27, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 27, 'cathelicidin'), ('UBERON_0002405', 'immune system', 47, 'immune'), ('CHEBI_35222', 'inhibitor', 54, 'mediators'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('UBERON_0002405', 'immune system', 104, 'immune')]
PMC4302429	1/2015	S191-PMC4302429	['constant Vitamin D supplementation (100\xa0ng 1,25(Oh)2D injection every other day during the whole study period), HOWEVER, did not reduce the Entry Of Eosinophils Into the Respiratory Epithelia [45]; this is IN ACCORDANCE WITH our observation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('INCOMPLETE_EVIDENCE', 206)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_82784', 'PVP38-Ag NP', 43, '1,25(OH)2D'), ('GO_0051639', 'actin filament network formation', 140, 'entry of eosinophils into ...'), ('CL_0000771', 'eosinophil', 149, 'eosinophils'), ('GO_0006314', 'intron homing', 170, 'respiratory epithelia'), ('UBERON_0004802', 'respiratory tract epithelium', 170, 'respiratory epithelia')]
PMC4302429	1/2015	S193-PMC4302429	['OTHER mechanisms COULD BE the Regulation of Anti- and proinflammatory Compounds by Vitamin D. for this PURPOSE, we INVESTIGATED the pattern of cytokine and Chemokine Production, a central feature in the development of Neuroinflammation, neurodegeneration, and demyelination in the Cns [46,47].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 30), ('QUESTION_ANSWERED_BY_THIS_WORK', 103), ('QUESTION_ANSWERED_BY_THIS_WORK', 115)]	5	[('GO_0065007', 'biological regulation', 30, 'regulation'), ('CHEBI_67437', 'Euparin', 44, 'anti-'), ('CHEBI_36357', 'polyatomic entity', 70, 'compounds'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0032602', 'chemokine production', 156, 'chemokine production'), ('GO_0007009', 'plasma membrane organization', 218, 'neuroinflammation'), ('UBERON_0001017', 'central nervous system', 281, 'CNS')]
PMC4302429	1/2015	S211-PMC4302429	['WHETHER high-dose Vitamin D has a PROTECTIVE EFFECT in combination with Antibiotics remains TO BE studied.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 34), ('SUPERFICIAL_RELATIONSHIP', 45), ('FUTURE_WORK', 92)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_33282', 'antibacterial agent', 72, 'antibiotics')]
PMC4303849	1/2015	S133-PMC4303849	['25Ohd values lesser than 50 nmol/l MAY sustain long-term adverse health consequences and are classified as “deficiency.” the 75 nmol/l cut-off is the point above which there is no upper stimulation of pth [102] and was thereafter designated as “sufficient.” HOWEVER, heaney POINTED out that 25Ohd concentrations < 80 nmol/l are ASSOCIATED with reduced calcium absorption and osteoporosis risk [103]; therefore, values lesser than 75 nmol/l are considered AS “insufficient.” the conversion factor between 25Ohd nmol/l and ng/ml is 2.5 (table 2).nutrients-07-00443-t001_table 1\n\ncaption (table-wrap): table 1\n\ntargets Modulated by Calcitriol in the Human Placenta (+ = stimulation; − = inhibition).targetbiological networkregulationbioeffectcell typereferenceplacental Lactogencell Life and death+growth controltrophoblast[97]Tnf-Αimmune function−restraining inflammationtrophoblast[91,92]−immunosupressiondecidual cells[89]Il-6Immune function−restraining inflammationtrophoblast[91,92]−immunosupressiondecidual cells[89]Csf2 (Colony Stimulating Factor 2)immune function−immunosupressiondecidual Cells[89]hctdimmune function+restraining infectiontrophoblast[90]Decidual Cells[89]Cyp24A1Bone and Mineral Metabolism+Calcitriol Catabolismtrophoblast[12]Decidual Cells[104]Cyp27B1Bone and Mineral Metabolism−Calcitriol synthesistrophoblast[12]Il-10 (Interleukin 10)immune function−reducing risk of infectiontrophoblast[105]Kcnh1 (potassium voltage-Gated channel)Cell Life and Death−unknowntrophoblast[106]Calbindin-D 28 kdabone and Mineral Metabolism+Calcium transfertrophoblast[61,62]Calbindin-D 9 kdabone and Mineral Metabolism+Calcium transfertrophoblast[61]hcg (Human Chorionic Gonadotrophin)Cell Life and Death+, −maintenance of Pregnancytrophoblast[96]3β-hsd (3Β-Hydroxysteroid dehydrogenase) *Cell Life and Death+Progesterone Synthesistrophoblast[95]Cyp19 (aromatase) *Cell Life and Death+Estradiol Synthesistrophoblast[95]Prolactincell Life and Death+Establishment Of Pregnancydecidual Cells[107]Vdrbone and Mineral Metabolism+allowing Calcitriol actionstrophoblast[62]Platelet-Activating factor acetylhydrolasecell life and Death−inactivation of Platelet-Activating factordecidual Macrophages[108]Hoxa10 (Homeobox A10)Cell Life and Death+Embryo Implantationdecidual cells[109]Osteopontinbone and Mineral Metabolism+Embryo Implantationdecidual Cells[104]Hbd2Immune function+restraining infectiontrophoblast[93]Hbd3Immune function+restraining infectiontrophoblast[93]\n* only observed at the enzyme activity level.nutrients-07-00443-t002_table 2\n\ncaption (table-wrap): table 2\n\ncut-offs in Vitamin D status according to the Endocrine society [110].Vitamin D status25ohd (nmol/l)25Ohd (ng/ml)severe deficiency<25<10deficiency<50<20insufficiency<75<30sufficiency75–11030–44toxicity>250>100\ntable 2shows the criteria for vd status as PROPOSED by the Endocrine society.']	[('INCOMPLETE_EVIDENCE', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 258), ('INCOMPLETE_EVIDENCE', 274), ('SUPERFICIAL_RELATIONSHIP', 328), ('PROBABLE_UNDERSTANDING', 455), ('INCOMPLETE_EVIDENCE', 2831)]	6	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 0, '25OHD'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 291, '25OHD'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 504, '25OHD'), ('GO_0065007', 'biological regulation', 616, 'modulated'), ('CHEBI_17823', 'calcitriol', 629, 'calcitriol'), ('NCBITaxon_9606', 'Homo sapiens', 647, 'human'), ('UBERON_0001987', 'placenta', 653, 'placenta'), ('CHEBI_35417', 'alpha-amino-acid residue radical', 767, 'lactogenCell'), ('PR_000009797', 'LIM/homeobox protein Lhx9', 767, 'lactogenCell'), ('UBERON_0000104', 'life cycle', 780, 'life'), ('PR_000000045', 'S-phase kinase-associated protein 1A', 824, 'TNF-αImmune'), ('PR_000008988', 'interleukin-1 family member 5', 922, 'IL-6Immune'), ('PR_000005890', 'crooked neck-like protein 1', 1019, 'CSF2'), ('PR_000005528', 'chloride channel protein, skeletal muscle', 1025, 'colony stimulating factor 2'), ('CL_0000573', 'retinal cone cell', 1094, 'cells'), ('CL_0000635', "Deiter's cell", 1159, 'Decidual cells'), ('PR_000006081', 'NADH-cytochrome b5 reductase 2', 1177, 'CYP24A1Bone'), ('CHEBI_46662', 'mineral', 1193, 'mineral'), ('GO_0008152', 'metabolic process', 1201, 'metabolism'), ('CHEBI_17823', 'calcitriol', 1212, 'Calcitriol'), ('GO_0019065', 'receptor-mediated endocytosis of virus by host cell', 1212, 'Calcitriol catabolismTrophoblast'), ('CL_0000635', "Deiter's cell", 1248, 'Decidual cells'), ('PR_000006081', 'NADH-cytochrome b5 reductase 2', 1267, 'CYP27B1Bone'), ('CHEBI_46662', 'mineral', 1283, 'mineral'), ('GO_0008152', 'metabolic process', 1291, 'metabolism'), ('CHEBI_17823', 'calcitriol', 1302, 'Calcitriol'), ('PR_000001470', 'interleukin-28B', 1337, 'IL-10'), ('PR_000001470', 'interleukin-28B', 1344, 'Interleukin 10'), ('PR_000000793', 'voltage-gated potassium channel KCNH4', 1417, 'KCNH1'), ('PR_000004587', 'beta-1,3-galactosyltransferase 6', 1441, '-gated'), ('GO_0008219', 'cell death', 1456, 'Cell life ... death'), ('PR_000004968', 'calretinin', 1499, 'Calbindin-D 28'), ('CHEBI_46662', 'mineral', 1526, 'mineral'), ('GO_0008152', 'metabolic process', 1534, 'metabolism'), ('CHEBI_31341', 'calcium dihydroxide', 1545, 'Calcium'), ('PR_000004998', 'calmodulin-regulated spectrin-associated protein 1', 1579, 'Calbindin-D'), ('CHEBI_46662', 'mineral', 1605, 'mineral'), ('GO_0008152', 'metabolic process', 1613, 'metabolism'), ('CHEBI_31341', 'calcium dihydroxide', 1624, 'Calcium'), ('NCBITaxon_9606', 'Homo sapiens', 1660, 'human'), ('PR_000005170', 'CD37 molecule', 1666, 'chorionic gonadotrophin'), ('UBERON_0003124', 'chorion', 1666, 'chorionic'), ('GO_0008219', 'cell death', 1690, 'Cell life ... death'), ('GO_0006412', 'translation', 1728, 'pregnancyTrophoblast'), ('CHEBI_36864', '25-hydroxy steroid', 1760, '3β-hydroxysteroid'), ('GO_0008219', 'cell death', 1794, 'Cell life ... death'), ('UBERON_0000104', 'life cycle', 1799, 'life'), ('CHEBI_17026', 'progesterone', 1814, 'Progesterone'), ('GO_0072598', 'protein localization to chloroplast', 1814, 'Progesterone synthesisTrophoblast'), ('PR_000006100', 'aromatase', 1851, 'CYP19'), ('GO_0008219', 'cell death', 1870, 'Cell life ... death'), ('UBERON_0000104', 'life cycle', 1875, 'life'), ('CHEBI_4856', 'esmolol', 1890, 'Estradiol'), ('GO_0072596', 'establishment of protein localization to chloroplast', 1890, 'Estradiol synthesisTrophoblast'), ('PR_000013039', 'POU domain, class 3, transcription factor 2', 1924, 'ProlactinCell'), ('GO_0006266', 'DNA ligation', 1938, 'life ... death'), ('GO_0006884', 'cell volume homeostasis', 1953, 'Establishment of pregnancyDecidual cells'), ('CL_0000573', 'retinal cone cell', 1988, 'cells'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 1998, 'VDRBone'), ('CHEBI_46662', 'mineral', 2010, 'mineral'), ('GO_0008152', 'metabolic process', 2018, 'metabolism'), ('CHEBI_17823', 'calcitriol', 2038, 'calcitriol'), ('CL_0000233', 'platelet', 2071, 'Platelet'), ('GO_0030168', 'platelet activation', 2071, 'Platelet-activating'), ('GO_0007608', 'sensory perception of smell', 2127, '... death'), ('CL_0000233', 'platelet', 2149, 'platelet'), ('GO_0030168', 'platelet activation', 2149, 'platelet-activating'), ('CL_0000235', 'macrophage', 2184, 'macrophages'), ('PR_000008689', 'homeobox protein Hox-A13', 2200, 'HOXA10'), ('PR_000008469', 'holocytochrome c-type synthase', 2208, 'Homeobox A10'), ('GO_0008219', 'cell death', 2221, 'Cell life ... death'), ('UBERON_0000104', 'life cycle', 2226, 'life'), ('GO_0007601', 'visual perception', 2241, 'Embryo'), ('UBERON_0000922', 'embryo', 2241, 'Embryo'), ('GO_0007446', 'imaginal disc growth', 2248, 'implantationDecidual'), ('PR_000021995', 'dual specificity mitogen-activated protein kinase kinase 4 phosphorylated form', 2279, 'OsteopontinBone'), ('CHEBI_46662', 'mineral', 2299, 'mineral'), ('GO_0008152', 'metabolic process', 2307, 'metabolism'), ('UBERON_0000922', 'embryo', 2318, 'Embryo'), ('GO_0007446', 'imaginal disc growth', 2325, 'implantationDecidual'), ('CL_0000573', 'retinal cone cell', 2346, 'cells'), ('PR_000000035', 'BMP receptor type-1A', 2356, 'HBD2Immune'), ('PR_000000035', 'BMP receptor type-1A', 2412, 'HBD3Immune'), ('CHEBI_27300', 'vitamin D', 2590, 'vitamin D'), ('UBERON_0005063', 'left ventricular compact myocardium', 2624, 'Endocrine'), ('CHEBI_28384', 'vitamin K', 2648, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 2648, 'Vitamin'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 2678, '25OHD'), ('UBERON_0005063', 'left ventricular compact myocardium', 2847, 'Endocrine')]
PMC4329404	10/2014	S14-PMC4329404	['an ASSOCIATION between Vitamin D Receptor (Vdr) Gene polymorphisms and asthma susceptibility is REPORTED (3,4); HOWEVER, the RELATIONSHIP between Serum Vitamin D levels and asthma REMAINS CONTROVERSIAL (5).']	[('SUPERFICIAL_RELATIONSHIP', 3), ('INCOMPLETE_EVIDENCE', 96), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('SUPERFICIAL_RELATIONSHIP', 125), ('INCOMPLETE_EVIDENCE', 180), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 188)]	6	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 23, 'vitamin D receptor'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 43, 'VDR'), ('SO_0000704', 'gene', 48, 'gene'), ('UBERON_0001977', 'blood serum', 146, 'serum'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D')]
PMC4329404	10/2014	S17-PMC4329404	['CONVERSELY, increased asthma was REPORTED in Adulthood after a period of Vitamin D supplementation during the first year of Life (10).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 33)]	2	[('UBERON_0000113', 'post-juvenile adult stage', 45, 'adulthood'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0000104', 'life cycle', 124, 'life')]
PMC4329404	10/2014	S18-PMC4329404	['a RECENT unselected cohort of over 2000 children OBSERVED no association between Serum Vitamin D and asthma or Lung function; HOWEVER, higher Serum Vitamin D was ASSOCIATED with a greater RISK of wheeze (11).']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 49), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 126), ('ANOMALY_CURIOUS_FINDING', 126), ('SUPERFICIAL_RELATIONSHIP', 162), ('IMPORTANT_CONSIDERATION', 188)]	6	[('UBERON_0001977', 'blood serum', 81, 'serum'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('UBERON_0002048', 'lung', 111, 'lung'), ('UBERON_0001977', 'blood serum', 142, 'serum'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
PMC4329404	10/2014	S21-PMC4329404	["maternal Vitamin D status during Pregnancy MAY also determine risk of asthma Development RATHER than the child's own Vitamin D levels."]	[('INCOMPLETE_EVIDENCE', 43), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 89)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('GO_0008289', 'lipid binding', 77, 'development'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC4329404	10/2014	S23-PMC4329404	['Cord Blood Vitamin D levels inversely CORRELATED with wheeze (17), WHILE a u-shaped RELATIONSHIP with total and Antigen-specific Ige HAS BEEN OBSERVED in a population of children in arizona (18).']	[('SUPERFICIAL_RELATIONSHIP', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 67), ('SUPERFICIAL_RELATIONSHIP', 84), ('INCOMPLETE_EVIDENCE', 133), ('INCOMPLETE_EVIDENCE', 142)]	5	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_59132', 'antigen', 112, 'antigen'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 129, 'IgE')]
PMC4329404	10/2014	S24-PMC4329404	['CONVERSELY, maternal Vitamin D status HAS BEEN REPORTED to have no associations with asthma or wheeze (19,20).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 38)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D')]
PMC4329404	10/2014	S31-PMC4329404	['TO DETERMINE WHETHER Vitamin D deficiency exacerbates allergic Airways disease (aad), and the mechanisms underlying this, we used a neonatal MODEL of inhaled house dust Mite (hdm) exposure (28).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('INCOMPLETE_EVIDENCE', 141)]	3	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0001005', 'respiratory airway', 63, 'airways'), ('CHEBI_46662', 'mineral', 169, 'mite'), ('NCBITaxon_10088', 'Mus <genus>', 169, 'mite')]
PMC4329404	10/2014	S90-PMC4329404	['CONVERSELY, Pulmonary cd3+Cd4+Il-10+T Regulatory Cells were significantly reduced in pups exposed to in utero and early-Life Vitamin D insufficiency (fig.3d).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('UBERON_0002048', 'lung', 12, 'pulmonary'), ('PR_000001204', 'C-C chemokine receptor type 8', 26, 'CD4'), ('PR_000001470', 'interleukin-28B', 30, 'IL-10'), ('CL_0000902', 'induced T-regulatory cell', 36, 'T regulatory cells'), ('GO_0007585', 'respiratory gaseous exchange by respiratory system', 36, 'T regulatory'), ('UBERON_0000104', 'life cycle', 120, 'life'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC4329404	10/2014	S121-PMC4329404	['HOWEVER, pups that were weaned onto a Vitamin D-replete diet at 3\xa0weeks of age after in utero and early-Life insufficiency had reduced levels of Lung collagen following 6\xa0weeks of Allergen exposure (fig.5b).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0000104', 'life cycle', 104, 'life'), ('UBERON_0002048', 'lung', 145, 'lung'), ('CHEBI_50904', 'allergen', 180, 'allergen')]
PMC4329404	10/2014	S141-PMC4329404	['a PREVIOUS STUDY has investigated the EFFECT of in utero and early-Life Vitamin D deficiency on aad, BUT Allergen challenge was commenced in Adult Mice, rather than during the Neonatal Period (32).']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 101)]	3	[('UBERON_0000104', 'life cycle', 67, 'life'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_50904', 'allergen', 105, 'allergen'), ('UBERON_0007023', 'adult organism', 141, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 147, 'mice'), ('UBERON_0007221', 'neonate stage', 176, 'neonatal period')]
PMC4329404	10/2014	S147-PMC4329404	['this highlights the IMPORTANCE of age and Vitamin D status on Lung function in Adults COMPARED TO in utero and early-Life deficiency.']	[('IMPORTANT_CONSIDERATION', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0002048', 'lung', 62, 'lung'), ('UBERON_0007023', 'adult organism', 79, 'adults'), ('UBERON_0000104', 'life cycle', 117, 'life')]
PMC4329404	10/2014	S148-PMC4329404	['it is CONSISTENT with FINDINGS from epidemiological studies which have FAILED TO SHOW reliable EFFECTS of Vitamin D deficiency or insufficiency on Lung function in children with asthma (6–8,11) ALTHOUGH ASSOCIATIONS are REPORTED in Adults (33).']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 22), ('DIFFICULT_TASK', 71), ('QUESTION_ANSWERED_BY_THIS_WORK', 78), ('INCOMPLETE_EVIDENCE', 81), ('SUPERFICIAL_RELATIONSHIP', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 194), ('ANOMALY_CURIOUS_FINDING', 194), ('SUPERFICIAL_RELATIONSHIP', 203), ('INCOMPLETE_EVIDENCE', 220)]	10	[('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('UBERON_0002048', 'lung', 147, 'lung'), ('UBERON_0007023', 'adult organism', 232, 'adults')]
PMC4329404	10/2014	S162-PMC4329404	['a mechanism for this FINDING was NOT REPORTED, but IN AGREEMENT with OUR FINDINGS, Vitamin D supplementation in that MODEL also ONLY SHOWED an improvement in allergic inflammation, BUT NOT a complete resolution down to levels in nonallergic Mice, and THUS, the authors conclude Vitamin D supplementation is LIKELY an IMPORTANT adjunct in the treatment of asthma, RATHER than a candidate that will achieve a cure.']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 51), ('QUESTION_ANSWERED_BY_THIS_WORK', 69), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 133), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('PROBABLE_UNDERSTANDING', 251), ('PROBABLE_UNDERSTANDING', 307), ('IMPORTANT_CONSIDERATION', 317), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 363)]	12	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 241, 'mice'), ('CHEBI_27300', 'vitamin D', 278, 'vitamin D')]
PMC4329404	10/2014	S173-PMC4329404	['a pilot STUDY of high-dose Vitamin D supplementation in Adults ( n \xa0=\xa04) HAS SHOWN an increase in circulating Il-10-producing Peripheral Blood Mononuclear Cells (Pbmcs) (37); HOWEVER, these were otherwise healthy subjects and only Circulating Cells were assessed.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 73), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 175)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('UBERON_0007023', 'adult organism', 56, 'adults'), ('PR_000001470', 'interleukin-28B', 110, 'IL-10'), ('UBERON_0012101', 'perinatal stage', 126, 'peripheral blood'), ('CL_0000226', 'single nucleate cell', 143, 'mononuclear cells'), ('GO_0031097', 'medial cortex', 143, 'mononuclear'), ('CL_0002246', 'peripheral blood stem cell', 162, 'PBMCs'), ('CL_0000080', 'circulating cell', 231, 'circulating cells')]
PMC4329404	10/2014	S183-PMC4329404	['HOWEVER, ahr is unaffected by Vitamin D deficiency in neonatal aad.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D')]
PMC4329745	10/2014	S84-PMC4329745	['the mean Vitamin D level among 321 Premenopausal saudi women was reduced at 27.5 nmol/l in ONE STUDY (14), WHILE a study in the lebanese population DEMONSTRATED that 60% of 465 women aged 20-59 years had Vitamin D levels below 25 nmol/l (15).']	[('INCOMPLETE_EVIDENCE', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 107), ('INCOMPLETE_EVIDENCE', 148)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0043277', 'apoptotic cell clearance', 35, 'premenopausal'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin D')]
PMC4329745	10/2014	S87-PMC4329745	['OUR finding of higher Vitamin D levels in younger ages is IN CONTRAST WITH SOME EXISTING FACTS in the LITERATURE (17).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 58), ('INCOMPLETE_EVIDENCE', 75), ('INCOMPLETE_EVIDENCE', 80)]	4	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D')]
PMC4329745	10/2014	S88-PMC4329745	['ALTHOUGH in OUR STUDY the ASSOCIATION between age and Vitamin D deficiency is not substantially.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('SUPERFICIAL_RELATIONSHIP', 26)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
PMC4329745	10/2014	S92-PMC4329745	['at first glance, it SEEMS that the MAJOR cause for these very low levels of Vitamin D in iranian women is the highly covered type of dressing in iran, BUT this would not rationalize the low vitamin status in iranian men (8,9).']	[('ANOMALY_CURIOUS_FINDING', 20), ('IMPORTANT_CONSIDERATION', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 151)]	3	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC4329745	10/2014	S94-PMC4329745	['OTHER POSSIBLE causes of reduced Vitamin D Synthesis in the skin in our area COULD BE dark skin color, indoor lifestyle and air pollution (2); lack of dietary fortification with Vitamin D multivitamin supplements MIGHT as well AGGRAVATE the situation in iranian women (18).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 213), ('SUPERFICIAL_RELATIONSHIP', 227)]	5	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 33, 'vitamin D synthesis'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
PMC4329745	10/2014	S96-PMC4329745	['ON THE OTHER HAND, Blood samples were taken REGARDLESS OF season or weather conditions WHEREAS this COULD INFLUENCE the Serum Vitamin D levels.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 87), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 106)]	5	[('UBERON_0000178', 'blood', 19, 'blood'), ('UBERON_0001977', 'blood serum', 120, 'serum'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
PMC4340999	3/2015	S93-PMC4340999	['INCONSISTENT findings and MIXED explanations of underlying mechanism HAVE BEEN REPORTED, including SPECULATION that early temperature exposure is ASSOCIATED with physiological Regulation Of Birth Weight or that extremely low ambient temperature INFLUENCES the Conceived Embryo or the selection of the Sperm that fuses with the Ovum.19–21HOWEVER, the findings from the current study APPEARED to more strongly SUGGEST the POSSIBLE etiological ROLE of Prenatal maternal exposure to ultraviolet b radiation (uvb) and Vitamin D status in Adult chronic diseases.29–31\nsun exposure provides one of the MAJOR ways to meet Vitamin D REQUIREMENTS during Pregnancy, ESPECIALLY for those of older generations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 26), ('INCOMPLETE_EVIDENCE', 69), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 146), ('SUPERFICIAL_RELATIONSHIP', 176), ('SUPERFICIAL_RELATIONSHIP', 245), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 334), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 335), ('ANOMALY_CURIOUS_FINDING', 382), ('INCOMPLETE_EVIDENCE', 408), ('INCOMPLETE_EVIDENCE', 420), ('SUPERFICIAL_RELATIONSHIP', 441), ('IMPORTANT_CONSIDERATION', 595), ('IMPORTANT_CONSIDERATION', 624), ('IMPORTANT_CONSIDERATION', 655)]	16	[('GO_0009937', 'regulation of gibberellic acid mediated signaling pathway', 176, 'regulation of birth weight'), ('GO_0070268', 'cornification', 260, 'conceived'), ('UBERON_0000922', 'embryo', 270, 'embryo'), ('CL_0000019', 'sperm', 301, 'sperm'), ('UBERON_0000978', 'leg', 327, 'ovum'), ('GO_0007565', 'female pregnancy', 449, 'prenatal'), ('CHEBI_27300', 'vitamin D', 513, 'vitamin D'), ('UBERON_0007023', 'adult organism', 533, 'adult'), ('CHEBI_27300', 'vitamin D', 614, 'vitamin D'), ('GO_0007565', 'female pregnancy', 644, 'pregnancy')]
PMC4340999	3/2015	S98-PMC4340999	['up to now, a FEW STUDIES have EXAMINED the ASSOCIATION between lower maternal Vitamin D levels in later Pregnancy and offspring adiposity at age 6 years34; at birth, age 9 months and age 9 years35; at ages 5 and 9.5 years36; and at age 35 years,37and shown INCONSISTENT results.']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 30), ('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('SUPERFICIAL_RELATIONSHIP', 43), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 257)]	5	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('GO_0007565', 'female pregnancy', 104, 'pregnancy')]
PMC4340999	3/2015	S107-PMC4340999	['besides significant seasonal variation in sunshine, peak and trough windows are also SUPPOSED to last long enough to INFLUENCE Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 85), ('SUPERFICIAL_RELATIONSHIP', 117)]	2	[('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
PMC4340999	3/2015	S109-PMC4340999	['results in the PRESENT STUDY IMPLY that Prenatal Vitamin D status MIGHT be a POTENTIAL pathway LINKING ll with Adult risks of obesity39,40and a range of chronic diseases.8–10HOWEVER, seasonal variation in ll DEPENDING ON region SUGGESTS that ll CAN ONLY be used as anthropometric BIOMARKER of Prenatal Vitamin D status in SOME geographic regions.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('PROBABLE_UNDERSTANDING', 29), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 172), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 208), ('INCOMPLETE_EVIDENCE', 228), ('INCOMPLETE_EVIDENCE', 245), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 280), ('INCOMPLETE_EVIDENCE', 322)]	12	[('GO_0007565', 'female pregnancy', 40, 'prenatal'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0007023', 'adult organism', 111, 'adult'), ('GO_0007565', 'female pregnancy', 293, 'prenatal'), ('CHEBI_27300', 'vitamin D', 302, 'vitamin D')]
PMC4340999	3/2015	S125-PMC4340999	['this is also the FIRST-ever population-BASED EVIDENCE LINKING low Prenatal sun-RELATED uvb exposure (and lower Vitamin D by PROXY) to ll and the susceptibility to obesity later in Life and also SUGGESTING that late second and early third trimesters MIGHT be a CRITICAL period for the above-mentioned EFFECTS ALTHOUGH such EVIDENCE is non-specific, it WARRANTS FURTHER STUDIES in this AREA.']	[('INCOMPLETE_EVIDENCE', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 39), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 54), ('SUPERFICIAL_RELATIONSHIP', 79), ('SUPERFICIAL_RELATIONSHIP', 124), ('INCOMPLETE_EVIDENCE', 194), ('INCOMPLETE_EVIDENCE', 249), ('IMPORTANT_CONSIDERATION', 260), ('SUPERFICIAL_RELATIONSHIP', 300), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 308), ('INCOMPLETE_EVIDENCE', 322), ('FUTURE_WORK', 351), ('FUTURE_WORK', 360), ('FUTURE_WORK', 384)]	15	[('GO_0007565', 'female pregnancy', 66, 'prenatal'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('UBERON_0000104', 'life cycle', 180, 'life')]
PMC4377870	3/2015	S75-PMC4377870	['maternal intake of Vitamin E, Vitamin D, milk, cheese and calcium during Pregnancy are negatively ASSOCIATED, WHILE Vitamin C is positively ASSOCIATED, with wheezing in early childhood [57,58].']	[('SUPERFICIAL_RELATIONSHIP', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 110), ('ANOMALY_CURIOUS_FINDING', 110), ('SUPERFICIAL_RELATIONSHIP', 140)]	4	[('CHEBI_27300', 'vitamin D', 19, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin C')]
PMC4377870	3/2015	S85-PMC4377870	['OBSERVATIONAL studies in children SHOWED Consumption of fruit, a rich source of Vitamin C, was RELATED to reduced wheezing [62] and Vitamin C intake was negatively ASSOCIATED with wheezing [63], WHILE ANOTHER STUDY reported no relationship between Vitamin C intake and Lung function [64].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 95), ('SUPERFICIAL_RELATIONSHIP', 164), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 195), ('INCOMPLETE_EVIDENCE', 201)]	6	[('GO_0007631', 'feeding behavior', 41, 'consumption'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin C'), ('UBERON_0002048', 'lung', 269, 'lung')]
PMC4377870	3/2015	S87-PMC4377870	['[22] also reported CONFLICTING EVIDENCE for EFFECTS of Vitamin C intake in Adults, with epidemiological STUDIES SHOWING a positive ASSOCIATION between Vitamin C intake and Lung function in SOME [65], but NOT ALL studies [23,66].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 44), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 112), ('SUPERFICIAL_RELATIONSHIP', 131), ('INCOMPLETE_EVIDENCE', 189), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 204), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 204)]	9	[('CHEBI_27300', 'vitamin D', 55, 'vitamin C'), ('UBERON_0007023', 'adult organism', 75, 'adults'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin C'), ('UBERON_0002048', 'lung', 172, 'lung')]
PMC4377870	3/2015	S94-PMC4377870	['THUS, in SUMMARY, WHILE OBSERVATIONAL data has SUGGESTED that Vitamin C is IMPORTANT for Lung health, intervention trials SHOWING efficacy are lacking and it APPEARS that supplementation with Vitamin C-rich whole foods, such as fruit and vegetables MAY BE more EFFECTIVE.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 18), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 47), ('IMPORTANT_CONSIDERATION', 75), ('INCOMPLETE_EVIDENCE', 122), ('ANOMALY_CURIOUS_FINDING', 158), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 261)]	10	[('CHEBI_27300', 'vitamin D', 62, 'vitamin C'), ('UBERON_0002048', 'lung', 89, 'lung'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin C')]
PMC4377870	3/2015	S103-PMC4377870	['the CONFLICTING results from these supplementation studies are LIKELY to be INFLUENCED by baseline Tissue levels of Vitamin E [72], with Α-Tocopherol supplementation leading to improved Lung function and wheeze in europe, where Γ-Tocopherol levels are low [78,79,80], BUT NOT in the us, where γ-Tocopherol Intake is high due to Soybean oil Consumption [81,82,83].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('PROBABLE_UNDERSTANDING', 63), ('SUPERFICIAL_RELATIONSHIP', 76), ('FULL_UNKNOWN', 268), ('ANOMALY_CURIOUS_FINDING', 272)]	5	[('UBERON_0000479', 'tissue', 99, 'tissue'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin E'), ('CHEBI_27725', 'butin', 137, 'α-tocopherol'), ('UBERON_0002048', 'lung', 186, 'lung'), ('CHEBI_27725', 'butin', 228, 'γ-tocopherol'), ('CHEBI_27013', 'tocopherol', 295, 'tocopherol'), ('GO_0007631', 'feeding behavior', 306, 'intake'), ('CHEBI_36933', 'oxygen-19 atom', 328, 'soybean'), ('GO_0007631', 'feeding behavior', 340, 'consumption')]
PMC4377870	3/2015	S104-PMC4377870	['as a result, meta-analysis of Vitamin E EFFECTS on asthma outcomes is EQUIVOCAL; it is LIKELY that supplementation with physiological concentrations of Α-Tocopherol in the context of a background diet low in Γ-Tocopherol, MAY BE MOST beneficial in asthma and FURTHER RESEARCH testing this HYPOTHESIS IS REQUIRED.']	[('SUPERFICIAL_RELATIONSHIP', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 70), ('PROBABLE_UNDERSTANDING', 87), ('INCOMPLETE_EVIDENCE', 222), ('PROBABLE_UNDERSTANDING', 229), ('FUTURE_WORK', 259), ('INCOMPLETE_EVIDENCE', 289), ('FUTURE_WORK', 300), ('IMPORTANT_CONSIDERATION', 303)]	9	[('CHEBI_27300', 'vitamin D', 30, 'vitamin E'), ('CHEBI_27725', 'butin', 152, 'α-tocopherol'), ('CHEBI_27725', 'butin', 208, 'γ-tocopherol')]
PMC4377870	3/2015	S134-PMC4377870	['THOUGH like Vitamin C, it MAY BE DIFFICULT to disentangle the EFFECTS of Flavonoids from OTHER Nutrients in Flavonoid-rich foods.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 26), ('DIFFICULT_TASK', 33), ('SUPERFICIAL_RELATIONSHIP', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 89)]	5	[('CHEBI_27300', 'vitamin D', 12, 'vitamin C'), ('PR_000004900', 'complement C3', 20, 'C'), ('CHEBI_72544', 'flavonoids', 73, 'flavonoids'), ('CHEBI_33284', 'nutrient', 95, 'nutrients'), ('CHEBI_47916', 'flavonoid', 108, 'flavonoid')]
PMC4377870	3/2015	S137-PMC4377870	['Vitamin D\nepidemiological studies SHOW PROMISING ASSOCIATIONS between Vitamin D and Lung health; HOWEVER the mechanisms responsible for these EFFECTS are POORLY UNDERSTOOD.']	[('INCOMPLETE_EVIDENCE', 34), ('PROBABLE_UNDERSTANDING', 39), ('SUPERFICIAL_RELATIONSHIP', 49), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 97), ('SUPERFICIAL_RELATIONSHIP', 142), ('FULL_UNKNOWN', 154)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('UBERON_0002048', 'lung', 84, 'lung')]
PMC4377870	3/2015	S138-PMC4377870	['Vitamin D CAN be obtained from dietary sources or supplementation; HOWEVER sun exposure is the main CONTRIBUTOR to Vitamin D levels [108].']	[('INCOMPLETE_EVIDENCE', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 67), ('SUPERFICIAL_RELATIONSHIP', 100)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC4377870	3/2015	S139-PMC4377870	['WHILE Vitamin D has beneficial EFFECTS INDEPENDENT of uv exposure [109], it can be DIFFICULT to separate this POTENTIAL CONFOUNDER from direct EFFECTS of Vitamin D on Lung health [110].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 31), ('SUPERFICIAL_RELATIONSHIP', 39), ('DIFFICULT_TASK', 83), ('INCOMPLETE_EVIDENCE', 110), ('PROBLEM_COMPLICATION', 120), ('SUPERFICIAL_RELATIONSHIP', 143)]	7	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('UBERON_0002048', 'lung', 167, 'lung')]
PMC4377870	3/2015	S146-PMC4377870	['epidemiological EVIDENCE LINKS low levels of Vitamin D with wheeze and Respiratory infections, THOUGH EVIDENCE for the LINK with asthma onset is weak and INCONSISTENT [111].']	[('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('ANOMALY_CURIOUS_FINDING', 95), ('INCOMPLETE_EVIDENCE', 102), ('SUPERFICIAL_RELATIONSHIP', 119), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 154)]	7	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 71, 'respiratory')]
PMC4377870	3/2015	S155-PMC4377870	['data for the ROLE of Vitamin D in copd onset is LIMITED, THOUGH SEVERAL cross-sectional STUDIES HAVE REPORTED an ASSOCIATION between low Vitamin D levels, or deficiency, with copd incidence [123].']	[('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 57), ('INCOMPLETE_EVIDENCE', 64), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 113)]	6	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC4377870	3/2015	S251-PMC4377870	['it APPEARS that Vitamin D is IMPORTANT in Respiratory diseases and infections, HOWEVER the temporal ROLE of Vitamin D deficiency in disease onset, pathogenesis and exacerbations and WHETHER supplementation is indicated is yet to be clarified.']	[('ANOMALY_CURIOUS_FINDING', 3), ('IMPORTANT_CONSIDERATION', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 79), ('ANOMALY_CURIOUS_FINDING', 79), ('SUPERFICIAL_RELATIONSHIP', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182)]	6	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 42, 'respiratory'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC4377879	3/2015	S90-PMC4377879	['OTHER Vitamins : DEFICIENCIES of YET OTHER Vitamins such as Vitamin B12 and PERHAPS Vitamin A MAY BE IMPORTANT BUT EVIDENCE IS SPARSE OR CONFLICTING [22,43].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 17), ('ANOMALY_CURIOUS_FINDING', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 37), ('INCOMPLETE_EVIDENCE', 76), ('INCOMPLETE_EVIDENCE', 94), ('IMPORTANT_CONSIDERATION', 101), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('INCOMPLETE_EVIDENCE', 115), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 134), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137)]	11	[('CHEBI_33277', 'gamma-tocotrienol', 6, 'vitamins'), ('CHEBI_33277', 'gamma-tocotrienol', 43, 'vitamins'), ('CHEBI_33279', 'vitamin D5', 60, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 60, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin A')]
PMC4377879	3/2015	S93-PMC4377879	['observational or experimental data LINKING Water-soluble Vitamins to any risk of maternal mortality are APPARENTLY unavailable [21]; these Vitamins, such as Vitamin C, Thiamin, niacin and riboflavin and others, do HOWEVER APPEAR to decline in Serum or Plasma levels, LIKELY due to extra uptake by the foetus or haemodilution, or in the case of niacin also increased Urinary Excretion [21].']	[('SUPERFICIAL_RELATIONSHIP', 35), ('ANOMALY_CURIOUS_FINDING', 104), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 214), ('ANOMALY_CURIOUS_FINDING', 222), ('PROBABLE_UNDERSTANDING', 267)]	5	[('CHEBI_15377', 'water', 43, 'water'), ('CHEBI_33277', 'gamma-tocotrienol', 57, 'vitamins'), ('CHEBI_33277', 'gamma-tocotrienol', 139, 'vitamins'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin C'), ('CHEBI_26948', 'vitamin B1', 168, 'thiamin'), ('UBERON_0001977', 'blood serum', 243, 'serum'), ('UBERON_0001969', 'blood plasma', 252, 'plasma'), ('GO_0046802', 'exit of virus from host cell nucleus by nuclear egress', 366, 'urinary excretion'), ('UBERON_0001088', 'urine', 366, 'urinary')]
PMC4377879	3/2015	S262-PMC4377879	['the provision of balanced energy protein supplementary Foods to underweight Pregnant women was also considered to have enough EVIDENCE of reduction in sga and stillbirths and improved Birthweights for widespread implementation, WHEREAS maternal Vitamin D and zinc supplementation, WHILE promising, were CONSIDERED to have INSUFFICIENT evidence [18].']	[('INCOMPLETE_EVIDENCE', 126), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 228), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 281), ('ANOMALY_CURIOUS_FINDING', 281), ('INCOMPLETE_EVIDENCE', 303), ('INCOMPLETE_EVIDENCE', 322)]	6	[('CHEBI_33290', 'food', 55, 'foods'), ('GO_0007565', 'female pregnancy', 76, 'pregnant'), ('GO_0007596', 'blood coagulation', 184, 'birthweights'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D')]
PMC4377888	3/2015	S69-PMC4377888	['ALTHOUGH the ROLE of Vitamin A is well ESTABLISHED, OTHER maternal Micronutrient deficiencies are ASSOCIATED with abnormal Kidney structure or function in her offspring; BUT with LESS clear mechanisms lisle et al.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 39), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 52), ('SUPERFICIAL_RELATIONSHIP', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('INCOMPLETE_EVIDENCE', 179)]	7	[('CHEBI_27300', 'vitamin D', 21, 'vitamin A'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 67, 'micronutrient'), ('UBERON_0002113', 'kidney', 123, 'kidney')]
PMC4377896	3/2015	S148-PMC4377896	['this MAY BE attributable to the synergistic EFFECTS of Food [34] and ASSOCIATED with fish being a source of OTHER Nutrients which are IMPORTANT for infant development such as Iodine and Vitamin D. presently, there HAVE BEEN NO randomised control TRIALS examining Neurocognitive outcomes ASSOCIATED with Prenatal multivitamin use and infant Neurodevelopment, and these are UNLIKELY to occur given ethical IMPLICATIONS of such [35].']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 108), ('IMPORTANT_CONSIDERATION', 134), ('INCOMPLETE_EVIDENCE', 214), ('FULL_UNKNOWN', 224), ('SUPERFICIAL_RELATIONSHIP', 287), ('PROBABLE_UNDERSTANDING', 372), ('IMPORTANT_CONSIDERATION', 404)]	10	[('CHEBI_33290', 'food', 55, 'food'), ('CHEBI_33284', 'nutrient', 114, 'nutrients'), ('CHEBI_24859', 'iodine atom', 175, 'iodine'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('GO_0050905', 'neuromuscular process', 263, 'neurocognitive'), ('GO_0007565', 'female pregnancy', 303, 'prenatal'), ('GO_0007399', 'nervous system development', 340, 'neurodevelopment')]
PMC4380518	9/2014	S0-PMC4380518	['Prenatal Vitamin use and Vitamin D status during Pregnancy, differences by race and overweight status\n\nabstract\n\nobjective\nwe AIMED TO STUDY WHETHER Prenatal Vitamin (pnv) use PROTECTS against low 25(Oh)D levels in all women and PARTICULARLY in obese and black women who are both AT RISK of Vitamin D deficiency and poor pregnancy outcomes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 126), ('QUESTION_ANSWERED_BY_THIS_WORK', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('SUPERFICIAL_RELATIONSHIP', 176), ('IMPORTANT_CONSIDERATION', 229), ('IMPORTANT_CONSIDERATION', 280)]	6	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_33229', 'vitamin (role)', 9, 'Vitamin'), ('CHEBI_28384', 'vitamin K', 25, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 49, 'Pregnancy'), ('GO_0007565', 'female pregnancy', 149, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 158, 'vitamin'), ('CHEBI_71657', 'versiconol acetate', 197, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 203, 'D'), ('CHEBI_27300', 'vitamin D', 291, 'vitamin D')]
PMC4380518	9/2014	S7-PMC4380518	['introduction\nPerinatal health outcomes VARY dramatically by race in the united states.1african american women develop Preeclampsia more OFTEN than their white counterparts2and are more LIKELY to develop preterm labor.3the result is that black infants are 60% more LIKELY BE preterm and four times more LIKELY to die due to prematurity than white infants.1BECAUSE of less efficient Vitamin D Synthesis in the skin of darker Pigmented Individuals, african americans are at higher RISK than white americans of Vitamin D deficiency.4,5black women are also more LIKELY than white women to be overweight or obese6which is of CONCERN BECAUSE obesity is another RISK FACTOR for Vitamin D deficiency5,7and poor Perinatal outcomes.8in OBSERVATIONAL studies, 25-Hydroxyvitamin D (25[Oh]D) levels HAVE BEEN SHOWN to be ASSOCIATED with higher risk of several adverse Perinatal outcomes including Gestational diabetes9,10, preeclampsia,11preterm Birth12And small-for-Gestational age status.13,14,15,16,17BECAUSE of the PAUCITY of Vitamin D trial data with respect to Perinatal outcomes, WHETHER DIFFERENCES in Vitamin D status during Pregnancy explains or partially explains Perinatal DISPARITIES is PLAUSIBLE18but REMAINS UNKNOWN.']	[('DIFFICULT_TASK', 39), ('PROBABLE_UNDERSTANDING', 136), ('PROBABLE_UNDERSTANDING', 185), ('PROBABLE_UNDERSTANDING', 264), ('PROBABLE_UNDERSTANDING', 302), ('PROBABLE_UNDERSTANDING', 355), ('IMPORTANT_CONSIDERATION', 478), ('PROBABLE_UNDERSTANDING', 557), ('PROBLEM_COMPLICATION', 619), ('PROBABLE_UNDERSTANDING', 627), ('SUPERFICIAL_RELATIONSHIP', 654), ('INCOMPLETE_EVIDENCE', 725), ('INCOMPLETE_EVIDENCE', 785), ('SUPERFICIAL_RELATIONSHIP', 807), ('PROBABLE_UNDERSTANDING', 990), ('INCOMPLETE_EVIDENCE', 1005), ('EXPLICIT_QUESTION', 1073), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1081), ('IMPORTANT_CONSIDERATION', 1171), ('INCOMPLETE_EVIDENCE', 1186), ('FULL_UNKNOWN', 1201)]	21	[('GO_0036268', 'swimming', 13, 'Perinatal'), ('UBERON_0012101', 'perinatal stage', 13, 'Perinatal'), ('GO_0007128', 'meiotic prophase I', 118, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 381, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 381, 'vitamin D synthesis'), ('CHEBI_26130', 'biological pigment', 423, 'pigmented'), ('NCBITaxon_1', 'root', 433, 'individuals'), ('CHEBI_27300', 'vitamin D', 507, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 670, 'vitamin D'), ('GO_0036268', 'swimming', 702, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 702, 'perinatal'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 748, '25-hydroxyvitamin D'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 769, '25[OH]D'), ('GO_0036268', 'swimming', 854, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 854, 'perinatal'), ('GO_0007565', 'female pregnancy', 883, 'gestational'), ('GO_0007594', 'puparial adhesion', 932, 'birth12and'), ('GO_0007565', 'female pregnancy', 953, 'gestational'), ('CHEBI_27300', 'vitamin D', 1016, 'vitamin D'), ('GO_0036268', 'swimming', 1053, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1053, 'perinatal'), ('CHEBI_27300', 'vitamin D', 1096, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1120, 'pregnancy'), ('GO_0036268', 'swimming', 1161, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1161, 'perinatal')]
PMC4380518	9/2014	S8-PMC4380518	['furthermore, WHILE multivitamin intake HAS BEEN SHOWN to VARY by race,19it REMAINS UNKNOWN WHETHER multivitamin intake improves Vitamin D status among the HIGHEST RISK groups (african americans and overweight/obese) during Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('INCOMPLETE_EVIDENCE', 39), ('DIFFICULT_TASK', 57), ('FULL_UNKNOWN', 75), ('EXPLICIT_QUESTION', 91), ('IMPORTANT_CONSIDERATION', 155)]	6	[('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('GO_0007565', 'female pregnancy', 223, 'pregnancy')]
PMC4380518	9/2014	S47-PMC4380518	['discussion\nour data SUGGEST that WHILE Prenatal pnv use is ASSOCIATED with lower odds of Vitamin D deficiency, the ASSOCIATION is NOT UNIFORM.']	[('INCOMPLETE_EVIDENCE', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 33), ('SUPERFICIAL_RELATIONSHIP', 59), ('SUPERFICIAL_RELATIONSHIP', 115), ('DIFFICULT_TASK', 130)]	5	[('GO_0007565', 'female pregnancy', 39, 'prenatal'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC4380518	9/2014	S52-PMC4380518	['shea et al studied 2500 elderly Adults and FOUND that lack of pnv use was ASSOCIATED with higher odds of Vitamin D insufficiency (<75 nmol/l) in both black (5.2 (95% ci: 3.5, 7.7)) and white participants (or 2.6, 95% ci: 2.0, 3.2), HOWEVER these subjects were much older and not Pregnant.26a SMALL turkish STUDY of 79 Pregnant women SHOWED significantly higher 25(Oh)D levels among women reporting pnv use in the third trimester,27BUT this study DID NOT include women of african descent and DID NOT have the power to address POTENTIAL INTERACTION by bmi.']	[('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 232), ('INCOMPLETE_EVIDENCE', 292), ('INCOMPLETE_EVIDENCE', 333), ('PROBLEM_COMPLICATION', 431), ('INCOMPLETE_EVIDENCE', 446), ('INCOMPLETE_EVIDENCE', 491), ('INCOMPLETE_EVIDENCE', 525), ('SUPERFICIAL_RELATIONSHIP', 535)]	10	[('UBERON_0007023', 'adult organism', 32, 'adults'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0007565', 'female pregnancy', 279, 'pregnant'), ('GO_0007565', 'female pregnancy', 318, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 361, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 361, '25(OH)D')]
PMC4380518	9/2014	S58-PMC4380518	['we had NO INFORMATION as to the duration of use or the Vitamin D dose in the pnv which typically is 400–600 iu per tablet, BUT can VARY.']	[('FULL_UNKNOWN', 7), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 123), ('DIFFICULT_TASK', 131)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC4380518	9/2014	S62-PMC4380518	['we also LACKED DATA on Vitamin D binding protein which MAY DIFFER by race/ethnicity and COULD AFFECT the ASSOCIATION between pnv use and 25(Oh)D measured in the Plasma.']	[('FULL_UNKNOWN', 8), ('INCOMPLETE_EVIDENCE', 55), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 59), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 94), ('SUPERFICIAL_RELATIONSHIP', 105)]	6	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 137, '25(OH)D'), ('UBERON_0001969', 'blood plasma', 161, 'plasma')]
PMC4380518	9/2014	S63-PMC4380518	['the OPTIMAL method of Vitamin D measurement REMAINS CONTROVERSIAL, BUT our laboratory uses u.s. national institute of standards and technology level 1 and this method is COMMONLY used clinically and in the literature.']	[('IMPORTANT_CONSIDERATION', 4), ('INCOMPLETE_EVIDENCE', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 67), ('PROBABLE_UNDERSTANDING', 170)]	5	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D')]
PMC4380518	9/2014	S65-PMC4380518	['IN CONTRAST, our data SUPPORT INVESTIGATION into higher doses of Vitamin D in subgroups at high RISK IF BENEFITS are demonstrated by ONGOING TRIALS in Pregnancy of achieving higher 25(Oh)D levels.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 22), ('FUTURE_WORK', 30), ('IMPORTANT_CONSIDERATION', 96), ('FUTURE_PREDICTION', 101), ('IMPORTANT_CONSIDERATION', 104), ('INCOMPLETE_EVIDENCE', 133)]	7	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 151, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 181, '25(OH)D')]
PMC4383226	2/2015	S0-PMC4383226	['vitamin a Supplements, routine immunization, and the subsequent risk of plasmodium infection among children under 5 years in sub-saharan africa\n\nabstract\nRECENT STUDIES, PARTLY based on Murine MODELS, SUGGEST childhood immunization and Vitamin A Supplements MAY confer protection against malaria infection, ALTHOUGH STRONG EVIDENCE TO SUPPORT these THEORIES in Humans has so far BEEN LACKING.']	[('INCOMPLETE_EVIDENCE', 154), ('INCOMPLETE_EVIDENCE', 170), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 193), ('INCOMPLETE_EVIDENCE', 193), ('INCOMPLETE_EVIDENCE', 201), ('INCOMPLETE_EVIDENCE', 258), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 307), ('ANOMALY_CURIOUS_FINDING', 307), ('INCOMPLETE_EVIDENCE', 316), ('INCOMPLETE_EVIDENCE', 349), ('INCOMPLETE_EVIDENCE', 379)]	11	[('CHEBI_33341', 'titanium atom', 10, 'supplements'), ('NCBITaxon_39107', 'Murinae', 186, 'murine'), ('CHEBI_27300', 'vitamin D', 236, 'vitamin A'), ('CHEBI_33341', 'titanium atom', 246, 'supplements'), ('NCBITaxon_9606', 'Homo sapiens', 361, 'humans')]
PMC4383226	2/2015	S7-PMC4383226	['FUTURE STUDIES focusing on climate seasonality, Placental malaria and hiv ARE NEEDED to characterize better the ASSOCIATION between Vitamin A and malaria infection in DIFFERENT settings.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 74), ('SUPERFICIAL_RELATIONSHIP', 112), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 167)]	4	[('UBERON_0001987', 'placenta', 48, 'placental'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin A')]
PMC4383226	2/2015	S15-PMC4383226	['it is LESS CLEAR WHETHER vaccines OR Vitamin A have antimalarial EFFECTS in Humans.']	[('FULL_UNKNOWN', 6), ('INCOMPLETE_EVIDENCE', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 17), ('SUPERFICIAL_RELATIONSHIP', 65)]	4	[('CHEBI_27300', 'vitamin D', 37, 'vitamin A'), ('NCBITaxon_9606', 'Homo sapiens', 76, 'humans')]
PMC4383226	2/2015	S31-PMC4383226	['SEVERAL STUDIES have SUGGESTED that childhood immunization MAY confer non-specific health EFFECTS beyond targeted diseases, BUT the IMPACT of standard vaccination and Vitamin A supplementation on malaria Infection is UNCLEAR.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124), ('SUPERFICIAL_RELATIONSHIP', 132), ('FULL_UNKNOWN', 217)]	7	[('CHEBI_27300', 'vitamin D', 167, 'vitamin A'), ('GO_0007586', 'digestion', 204, 'infection')]
PMC4383226	2/2015	S41-PMC4383226	['WHILE Vitamin A did not APPEAR to Modulate the risk of parasitemia in a clinical trial study of ghanaian children (binka et al., 1995) and tanzanian children previously hospitalized with pneumonia (villamor et al., 2003), a cluster randomized intervention trial for breastfeeding in uganda OBSERVED a sixfold decrease in the adjusted risk of malaria infection among children receiving Vitamin A (nankabirwa et al., 2011).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 24), ('INCOMPLETE_EVIDENCE', 290)]	3	[('CHEBI_27300', 'vitamin D', 6, 'vitamin A'), ('GO_0065007', 'biological regulation', 34, 'modulate'), ('CHEBI_27300', 'vitamin D', 385, 'vitamin A')]
PMC4383226	2/2015	S42-PMC4383226	['ON THE OTHER HAND, CONCERN HAS BEEN RAISED by an APPARENT increase in levels of parasitemia within Mouse MODELS, when combining Vitamin A supplements with dtp vaccination; an EFFECT THOUGHT TO be stronger among female Mice (jorgensen et al., 2011).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 19), ('INCOMPLETE_EVIDENCE', 27), ('EXPLICIT_QUESTION', 36), ('ANOMALY_CURIOUS_FINDING', 49), ('INCOMPLETE_EVIDENCE', 105), ('SUPERFICIAL_RELATIONSHIP', 175), ('INCOMPLETE_EVIDENCE', 182)]	8	[('NCBITaxon_10088', 'Mus <genus>', 99, 'mouse'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 218, 'mice')]
PMC4383226	2/2015	S101-PMC4383226	["NOT ONLY did we identify a PROTECTIVE ASSOCIATION between Vitamin A and malaria in a study population with high immunization coverage for bcg, dtp, and poliomyelitis, we also FOUND in unadjusted MODELS that dtp did not modify Vitamin A's ASSOCIATION with malaria."]	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 27), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 175), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 195), ('SUPERFICIAL_RELATIONSHIP', 238)]	6	[('CHEBI_27300', 'vitamin D', 58, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin A')]
PMC4383226	2/2015	S133-PMC4383226	["in particular, our study ONLY CONSIDERED information regarding the last recorded dose of Vitamin A supplement RATHER than a child's history of supplementation."]	[('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 110)]	3	[('CHEBI_27300', 'vitamin D', 89, 'vitamin A')]
PMC4383226	2/2015	S134-PMC4383226	['given that Vitamin A is fat soluble and CAN be stored in the Liver for long periods of time (blomhoff, 1994;tanumihardjo, 2011), ADDITIONAL RESEARCH IS NEEDED to examine WHETHER regular supplementation has an IMPACT on increased protection.']	[('INCOMPLETE_EVIDENCE', 40), ('FUTURE_WORK', 129), ('FUTURE_WORK', 149), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('SUPERFICIAL_RELATIONSHIP', 209)]	5	[('CHEBI_27300', 'vitamin D', 11, 'vitamin A'), ('UBERON_0002107', 'liver', 61, 'liver')]
PMC4383226	2/2015	S147-PMC4383226	['WHILE the PROTECTIVE ASSOCIATION between Vitamin A and malaria REMAINED, the low prevalence of maternal hiv in our study population (and HENCE LOW statistical power) makes it DIFFICULT to RULE OUT POTENTIAL Vitamin A–hiv INTERACTIONS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('SUPERFICIAL_RELATIONSHIP', 21), ('INCOMPLETE_EVIDENCE', 63), ('PROBABLE_UNDERSTANDING', 137), ('PROBLEM_COMPLICATION', 143), ('DIFFICULT_TASK', 175), ('INCOMPLETE_EVIDENCE', 188), ('INCOMPLETE_EVIDENCE', 197), ('SUPERFICIAL_RELATIONSHIP', 221)]	11	[('CHEBI_27300', 'vitamin D', 41, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin A')]
PMC4383575	1/2015	S129-PMC4383575	['HOWEVER, country of Birth, higher maternal bmi, Delivery by cesarean section, male infant sex (table 2), and low maternal intake of Fruits rich in Vitamin C and high intake of diary products as well as low adherence to healthy diet were ASSOCIATED with higher dna adduct levels in adjusted models (table 3).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 237)]	3	[('GO_0007567', 'parturition', 20, 'birth'), ('GO_0007567', 'parturition', 48, 'delivery'), ('CHEBI_33290', 'food', 132, 'fruits'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin C'), ('PR_000004900', 'complement C3', 155, 'C')]
PMC4383575	1/2015	S196-PMC4383575	['1997), BUT these two SMALL STUDIES DID NOT estimate fruits rich in Vitamin C. LIKEWISE, the inverse ASSOCIATION between dried fruits (rich in Flavonoids) and adduct levels COULD SUGGEST a POTENTIAL inhibition of adduct formation by these Nutrients.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 7), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 78), ('SUPERFICIAL_RELATIONSHIP', 100), ('INCOMPLETE_EVIDENCE', 172), ('INCOMPLETE_EVIDENCE', 178), ('INCOMPLETE_EVIDENCE', 188)]	8	[('CHEBI_27300', 'vitamin D', 67, 'vitamin C'), ('CHEBI_72544', 'flavonoids', 142, 'flavonoids'), ('CHEBI_33284', 'nutrient', 238, 'nutrients')]
PMC4383575	1/2015	S238-PMC4383575	['OTHER POTENTIAL LIMITATIONS of OUR STUDY were the INABILITY to assess the intake of IMPORTANT dietary variables (i.e., Vitamins E, A, and C) (ragin et al.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('INCOMPLETE_EVIDENCE', 50), ('IMPORTANT_CONSIDERATION', 84)]	6	[('CHEBI_27300', 'vitamin D', 119, 'vitamins E'), ('PR_000024090', 'sensor protein TorS', 119, 'vitamins E'), ('PR_000004370', 'asialoglycoprotein receptor 2', 131, 'A'), ('PR_000004900', 'complement C3', 138, 'C')]
PMC4392531	3/2015	S75-PMC4392531	['it is SUGGESTED that higher Consumption of fruits and vegetables containing Vitamin C and OTHER Antioxidants MAY reduce the incidence of pre-eclampsia.']	[('INCOMPLETE_EVIDENCE', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90), ('INCOMPLETE_EVIDENCE', 109)]	3	[('GO_0007631', 'feeding behavior', 28, 'consumption'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin C'), ('CHEBI_60641', 'methyl 5-aminolevulinate hydrochloride', 96, 'antioxidants')]
PMC4392531	3/2015	S89-PMC4392531	['HOWEVER, DUE TO the high amount of Vitamin A and e to protect Fatty Acids, the POSSIBILITY of hypervitaminosis SHOULD BE taken into account.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('INCOMPLETE_EVIDENCE', 79), ('FUTURE_WORK', 111)]	4	[('CHEBI_27300', 'vitamin D', 35, 'vitamin A'), ('CHEBI_35366', 'fatty acid', 62, 'fatty acids')]
PMC4396835	1/2015	S7-PMC4396835	['conclusions\nthe FINDINGS SUGGEST that low Prenatal Vitamin D MAY act as a risk factor for asd, HOWEVER, there is a NEED FOR replication with larger samples.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 61), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('FUTURE_WORK', 115)]	5	[('GO_0007565', 'female pregnancy', 42, 'prenatal'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC4396835	1/2015	S8-PMC4396835	['FUTURE RESEARCH SHOULD study WHETHER OR NOT adequate supplementation of Vitamin D to Pregnant women MIGHT lower the RISK for asd in the offspring.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 29), ('INCOMPLETE_EVIDENCE', 100), ('IMPORTANT_CONSIDERATION', 116)]	5	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007565', 'female pregnancy', 85, 'pregnant')]
PMC4396835	1/2015	S35-PMC4396835	['HOWEVER, TO OUR KNOWLEDGE there HAS BEEN no study analysing Vitamin D levels in samples taken in the Neonatal Period.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 9), ('INCOMPLETE_EVIDENCE', 32)]	3	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0007221', 'neonate stage', 101, 'neonatal period')]
PMC4396835	1/2015	S89-PMC4396835	['GIVEN our main HYPOTHESIS of lower Vitamin D status in asd compared to controls, a case COULD BE made for one-tailed tests, HOWEVER, our results are conservatively reported as two-tailed with probabilities <0.05 accepted as significant.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124)]	5	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
PMC4396835	1/2015	S126-PMC4396835	['this is IN LINE WITH OTHER scandinavian RESEARCH, SHOWING that somali born women have the lowest Vitamin D levels of all ethnic groups REPORTED in sweden [37], EVEN lower than in turkish and pakistani mothers living in norway [59].']	[('INCOMPLETE_EVIDENCE', 8), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 21), ('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 50), ('INCOMPLETE_EVIDENCE', 135), ('ANOMALY_CURIOUS_FINDING', 160)]	6	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D')]
PMC4396835	1/2015	S129-PMC4396835	['seasonal EFFECTS\nOUR FINDING that more children with asd of swedish or other non-african/non-middle east background were Born in the spring than during other seasons - COULD POSSIBLY implicate OTHER aetiological FACTORS THAN Vitamin D levels, such as, for instance, infections.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('INCOMPLETE_EVIDENCE', 168), ('INCOMPLETE_EVIDENCE', 174), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 193), ('SUPERFICIAL_RELATIONSHIP', 212), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 220)]	7	[('GO_0007567', 'parturition', 121, 'born'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D')]
PMC4396835	1/2015	S130-PMC4396835	['HOWEVER, the LACK OF effect of season of sampling (= season of Birth in OUR STUDY) on 25(Oh)D levels in our african/middle east group, all having low Vitamin D status throughout the year, HAS also BEEN REPORTED in women with african/middle east origin living in norway [59].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 72), ('INCOMPLETE_EVIDENCE', 188), ('INCOMPLETE_EVIDENCE', 202)]	5	[('GO_0007567', 'parturition', 63, 'birth'), ('CHEBI_71657', 'versiconol acetate', 86, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 86, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D')]
PMC4396835	1/2015	S131-PMC4396835	['in conjunction with the elevated incidence of asd in these populations, this MAY SUPPORT a ROLE of Vitamin D deficiency - RATHER than OTHER seasonal factors - in the Development Of Autism.']	[('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 81), ('SUPERFICIAL_RELATIONSHIP', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 134)]	5	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('GO_0044419', 'biological process involved in interspecies interaction between organisms', 166, 'development of autism')]
PMC4396835	1/2015	S134-PMC4396835	['OUR FINDINGS of lower Vitamin D levels in children with asd, COMPARED TO their siblings, also ACCORD WITH results from a population-based study from the faroe islands, in the north atlantic ocean, of Vitamin D levels in adolescents and young Adults with asd.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 61), ('INCOMPLETE_EVIDENCE', 94)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('UBERON_0007023', 'adult organism', 242, 'adults')]
PMC4396835	1/2015	S141-PMC4396835	['ON THE OTHER HAND, a LINK between Genomic actions of Vitamin D and serotonergic deviations in asd HAS BEEN PROPOSED by patrick and ames [63].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 21), ('INCOMPLETE_EVIDENCE', 98), ('INCOMPLETE_EVIDENCE', 107)]	4	[('SO_0001026', 'genome', 34, 'genomic'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC4396835	1/2015	S153-PMC4396835	['HOWEVER, no difference in Vitamin D levels related to gender HAS BEEN FOUND in neonates [65].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 70)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D')]
PMC4396835	1/2015	S167-PMC4396835	['HOWEVER, as low Vitamin D is SUGGESTED to CONTRIBUTE to the pathogenesis of autoimmunity [69], OUR FINDINGS COULD BE relevant in this context as well.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 42), ('QUESTION_ANSWERED_BY_THIS_WORK', 95), ('INCOMPLETE_EVIDENCE', 108)]	5	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D')]
PMC4396835	1/2015	S169-PMC4396835	['three DIFFERENT independent findings POINT towards a ROLE for Vitamin D in the development of asd: (1) increased risk for asd in offspring of migrants, especially from countries with a dark-skinned population and from cultures where women use covered clothing; (2) low 25(Oh)D levels in groups of newborn children, who later have developed asd, and in groups of children and Adults with asd; and (3) an ASSOCIATION between season of Birth and asd, in OUR STUDY not extending to the high-risk groups of migrants, SUGGESTING that these groups are exposed to suboptimal Vitamin D levels the whole year.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 403), ('QUESTION_ANSWERED_BY_THIS_WORK', 451), ('INCOMPLETE_EVIDENCE', 512)]	6	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 269, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 269, '25(OH)D'), ('UBERON_0007023', 'adult organism', 375, 'adults'), ('GO_0007567', 'parturition', 433, 'birth'), ('CHEBI_27300', 'vitamin D', 567, 'vitamin D')]
PMC4396835	1/2015	S170-PMC4396835	['ALTHOUGH low levels of Vitamin D COULD have a Genetic origin and as SUCH be ASSOCIATED with asd, OUR STUDY is the FIRST TO RULE OUT asd-related lifestyle mechanisms AS EXPLANATION for low 25(Oh)D levels, SINCE the samples were taken in the Newborn Period.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 33), ('PROBABLE_UNDERSTANDING', 68), ('SUPERFICIAL_RELATIONSHIP', 76), ('QUESTION_ANSWERED_BY_THIS_WORK', 97), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 123), ('PROBABLE_UNDERSTANDING', 165), ('PROBABLE_UNDERSTANDING', 168), ('PROBABLE_UNDERSTANDING', 204)]	10	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('SO_0000704', 'gene', 46, 'genetic'), ('CHEBI_71657', 'versiconol acetate', 188, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 194, 'D'), ('UBERON_0007221', 'neonate stage', 240, 'newborn period')]
PMC4396835	1/2015	S171-PMC4396835	['FUTURE RESEARCH SHOULD include a larger cohort followed prospectively and also study WHETHER OR NOT adequate supplementation of Vitamin D to Pregnant women MIGHT lower the RISK for asd in the offspring.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 85), ('INCOMPLETE_EVIDENCE', 156), ('IMPORTANT_CONSIDERATION', 172)]	5	[('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('GO_0007565', 'female pregnancy', 141, 'pregnant')]
PMC4396888	3/2015	S134-PMC4396888	['HOWEVER, Micronutrient intakes especially of Iron and Vitamin A were lower in a higher proportion of OUR STUDY population as COMPARED TO the study by kapil et al.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 101), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 125)]	3	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 9, 'micronutrient'), ('CHEBI_24870', 'ion', 45, 'iron'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin A')]
PMC4405493	4/2015	S13-PMC4405493	['HOWEVER, the high percentage of affected Individuals HIGHLIGHTS the prevalence of Vitamin D deficiency in young, Reproductive-aged women.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 53)]	2	[('NCBITaxon_1', 'root', 41, 'individuals'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0000003', 'reproduction', 113, 'reproductive')]
PMC4405493	4/2015	S19-PMC4405493	['HOWEVER, the EFFECT of less SEVERE Vitamin D deficiency and insufficiency on maternal and fetal outcomes during Pregnancy is LESS CLEAR.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('IMPORTANT_CONSIDERATION', 28), ('FULL_UNKNOWN', 125)]	4	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 112, 'pregnancy')]
PMC4405493	4/2015	S22-PMC4405493	['HOWEVER, OTHER STUDIES have DEMONSTRATED no association between Vitamin D status and adverse Pregnancy outcomes [11–12].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 28)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007565', 'female pregnancy', 93, 'pregnancy')]
PMC4405493	4/2015	S24-PMC4405493	['THUS, we SOUGHT TO DETERMINE IF Vitamin D deficiency in the first trimester of nulliparous patients is ASSOCIATED with clinical outcomes MOST ASSOCIATED with SIGNIFICANT maternal and fetal morbidity and mortality: Preeclampsia, Gestational diabetes, Preterm Delivery, spontaneous abortion, and growth restriction.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 29), ('SUPERFICIAL_RELATIONSHIP', 103), ('PROBABLE_UNDERSTANDING', 137), ('SUPERFICIAL_RELATIONSHIP', 142), ('IMPORTANT_CONSIDERATION', 158)]	8	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 214, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 228, 'gestational'), ('GO_0007565', 'female pregnancy', 250, 'preterm'), ('GO_0007567', 'parturition', 258, 'delivery')]
PMC4405493	4/2015	S122-PMC4405493	['recent clinical GUIDELINES SUGGEST that doses of Vitamin D greater than 600 iu/day MAY BE needed to maintain adequate Plasma levels greater than 30 ng/ml (75 nmol/l), BUT the appropriate standard is still DEBATED [19,42–43].']	[('PROBABLE_UNDERSTANDING', 16), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 83), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 167), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 205)]	5	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 118, 'plasma')]
PMC4405493	4/2015	S126-PMC4405493	['BECAUSE Vitamin D deficiency is so widespread, determining WHETHER Vitamin D deficiency is ASSOCIATED with adverse Pregnancy outcomes is an area of MAJOR PUBLIC HEALTH CONCERN.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 59), ('SUPERFICIAL_RELATIONSHIP', 91), ('IMPORTANT_CONSIDERATION', 148), ('IMPORTANT_CONSIDERATION', 154)]	5	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'pregnancy')]
PMC4405493	4/2015	S127-PMC4405493	['it is UNCLEAR WHETHER Vitamin D deficiency is causal in the DISPARITIES in adverse Pregnancy outcomes between caucasians and african americans.']	[('FULL_UNKNOWN', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('IMPORTANT_CONSIDERATION', 60)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'pregnancy')]
PMC4405493	4/2015	S152-PMC4405493	['HOWEVER, Vitamin D deficiency did not increase the odds of preeclampsia, EVEN when stratifying by disease severity.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 73)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
PMC4405493	4/2015	S154-PMC4405493	['during Pregnancy, 25-Oh Vitamin D diffuses across the Placenta and the fetus relies entirely on the Vitamin D stores of the mother: IF the mother is deficient, so is the fetus [5].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 132)]	1	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 18, '25-OH'), ('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('UBERON_0001987', 'placenta', 54, 'placenta'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC4405493	4/2015	S157-PMC4405493	['HOWEVER, WHETHER Vitamin D deficiency is a RISK FACTOR for Gestational diabetes in itself OR IF Vitamin D supplementation CAN PREVENT gdm is YET UNKNOWN [72].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('SUPERFICIAL_RELATIONSHIP', 43), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93), ('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 126), ('FULL_UNKNOWN', 141)]	7	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0007565', 'female pregnancy', 59, 'gestational'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D')]
PMC4405493	4/2015	S163-PMC4405493	['we reviewed the bmi of our study participants to see IF there was any ASSOCIATION between Vitamin D deficiency classification and bmi.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 53), ('SUPERFICIAL_RELATIONSHIP', 70)]	2	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC4405493	4/2015	S176-PMC4405493	['HOWEVER, the high percentage of affected Individuals HIGHLIGHTS the prevalence of Vitamin D deficiency and insufficiency in young, healthy Reproductive-aged women in OUR STUDY population.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 53), ('QUESTION_ANSWERED_BY_THIS_WORK', 166)]	3	[('NCBITaxon_1', 'root', 41, 'individuals'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0000003', 'reproduction', 139, 'reproductive')]
PMC4405493	4/2015	S178-PMC4405493	['ALTHOUGH OUR STUDY DID NOT DEMONSTRATE an association of Vitamin D Plasma concentration with select clinical outcomes, the prevalence of sub-optimal Vitamin D concentrations in patient plasma EMPHASIZES THE NEED for CONTINUED RESEARCH on hypovitaminosis d in Pregnancy and Reproductive health.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('INCOMPLETE_EVIDENCE', 19), ('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('IMPORTANT_CONSIDERATION', 192), ('INCOMPLETE_EVIDENCE', 192), ('INCOMPLETE_EVIDENCE', 203), ('FUTURE_WORK', 207), ('FUTURE_WORK', 216)]	10	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 67, 'plasma'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('GO_0007565', 'female pregnancy', 259, 'pregnancy'), ('GO_0000003', 'reproduction', 273, 'reproductive')]
PMC4408096	4/2015	S14-PMC4408096	['WHILE iron deficiency IS CONSIDERED the LEADING cause of anemia, OTHER causes include deficiencies in Micronutrients such as Folate, Vitamin B12, and Vitamin A, infestations with parasites such as helminths or malaria, Genetically-inherited hemoglobinopathies, hiv/aids, and chronic inflammation [3,4].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 22), ('IMPORTANT_CONSIDERATION', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 65)]	4	[('CHEBI_33839', 'macromolecule', 102, 'micronutrients'), ('CHEBI_30863', '5-azaorotic acid', 125, 'folate'), ('CHEBI_33279', 'vitamin D5', 133, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin A'), ('SO_0000704', 'gene', 219, 'genetically')]
PMC4417995	4/2015	S2-PMC4417995	['HOWEVER, OBSERVATIONS LINKING high Vitamin D levels to an INCREASED RISK of developing ad HAVE also BEEN published, EFFECTIVELY creating a CONTROVERSY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 22), ('IMPORTANT_CONSIDERATION', 58), ('INCOMPLETE_EVIDENCE', 90), ('IMPORTANT_CONSIDERATION', 116), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139)]	7	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
PMC4417995	4/2015	S29-PMC4417995	['the american academy of pediatrics RECOMMENDS a daily intake of 400\u2009iu of Vitamin D for infants and children, WHEREAS the institute of medicine and the Endocrine society RECOMMEND 400\u2009iu daily for infants and 600\u2009iu daily for children of 1 to 18 years old [16].']	[('FUTURE_WORK', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 110), ('FUTURE_WORK', 170)]	3	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('UBERON_0005063', 'left ventricular compact myocardium', 152, 'Endocrine')]
PMC4417995	4/2015	S31-PMC4417995	["Vitamin D and Immune Regulation\nthe extent of Vitamin D's biological actions goes further THAN Calcium Homeostasis and bone Metabolism."]	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 90)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0002326', 'B cell lineage commitment', 14, 'Immune Regulation'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0050817', 'coagulation', 95, 'calcium'), ('GO_0042592', 'homeostatic process', 103, 'homeostasis'), ('GO_0008152', 'metabolic process', 124, 'metabolism')]
PMC4417995	4/2015	S39-PMC4417995	['HOWEVER LIMITED DATA showed Vitamin D MIGHT attenuate, RATHER than promote, Th2 responses.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 55)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0006285', 'base-excision repair, AP site formation', 76, 'Th2')]
PMC4417995	4/2015	S64-PMC4417995	['[31] FOUND a significantly reduced risk of eczema for the lowest Vitamin D Serum quartile COMPARED TO the reference quartile in a multivariate analysis.']	[('INCOMPLETE_EVIDENCE', 5), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90)]	2	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('UBERON_0001977', 'blood serum', 75, 'serum')]
PMC4417995	4/2015	S90-PMC4417995	['[41] DEMONSTRATED a negative CORRELATION between the scorad [42] and Serum Vitamin D levels in allergic sensitized Individuals, WHEREAS no correlation was noted in the group without sensitization.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 128)]	3	[('UBERON_0001977', 'blood serum', 69, 'serum'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('NCBITaxon_1', 'root', 115, 'individuals')]
PMC4417995	4/2015	S93-PMC4417995	['Pregnancy Vitamin D levels\nthe maternal Vitamin D profile during Pregnancy HAS also BEEN long DEBATED.']	[('INCOMPLETE_EVIDENCE', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 94)]	2	[('GO_0007565', 'female pregnancy', 0, 'Pregnancy'), ('CHEBI_28384', 'vitamin K', 10, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'pregnancy')]
PMC4417995	4/2015	S97-PMC4417995	['CONVERSELY, OTHER STUDIES DEMONSTRATED that children Born from mothers with low Fish or Vitamin D intake during Pregnancy had an increased prevalence of ad [45,46].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 26)]	4	[('GO_0007567', 'parturition', 53, 'born'), ('CHEBI_83324', 'pent-2-enoyl-CoA(4-)', 80, 'fish'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('GO_0007565', 'female pregnancy', 112, 'pregnancy')]
PMC4417995	4/2015	S110-PMC4417995	['[30] also EVIDENCED that breastfeeding is GENERALLY ASSOCIATED with low Vitamin D intake, AS OPPOSED TO replacement formulas and dairy drinks fortified with Vitamin D, which provide a CONSIDERABLY higher Intake.']	[('INCOMPLETE_EVIDENCE', 10), ('PROBABLE_UNDERSTANDING', 42), ('SUPERFICIAL_RELATIONSHIP', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90), ('ANOMALY_CURIOUS_FINDING', 184)]	5	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('GO_0007631', 'feeding behavior', 204, 'intake')]
PMC4417995	4/2015	S111-PMC4417995	['TRYING to elucidate WHETHER maternal Vitamin D supplementation during Lactation improves infantile eczema and other subsequent allergic disorders, a randomized double-blind, placebo-controlled trial [52] was conducted on 164 breastfeeding mothers of infants with Facial eczema.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 20)]	2	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007595', 'lactation', 70, 'lactation'), ('UBERON_0001456', 'face', 263, 'facial')]
PMC4417995	4/2015	S112-PMC4417995	['the analysis SHOWED that Vitamin D supplementation MAY not decrease the severity of infantile eczema at 3 months of age but MAY RATHER increase the risk of later Food allergy up to 2 years of age.']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 124), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 128)]	4	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_33290', 'food', 162, 'food')]
PMC4417995	4/2015	S116-PMC4417995	['HOWEVER, data on Vitamin D dietary intake and higher prevalence of ad MUST BE assessed CRITICALLY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 70), ('IMPORTANT_CONSIDERATION', 87)]	3	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D')]
PMC4417995	4/2015	S118-PMC4417995	['THEREFORE, the increased prevalence of ad in children with a higher dietary intake of Vitamin D COULD result from such early alimentary exposure to this Antigen, RATHER than being a direct consequence of Vitamin D Serum levels.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 96), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 162)]	3	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_59132', 'antigen', 153, 'antigen'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin D'), ('UBERON_0001977', 'blood serum', 214, 'serum')]
PMC4417995	4/2015	S135-PMC4417995	['HOWEVER, Serum Vitamin D levels were NOT MEASURED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 37)]	2	[('UBERON_0001977', 'blood serum', 9, 'serum'), ('CHEBI_27300', 'vitamin D', 15, 'vitamin D')]
PMC4417995	4/2015	S154-PMC4417995	['HOWEVER, DESPITE all of the above EVIDENCES, no significant difference in ad severity after Vitamin D supplementation compared with Placebo was FOUND in a 2012 systematic literature review [65].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 9), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 144)]	5	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_26130', 'biological pigment', 132, 'placebo')]
PMC4417995	4/2015	S186-PMC4417995	['similarly, to devise a STRATEGY for using Vitamin D in the therapy of ad SEEMS at present to be NOT FEASIBLE for DIFFERENT reasons: many CONFOUNDING and unidentified VARIABLES appear in EXISTING STUDIES, and they are OFTEN LIMITED by SMALL numbers of participants, their short durations, and the use of a fixed dose without optimizing for adequate Serum levels.']	[('FUTURE_WORK', 23), ('ANOMALY_CURIOUS_FINDING', 73), ('DIFFICULT_TASK', 96), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113), ('PROBLEM_COMPLICATION', 137), ('SUPERFICIAL_RELATIONSHIP', 166), ('INCOMPLETE_EVIDENCE', 186), ('PROBABLE_UNDERSTANDING', 217), ('INCOMPLETE_EVIDENCE', 223), ('INCOMPLETE_EVIDENCE', 234)]	10	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0001977', 'blood serum', 348, 'serum')]
PMC4417995	4/2015	S187-PMC4417995	['THEREFORE systematic supplementation of Vitamin D in childhood ad currently cannot be RECOMMENDED EXCEPT for UNCOMMON cases which MAY prove refractory to traditional therapeutic options.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 86), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('INCOMPLETE_EVIDENCE', 109), ('INCOMPLETE_EVIDENCE', 130)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC4427001	4/2015	S20-PMC4427001	['Vitamin D—via its binding to the Vitamin D receptor (vdr)—Regulates Expression of hundreds of Genes (directly OR indirectly) including those that Control key processes AFFECTING cell fate [8].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 110), ('SUPERFICIAL_RELATIONSHIP', 168)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0065007', 'biological regulation', 58, 'regulates'), ('GO_0010467', 'gene expression', 68, 'expression'), ('SO_0000704', 'gene', 94, 'genes'), ('GO_0065007', 'biological regulation', 146, 'control')]
PMC4427001	4/2015	S97-PMC4427001	['ALTHOUGH there is NO GENERAL CONSENSUS on the criteria for Vitamin D deficiency in Pregnant women, in OUR STUDY we have FOUND high prevalence of deficiency (when using cut-off < 50\u2009nmol/l) in overall study sample: 95.7% of women with gdm and 93.1% of controls were Vitamin D deficient during Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 102), ('INCOMPLETE_EVIDENCE', 120)]	5	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'pregnant'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D'), ('GO_0007565', 'female pregnancy', 292, 'pregnancy')]
PMC4427001	4/2015	S109-PMC4427001	['CONTRADICTORY results COULD BE EXPLAINED by seasonal, geographical, or ethnic Vitamin D variation; the paper does NOT UNFORTUNATELY mention in WHAT season women were included in the study.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 22), ('PROBABLE_UNDERSTANDING', 31), ('ANOMALY_CURIOUS_FINDING', 114), ('IMPORTANT_CONSIDERATION', 118), ('EXPLICIT_QUESTION', 143)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC4427001	4/2015	S113-PMC4427001	['NEVERTHELESS, Vitamin D levels in asian population are in general lower than in caucasian population and criteria used in her study would classify most european women as having optimal Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
PMC4427001	4/2015	S118-PMC4427001	['[26] FOUND an inverse ASSOCIATION between second trimester 25(Oh)D levels < 25\u2009nmol/l and 1\u2009hr after load Glucose (50\u2009g) levels; HOWEVER, ONLY 5% of studied women developed gdm and as mentioned above THRESHOLD for Vitamin D deficiency DIFFERED from our study.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 129), ('INCOMPLETE_EVIDENCE', 138), ('PROBABLE_UNDERSTANDING', 200), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 235)]	6	[('CHEBI_71657', 'versiconol acetate', 59, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 59, '25(OH ... D'), ('CHEBI_17234', 'glucose', 106, 'glucose'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]
PMC4427001	4/2015	S139-PMC4427001	['[31] studied WHETHER Vitamin D supplementation MAY improve Glycaemic Control in women with gdm.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('INCOMPLETE_EVIDENCE', 47)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0051162', 'L-arabitol metabolic process', 59, 'glycaemic control')]
PMC4427001	4/2015	S150-PMC4427001	['conclusions\nour study in Pregnant women of central european population DID NOT REPLICATE sporadic PREVIOUS FINDINGS of significantly decreased levels of Vitamin D in Gdm Pregnancy; HOWEVER, results SEEM TO BE criteria-sensitive (who versus iadpsg) and the topic WARRANTS FURTHER STUDY.']	[('INCOMPLETE_EVIDENCE', 71), ('ANOMALY_CURIOUS_FINDING', 75), ('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 98), ('INCOMPLETE_EVIDENCE', 107), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('ANOMALY_CURIOUS_FINDING', 198), ('FUTURE_WORK', 262), ('FUTURE_WORK', 271)]	9	[('GO_0007565', 'female pregnancy', 25, 'pregnant'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D'), ('GO_0070477', 'endospore core', 166, 'GDM'), ('GO_0007565', 'female pregnancy', 170, 'pregnancy')]
PMC4438628	5/2015	S151-PMC4438628	['WHETHER through changes in dietary patterns and/OR less time spent outdoors, the levels of Vitamin D MIGHT be lower [201-203].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 101)]	2	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
PMC4448820	5/2015	S192-PMC4448820	['INITIALLY, THESE OBSERVATIONS were RESTRICTED to Monocytes and Macrophages; HOWEVER, RECENT STUDIES SHOWED that cathelicidin Antimicrobial peptide (camp) is induced by Vitamin D in Keratinocytes and Respiratory and Bladder Epithelial Cells (113).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 76), ('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 100)]	7	[('CL_0000576', 'monocyte', 49, 'monocytes'), ('CL_0000235', 'macrophage', 63, 'macrophages'), ('CHEBI_65381', 'albizoside C', 125, 'antimicrobial'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D'), ('CL_0000312', 'keratinocyte', 181, 'keratinocytes'), ('CL_0000006', 'neuronal receptor cell', 199, 'respiratory ...'), ('GO_0045333', 'cellular respiration', 199, 'respiratory'), ('UBERON_0001004', 'respiratory system', 199, 'respiratory'), ('CL_1001428', 'bladder urothelial cell', 215, 'bladder epithelial cells'), ('UBERON_0001915', 'endothelium of capillary', 215, 'bladder epithelial')]
PMC4448820	5/2015	S242-PMC4448820	['in addition to Vitamins A and D, OTHER Nutrients MAY AFFECT the induction of Tregs.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 33), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 53)]	3	[('CHEBI_27300', 'vitamin D', 15, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 30, 'D'), ('CHEBI_33284', 'nutrient', 39, 'nutrients'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 77, 'Tregs')]
PMC4448820	5/2015	S351-PMC4448820	['because this mechanism has the POTENTIAL to alter the global abundance of Methyl Donors, and because Vitamin A has general actions on Cell Differentiation, it is UNKNOWN whether these EFFECTS are indirect OR WHETHER specific Genes are targeted for epigenetic Regulation by Vitamin A in vivo.']	[('INCOMPLETE_EVIDENCE', 31), ('FULL_UNKNOWN', 162), ('SUPERFICIAL_RELATIONSHIP', 184), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 205), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 208)]	5	[('CHEBI_6842', 'methoxychlor', 74, 'methyl donors'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin A'), ('GO_0030154', 'cell differentiation', 134, 'cell differentiation'), ('SO_0000704', 'gene', 225, 'genes'), ('GO_0065007', 'biological regulation', 259, 'regulation'), ('CHEBI_27300', 'vitamin D', 273, 'vitamin A')]
PMC4448820	5/2015	S378-PMC4448820	['Plasma Mirna profiles HAVE BEEN determined in subjects given high-dose Vitamin D, BUT the within-subject heterogeneity and SMALL number of subjects PRECLUDED any determination of definitive Vitamin D–Regulated Mirna (220).']	[('INCOMPLETE_EVIDENCE', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('INCOMPLETE_EVIDENCE', 123), ('INCOMPLETE_EVIDENCE', 148)]	4	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('SO_0000276', 'miRNA', 7, 'miRNA'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D'), ('GO_0065007', 'biological regulation', 200, 'regulated'), ('SO_0000276', 'miRNA', 210, 'miRNA')]
PMC4448820	5/2015	S380-PMC4448820	['there is OTHER EVIDENCE for a transgenerational EFFECT of Vitamin D on immunity.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 48)]	3	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC4448820	5/2015	S470-PMC4448820	['RATHER than a full discussion of each of the putative App mechanisms, a case study exploration of the various PROPOSED scenarios using Vitamin A as an example will be illuminating.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 110)]	2	[('PR_000004168', 'amyloid-beta precursor protein', 54, 'APP'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin A')]
PMC4448820	5/2015	S537-PMC4448820	['caption (table-wrap): table 6\n\neffects of Micronutrient supplementation on Immune function and vaccine responses (Human studies)1type of malnutrition and type of Immune functioneffects of supplementation on Immune System (reference)vitamin a\u2003Epithelial barrier function● high-dose vas above 6 mo of age decreases risk of death from infections such as measles and diarrheal diseases (290)● vas in the context of hiv infection or Lower Respiratory Tract infections HAS BEEN ASSOCIATED with adverse outcomes (105,263,290–292)● improved barrier function (105)● abnormal dual-Sugar (Lactulose, Mannitol) Intestinal permeability inversely CORRELATED with Serum Retinol (293) and PARTIALLY normalized by supplementation in va-deficient Individuals in SOME STUDIES (294) BUT NOT OTHERS (295,296)● increased symptomatology after high-dose vas during acute Lower Respiratory Tract infections REPORTED in SOME STUDIES (105) MAY INDICATE restored Mucus Production\u2003innate physiologic barriers● vas did not affect crp, saa, and/or agp concentrations among children with subclinical or clinical vad (297–299)● crp and agp did not change in men with low va stores given va (300)\u2003Macrophage function● increased Monocyte numbers (301)● decreased Tnf-Α concentrations in children (301) BUT the OPPOSITE in men (106)● decreased Ifn-Γ concentrations in children (302) but not in Pregnant women (303)● increased Il-10 concentrations in children (105,301) BUT no or an opposite effect in Adults (106,303,304)\u2003Neutrophil function● Neutrophil Phagocytosis of latex beads increased in va-deficient children given a single dose of Va (305)● Neutrophil Phagocytosis of E. Coli did not change in men with low Va stores given Va (300)\u2003Nk Cell function● an increase in Nk Cells in hiv-infected children supplemented with Va (105)● Nk Cell numbers did not change in men with low Va given supplemental Va; HOWEVER, there was a positive CORRELATION between Va stores and Peripheral Blood Nk Cells (300)\u2003T Cell function● increased Lymphocyte counts, particularly cd4 counts (105)● Cd4:Cd8 ratios were increased or unchanged by supplementation (306)● increase in Naive cd4 T Cells after supplementation; higher Memory Cd8, Cd45Ro (307)● higher Mitogen-induced Il-2, Il-4, and Tnf in response to supplementation (106)\u2003B Cell function● supplementation had no overall effect on Measles vaccine response (308) and a negative response in Individuals with baseline high titers (103)● no overall effect on oral polio vaccination● supplemented children increased Igg1 responses to dtp, minor igg3 response, no change in igg2 and igg4 (309)● no overall effect on bcg vaccine in Va-supplemented children, lower response in va-supplemented boys at 2 mo (310)● increased Antibody responses to some vaccines (Measles vaccine by 9 mo of age, oral polio vaccine, type 1, hepatitis b vaccine, rabies vaccine) (103)● short-term diminished cellular response to ppd in boys (103) and hospitalized children (105)Zinc\u2003Epithelial barrier function● zn supplementation in children LED TO an improvement in the lactulose:Mannitol Excretion ratio in SOME (311) BUT NOT OTHER (312,313) STUDIES; ratio MAY improve in infected children without zn deficiency given supplemental zn (314)\u2003innate physiologic barriers ● zn-supplemented children had higher Serum Complement C3 (315)\u2003Nk Cell function● children with diarrhea supplemented with zn supplementation do not exhibit an increase in Nk Cells (316)● increased Nk Cell activity in the elderly (317)\u2003T Cell function● increased cd4+ cell count in aids patients (318)● increased Thymocyte count in Thymus (319)● increased thymulin activity (320)● no CONSISTENT effect of zn supplementation on dth to tb Antigen [reviewed in (103)]\u2003B Cell function● no effect of zn supplementation of mothers on Bcg response in children (321)\nagp, α1-acid Glycoprotein; bcg, bacille calmette-guérin; cd, cluster of differentiation; Cd45Ro , Cluster Of Differentiation Antigen 45 Ro; Crp, c-reactive protein; dth, delayed-type hypersensitivity; dtp, diphtheria tetanus-pertussis; ppd, purified protein derivative; saa, Serum Amyloid a; tb, tuberculosis; va, Vitamin A; vad, Vitamin A deficiency; vas, Vitamin A supplementation.']	[('INCOMPLETE_EVIDENCE', 463), ('SUPERFICIAL_RELATIONSHIP', 472), ('SUPERFICIAL_RELATIONSHIP', 633), ('INCOMPLETE_EVIDENCE', 673), ('INCOMPLETE_EVIDENCE', 744), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 763), ('INCOMPLETE_EVIDENCE', 882), ('INCOMPLETE_EVIDENCE', 894), ('INCOMPLETE_EVIDENCE', 913), ('INCOMPLETE_EVIDENCE', 917), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1267), ('ANOMALY_CURIOUS_FINDING', 1267), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1275), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1433), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1873), ('SUPERFICIAL_RELATIONSHIP', 1903), ('SUPERFICIAL_RELATIONSHIP', 3021), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 3088), ('INCOMPLETE_EVIDENCE', 3088), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 3099), ('INCOMPLETE_EVIDENCE', 3123), ('INCOMPLETE_EVIDENCE', 3138), ('INCOMPLETE_EVIDENCE', 3633)]	23	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 42, 'micronutrient'), ('UBERON_0002405', 'immune system', 75, 'immune'), ('NCBITaxon_9606', 'Homo sapiens', 114, 'human'), ('UBERON_0002405', 'immune system', 162, 'immune'), ('UBERON_0002405', 'immune system', 207, 'immune system'), ('UBERON_0000483', 'epithelium', 242, 'Epithelial'), ('UBERON_0004905', 'articulation', 428, 'lower respiratory tract'), ('CHEBI_24870', 'ion', 571, 'sugar'), ('CHEBI_25098', 'lyxoside', 578, 'lactulose'), ('CHEBI_25169', 'mannoside', 589, 'mannitol'), ('UBERON_0000160', 'intestine', 599, 'intestinal'), ('UBERON_0001977', 'blood serum', 649, 'serum'), ('CHEBI_26536', 'retinoic acid', 655, 'retinol'), ('NCBITaxon_1', 'root', 729, 'individuals'), ('UBERON_0004905', 'articulation', 847, 'lower respiratory tract'), ('GO_0007498', 'mesoderm development', 935, 'mucus production'), ('UBERON_0000912', 'mucus', 935, 'mucus'), ('CL_0000235', 'macrophage', 1163, 'Macrophage'), ('CL_0000576', 'monocyte', 1194, 'monocyte'), ('PR_000000134', 'tumor necrosis factor alpha', 1228, 'TNF-α'), ('PR_000008920', 'interferon alpha-7', 1308, 'IFN-γ'), ('GO_0007565', 'female pregnancy', 1358, 'pregnant'), ('PR_000001470', 'interleukin-28B', 1390, 'IL-10'), ('UBERON_0007023', 'adult organism', 1465, 'adults'), ('CL_0000775', 'neutrophil', 1486, 'Neutrophil'), ('CL_0000775', 'neutrophil', 1507, 'Neutrophil'), ('GO_0007608', 'sensory perception of smell', 1507, 'Neutrophil'), ('GO_0006909', 'phagocytosis', 1518, 'phagocytosis'), ('CHEBI_37958', 'dye', 1604, 'VA'), ('CL_0000775', 'neutrophil', 1614, 'Neutrophil'), ('GO_0070231', 'T cell apoptotic process', 1614, 'Neutrophil phagocytosis'), ('NCBITaxon_10088', 'Mus <genus>', 1641, 'E. coli'), ('CHEBI_37958', 'dye', 1680, 'VA'), ('CHEBI_37958', 'dye', 1696, 'VA'), ('CL_0000623', 'natural killer cell', 1705, 'NK cell'), ('GO_0005634', 'nucleus', 1705, 'NK'), ('CL_0000623', 'natural killer cell', 1738, 'NK cells'), ('GO_0005634', 'nucleus', 1738, 'NK'), ('CHEBI_37958', 'dye', 1790, 'VA'), ('CL_0000623', 'natural killer cell', 1800, 'NK cell'), ('GO_0005634', 'nucleus', 1800, 'NK'), ('CHEBI_37958', 'dye', 1847, 'VA'), ('CHEBI_37958', 'dye', 1869, 'VA'), ('CHEBI_37958', 'dye', 1923, 'VA'), ('UBERON_0012101', 'perinatal stage', 1937, 'peripheral blood'), ('CL_0000623', 'natural killer cell', 1954, 'NK cells'), ('GO_0005634', 'nucleus', 1954, 'NK'), ('CL_0000084', 'T cell', 1969, 'T cell'), ('CL_0000542', 'lymphocyte', 1996, 'lymphocyte'), ('PR_000001204', 'C-C chemokine receptor type 8', 2046, 'CD4'), ('PR_000005170', 'CD37 molecule', 2050, 'CD8'), ('CL_0000898', 'naive T cell', 2127, 'naive ... T cells'), ('GO_0007613', 'memory', 2175, 'memory'), ('PR_000005170', 'CD37 molecule', 2182, 'CD8'), ('PR_000005170', 'CD37 molecule', 2187, 'CD45RO'), ('CHEBI_52290', 'mitogen', 2208, 'mitogen'), ('PR_000001470', 'interleukin-28B', 2224, 'IL-2'), ('PR_000001470', 'interleukin-28B', 2230, 'IL-4'), ('PR_000016482', 'tumor necrosis factor receptor superfamily member 18', 2240, 'TNF'), ('CL_0000236', 'B cell', 2281, 'B cell'), ('NCBITaxon_33208', 'Metazoa', 2339, 'measles'), ('NCBITaxon_1', 'root', 2397, 'individuals'), ('GO_0071735', 'IgG immunoglobulin complex', 2519, 'IgG1'), ('CHEBI_37958', 'dye', 2633, 'VA'), ('GO_0042571', 'immunoglobulin complex, circulating', 2723, 'antibody'), ('NCBITaxon_33208', 'Metazoa', 2760, 'measles'), ('CHEBI_27377', "Unsym-bis(4'-chlorophenyl)ethylene", 2956, 'Zinc'), ('UBERON_0000483', 'epithelium', 2961, 'Epithelial'), ('CHEBI_25169', 'mannoside', 3060, 'mannitol'), ('GO_0007588', 'excretion', 3069, 'excretion'), ('UBERON_0001977', 'blood serum', 3287, 'serum'), ('PR_000004908', 'complement component C8 alpha chain', 3293, 'complement C3'), ('CL_0000623', 'natural killer cell', 3313, 'NK cell'), ('GO_0005634', 'nucleus', 3313, 'NK'), ('CL_0000623', 'natural killer cell', 3421, 'NK cells'), ('CL_0000623', 'natural killer cell', 3447, 'NK cell'), ('CL_0000084', 'T cell', 3485, 'T cell'), ('CL_0000893', 'thymocyte', 3562, 'thymocyte'), ('UBERON_0002370', 'thymus', 3581, 'thymus'), ('CHEBI_59132', 'antigen', 3686, 'antigen'), ('CL_0000236', 'B cell', 3714, 'B cell'), ('CHEBI_33250', 'atom', 3777, 'BCG'), ('CHEBI_17089', 'glycoprotein', 3821, 'glycoprotein'), ('PR_000005170', 'CD37 molecule', 3897, 'CD45RO'), ('PR_000011040', 'nuclear receptor coactivator 1', 3906, 'cluster of differentiation antigen 45 RO'), ('CHEBI_59132', 'antigen', 3933, 'antigen'), ('PR_000005890', 'crooked neck-like protein 1', 3948, 'CRP'), ('UBERON_0001977', 'blood serum', 4083, 'serum'), ('CHEBI_60425', 'amyloid fibril', 4089, 'amyloid'), ('CHEBI_27300', 'vitamin D', 4122, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 4138, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 4165, 'vitamin A')]
PMC4448820	5/2015	S581-PMC4448820	['ALTHOUGH Vitamin A MAY have a preventive EFFECT on the incidence or severity of diarrhea and measles in community trials, it has had LITTLE or the OPPOSITE EFFECT on Respiratory infections (105).']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 133), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 147), ('SUPERFICIAL_RELATIONSHIP', 156)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin A'), ('UBERON_0001004', 'respiratory system', 166, 'respiratory')]
PMC4448820	5/2015	S584-PMC4448820	['for instance, neonatal Vitamin A supplementation had a DIFFERENT EFFECT on in vitro whole-Blood cytokine responses DEPENDING ON the sex and the vaccination status of the children (301).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 55), ('SUPERFICIAL_RELATIONSHIP', 65), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin A'), ('UBERON_0000178', 'blood', 90, 'blood')]
PMC4448820	5/2015	S593-PMC4448820	['HOWEVER, the EFFECTS of Vitamin A supplementation on the Immune System MAY lead TO variable clinical outcomes, DEPENDING ON the nature of the Immune Response NEEDED to combat the infecting pathogens.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 71), ('QUESTION_ANSWERED_BY_THIS_WORK', 80), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('IMPORTANT_CONSIDERATION', 158)]	6	[('CHEBI_27300', 'vitamin D', 24, 'vitamin A'), ('UBERON_0002405', 'immune system', 57, 'immune system'), ('GO_0006955', 'immune response', 142, 'immune response'), ('UBERON_0002405', 'immune system', 142, 'immune')]
PMC4448820	5/2015	S595-PMC4448820	['for SOME—and on THE BASIS of the clinical trials, PRESUMABLY most—infectious diseases, Vitamin A supplementation MAY BE beneficial; in OTHER situations it MAY be harmful (369,370).']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 16), ('PROBABLE_UNDERSTANDING', 50), ('INCOMPLETE_EVIDENCE', 113), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135), ('INCOMPLETE_EVIDENCE', 155)]	6	[('CHEBI_27300', 'vitamin D', 87, 'vitamin A')]
PMC4448820	5/2015	S867-PMC4448820	['ANOTHER example is the observation that Vitamin A supplementation, which GENERALLY lowers mortality in children, increased the RISK of Mother-To-Child Hiv Transmission in pregnant and Postpartum hiv-infected women in tanzania (469), ALTHOUGH not in south africa (470) or malawi (471).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 73), ('IMPORTANT_CONSIDERATION', 127), ('ANOMALY_CURIOUS_FINDING', 233)]	4	[('CHEBI_27300', 'vitamin D', 40, 'vitamin A'), ('GO_0007063', 'regulation of sister chromatid cohesion', 135, 'mother-to-child HIV transmission'), ('GO_0007565', 'female pregnancy', 184, 'postpartum')]
PMC4448820	5/2015	S1039-PMC4448820	['Vitamin D\n\n● POOR Prenatal Vitamin D status HAS BEEN IMPLICATED in increased asthma risk and severity in the offspring, ALTHOUGH EVIDENCE TO SUPPORT an IMPORTANT RELATION remains CONTROVERSIAL (577).']	[('IMPORTANT_CONSIDERATION', 13), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 53), ('ANOMALY_CURIOUS_FINDING', 120), ('INCOMPLETE_EVIDENCE', 129), ('IMPORTANT_CONSIDERATION', 152), ('SUPERFICIAL_RELATIONSHIP', 162), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 179)]	8	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 18, 'prenatal'), ('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
PMC4448820	5/2015	S1135-PMC4448820	['in SOME conditions, supplementation with Vitamins A, d, and e and copper and Selenium was PROTECTIVE against mastitis (652), BUT others REPORTED in hiv-infected women that antioxidant Micronutrient supplementation did not lower (660), and MIGHT EVEN increase the risk of scm (661).']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 125), ('INCOMPLETE_EVIDENCE', 136), ('INCOMPLETE_EVIDENCE', 239), ('ANOMALY_CURIOUS_FINDING', 245)]	6	[('CHEBI_27300', 'vitamin D', 41, 'vitamins A'), ('CHEBI_27568', 'selenium atom', 77, 'selenium'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 184, 'micronutrient')]
PMC4448820	5/2015	S1457-PMC4448820	['● Retinol isotope dilution: ALTHOUGH not widely used clinically or programmatically, this is the most sensitive BIOMARKER of Vitamin A status to Liver reserves of Vitamin A.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('SUPERFICIAL_RELATIONSHIP', 112)]	2	[('CHEBI_27810', 'resorcinol', 2, 'Retinol'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin A'), ('UBERON_0002107', 'liver', 145, 'liver'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin A')]
PMC4448820	5/2015	S1471-PMC4448820	['BECAUSE Human Milk HAS BEEN SUGGESTED as a POTENTIALLY useful BIOMARKER of Vitamin A status of women and, by extrapolation, of their children and POTENTIALLY OTHER groups within the population (324), it is useful to explore the POTENTIAL IMPACT of inflammation on the use of Breast-Milk Vitamin A concentrations and interpretation.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 62), ('INCOMPLETE_EVIDENCE', 146), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158), ('INCOMPLETE_EVIDENCE', 228), ('SUPERFICIAL_RELATIONSHIP', 238)]	8	[('NCBITaxon_9606', 'Homo sapiens', 8, 'human'), ('UBERON_0001913', 'milk', 14, 'milk'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin A'), ('UBERON_0000310', 'breast', 275, 'breast'), ('UBERON_0001913', 'milk', 282, 'milk'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin A')]
PMC4448820	5/2015	S1473-PMC4448820	['HOWEVER, recent data from a subset of women recruited as part of a national survey in cameroon INDICATE that Human-milk Vitamin A concentrations (casual samples at ≥1 mo Postpartum) were ASSOCIATED with crp, and this ASSOCIATION SEEMED TO BE EXPLAINED by a decrease in Plasma rbp (776).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 95), ('SUPERFICIAL_RELATIONSHIP', 187), ('SUPERFICIAL_RELATIONSHIP', 217), ('ANOMALY_CURIOUS_FINDING', 229), ('PROBABLE_UNDERSTANDING', 242)]	6	[('NCBITaxon_9606', 'Homo sapiens', 109, 'human'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin A'), ('GO_0007565', 'female pregnancy', 170, 'postpartum'), ('UBERON_0001969', 'blood plasma', 269, 'plasma')]
PMC4448820	5/2015	S1474-PMC4448820	['the overall RELATION between inflammation, specific BIOMARKERS such as crp and Human-milk Vitamin A REMAINS UNRESOLVED.']	[('SUPERFICIAL_RELATIONSHIP', 12), ('SUPERFICIAL_RELATIONSHIP', 52), ('INCOMPLETE_EVIDENCE', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 108)]	4	[('NCBITaxon_9606', 'Homo sapiens', 79, 'human'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin A')]
PMC4448820	5/2015	S1550-PMC4448820	['HOWEVER, it was POSSIBLE to interpret these Micronutrients IF the systemic inflammatory response was less severe: for zinc when crp is <20 mg/l, for Selenium and Vitamins A and D when crp is <10 mg/l, and for Vitamins B-6 and C when crp is <5 mg/l.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 59)]	3	[('CHEBI_33839', 'macromolecule', 44, 'micronutrients'), ('CHEBI_27568', 'selenium atom', 149, 'selenium'), ('CHEBI_27300', 'vitamin D', 162, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 162, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 177, 'D'), ('PR_000006444', 'diacylglycerol kinase delta', 177, 'D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamins B'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 209, 'vitamins B-6'), ('PR_000004900', 'complement C3', 226, 'C')]
PMC4452099	6/2015	S0-PMC4452099	['Gestational and early infancy exposure to margarine fortified with Vitamin D through a national danish programme and the risk of type 1 diabetes: the d-tect study\n\nabstract\nthe OBJECTIVE of the study was TO ASSESS WHETHER Gestational and early Infancy exposure to low dose Vitamin D from a mandatory Margarine fortification programme in denmark INFLUENCED the risk of developing type 1 diabetes (t1d) before age of 15 years.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 177), ('QUESTION_ANSWERED_BY_THIS_WORK', 204), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 214), ('SUPERFICIAL_RELATIONSHIP', 345)]	4	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('CHEBI_28384', 'vitamin K', 67, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 67, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 222, 'gestational'), ('UBERON_0000023', 'wing', 244, 'infancy'), ('CHEBI_27300', 'vitamin D', 273, 'vitamin D'), ('CHEBI_6784', 'mestranol', 300, 'margarine')]
PMC4452099	6/2015	S27-PMC4452099	['the REPORTED REASON to initiate mandatory fortification was the need to substitute the lack of Vitamin D in Margarine COMPARED to butter, WHILE the decision to cancel mandatory margarine fortification was justified by the low Vitamin D doses added to the Margarine products—an ARGUMENT which, HOWEVER, DID NOT SEEM TO BE EVIDENCE-BASED.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 13), ('ANOMALY_CURIOUS_FINDING', 118), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 138), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 277), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 293), ('INCOMPLETE_EVIDENCE', 302), ('ANOMALY_CURIOUS_FINDING', 310), ('INCOMPLETE_EVIDENCE', 315)]	9	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_6784', 'mestranol', 108, 'margarine'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('CHEBI_6784', 'mestranol', 255, 'margarine')]
PMC4452099	6/2015	S28-PMC4452099	['the AIM of THIS STUDY was TO ASSESS WHETHER Gestational and early Infancy exposure to small extra doses of Vitamin D coming from fortified Margarine INFLUENCED the risk of developing t1d later in Life.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 36), ('SUPERFICIAL_RELATIONSHIP', 149)]	5	[('GO_0007565', 'female pregnancy', 44, 'gestational'), ('UBERON_0000023', 'wing', 66, 'infancy'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('CHEBI_6784', 'mestranol', 139, 'margarine'), ('UBERON_0000104', 'life cycle', 196, 'life')]
PMC4452099	6/2015	S91-PMC4452099	['ON THE OTHER HAND, only a small proportion of Vitamin D passes from the maternal circulation to Breast Milk[30].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0001348', 'brown adipose tissue', 96, 'breast milk')]
PMC4452099	6/2015	S96-PMC4452099	['ANOTHER POTENTIAL REASON WHY we DID NOT detect EFFECTS of early exposure to Vitamin D fortification on later t1d risk MAY BE RELATED to statistical power ISSUES [32].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('PROBABLE_UNDERSTANDING', 18), ('EXPLICIT_QUESTION', 25), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 125), ('PROBLEM_COMPLICATION', 154)]	9	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC4452099	6/2015	S100-PMC4452099	['all of these FACTORS, which in DIFFERENT ways MAY BE RELATED to either Vitamin D intake and/or t1d risk, can be ASSUMED to be balanced between the Individuals from the various exposure groups, and THEREFORE CONFOUNDING is not to be expected.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 53), ('PROBABLE_UNDERSTANDING', 112), ('PROBABLE_UNDERSTANDING', 197), ('PROBLEM_COMPLICATION', 207)]	7	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('NCBITaxon_1', 'root', 147, 'individuals')]
PMC4466139	6/2015	S88-PMC4466139	['these two classifications of Vitamin D status are significantly DIVERGENT and the issue of DESIRABLE Vitamin D levels for a given age is a matter of great DEBATE, especially in the light of the Skeletal and Extraskeletal EFFECTS of Vitamin D (these were NOT BEEN INVESTIGATED in this study).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 64), ('IMPORTANT_CONSIDERATION', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 155), ('SUPERFICIAL_RELATIONSHIP', 221), ('FULL_UNKNOWN', 254)]	5	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('UBERON_0004288', 'skeleton', 194, 'skeletal'), ('UBERON_0001431', 'distal carpal bone 2', 207, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 232, 'vitamin D')]
PMC4466139	6/2015	S93-PMC4466139	['THESE STUDIES EVEN IF LIMITED to specific populations (caucasians [28], arab an asian [29], rural populations of south china [30]) SHOW a COMPLEX picture of Genetic FACTORS determining the level of 25Ohd and consequent risks of deficiency of Vitamin D. DESPITE this, the environmental COMPONENT is STILL preponderant ALTHOUGH LIMITED to 57–71% in determining the level of 25Ohd.']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 131), ('DIFFICULT_TASK', 138), ('SUPERFICIAL_RELATIONSHIP', 165), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 253), ('ANOMALY_CURIOUS_FINDING', 253), ('SUPERFICIAL_RELATIONSHIP', 285), ('IMPORTANT_CONSIDERATION', 298), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 317), ('INCOMPLETE_EVIDENCE', 326)]	13	[('SO_0000704', 'gene', 157, 'genetic'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 198, '25OHD'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 372, '25OHD')]
PMC4466139	6/2015	S98-PMC4466139	['the mechanisms INVOLVED in this reduction of neonatal 25Ohd levels are NOT YET KNOWN; it MAY BE the result of DIFFERENT Vitamin D binding proteins concentrations OR a different 25Ohd half-life in the neonatal age [23,32].']	[('SUPERFICIAL_RELATIONSHIP', 15), ('FULL_UNKNOWN', 71), ('INCOMPLETE_EVIDENCE', 89), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 110), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 162)]	5	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 54, '25OHD'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 177, '25OHD')]
PMC4476607	1/2015	S147-PMC4476607	['ALTHOUGH antioxidant treatments in Animal MODELS are encouraging, researchers PREMATURELY terminated a clinical trial utilizing high doses of Vitamins C and E in women with Alcohol-exposed Pregnancies BECAUSE of SAFETY CONCERNS (goh et al.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('INCOMPLETE_EVIDENCE', 42), ('PROBLEM_COMPLICATION', 78), ('PROBLEM_COMPLICATION', 201), ('IMPORTANT_CONSIDERATION', 212), ('IMPORTANT_CONSIDERATION', 219), ('PROBLEM_COMPLICATION', 219)]	9	[('NCBITaxon_33208', 'Metazoa', 35, 'animal'), ('CHEBI_27300', 'vitamin D', 142, 'vitamins C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 157, 'E'), ('CHEBI_30879', 'alcohol', 173, 'alcohol'), ('GO_0007565', 'female pregnancy', 189, 'pregnancies')]
PMC4488777	5/2015	S10-PMC4488777	['ON THE OTHER HAND, EVIDENCE-BASED research DID NOT prove a significant DIFFERENCE so far in Ovulation stimulation or Embryo Development depending on Vitamin D level.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 43), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71)]	4	[('GO_0030728', 'ovulation', 92, 'ovulation'), ('GO_0009790', 'embryo development', 117, 'embryo development'), ('UBERON_0000922', 'embryo', 117, 'embryo'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC4488777	5/2015	S12-PMC4488777	['Vitamin D is definitely not a trojan horse in Reproductive health, SINCE there were no adverse effects REPORTED for Vitamin D intake of up to 10,000 iu/day, BUT to PROCLAIM it the golden fleece, MORE EVIDENCE IS NEEDED.']	[('PROBABLE_UNDERSTANDING', 67), ('INCOMPLETE_EVIDENCE', 103), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 157), ('INCOMPLETE_EVIDENCE', 164), ('FUTURE_WORK', 195)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0000003', 'reproduction', 46, 'reproductive'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC4488777	5/2015	S191-PMC4488777	['Vitamin D is definitely not a trojan horse in Reproductive health since there were no adverse EFFECTS REPORTED for Vitamin D intake of up to 10,000 iu/d [66], BUT to PROCLAIM it the golden fleece, MORE EVIDENCE IS still REQUIRED.']	[('SUPERFICIAL_RELATIONSHIP', 94), ('INCOMPLETE_EVIDENCE', 102), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 159), ('INCOMPLETE_EVIDENCE', 166), ('FUTURE_WORK', 197)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0000003', 'reproduction', 46, 'reproductive'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC4490503	6/2015	S298-PMC4490503	['FOUND that increased Parathyroid hormone, RATHER than Vitamin D deficiency was INDEPENDENTLY ASSOCIATED with dysglycaemia in Pregnancy in 524 women when tested in conjunction with the ogtt [124].']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('SUPERFICIAL_RELATIONSHIP', 79), ('SUPERFICIAL_RELATIONSHIP', 93)]	4	[('UBERON_0001132', 'parathyroid gland', 21, 'parathyroid'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007565', 'female pregnancy', 125, 'pregnancy')]
PMC4490503	6/2015	S308-PMC4490503	['FURTHER rcts are CRUCIAL to determining WHETHER Vitamin D has a ROLE in pathophysiology of gdm and WHETHER supplementation has a ROLE in preventing gdm [129].']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 40), ('SUPERFICIAL_RELATIONSHIP', 64), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99), ('SUPERFICIAL_RELATIONSHIP', 129)]	6	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
PMC4499946	7/2015	S1-PMC4499946	['SOME observational STUDIES have SUGGESTED that Prenatal Vitamin D deficiency increases the RISK of adverse Pregnancy and/or Birth outcomes; HOWEVER, there is SCANT EVIDENCE from controlled trials, leading the world health organization to advise against routine Vitamin D supplementation in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 32), ('IMPORTANT_CONSIDERATION', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 140), ('INCOMPLETE_EVIDENCE', 158)]	5	[('GO_0007565', 'female pregnancy', 47, 'prenatal'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007608', 'sensory perception of smell', 107, 'pregnancy ...'), ('GO_0007567', 'parturition', 124, 'birth'), ('CHEBI_27300', 'vitamin D', 261, 'vitamin D'), ('GO_0007565', 'female pregnancy', 290, 'pregnancy')]
PMC4499946	7/2015	S9-PMC4499946	['discussion\nthe ROLE of Vitamin D in maternal and infant health remains UNRESOLVED.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D')]
PMC4499946	7/2015	S22-PMC4499946	['EFFECTS of improvements in Vitamin D status on linear growth in infants and children without rickets have not been widely studied; HOWEVER, in one TRIAL in india, weekly Vitamin D supplementation of low Birth weight infants reduced the risk of stunting in adjusted analyses [14].']	[('SUPERFICIAL_RELATIONSHIP', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('INCOMPLETE_EVIDENCE', 147)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('GO_0007567', 'parturition', 203, 'birth')]
PMC4499946	7/2015	S28-PMC4499946	['OBSERVATIONAL studies of the ASSOCIATION between maternal Prenatal Vitamin D status and infant anthropometry have yielded CONFLICTING findings [19–23].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122)]	3	[('GO_0007565', 'female pregnancy', 58, 'prenatal'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC4499946	7/2015	S36-PMC4499946	['the EFFECT APPEARED TO BE attributable to a significantly accelerated increase in mean Laz from Birth to 1 month of age (change of 0.53 z-score in Vitamin D versus 0.19 z-score in placebo group; p = 0.004) RATHER than a significant difference in Birth length [26].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('ANOMALY_CURIOUS_FINDING', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 206)]	3	[('PR_000009655', 'laminin subunit beta-2', 87, 'LAZ'), ('GO_0007567', 'parturition', 96, 'birth'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0007567', 'parturition', 246, 'birth')]
PMC4499946	7/2015	S37-PMC4499946	['HOWEVER, SOME Animal [27] and observational [21,28] studies have SUGGESTED an EFFECT of maternal Prenatal Vitamin D status on growth of the fetus.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 65), ('SUPERFICIAL_RELATIONSHIP', 78)]	4	[('NCBITaxon_33208', 'Metazoa', 14, 'animal'), ('GO_0007565', 'female pregnancy', 97, 'prenatal'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D')]
PMC4499946	7/2015	S40-PMC4499946	['HOWEVER, there is SCANT EVIDENCE from controlled clinical trials [31,32], and the world health organization (who) RECENTLY advised against routine Vitamin D supplementation in Pregnancy until further data become available [33].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 114)]	3	[('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0007565', 'female pregnancy', 176, 'pregnancy')]
PMC4499946	7/2015	S42-PMC4499946	['the primary AIM is TO INVESTIGATE the EFFECT of maternal Vitamin D supplementation on infant length at 1 year of age, but the trial also provides an OPPORTUNITY to study a range of OTHER POTENTIAL Vitamin D–responsive outcomes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('SUPERFICIAL_RELATIONSHIP', 38), ('FUTURE_WORK', 149), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('INCOMPLETE_EVIDENCE', 187)]	6	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D')]
PMC4499946	7/2015	S271-PMC4499946	['HOWEVER, this test is non-specific and frequently led TO the need for repeat testing that was burdensome but uninformative; in no cases did an isolated ca:cr ratio indicate Vitamin D toxicity.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 54)]	2	[('CHEBI_27300', 'vitamin D', 173, 'vitamin D')]
PMC4499946	7/2015	S273-PMC4499946	['HOWEVER, we will measure Urinary ca:cr ratio in mothers at Delivery as a screening test for hypercalciuria RATHER than for overt Vitamin D toxicity.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 107)]	2	[('UBERON_0001088', 'urine', 25, 'urinary'), ('GO_0007567', 'parturition', 59, 'delivery'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D')]
PMC4499946	7/2015	S294-PMC4499946	['HOWEVER, these and OTHER registered Prenatal Vitamin D trials are being conducted in high-income countries.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 19)]	2	[('GO_0007565', 'female pregnancy', 36, 'prenatal'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC4499946	7/2015	S296-PMC4499946	['the trial is primarily DESIGNED and powered TO EVALUATE the dose–response EFFECTS of Vitamin D on infant length, an outcome that is directly ALIGNED with the classical ROLE of Vitamin D in Mineral Metabolism and bone health BUT MAY also be interpreted as a SURROGATE marker for Organ (including Brain) Growth and Development.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 44), ('SUPERFICIAL_RELATIONSHIP', 74), ('SUPERFICIAL_RELATIONSHIP', 141), ('SUPERFICIAL_RELATIONSHIP', 168), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 224), ('INCOMPLETE_EVIDENCE', 228), ('SUPERFICIAL_RELATIONSHIP', 257)]	8	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin D'), ('CHEBI_46662', 'mineral', 189, 'mineral'), ('GO_0008152', 'metabolic process', 197, 'metabolism'), ('UBERON_0000062', 'organ', 278, 'organ'), ('GO_0007420', 'brain development', 295, 'brain ... growth ... development'), ('UBERON_0000955', 'brain', 295, 'brain')]
PMC4499946	7/2015	S298-PMC4499946	['longer-term surveillance of the infant cohort will IDEALLY enable the assessment of OTHER IMPORTANT clinical outcomes (e.g., asthma, Neurodevelopment) that MAY be INFLUENCED by the NON-CLASSICAL ROLE of Vitamin D in immunoregulation and Extraskeletal Cellular Proliferation and Differentiation.']	[('IMPORTANT_CONSIDERATION', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 84), ('IMPORTANT_CONSIDERATION', 90), ('INCOMPLETE_EVIDENCE', 156), ('SUPERFICIAL_RELATIONSHIP', 163), ('PROBLEM_COMPLICATION', 181), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 185), ('SUPERFICIAL_RELATIONSHIP', 195)]	8	[('GO_0007399', 'nervous system development', 133, 'neurodevelopment'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 237, 'extraskeletal'), ('GO_0030154', 'cell differentiation', 251, 'cellular proliferation ... differentiation')]
PMC4514967	12/2014	S87-PMC4514967	['low Cord Blood Vitamin D levels are a PREDICTOR of subsequent infant Respiratory infections.70,71HOWEVER, data from clinical trials are too LIMITED to draw conclusions about the efficacy and SAFETY of Vitamin D supplementation in Pregnancy.72meta-analyses have HIGHLIGHTED THE NEED to extend endpoints in intervention trials of multiple Micronutrients in Pregnancy.30the timing of Nutrient interventions during Pregnancy or before Conception is an IMPORTANT clinical study parameter to CONSIDER in any meta-analysis designed to evaluate the EFFECTS of an intervention or interventions and the OBSERVED effect size.']	[('SUPERFICIAL_RELATIONSHIP', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('INCOMPLETE_EVIDENCE', 140), ('IMPORTANT_CONSIDERATION', 191), ('INCOMPLETE_EVIDENCE', 261), ('INCOMPLETE_EVIDENCE', 273), ('FUTURE_WORK', 277), ('IMPORTANT_CONSIDERATION', 448), ('FUTURE_WORK', 486), ('SUPERFICIAL_RELATIONSHIP', 541), ('INCOMPLETE_EVIDENCE', 593)]	11	[('UBERON_0002240', 'spinal cord', 4, 'cord'), ('UBERON_0000178', 'blood', 9, 'blood'), ('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 69, 'respiratory'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D'), ('GO_0007565', 'female pregnancy', 230, 'pregnancy'), ('CHEBI_33839', 'macromolecule', 337, 'micronutrients'), ('GO_0007565', 'female pregnancy', 355, 'pregnancy'), ('CHEBI_33284', 'nutrient', 381, 'nutrient'), ('GO_0007565', 'female pregnancy', 411, 'pregnancy'), ('GO_0007620', 'copulation', 431, 'conception')]
PMC4516109	5/2015	S20-PMC4516109	['clinical presentations include Abdominal pain, vomiting, lethargy, hallucinations, confusion, hypoglycemia, deafness, tinnitus, tachypnea, irritability, Metabolic acidosis, coma and death.15\nrisks of OTHER topical agents, such as Anthralin and Calcipotriol on Human studies are NOT KNOWN and THUS most authors CONTRAINDICATE these treatments.7,15calcipotriol is a by-product of Vitamin D3, OFTEN used in combination with topical Corticosteroids in order to increase their effectiveness and minimize irritation.12nevertheless, studies evidenced its systemic absorption in Humans after application on psoriasis plaques and the development of Vitamin D-induced toxicity after treatment with Calcipotriol TENDS to increase the risk of teratogenicity.12\nALTHOUGH the NUMBER OF cases is LIMITED, coal tar HAS BEEN ASSOCIATED with spontaneous Abortions and congenital disorders, and WAS CONSIDERED Teratogenic in Animal studies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 200), ('FULL_UNKNOWN', 278), ('PROBABLE_UNDERSTANDING', 292), ('IMPORTANT_CONSIDERATION', 310), ('PROBABLE_UNDERSTANDING', 390), ('SUPERFICIAL_RELATIONSHIP', 701), ('ANOMALY_CURIOUS_FINDING', 749), ('INCOMPLETE_EVIDENCE', 762), ('INCOMPLETE_EVIDENCE', 781), ('INCOMPLETE_EVIDENCE', 799), ('SUPERFICIAL_RELATIONSHIP', 808), ('INCOMPLETE_EVIDENCE', 876)]	12	[('UBERON_0000916', 'abdomen', 31, 'abdominal'), ('GO_0008152', 'metabolic process', 153, 'metabolic'), ('CHEBI_37510', 'anthralin', 230, 'anthralin'), ('CHEBI_50749', 'calcipotriol', 244, 'calcipotriol'), ('NCBITaxon_9606', 'Homo sapiens', 260, 'human'), ('CHEBI_33279', 'vitamin D5', 378, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 378, 'vitamin D3'), ('CHEBI_50850', 'etabonate ester', 429, 'corticosteroids'), ('NCBITaxon_9606', 'Homo sapiens', 571, 'humans'), ('CHEBI_27300', 'vitamin D', 640, 'vitamin D'), ('CHEBI_50749', 'calcipotriol', 688, 'calcipotriol'), ('GO_0006915', 'apoptotic process', 836, 'abortions'), ('CHEBI_50905', 'teratogenic agent', 891, 'teratogenic'), ('NCBITaxon_33208', 'Metazoa', 906, 'animal')]
PMC4516377	6/2015	S13-PMC4516377	['the deficiency of Micronutrients, such as Calcium and Vitamin D, is common in many countries, REGARDLESS OF the nutritional status; HOWEVER, its magnitude is greater in children with excess weight.2,5-7in this context, CONCERNS about the ASSOCIATION between Calcium intake and Serum Vitamin D and Metabolic diseases in children has gained prominence in the scientific world for at least 30 years,8and SEVERAL STUDIES HAVE ATTEMPTED to clarify the several QUESTIONS about the subject,6,9,10as the combination of low Serum 25-Hydroxyvitamin D (25 [Oh] D) and INADEQUATE Calcium Intake HAS BEEN ASSOCIATED with Cardiovascular risk factors such as hypertension, obesity, Metabolic syndrome (ms) and type 2 diabetes mellitus.2,4,5,8that is, the combined deficiency of both Nutrients DESERVE special CONSIDERATION in children.4\nHOWEVER, the RECOMMENDATIONS of Calcium and Vitamin D intake have NOT been PROPOSED for the PREVENTION of noncommunicable chronic diseases, AS the STUDIES are STILL SCARCE, INCONSISTENT and SOMETIMES of poor quality.11ALTHOUGH Vitamin D insufficiency and low Calcium intake are commonly REPORTED, LITTLE IS KNOWN about the EFFECT of these Micronutrients in the prevention and treatment of diseases such as obesity.']	[('INCOMPLETE_EVIDENCE', 94), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('PROBLEM_COMPLICATION', 219), ('SUPERFICIAL_RELATIONSHIP', 238), ('INCOMPLETE_EVIDENCE', 401), ('IMPORTANT_CONSIDERATION', 417), ('DIFFICULT_TASK', 422), ('INCOMPLETE_EVIDENCE', 422), ('EXPLICIT_QUESTION', 455), ('IMPORTANT_CONSIDERATION', 557), ('INCOMPLETE_EVIDENCE', 583), ('SUPERFICIAL_RELATIONSHIP', 592), ('IMPORTANT_CONSIDERATION', 778), ('FUTURE_WORK', 794), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 822), ('FUTURE_WORK', 835), ('ANOMALY_CURIOUS_FINDING', 888), ('INCOMPLETE_EVIDENCE', 897), ('SUPERFICIAL_RELATIONSHIP', 914), ('PROBABLE_UNDERSTANDING', 962), ('INCOMPLETE_EVIDENCE', 969), ('IMPORTANT_CONSIDERATION', 981), ('INCOMPLETE_EVIDENCE', 987), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 995), ('INCOMPLETE_EVIDENCE', 1012), ('ANOMALY_CURIOUS_FINDING', 1038), ('INCOMPLETE_EVIDENCE', 1109), ('FULL_UNKNOWN', 1119), ('SUPERFICIAL_RELATIONSHIP', 1145)]	29	[('CHEBI_33839', 'macromolecule', 18, 'micronutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 42, 'calcium'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 258, 'calcium'), ('UBERON_0001977', 'blood serum', 277, 'serum'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D'), ('GO_0008152', 'metabolic process', 297, 'metabolic'), ('UBERON_0001977', 'blood serum', 515, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 521, '25-hydroxyvitamin D'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 542, '25 [OH] D'), ('CHEBI_22313', 'alkaline earth metal atom', 568, 'calcium'), ('GO_0007631', 'feeding behavior', 576, 'intake'), ('UBERON_0004535', 'cardiovascular system', 608, 'cardiovascular'), ('GO_0008152', 'metabolic process', 667, 'metabolic'), ('CHEBI_33284', 'nutrient', 768, 'nutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 854, 'calcium'), ('CHEBI_27300', 'vitamin D', 866, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1049, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 1081, 'calcium'), ('CHEBI_33839', 'macromolecule', 1161, 'micronutrients')]
PMC4516377	6/2015	S43-PMC4516377	['Serum levels of Vitamin D were significantly ASSOCIATED with higher bmi, waist circumference and Serum Triacylglycerols, as well as lower hdl levels.20the authors of this study used the same categorization of Vitamin D levels of the iom, BUT cited another reference.22finally, a longitudinal study in the brazilian amazon region, followed children from 2007 to 2012 with the OBJECTIVE of evaluating the EFFECT of the Fto Gene on bmi modifications during childhood, as well as verifying WHETHER the Vitamin D status COULD modify this EFFECT.']	[('SUPERFICIAL_RELATIONSHIP', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 238), ('QUESTION_ANSWERED_BY_THIS_WORK', 375), ('SUPERFICIAL_RELATIONSHIP', 403), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 486), ('INCOMPLETE_EVIDENCE', 515), ('SUPERFICIAL_RELATIONSHIP', 533)]	7	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('UBERON_0001977', 'blood serum', 97, 'serum'), ('CHEBI_17075', '6-hydroxyhexano-6-lactone', 103, 'triacylglycerols'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D'), ('PR_000007702', 'galactoside alpha-(1,2)-fucosyltransferase 1', 417, 'FTO'), ('SO_0000704', 'gene', 421, 'gene'), ('CHEBI_27300', 'vitamin D', 498, 'vitamin D')]
PMC4516377	6/2015	S50-PMC4516377	['these mechanisms are not yet FULLY ELUCIDATED; HOWEVER, SOME STUDIES have provided a FEW PLAUSIBLE explanations.24,25one EXPLANATION is that low Calcium intake increases serum Calcitriol levels, which can stimulate the flow of calcium from Adipocytes by Vitamin D Membrane receptors, identified as ASSOCIATED with rapid Membrane response to Steroids.']	[('INCOMPLETE_EVIDENCE', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('INCOMPLETE_EVIDENCE', 56), ('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 89), ('PROBABLE_UNDERSTANDING', 121), ('SUPERFICIAL_RELATIONSHIP', 298)]	7	[('CHEBI_22313', 'alkaline earth metal atom', 145, 'calcium'), ('CHEBI_17823', 'calcitriol', 176, 'calcitriol'), ('CL_0000136', 'fat cell', 240, 'adipocytes'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D'), ('GO_0016020', 'membrane', 264, 'membrane'), ('GO_0016020', 'membrane', 320, 'membrane'), ('CHEBI_35341', 'steroid', 341, 'steroids')]
PMC4516377	6/2015	S70-PMC4516377	['it is NOTEWORTHY that ALTHOUGH 25 (Oh) D3 (Calcidiol) is not the most active Metabolite, is the most COMMONLY ASSESSED, AS Plasma levels of active Vitamin D, 1,25 Dihydroxyvitamin D (1,25 (Oh) 2D3), are regularly maintained at normal concentrations; furthermore, Plasma levels of 25 (Oh) D3 are APPROXIMATELY 100 times higher than those of 1,25 (Oh) 2D3 and the half-life of 1,25 (Oh) 2D3 is APPROXIMATELY six hours, whereas that of 25 (Oh) D3 is two to three weeks.11\nwhen comparing Serum levels of Vitamin D in the children assessed in the study carried out by lourenço21in brazil with a study carried out in the usa,35higher levels were observed in brazil.']	[('ANOMALY_CURIOUS_FINDING', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('ANOMALY_CURIOUS_FINDING', 22), ('INCOMPLETE_EVIDENCE', 101), ('INCOMPLETE_EVIDENCE', 110), ('PROBABLE_UNDERSTANDING', 120), ('INCOMPLETE_EVIDENCE', 295), ('INCOMPLETE_EVIDENCE', 392)]	8	[('CHEBI_62946', 'ammonium sulfate', 31, '25 (OH) D3'), ('CHEBI_17933', 'calcidiol', 43, 'calcidiol'), ('CHEBI_39382', 'flufenoxuron', 77, 'metabolite'), ('UBERON_0001969', 'blood plasma', 123, 'plasma'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('CHEBI_67469', '15-hydroxyajubractin C', 158, '1,25 dihydroxyvitamin D'), ('CHEBI_72779', '11-trans-LTE4', 183, '1,25 (OH) 2D3'), ('UBERON_0001969', 'blood plasma', 263, 'plasma'), ('CHEBI_62946', 'ammonium sulfate', 280, '25 (OH) D3'), ('CHEBI_73394', 'Ala-Ser', 342, '25 (OH) 2D3'), ('CHEBI_34898', 'OM-174', 381, 'OH) 2D3'), ('CHEBI_62946', 'ammonium sulfate', 433, '25 (OH) D3'), ('UBERON_0001977', 'blood serum', 484, 'serum'), ('CHEBI_27300', 'vitamin D', 500, 'vitamin D')]
PMC4516377	6/2015	S73-PMC4516377	['as these FACTORS are INTERCONNECTED with worsening in the obesity context, the cause-and-effect ASSOCIATION between the two pathologies is NOT yet CLEAR.37\nlee et al.18EMPHASIZED that DIFFERENCES in Serum levels of Vitamin D in RELATION to gender CAN be EXPLAINED by the fact that girls reported having a healthier diet for all questions asked.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('SUPERFICIAL_RELATIONSHIP', 21), ('SUPERFICIAL_RELATIONSHIP', 96), ('FULL_UNKNOWN', 139), ('INCOMPLETE_EVIDENCE', 166), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 184), ('SUPERFICIAL_RELATIONSHIP', 228), ('INCOMPLETE_EVIDENCE', 247), ('PROBABLE_UNDERSTANDING', 254)]	9	[('UBERON_0001977', 'blood serum', 199, 'serum'), ('CHEBI_27300', 'vitamin D', 215, 'vitamin D')]
PMC4516377	6/2015	S74-PMC4516377	['ON THE OTHER HAND, this gender DIFFERENCE was NOT FOUND in ANOTHER study.20\nthe mechanism by which Vitamin D INFLUENCES adiposity is not COMPLETELY understood, but there are LINES OF RESEARCH that try to explain this phenomenon.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 46), ('ANOMALY_CURIOUS_FINDING', 46), ('INCOMPLETE_EVIDENCE', 50), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 109), ('PROBABLE_UNDERSTANDING', 137), ('INCOMPLETE_EVIDENCE', 174)]	9	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
PMC4586450	10/2015	S233-PMC4586450	['the DIFFERENCES in SOME Micronutrients were substantial, e.g., Vitamin C was 23% lower, Carotene was 15% lower, Retinol was 12% lower, and Sodium was 3% higher in the low compared with the high Maternal education groups.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 19)]	2	[('CHEBI_33839', 'macromolecule', 24, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin C'), ('CHEBI_23042', 'carotene', 88, 'carotene'), ('CHEBI_26536', 'retinoic acid', 112, 'retinol'), ('CHEBI_52632', 'potassium-39 atom', 139, 'sodium'), ('GO_0007618', 'mating', 194, 'maternal')]
PMC4586450	10/2015	S252-PMC4586450	['WHETHER fortification of Foods COULD BE the answer to THIS problem was EXAMINED; the THEORETICAL intakes from DIFFERENT fortification regimens tested SUGGESTED that milk fortified at 2 µg vitamin d/100 g would provide MOST preschool children with adequate but not excessive intakes.24later work in the alspac looking at Plasma concentrations in mid-childhood of Vitamin D (25-Hydroxyvitamin-D2And 25-Hydroxyvitamin-D3) in RELATION to Cortical bone measures FOUND positive ASSOCIATIONS with D3Only, SUGGESTING that in supplementation OR fortification, d3should be used in PREFERENCE to d2.25these 2 PAPERS give valuable INSIGHTS into HOW the lack of Vitamin D in the diets of the majority of uk residents COULD BE TACKLED.iron\niron is a Nutrient that is ESSENTIAL to a child’s growth and development.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 54), ('QUESTION_ANSWERED_BY_THIS_WORK', 71), ('INCOMPLETE_EVIDENCE', 85), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 110), ('INCOMPLETE_EVIDENCE', 150), ('PROBABLE_UNDERSTANDING', 218), ('SUPERFICIAL_RELATIONSHIP', 422), ('INCOMPLETE_EVIDENCE', 457), ('SUPERFICIAL_RELATIONSHIP', 472), ('INCOMPLETE_EVIDENCE', 498), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 533), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 571), ('INCOMPLETE_EVIDENCE', 598), ('INCOMPLETE_EVIDENCE', 619), ('EXPLICIT_QUESTION', 633), ('INCOMPLETE_EVIDENCE', 704), ('FUTURE_WORK', 713), ('IMPORTANT_CONSIDERATION', 753)]	20	[('CHEBI_33290', 'food', 25, 'foods'), ('UBERON_0001969', 'blood plasma', 320, 'plasma'), ('CHEBI_27300', 'vitamin D', 362, 'vitamin D'), ('CHEBI_66469', 'senegin III', 373, '25-hydroxyvitamin-D2and'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 373, '25'), ('PR_000000045', 'S-phase kinase-associated protein 1A', 390, '-D2and'), ('CHEBI_65129', '2-hydroxy-AMP', 397, '25-hydroxyvitamin-D3'), ('PR_000000037', 'BMP receptor type-2', 414, '-D3'), ('UBERON_0001851', 'cortex', 434, 'cortical'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 490, 'D3only'), ('CHEBI_27300', 'vitamin D', 649, 'vitamin D'), ('CHEBI_33284', 'nutrient', 736, 'nutrient')]
PMC4586450	10/2015	S288-PMC4586450	['it PROVED IMPOSSIBLE to incorporate enough Vitamin D–containing foods to cover the RECOMMENDATIONS, implying that Vitamin D–deficient diets are LIKELY to be the norm.32\nin the mid-2000s, there was a great deal of CONTROVERSY about the nutritional content of school meals.']	[('PROBABLE_UNDERSTANDING', 3), ('DIFFICULT_TASK', 10), ('FUTURE_WORK', 83), ('PROBABLE_UNDERSTANDING', 144), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 213)]	5	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC4586450	10/2015	S445-PMC4586450	['both Iron and Vitamin C intakes were lower and calcium intakes higher in the highest compared with the lowest fat intake quartiles ( p< 0.001), and these DIFFERENCES MAY ACCOUNT FOR the lower ferritin concentration FOUND.60because the strongest ASSOCIATION between Nutrient intake and ferritin at age 1.5 years was a negative one with Calcium Intake ( p< 0.001), IT IS POSSIBLE that this is due to the presence of Calcium in the Gut adversely AFFECTING the absorption of iron from the diet.114cows’ Milk is the main source of calcium in the diet at this age (61% of calcium), and the amount of Cows’ Milk consumed was negatively ASSOCIATED with ferritin ( p< 0.001).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 154), ('INCOMPLETE_EVIDENCE', 166), ('PROBABLE_UNDERSTANDING', 170), ('INCOMPLETE_EVIDENCE', 215), ('SUPERFICIAL_RELATIONSHIP', 245), ('INCOMPLETE_EVIDENCE', 363), ('SUPERFICIAL_RELATIONSHIP', 443), ('SUPERFICIAL_RELATIONSHIP', 629)]	8	[('CHEBI_24870', 'ion', 5, 'iron'), ('CHEBI_27300', 'vitamin D', 14, 'vitamin C'), ('CHEBI_33284', 'nutrient', 265, 'nutrient'), ('CHEBI_22313', 'alkaline earth metal atom', 335, 'calcium'), ('GO_0007631', 'feeding behavior', 343, 'intake'), ('CHEBI_22313', 'alkaline earth metal atom', 414, 'calcium'), ('UBERON_0001555', 'digestive tract', 429, 'gut'), ('UBERON_0001913', 'milk', 499, 'milk'), ('NCBITaxon_33208', 'Metazoa', 594, 'cows'), ('UBERON_0001913', 'milk', 600, 'milk')]
PMC4586450	10/2015	S545-PMC4586450	['it was also EVIDENT that relative intakes of OTHER IMPORTANT Nutrients such as Calcium and Vitamin A declined in the preschool years,23and this was DUE TO the children starting to Consume more energy-dense, Nutrient-poor Foods (table 6).']	[('PROBABLE_UNDERSTANDING', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 45), ('IMPORTANT_CONSIDERATION', 51), ('PROBLEM_COMPLICATION', 148)]	4	[('CHEBI_33284', 'nutrient', 61, 'nutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 79, 'calcium'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin A'), ('GO_0007631', 'feeding behavior', 180, 'consume'), ('CHEBI_33284', 'nutrient', 207, 'nutrient'), ('CHEBI_33290', 'food', 221, 'foods')]
PMC4586451	10/2015	S21-PMC4586451	['it is also POSSIBLE that fish Intake during Pregnancy INFLUENCES Neurodevelopment via a mechanism not related to its Fatty Acid content; OTHER active substances include its Vitamin D and Iodine content or its POSSIBLE contamination with mercury.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 54), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137), ('INCOMPLETE_EVIDENCE', 209)]	4	[('GO_0007631', 'feeding behavior', 30, 'intake'), ('GO_0007565', 'female pregnancy', 44, 'pregnancy'), ('GO_0007399', 'nervous system development', 65, 'neurodevelopment'), ('CHEBI_35366', 'fatty acid', 117, 'fatty acid'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 187, 'iodine')]
PMC4586451	10/2015	S170-PMC4586451	['in regard to the quality of the diet in terms of Foods and Nutrients, smokers had higher intakes of energy, saturated fat, and free Sugars but lower intakes of protein and most Micronutrients, particularly Vitamin C, THAN nonsmokers.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 217)]	1	[('CHEBI_33290', 'food', 49, 'foods'), ('CHEBI_33284', 'nutrient', 59, 'nutrients'), ('CHEBI_26822', 'sulfide', 132, 'sugars'), ('CHEBI_33839', 'macromolecule', 177, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin C')]
PMC4595656	10/2015	S1-PMC4595656	['the pleiotropic EFFECTS of Vitamin D are now BEYOND DISPUTE and a GROWING NUMBER OF STUDIES provide ACCUMULATING EVIDENCE of a ROLE for Vitamin D in Brain Development and function.']	[('SUPERFICIAL_RELATIONSHIP', 16), ('IMPORTANT_CONSIDERATION', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 52), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 127)]	7	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('GO_0007420', 'brain development', 149, 'brain development'), ('UBERON_0000955', 'brain', 149, 'brain')]
PMC4595656	10/2015	S4-PMC4595656	['HOWEVER, a SMALL NUMBER OF STUDIES, MOSTLY in vitro , POINT to a ROLE for Vitamin D in Differentiation and Development Of Hippocampal Neurons.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 17), ('PROBABLE_UNDERSTANDING', 36), ('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 65)]	6	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0030254', 'protein secretion by the type III secretion system', 87, 'differentiation ...'), ('GO_0048513', 'animal organ development', 107, 'development of ... neurons'), ('CL_0002608', 'hippocampal neuron', 122, 'hippocampal neurons')]
PMC4595656	10/2015	S7-PMC4595656	['it also REMAINS TO BE ESTABLISHED IF there are CRITICAL developmental windows during which Vitamin D is REQUIRED.']	[('FULL_UNKNOWN', 8), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('IMPORTANT_CONSIDERATION', 47), ('IMPORTANT_CONSIDERATION', 104)]	4	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
PMC4595656	10/2015	S10-PMC4595656	['HOWEVER in RECENT YEARS, myriad OTHER functions and ROLES for Vitamin D HAVE BEEN gradually POSTULATED and VERIFIED, and its pleiotropic EFFECTS are now BEYOND DISPUTE (kalueff and tuohimaa,2007; mccann and ames,2008; lai and fang,2013; schlogl and holick,2014).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('SUPERFICIAL_RELATIONSHIP', 52), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 92), ('INCOMPLETE_EVIDENCE', 107), ('SUPERFICIAL_RELATIONSHIP', 137), ('IMPORTANT_CONSIDERATION', 153), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 160)]	11	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC4595656	10/2015	S74-PMC4595656	['HOWEVER the phenotype did not extend into Adulthood, SUGGESTING that EITHER normal Postnatal development OR the reintroduction of Vitamin D at Birth MAY have corrected the deficit (harms et al.,2012).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 69), ('INCOMPLETE_EVIDENCE', 149)]	5	[('UBERON_0000113', 'post-juvenile adult stage', 42, 'adulthood'), ('GO_0007567', 'parturition', 83, 'postnatal'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007567', 'parturition', 143, 'birth')]
PMC4595656	10/2015	S85-PMC4595656	['HOWEVER the FINDING of increased numbers of Apoptotic Cells in the hippocampus is IN CONTRAST TO the FINDINGS of decreased numbers of Apoptotic Cells at Birth in the developing Cortex (ko et al.,2004) and with the KNOWN overall EFFECTS of Vitamin D on Apoptosis.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('INCOMPLETE_EVIDENCE', 101), ('INCOMPLETE_EVIDENCE', 214), ('SUPERFICIAL_RELATIONSHIP', 228)]	6	[('CL_0000445', 'apoptosis fated cell', 44, 'apoptotic cells'), ('CL_0000445', 'apoptosis fated cell', 134, 'apoptotic cells'), ('GO_0007567', 'parturition', 153, 'birth'), ('UBERON_0001851', 'cortex', 177, 'cortex'), ('CHEBI_27300', 'vitamin D', 239, 'vitamin D'), ('GO_0006915', 'apoptotic process', 252, 'apoptosis')]
PMC4595656	10/2015	S106-PMC4595656	['this FINDING POINTS to DIFFERENTIAL EFFECTS of varying concentrations of Vitamin D on Cellular Hippocampal Development and WARRANT FURTHER EXPLORATION.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('SUPERFICIAL_RELATIONSHIP', 36), ('FUTURE_WORK', 123)]	5	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0045168', 'cell-cell signaling involved in cell fate commitment', 86, 'cellular hippocampal development')]
PMC4595656	10/2015	S112-PMC4595656	['this CONTRASTS with the restoration of normal development following Vitamin D repletion in whole Animals (féron et al.,2005), and highlights the POTENTIAL DISPARITY between in vitro and in vivo FINDINGS.']	[('ANOMALY_CURIOUS_FINDING', 5), ('ANOMALY_CURIOUS_FINDING', 5), ('INCOMPLETE_EVIDENCE', 145), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 155), ('INCOMPLETE_EVIDENCE', 194)]	5	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 97, 'animals')]
PMC4598849	10/2015	S9-PMC4598849	['WHETHER the common Vitamin D deficiency during Pregnancy CONTRIBUTES to any of the GLOBAL adverse fetal growth epidemic REMAINS UNKNOWN.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('EXPLICIT_QUESTION', 0), ('SUPERFICIAL_RELATIONSHIP', 57), ('IMPORTANT_CONSIDERATION', 83), ('FULL_UNKNOWN', 120)]	5	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0007565', 'female pregnancy', 47, 'pregnancy')]
PMC4598849	10/2015	S11-PMC4598849	['the LINK between maternal Vitamin D status and fetal growth, AS measured most frequently by infant Birth weight and small for Gestational age (sga), HAS BEEN explored by a NUMBER OF observational STUDIES9101112131415AND randomized supplementation trials1617181920worldwide with MIXED results.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('PROBABLE_UNDERSTANDING', 61), ('INCOMPLETE_EVIDENCE', 149), ('INCOMPLETE_EVIDENCE', 172), ('INCOMPLETE_EVIDENCE', 196), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 278)]	6	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007567', 'parturition', 99, 'birth'), ('GO_0007565', 'female pregnancy', 126, 'gestational')]
PMC4598849	10/2015	S15-PMC4598849	['the CONFLICTING findings MAY BE DUE TO VARIATIONS of study designs including the Gestational weeks of Vitamin D testing, the cut-point of Vitamin D, ethnicity of the study population, Genetic variation and outcome variables.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 25), ('PROBLEM_COMPLICATION', 32), ('DIFFICULT_TASK', 39)]	4	[('GO_0007565', 'female pregnancy', 81, 'gestational'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('SO_0000704', 'gene', 184, 'genetic')]
PMC4598849	10/2015	S54-PMC4598849	['another case-control study SUGGESTED that infants Born before 32 wks’ Gestation had an increased RISK of Vitamin D deficiency compared with mature infant, HOWEVER, there was no statistically significant difference in mean Cord Blood 25(Oh)D levels between sga and non-sga infants29.']	[('INCOMPLETE_EVIDENCE', 27), ('IMPORTANT_CONSIDERATION', 97), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 155), ('ANOMALY_CURIOUS_FINDING', 155)]	4	[('GO_0007567', 'parturition', 50, 'born'), ('GO_0007565', 'female pregnancy', 70, 'gestation'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 222, 'cord'), ('UBERON_0000178', 'blood', 227, 'blood'), ('CHEBI_71657', 'versiconol acetate', 233, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 233, '25(OH ... D')]
PMC4598849	10/2015	S55-PMC4598849	['PREVIOUS STUDIES have several LIMITATIONS including SMALL sample sizes, INCONSISTENT definitions for fetal Vitamin D status, FEW adjustment for confounders and ONLY linear models performed.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 72), ('INCOMPLETE_EVIDENCE', 125), ('INCOMPLETE_EVIDENCE', 160)]	6	[('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]
PMC4598849	10/2015	S60-PMC4598849	['ALTHOUGH the neonatal 25(Oh)D levels at Birth cannot fully represent the Vitamin D status during CRITICAL times of Gestation DUE TO a half-life of several weeks of 25(Oh)D34, IT was quite POSSIBLE that the neonates with lower or higher Cord Blood 25(Oh)D levels MAY also have lower or higher average levels of 25(Oh)D during the whole Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 97), ('PROBLEM_COMPLICATION', 125), ('ANOMALY_CURIOUS_FINDING', 175), ('INCOMPLETE_EVIDENCE', 188), ('INCOMPLETE_EVIDENCE', 262)]	7	[('CHEBI_71657', 'versiconol acetate', 22, '25(OH)D'), ('GO_0007567', 'parturition', 40, 'birth'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'gestation'), ('CHEBI_79189', 'D-ribofuranose-2,5-bisphosphate', 164, '25(OH)D34'), ('PR_000001177', 'D(2) dopamine receptor', 170, 'D34'), ('UBERON_0002240', 'spinal cord', 236, 'cord'), ('UBERON_0000178', 'blood', 241, 'blood'), ('CHEBI_71657', 'versiconol acetate', 247, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 253, 'D'), ('CHEBI_71657', 'versiconol acetate', 310, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 316, 'D'), ('GO_0007565', 'female pregnancy', 335, 'pregnancy')]
PMC4598849	10/2015	S74-PMC4598849	['THUS, FUTURE STUDIES of Vitamin D and growth restriction would BENEFIT from the CONSIDERATION of OTHER Vitamin D family members.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 6), ('IMPORTANT_CONSIDERATION', 63), ('FUTURE_WORK', 80), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 97)]	5	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC4598849	10/2015	S76-PMC4598849	['HOWEVER, we were UNABLE TO assess the EFFECT of Vitamin D levels during early Pregnancy on fetal growth as these data are unavailable.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('DIFFICULT_TASK', 17), ('SUPERFICIAL_RELATIONSHIP', 38)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007565', 'female pregnancy', 78, 'pregnancy')]
PMC4598849	10/2015	S80-PMC4598849	['the FINDINGS SUGGESTED that Vitamin D supplements during Pregnancy SHOULD BE ENCOURAGED, BUT with CAUTION.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 13), ('FUTURE_WORK', 67), ('FUTURE_WORK', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 89), ('INCOMPLETE_EVIDENCE', 98)]	6	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007565', 'female pregnancy', 57, 'pregnancy')]
PMC4600246	10/2015	S4-PMC4600246	['introduction\nVitamin K is a fat-soluble Vitamin, IMPORTANT for the function of numerous proteins within the body, such as the Coagulation factors (ii, vii, Ix, x and protein c and protein s), Osteocalcin (a bone-Forming Protein) and Matrix-Gla Protein (Mgp) (an anticalcification protein), to name a few.1–3vitamin K exists naturally as Vitamin K1(Phylloquinone) and Vitamin K2(Menaquinone, mk-4 through mk-10).2–5vitamin K1Is mainly found in green leafy vegetables as well as olive oil and soyabean oil, whereas Vitamin K2(Menaquinone) is found in small amounts in Chicken, butter, Egg Yolks, cheese and fermented soyabeans (BETTER KNOWN as natto).26–9\nVitamin K1And Vitamin K2Are REQUIRED for the γ-glutamyl carboxylation of all Vitamin K-dependent proteins.2DESPITE the fact that Mammalian bacterial Intestinal flora are able to produce Vitamin K2, the amount produced IS THOUGHT TO be negligible.2the adequate intake (ai) for Vitamin K HAS BEEN PROPOSED to be 90\u2005µg/day for women and 120\u2005µg/day for men.210HOWEVER, it HAS BEEN SPECULATED that the ai for Vitamin K (90–120\u2005µg/day) is not sufficient to induce complete carboxylation of all Vitamin K-dependent proteins.21112\n\nvitamin K deficiency\nthe measurement and treatment of Vitamin K deficiency based on Blood tests is not perfect.']	[('IMPORTANT_CONSIDERATION', 49), ('INCOMPLETE_EVIDENCE', 626), ('IMPORTANT_CONSIDERATION', 682), ('ANOMALY_CURIOUS_FINDING', 760), ('INCOMPLETE_EVIDENCE', 872), ('INCOMPLETE_EVIDENCE', 875), ('INCOMPLETE_EVIDENCE', 940), ('INCOMPLETE_EVIDENCE', 949), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1007), ('INCOMPLETE_EVIDENCE', 1022), ('INCOMPLETE_EVIDENCE', 1031)]	11	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin K'), ('CHEBI_33229', 'vitamin (role)', 40, 'vitamin'), ('GO_0050817', 'coagulation', 126, 'coagulation'), ('PR_000008875', 'islet amyloid polypeptide', 156, 'IX'), ('PR_000011634', 'oxidized low-density lipoprotein receptor 1', 192, 'osteocalcin'), ('PR_000004759', 'Bloom syndrome protein', 211, '-forming protein'), ('GO_0031012', 'extracellular matrix', 233, 'matrix'), ('PR_000010430', 'MAP kinase-interacting serine/threonine-protein kinase 2', 233, 'matrix-Gla protein'), ('PR_000010430', 'MAP kinase-interacting serine/threonine-protein kinase 2', 253, 'MGP'), ('CHEBI_52071', 'dextran', 315, 'K'), ('CHEBI_33229', 'vitamin (role)', 337, 'vitamin'), ('PR_000004483', 'V-type proton ATPase subunit C 1', 337, 'vitamin K1'), ('CHEBI_26124', 'phytosteroid', 348, 'phylloquinone'), ('CHEBI_28934', 'vitamin D2', 367, 'vitamin K2'), ('PR_000017299', 'VIP peptides', 367, 'vitamin K2'), ('CHEBI_18154', 'polysaccharide', 378, 'menaquinone'), ('PR_000009255', 'potassium voltage-gated channel subfamily E member 1', 422, 'K1is'), ('CHEBI_28934', 'vitamin D2', 513, 'vitamin K2'), ('PR_000017299', 'VIP peptides', 513, 'vitamin K2'), ('CHEBI_18154', 'polysaccharide', 524, 'menaquinone'), ('NCBITaxon_33208', 'Metazoa', 566, 'chicken'), ('UBERON_0005079', 'eggshell', 583, 'egg yolks'), ('CHEBI_33229', 'vitamin (role)', 654, 'Vitamin'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 654, 'Vitamin K1and'), ('PR_000017209', 'utrophin', 668, 'vitamin K2are'), ('CHEBI_27300', 'vitamin D', 731, 'vitamin K'), ('NCBITaxon_40674', 'Mammalia', 783, 'mammalian'), ('UBERON_0000160', 'intestine', 803, 'intestinal'), ('CHEBI_28934', 'vitamin D2', 840, 'vitamin K2'), ('PR_000017299', 'VIP peptides', 840, 'vitamin K2'), ('CHEBI_27300', 'vitamin D', 930, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 1058, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 1142, 'vitamin K'), ('CHEBI_52071', 'dextran', 1186, 'K'), ('CHEBI_27300', 'vitamin D', 1232, 'vitamin K'), ('UBERON_0000178', 'blood', 1262, 'blood')]
PMC4600246	10/2015	S6-PMC4600246	['moreover, a normal carboxylated mgp protein in the Serum MAY NOT NECESSARILY INDICATE a normal Vitamin K status, AS carboxylated mgp in the Serum COULD BE normal, BUT suboptimal in the Arteries (where Vitamin K2Is needed to prevent vascular calcification.)']	[('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 77), ('PROBABLE_UNDERSTANDING', 113), ('INCOMPLETE_EVIDENCE', 146), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 163)]	6	[('UBERON_0001977', 'blood serum', 51, 'serum'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin K'), ('UBERON_0001977', 'blood serum', 140, 'serum'), ('UBERON_0001637', 'artery', 185, 'arteries'), ('CHEBI_35684', 'antiplatyhelmintic drug', 201, 'vitamin K2is')]
PMC4600246	10/2015	S9-PMC4600246	['HOWEVER, the RECENTLY updated usa preventive services task force (uspstf) has RECENTLY STATED that there is INSUFFICIENT EVIDENCE that Calcium and Vitamin D PREVENT a fracture in Premenopausal women or in men who have not experienced a fracture and now RECOMMENDS against daily supplementation with 400\u2005iu or less of Vitamin D3 and 1000\u2005mg or less of calcium for the primary prevention of fractures in non-institutionalised Postmenopausal women.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 78), ('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 157), ('FUTURE_WORK', 253)]	7	[('CHEBI_22313', 'alkaline earth metal atom', 135, 'calcium'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0043277', 'apoptotic cell clearance', 179, 'premenopausal'), ('CHEBI_33279', 'vitamin D5', 317, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 317, 'vitamin D3'), ('GO_0007595', 'lactation', 424, 'postmenopausal')]
PMC4600246	10/2015	S10-PMC4600246	['THUS, UNLESS you are an institutionalised Postmenopausal woman or you have already experienced a fracture, the uspstf does not RECOMMEND Calcium and Vitamin D for preventing a first-time fracture, AS there is a LACK OF EVIDENCE.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('FUTURE_WORK', 127), ('PROBABLE_UNDERSTANDING', 197), ('INCOMPLETE_EVIDENCE', 211)]	5	[('GO_0007595', 'lactation', 42, 'postmenopausal'), ('CHEBI_22313', 'alkaline earth metal atom', 137, 'calcium'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC4600246	10/2015	S12-PMC4600246	['a broad amount of DATA SEEMS to INDICATE substantial POTENTIAL for supplementary Vitamin K. HOWEVER, currently FEW GUIDELINES RECOMMEND Vitamin K therapy for PREVENTION or treatment of osteoporosis.']	[('FUTURE_WORK', 18), ('ANOMALY_CURIOUS_FINDING', 23), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('INCOMPLETE_EVIDENCE', 111), ('PROBABLE_UNDERSTANDING', 115), ('FUTURE_WORK', 126), ('SUPERFICIAL_RELATIONSHIP', 158)]	9	[('CHEBI_27300', 'vitamin D', 81, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin K')]
PMC4600246	10/2015	S14-PMC4600246	['the benefit of Vitamin K on bone IS THOUGHT TO be UNRELATED to increasing bmd BUT RATHER increasing bone strength.19a RECENT meta-analysis HAS SHOWN that vitamin K2(45\u2005mg/day) significantly reduces Hip (77% reduction), vertebral (60% reduction) and all non-vertebral fractures (81% reduction).20whether the results of vitamin K2At a dose of 45\u2005mg CAN be translated to over the counter doses of Vitamin K1(such as 1–5\u2005mg) is STILL a matter of DEBATE, BUT Vitamin K1On its own HAS already BEEN SHOWN to reduce fractures and cancer in a clinical TRIAL, ALTHOUGH more DATA ARE NEEDED TO CONFIRM these benefits.']	[('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 50), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 139), ('INCOMPLETE_EVIDENCE', 347), ('IMPORTANT_CONSIDERATION', 424), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 442), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 450), ('INCOMPLETE_EVIDENCE', 475), ('INCOMPLETE_EVIDENCE', 543), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 550), ('FUTURE_WORK', 564), ('INCOMPLETE_EVIDENCE', 583)]	16	[('CHEBI_27300', 'vitamin D', 15, 'vitamin K'), ('PR_000009450', 'keratin, type II cytoskeletal 1', 162, 'K2'), ('UBERON_0001464', 'hip', 198, 'hip'), ('CHEBI_34810', 'Lactitol dihydrate', 326, 'K2at'), ('PR_000009481', 'keratin, type II cytoskeletal 5', 326, 'K2at'), ('PR_000004483', 'V-type proton ATPase subunit C 1', 394, 'vitamin K1'), ('CHEBI_33227', '(E)-cinnamyl alcohol', 454, 'vitamin K1on'), ('PR_000009495', 'keratin, type II cytoskeletal 8', 462, 'K1on')]
PMC4600246	10/2015	S31-PMC4600246	['DESPITE the fact that Serum mgp increased in the vitamin k1group, WHEREAS mgp was decreased in the control group (treatment effect: p<0.03 in itt and secondary analyses), neither baseline nor change in mgp predicted the change in cac, SUGGESTING that the benefit of Vitamin K on cac progression is not related to increases in Serum mgp.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 66), ('ANOMALY_CURIOUS_FINDING', 66), ('INCOMPLETE_EVIDENCE', 235)]	4	[('UBERON_0001977', 'blood serum', 22, 'serum'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin K'), ('UBERON_0001977', 'blood serum', 326, 'serum')]
PMC4600246	10/2015	S35-PMC4600246	["THUS, the EFFECT of Vitamin K on cac MIGHT be independent of changes in Serum cytokine levels (BUT NOT NECESSARILY RULING out Vitamin K's benefit on the blunting of the EFFECTS of these cytokines)."]	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('INCOMPLETE_EVIDENCE', 99), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115), ('SUPERFICIAL_RELATIONSHIP', 169)]	7	[('CHEBI_27300', 'vitamin D', 20, 'vitamin K'), ('UBERON_0001977', 'blood serum', 72, 'serum'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin K')]
PMC4600246	10/2015	S36-PMC4600246	['DESPITE the fact that Vitamin K1Has a beneficial EFFECT on cac in older men and women, LARGER STUDIES powered for clinical end points (stroke, Myocardial infarction and death) ARE NEEDED TO ASSESS the risks and benefits of Vitamin K therapy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 49), ('FUTURE_WORK', 87), ('FUTURE_WORK', 176), ('FUTURE_WORK', 187)]	6	[('CHEBI_26871', 'terpene alkaloid', 22, 'vitamin K1has'), ('PR_000009481', 'keratin, type II cytoskeletal 5', 30, 'K1has'), ('UBERON_0002349', 'myocardium', 143, 'myocardial'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin K')]
PMC4600246	10/2015	S79-PMC4600246	['on THE BASIS of PREVIOUSLY PRESENTED data, Warfarin MAY increase Arterial calcifications and osteoporosis through the inhibition of Vitamin K. LARGER TRIALS SHOULD BE performed to FURTHER ELUCIDATE the negative long-term health CONSEQUENCES of warfarin and IF these CAN PERHAPS be PREVENTED through the institution of supplemental Vitamin K.\n\npubmed central:']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 52), ('FUTURE_WORK', 143), ('FUTURE_WORK', 157), ('FUTURE_WORK', 180), ('INCOMPLETE_EVIDENCE', 188), ('PROBLEM_COMPLICATION', 228), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 257), ('INCOMPLETE_EVIDENCE', 266), ('INCOMPLETE_EVIDENCE', 270), ('SUPERFICIAL_RELATIONSHIP', 281)]	12	[('CHEBI_10033', 'warfarin', 43, 'warfarin'), ('UBERON_0001637', 'artery', 65, 'arterial'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 331, 'vitamin K')]
PMC4624803	10/2015	S6-PMC4624803	['HOWEVER, the statistical power of the study was too weak to detect an eventual small to medium size ASSOCIATION between Vitamin D levels and attention deficit/hyperactivity disorder.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 100)]	2	[('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC4624803	10/2015	S9-PMC4624803	['several HYPOTHESES concerning the IMPORTANCE of Vitamin D for Brain Development, ESPECIALLY Prenatally and during the early Neonatal Period, HAVE BEEN formulated.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 8), ('IMPORTANT_CONSIDERATION', 34), ('IMPORTANT_CONSIDERATION', 81), ('INCOMPLETE_EVIDENCE', 141)]	4	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007420', 'brain development', 62, 'brain development'), ('UBERON_0000955', 'brain', 62, 'brain'), ('GO_0019230', 'proprioception', 92, 'prenatally'), ('UBERON_0007221', 'neonate stage', 124, 'neonatal period')]
PMC4624803	10/2015	S17-PMC4624803	['EVEN IF it is PROBABLE that the Vitamin D levels of the mother is close to the levels of the foetus, it is of INTEREST to compare these results with a study of Vitamin D levels in the child AS a hypothetical RISK FACTOR for later development of adhd.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('PROBABLE_UNDERSTANDING', 14), ('ANOMALY_CURIOUS_FINDING', 110), ('FUTURE_WORK', 110), ('PROBABLE_UNDERSTANDING', 190), ('SUPERFICIAL_RELATIONSHIP', 208)]	7	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D')]
PMC4624803	10/2015	S94-PMC4624803	['[17] reviewed the Animal research literature and CONCLUDED that there are INDICATIONS of behavioural EFFECTS of Vitamin D inadequacy, BUT that the EVIDENCE is WEAK.']	[('INCOMPLETE_EVIDENCE', 49), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 101), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 134), ('INCOMPLETE_EVIDENCE', 147), ('INCOMPLETE_EVIDENCE', 159)]	6	[('NCBITaxon_33208', 'Metazoa', 18, 'animal'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
PMC4624803	10/2015	S101-PMC4624803	['WHILE strøm et al have analysed the levels of D Vitamin in the Serum from the mothers at Pregnancy, we have analysed D Vitamin levels in the Serum collected from the child at Birth, which should REFLECT the Prenatal Vitamin D status of the child.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 195)]	2	[('CHEBI_28748', 'doxorubicin', 46, 'D vitamin'), ('UBERON_0001977', 'blood serum', 63, 'serum'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy'), ('CHEBI_28748', 'doxorubicin', 117, 'D vitamin'), ('UBERON_0001977', 'blood serum', 141, 'serum'), ('GO_0007567', 'parturition', 175, 'birth'), ('GO_0007565', 'female pregnancy', 207, 'prenatal'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D')]
PMC4624803	10/2015	S103-PMC4624803	['THIS MEANS THAT our study, like the studies by strøm et al., gale et al., and whitehouse et al [10–12] BUT UNLIKE the RECENTLY published studies in quatar and turkey [5,6], has a prospective design where Vitamin D levels are measured at a time before the child receives a diagnosis.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 107), ('INCOMPLETE_EVIDENCE', 118)]	4	[('CHEBI_27300', 'vitamin D', 204, 'vitamin D')]
PMC4624803	10/2015	S115-PMC4624803	['conclusion\nwe FOUND NO SUPPORT for the HYPOTHESIS that low levels of Vitamin D during Pregnancy are a risk factor for adhd in the offspring.']	[('INCOMPLETE_EVIDENCE', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 20), ('INCOMPLETE_EVIDENCE', 39)]	3	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0007565', 'female pregnancy', 86, 'pregnancy')]
PMC4627942	10/2015	S180-PMC4627942	['compared with the 3-year period before the war, the authors REPORTED that children offered Vitamin A at home during the war had a 12% reduction in mortality, WHEREAS the overall IMPACT of the war was an 89% increase in mortality.']	[('INCOMPLETE_EVIDENCE', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158), ('SUPERFICIAL_RELATIONSHIP', 178)]	3	[('CHEBI_27300', 'vitamin D', 91, 'vitamin A')]
PMC4627942	10/2015	S184-PMC4627942	['the effectiveness of Vitamin A supplementation HAS also BEEN QUESTIONED.']	[('INCOMPLETE_EVIDENCE', 47), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 61)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin A')]
PMC4627942	10/2015	S221-PMC4627942	["caption (table-wrap): table 5\n\ntackling malnutrition – prevention EFFORTS: findings from indepth studieshdss siteyearauthorsmain findingsbandim hdss, guinea-bissau2004nielsen et al.during civil war, Vitamin A supplementation for children helped reduce mortality.bandim hdss, guinea-bissau2005nielsen et al.during civil war, supplementary Feeding programme helped reduce mortality in children.filabavi hdss, vietnam2009nga et al.fortification with multiple Micronutrients of biscuits provided in schools reduced risk of anaemia and of iron and zinc deficiencies by 40%.nouna hdss, burkina faso2003müller et al.no significant impact of Zinc supplementation for children on height-for-age, weight-for-age, and weight-for-height scores.kintampo hdss, ghana2007newton et al.no positive EFFECT of Vitamin A supplements in combination with vaccines during the first few months of Life.farafenni hdss, gambia2013van der merwe et al.fish oil supplementation had no effect on growth, Intestinal integrity, morbidity, or cognitive development.kilifi hdss, kenya2010akech et al.use of low-dose hypotonic Fluid resuscitation for children who develop shock AS a result of SEVERE malnutrition has poor outcomes in terms of persistent shock, oliguria, and high case fatality.agincourt hdss, south africa2003deen et al.introduction of who guidelines in two hospitals strengthened the management of malnutrition.kintampo hdss, ghana2006tchum et al.vitamin a supplementation increased Liver reserves of mothers during the Postpartum period, with EFFECTS persisting for at least five months.niakhar hdss, senegal2006ly et al.provision of high energy, Nutrient-dense Food supplements to infants aged between four and seven months contributed to decreased Postpartum weight loss in their mothers.west kiang hdss, gambia2011hawkesworth et al.Nutrient supplementation during Pregnancy had little effect on infants’ risk of cardiovascular disease.west kiang hdss, gambia2009hawkesworth et al.protein-energy supplementation of mothers during Pregnancy had no effect on the Blood pressure of their children in adolescence.west kiang hdss, gambia2009prentice et al.Calcium supplementation for Pregnant mothers had no effect on foetal and infant growth.west kiang hdss, gambia2010jarjou et al.women given Calcium Supplements while Pregnant had lower bone Mineral content, bone area and bone Mineral density at the Hip during the 12-month Lactation period than other women.dikgale hdss, south africa2002nthangeni et al.the majority of People with type 2 diabetes had poor Glycaemic Control and were obese or had high blood pressure and were given poor advice by health educators.africa centre hdss, south africa2002o'donnell et al.agencies working to tackle a flood disaster in bangladesh in 1998 achieved MIXED results in terms of meeting international disaster response standards."]	[('FUTURE_WORK', 66), ('SUPERFICIAL_RELATIONSHIP', 781), ('PROBABLE_UNDERSTANDING', 1143), ('IMPORTANT_CONSIDERATION', 1158), ('SUPERFICIAL_RELATIONSHIP', 1527), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2776)]	6	[('CHEBI_27300', 'vitamin D', 199, 'vitamin A'), ('GO_0007631', 'feeding behavior', 338, 'feeding'), ('CHEBI_33839', 'macromolecule', 456, 'micronutrients'), ('CHEBI_33340', 'zinc group element atom', 634, 'zinc'), ('CHEBI_27300', 'vitamin D', 791, 'vitamin A'), ('UBERON_0000104', 'life cycle', 873, 'life'), ('UBERON_0000160', 'intestine', 974, 'intestinal'), ('UBERON_0006314', 'bodily fluid', 1092, 'fluid'), ('UBERON_0002107', 'liver', 1466, 'liver'), ('GO_0007565', 'female pregnancy', 1503, 'postpartum'), ('CHEBI_33284', 'nutrient', 1631, 'nutrient'), ('CHEBI_33290', 'food', 1646, 'food'), ('GO_0007565', 'female pregnancy', 1734, 'postpartum'), ('CHEBI_33284', 'nutrient', 1819, 'Nutrient'), ('GO_0007565', 'female pregnancy', 1851, 'pregnancy'), ('GO_0007565', 'female pregnancy', 2016, 'pregnancy'), ('UBERON_0000178', 'blood', 2047, 'blood'), ('CHEBI_31341', 'calcium dihydroxide', 2137, 'Calcium'), ('GO_0007565', 'female pregnancy', 2165, 'pregnant'), ('CHEBI_22313', 'alkaline earth metal atom', 2276, 'calcium'), ('CHEBI_33341', 'titanium atom', 2284, 'supplements'), ('GO_0007565', 'female pregnancy', 2302, 'pregnant'), ('CHEBI_46662', 'mineral', 2326, 'mineral'), ('CHEBI_46662', 'mineral', 2362, 'mineral'), ('UBERON_0001464', 'hip', 2385, 'hip'), ('GO_0007595', 'lactation', 2409, 'lactation'), ('NCBITaxon_10088', 'Mus <genus>', 2505, 'people'), ('GO_0051162', 'L-arabitol metabolic process', 2542, 'glycaemic control')]
PMC4632418	10/2015	S0-PMC4632418	['Vitamin D deficiency increases the risk of Gestational diabetes mellitus: a meta-analysis of observational studies\n\nabstract\nthe results investigating the RELATIONSHIP between Vitamin D levels and Gestational diabetes mellitus (gdm) are INCONSISTENT.']	[('SUPERFICIAL_RELATIONSHIP', 155), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 237)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 43, 'Gestational'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin D'), ('GO_0007565', 'female pregnancy', 197, 'gestational')]
PMC4632418	10/2015	S8-PMC4632418	['HOWEVER, well-designed randomized controlled TRIALS ARE NEEDED to elicit the clear EFFECT of Vitamin D supplementation on PREVENTION of gdm.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 45), ('SUPERFICIAL_RELATIONSHIP', 83), ('SUPERFICIAL_RELATIONSHIP', 122)]	4	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC4632418	10/2015	S14-PMC4632418	['HOWEVER, it is NOT CLEAR WHETHER a POOR Vitamin D status is ASSOCIATED with the RISK of gdm.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FULL_UNKNOWN', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('IMPORTANT_CONSIDERATION', 35), ('SUPERFICIAL_RELATIONSHIP', 60), ('IMPORTANT_CONSIDERATION', 80)]	6	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC4632418	10/2015	S15-PMC4632418	['the NON-CLASSICAL functions of Vitamin D are GAINING ATTENTION for its closer ASSOCIATIONS between Vitamin D deficiency and t2dm, Heart disease, Autoimmune diseases and certain types of cancers [4,5].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 78)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('UBERON_0000948', 'heart', 130, 'heart'), ('UBERON_0001442', 'skeleton of manus', 145, 'autoimmune')]
PMC4632418	10/2015	S21-PMC4632418	['the scientific EVIDENCE LINKING Vitamin D deficiency with diabetes is GROWING large, but data investigating the RELATIONSHIP between Vitamin D levels and gdm are INCONSISTENT.']	[('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 24), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 112), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 162)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D')]
PMC4632418	10/2015	S75-PMC4632418	['HOWEVER, this meta-analysis SHOWED that women with Vitamin D deficiency COMPARED TO the control group experienced a significantly INCREASED RISK for developing gdm (or = 1.53; 95% ci, 1.33, 1.75) on a fixed-effects model (figure 2).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 72), ('IMPORTANT_CONSIDERATION', 130)]	4	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC4632418	10/2015	S109-PMC4632418	['UNDOUBTEDLY, the 25(Oh)D level in two studies was high, WHEREAS the prevalence of Vitamin D deficiency was low.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 56)]	3	[('CHEBI_71657', 'versiconol acetate', 17, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
PMC4632418	10/2015	S115-PMC4632418	['in words, there is a CONNECTION between Glucose Metabolism and Vitamin D pathways, EVEN IF FURTHER STUDIES based on larger population ARE NEEDED to get more evidence about the topic.']	[('SUPERFICIAL_RELATIONSHIP', 21), ('ANOMALY_CURIOUS_FINDING', 83), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 88), ('FUTURE_WORK', 91), ('FUTURE_WORK', 99), ('FUTURE_WORK', 134)]	6	[('CHEBI_17234', 'glucose', 40, 'glucose'), ('GO_0006006', 'glucose metabolic process', 40, 'glucose metabolism'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC4632418	10/2015	S117-PMC4632418	['HOWEVER, there is an active DEBATE on the appropriate intake of Vitamin D in Pregnancy [12].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28)]	2	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy')]
PMC4632418	10/2015	S118-PMC4632418	['apart from diet and Supplements, ANOTHER way of keeping OPTIMAL level of body Vitamin D is from skin exposure to sunlight, which is REMARKABLY INFLUENCED by geographical location, season, dark skin tone, sunscreen use and EVEN the air pollution [48].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 33), ('IMPORTANT_CONSIDERATION', 56), ('ANOMALY_CURIOUS_FINDING', 132), ('SUPERFICIAL_RELATIONSHIP', 143), ('ANOMALY_CURIOUS_FINDING', 222)]	5	[('CHEBI_33341', 'titanium atom', 20, 'supplements'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC4632418	10/2015	S129-PMC4632418	['HOWEVER, the ASSOCIATION between Vitamin D deficiency and gdm STILL REMAINS (or = 1.67; 95% ci, 1.31, 2.13; i2= 25.6%, p = 0.251) EVEN after adjusting for maternal age, bmi and ethnicity (supplementary figure s4).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('ANOMALY_CURIOUS_FINDING', 62), ('IMPORTANT_CONSIDERATION', 62), ('INCOMPLETE_EVIDENCE', 68), ('ANOMALY_CURIOUS_FINDING', 130)]	7	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC4632418	10/2015	S134-PMC4632418	['HOWEVER, well-designed randomized controlled TRIALS ARE NEEDED to determine the explicit EFFECT of Vitamin D supplementation on PREVENTION of gdm.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 45), ('SUPERFICIAL_RELATIONSHIP', 89), ('SUPERFICIAL_RELATIONSHIP', 128)]	4	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
PMC4645901	8/2014	S14-PMC4645901	['WHILE an increase in government advertising would have CONTRIBUTED to the rise in uptake of Vitamin D supplementation, a leaflet proved to be a simple YET EFFECTIVE INTERVENTION in improving Vitamin uptake in babies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 55), ('ANOMALY_CURIOUS_FINDING', 151), ('SUPERFICIAL_RELATIONSHIP', 155), ('SUPERFICIAL_RELATIONSHIP', 165)]	5	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 191, 'vitamin')]
PMC4645901	8/2014	S19-PMC4645901	['[2]\nHOWEVER, it is ESSENTIAL to APPRECIATE that RECOMMENDED doses of Vitamin D supplementation are arbitary, and the THRESHOLD for toxicity is far higher.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('IMPORTANT_CONSIDERATION', 19), ('IMPORTANT_CONSIDERATION', 32), ('FUTURE_WORK', 48), ('IMPORTANT_CONSIDERATION', 117)]	5	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC4645901	8/2014	S32-PMC4645901	['WHILE Vitamin D CAN be found in some Foods, the only dietary source for babies is formula milk that has Vitamin D added.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 16)]	2	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('CHEBI_33290', 'food', 37, 'foods'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D')]
PMC4645901	8/2014	S89-PMC4645901	['HOWEVER, many FACTORS would have CONTRIBUTED to the increase of Vitamin D uptake, including government advertising and better education for Health care professionals.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 14), ('SUPERFICIAL_RELATIONSHIP', 33)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0000025', 'tube', 140, 'health')]
PMC4645901	8/2014	S91-PMC4645901	['the most DESIRABLE follow up would be to measure their Vitamin D levels in a few years time, BUT this was beyond the scope of this project.']	[('IMPORTANT_CONSIDERATION', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93)]	2	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC4673623	11/2015	S22-PMC4673623	['ALTERNATIVELY, the remethylation of Homocysteine to methionine can proceed via the Folate and Vitamin B-12 dependent methionine synthase (ms) reaction.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('CHEBI_17088', 'monoacyl-sn-glycerol 3-phosphate', 36, 'homocysteine'), ('CHEBI_30863', '5-azaorotic acid', 83, 'folate'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 94, 'vitamin B-12')]
PMC4673623	11/2015	S118-PMC4673623	['IN CONTRAST, ALTHOUGH absolute Vitamin B-12 Intake MAY HAVE been slightly lower among the hf-hed (vs. control) group, this modestly lower Intake would not be expected to cause the functional B-12 deficiency OBSERVED in the hf-hed moms.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 13), ('INCOMPLETE_EVIDENCE', 51), ('IMPORTANT_CONSIDERATION', 55), ('INCOMPLETE_EVIDENCE', 207)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 31, 'vitamin B-12'), ('GO_0007631', 'feeding behavior', 44, 'intake'), ('GO_0007631', 'feeding behavior', 138, 'intake'), ('PR_000004770', 'Polycomb complex protein BMI-1', 191, 'B-12')]
PMC4684854	12/2015	S43-PMC4684854	['a primary OBSERVATION, HOWEVER, was that LIMITED scientific LITERATURE is available on the issue of Gestational Vitamin D insufficiency as it RELATES to long-term health outcomes.']	[('ANOMALY_CURIOUS_FINDING', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 142)]	4	[('GO_0007565', 'female pregnancy', 100, 'gestational'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
PMC4684854	12/2015	S49-PMC4684854	['the medical literature has achieved GENERAL CONSENSUS that Vitamin D levels throughout much of the globe, as reflected by population measurements of 25(Oh)D3Levels, are generally INADEQUATE [38].']	[('PROBABLE_UNDERSTANDING', 36), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 44), ('PROBLEM_COMPLICATION', 179)]	3	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_51924', 'ethyl 2-cyanoacetoacetate', 149, '25(OH)D3levels'), ('PR_000006775', 'cytoplasmic dynein 2 heavy chain 1', 155, 'D3levels')]
PMC4684854	12/2015	S51-PMC4684854	['with such widespread deficiency, it is VITAL to determine WHETHER OR NOT low Gestational levels of Vitamin D are a SIGNIFICANT DETERMINANT of Reproductive and pediatric health outcomes.']	[('IMPORTANT_CONSIDERATION', 39), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 58), ('IMPORTANT_CONSIDERATION', 115), ('SUPERFICIAL_RELATIONSHIP', 127)]	4	[('GO_0007565', 'female pregnancy', 77, 'gestational'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('GO_0000003', 'reproduction', 142, 'reproductive')]
PMC4684854	12/2015	S54-PMC4684854	['these iom RECOMMENDATIONS for REQUIRED Vitamin D intake HAVE BEEN put into SERIOUS question [42], HOWEVER, AS a significant statistical ERROR HAS BEEN identified in the way their recommendations were arrived AT [43].']	[('FUTURE_WORK', 10), ('IMPORTANT_CONSIDERATION', 30), ('INCOMPLETE_EVIDENCE', 56), ('IMPORTANT_CONSIDERATION', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('PROBABLE_UNDERSTANDING', 107), ('PROBLEM_COMPLICATION', 136), ('INCOMPLETE_EVIDENCE', 142), ('IMPORTANT_CONSIDERATION', 208)]	9	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC4684854	12/2015	S57-PMC4684854	['LIMITATIONS of Vitamin D research as RELATED to Gestational outcomes\nALTHOUGH maternal-fetal outcomes in the presence of adequate Gestational Vitamin D are GENERALLY favorable as REPORTED in the medical literature, SOME reports HAVE BEEN INCONSISTENT and CAST DOUBT on the LINK between Gestational Vitamin D sufficiency and health.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 69), ('ANOMALY_CURIOUS_FINDING', 69), ('PROBABLE_UNDERSTANDING', 156), ('INCOMPLETE_EVIDENCE', 179), ('INCOMPLETE_EVIDENCE', 215), ('INCOMPLETE_EVIDENCE', 228), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 238), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 255), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 260), ('INCOMPLETE_EVIDENCE', 260), ('SUPERFICIAL_RELATIONSHIP', 273)]	13	[('CHEBI_28384', 'vitamin K', 15, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 48, 'Gestational'), ('GO_0007565', 'female pregnancy', 130, 'gestational'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('GO_0007565', 'female pregnancy', 286, 'gestational'), ('CHEBI_27300', 'vitamin D', 298, 'vitamin D')]
PMC4684854	12/2015	S58-PMC4684854	['specifically, supplementation of Vitamin D in Pregnancy in SOME studies APPEARS TO SUGGEST marked BENEFIT WHILE research in OTHER publications does NOT APPEAR TO confer significant improvement in maternal-fetal outcomes [44].']	[('INCOMPLETE_EVIDENCE', 59), ('ANOMALY_CURIOUS_FINDING', 72), ('INCOMPLETE_EVIDENCE', 83), ('IMPORTANT_CONSIDERATION', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 106), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124), ('ANOMALY_CURIOUS_FINDING', 148), ('ANOMALY_CURIOUS_FINDING', 152)]	8	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007565', 'female pregnancy', 46, 'pregnancy')]
PMC4684854	12/2015	S60-PMC4684854	['FOUND that Gestational Vitamin D supplementation was ASSOCIATED with increased Birth weight and Birth length BUT, UNLIKE SOME OTHER RESEARCH, was not associated with other beneficial maternal and neonatal outcomes such as reductions in preeclampsia, Gestational diabetes, small for Gestational age infants, Preterm Birth, or rates of cesarean Delivery [44].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 109), ('ANOMALY_CURIOUS_FINDING', 109), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114), ('INCOMPLETE_EVIDENCE', 121), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 126)]	7	[('GO_0007565', 'female pregnancy', 11, 'gestational'), ('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0007567', 'parturition', 79, 'birth'), ('GO_0007567', 'parturition', 96, 'birth'), ('GO_0007565', 'female pregnancy', 250, 'gestational'), ('GO_0007565', 'female pregnancy', 282, 'gestational'), ('GO_0007565', 'female pregnancy', 307, 'preterm birth'), ('GO_0007567', 'parturition', 343, 'delivery')]
PMC4684854	12/2015	S61-PMC4684854	['the APPARENT DISPARITY between findings in VARIOUS STUDIES has caused SOME to reflexively CONCLUDE that Vitamin D status in Pregnancy is IRRELEVANT to maternal-fetal outcomes.']	[('ANOMALY_CURIOUS_FINDING', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('ANOMALY_CURIOUS_FINDING', 13), ('IMPORTANT_CONSIDERATION', 13), ('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 70), ('PROBABLE_UNDERSTANDING', 90), ('IMPORTANT_CONSIDERATION', 137)]	8	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('GO_0007565', 'female pregnancy', 124, 'pregnancy')]
PMC4684854	12/2015	S62-PMC4684854	['studies on Reproductive outcomes RELATED to Vitamin D supplementation, HOWEVER, are inherently PLAGUED by a NUMBER OF common CONFOUNDERS which CLOUD the picture.']	[('SUPERFICIAL_RELATIONSHIP', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('INCOMPLETE_EVIDENCE', 108), ('PROBLEM_COMPLICATION', 125), ('INCOMPLETE_EVIDENCE', 143)]	6	[('GO_0000003', 'reproduction', 11, 'reproductive'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC4684854	12/2015	S63-PMC4684854	['it is IMPORTANT TO REALIZE that Vitamin D status is very different from WHETHER OR not someone is consuming Vitamin D supplementation.']	[('IMPORTANT_CONSIDERATION', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 72)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC4684854	12/2015	S68-PMC4684854	['(i) there is wide HETEROGENEITY of studied populations with VARIATIONS in Vitamin D supplement dosing, geophysical location, social and dietary conditions, and OTHER FACTORS in studied groups [45].']	[('DIFFICULT_TASK', 18), ('DIFFICULT_TASK', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 160), ('SUPERFICIAL_RELATIONSHIP', 166)]	4	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC4684854	12/2015	S71-PMC4684854	['(iii) DIFFERENT types of Vitamin D (Vitamin D2Versus Vitamin D3) have DIFFERENT physiological IMPACT.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 70), ('SUPERFICIAL_RELATIONSHIP', 94)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_78720', 'tetramethylrhodamine ethyl ester perchlorate', 36, 'vitamin D2versus'), ('PR_000017350', 'serine/threonine-protein kinase VRK2', 36, 'vitamin D2versus'), ('CHEBI_33279', 'vitamin D5', 53, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 53, 'vitamin D3')]
PMC4684854	12/2015	S112-PMC4684854	['AS hypersensitivity outcomes MAY also be seen in those children Born to mothers contaminated with assorted Xenobiotics in Pregnancy [84–89], HOWEVER, it is NOT KNOWN WHETHER the Immune Dysregulation and hypersensitivity MAY BE the consequence of a primary Gestational insufficiency of Vitamin D, OR WHETHER various chemical Toxicants MIGHT play a ROLE by impairing Vitamin D Uptake, Renal synthesis, and assimilation [25,90] WHILE at the same time inducing Immune compromise and hypersensitivity through OTHER mechanisms [91].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('FULL_UNKNOWN', 156), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 166), ('INCOMPLETE_EVIDENCE', 220), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 296), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 299), ('INCOMPLETE_EVIDENCE', 334), ('SUPERFICIAL_RELATIONSHIP', 347), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 425), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 504)]	12	[('GO_0007567', 'parturition', 64, 'born'), ('CHEBI_35703', 'xenobiotic', 107, 'xenobiotics'), ('GO_0007565', 'female pregnancy', 122, 'pregnancy'), ('GO_0001774', 'microglial cell activation', 178, 'immune dysregulation'), ('UBERON_0002405', 'immune system', 178, 'immune'), ('GO_0007565', 'female pregnancy', 256, 'gestational'), ('CHEBI_27300', 'vitamin D', 285, 'vitamin D'), ('CHEBI_35704', 'N(2)-acetyl-L-lysine', 324, 'toxicants'), ('CHEBI_27300', 'vitamin D', 365, 'vitamin D'), ('GO_0071939', 'vitamin A import', 365, 'vitamin D uptake'), ('UBERON_0002113', 'kidney', 383, 'renal'), ('UBERON_0002405', 'immune system', 457, 'immune')]
PMC4684854	12/2015	S113-PMC4684854	['maternal Vitamin D status during Gestation also APPEARS TO have INFLUENCE on many OTHER health indices in the future of the offspring.']	[('ANOMALY_CURIOUS_FINDING', 48), ('SUPERFICIAL_RELATIONSHIP', 64), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'gestation')]
PMC4684854	12/2015	S133-PMC4684854	['as Pregnant women [105], particularly those with dark skin [106], are at CONSIDERABLE RISK for experiencing Vitamin D insufficiency [39], it is IMPORTANT to have a HIGH INDEX OF SUSPICION and to EFFECTIVELY preclude, assess for, and manage Vitamin D inadequacy, as would be done with OTHER biochemical irregularities.']	[('IMPORTANT_CONSIDERATION', 73), ('IMPORTANT_CONSIDERATION', 144), ('INCOMPLETE_EVIDENCE', 164), ('IMPORTANT_CONSIDERATION', 195), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 284)]	5	[('GO_0007565', 'female pregnancy', 3, 'pregnant'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D')]
PMC4684854	12/2015	S136-PMC4684854	['one researcher has SUGGESTED that the dietary REQUIREMENT during Pregnancy and Lactation MAY actually be as high as 6000\u2009iu/day [108], BUT most researchers have concluded, with OUR CURRENT KNOWLEDGE, that a supplemental Vitamin D intake of 4000\u2009iu/day is OPTIMAL [30].']	[('INCOMPLETE_EVIDENCE', 19), ('IMPORTANT_CONSIDERATION', 46), ('INCOMPLETE_EVIDENCE', 89), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135), ('QUESTION_ANSWERED_BY_THIS_WORK', 177), ('INCOMPLETE_EVIDENCE', 181), ('FUTURE_WORK', 189), ('IMPORTANT_CONSIDERATION', 255)]	8	[('GO_0007565', 'female pregnancy', 65, 'pregnancy'), ('GO_0007595', 'lactation', 79, 'lactation'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D')]
PMC4689556	12/2015	S15-PMC4689556	['there is MIXED OBSERVATIONAL evidence with regards to the EFFECT of pre-Natal 25(Oh) Vitamin D status on child health outcomes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 58)]	3	[('GO_0007567', 'parturition', 72, 'natal'), ('CHEBI_30778', 'gallic acid', 78, '25(OH)'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC4689556	12/2015	S20-PMC4689556	['thus FAR there HAS BEEN a LACK OF randomised controlled trial evidence to definitively confirm OR REFUTE the RELATIONSHIP between Prenatal Vitamin D and childhood health outcomes FOUND in OBSERVATIONAL studies.']	[('ANOMALY_CURIOUS_FINDING', 5), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 26), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('SUPERFICIAL_RELATIONSHIP', 109), ('INCOMPLETE_EVIDENCE', 179), ('INCOMPLETE_EVIDENCE', 188)]	8	[('GO_0007565', 'female pregnancy', 130, 'prenatal'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC4689556	12/2015	S137-PMC4689556	['to further investigate the WEAK EVIDENCE for a LINK between Cord Blood 25(Oh) Vitamin D concentration and eczema cost (table 9), we analysed WHETHER there was a RELATIONSHIP between Cord 25(Oh) Vitamin D level and prescription of a medicated cream (aor 2.52, p = 0.10, 95% ci 0.85–7.47) and WHETHER cord 25(Oh) Vitamin D was ASSOCIATED with the number of eczema Medications prescribed (r = 0.07, p = 0.91, 95% ci -0.72–7.80).']	[('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 47), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('SUPERFICIAL_RELATIONSHIP', 161), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 291), ('SUPERFICIAL_RELATIONSHIP', 325)]	6	[('UBERON_0002240', 'spinal cord', 60, 'cord'), ('UBERON_0000178', 'blood', 65, 'blood'), ('CHEBI_30778', 'gallic acid', 71, '25(OH)'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 182, 'cord'), ('CHEBI_30778', 'gallic acid', 187, '25(OH)'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 304, '25(OH)'), ('CHEBI_27300', 'vitamin D', 311, 'vitamin D'), ('CHEBI_25441', 'mycothiols', 362, 'medications')]
PMC4689556	12/2015	S141-PMC4689556	['discussion\nwe EVALUATED WHETHER two specific dosing regimens of Prenatal Vitamin D supplementation COULD reduce health care utilisation in the first three years of Life.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('INCOMPLETE_EVIDENCE', 99)]	3	[('GO_0007565', 'female pregnancy', 64, 'prenatal'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0000104', 'life cycle', 164, 'life')]
PMC4689556	12/2015	S142-PMC4689556	['we FOUND NO CONSISTENT evidence for a treatment effect on overall or disease-specific unscheduled healthcare utilisation in the first three years, ALTHOUGH it should be NOTED that neither of the intervention regimens resulted in adequate Vitamin D levels in mothers or Cord Blood, JUDGED by current international Vitamin D RECOMMENDATIONS [36,37].']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('ANOMALY_CURIOUS_FINDING', 147), ('ANOMALY_CURIOUS_FINDING', 169), ('PROBABLE_UNDERSTANDING', 281), ('FUTURE_WORK', 323)]	7	[('CHEBI_27300', 'vitamin D', 238, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 269, 'cord'), ('UBERON_0000178', 'blood', 274, 'blood'), ('CHEBI_27300', 'vitamin D', 313, 'vitamin D')]
PMC4689556	12/2015	S143-PMC4689556	['we FOUND NO EVIDENCE that Prenatal Vitamin D status is RELATED to healthcare utilisation, HOWEVER one MIGHT argue that the very SMALL number of subjects with adequate Vitamin D status LIMITED the power of this analysis.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 55), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90), ('INCOMPLETE_EVIDENCE', 102), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 184)]	7	[('GO_0007565', 'female pregnancy', 26, 'prenatal'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D')]
PMC4689556	12/2015	S144-PMC4689556	['these data CONTRAST WITH RECENT FINDINGS that higher dose Vitamin D during Pregnancy and infancy CAN reduce Upper Respiratory Tract infections in infancy [38].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 97)]	3	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0007565', 'female pregnancy', 75, 'pregnancy'), ('UBERON_0001557', 'upper respiratory tract', 108, 'upper respiratory tract')]
PMC4689556	12/2015	S149-PMC4689556	['[39]\nstudies in OTHER populations, USUALLY with higher Prenatal Vitamin D status THAN ours, have FOUND an inverse RELATIONSHIP between Cord Blood 25(Oh) Vitamin D level and child health outcomes [4].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('INCOMPLETE_EVIDENCE', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('INCOMPLETE_EVIDENCE', 97), ('SUPERFICIAL_RELATIONSHIP', 114)]	5	[('GO_0007565', 'female pregnancy', 55, 'prenatal'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 135, 'cord'), ('UBERON_0000178', 'blood', 140, 'blood'), ('CHEBI_30778', 'gallic acid', 146, '25(OH)'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC4689556	12/2015	S151-PMC4689556	['the FINDINGS from our trial, the FIRST Prenatal Vitamin D intervention trial to report child health outcomes, SUGGEST that either the dosing regimen used in this study was INADEQUATE, OR that the RELATIONSHIP between Cord Blood 25(Oh) Vitamin D and child health SEEN in OBSERVATIONAL studies MAY BE RELATED to hidden CONFOUNDERS.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 110), ('IMPORTANT_CONSIDERATION', 172), ('PROBLEM_COMPLICATION', 172), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 184), ('SUPERFICIAL_RELATIONSHIP', 196), ('INCOMPLETE_EVIDENCE', 262), ('INCOMPLETE_EVIDENCE', 270), ('INCOMPLETE_EVIDENCE', 292), ('SUPERFICIAL_RELATIONSHIP', 299), ('PROBLEM_COMPLICATION', 317)]	12	[('GO_0007565', 'female pregnancy', 39, 'prenatal'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0009472', 'axilla', 217, 'cord blood'), ('CHEBI_30778', 'gallic acid', 228, '25(OH)'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin D')]
PMC4689556	12/2015	S153-PMC4689556	['first the EFFECT (or lack OF effect) of the specific timing and dose of Vitamin D used in our study CANNOT BE generalised to OTHER dosing and timing schedules.']	[('SUPERFICIAL_RELATIONSHIP', 10), ('ANOMALY_CURIOUS_FINDING', 26), ('DIFFICULT_TASK', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 125)]	4	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC4689556	12/2015	S159-PMC4689556	['HOWEVER, guidance from the national institute for clinical excellence and royal college of obstetricians and gynaecologists in the uk now acknowledge this as a minimum dose for all Pregnant or breastfeeding women and that higher dosing SHOULD BE CONSIDERED in those at high RISK of Vitamin D deficiency [41,42].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 236), ('FUTURE_WORK', 246), ('IMPORTANT_CONSIDERATION', 246), ('IMPORTANT_CONSIDERATION', 274)]	5	[('GO_0007565', 'female pregnancy', 181, 'pregnant'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin D')]
PMC4689556	12/2015	S165-PMC4689556	['), there REMAINS an IMPORTANT QUESTION WHETHER Prenatal Vitamin D supplementation at doses which reliably achieve sufficiency in the target population, CAN improve healthcare outcomes for young children.']	[('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 20), ('EXPLICIT_QUESTION', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 39), ('EXPLICIT_QUESTION', 39), ('INCOMPLETE_EVIDENCE', 152)]	6	[('GO_0007565', 'female pregnancy', 47, 'prenatal'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D')]
PMC4689556	12/2015	S180-PMC4689556	['HOWEVER, multivariate analysis of our data SHOWED that ALTHOUGH maternal ethnicity CORRELATED with 25(Oh) Vitamin D level there was no relationship between maternal ethnicity and our measures of healthcare utilization in this trial.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 43), ('ANOMALY_CURIOUS_FINDING', 55), ('SUPERFICIAL_RELATIONSHIP', 83)]	4	[('CHEBI_30778', 'gallic acid', 99, '25(OH)'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D')]
PMC4689556	12/2015	S183-PMC4689556	['ALTHOUGH our confidence in the findings is LIMITED by the SMALL SAMPLE size, these data SUGGEST that IF Prenatal Vitamin D is used to promote improved child health outcome, then a Postnatal component to treatment, and/or or higher doses MAY BE NEEDED.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 101), ('INCOMPLETE_EVIDENCE', 237), ('FUTURE_WORK', 244)]	7	[('GO_0007565', 'female pregnancy', 104, 'prenatal'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('GO_0007567', 'parturition', 180, 'postnatal')]
PMC4689556	12/2015	S184-PMC4689556	['a RECENT systematic REVIEW of Prenatal Vitamin D supplementation FOUND HETEROGENEOUS study designs and INCONSISTENT findings [52].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 65), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103)]	5	[('GO_0007565', 'female pregnancy', 30, 'prenatal'), ('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC4689556	12/2015	S186-PMC4689556	['in that context FURTHER DATA are AWAITED from two larger randomised controlled trials, vdarrt [53] and abcvitamind [54], to establish WHETHER higher dose daily Prenatal Vitamin D supplementation will IMPACT on child health outcomes.']	[('FUTURE_WORK', 16), ('FUTURE_WORK', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 134), ('SUPERFICIAL_RELATIONSHIP', 200)]	4	[('GO_0007565', 'female pregnancy', 160, 'prenatal'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC4690051	12/2015	S12-PMC4690051	['WHILE THRESHOLDS for Vitamin D sufficiency HAVE BEEN DEBATED RECENTLY [10,11], low circulating levels of 25(Oh)D HAVE BEEN ASSOCIATED with increased mortality in black and white older adults dwelling in north america [12].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 6), ('INCOMPLETE_EVIDENCE', 43), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 53), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 113), ('SUPERFICIAL_RELATIONSHIP', 123)]	7	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 105, '25(OH)D')]
PMC4690051	12/2015	S18-PMC4690051	['this transport mechanism, along with OTHER Renal and Skeletal adaptations by aa [21,22,23], MAY buffer the developing Brain from ambient Vitamin D insufficiency.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 37), ('INCOMPLETE_EVIDENCE', 92)]	2	[('UBERON_0002113', 'kidney', 43, 'renal'), ('UBERON_0004288', 'skeleton', 53, 'skeletal'), ('UBERON_0000955', 'brain', 118, 'brain'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC4691762	12/2015	S17-PMC4691762	['RECENT EVIDENCE SUGGESTS that low Vitamin D at Birth or during Infancy is ASSOCIATED with an increased RISK of Food allergy6and eczema.7in addition Food allergy and eczema prevalence is higher the further from the equator a Person resides, LENDING SUPPORT to the HYPOTHESES that low Vitamin D (through low ultraviolet (uv) exposure) MAY play a ROLE in aberrant Immune Development in early Life and increase the risk of developing Food allergy and eczema.3food allergy is one of the earliest manifestations of the Immune deviation,8but also STRONGLY COASSOCIATES with eczema in infancy and asthma later in Life.9\nVitamin D supplementation in the first year of Life has also BEEN ASSOCIATED with a reduced risk of lris10and reduced recovery time in infants with acute bronchiolitis.11since early Life wheezy lris are also strongly ASSOCIATED with longer term respiratory outcomes including asthma12understanding the ROLE of Vitamin D in the RISK of early Life Respiratory diseases is also IMPORTANT.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 74), ('IMPORTANT_CONSIDERATION', 103), ('INCOMPLETE_EVIDENCE', 240), ('INCOMPLETE_EVIDENCE', 248), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 263), ('INCOMPLETE_EVIDENCE', 263), ('INCOMPLETE_EVIDENCE', 333), ('SUPERFICIAL_RELATIONSHIP', 344), ('PROBABLE_UNDERSTANDING', 540), ('SUPERFICIAL_RELATIONSHIP', 549), ('ANOMALY_CURIOUS_FINDING', 673), ('SUPERFICIAL_RELATIONSHIP', 678), ('SUPERFICIAL_RELATIONSHIP', 829), ('SUPERFICIAL_RELATIONSHIP', 914), ('IMPORTANT_CONSIDERATION', 939), ('IMPORTANT_CONSIDERATION', 987)]	18	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007567', 'parturition', 47, 'birth'), ('GO_0007631', 'feeding behavior', 63, 'infancy'), ('CHEBI_33290', 'food', 111, 'food'), ('CHEBI_33290', 'food', 148, 'food'), ('NCBITaxon_10088', 'Mus <genus>', 224, 'person'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D'), ('GO_0001822', 'kidney development', 361, 'immune development'), ('UBERON_0002405', 'immune system', 361, 'immune'), ('UBERON_0000104', 'life cycle', 389, 'life'), ('CHEBI_33290', 'food', 430, 'food'), ('UBERON_0002405', 'immune system', 513, 'immune'), ('UBERON_0000104', 'life cycle', 605, 'life'), ('CHEBI_28384', 'vitamin K', 612, 'Vitamin D'), ('UBERON_0000104', 'life cycle', 659, 'life'), ('UBERON_0000104', 'life cycle', 794, 'life'), ('CHEBI_27300', 'vitamin D', 922, 'vitamin D'), ('UBERON_0000104', 'life cycle', 953, 'life'), ('UBERON_0001004', 'respiratory system', 958, 'respiratory')]
PMC4691762	12/2015	S18-PMC4691762	['Vitamin D deficiency (currently defined as 25Ohd3<50\u2005nmol/l) has become MORE COMMON in modern communities over time, PRESUMABLY DUE TO INADEQUATE sun exposure resulting from indoor activities and skin cancer CONCERNS.13vitamin d deficiency is common in victoria, australia and also APPEARS TO BE increasing among Pregnant women14and infants.6in addition, the prevalence of infant Vitamin D deficiency was fourfold higher among fully Breastfed infants than fully formula Fed (p<0.001) EVEN at 12\u2005months after solid Food had been introduced.15\nUNLIKE OTHER countries in the northern hemisphere, australia does not RECOMMEND universal Vitamin D supplementation.']	[('PROBABLE_UNDERSTANDING', 72), ('PROBABLE_UNDERSTANDING', 117), ('PROBABLE_UNDERSTANDING', 128), ('IMPORTANT_CONSIDERATION', 135), ('IMPORTANT_CONSIDERATION', 208), ('ANOMALY_CURIOUS_FINDING', 282), ('ANOMALY_CURIOUS_FINDING', 484), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 542), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 549), ('FUTURE_WORK', 612)]	10	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_63058', '(2R,3S)-EHNA', 43, '25OHD3'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 43, '25OHD3'), ('GO_0007565', 'female pregnancy', 313, 'pregnant'), ('CHEBI_27300', 'vitamin D', 380, 'vitamin D'), ('GO_0007567', 'parturition', 433, 'breastfed'), ('GO_0007631', 'feeding behavior', 470, 'fed'), ('CHEBI_33290', 'food', 514, 'food'), ('CHEBI_27300', 'vitamin D', 632, 'vitamin D')]
PMC4691762	12/2015	S20-PMC4691762	['objectives\nwith the ultimate GOAL of developing improved PUBLIC HEALTH GUIDELINES for Vitamin D supplementation of infants, we AIM TO DETERMINE IF Vitamin D supplementation in infants from 6 to 8\u2005weeks of age LEADS to a reduction in the following during the first year of Life:\nchallenge-proven Food allergy\nlower Respiratory infections\nFood sensitisation\ndoctor diagnosed eczema\nvitamin D deficiency\n\nmethods and analysis\n\ndesign\nvitality is a double-blind, randomised, placebo-controlled trial of Vitamin D supplementation during the first year of Life.']	[('IMPORTANT_CONSIDERATION', 29), ('IMPORTANT_CONSIDERATION', 57), ('IMPORTANT_CONSIDERATION', 71), ('FUTURE_WORK', 127), ('QUESTION_ANSWERED_BY_THIS_WORK', 127), ('QUESTION_ANSWERED_BY_THIS_WORK', 131), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 144), ('SUPERFICIAL_RELATIONSHIP', 209)]	8	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('UBERON_0000104', 'life cycle', 272, 'life'), ('CHEBI_33290', 'food', 295, 'food'), ('UBERON_0001004', 'respiratory system', 314, 'respiratory'), ('CHEBI_33290', 'food', 337, 'Food'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 388, 'D'), ('CHEBI_27300', 'vitamin D', 499, 'vitamin D'), ('UBERON_0000104', 'life cycle', 550, 'life')]
PMC4691762	12/2015	S69-PMC4691762	["participant's Vitamin D status will be defined by their Blood 25Ohd3 level, AS: severely deficient <12.5\u2005nmol/l; moderately deficient 12.5–25\u2005nmol/l; mild deficiency 26–49\u2005nmol/l; sufficient ≥50\u2005nmol/l; and elevated >220\u2005nmol/l.23\nparent baseline questionnaire : to check that potential environmental and OTHER CONFOUNDING factors are balanced between the two randomisation groups, baseline parent questionnaires will collect data on: parental smoking, medication use, parental ancestry, ethnicity, education, employment, occupation, family history of allergy, use of supplements including Vitamin A, d and cod Liver oil, number of siblings; and pet ownership."]	[('PROBABLE_UNDERSTANDING', 76), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 305), ('PROBLEM_COMPLICATION', 311)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('UBERON_0000178', 'blood', 56, 'blood'), ('CHEBI_63058', '(2R,3S)-EHNA', 62, '25OHD3'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 62, '25OHD3'), ('CHEBI_27300', 'vitamin D', 590, 'vitamin A'), ('UBERON_0002107', 'liver', 611, 'liver')]
PMC4691762	12/2015	S73-PMC4691762	['we have established that composite maternal uvr dose (or 0.50 (95% ci 0.37 to 0.69) p<0.001) and maternal skin exposure index (or 0.81 (95% ci 0.66 to 0.98) p=0.03) were ASSOCIATED with breastfed infant Vitamin D status BUT infant time in the sun during the first year was NOT.15infant Feeding (amount of breastfeeding, Formula Feeding and type of formula, introduction of solid Foods) will also be recorded.']	[('SUPERFICIAL_RELATIONSHIP', 170), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 220), ('ANOMALY_CURIOUS_FINDING', 220), ('ANOMALY_CURIOUS_FINDING', 273)]	4	[('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('GO_0007631', 'feeding behavior', 286, 'feeding'), ('GO_0009057', 'macromolecule catabolic process', 320, 'formula'), ('GO_0007631', 'feeding behavior', 328, 'feeding'), ('CHEBI_33290', 'food', 379, 'foods')]
PMC4691762	12/2015	S79-PMC4691762	['it will MODEL the POTENTIAL cost-effectiveness of routine infant Vitamin D supplementation compared to no supplementation, ASSUMING australia-wide implementation.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 123)]	3	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 73, 'D')]
PMC4691762	12/2015	S106-PMC4691762	['we will not be monitoring Serum 25(Oh)D for safety reasons nor considering the association between 25(Oh)D and outcome frequency given that 400\u2005Iu HAS BEEN SHOWN to be SAFE in term babies,1926preterm infants27and is the current RECOMMENDED dose in the usa, canada, the uk and europe.18\n\ndiscussion\nthe results of the vitality trial will determine WHETHER Vitamin D supplementation has a ROLE in optimising infant Immune health in the first year of Life, reducing the risk of allergic disease and Respiratory diseases.']	[('INCOMPLETE_EVIDENCE', 147), ('IMPORTANT_CONSIDERATION', 168), ('FUTURE_WORK', 228), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 347), ('SUPERFICIAL_RELATIONSHIP', 387)]	5	[('UBERON_0001977', 'blood serum', 26, 'serum'), ('CHEBI_71657', 'versiconol acetate', 32, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 32, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 99, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 99, '25(OH)D'), ('CHEBI_17883', 'hydrogen chloride', 144, 'IU'), ('CHEBI_27300', 'vitamin D', 355, 'vitamin D'), ('UBERON_0002405', 'immune system', 413, 'immune'), ('UBERON_0000104', 'life cycle', 448, 'life'), ('UBERON_0001004', 'respiratory system', 496, 'respiratory')]
PMC4691762	12/2015	S113-PMC4691762	['restricting the trial to infants with Vitamin D deficiency would REQUIRE a smaller trial, HOWEVER it would be UNETHICAL to randomise these infants to placebo thereby not treating with Vitamin D. the use of Vitamin D supplements in the placebo group is ANOTHER POTENTIAL ISSUE HOWEVER we are collecting sufficient data regarding Feeding practices, Supplement use and sun exposure to account for this.']	[('FUTURE_WORK', 65), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90), ('DIFFICULT_TASK', 110), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 252), ('INCOMPLETE_EVIDENCE', 260), ('PROBLEM_COMPLICATION', 270), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 276)]	7	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('GO_0007631', 'feeding behavior', 328, 'feeding'), ('CHEBI_16158', 'steroid sulfate', 347, 'supplement')]
PMC4691762	12/2015	S118-PMC4691762	['it acts by inducing Antimicrobial peptides in Epithelial Cells, Neutrophils and Macrophages28And increases transcription of the innate Immune protein (hcap-18) which is capable of killing a wide variety of Viral and bacterial pathogens.29THESE FINDINGS are SUPPORTED by the observation that Vitamin D receptor polymorphisms (which decrease the bioavailability of Vitamin D to the cell) are ASSOCIATED with more SEVERE bronchiolitis30and that defective Control Of Vitamin D receptor-Mediated Cell Signalling PREDISPOSES to SEVERE Respiratory syncytial Virus bronchiolitis.31\n\nconclusions\ninternational enthusiasm for supplemental Vitamin D has OUTPACED AVAILABLE EVIDENCE on its EFFECTIVENESS32AND in fact ARGUMENT for routine supplementation is in equipoise.']	[('INCOMPLETE_EVIDENCE', 236), ('INCOMPLETE_EVIDENCE', 257), ('SUPERFICIAL_RELATIONSHIP', 390), ('IMPORTANT_CONSIDERATION', 411), ('SUPERFICIAL_RELATIONSHIP', 507), ('IMPORTANT_CONSIDERATION', 522), ('ANOMALY_CURIOUS_FINDING', 643), ('ANOMALY_CURIOUS_FINDING', 643), ('INCOMPLETE_EVIDENCE', 652), ('SUPERFICIAL_RELATIONSHIP', 678), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 705)]	11	[('CHEBI_65381', 'albizoside C', 20, 'antimicrobial'), ('CL_0000066', 'epithelial cell', 46, 'epithelial cells'), ('UBERON_0000483', 'epithelium', 46, 'epithelial'), ('CL_0000775', 'neutrophil', 64, 'neutrophils'), ('CL_0000091', 'Kupffer cell', 80, 'macrophages28and'), ('UBERON_0002405', 'immune system', 135, 'immune'), ('NCBITaxon_1', 'root', 206, 'viral'), ('CHEBI_27300', 'vitamin D', 291, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 363, 'vitamin D'), ('GO_0060070', 'canonical Wnt signaling pathway', 452, 'control of ... -mediated cell signalling'), ('CHEBI_27300', 'vitamin D', 463, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 529, 'respiratory'), ('NCBITaxon_1', 'root', 551, 'virus'), ('CHEBI_27300', 'vitamin D', 629, 'vitamin D')]
PMC4691762	12/2015	S120-PMC4691762	['the vitality trial will also enable a FUTURE evaluation of WHETHER Postnatal Vitamin D supplementation is ASSOCIATED with IMPROVED bone health in later childhood—the historical basis of widespread Postnatal Vitamin D supplementation, which REMAINS essentially UNTESTED.']	[('FUTURE_WORK', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 59), ('SUPERFICIAL_RELATIONSHIP', 106), ('IMPORTANT_CONSIDERATION', 122), ('INCOMPLETE_EVIDENCE', 240), ('INCOMPLETE_EVIDENCE', 260)]	6	[('GO_0007567', 'parturition', 67, 'postnatal'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0007567', 'parturition', 197, 'postnatal'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D')]
PMC4714725	1/2016	S96-PMC4714725	['ab, a Micronutrients and Herbal supplements\nthere is NO CLEAR EVIDENCE that dietary supplementation with Vitamins, Minerals, herbs, or spices CAN improve diabetes, and there MAY BE safety CONCERNS regarding the long-term use of antioxidant supplements such as Vitamins E and C and Carotene.c Alcohol\nadults with diabetes who drink alcohol SHOULD do so in moderation (no more than one drink per day for Adult women and no more than two drinks per day for Adult men).c\nAlcohol Consumption MAY place People with diabetes at INCREASED risk for delayed hypoglycemia, ESPECIALLY IF taking Insulin or Insulin secretagogues.']	[('FULL_UNKNOWN', 53), ('PROBABLE_UNDERSTANDING', 56), ('INCOMPLETE_EVIDENCE', 142), ('INCOMPLETE_EVIDENCE', 174), ('PROBLEM_COMPLICATION', 188), ('FUTURE_WORK', 339), ('INCOMPLETE_EVIDENCE', 487), ('IMPORTANT_CONSIDERATION', 521), ('ANOMALY_CURIOUS_FINDING', 562), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 573)]	10	[('CHEBI_34850', 'milrinone lactate', 6, 'Micronutrients'), ('NCBITaxon_7955', 'Danio rerio', 25, 'herbal'), ('CHEBI_33277', 'gamma-tocotrienol', 105, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 115, 'minerals'), ('CHEBI_27300', 'vitamin D', 260, 'vitamins E'), ('CHEBI_18245', 'carboxylato group', 275, 'C'), ('PR_000004900', 'complement C3', 275, 'C'), ('CHEBI_23042', 'carotene', 281, 'carotene'), ('CHEBI_30879', 'alcohol', 292, 'Alcohol'), ('UBERON_0007023', 'adult organism', 402, 'adult'), ('UBERON_0007023', 'adult organism', 454, 'adult'), ('CHEBI_30879', 'alcohol', 467, 'Alcohol'), ('GO_0007631', 'feeding behavior', 475, 'consumption'), ('NCBITaxon_10088', 'Mus <genus>', 497, 'people'), ('PR_000045358', 'insulin family protein', 583, 'insulin'), ('PR_000045358', 'insulin family protein', 594, 'insulin')]
PMC4714725	1/2016	S282-PMC4714725	['management of ckd in diabetesgfr (ml/min/1.73 m2)recommended managementall patientsyearly measurement of creatinine, uacr, potassium45–60referral to a nephrologist IF POSSIBILITY for nondiabetic Kidney disease exists (duration of type 1 diabetes <10 years, persistent albuminuria, abnormal findings on Renal ultrasound, resistant hypertension, rapid fall in egfr, or active Urinary sediment on Urine microscopic examination)consider THE NEED for dose adjustment of Medicationsmonitor egfr every 6 monthsmonitor electrolytes, bicarbonate, hemoglobin, calcium, Phosphorus, and Parathyroid hormone at least yearlyassure Vitamin D sufficiencyconsider bone density testingreferral for dietary counseling30–44monitor egfr every 3 monthsmonitor electrolytes, bicarbonate, calcium, phosphorus, Parathyroid hormone, hemoglobin, albumin, and weight every 3–6 monthsconsider the need for dose adjustment of Medications<30referral to a nephrologist\n\ndiabetic retinopathy\n\nrecommendations\n\noptimize Glycemic Control to reduce the RISK or slow the progression of diabetic retinopathy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 164), ('INCOMPLETE_EVIDENCE', 167), ('INCOMPLETE_EVIDENCE', 433), ('IMPORTANT_CONSIDERATION', 1017)]	4	[('UBERON_0002113', 'kidney', 195, 'kidney'), ('UBERON_0002113', 'kidney', 302, 'renal'), ('UBERON_0001088', 'urine', 374, 'urinary'), ('UBERON_0001088', 'urine', 394, 'urine'), ('CHEBI_25354', 'mineralocorticoid', 465, 'medicationsMonitor'), ('CHEBI_35885', 'secondary phosphine', 559, 'phosphorus'), ('UBERON_0001132', 'parathyroid gland', 575, 'parathyroid'), ('CHEBI_27300', 'vitamin D', 617, 'vitamin D'), ('UBERON_0001132', 'parathyroid gland', 786, 'parathyroid'), ('CHEBI_25441', 'mycothiols', 896, 'medications'), ('GO_0006094', 'gluconeogenesis', 986, 'glycemic control')]
PMC4719746	1/2016	S0-PMC4719746	['Vitamin D deficiency and supplementation in Pregnancy in a multiethnic population-based cohort\n\nabstract\n\nbackground\nTO INVESTIGATE ethnic DIFFERENCES in Vitamin D levels during Pregnancy, assess RISK factors for Vitamin D deficiency and explore the EFFECT of Vitamin D supplementation in women with deficiency in early Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 117), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139), ('SUPERFICIAL_RELATIONSHIP', 196), ('SUPERFICIAL_RELATIONSHIP', 250)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 44, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('GO_0007565', 'female pregnancy', 178, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 260, 'vitamin D'), ('GO_0007565', 'female pregnancy', 320, 'pregnancy')]
PMC4719746	1/2016	S17-PMC4719746	['studies provide INCONSISTENT and CONFLICTING evidence for adverse maternal and child health outcomes RELATED to Vitamin D deficiency [11–16].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 33), ('SUPERFICIAL_RELATIONSHIP', 101)]	3	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
PMC4719746	1/2016	S18-PMC4719746	['HOWEVER, the current state of evidence SUGGESTS unclear benefits of routine Vitamin D supplementation for most maternal or child health outcomes [17].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 39)]	2	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC4719746	1/2016	S20-PMC4719746	['DESPITE the CONTROVERSIES RELATED to adverse outcomes, and LACK OF EVIDENCE of clear benefits of routine supplementation, most western countries RECOMMEND Vitamin D supplementation during Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 59), ('FUTURE_WORK', 145)]	5	[('CHEBI_27300', 'vitamin D', 155, 'vitamin D'), ('GO_0007565', 'female pregnancy', 188, 'pregnancy')]
PMC4719746	1/2016	S21-PMC4719746	['the AIMS of THIS PAPER were TO INVESTIGATE ethnic DIFFERENCES in Vitamin D levels during Pregnancy, ASSESS RISK FACTORS for Vitamin D deficiency and explore the EFFECT of Vitamin D supplementation in women identified with low values during early Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 50), ('QUESTION_ANSWERED_BY_THIS_WORK', 100), ('SUPERFICIAL_RELATIONSHIP', 107), ('SUPERFICIAL_RELATIONSHIP', 161)]	7	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 171, 'vitamin'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 179, 'D'), ('GO_0007565', 'female pregnancy', 246, 'pregnancy')]
PMC4719746	1/2016	S75-PMC4719746	['about two thirds of western european and east asian women reported using Vitamin D supplements regularly at inclusion COMPARED TO 50\xa0% of OTHER ethnic groups.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 118), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 138)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC4719746	1/2016	S129-PMC4719746	['HOWEVER, 73\xa0% reported use of ≥10\xa0μg/day of Vitamin D supplements at the post-test, and only 3.5\xa0% STILL had severe deficiency, COMPARED TO 20\xa0% at inclusion.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 99), ('ANOMALY_CURIOUS_FINDING', 128)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC4719746	1/2016	S131-PMC4719746	['INTERPRETATION\nOUR FINDINGS are IN LINE WITH others CONFIRMING widespread Vitamin D deficiency during Pregnancy among ethnic minorities [2,3,11,23,24], although SOME STUDIES from northern europe have FOUND a comparatively higher prevalence and more SEVERE deficiency THAN observed in OUR STUDY [6,25].']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('INCOMPLETE_EVIDENCE', 32), ('PROBABLE_UNDERSTANDING', 52), ('INCOMPLETE_EVIDENCE', 161), ('INCOMPLETE_EVIDENCE', 200), ('IMPORTANT_CONSIDERATION', 249), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 267), ('QUESTION_ANSWERED_BY_THIS_WORK', 284)]	9	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007565', 'female pregnancy', 102, 'pregnancy')]
PMC4719746	1/2016	S133-PMC4719746	['HOWEVER, direct comparison of 25(Oh)D values between studies are hampered by DIFFERENT methodologies such as INCONSISTENT definitions of Vitamin D deficiency, laboratory measurements and degree of adjustment for POSSIBLE CONFOUNDERS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 109), ('INCOMPLETE_EVIDENCE', 212), ('PROBLEM_COMPLICATION', 221)]	5	[('CHEBI_71657', 'versiconol acetate', 30, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC4719746	1/2016	S141-PMC4719746	['the DEBATE about the OPTIMAL dose of Vitamin D supplementation during Pregnancy is ONGOING.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('IMPORTANT_CONSIDERATION', 21), ('IMPORTANT_CONSIDERATION', 83)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy')]
PMC4719746	1/2016	S149-PMC4719746	['HOWEVER, SOME EVIDENCE SUGGESTS Vitamin D binding protein MAY increase and the free fraction of 25(Oh)D MAY decrease [46,47].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 104)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 96, '25(OH)D')]
PMC4719746	1/2016	S154-PMC4719746	['compared with no change or a small increase in 25(Oh)D concentrations in women with adequate levels or mild Vitamin D deficiency, this DIFFERENTIAL change may INDICATE a beneficial EFFECT of the RECOMMENDATIONS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 135), ('INCOMPLETE_EVIDENCE', 159), ('SUPERFICIAL_RELATIONSHIP', 181), ('FUTURE_WORK', 195)]	4	[('CHEBI_71657', 'versiconol acetate', 47, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 53, 'D'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC4719746	1/2016	S155-PMC4719746	['HOWEVER, it SHOULD BE NOTED that severe Vitamin D deficiency was STILL FOUND in 15-20\xa0% of the high risk groups.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 12), ('ANOMALY_CURIOUS_FINDING', 22), ('IMPORTANT_CONSIDERATION', 65), ('INCOMPLETE_EVIDENCE', 71)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC4728621	1/2016	S193-PMC4728621	['finally, maternal trimester 2 Vitamin C intake was negatively ASSOCIATED with the sum of the 6 months old Triceps and Subscapular Skinfolds, a measure of overall adiposity, WHILE maternal trimester 3 Vitamin C intake was negatively ASSOCIATED with 6 months old Triceps-for-age skinfold thickness z-score.']	[('SUPERFICIAL_RELATIONSHIP', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 173), ('ANOMALY_CURIOUS_FINDING', 173), ('SUPERFICIAL_RELATIONSHIP', 232)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin C'), ('UBERON_0001509', 'triceps brachii', 106, 'triceps'), ('UBERON_3010813', 'vent glands', 118, 'subscapular skinfolds'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin C'), ('UBERON_0001509', 'triceps brachii', 261, 'triceps')]
PMC4729160	1/2016	S19-PMC4729160	['the world health organization (who) DEFINES vitamin a deficiency (vad) AS Tissue concentrations of Vitamin A (Va) low enough to have adverse health consequences, EVEN IF there is no evidence of clinical deficiency [2].']	[('PROBABLE_UNDERSTANDING', 36), ('PROBABLE_UNDERSTANDING', 71), ('ANOMALY_CURIOUS_FINDING', 162), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 167)]	4	[('UBERON_0000479', 'tissue', 74, 'tissue'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin A'), ('CHEBI_37958', 'dye', 110, 'VA')]
PMC4764019	1/2016	S7-PMC4764019	['the barker HYPOTHESIS HAS BEEN ELABORATED and evaluated in several reviews,2–4BUT TO THE BEST OF MY KNOWLEDGE, there HAS BEEN NO ATTEMPT to evaluate the HYPOTHESIS specifically for Vitamin D. THUS, what i PROPOSE TO explore in THIS very brief REVIEW is the EVIDENCE RELATING UNRECOGNIZED, Perinatal Vitamin D inadequacy to increased risk of certain chronic diseases later in Life, that is, to ascertain WHETHER any such EFFECTS MIGHT be an instance of the “barker HYPOTHESIS.”\ni deliberately avoid use of labels such as “deficient” or “insufficient” in characterizing Vitamin D status, AS these terms are OFTEN LINKED to specific values for serum 25-Hydroxyvitamin D [25(Oh)D], about which there is considerable CONTROVERSY.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('PROBABLE_UNDERSTANDING', 82), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 126), ('INCOMPLETE_EVIDENCE', 153), ('PROBABLE_UNDERSTANDING', 192), ('INCOMPLETE_EVIDENCE', 205), ('QUESTION_ANSWERED_BY_THIS_WORK', 205), ('QUESTION_ANSWERED_BY_THIS_WORK', 213), ('QUESTION_ANSWERED_BY_THIS_WORK', 227), ('QUESTION_ANSWERED_BY_THIS_WORK', 243), ('INCOMPLETE_EVIDENCE', 257), ('SUPERFICIAL_RELATIONSHIP', 266), ('INCOMPLETE_EVIDENCE', 275), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 403), ('SUPERFICIAL_RELATIONSHIP', 420), ('INCOMPLETE_EVIDENCE', 428), ('INCOMPLETE_EVIDENCE', 464), ('PROBABLE_UNDERSTANDING', 586), ('PROBABLE_UNDERSTANDING', 605), ('SUPERFICIAL_RELATIONSHIP', 611), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 712)]	25	[('CHEBI_27300', 'vitamin D', 181, 'vitamin D'), ('GO_0036268', 'swimming', 289, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 289, 'perinatal'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin D'), ('UBERON_0000104', 'life cycle', 375, 'life'), ('CHEBI_27300', 'vitamin D', 568, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 647, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 668, '25(OH)D')]
PMC4764019	1/2016	S8-PMC4764019	['INSTEAD, i use terms such as “low” or “inadequate,” referencing in each such use prevailing values for Vitamin D status or input relative to values FOUND in those Individuals who do not manifest the disorders concerned.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 148)]	2	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('NCBITaxon_1', 'root', 163, 'individuals')]
PMC4764019	1/2016	S12-PMC4764019	['INSTEAD, where i FOCUS HERE is on the nonskeletal CONSEQUENCES both of untreated rickets and of lesser degrees of Vitamin D inadequacy, OFTEN not clinically apparent and occurring at critical periods during maturation, in some instances well before the Life Stages when rickets is typically manifest.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('PROBLEM_COMPLICATION', 50), ('PROBABLE_UNDERSTANDING', 136)]	5	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('UBERON_0000104', 'life cycle', 253, 'life stages')]
PMC4764019	1/2016	S31-PMC4764019	['once again, may Births would have followed a winter-long, Vitamin D–deprived Pregnancy, WHEREAS november Births would have followed a summer-long pregnancy with PRESUMABLY higher Vitamin D status values.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 88), ('PROBABLE_UNDERSTANDING', 161)]	2	[('GO_0007567', 'parturition', 16, 'births'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy'), ('GO_0007567', 'parturition', 105, 'births'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D')]
PMC4764019	1/2016	S40-PMC4764019	['WHILE this ASSOCIATION MIGHT initially SEEM far-fetched, it is IMPORTANT TO NOTE that the great famine in china in 1958 to 1961 was ASSOCIATED with a subsequent rise in the incidence of schizophrenia in famine victims.2measured Vitamin D status values in these Individuals are NOT AVAILABLE, but it HAS long BEEN KNOWN that rickets was endemic in china and certainly was so at the time of the famine.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 23), ('ANOMALY_CURIOUS_FINDING', 39), ('IMPORTANT_CONSIDERATION', 63), ('SUPERFICIAL_RELATIONSHIP', 132), ('INCOMPLETE_EVIDENCE', 277), ('INCOMPLETE_EVIDENCE', 299)]	8	[('CHEBI_27300', 'vitamin D', 228, 'vitamin D'), ('NCBITaxon_1', 'root', 261, 'individuals')]
PMC4764019	1/2016	S41-PMC4764019	['HENCE, it is LIKELY that the malnutrition of the famine would have included Vitamin D deficiency as well as OTHER inadequacies.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 108)]	3	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC4764019	1/2016	S42-PMC4764019	['mcgrath et al also POINT out that Rats reared on Vitamin D–deficient diets produce pups that have morphologically abnormal Brain structures.9–11schizophrenia is USUALLY considered more a functional disorder with morphological alterations THAN a primarily morphologic one, and the Rat data INDICATE that Vitamin D is ESSENTIAL for normal Brain Development and HENCE plausibly for normal Brain function.']	[('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 161), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 238), ('INCOMPLETE_EVIDENCE', 289), ('IMPORTANT_CONSIDERATION', 316), ('PROBABLE_UNDERSTANDING', 359)]	6	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 34, 'rats'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000955', 'brain', 123, 'brain'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 280, 'rat'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin D'), ('GO_0007420', 'brain development', 337, 'brain development'), ('UBERON_0000955', 'brain', 337, 'brain'), ('UBERON_0000955', 'brain', 386, 'brain')]
PMC4764019	1/2016	S45-PMC4764019	['BECAUSE OTHER FACTORS, such as socioeconomic status and ethnic background, COULD EXPLAIN both the low Vitamin D status and the poor performance in school in this group of children, this ASSOCIATION CANNOT BE CONSIDERED causal.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 8), ('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 75), ('PROBABLE_UNDERSTANDING', 81), ('SUPERFICIAL_RELATIONSHIP', 186), ('INCOMPLETE_EVIDENCE', 198)]	7	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC4764019	1/2016	S49-PMC4764019	['this is BECAUSE, EVEN IF there were no connection between the Vitamin D status and the observed Learning difficulty, the group of Pregnant women to be studied would HAVE TO BE placed and maintained on a Vitamin D status, which is recognized to be INADEQUATE on OTHER grounds (ie, <18 ng/ml) and THEREFORE productive of harmful outcomes.']	[('PROBLEM_COMPLICATION', 8), ('ANOMALY_CURIOUS_FINDING', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('IMPORTANT_CONSIDERATION', 165), ('IMPORTANT_CONSIDERATION', 247), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 261), ('PROBABLE_UNDERSTANDING', 295)]	7	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007612', 'learning', 96, 'learning'), ('GO_0007565', 'female pregnancy', 130, 'pregnant'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D')]
PMC4764019	1/2016	S55-PMC4764019	['THUS, the EFFECTS of Vitamin D inadequacy are as far-RANGING as the Tissues concerned, all of which require Vitamin D to gain access to information stored in their Genes.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 53)]	3	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0000479', 'tissue', 68, 'tissues'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('SO_0000704', 'gene', 164, 'genes')]
PMC4764019	1/2016	S59-PMC4764019	['in the final analysis, the underlying HYPOTHESIS is not that Vitamin D supplementation will reduce the disease BURDEN of dm1, preeclampsia, ms, schizophrenia, or the OTHER disorders listed, RATHER, the RELEVANT HYPOTHESIS is, INSTEAD, that it is precisely Vitamin D inadequacy that increases or aggravates the disease BURDEN of these varied outcomes.']	[('INCOMPLETE_EVIDENCE', 38), ('IMPORTANT_CONSIDERATION', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 166), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 190), ('IMPORTANT_CONSIDERATION', 202), ('INCOMPLETE_EVIDENCE', 211), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 226), ('IMPORTANT_CONSIDERATION', 318)]	8	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D')]
PMC4764019	1/2016	S75-PMC4764019	['BUT the fact is that HOW we function after Birth does APPEAR TO BE SUSCEPTIBLE to INFLUENCE by Perinatal Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('EXPLICIT_QUESTION', 21), ('ANOMALY_CURIOUS_FINDING', 54), ('SUPERFICIAL_RELATIONSHIP', 67), ('SUPERFICIAL_RELATIONSHIP', 82)]	5	[('GO_0007567', 'parturition', 43, 'birth'), ('GO_0036268', 'swimming', 95, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 95, 'perinatal'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC4764019	1/2016	S76-PMC4764019	['HENCE, the barker HYPOTHESIS, OR something closely approximating it, is very LIKELY to be operative in the functioning of the Vitamin D economy during Human development.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('PROBABLE_UNDERSTANDING', 77)]	4	[('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 151, 'human')]
PMC4764019	1/2016	S83-PMC4764019	['african nationals living under ancestral conditions exhibit Vitamin D status values in the middle of this range (ie, approximately 46 ng/ml).16\nin conclusion, WHILE one cannot say that the barker HYPOTHESIS HAS BEEN definitively ESTABLISHED for each of the delayed Vitamin D inadequacy outcomes DESCRIBED HERE, it would SEEM that the PRUDENT course, both for oneself as an Individual and for one’s patients and clients, is to assume the applicability of the HYPOTHESIS and, accordingly, to ensure a Vitamin D status approximating that of ancestral Humans.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 159), ('INCOMPLETE_EVIDENCE', 196), ('INCOMPLETE_EVIDENCE', 207), ('INCOMPLETE_EVIDENCE', 229), ('INCOMPLETE_EVIDENCE', 295), ('QUESTION_ANSWERED_BY_THIS_WORK', 305), ('ANOMALY_CURIOUS_FINDING', 320), ('FUTURE_WORK', 334), ('INCOMPLETE_EVIDENCE', 458)]	9	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D'), ('NCBITaxon_1', 'root', 373, 'individual'), ('CHEBI_27300', 'vitamin D', 499, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 548, 'humans')]
PMC4765528	12/2015	S117-PMC4765528	['one of the MODELS that HAS BEEN POSTULATED is the ROLE of maternal Vitamin D status and Postnatal calcium transfer.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 50)]	5	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007567', 'parturition', 88, 'postnatal')]
PMC4765528	12/2015	S123-PMC4765528	['studies using the alspac cohort SHOW that Bone Development of the child is clearly RELATED to the in utero environment, BUT that SOME of the ASSOCIATIONS CAN be explained IN PART by the shared ASSOCIATIONS with bone and body size, ALTHOUGH maternal Vitamin D status exerts persisting EFFECTS on bone mass development [19].']	[('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 83), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 120), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 141), ('INCOMPLETE_EVIDENCE', 154), ('INCOMPLETE_EVIDENCE', 171), ('SUPERFICIAL_RELATIONSHIP', 193), ('ANOMALY_CURIOUS_FINDING', 231), ('SUPERFICIAL_RELATIONSHIP', 284)]	10	[('GO_0048539', 'bone marrow development', 42, 'bone development'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D')]
PMC4770602	1/2016	S17-PMC4770602	['[9] WHEREAS, an INCREASED RISK for preeclampsia is REPORTED in an investigation when Serum Vitamin D levels decreased around 20 ng/ml after adjusting for CONFOUNDERS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('IMPORTANT_CONSIDERATION', 16), ('INCOMPLETE_EVIDENCE', 51), ('PROBLEM_COMPLICATION', 154)]	4	[('UBERON_0001977', 'blood serum', 85, 'serum'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
PMC4770602	1/2016	S21-PMC4770602	['[5] deficiency of Vitamin D is diagnosed at level of <32 ng/ml and using the secriteria,[10] Vitamin D deficiency is very common in Pregnancy with up to 50% of Individuals,[111213] THOUGH, DEPENDING ON the country of residence and local clothing customs, a prevalence ranges from 18-84% is REPORTED by PREVIOUS STUDIES.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('ANOMALY_CURIOUS_FINDING', 181), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 189), ('INCOMPLETE_EVIDENCE', 290), ('INCOMPLETE_EVIDENCE', 302)]	5	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('GO_0007565', 'female pregnancy', 132, 'pregnancy'), ('NCBITaxon_1', 'root', 160, 'individuals')]
PMC4770602	1/2016	S58-PMC4770602	['cases included 68 pregnant women who received supplementation contain Vitamin D (600 iu/d) and control group included 70 pregnant women who received supplementation without Vitamin D. differences between both groups were not statistically significant ( p -value = 0.84)\n\ndiscussion\nEVIDENCE TO EVALUATE the effectiveness of Vitamin D in Pregnancy is no enough and much of what we KNOW comes from observational RATHER than experimental design, THEREFORE, AT PRESENT Vitamin D supplementation is NOT routinely offered to all pregnant women.']	[('INCOMPLETE_EVIDENCE', 282), ('QUESTION_ANSWERED_BY_THIS_WORK', 291), ('INCOMPLETE_EVIDENCE', 380), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 410), ('PROBABLE_UNDERSTANDING', 443), ('INCOMPLETE_EVIDENCE', 454), ('ANOMALY_CURIOUS_FINDING', 494)]	7	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 324, 'vitamin D'), ('GO_0007565', 'female pregnancy', 337, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 465, 'vitamin D')]
PMC4770602	1/2016	S66-PMC4770602	['[20] also, ROLE of Vitamin D in the PREVENTION of Preeclampsia is SUPPORTED by two clinical TRIALS, HOWEVER, in one of these STUDIES as an uncontrolled trial, supplementation with a multivitamin/Mineral supplement and halibut Liver oil provided at 20 week Gestation reduced the odds of Preeclampsia.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 66), ('FUTURE_WORK', 92), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 100), ('INCOMPLETE_EVIDENCE', 125)]	6	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 50, 'preeclampsia'), ('CHEBI_46662', 'mineral', 195, 'mineral'), ('UBERON_0002107', 'liver', 226, 'liver'), ('GO_0007565', 'female pregnancy', 256, 'gestation'), ('GO_0007128', 'meiotic prophase I', 286, 'preeclampsia')]
PMC4770602	1/2016	S73-PMC4770602	['[24] in ANOTHER STUDY asian woman with Vitamin D-deficient received 1,000 iu/day of Vitamin D during the third Trimester and result shows a lower proportion of neonates with low Birthweight COMPARED TO the placebo group.']	[('INCOMPLETE_EVIDENCE', 8), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 190)]	2	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 111, 'trimester'), ('GO_0007596', 'blood coagulation', 178, 'birthweight')]
PMC4770602	1/2016	S75-PMC4770602	['[22] IN CONTRAST WITH our results OTHER study SHOWED that low Birth weight is NOTED in infants of mothers supplemented with Vitamin D.\nwe THINKS that some POSSIBLE LIMITATIONS of the present study that SHOULD BE addressed and noted in FUTURE STUDIES are included; unmeasured sun exposure, maternal baseline 25-Oh-D and Preconception, physical activity, local area and early Pregnancy dietary Intake to HELP realize the EFFECT of these FACTORS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('INCOMPLETE_EVIDENCE', 46), ('ANOMALY_CURIOUS_FINDING', 78), ('INCOMPLETE_EVIDENCE', 138), ('INCOMPLETE_EVIDENCE', 155), ('INCOMPLETE_EVIDENCE', 164), ('FUTURE_WORK', 202), ('FUTURE_WORK', 235), ('FUTURE_WORK', 402), ('SUPERFICIAL_RELATIONSHIP', 419), ('SUPERFICIAL_RELATIONSHIP', 435)]	12	[('GO_0007567', 'parturition', 62, 'birth'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 307, '25-OH-D'), ('PR_000000164', 'BMP2', 309, '-OH'), ('PR_000006444', 'diacylglycerol kinase delta', 313, 'D'), ('GO_0007565', 'female pregnancy', 319, 'preconception'), ('GO_0007565', 'female pregnancy', 374, 'pregnancy'), ('GO_0007631', 'feeding behavior', 392, 'intake')]
PMC4770602	1/2016	S76-PMC4770602	['level of calcium in studied women was an IMPORTANT unmeasured covariate in OUR STUDY, WHEREAS, low calcium intake MAY BE ASSOCIATED with Vitamin D deficiency and MAY be a RISK FACTOR for Preeclampsia.']	[('IMPORTANT_CONSIDERATION', 41), ('QUESTION_ANSWERED_BY_THIS_WORK', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('INCOMPLETE_EVIDENCE', 114), ('SUPERFICIAL_RELATIONSHIP', 121), ('INCOMPLETE_EVIDENCE', 162), ('SUPERFICIAL_RELATIONSHIP', 171)]	7	[('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 187, 'preeclampsia')]
PMC4770602	1/2016	S79-PMC4770602	['in CONCLUSION, results of the PRESENT STUDY DEMONSTRATED that Vitamin D supplementation during the third Trimester of Pregnancy; reduce the RISK of Preeclampsia HOWEVER, this was not statistically significant.']	[('INCOMPLETE_EVIDENCE', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('INCOMPLETE_EVIDENCE', 44), ('IMPORTANT_CONSIDERATION', 140), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 161)]	5	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 105, 'trimester'), ('GO_0007565', 'female pregnancy', 118, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 148, 'preeclampsia')]
PMC4778858	3/2016	S23-PMC4778858	['HOWEVER, PREVIOUS STUDIES on Birth weight outcomes and RISK of gdm among Vitamin D deficient mothers DID NOT adequately address rates of maternal obesity, used an inaccurate vitamin d assay, or studied neonates of varying Gestational ages, thus CONFOUNDING interpretation of results.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 55), ('INCOMPLETE_EVIDENCE', 101), ('PROBLEM_COMPLICATION', 245)]	5	[('GO_0007567', 'parturition', 29, 'birth'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007565', 'female pregnancy', 222, 'gestational')]
PMC4778858	3/2016	S100-PMC4778858	['HOWEVER, CAUTION for too much Vitamin D supplementation SHOULD BE raised AS ONE STUDY DETERMINED higher concentrations of neonatal 25-Ohd are POSSIBLY ASSOCIATED with an elevated risk of becoming overweight in Adult Life [26].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('FUTURE_WORK', 56), ('PROBABLE_UNDERSTANDING', 73), ('INCOMPLETE_EVIDENCE', 76), ('QUESTION_ANSWERED_BY_THIS_WORK', 86), ('INCOMPLETE_EVIDENCE', 142), ('SUPERFICIAL_RELATIONSHIP', 151)]	8	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_72765', 'verruculogen', 131, '25-OHD'), ('UBERON_0000113', 'post-juvenile adult stage', 210, 'adult life')]
PMC4778858	3/2016	S102-PMC4778858	['as addressed PREVIOUSLY by our group [12] and others [27], obese women MAY REQUIRE larger amounts of Vitamin D supplementation compared to normal weight women to provide their neonates with sufficient levels of Vitamin D. YET the definition of neonatal Vitamin D sufficiency has NOT BEEN DETERMINED.']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 71), ('IMPORTANT_CONSIDERATION', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 222), ('ANOMALY_CURIOUS_FINDING', 222), ('FULL_UNKNOWN', 279)]	6	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 253, 'vitamin D')]
PMC4778858	3/2016	S108-PMC4778858	['these results are IN CONTRAST TO OTHER reports SUGGESTING that Vitamin D levels INFLUENCE the RISK of gdm [15,32].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 33), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 80), ('IMPORTANT_CONSIDERATION', 94)]	5	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC4778858	3/2016	S120-PMC4778858	['WHETHER the Vitamin D amount of 400–600 iu of D2Or D3In most Prenatal Vitamin formulations is sufficient to maintain levels > 30 ng/ml, especially among obese women, REMAINS UNKNOWN.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FULL_UNKNOWN', 166)]	2	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('PR_000011011', 'neurobeachin-like protein 1', 46, 'D2or D3in'), ('GO_0007565', 'female pregnancy', 61, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 70, 'vitamin')]
PMC4784858	3/2016	S87-PMC4784858	['EVEN IF national GUIDELINES RECOMMEND the use of dietary supplements to meet REQUIREMENTS for some Nutrients (Folate, Vitamin D, iron or Iodine) during Pregnancy, Nutrient intakes from dietary supplements were not included in the pandiet calculation, like in other studies using diet quality indexes for Pregnancy [11–13].']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('PROBABLE_UNDERSTANDING', 17), ('FUTURE_WORK', 28), ('IMPORTANT_CONSIDERATION', 77)]	5	[('CHEBI_33284', 'nutrient', 99, 'nutrients'), ('CHEBI_30863', '5-azaorotic acid', 110, 'folate'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 137, 'iodine'), ('GO_0007565', 'female pregnancy', 152, 'pregnancy'), ('CHEBI_33284', 'nutrient', 163, 'nutrient'), ('GO_0007565', 'female pregnancy', 304, 'pregnancy')]
PMC4784858	3/2016	S166-PMC4784858	['HOWEVER, the risk of Neural Tube defects HAS also BEEN ASSOCIATED with a diet quality scoring that takes into account more Nutrients in addition to Folate (Calcium, iron, Vitamin B6 and Vitamin A, and percentage of calories from fat and from sweets) [43].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 55)]	3	[('UBERON_0001049', 'neural tube', 21, 'neural tube'), ('CHEBI_33284', 'nutrient', 123, 'nutrients'), ('CHEBI_30863', '5-azaorotic acid', 148, 'folate'), ('CHEBI_22313', 'alkaline earth metal atom', 156, 'calcium'), ('CHEBI_33237', 'vitamin D4', 171, 'vitamin B6'), ('PR_000017255', 'Vang-like protein 1', 171, 'vitamin B6'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin A')]
PMC4785305	3/2016	S20-PMC4785305	['results derived from Nutrient rct, specifically Vitamin D supplementation, SUFFER from several CONFOUNDING FACTORS RELATED to the baseline status, intake of OTHER Nutrients, such as calcium and proteins, and sun exposure, which are DIFFICULT to quantify accurately.']	[('IMPORTANT_CONSIDERATION', 75), ('PROBLEM_COMPLICATION', 95), ('SUPERFICIAL_RELATIONSHIP', 115), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 157), ('DIFFICULT_TASK', 232)]	5	[('CHEBI_33284', 'nutrient', 21, 'nutrient'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('CHEBI_33284', 'nutrient', 163, 'nutrients')]
PMC4785305	3/2016	S23-PMC4785305	['maternal Vitamin D status during Pregnancy\nvitamin D deficiency during Pregnancy is PREVALENT worldwide, ESPECIALLY in developing countries.8in a systematic review of 18 studies conducted in western countries during the first Trimester, white caucasian Pregnant women were found to have a mean 25(Oh)D level between 29 and 73\u2005nmol/l.9mean 25(Oh)D levels were lower in non-caucasian Pregnant women, ranging between 15.2 and 43\u2005nmol/l.9in addition to ethnicity, higher latitude was a significant predisposing FACTOR for hypovitaminosis d.9similarly, in non-western countries, more than half of the Pregnant women who were beyond their first trimester had 25(Oh)D levels below 75\u2005nmol/l; these include countries such as india,10kuwait,11pakistan12and turkey.13even lower levels (<25\u2005nmol/l) HAVE BEEN REPORTED at Delivery in saudi arabia, iran and the united arab emirates.14furthermore, immigrant women were at PARTICULAR RISK.1516an OBSERVATIONAL study from the netherlands SHOWED significantly lower 25(Oh)D levels during the first Trimester in immigrant Pregnant women (turkish, moroccan and others), compared to western participants.17\n\nASSOCIATION between maternal Vitamin D status and maternal adverse outcomes\nVitamin D insufficiency during Pregnancy is ASSOCIATED with adverse maternal outcomes such as increased risk of Gestational diabetes mellitus (gdm), preeclampsia, caesarean-section Delivery and bacterial vaginosis.18in a recent meta-analysis of observational studies, the risk of gdm was FOUND TO BE increased by 40–84% in Pregnant women with low 25(Oh)D levels, defined as <50\u2005nmol/l or <75\u2005nmol/l, DEPENDING ON the studies.19–21while Preeclampsia risk was significantly increased in Vitamin D insufficient women,22c-section rates were INCONSISTENTLY AFFECTED by Vitamin D status.23HOWEVER, THESE FINDINGS REMAIN LIMITED by the inherent BIASES of OBSERVATIONAL studies, INCONSISTENT adjustment for CONFOUNDERS, in addition to the wide HETEROGENEITY in Vitamin D assays and Vitamin D cut-offs definition.']	[('IMPORTANT_CONSIDERATION', 84), ('IMPORTANT_CONSIDERATION', 105), ('SUPERFICIAL_RELATIONSHIP', 507), ('INCOMPLETE_EVIDENCE', 788), ('IMPORTANT_CONSIDERATION', 909), ('INCOMPLETE_EVIDENCE', 932), ('INCOMPLETE_EVIDENCE', 973), ('SUPERFICIAL_RELATIONSHIP', 1139), ('SUPERFICIAL_RELATIONSHIP', 1259), ('ANOMALY_CURIOUS_FINDING', 1503), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1615), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1752), ('SUPERFICIAL_RELATIONSHIP', 1767), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1796), ('INCOMPLETE_EVIDENCE', 1807), ('INCOMPLETE_EVIDENCE', 1822), ('INCOMPLETE_EVIDENCE', 1829), ('PROBLEM_COMPLICATION', 1853), ('INCOMPLETE_EVIDENCE', 1863), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1886), ('PROBLEM_COMPLICATION', 1914), ('DIFFICULT_TASK', 1951)]	22	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 51, 'D'), ('GO_0007565', 'female pregnancy', 71, 'pregnancy'), ('GO_0009294', 'DNA mediated transformation', 226, 'trimester'), ('GO_0007565', 'female pregnancy', 253, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 294, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 294, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 339, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 345, 'D'), ('GO_0007565', 'female pregnancy', 382, 'pregnant'), ('GO_0007565', 'female pregnancy', 596, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 653, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 653, '25(OH)D'), ('GO_0007567', 'parturition', 810, 'delivery'), ('CHEBI_71657', 'versiconol acetate', 1000, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1000, '25(OH)D'), ('GO_0009294', 'DNA mediated transformation', 1032, 'trimester'), ('GO_0007565', 'female pregnancy', 1055, 'pregnant'), ('CHEBI_27300', 'vitamin D', 1168, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 1215, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 1246, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1327, 'gestational'), ('GO_0007567', 'parturition', 1396, 'delivery'), ('GO_0007565', 'female pregnancy', 1538, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 1562, '25(OH)D'), ('GO_0007128', 'meiotic prophase I', 1651, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 1700, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1779, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1968, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1989, 'vitamin D')]
PMC4785305	3/2016	S24-PMC4785305	["ASSOCIATION between maternal Vitamin D level and neonatal adverse outcomes\nlow maternal 25(Oh)D levels were RECENTLY LINKED to fetal programming, and were found TO be ASSOCIATED with adverse events in neonates, resulting in small for Gestational age (sga) at Birth,1923and also later on during childhood, leading to reduced muscle and bone mass in offspring at 4 and 9\u2005years.2425this MAY BE EXPLAINED by the fact that maternal Vitamin D is ESSENTIAL for fetal Musculoskeletal integrity, as it Regulates neonatal bone accrual, POSSIBLY through specific proteins that are responsible for Placental Calcium Transport.26RECENTLY, data from the southampton women's survey (sws) SHOWED that maternal 25(Oh)D level is significantly CORRELATED with Placental Amino Acid transporters Expression, that mediate the Transport Of various Nutrients to the fetus.27furthermore, maternal Vitamin D MAY INFLUENCE the fetal muscle motor Unit size, and CONSEQUENTLY muscle mass and strength after Birth.25it is NOTEWORTHY that fetal bone development is one of the PREDICTORS of peak bone mass, Adult bone Mineral content and Hip geometry, THUS CORRELATING with fracture risk later in Life.2628\n\nVitamin d replacement guidelines during Pregnancy\nthe guidelines regarding Vitamin D replacement or supplementation during Pregnancy VARY substantially."]	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 117), ('QUESTION_ANSWERED_BY_THIS_WORK', 161), ('SUPERFICIAL_RELATIONSHIP', 167), ('INCOMPLETE_EVIDENCE', 384), ('ANOMALY_CURIOUS_FINDING', 388), ('PROBABLE_UNDERSTANDING', 391), ('IMPORTANT_CONSIDERATION', 440), ('INCOMPLETE_EVIDENCE', 526), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 614), ('INCOMPLETE_EVIDENCE', 673), ('SUPERFICIAL_RELATIONSHIP', 725), ('INCOMPLETE_EVIDENCE', 882), ('SUPERFICIAL_RELATIONSHIP', 886), ('PROBABLE_UNDERSTANDING', 934), ('ANOMALY_CURIOUS_FINDING', 992), ('SUPERFICIAL_RELATIONSHIP', 1045), ('PROBABLE_UNDERSTANDING', 1120), ('SUPERFICIAL_RELATIONSHIP', 1125), ('DIFFICULT_TASK', 1309)]	21	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 88, '25(OH)D'), ('GO_0007565', 'female pregnancy', 234, 'gestational'), ('GO_0007567', 'parturition', 259, 'birth'), ('CHEBI_27300', 'vitamin D', 427, 'vitamin D'), ('UBERON_0002204', 'musculoskeletal system', 460, 'musculoskeletal'), ('GO_0065007', 'biological regulation', 493, 'regulates'), ('UBERON_0001987', 'placenta', 586, 'placental'), ('GO_0006816', 'calcium ion transport', 596, 'calcium transport'), ('CHEBI_71657', 'versiconol acetate', 694, '25(OH)D'), ('UBERON_0001987', 'placenta', 741, 'placental'), ('CHEBI_82880', 'N-acyltetradecaphytosphingosine', 751, 'amino acid'), ('GO_0010467', 'gene expression', 775, 'expression'), ('GO_0006415', 'translational termination', 804, 'transport of ... nutrients'), ('CHEBI_33284', 'nutrient', 825, 'nutrients'), ('CHEBI_27300', 'vitamin D', 872, 'vitamin D'), ('UBERON_0002105', 'vestibulo-auditory system', 919, 'unit'), ('GO_0007567', 'parturition', 978, 'birth'), ('UBERON_0007023', 'adult organism', 1075, 'adult'), ('CHEBI_46662', 'mineral', 1086, 'mineral'), ('UBERON_0001464', 'hip', 1106, 'hip'), ('UBERON_0000104', 'life cycle', 1165, 'life'), ('CHEBI_33229', 'vitamin (role)', 1176, 'Vitamin'), ('GO_0007565', 'female pregnancy', 1216, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1251, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1299, 'pregnancy')]
PMC4785305	3/2016	S25-PMC4785305	['the 2010 institute of medicine (iom) report on dietary reference intakes for Calcium and Vitamin D RECOMMENDED 600\u2005iu to Pregnant women as the recommended daily allowance (rda), the rda being the dose that is projected to allow at least 97.5% of the Pregnant women population to reach the DESIRABLE target 25(Oh)D level ≥50\u2005nmol/l.29this RECOMMENDATION was BASED ON OBSERVATIONAL studies, NONE of which were conducted in the middle east.29CONVERSELY, the Endocrine society 2011 GUIDELINES RECOMMENDED that 1500–2000\u2005iu daily of Vitamin D is NEEDED to reach a target 25(Oh)D level ≥75\u2005nmol/l (a RECOMMENDATION that was graded as weak with moderate quality of evidence).30the american college of obstetricians and gynecologists (acog) does not RECOMMEND screening for Vitamin D level in Pregnancy, and abides by the iom RECOMMENDATIONS.31moreover, the who 2012 guidelines on Vitamin D replacement during Pregnancy DID NOT RECOMMEND vitamin D supplementation as part of Prenatal care.32this was based ON a meta-analysis of Vitamin D trials during Pregnancy, which IDENTIFIED a LIMITED NUMBER of high-quality studies DEMONSTRATING a beneficial EFFECT of supplementation on maternal and neonatal outcomes, and CONCLUDED that FURTHER randomised controlled trials (rcts) ARE NEEDED.33in the uk, HOWEVER, Pregnant women are CONSIDERED AT RISK of Vitamin D deficiency, and supplementation with 400\u2005iu daily is REQUIRED.34\nit is NOT CLEAR WHETHER any of the above RECOMMENDED doses are applicable to non-western populations, with lower baseline Vitamin D levels, such as in lebanon and other middle eastern countries.']	[('FUTURE_WORK', 99), ('IMPORTANT_CONSIDERATION', 289), ('FUTURE_WORK', 338), ('INCOMPLETE_EVIDENCE', 357), ('INCOMPLETE_EVIDENCE', 366), ('INCOMPLETE_EVIDENCE', 389), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 437), ('PROBABLE_UNDERSTANDING', 478), ('FUTURE_WORK', 489), ('FUTURE_WORK', 541), ('IMPORTANT_CONSIDERATION', 541), ('FUTURE_WORK', 594), ('FUTURE_WORK', 742), ('FUTURE_WORK', 818), ('INCOMPLETE_EVIDENCE', 912), ('FUTURE_WORK', 920), ('ANOMALY_CURIOUS_FINDING', 998), ('ANOMALY_CURIOUS_FINDING', 998), ('INCOMPLETE_EVIDENCE', 1061), ('INCOMPLETE_EVIDENCE', 1074), ('INCOMPLETE_EVIDENCE', 1113), ('SUPERFICIAL_RELATIONSHIP', 1140), ('INCOMPLETE_EVIDENCE', 1205), ('FUTURE_WORK', 1220), ('FUTURE_WORK', 1264), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1288), ('IMPORTANT_CONSIDERATION', 1316), ('INCOMPLETE_EVIDENCE', 1316), ('IMPORTANT_CONSIDERATION', 1327), ('IMPORTANT_CONSIDERATION', 1401), ('FULL_UNKNOWN', 1419), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1429), ('FUTURE_WORK', 1454)]	33	[('CHEBI_31341', 'calcium dihydroxide', 77, 'Calcium'), ('CHEBI_28384', 'vitamin K', 89, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 89, 'Vitamin'), ('GO_0007565', 'female pregnancy', 121, 'pregnant'), ('GO_0007565', 'female pregnancy', 250, 'pregnant'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 309, 'OH)D'), ('PR_000013502', 'parvalbumin alpha', 311, ')D'), ('UBERON_0005063', 'left ventricular compact myocardium', 455, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 528, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 566, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 566, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 766, 'vitamin D'), ('GO_0007565', 'female pregnancy', 785, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 873, 'vitamin D'), ('GO_0007565', 'female pregnancy', 902, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 938, 'D'), ('GO_0007565', 'female pregnancy', 967, 'prenatal'), ('CHEBI_27300', 'vitamin D', 1020, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1044, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1297, 'pregnant'), ('CHEBI_27300', 'vitamin D', 1338, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1535, 'vitamin D')]
PMC4785305	3/2016	S29-PMC4785305	['cooper et al 36SHOWED that Vitamin D supplementation of 1000\u2005iu daily, COMPARED TO placebo, in Pregnant women in the uk allowed a significant increase in bone Mineral content (bmc) of neonates, HOWEVER, ONLY when they were Born in winter.']	[('INCOMPLETE_EVIDENCE', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71), ('ANOMALY_CURIOUS_FINDING', 194), ('ANOMALY_CURIOUS_FINDING', 203)]	4	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 95, 'pregnant'), ('CHEBI_46662', 'mineral', 159, 'Mineral'), ('GO_0007567', 'parturition', 223, 'born')]
PMC4785305	3/2016	S31-PMC4785305	['in the middle east and north africa region, there are FEW RECENT rcts that attempted to determine the OPTIMAL regimen of Vitamin D replacement in healthy Pregnant women.38–41WITH the exception of soheilykhah et al 40who ASSESSED the EFFECT of Vitamin D supplementation on Insulin resistance, the primary outcomes in THESE studies were MOSTLY maternal and neonatal 25(Oh)D levels (seeonline supplementary appendix1).']	[('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 58), ('IMPORTANT_CONSIDERATION', 102), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 172), ('INCOMPLETE_EVIDENCE', 220), ('SUPERFICIAL_RELATIONSHIP', 233), ('INCOMPLETE_EVIDENCE', 316), ('PROBABLE_UNDERSTANDING', 335)]	8	[('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('GO_0007565', 'female pregnancy', 154, 'pregnant'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D'), ('PR_000045358', 'insulin family protein', 272, 'insulin'), ('CHEBI_71657', 'versiconol acetate', 364, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 364, '25 ... OH ... D')]
PMC4785305	3/2016	S32-PMC4785305	['none of the other clinically IMPORTANT outcomes, such as neonatal size and OTHER anthropometric measurements, neonatal bmc, gdm and c-section rates, were evaluated as primary outcomes in any of these trials (seeonline supplementary appendix1).10.1136/bmjopen-2015-010818.supp1\n\nwe therefore compiled a registry of all ongoing Vitamin D trials in Pregnancy, as captured by their registration on clinicaltrial.gov42(seeonline supplementary appendix2).']	[('IMPORTANT_CONSIDERATION', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 75)]	2	[('CHEBI_27300', 'vitamin D', 326, 'vitamin D'), ('GO_0007565', 'female pregnancy', 346, 'pregnancy')]
PMC4785305	3/2016	S33-PMC4785305	['in these trials, DIFFERENT doses of Vitamin D, reaching up to 7000\u2005iu daily, are being administered, and the outcomes to be assessed include neonatal weight and length, childhood asthma, maternal bone Mineral density, maternal adverse outcomes, including Preeclampsia and Preterm labour, and neonatal adverse outcomes, such as sga.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 17)]	1	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_46662', 'mineral', 201, 'mineral'), ('GO_0007128', 'meiotic prophase I', 255, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 272, 'preterm')]
PMC4785305	3/2016	S174-PMC4785305	['FINDINGS from our trial, and SIMILAR TO results derived from Nutrient rcts, are PRONE to the CONFOUNDING effect of several FACTORS.52indeed, the baseline 25(Oh)D level, the dietary Intake of Vitamin D and OTHER Nutrients, such as Calcium and proteins, sun exposure and others, REMAIN IMPORTANT PREDICTORS AFFECTING the response to Vitamin D supplementation, but are very DIFFICULT to quantify accurately.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 29), ('PROBABLE_UNDERSTANDING', 80), ('PROBLEM_COMPLICATION', 93), ('SUPERFICIAL_RELATIONSHIP', 123), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 205), ('INCOMPLETE_EVIDENCE', 277), ('IMPORTANT_CONSIDERATION', 284), ('SUPERFICIAL_RELATIONSHIP', 294), ('SUPERFICIAL_RELATIONSHIP', 305), ('DIFFICULT_TASK', 371)]	11	[('CHEBI_33284', 'nutrient', 61, 'nutrient'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 157, 'OH)D'), ('GO_0007631', 'feeding behavior', 181, 'intake'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('CHEBI_33284', 'nutrient', 211, 'nutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 230, 'calcium'), ('CHEBI_27300', 'vitamin D', 331, 'vitamin D')]
PMC4800340	5/2016	S13-PMC4800340	["we FOCUS on selective common Food Allergens (Peanuts and Tree nuts, Cow's Milk, and egg) and Nutrients (Vitamin D and n-3 Fatty Acids) that HAVE BEEN RATHER widely studied."]	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 140), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 150)]	3	[('CHEBI_33290', 'food', 29, 'food'), ('CHEBI_33663', 'cyclic hydrocarbon', 34, 'allergens'), ('NCBITaxon_10088', 'Mus <genus>', 45, 'peanuts'), ('NCBITaxon_1', 'root', 57, 'tree'), ('NCBITaxon_33208', 'Metazoa', 68, 'cow'), ('UBERON_0001913', 'milk', 74, 'milk'), ('CHEBI_33284', 'nutrient', 93, 'nutrients'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_35366', 'fatty acid', 122, 'fatty acids')]
PMC4800340	5/2016	S25-PMC4800340	["THIS STUDY SUGGESTS that low sunlight and PRESUMABLY suboptimal Vitamin D status at Birth is ASSOCIATED with Food Allergy Development in childhood.30a large scale population-based study in australia SHOWED that infants with low Serum 25-Hydroxyvitamin (Oh) D3Levels (≤50 nmol/l) had almost 12 times and 4 times higher risk of developing Peanut and egg allergies, respectively, in the first year of Life THAN infants with adequate Serum Vitamin D level.31HOWEVER, ANOTHER STUDY conducted in germany DEMONSTRATED that 25(Oh)D3Concentration in Pregnant women's Serum and in Cord Blood were positively ASSOCIATED with increased risk of Food Allergy Development among children in the first 2 years.32a RECENT randomized double-blind controlled TRIAL SHOWED that maternal Vitamin D3Supplementation for 6 weeks during Lactation increased the risk of Food allergy diagnosis by 3.42 times [95% confidence interval (ci)=1.02–11.77] among children of supplementation group compared to control group by 2 years of age.33due to lack OF robustly designed studies, a causal ASSOCIATION between Vitamin D status during Prenatal and Neonatal Period and Food allergy Development In Children remains INCONCLUSIVE."]	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 11), ('PROBABLE_UNDERSTANDING', 42), ('SUPERFICIAL_RELATIONSHIP', 93), ('INCOMPLETE_EVIDENCE', 199), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 403), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 452), ('INCOMPLETE_EVIDENCE', 463), ('INCOMPLETE_EVIDENCE', 498), ('SUPERFICIAL_RELATIONSHIP', 598), ('INCOMPLETE_EVIDENCE', 697), ('INCOMPLETE_EVIDENCE', 739), ('INCOMPLETE_EVIDENCE', 745), ('ANOMALY_CURIOUS_FINDING', 1020), ('SUPERFICIAL_RELATIONSHIP', 1059), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1181)]	16	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007567', 'parturition', 84, 'birth'), ('CHEBI_33290', 'food', 109, 'food'), ('GO_0048467', 'gynoecium development', 109, 'food allergy development'), ('UBERON_0001977', 'blood serum', 228, 'serum'), ('CHEBI_60346', 'alpha-Kdo-(2->8)-alpha-Kdo-OAll', 234, '25-hydroxyvitamin (OH) D3levels'), ('NCBITaxon_10088', 'Mus <genus>', 337, 'peanut'), ('UBERON_0000104', 'life cycle', 398, 'life'), ('UBERON_0001977', 'blood serum', 430, 'serum'), ('CHEBI_27300', 'vitamin D', 436, 'vitamin D'), ('CHEBI_74304', '(6Z,9Z,12Z,15Z,18Z,21Z)-3-oxotetracosahexaenoyl-CoA(4-)', 516, '25(OH)D3concentration'), ('GO_0007565', 'female pregnancy', 541, 'pregnant'), ('UBERON_0001977', 'blood serum', 558, 'serum'), ('UBERON_0009472', 'axilla', 571, 'cord blood'), ('CHEBI_33290', 'food', 632, 'food'), ('GO_0048467', 'gynoecium development', 632, 'food allergy development'), ('CHEBI_52915', 'phosphatediyl group', 766, 'vitamin D3supplementation'), ('GO_0007595', 'lactation', 811, 'lactation'), ('CHEBI_33290', 'food', 843, 'food'), ('CHEBI_27300', 'vitamin D', 1079, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1103, 'prenatal'), ('UBERON_0007221', 'neonate stage', 1116, 'neonatal period'), ('CHEBI_33290', 'food', 1136, 'food'), ('GO_0030163', 'protein catabolic process', 1149, 'development in children')]
PMC4800340	5/2016	S40-PMC4800340	['in the boston Birth cohort study, Cord Blood Vitamin D deficiency [25(Oh)D concentration <11 ng/ml] was not FOUND TO be ASSOCIATED with Food sensitization to eight common Food Allergen in children.67HOWEVER, when individual Genetic variant of 4 CANDIDATE Genes INVOLVED in Ige synthesis and Vitamin D Metabolism were jointly considered, there is a statistically strong Gene-Vitamin D INTERACTION (pinteraction=9×10-6) on Food sensitization.']	[('ANOMALY_CURIOUS_FINDING', 108), ('SUPERFICIAL_RELATIONSHIP', 120), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 197), ('INCOMPLETE_EVIDENCE', 245), ('SUPERFICIAL_RELATIONSHIP', 261), ('SUPERFICIAL_RELATIONSHIP', 384)]	6	[('GO_0007567', 'parturition', 14, 'birth'), ('UBERON_0002240', 'spinal cord', 34, 'cord'), ('UBERON_0000178', 'blood', 39, 'blood'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 67, '25(OH)D'), ('CHEBI_33290', 'food', 136, 'food'), ('CHEBI_33290', 'food', 171, 'food'), ('CHEBI_50904', 'allergen', 176, 'allergen'), ('SO_0000704', 'gene', 224, 'genetic'), ('SO_0000704', 'gene', 255, 'genes'), ('GO_0007630', 'jump response', 273, 'IgE'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 273, 'IgE'), ('CHEBI_27300', 'vitamin D', 291, 'vitamin D'), ('GO_0018977', '1,1,1-trichloro-2,2-bis-(4-chlorophenyl)ethane metabolic process', 299, 'D metabolism'), ('SO_0000704', 'gene', 369, 'gene'), ('CHEBI_27300', 'vitamin D', 374, 'vitamin D'), ('CHEBI_33290', 'food', 421, 'food')]
PMC4800340	5/2016	S51-PMC4800340	['the results of these studies SUGGEST that differential Dna Methylation in the regions of Genes RELATED to T-Cell Differentiation and balance between th1 and th2 during the critical Period Of early Life MAY BE POTENTIAL mechanisms of allergic disease development.73\n\nepigenetic Regulation by Nutrients\nALTHOUGH POSSIBLE ROLES of Prenatal Folate, N-3 Pufa, and Vitamin D in Immune programming HAVE BEEN SUGGESTED,3474only a LIMITED NUMBER OF STUDIES examined epigenetic Regulation by these Nutrients as a POTENTIAL biological pathway of allergic diseases.']	[('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 95), ('INCOMPLETE_EVIDENCE', 202), ('INCOMPLETE_EVIDENCE', 209), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 301), ('ANOMALY_CURIOUS_FINDING', 301), ('INCOMPLETE_EVIDENCE', 310), ('SUPERFICIAL_RELATIONSHIP', 319), ('INCOMPLETE_EVIDENCE', 391), ('INCOMPLETE_EVIDENCE', 401), ('INCOMPLETE_EVIDENCE', 422), ('INCOMPLETE_EVIDENCE', 503)]	12	[('GO_0006306', 'DNA methylation', 55, 'DNA methylation'), ('SO_0000704', 'gene', 89, 'genes'), ('CL_0000084', 'T cell', 106, 'T-cell'), ('GO_0030217', 'T cell differentiation', 106, 'T-cell differentiation'), ('UBERON_0008266', 'periodontal ligament', 181, 'period of ... life'), ('GO_0065007', 'biological regulation', 277, 'regulation'), ('CHEBI_33284', 'nutrient', 291, 'nutrients'), ('GO_0007565', 'female pregnancy', 328, 'prenatal'), ('CHEBI_30863', '5-azaorotic acid', 337, 'folate'), ('CHEBI_80445', '9,10-EOT', 345, 'n-3 PUFA'), ('CHEBI_27300', 'vitamin D', 359, 'vitamin D'), ('GO_0007566', 'embryo implantation', 372, 'immune'), ('UBERON_0002405', 'immune system', 372, 'immune'), ('GO_0065007', 'biological regulation', 468, 'regulation'), ('CHEBI_33284', 'nutrient', 488, 'nutrients')]
PMC4811107	3/2016	S15-PMC4811107	['DESPITE its positive ROLE in health, Vitamin D deficiency is a pandemic [5].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 21)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC4811107	3/2016	S97-PMC4811107	['EXAMINED WHETHER Prepregnancy obesity PREDICTED POOR Vitamin D status in neonates in their study of 400 women in pittsburgh, pennsylvania [7].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('SUPERFICIAL_RELATIONSHIP', 38), ('IMPORTANT_CONSIDERATION', 48)]	4	[('GO_0007565', 'female pregnancy', 17, 'prepregnancy'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC4811107	3/2016	S99-PMC4811107	['this DIFFERENCE LIKELY LED to the result in which women who were obese before Pregnancy were more LIKELY to have Delivered a child with Vitamin D deficiency COMPARED TO women who had a normal bmi (odds ratio = or = 2.1, 95% confidence interval = ci 1.2, 3.6).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('PROBABLE_UNDERSTANDING', 16), ('SUPERFICIAL_RELATIONSHIP', 23), ('PROBABLE_UNDERSTANDING', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 157)]	5	[('GO_0007565', 'female pregnancy', 78, 'pregnancy'), ('GO_0007567', 'parturition', 113, 'delivered'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D')]
PMC4811441	3/2016	S29-PMC4811441	['poorer Vitamin D status (measured as 25-Hydroxyvitamin D (25(Oh)D) during Pregnancy HAS BEEN ASSOCIATED with INCREASED RISKS of pe and Gestational hypertension in SOME [11,12] BUT NOT ALL observational studies [13,14].']	[('INCOMPLETE_EVIDENCE', 84), ('SUPERFICIAL_RELATIONSHIP', 93), ('IMPORTANT_CONSIDERATION', 109), ('INCOMPLETE_EVIDENCE', 163), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 176), ('ANOMALY_CURIOUS_FINDING', 180)]	6	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 37, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 58, '25(OH)D'), ('GO_0007565', 'female pregnancy', 74, 'pregnancy'), ('GO_0007565', 'female pregnancy', 135, 'gestational')]
PMC4811441	3/2016	S30-PMC4811441	['cross sectional and cohort studies investigating the ASSOCIATION between Vitamin D status and pe show CONFLICTING results [11–14].']	[('SUPERFICIAL_RELATIONSHIP', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC4829940	5/2016	S14-PMC4829940	['low 25(Oh)D levels HAVE BEEN ASSOCIATED with a range of adverse conditions, from Pregnancy outcomes to childhood illnesses and chronic disease including osteoporosis, cancer and Cardiovascular disease in Adulthood[3], ALTHOUGH randomized controlled trials of Vitamin D supplements do NOT SUPPORT causality for Extra-Skeletal outcomes[4],[5].']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 29), ('ANOMALY_CURIOUS_FINDING', 218), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 284)]	4	[('CHEBI_71657', 'versiconol acetate', 4, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 4, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 81, 'pregnancy'), ('UBERON_0004535', 'cardiovascular system', 178, 'cardiovascular'), ('UBERON_0000113', 'post-juvenile adult stage', 204, 'adulthood'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 310, 'extra-skeletal')]
PMC4829940	5/2016	S19-PMC4829940	['ALTHOUGH a NUMBER OF STUDIES have REPORTED inverse ASSOCIATIONS between maternal Vitamin D status and Postnatal health outcomes, systematic reviews SHOW that there is STILL substantial heterogeneity between studies in terms of methodology and results, and FEW or NO randomized TRIALS HAVE BEEN performed[6],[8],[10],[11].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 148), ('IMPORTANT_CONSIDERATION', 167), ('INCOMPLETE_EVIDENCE', 256), ('FULL_UNKNOWN', 263), ('INCOMPLETE_EVIDENCE', 284)]	10	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007567', 'parturition', 102, 'postnatal')]
PMC4829940	5/2016	S20-PMC4829940	['ALTHOUGH two RECENT randomized controlled trials observed SUGGESTIVE reductions in the incidence of asthma and recurrent wheezing following Vitamin D supplementation during Pregnancy[12],[13], the primary endpoints were not statistically significant.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 58)]	4	[('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('GO_0007565', 'female pregnancy', 173, 'pregnancy')]
PMC4829940	5/2016	S28-PMC4829940	['another STUDY explored epigenetic Regulation of Vitamin D converting enzymes[18], WHILE a third FOUND a RELATIONSHIP between methylation of the Genes Cyp24R1 and Cyp27A1 and variations in circulating 25(Oh)D levels[19].']	[('INCOMPLETE_EVIDENCE', 8), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 104)]	4	[('GO_0065007', 'biological regulation', 34, 'regulation'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('SO_0000704', 'gene', 144, 'genes'), ('PR_000006101', 'cytochrome P450 1A1', 150, 'CYP24R1'), ('PR_000006101', 'cytochrome P450 1A1', 162, 'CYP27A1'), ('CHEBI_71657', 'versiconol acetate', 200, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 200, '25(OH ... D')]
PMC4829940	5/2016	S115-PMC4829940	['DESPITE the EXISTING HYPOTHESIS that maternal Vitamin D status MAY INFLUENCE offspring health[41], we FOUND NO EVIDENCE for any Dna Methylation based EFFECT in Cord Blood, EITHER Genome-wide or in four candidate Genes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 67), ('INCOMPLETE_EVIDENCE', 102), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 150), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 172)]	10	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0006306', 'DNA methylation', 128, 'DNA methylation'), ('UBERON_0002240', 'spinal cord', 160, 'cord'), ('UBERON_0000178', 'blood', 165, 'blood'), ('SO_0001026', 'genome', 179, 'genome'), ('SO_0000704', 'gene', 212, 'genes')]
PMC4829940	5/2016	S118-PMC4829940	['epigenetic EFFECTS of maternal Vitamin D levels on offspring methylomes can NEVERTHELESS not be excluded; the cpg’s in the neighborhood of the CANDIDATE Genes, as mapped by the illumina humanmethylation450 beadchip, MAY not be the same as the ones REPORTED from OTHER studies.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 76), ('INCOMPLETE_EVIDENCE', 143), ('INCOMPLETE_EVIDENCE', 216), ('INCOMPLETE_EVIDENCE', 248), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 262), ('INCOMPLETE_EVIDENCE', 262)]	7	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('SO_0000704', 'gene', 153, 'genes')]
PMC4829940	5/2016	S127-PMC4829940	['HOWEVER, a FEW other STUDIES have explored RELATIONSHIPS between Vitamin D supplementation or circulating 25(Oh)D and methylation at a few Cpg Sites in two to four candidate Genes in Adults[18],[46], and one Genome-wide Dna Methylation study explored ASSOCIATION with Vitamin D deficiency in african children[17].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 251)]	4	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 106, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 106, '25(OH)D'), ('SO_0000036', 'matrix_attachment_site', 139, 'CpG sites'), ('SO_0000704', 'gene', 174, 'genes'), ('UBERON_0007023', 'adult organism', 183, 'adults'), ('SO_0001026', 'genome', 208, 'genome'), ('GO_0006306', 'DNA methylation', 220, 'DNA methylation'), ('CHEBI_27300', 'vitamin D', 268, 'vitamin D')]
PMC4832516	10/2015	S0-PMC4832516	['season of Birth is ASSOCIATED with Birth weight, Pubertal timing, Adult body size and educational attainment: a uk biobank study\n\nabstract\nseason of Birth, a marker of in utero Vitamin D exposure, HAS BEEN ASSOCIATED with a WIDE RANGE of health outcomes.']	[('SUPERFICIAL_RELATIONSHIP', 19), ('INCOMPLETE_EVIDENCE', 197), ('SUPERFICIAL_RELATIONSHIP', 206), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 224)]	4	[('GO_0007567', 'parturition', 10, 'birth'), ('GO_0007567', 'parturition', 35, 'birth'), ('GO_0007567', 'parturition', 49, 'pubertal'), ('UBERON_0007023', 'adult organism', 66, 'adult'), ('GO_0007567', 'parturition', 149, 'birth'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D')]
PMC4832516	10/2015	S10-PMC4832516	['WHILST OTHER mechanisms MAY contribute to these ASSOCIATIONS, these FINDINGS are CONSISTENT with a POSSIBLE ROLE of in utero Vitamin D exposure.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 7), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 81), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 108)]	8	[('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC4832516	10/2015	S139-PMC4832516	['WHILE the ASSOCIATIONS between season of Birth, or ESTIMATED Antenatal sunshine exposure, with Birth weight are CONSISTENT with experimental EFFECTS of in utero Vitamin D exposure on fetal growth, differing patterns of seasonality and INDEPENDENT ASSOCIATIONS SUGGEST that OTHER mechanisms MAY LINK season of Birth to Adult height and also puberty timing in women.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 112), ('SUPERFICIAL_RELATIONSHIP', 141), ('SUPERFICIAL_RELATIONSHIP', 235), ('SUPERFICIAL_RELATIONSHIP', 247), ('INCOMPLETE_EVIDENCE', 260), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 273), ('INCOMPLETE_EVIDENCE', 290), ('SUPERFICIAL_RELATIONSHIP', 294)]	12	[('GO_0007567', 'parturition', 41, 'birth'), ('GO_0007567', 'parturition', 61, 'antenatal'), ('GO_0007567', 'parturition', 95, 'birth'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D'), ('GO_0007567', 'parturition', 309, 'birth'), ('UBERON_0007023', 'adult organism', 318, 'adult')]
PMC4843009	4/2016	S122-PMC4843009	['CONVERSELY, Vitamin D supplementation HAS BEEN REPORTED to counteract depressive symptoms515253.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 38), ('INCOMPLETE_EVIDENCE', 47)]	3	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D')]
PMC4843009	4/2016	S124-PMC4843009	['CONVERSELY Vitamin D supplementation decreases the RISK to develop psychotic-like symptoms44.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 51)]	2	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D')]
PMC4859539	5/2016	S1-PMC4859539	['THIS STUDY SOUGHT TO DETERMINE IF circulating Cathelicidin concentrations in healthy children are RELATED to the age of the child, body composition and Vitamin D status at Birth and at the time of the study visit.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('SUPERFICIAL_RELATIONSHIP', 98)]	5	[('PR_000006009', 'alpha-catulin', 46, 'cathelicidin'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D'), ('GO_0007567', 'parturition', 172, 'birth')]
PMC4859539	5/2016	S14-PMC4859539	['additionally, WHILE ONE STUDY examined the levels of maternal and neonatal Vitamin D and Cathelicidin concentrations in healthy children at Delivery, there is a LACK OF research TO DETERMINE CORRELATIONS between Vitamin D status and cathelicidin among healthy children over time [20], as well as WHICH FACTORS such as age of the child, gender, and body composition MAY INDEPENDENTLY IMPACT Cathelicidin concentrations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 161), ('QUESTION_ANSWERED_BY_THIS_WORK', 178), ('SUPERFICIAL_RELATIONSHIP', 191), ('EXPLICIT_QUESTION', 296), ('SUPERFICIAL_RELATIONSHIP', 302), ('INCOMPLETE_EVIDENCE', 365), ('SUPERFICIAL_RELATIONSHIP', 369), ('SUPERFICIAL_RELATIONSHIP', 383)]	10	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_3364', 'Canthiumine', 89, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 89, 'cathelicidin'), ('GO_0007567', 'parturition', 140, 'delivery'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('CHEBI_3364', 'Canthiumine', 390, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 390, 'cathelicidin')]
PMC4859539	5/2016	S15-PMC4859539	['to address this GAP in the literature, the AIM of THIS follow-up STUDY was TO DETERMINE IF maternal Vitamin D status during Pregnancy and/or a child’s current Vitamin D status AFFECT the circulating concentration of Cathelicidin in healthy children years after Delivery.']	[('FULL_UNKNOWN', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 43), ('QUESTION_ANSWERED_BY_THIS_WORK', 50), ('QUESTION_ANSWERED_BY_THIS_WORK', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 88), ('SUPERFICIAL_RELATIONSHIP', 176)]	6	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('GO_0007565', 'female pregnancy', 124, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('PR_000006009', 'alpha-catulin', 216, 'cathelicidin'), ('GO_0007567', 'parturition', 261, 'delivery')]
PMC4859539	5/2016	S16-PMC4859539	['a second AIM was TO DETERMINE IF the concentration of cathelicidin and Vitamin D CORRELATE with the number of infections a child experiences during childhood and as a function of age.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('SUPERFICIAL_RELATIONSHIP', 81)]	4	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC4859539	5/2016	S47-PMC4859539	['four multivariable regressions were performed TO ASSESS WHETHER any significant ASSOCIATIONS existed between the natural logarithm of each subject’s cathelicidin concentration and each of the following Vitamin D measurements: (1) child’s current 25(Oh)D at time of follow-up, (2) child’s 25(Oh)d at Birth, (3) maternal 25(Oh)D throughout Pregnancy (visits 3 to 7 as area under the curve), and (4) maternal 25(Oh)D one month before Delivery; all analyses controlled for race/ethnicity, age, gender, and percent fat.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 56), ('SUPERFICIAL_RELATIONSHIP', 80)]	3	[('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 246, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 246, '25(OH)D'), ('CHEBI_37972', 'phosphorus-32 atom', 288, '25'), ('CHEBI_17792', 'organohalogen compound', 291, 'OH'), ('GO_0007567', 'parturition', 299, 'birth'), ('CHEBI_71657', 'versiconol acetate', 319, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 319, '25 ... OH ... D'), ('GO_0007565', 'female pregnancy', 338, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 406, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 406, '25(OH)D'), ('GO_0007567', 'parturition', 431, 'delivery')]
PMC4859539	5/2016	S69-PMC4859539	['DESPITE DIFFERENCES in Vitamin D status, there were no significant associations between Cathelicidin, race/ethnicity and Vitamin D status (see table 2 ).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 8)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('PR_000006009', 'alpha-catulin', 88, 'cathelicidin'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC4859539	5/2016	S97-PMC4859539	["in MODELS 1 and 4, there was also a TREND NOTED with the child’s percent fat being positively ASSOCIATED with Cathelicidin (beta = 0.028, p = 0.052 and beta = 0.025, p = 0.087).10.1371/journal.pone.0152711.t003\n\ncaption (table-wrap): table 3\nmultivariable linear regression models assessing factors associated with natural logarithm for Cathelicidin.model 1 \xa0\xa0independent variablesbetase1p valuerace/ethnicity\xa0\xa0black-0.0390.230.864white---------hispanic-0.1490.2000.459genderfemale---------male0.3180.16 0.047 age0.1450.065 0.028 percent fat0.0280.0140.052child's current 25(Oh)D-0.0050.010.598 model 2 \xa0\xa0\xa0independent variablesbetasep valuerace/ethnicityblack0.0350.210.868white---------hispanic-0.1490.210.470genderfemale---------male0.2750.170.104age0.2120.07 0.004 percent fat0.0250.020.087child's 25(Oh)D at Birth-0.0030.010.748 model 3 \xa0\xa0\xa0independent variablesbetasep valuerace/ethnicity\xa0\xa0black0.0410.180.821white---------hispanic-0.1220.160.458genderfemale---------male0.0910.140.507age0.1550.07 0.023 percent fat0.0120.010.359maternal 25(Oh)D throughout Pregnancy<-0.000100.999 model 4 \xa0\xa0\xa0independent variablesbetasep valuerace/ethnicity\xa0\xa0black0.0460.1990.816white---------hispanic-0.0800.1850.669genderfemale---------male0.3180.158 0.047 age0.1510.064 0.021 percent fat0.0260.010.069maternal 25(Oh)D 1-month before Delivery0.0030.010.606\n1se represents standard error\n\ndiscussion\nin THIS STUDY of healthy children whose mothers had participated in a Vitamin D supplementation trial during Pregnancy, DESPITE DIFFERENCES in both maternal and childhood Vitamin D status, there were no significant differences in Cathelicidin concentration between the three racial/ethnic groups studied."]	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 3), ('INCOMPLETE_EVIDENCE', 36), ('ANOMALY_CURIOUS_FINDING', 42), ('SUPERFICIAL_RELATIONSHIP', 94), ('QUESTION_ANSWERED_BY_THIS_WORK', 1391), ('ANOMALY_CURIOUS_FINDING', 1508), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1516)]	7	[('CHEBI_3364', 'Canthiumine', 110, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 110, 'cathelicidin'), ('CHEBI_3461', 'Casuarictin', 337, 'Cathelicidin'), ('CHEBI_71657', 'versiconol acetate', 572, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 572, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 801, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 807, 'D'), ('GO_0007567', 'parturition', 812, 'birth'), ('CHEBI_71657', 'versiconol acetate', 1042, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 1048, 'D'), ('GO_0007565', 'female pregnancy', 1061, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 1300, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1300, '25(OH)D'), ('GO_0007567', 'parturition', 1323, 'delivery0'), ('CHEBI_27300', 'vitamin D', 1458, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1497, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1559, 'vitamin D'), ('CHEBI_3364', 'Canthiumine', 1618, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 1618, 'cathelicidin')]
PMC4859539	5/2016	S102-PMC4859539	['DIFFERENCES in age, health and initial Vitamin D status between cohorts, as well as study design, MAY EXPLAIN the CONFLICTING data.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 98), ('PROBABLE_UNDERSTANDING', 102), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114)]	4	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC4859539	5/2016	S124-PMC4859539	['lastly, total circulating Cathelicidin was measured RATHER than cell-specific mrna Expression of Cathelicidin or 1,25(Oh)2D3Concentration [17], which MAY BE more closely LINKED with Vitamin D status during Fetal and childhood Development.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 52), ('INCOMPLETE_EVIDENCE', 150), ('SUPERFICIAL_RELATIONSHIP', 170)]	3	[('PR_000006009', 'alpha-catulin', 26, 'cathelicidin'), ('GO_0010467', 'gene expression', 83, 'expression'), ('PR_000006009', 'alpha-catulin', 97, 'cathelicidin'), ('CHEBI_52815', 'cresyl violet', 113, '1,25(OH)2D3concentration'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D'), ('GO_0030540', 'female genitalia development', 206, 'fetal ... development')]
PMC4864049	1/2016	S350-PMC4864049	['this is PARTICULARLY INTERESTING because it LINKS FINDINGS SHOWING decreased levels of Serotonin in asd patients\xa0[160] and reduced levels of Vitamin D. HOWEVER, a previous study FOUND LITTLE EVIDENCE that maternal Gestational Vitamin D levels are RELATED to the asd phenotype among offspring\xa0[161].']	[('ANOMALY_CURIOUS_FINDING', 8), ('ANOMALY_CURIOUS_FINDING', 21), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 44), ('INCOMPLETE_EVIDENCE', 50), ('INCOMPLETE_EVIDENCE', 59), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 152), ('INCOMPLETE_EVIDENCE', 178), ('INCOMPLETE_EVIDENCE', 184), ('SUPERFICIAL_RELATIONSHIP', 247)]	10	[('CHEBI_28790', 'serotonin', 87, 'serotonin'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('GO_0007565', 'female pregnancy', 214, 'gestational'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D')]
PMC4864049	1/2016	S351-PMC4864049	['in addition, WHILE THERE IS EVIDENCE that Vitamin D MAY increase Dna Demethylation of selected Gene Promoters, the mechanisms behind this EFFECT are NOT CLEAR\xa0[162].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 138), ('FULL_UNKNOWN', 149)]	5	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0006306', 'DNA methylation', 65, 'DNA demethylation'), ('SO_0000704', 'gene', 95, 'gene'), ('SO_0000167', 'promoter', 100, 'promoters')]
PMC4874157	5/2016	S115-PMC4874157	['several other STUDIES SUGGEST that, WHENEVER POSSIBLE, Interferon Β treatment SHOULD BE discontinued prior to Conception.21–28HOWEVER, SIMILAR women in OTHER STUDIES continued to receive treatment modalities throughout Pregnancy.1015–19\ninitially, Vitamin D was given as a supplement to address the paucity women MAY SUFFER from during Pregnancy,29and to attend to the Vitamin D deficiency in the general lebanese population.30more RECENT STUDIES have also SHOWN that maintaining adequate levels of Vitamin D during Pregnancy MIGHT have a PROTECTIVE EFFECT and lower the risk of developing Postpartum relapses.31\npsychological support was CRUCIAL in maintaining the mental well-Being of the mother.32some women exhibited signs of anxiety and depression.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 36), ('INCOMPLETE_EVIDENCE', 45), ('FUTURE_WORK', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124), ('INCOMPLETE_EVIDENCE', 135), ('INCOMPLETE_EVIDENCE', 152), ('INCOMPLETE_EVIDENCE', 313), ('IMPORTANT_CONSIDERATION', 317), ('INCOMPLETE_EVIDENCE', 432), ('INCOMPLETE_EVIDENCE', 457), ('INCOMPLETE_EVIDENCE', 526), ('SUPERFICIAL_RELATIONSHIP', 539), ('SUPERFICIAL_RELATIONSHIP', 550), ('IMPORTANT_CONSIDERATION', 639)]	16	[('CHEBI_76163', 'isoxicam', 55, 'interferon β'), ('PR_000008918', 'interferon alpha-5', 55, 'interferon β'), ('GO_0007620', 'copulation', 110, 'conception'), ('GO_0007565', 'female pregnancy', 219, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin D'), ('GO_0007565', 'female pregnancy', 336, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 369, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 499, 'vitamin D'), ('GO_0007565', 'female pregnancy', 516, 'pregnancy'), ('GO_0007565', 'female pregnancy', 590, 'postpartum'), ('GO_0016441', 'posttranscriptional gene silencing', 677, '-being')]
PMC4877864	6/2015	S87-PMC4877864	['WHILE, the results of THIS STUDY SHOWED that Vitamin C and Folate contents were ranged between borderline and inadequate Intake in both groups (group 1 and group 2) COMPARED TO their rdas (p<0.005), HOWEVER Vitamin A was ON THE OTHER HAND adequate.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('INCOMPLETE_EVIDENCE', 33), ('ANOMALY_CURIOUS_FINDING', 165), ('QUESTION_ANSWERED_BY_THIS_WORK', 174), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 199), ('ANOMALY_CURIOUS_FINDING', 199), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221)]	8	[('CHEBI_27300', 'vitamin D', 45, 'vitamin C'), ('CHEBI_30863', '5-azaorotic acid', 59, 'folate'), ('GO_0007631', 'feeding behavior', 121, 'intake'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin A')]
PMC4889866	5/2016	S9-PMC4889866	['in CONCLUSION, OUR STUDY HAD SHOWN that maternal Vitamin D, BUT NOT cord Vitamin D level, was ASSOCIATED with Viral tlr-triggered Il-10 response.']	[('INCOMPLETE_EVIDENCE', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('INCOMPLETE_EVIDENCE', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 60), ('SUPERFICIAL_RELATIONSHIP', 94)]	5	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('NCBITaxon_1', 'root', 110, 'viral'), ('PR_000001470', 'interleukin-28B', 130, 'IL-10')]
PMC4889866	5/2016	S17-PMC4889866	['IN CONTRAST, SOME reports HAVE SHOWN treatment with Vitamin D to result in increased Tlr Activation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 26)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('GO_0034104', 'negative regulation of tissue remodeling', 85, 'TLR activation')]
PMC4889866	5/2016	S19-PMC4889866	['THUS, DESPITE a WIDE VARIETY of studies that acknowledged the immunomodulatory ROLE of Vitamin D, the results HAVE BEEN CONFLICTING.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('ANOMALY_CURIOUS_FINDING', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('SUPERFICIAL_RELATIONSHIP', 79), ('INCOMPLETE_EVIDENCE', 110), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 120)]	7	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D')]
PMC4889866	5/2016	S23-PMC4889866	['in addition, we SOUGHT TO INVESTIGATE WHETHER maternal Blood and Cord Blood Vitamin D CORRESPOND in their ASSOCIATION with tlr-related Innate Immunity.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 38), ('EXPLICIT_QUESTION', 38), ('SUPERFICIAL_RELATIONSHIP', 86), ('SUPERFICIAL_RELATIONSHIP', 106)]	6	[('UBERON_0000178', 'blood', 55, 'blood'), ('UBERON_0002240', 'spinal cord', 65, 'cord'), ('UBERON_0000178', 'blood', 70, 'blood'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0045087', 'innate immune response', 135, 'innate immunity')]
PMC4889866	5/2016	S84-PMC4889866	['analysis was made to INVESTIGATE WHETHER maternal or Cord Blood Vitamin D status was ASSOCIATED with Lower Respiratory Tract infection (bronchiolitis, pneumonia, and croup), infectious enteritis, and Urinary Tract infection at 1 year of age.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 33), ('SUPERFICIAL_RELATIONSHIP', 85)]	3	[('UBERON_0002240', 'spinal cord', 53, 'cord'), ('UBERON_0000178', 'blood', 58, 'blood'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0004905', 'articulation', 101, 'lower respiratory tract'), ('UBERON_0001553', 'medial tarsal artery', 200, 'urinary tract')]
PMC4889866	5/2016	S88-PMC4889866	['discussion\nthe result from OUR STUDY SHOWED that maternal, BUT NOT Cord Blood Vitamin D level, was ASSOCIATED with Tlr-3 and Tlr7-8 triggered il-10 response.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('INCOMPLETE_EVIDENCE', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 59), ('SUPERFICIAL_RELATIONSHIP', 99)]	4	[('UBERON_0002240', 'spinal cord', 67, 'cord'), ('UBERON_0000178', 'blood', 72, 'blood'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('PR_000001959', 'tumor necrosis factor receptor superfamily member 1B', 115, 'TLR-3'), ('PR_000001155', 'Toll-like receptor 4', 125, 'TLR7')]
PMC4889866	5/2016	S90-PMC4889866	['DESPITE extensive investigations on Vitamin D, its ROLE in Neonatal Immune Development and health outcome REMAINS INCONSISTENT.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 106), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114)]	5	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0007567', 'parturition', 59, 'neonatal'), ('GO_0001822', 'kidney development', 68, 'immune development'), ('UBERON_0002405', 'immune system', 68, 'immune')]
PMC4889866	5/2016	S91-PMC4889866	['the REASONS for various CONFLICTING results MIGHT be DUE TO DIFFERENCES in the study designs, age of the study population, definition of clinical outcomes, and also DISPARITIES in the assessment of Vitamin D concentration (use of maternal Blood or Cord Blood).']	[('PROBABLE_UNDERSTANDING', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('INCOMPLETE_EVIDENCE', 44), ('PROBLEM_COMPLICATION', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 165), ('IMPORTANT_CONSIDERATION', 165)]	7	[('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('UBERON_0000178', 'blood', 239, 'blood'), ('UBERON_0002240', 'spinal cord', 248, 'cord'), ('UBERON_0000178', 'blood', 253, 'blood')]
PMC4889866	5/2016	S92-PMC4889866	['our result SUGGESTED that the latter MIGHT be an IMPORTANT ISSUE to CONSIDER, BECAUSE DESPITE a strong CORRELATION between maternal and Cord Vitamin D level, OUR study had OBSERVED a distinction between maternal and cord Vitamin D status in their ASSOCIATION with tlr-triggered cytokine response.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 37), ('IMPORTANT_CONSIDERATION', 49), ('PROBLEM_COMPLICATION', 59), ('FUTURE_WORK', 68), ('IMPORTANT_CONSIDERATION', 68), ('PROBLEM_COMPLICATION', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('ANOMALY_CURIOUS_FINDING', 86), ('SUPERFICIAL_RELATIONSHIP', 103), ('QUESTION_ANSWERED_BY_THIS_WORK', 158), ('INCOMPLETE_EVIDENCE', 172), ('SUPERFICIAL_RELATIONSHIP', 247)]	13	[('UBERON_0002240', 'spinal cord', 136, 'cord'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin D')]
PMC4889866	5/2016	S96-PMC4889866	["ANOTHER RECENT publication had DEMONSTRATED that ALTHOUGH low levels of Vitamin D in the Cord Blood were ASSOCIATED with higher Airway resistance in childhood, maternal Vitamin D level was not related to the children's Airway resistance [20]."]	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 31), ('ANOMALY_CURIOUS_FINDING', 49), ('SUPERFICIAL_RELATIONSHIP', 105)]	5	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 89, 'cord'), ('UBERON_0000178', 'blood', 94, 'blood'), ('UBERON_0001005', 'respiratory airway', 128, 'airway'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D'), ('UBERON_0001005', 'respiratory airway', 219, 'airway')]
PMC4889866	5/2016	S102-PMC4889866	['the DIFFERENCE between OUR FINDINGS and those of published reports MIGHT BE EXPLAINED by distinctive study design, AS ours assessed cytokine response to tlr ligands under different Vitamin D concentrations, and not cytokine response to direct Vitamin D stimulation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('INCOMPLETE_EVIDENCE', 67), ('ANOMALY_CURIOUS_FINDING', 73), ('PROBABLE_UNDERSTANDING', 76), ('PROBABLE_UNDERSTANDING', 115)]	6	[('CHEBI_27300', 'vitamin D', 181, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D')]
PMC4889866	5/2016	S111-PMC4889866	['HOWEVER, in present analyses, ALBEIT an ASSOCIATION between maternal Vitamin D level and Viral Tlr-Triggered Il-10 Response, there was no effect on the PREVALENCE of infectious diseases during the first 12 months of Life.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('ANOMALY_CURIOUS_FINDING', 30), ('SUPERFICIAL_RELATIONSHIP', 40), ('IMPORTANT_CONSIDERATION', 152)]	5	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('NCBITaxon_1', 'root', 89, 'viral'), ('GO_0033153', 'T cell receptor V(D)J recombination', 95, 'TLR-triggered ... -10 response'), ('PR_000001470', 'interleukin-28B', 109, 'IL-10'), ('UBERON_0000104', 'life cycle', 216, 'life')]
PMC4889866	5/2016	S112-PMC4889866	['our OBSERVATIONS are AT ODDS with SEVERAL STUDIES that SHOWED lower Vitamin D status to be ASSOCIATED with increased incidence or severity of infection during early childhood.']	[('INCOMPLETE_EVIDENCE', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 21), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 55), ('SUPERFICIAL_RELATIONSHIP', 91)]	5	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC4889866	5/2016	S113-PMC4889866	['HOWEVER, most studies that SHOWED PROTECTIVE EFFECT of Vitamin D against Respiratory diseases were of interventional studies that used supplementary Vitamin D and DID NOT measure Serum Vitamin D level.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 34), ('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 163)]	5	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 73, 'respiratory'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('UBERON_0001977', 'blood serum', 179, 'serum'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
PMC4889866	5/2016	S115-PMC4889866	['DEMONSTRATED an ASSOCIATION between low Cord Blood Vitamin D level and increased Respiratory syncytial Virus infections in infancy, HOWEVER, UNLIKE our participants, around 50% of their neonates were Vitamin D sufficient [27–29].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('ANOMALY_CURIOUS_FINDING', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141)]	5	[('UBERON_0002240', 'spinal cord', 40, 'cord'), ('UBERON_0000178', 'blood', 45, 'blood'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 81, 'respiratory'), ('NCBITaxon_1', 'root', 103, 'virus'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D')]
PMC4889866	5/2016	S116-PMC4889866	['SINCE the MAJORITY of our participants were Vitamin D deficient, IT IS POSSIBLE that higher Serum levels MIGHT be REQUIRED to reach optimal PROTECTIVE EFFECT to result in significant clinical DIFFERENCES.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 0), ('PROBABLE_UNDERSTANDING', 10), ('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 105), ('IMPORTANT_CONSIDERATION', 114), ('SUPERFICIAL_RELATIONSHIP', 140), ('SUPERFICIAL_RELATIONSHIP', 151), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 192)]	9	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('UBERON_0001977', 'blood serum', 92, 'serum')]
PMC4889866	5/2016	S117-PMC4889866	['NONETHELESS, in SUPPORT of our results, SEVERAL STUDIES also FAILED to show a difference in Serum Vitamin D level between children with and without Respiratory infections [30–32].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 61)]	4	[('UBERON_0001977', 'blood serum', 92, 'serum'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 148, 'respiratory')]
PMC4889866	5/2016	S118-PMC4889866	['these INCONSISTENT OBSERVATIONS POINT to the COMPLICATED ROLE of Vitamin D in the Immune modulation and disease process.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 32), ('DIFFICULT_TASK', 45), ('SUPERFICIAL_RELATIONSHIP', 57)]	5	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('UBERON_0002405', 'immune system', 82, 'immune')]
PMC4889866	5/2016	S121-PMC4889866	['first, the predominantly low Serum level of 25(Oh)D in THIS STUDY has LIMITED our ability TO DETERMINE WHETHER there is an ASSOCIATION between higher concentration of Vitamin D and infection.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 55), ('INCOMPLETE_EVIDENCE', 70), ('QUESTION_ANSWERED_BY_THIS_WORK', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('SUPERFICIAL_RELATIONSHIP', 123)]	5	[('UBERON_0001977', 'blood serum', 29, 'serum'), ('CHEBI_71657', 'versiconol acetate', 44, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D')]
PMC4889866	5/2016	S127-PMC4889866	['finally, ALTHOUGH PRESENT STUDY had OBSERVED an ASSOCIATION between Prenatal Vitamin D status and Viral tlrs-triggered response (Tlr3 and Tlr7/8, both of which recognize Viral rna), the EFFECT of Vitamin D on cpg Double Stranded dna motif (Tlr9) of the Viral Genome also DEMANDS FURTHER EXPLORATION.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 48), ('SUPERFICIAL_RELATIONSHIP', 186), ('IMPORTANT_CONSIDERATION', 271), ('FUTURE_WORK', 279)]	7	[('GO_0007565', 'female pregnancy', 68, 'prenatal'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('NCBITaxon_1', 'root', 98, 'viral'), ('PR_000001155', 'Toll-like receptor 4', 129, 'TLR3'), ('PR_000001155', 'Toll-like receptor 4', 138, 'TLR7'), ('NCBITaxon_1', 'root', 170, 'viral'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin D'), ('SO_0000985', 'double', 213, 'double stranded'), ('PR_000001155', 'Toll-like receptor 4', 240, 'TLR9'), ('NCBITaxon_1', 'root', 253, 'viral'), ('SO_0001026', 'genome', 259, 'genome')]
PMC4889866	5/2016	S129-PMC4889866	['the result SHOWED no correlation between maternal Vitamin D status and neonatal Tlr9 triggered cytokine response (supplement 2), THOUGH such conclusion NEEDED to be INTERPRETED with CAUTION for the null CORRELATION MIGHT be DUE TO LACK OF POWER OWING TO SMALL number of test samples.']	[('INCOMPLETE_EVIDENCE', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 129), ('ANOMALY_CURIOUS_FINDING', 129), ('FUTURE_WORK', 152), ('FULL_UNKNOWN', 165), ('INCOMPLETE_EVIDENCE', 182), ('SUPERFICIAL_RELATIONSHIP', 203), ('INCOMPLETE_EVIDENCE', 215), ('PROBLEM_COMPLICATION', 224), ('INCOMPLETE_EVIDENCE', 231), ('PROBLEM_COMPLICATION', 231), ('PROBLEM_COMPLICATION', 245), ('INCOMPLETE_EVIDENCE', 254)]	13	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('PR_000001155', 'Toll-like receptor 4', 80, 'TLR9')]
PMC4889866	5/2016	S130-PMC4889866	['in CONCLUSION, OUR STUDY HAD SHOWN that maternal Vitamin D level, BUT NOT cord Vitamin D, was ASSOCIATED with Tlr3 and Tlr7-8 triggered il-10 response.']	[('INCOMPLETE_EVIDENCE', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('INCOMPLETE_EVIDENCE', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 66), ('SUPERFICIAL_RELATIONSHIP', 94)]	5	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('PR_000001155', 'Toll-like receptor 4', 110, 'TLR3'), ('PR_000001155', 'Toll-like receptor 4', 119, 'TLR7')]
PMC4896250	4/2016	S1046-PMC4896250	['data on the RELATION of Vitamin D status and allergy are CONTROVERSIAL.']	[('SUPERFICIAL_RELATIONSHIP', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 57)]	2	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC4896250	4/2016	S3005-PMC4896250	['the PRESENT STUDY AIMED TO EXAMINE the regional DIFFERENCES in incidence of Food-induced anaphylaxis (fia) and Serum Vitamin D level in korea.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 48)]	4	[('CHEBI_33290', 'food', 76, 'food'), ('UBERON_0001977', 'blood serum', 111, 'serum'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC4896250	4/2016	S3017-PMC4896250	['after stratification by age groups and gender, fia incidences and Serum Vitamin D levels were INCONSISTENT in aspect of the regional differences.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 94)]	1	[('UBERON_0001977', 'blood serum', 66, 'serum'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC4896250	4/2016	S3696-PMC4896250	['THIS STUDY SOUGHT TO EVALUATE WHETHER Genetic variants in the Vitamin D pathway-related Genes are ASSOCIATED with allergic rhinitis in a han chinese population.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('SUPERFICIAL_RELATIONSHIP', 98)]	5	[('SO_0000704', 'gene', 38, 'genetic'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007601', 'visual perception', 62, 'vitamin D'), ('SO_0000704', 'gene', 88, 'genes')]
PMC4896250	4/2016	S4150-PMC4896250	['HOWEVER, the EFFECT of Vitamin D on house dust Mite (hdm) sensitization in patients with ad has NOT BEEN ESTABLISHED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('FULL_UNKNOWN', 96)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_46662', 'mineral', 47, 'mite')]
PMC4896250	4/2016	S4156-PMC4896250	['in the severe ad group, high hdm sensitization group had lower Serum Vitamin D levels COMPARED TO low hdm sensitization group with statistical significance.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 86)]	1	[('UBERON_0001977', 'blood serum', 63, 'serum'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC4896250	4/2016	S4491-PMC4896250	['HOWEVER, there were no associations with Vitamin D level and Pulmonary function and sunshine related FACTORS, such as housing type, living floor, and indoor/outdoor activity time.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 101)]	3	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('UBERON_0002048', 'lung', 61, 'pulmonary')]
PMC4896250	4/2016	S6132-PMC4896250	['SINCE THESE studies were very HETEROGENEOUS and the retrospective or the observational cohort studies, large randomized controlled TRIALS ARE NEEDED to determine WHETHER Vitamin D supplementation MAY BE beneficial in the PREVENTION of ar.']	[('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 6), ('DIFFICULT_TASK', 30), ('FUTURE_WORK', 131), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 162), ('INCOMPLETE_EVIDENCE', 196), ('SUPERFICIAL_RELATIONSHIP', 221)]	7	[('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
PMC4896250	4/2016	S6528-PMC4896250	['we SOUGHT TO DETERMINE WHETHER the immunomodulatory properties of Vitamin D MIGHT have beneficial EFFECTS on crs.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 98)]	5	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC4896250	4/2016	S7522-PMC4896250	['a531 the ASSOCIATION between Serum Vitamin D levels and allergic diseases in elementary schoolchildren\n\nhea-kyoung yang1, ji young lee1, minji kim1, kangmo ahn2, jihyun kim1, young-min kim1, hye-young kim3, yong mean park4, woo kyung kim5, so-yeon lee6\n\n1samsung medical center, south korea;2samsung;3medical research institute of pusan national university hospital;4konkuk university school of medicine;5seoul paik hospital/inje university college of medicine;6department of pediatrics, hallym sacred Heart hospital, hallym university college of medicine\n\ncorrespondence: hea-kyoung yang – samsung medical center, south korea\npurpose: there are CONTROVERSIES about the RELATIONSHIP between Vitamin D and allergic diseases, ALTHOUGH there HAS BEEN GROWING INTEREST in Vitamin D insufficiency.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 646), ('SUPERFICIAL_RELATIONSHIP', 670), ('ANOMALY_CURIOUS_FINDING', 724), ('INCOMPLETE_EVIDENCE', 739), ('INCOMPLETE_EVIDENCE', 748)]	6	[('UBERON_0001977', 'blood serum', 29, 'Serum'), ('CHEBI_28384', 'vitamin K', 35, 'Vitamin D'), ('UBERON_0000948', 'heart', 502, 'Heart'), ('CHEBI_27300', 'vitamin D', 691, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 768, 'vitamin D')]
PMC4896250	4/2016	S8292-PMC4896250	['objective\nwe AIMED TO INVESTIGATE WHETHER Vitamin D insufficiency in asthmatic Adults ASSOCIATES with atopy, poor asthma Control, and more frequent Respiratory Tract infections, and WHETHER these patients CAN BENEFIT from Vitamin D supplementation.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('SUPERFICIAL_RELATIONSHIP', 86), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182), ('INCOMPLETE_EVIDENCE', 205), ('IMPORTANT_CONSIDERATION', 209)]	7	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0007023', 'adult organism', 79, 'adults'), ('GO_0065007', 'biological regulation', 121, 'control'), ('UBERON_0000065', 'respiratory tract', 148, 'respiratory tract'), ('CHEBI_27300', 'vitamin D', 222, 'vitamin D')]
PMC4897157	5/2016	S92-PMC4897157	['ALTHOUGH results are EQUIVOCAL, a CONSIDERABLE body of EVIDENCE SUGGESTS that Vitamin D has an IMPORTANT IMPACT on the progression of allergic diseases11).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 21), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 64), ('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 105)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC4897157	5/2016	S135-PMC4897157	['HOWEVER, OTHER reports SUGGEST that the recent Vitamin D status is ASSOCIATED with Allergen sensitization32526).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 67)]	4	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_50904', 'allergen', 83, 'allergen')]
PMC4897523	10/2014	S109-PMC4897523	['ON THE OTHER HAND, the involvement of maternal Vitamin D during Pregnancy in autism REQUIRES PROPER INVESTIGATION.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 84), ('FUTURE_WORK', 93)]	3	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'pregnancy')]
PMC4903143	5/2016	S87-PMC4903143	['Vitamin D\nthere is general CONSENSUS in the medical literature that the Vitamin D status of many Individuals and population groups throughout much of the world (as reflected by population measurements of Serum 25(Oh)D levels) is INSUFFICIENT for OPTIMAL health [74].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 27), ('PROBABLE_UNDERSTANDING', 27), ('PROBLEM_COMPLICATION', 229), ('IMPORTANT_CONSIDERATION', 246)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('NCBITaxon_1', 'root', 97, 'individuals'), ('UBERON_0001977', 'blood serum', 204, 'serum'), ('CHEBI_71657', 'versiconol acetate', 210, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 210, '25(OH ... D')]
PMC4903143	5/2016	S100-PMC4903143	['because of widespread Vitamin D INSUFFICIENCY in many population groups and INCONSISTENT response to fixed doses of Vitamin D supplementation, the authors RECOMMEND testing for 25(Oh)d levels and SUITABLE intervention as REQUIRED [76].']	[('IMPORTANT_CONSIDERATION', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 76), ('FUTURE_WORK', 155), ('IMPORTANT_CONSIDERATION', 196), ('IMPORTANT_CONSIDERATION', 221)]	5	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 177, '25(OH)')]
PMC4908484	6/2016	S8-PMC4908484	['ALTHOUGH in Human, most of the Vitamin D that ends up in the Blood is produced in the Kidneys, Vitamin D MAY BE synthesized in OTHER Tissues such as Endothelium, Placenta, Prostate, skin, Colon, Breast, and the Central Nervous System (Cns).']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127)]	3	[('NCBITaxon_9606', 'Homo sapiens', 12, 'human'), ('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('UBERON_0000178', 'blood', 61, 'blood'), ('UBERON_0002113', 'kidney', 86, 'kidneys'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('UBERON_0000479', 'tissue', 133, 'tissues'), ('UBERON_0001986', 'endothelium', 149, 'endothelium'), ('UBERON_0001987', 'placenta', 162, 'placenta'), ('UBERON_0002367', 'prostate gland', 172, 'prostate'), ('UBERON_0001155', 'colon', 188, 'colon'), ('UBERON_0000310', 'breast', 195, 'breast'), ('UBERON_0001017', 'central nervous system', 211, 'central nervous system'), ('UBERON_0001017', 'central nervous system', 235, 'CNS')]
PMC4908484	6/2016	S9-PMC4908484	['the Production Of Vitamin D by these Tissues/Organs is low compared to the amount produced by Kidneys, and this Vitamin D is PROBABLY not released back into the Blood BUT acts within the Tissue where it is made (garcion et\xa0al.2002; tetich et\xa0al.2004; cranney et\xa0al.2007).']	[('PROBABLE_UNDERSTANDING', 125), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 167)]	2	[('GO_0018240', 'protein S-linked glycosylation via cysteine', 4, 'production of vitamin D'), ('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('UBERON_0000479', 'tissue', 37, 'tissues'), ('UBERON_0000062', 'organ', 45, 'organs'), ('UBERON_0002113', 'kidney', 94, 'kidneys'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('UBERON_0000178', 'blood', 161, 'blood'), ('UBERON_0000479', 'tissue', 187, 'tissue')]
PMC4910255	6/2016	S94-PMC4910255	['[30]individual1200112\xa0days until Birthiron 60\xa0mg, Folic Acid 400\xa0μgunimmap; IF haemoglobin concentration\u2009<\u200970\xa0g/l, given extra Iron 60\xa0mg daily and Anthelminthic treatment; if symptoms of night-blindness, Vitamin A 2000\xa0μg19.9birthweight, + 77\xa0g (95\xa0% ci, 24–130\xa0g)Gestation, 0.2\xa0weeks (95\xa0% ci, –0.1 to 0.4\xa0weeks)pmr in mmn, 49.0; pmr in control, 40.5nmr in Mmn, 30.6; nmr in control, 20.0nepal sarlahichristian et al.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 76)]	1	[('GO_0007567', 'parturition', 33, 'birthIron'), ('CHEBI_30751', 'formic acid', 50, 'folic acid'), ('CHEBI_24870', 'ion', 127, 'iron'), ('CHEBI_35443', 'anthelminthic drug', 148, 'anthelminthic'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin A'), ('GO_0006266', 'DNA ligation', 265, 'Gestation'), ('UBERON_0003109', 'parapophysis', 359, 'MMN')]
PMC4910255	6/2016	S283-PMC4910255	['the mechanisms of action are LIKELY to be MULTIFACTORIAL and follow-up REPORTS SUGGEST OTHER mechanisms such as the EFFECT of Vitamin A on Regulation of fetal Lung growth, branching and alveolarisation [67,68].']	[('PROBABLE_UNDERSTANDING', 29), ('DIFFICULT_TASK', 42), ('INCOMPLETE_EVIDENCE', 71), ('INCOMPLETE_EVIDENCE', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 87), ('SUPERFICIAL_RELATIONSHIP', 116)]	6	[('CHEBI_27300', 'vitamin D', 126, 'vitamin A'), ('GO_0065007', 'biological regulation', 139, 'regulation'), ('UBERON_0002048', 'lung', 159, 'lung')]
PMC4910734	6/2015	S86-PMC4910734	['HOWEVER, SOME reports INDICATE that the same children do not have night blindness,53and SOME reports SUGGEST that asd symptoms are reduced by Retinol treatment.54the lack of night blindness in asd cases of Vitamin A deficiencies SUGGESTS that Retinal is present, but conversion to Retinoic Acid is blocked.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 101), ('INCOMPLETE_EVIDENCE', 229)]	7	[('CHEBI_26536', 'retinoic acid', 142, 'retinol'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin A'), ('UBERON_0000966', 'retina', 243, 'retinal'), ('CHEBI_26536', 'retinoic acid', 281, 'retinoic acid')]
PMC4910734	6/2015	S133-PMC4910734	['autistic children are NOTORIOUS picky eaters, leading to SOME DOCUMENTED DEFICIENCIES in individual case STUDIES, such as Vitamin A deficiencies.53nutritional status based on dietary record keeping, not surprisingly, gives CONFLICTING results,118in PART BECAUSE autistic children OFTEN SUFFER from Gastrointestinal mal-absorption PROBLEMS77OR BECAUSE Genetic factors MAY play a ROLE in nutritional deficiency.']	[('IMPORTANT_CONSIDERATION', 22), ('IMPORTANT_CONSIDERATION', 22), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 62), ('IMPORTANT_CONSIDERATION', 73), ('INCOMPLETE_EVIDENCE', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 223), ('SUPERFICIAL_RELATIONSHIP', 249), ('PROBABLE_UNDERSTANDING', 254), ('PROBABLE_UNDERSTANDING', 280), ('IMPORTANT_CONSIDERATION', 286), ('IMPORTANT_CONSIDERATION', 330), ('PROBABLE_UNDERSTANDING', 343), ('INCOMPLETE_EVIDENCE', 367), ('SUPERFICIAL_RELATIONSHIP', 378)]	15	[('CHEBI_27300', 'vitamin D', 122, 'vitamin A'), ('UBERON_0005409', 'alimentary part of gastrointestinal system', 298, 'gastrointestinal'), ('SO_0000704', 'gene', 351, 'genetic')]
PMC4910734	6/2015	S135-PMC4910734	['MANY of the Micronutrients STUDIES HAVE BEEN BASED ON Plasma and Urinary clinical results, which SUGGEST the elevation of Lipid Peroxide-generated Aldehydes (Hne, mda)84–86as well as deficiencies in antioxidants, such as Vitamin E, Sulfur-containing Compounds, such as cysteine, methionine, and Gsh,119carnitine,120biotin,121and ( n -3) pufas.122given the depressed levels of Sulfur-containing Compounds in asd Individuals, it is NOT SURPRISING that these children are more sensitive than neurotypicals to the exposure of mercury and other heavy metals.78the antioxidant supplements, which SHOW symptom improvements include, but are not limited to Ubiquinol,123nac,124carnosine, and Vitamin C.125other Micronutrients, including b1,126B6-Mg2+,127Folate, Vitamin E, Retinol, and Zn2+, HAVE BEEN selected for a variety of reasons RELATING to the INVOLVEMENT in abnormal Metabolic pathways IMPLICATED in asd,1even THOUGH the clinical assays do not always show a deficiency in asd Individuals compared to neurotypical controls.119with all of the single Micronutrient STUDIES, there are CONFLICTING results regarding efficacy.119there are a FEW STUDIES, which utilize broad-spectrum Micronutrient supplementation and report improvements in clinical BIOMARKERS and/or various autism-rating scales.76,121,128the broad-spectrum Micronutrient STUDIES are very PROMISING BECAUSE all DEMONSTRATE a significant CORRELATION between nutritional deficiencies and severity of autistic symptoms.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 97), ('PROBABLE_UNDERSTANDING', 430), ('ANOMALY_CURIOUS_FINDING', 434), ('INCOMPLETE_EVIDENCE', 590), ('INCOMPLETE_EVIDENCE', 783), ('SUPERFICIAL_RELATIONSHIP', 827), ('SUPERFICIAL_RELATIONSHIP', 843), ('SUPERFICIAL_RELATIONSHIP', 886), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 910), ('ANOMALY_CURIOUS_FINDING', 910), ('INCOMPLETE_EVIDENCE', 1062), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1081), ('INCOMPLETE_EVIDENCE', 1135), ('SUPERFICIAL_RELATIONSHIP', 1243), ('INCOMPLETE_EVIDENCE', 1333), ('PROBABLE_UNDERSTANDING', 1350), ('PROBABLE_UNDERSTANDING', 1360), ('INCOMPLETE_EVIDENCE', 1372), ('SUPERFICIAL_RELATIONSHIP', 1398)]	23	[('CHEBI_33839', 'macromolecule', 12, 'micronutrients'), ('UBERON_0001969', 'blood plasma', 54, 'plasma'), ('UBERON_0001088', 'urine', 65, 'urinary'), ('CHEBI_48107', 'nitric acid', 122, 'lipid peroxide'), ('CHEBI_17478', 'aldehyde', 147, 'aldehydes'), ('CHEBI_17759', 'cholesta-5,7-dien-3beta-ol', 158, 'HNE'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin E'), ('CHEBI_36933', 'oxygen-19 atom', 232, 'sulfur'), ('CHEBI_36357', 'polyatomic entity', 250, 'compounds'), ('CHEBI_16856', 'glutathione', 295, 'GSH'), ('CHEBI_36933', 'oxygen-19 atom', 376, 'sulfur'), ('CHEBI_36357', 'polyatomic entity', 394, 'compounds'), ('NCBITaxon_1', 'root', 411, 'individuals'), ('CHEBI_17976', 'ubiquinol', 648, 'ubiquinol'), ('CHEBI_27300', 'vitamin D', 683, 'vitamin C'), ('CHEBI_33839', 'macromolecule', 702, 'micronutrients'), ('CHEBI_73173', '2,4-DB', 731, '126B6'), ('CHEBI_6636', 'magnesium dichloride', 737, 'Mg2+,'), ('CHEBI_75275', 'tetradecyl sulfonic acid', 742, '127folate'), ('CHEBI_27300', 'vitamin D', 753, 'vitamin E'), ('CHEBI_26536', 'retinoic acid', 764, 'retinol'), ('CHEBI_29105', 'zinc(2+)', 777, 'Zn2+,'), ('GO_0008152', 'metabolic process', 867, 'metabolic'), ('NCBITaxon_1', 'root', 976, 'individuals'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 1048, 'micronutrient'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 1177, 'micronutrient'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 1319, 'micronutrient')]
PMC4910734	6/2015	S189-PMC4910734	['HOWEVER, SOME reports INDICATE that the same children do not have night blindness53and SOME SUGGEST that asd symptoms are reduced by Retinol treatment.54the lack of night blindness in asd cases of Vitamin A deficiencies SUGGESTS that Retinal is present, but conversion to Retinoic Acid is blocked.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 92), ('INCOMPLETE_EVIDENCE', 220)]	7	[('CHEBI_26536', 'retinoic acid', 133, 'retinol'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin A'), ('UBERON_0000966', 'retina', 234, 'retinal'), ('CHEBI_26536', 'retinoic acid', 272, 'retinoic acid')]
PMC4910734	6/2015	S243-PMC4910734	['additionally, Sulfur-containing antioxidants, such as Taurine and Nac, are superior to Vitamin C and form the ESSENTIAL core of any supplementation plan to counteract Aldehyde toxicity or oxidative stress.L-Carnitine, BUT NOT Acetyl-Carnitine, is LIKELY beneficial for many and can be included.']	[('IMPORTANT_CONSIDERATION', 110), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 218), ('PROBABLE_UNDERSTANDING', 247)]	3	[('CHEBI_36933', 'oxygen-19 atom', 14, 'sulfur'), ('CHEBI_15891', 'taurine', 54, 'taurine'), ('CHEBI_7421', 'NAC', 66, 'NAC'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin C'), ('CHEBI_17478', 'aldehyde', 167, 'aldehyde'), ('CHEBI_86085', '(Z)-p-coumaroylagmatine', 205, 'l-carnitine'), ('CHEBI_17387', 'O-acylcarnitine', 226, 'acetyl-carnitine')]
PMC4918713	6/2015	S55-PMC4918713	['Animal STUDIES HAVE SHOWN that neonatal copper deficiency is ASSOCIATED with developmental abnormalities and altered Thyroid and Immune function.38\na similar DIFFERENTIAL EFFECT between mother and fetus is also SEEN in Vitamin A Metabolism.']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 61), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158), ('SUPERFICIAL_RELATIONSHIP', 171), ('INCOMPLETE_EVIDENCE', 211)]	6	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('UBERON_0002046', 'thyroid gland', 117, 'thyroid'), ('UBERON_0002405', 'immune system', 129, 'immune'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin A'), ('GO_0070639', 'vitamin D2 metabolic process', 219, 'vitamin A metabolism'), ('PR_000004370', 'asialoglycoprotein receptor 2', 227, 'A')]
PMC4923982	5/2016	S74-PMC4923982	['ALTHOUGH those in the highest quintiles for both Heme and non-heme iron Intake had higher average Glycemic loads, and Consumed more of each dietary factor on average than those in the lower quintiles, those in the highest quintile of Heme iron consumed more Saturated Fat, Cholesterol, and red/processed meat on average compared to those in the highest quintile of non-Heme iron, WHEREAS those in the highest quintile of non-Heme iron Intake consumed more polyunsaturated fat, dietary fiber, Vitamin C, and calcium on average than those in the lower quintiles.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 380)]	2	[('CHEBI_30413', 'heme', 49, 'heme'), ('GO_0007631', 'feeding behavior', 72, 'intake'), ('GO_0006096', 'glycolytic process', 98, 'glycemic'), ('GO_0007631', 'feeding behavior', 118, 'consumed'), ('CHEBI_30413', 'heme', 234, 'heme'), ('CHEBI_26710', 'sodium chloride', 258, 'saturated fat'), ('CHEBI_16113', 'cholesterol', 273, 'cholesterol'), ('CHEBI_30413', 'heme', 369, 'heme'), ('CHEBI_30413', 'heme', 425, 'heme'), ('GO_0007631', 'feeding behavior', 435, 'intake'), ('CHEBI_27300', 'vitamin D', 492, 'vitamin C')]
PMC4930210	7/2016	S0-PMC4930210	['the current recommended Vitamin D intake guideline for diet and supplements during Pregnancy is not adequate to achieve Vitamin D sufficiency for most Pregnant women\n\nabstract\n\nbackground\nthe aims of THIS STUDY were TO DETERMINE IF Pregnant women consumed the RECOMMENDED Vitamin D through diet alone or through diet and supplements, and if they achieved the current reference range Vitamin D status when their reported dietary intake met the current RECOMMENDATIONS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 200), ('QUESTION_ANSWERED_BY_THIS_WORK', 216), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 229), ('FUTURE_WORK', 260), ('FUTURE_WORK', 451)]	5	[('CHEBI_28384', 'vitamin K', 24, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'Pregnancy'), ('CHEBI_28384', 'vitamin K', 120, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 151, 'Pregnant'), ('GO_0007565', 'female pregnancy', 232, 'pregnant'), ('CHEBI_27300', 'vitamin D', 272, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 383, 'vitamin D')]
PMC4930210	7/2016	S13-PMC4930210	['CURRENTLY, there is a LACK OF CONSENSUS on WHAT constitutes Vitamin D sufficiency.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('INCOMPLETE_EVIDENCE', 22), ('EXPLICIT_QUESTION', 43)]	4	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC4930210	7/2016	S18-PMC4930210	['HOWEVER, the daily use of Vitamin D supplements CONTRIBUTED to a better 25-Hydroxycholecalciferol (25(Oh)D) status [8].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 48)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_50545', 'trans-isoeugenol', 72, '25-hydroxycholecalciferol'), ('CHEBI_71657', 'versiconol acetate', 99, '25(OH)D')]
PMC4930210	7/2016	S20-PMC4930210	['HOWEVER, THESE STUDIES used sub-optimal quantification methods (radio-immunoassays) and DID NOT CONSIDER the POTENTIAL CONTRIBUTION of dietary Vitamin D to total intake.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 109), ('SUPERFICIAL_RELATIONSHIP', 119)]	5	[('CHEBI_27300', 'vitamin D', 143, 'vitamin D')]
PMC4930210	7/2016	S28-PMC4930210	['our AIMS in the CURRENT STUDY were TO DETERMINE: a) if Pregnant women were Consuming the RECOMMENDED Vitamin D through diet alone or through diet and supplements, and b) IF Pregnant women can achieve the current reference range Vitamin D status when their reported dietary intake of Vitamin D met the current RECOMMENDATIONS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 35), ('FUTURE_WORK', 89), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('FUTURE_WORK', 309)]	6	[('GO_0007565', 'female pregnancy', 55, 'pregnant'), ('GO_0007631', 'feeding behavior', 75, 'consuming'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('GO_0007565', 'female pregnancy', 173, 'pregnant'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D')]
PMC4930210	7/2016	S106-PMC4930210	['three-epi-25(Oh)D3Comprised 5.0% of total 25(Oh)D. when 3-epi-25(oh)D3Was EXCLUDED from the Vitamin D estimations, 19% of women were considered to have levels <75 nmol/l; HOWEVER, with 3-Epi-25(Oh)D3Included, the percentage of women with Vitamin D concentration of <75 nmol/l decreased to 12%.']	[('INCOMPLETE_EVIDENCE', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 171)]	2	[('CHEBI_37194', 'nonaplumbide(4-)', 10, '25(OH)D3comprised'), ('CHEBI_71657', 'versiconol acetate', 42, '25(OH)D'), ('PR_000012979', 'DNA-directed DNA/RNA polymerase mu', 68, 'D3was'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_62409', 'trans,trans-deca-2,4-dienoyl-CoA', 185, '3-epi'), ('CHEBI_75897', 'iron(2+) sulfides', 191, '25(OH)D3included'), ('PR_000027695', 'nuclear receptor coactivator 3 isoform 1 phosphorylated 3', 191, '25(OH)D3included'), ('CHEBI_27300', 'vitamin D', 238, 'vitamin D')]
PMC4930210	7/2016	S142-PMC4930210	['ALTHOUGH PREVIOUS STUDIES HAVE SHOWN FACTORS like age, season, and Vitamin D supplementation AFFECT 3-Epi-25(Oh)D3[29,30], in OUR STUDY the ONLY FACTOR positively CORRELATED with level of the 3-Epi-25(Oh)D3Was Vitamin D intake.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 37), ('SUPERFICIAL_RELATIONSHIP', 93), ('QUESTION_ANSWERED_BY_THIS_WORK', 126), ('ANOMALY_CURIOUS_FINDING', 140), ('INCOMPLETE_EVIDENCE', 140), ('SUPERFICIAL_RELATIONSHIP', 145), ('SUPERFICIAL_RELATIONSHIP', 163)]	10	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_76629', '2-lysophosphatidic acid', 100, '3-epi-25(OH)D3'), ('PR_000001177', 'D(2) dopamine receptor', 112, 'D3'), ('CHEBI_73839', 'D-Leu-D-Leu', 192, '3-epi-25(OH)D3was'), ('PR_000012979', 'DNA-directed DNA/RNA polymerase mu', 204, 'D3was'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D')]
PMC4930210	7/2016	S143-PMC4930210	['the fact that season significantly AFFECTED 25(Oh)D concentration BUT NOT 3-epi-25(oh)d3suggests that Vitamin D supplements COULD BE a source for 3-Epi-25(Oh)D3As SHOWN in a PREVIOUS STUDY [30].']	[('SUPERFICIAL_RELATIONSHIP', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 66), ('INCOMPLETE_EVIDENCE', 124), ('INCOMPLETE_EVIDENCE', 163), ('INCOMPLETE_EVIDENCE', 174)]	5	[('CHEBI_71657', 'versiconol acetate', 44, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 50, 'D'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('CHEBI_63219', "alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-[alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-[alpha-L-Fuc-(1->3)]-beta-D-GlcNAc-(1->6)]-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer", 146, '3-epi-25(OH)D3as'), ('PR_000006270', 'triokinase/FMN cyclase', 158, 'D3as')]
PMC4930210	7/2016	S157-PMC4930210	['HOWEVER, given that Vitamin D from Foods in canada makes such a small overall CONTRIBUTION to Vitamin D dietary Intake (table 3), the accuracy of the 24-hour recalls is LESS CRITICAL in estimating women’s total Vitamin D intake.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 78), ('INCOMPLETE_EVIDENCE', 169), ('IMPORTANT_CONSIDERATION', 174)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_33290', 'food', 35, 'foods'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('GO_0007631', 'feeding behavior', 112, 'intake'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D')]
PMC4930210	7/2016	S165-PMC4930210	['ANOTHER RECENT canadian STUDY [35] SHOWED summer sun exposure was a PREDICTOR of 25(Oh)D3Concentration BUT fall sun exposure was NOT, which MAY BE RELATED to lower Vitamin D-weighted climatological uv in toronto during the fall.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('ANOMALY_CURIOUS_FINDING', 129), ('INCOMPLETE_EVIDENCE', 140), ('SUPERFICIAL_RELATIONSHIP', 147)]	9	[('CHEBI_74304', '(6Z,9Z,12Z,15Z,18Z,21Z)-3-oxotetracosahexaenoyl-CoA(4-)', 81, '25(OH)D3concentration'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 81, '25('), ('PR_000012527', 'Na(+)/H(+) exchange regulatory cofactor NHE-RF4', 86, ')D3concentration'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D')]
PMC4930210	7/2016	S168-PMC4930210	['WHILE the current canadian cancer society RECOMMENDATIONS [38] are to avoid sun exposure or failing that, use of sunscreen at all times when out in the sun, our participants undoubtedly were getting sunlight exposure AS SEEN by a seasonal variation in 25(Oh)D.\nin CONCLUSION, we FOUND a 20% rate of Vitamin D insufficiency (<75 nmol/l) in a large, well-nourished cohort of Pregnant women.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 42), ('INCOMPLETE_EVIDENCE', 217), ('INCOMPLETE_EVIDENCE', 220), ('INCOMPLETE_EVIDENCE', 264), ('INCOMPLETE_EVIDENCE', 279)]	6	[('CHEBI_71657', 'versiconol acetate', 252, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 252, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin D'), ('GO_0007565', 'female pregnancy', 373, 'pregnant')]
PMC4933715	7/2016	S598-PMC4933715	['(4) ALTHOUGH SOMETIMES SUGGESTED, there SEEMS to be sufficient EVIDENCE that there is no association with asd for many Maternal infections in Pregnancy (i.e., herpes viruses, epstein barr virus, varicella—Zoster Virus, Parvovirus), smoking, exposure to heavy metals or Vitamin D deficiency.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('ANOMALY_CURIOUS_FINDING', 4), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 23), ('ANOMALY_CURIOUS_FINDING', 40), ('INCOMPLETE_EVIDENCE', 63)]	6	[('GO_0007618', 'mating', 119, 'maternal'), ('GO_0007565', 'female pregnancy', 142, 'pregnancy'), ('NCBITaxon_10088', 'Mus <genus>', 205, 'zoster virus'), ('NCBITaxon_10088', 'Mus <genus>', 219, 'parvovirus'), ('CHEBI_27300', 'vitamin D', 269, 'vitamin D')]
PMC4934634	11/2015	S1-PMC4934634	['RECENT RESEARCH has SUGGESTED that Vitamin D MAY exert a broad RANGE of ROLES throughout the Human Life Cycle starting from Reproduction to Adult chronic disease risk.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63), ('SUPERFICIAL_RELATIONSHIP', 72)]	5	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 93, 'human'), ('UBERON_0000104', 'life cycle', 99, 'life cycle'), ('GO_0007049', 'cell cycle', 104, 'cycle'), ('GO_0000003', 'reproduction', 124, 'reproduction'), ('UBERON_0007023', 'adult organism', 140, 'adult')]
PMC4934634	11/2015	S8-PMC4934634	['introduction\nWHILE the beneficial EFFECTS of Vitamin D supplementation with respect to reducing the RISK of rickets HAS BEEN recognized for close to 100 years, there is increasing concern that rickets in young children is reemerging in numerous countries [1,2].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('SUPERFICIAL_RELATIONSHIP', 34), ('IMPORTANT_CONSIDERATION', 100), ('INCOMPLETE_EVIDENCE', 116)]	4	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC4934634	11/2015	S13-PMC4934634	['HOWEVER, the prevalence of Vitamin D deficiency is a subject of intense DEBATE, IN PART DUE TO DIFFERENCES of opinion regarding WHAT actually constitutes a “deficiency”.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 72), ('INCOMPLETE_EVIDENCE', 80), ('PROBLEM_COMPLICATION', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('EXPLICIT_QUESTION', 128)]	6	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
PMC4934634	11/2015	S14-PMC4934634	['ILLUSTRATIVE of the above, are the markedly DIFFERENT circulating Vitamin D concentration cut-offs for the risk of Vitamin D deficiency, insufficiency, and sufficiency levels that have been identified by the u.s. institute of medicine (iom) and the u.s. Endocrine society (table 1).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 44)]	2	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('UBERON_0005063', 'left ventricular compact myocardium', 254, 'Endocrine')]
PMC4934634	11/2015	S15-PMC4934634	['WHILE the incidence of Vitamin D deficiency in most countries would SEEM TO BE moderate if the iom cut-offs are used, the incidence is high in many countries IF the cut-off values advanced by the endocrine society are embraced [3].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158)]	4	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D')]
PMC4934634	11/2015	S18-PMC4934634	['estimates of Vitamin D deficiency during Pregnancy worldwide range from 8% to 99% of women DEPENDING ON the population and cut-offs used.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 91)]	1	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007565', 'female pregnancy', 41, 'pregnancy')]
PMC4934634	11/2015	S31-PMC4934634	['CONSISTENT with this, it HAS BEEN REPORTED that obese Pregnant women have lower Vitamin D levels THAN non-obese women, EVEN when they have higher Vitamin D Intakes during the first trimester [9].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 97), ('ANOMALY_CURIOUS_FINDING', 119)]	5	[('GO_0007565', 'female pregnancy', 54, 'pregnant'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('GO_0007631', 'feeding behavior', 156, 'intakes')]
PMC4934634	11/2015	S45-PMC4934634	['circulating levels of Vitamin D are used as BIOMARKERS of exposure combining both production from uvb exposure and dietary Intake RATHER than as BIOMARKERS of effect.']	[('SUPERFICIAL_RELATIONSHIP', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 130), ('SUPERFICIAL_RELATIONSHIP', 145)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0007631', 'feeding behavior', 123, 'intake')]
PMC4934634	11/2015	S50-PMC4934634	['convincing data from Animal MODELS SHOW that Vitamin D deficiency or altered function CAN result in reduced liter size or loss of overall fertility in CONJUNCTION with an increase in maternal and offspring mortality [16,17].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 86), ('SUPERFICIAL_RELATIONSHIP', 151)]	4	[('NCBITaxon_33208', 'Metazoa', 21, 'animal'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC4934634	11/2015	S62-PMC4934634	[', restored fertility and litter size by Feeding a high calcium diet to female Vdr null Mice SUGGESTING a PLAUSIBLE ROLE of Vitamin D in Calcium Homeostasis RATHER than a direct EFFECT on vdr [17].']	[('INCOMPLETE_EVIDENCE', 92), ('INCOMPLETE_EVIDENCE', 105), ('SUPERFICIAL_RELATIONSHIP', 115), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 156), ('SUPERFICIAL_RELATIONSHIP', 177)]	5	[('GO_0007631', 'feeding behavior', 40, 'feeding'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 78, 'VDR'), ('NCBITaxon_10088', 'Mus <genus>', 87, 'mice'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 136, 'calcium'), ('GO_0055073', 'cadmium ion homeostasis', 136, 'calcium homeostasis')]
PMC4934634	11/2015	S72-PMC4934634	[', DETECTED no difference in Pre-Pregnancy Vitamin D status among healthy danish women who were able to Conceive COMPARED TO those who could not Conceive in a ~6 month time period [28].']	[('INCOMPLETE_EVIDENCE', 2), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112)]	2	[('GO_0007568', 'aging', 28, 'pre'), ('GO_0007565', 'female pregnancy', 32, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0007631', 'feeding behavior', 103, 'conceive'), ('GO_0007631', 'feeding behavior', 144, 'conceive')]
PMC4934634	11/2015	S80-PMC4934634	['the positive RELATIONSHIP between maternal Vitamin D status and post-Ivf Pregnancy in non-hispanic white, BUT NOT in asian women, SUGGESTS that genetics play a ROLE in the RELATIONSHIP between Vitamin D and fertility.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 106), ('ANOMALY_CURIOUS_FINDING', 106), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 160), ('SUPERFICIAL_RELATIONSHIP', 172)]	6	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0002006', 'vasoconstriction by vasopressin involved in systemic arterial blood pressure control', 69, 'IVF'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D')]
PMC4934634	11/2015	S89-PMC4934634	['ALTHOUGH the amount of Vitamin D provided through the Supplement is lower than the current rdas set by EITHER the iom or Endocrine society, this study SHOULD provide new INSIGHTS into HOW Periconceptional dietary interventions CAN IMPACT Female and Male Fertility, a RESEARCH area that is presently LACKING.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('FUTURE_WORK', 151), ('INCOMPLETE_EVIDENCE', 170), ('EXPLICIT_QUESTION', 184), ('INCOMPLETE_EVIDENCE', 227), ('SUPERFICIAL_RELATIONSHIP', 231), ('INCOMPLETE_EVIDENCE', 267), ('INCOMPLETE_EVIDENCE', 299)]	9	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_16158', 'steroid sulfate', 54, 'supplement'), ('UBERON_0005063', 'left ventricular compact myocardium', 121, 'Endocrine'), ('GO_0007565', 'female pregnancy', 188, 'periconceptional'), ('GO_0007601', 'visual perception', 238, 'female ...'), ('GO_0007141', 'male meiosis I', 249, 'male fertility')]
PMC4934634	11/2015	S94-PMC4934634	['these data FURTHER ILLUSTRATE HOW DIFFERENT cut-offs used by the iom vs. endocrine society for defining Vitamin D status (table 1) INFLUENCES the reporting of Vitamin D deficiency PREVALENCE in the population.']	[('INCOMPLETE_EVIDENCE', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('EXPLICIT_QUESTION', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('SUPERFICIAL_RELATIONSHIP', 131), ('IMPORTANT_CONSIDERATION', 180)]	6	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D')]
PMC4934634	11/2015	S97-PMC4934634	['IN CONTRAST TO iom RECOMMENDATIONS, the endocrine society RECOMMENDS a Vitamin D intake of AT LEAST 600 iu/day, BUT states that 1500–2000 iu/day MAY BE needed for Pregnant or Lactating females to maintain a 25(Oh)D level ≥ 30 ng/ml.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 19), ('FUTURE_WORK', 58), ('PROBABLE_UNDERSTANDING', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('INCOMPLETE_EVIDENCE', 145)]	6	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0007565', 'female pregnancy', 163, 'pregnant'), ('GO_0007594', 'puparial adhesion', 175, 'lactating'), ('CHEBI_71657', 'versiconol acetate', 207, '25(OH)D')]
PMC4934634	11/2015	S112-PMC4934634	['first Trimester 25(Oh)D levels were found to be lower in women diagnosed with Gestational diabetes COMPARED TO controls, translating to a 2.6-fold increased risk of developing Gestational diabetes when Serum Vitamin D levels were ≤20 ng/ml, the iom cut-off for Vitamin D sufficiency [42].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 99)]	1	[('GO_0009294', 'DNA mediated transformation', 6, 'trimester'), ('CHEBI_71657', 'versiconol acetate', 16, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 22, 'D'), ('GO_0007565', 'female pregnancy', 78, 'gestational'), ('GO_0007565', 'female pregnancy', 176, 'gestational'), ('UBERON_0001977', 'blood serum', 202, 'serum'), ('CHEBI_27300', 'vitamin D', 208, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 261, 'vitamin D')]
PMC4934634	11/2015	S132-PMC4934634	['WHILE Vitamin D supplementation to women with Gestational diabetes improved Metabolic parameters, what IS NEEDED are clinical trials investigating the extent to WHICH Vitamin D supplementation decreases adverse Perinatal outcomes ASSOCIATED with Gestational diabetes including macrosomia, Respiratory distress, and Postnatal hypoglycemia.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 103), ('EXPLICIT_QUESTION', 161), ('SUPERFICIAL_RELATIONSHIP', 230)]	4	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('GO_0007565', 'female pregnancy', 46, 'gestational'), ('GO_0008152', 'metabolic process', 76, 'metabolic'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('GO_0036268', 'swimming', 211, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 211, 'perinatal'), ('GO_0007565', 'female pregnancy', 246, 'gestational'), ('UBERON_0001004', 'respiratory system', 289, 'respiratory'), ('GO_0007567', 'parturition', 315, 'postnatal')]
PMC4934634	11/2015	S142-PMC4934634	['it SHOULD BE NOTED that OTHER STUDIES have FAILED TO CONFIRM OBSERVATIONS that lower 25(Oh)D status is ASSOCIATED with the occurrence of Preeclampsia, and it is STILL UNCLEAR WHETHER suboptimal Vitamin D status is a cause, OR an EFFECT, of preeclampsia [55,56].']	[('IMPORTANT_CONSIDERATION', 3), ('ANOMALY_CURIOUS_FINDING', 10), ('ANOMALY_CURIOUS_FINDING', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('INCOMPLETE_EVIDENCE', 24), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 43), ('ANOMALY_CURIOUS_FINDING', 43), ('DIFFICULT_TASK', 43), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 103), ('FULL_UNKNOWN', 161), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 175), ('SUPERFICIAL_RELATIONSHIP', 229)]	14	[('CHEBI_71657', 'versiconol acetate', 85, '25(OH)D'), ('GO_0007128', 'meiotic prophase I', 137, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D')]
PMC4934634	11/2015	S158-PMC4934634	['when the data were combined with a concurrently run Vitamin D intervention trial (nichd; national institute of child health and Human development) by the same group, there was a marginally significant reduction in hypertension disorders ( p = 0.052) after adjustment for race and study in the 4000 iu/day group when COMPARED TO control women receiving 400 iu/day [60].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 316)]	1	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 128, 'Human')]
PMC4934634	11/2015	S166-PMC4934634	[', provided Vitamin D supplement doses DEPENDING ON baseline level of Serum 25(Oh)D levels or placebo [62].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 38)]	1	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('UBERON_0001977', 'blood serum', 69, 'serum'), ('CHEBI_71657', 'versiconol acetate', 75, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 75, '25(OH)D')]
PMC4934634	11/2015	S182-PMC4934634	['Respiratory health and allergic disease in children\nover the last decade, there is CONFLICTING data on the ROLE of maternal Vitamin D on offspring allergic outcomes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('SUPERFICIAL_RELATIONSHIP', 107)]	2	[('UBERON_0001004', 'respiratory system', 0, 'Respiratory'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC4934634	11/2015	S212-PMC4934634	['SINCE THE study LOOKED AT the number of visits RATHER than confirmed diagnosis of infection, THIS STUDY SUGGESTS infant Vitamin D supplementation in addition to Prenatal supplementation MIGHT be BENEFICIAL in reducing health care visits for acute Respiratory infections.']	[('PROBLEM_COMPLICATION', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('INCOMPLETE_EVIDENCE', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('QUESTION_ANSWERED_BY_THIS_WORK', 93), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 186), ('SUPERFICIAL_RELATIONSHIP', 195)]	8	[('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('GO_0007565', 'female pregnancy', 161, 'prenatal'), ('UBERON_0001004', 'respiratory system', 247, 'respiratory')]
PMC4934634	11/2015	S252-PMC4934634	['similarly, STUDIES ARE NEEDED to address WHETHER women who are Vitamin D sufficient at Conception and receiving high doses of Vitamin D (≥4000 iu/daily) have adverse Pregnancy outcomes.']	[('FUTURE_WORK', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 41), ('EXPLICIT_QUESTION', 41)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0007620', 'copulation', 87, 'conception'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('GO_0007565', 'female pregnancy', 166, 'pregnancy')]
PMC4934634	11/2015	S266-PMC4934634	['as PREVIOUSLY mentioned, short-term studies GENERALLY AGREE with its SAFETY BUT long-term STUDIES ARE NEEDED to address the QUESTION of WHETHER large bolus Vitamin D supplementation during Pregnancy is ASSOCIATED with any adverse health outcomes in the offspring later in Life.']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 44), ('INCOMPLETE_EVIDENCE', 54), ('IMPORTANT_CONSIDERATION', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 76), ('FUTURE_WORK', 90), ('EXPLICIT_QUESTION', 124), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 136), ('EXPLICIT_QUESTION', 136), ('SUPERFICIAL_RELATIONSHIP', 202)]	10	[('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('GO_0007565', 'female pregnancy', 189, 'pregnancy'), ('UBERON_0000104', 'life cycle', 272, 'life')]
PMC4934634	11/2015	S291-PMC4934634	['with large percentages of Individuals having INSUFFICIENT Vitamin D levels, this RAISES the QUESTION of WHETHER fortification EFFORTS SHOULD BE increased.']	[('IMPORTANT_CONSIDERATION', 45), ('EXPLICIT_QUESTION', 81), ('EXPLICIT_QUESTION', 92), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 104), ('EXPLICIT_QUESTION', 104), ('FUTURE_WORK', 126), ('FUTURE_WORK', 134)]	7	[('NCBITaxon_1', 'root', 26, 'individuals'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC4934634	11/2015	S292-PMC4934634	['MANY countries currently mandate the fortification of certain Foods with Vitamin D, e.g., 100 iu/cup milk in the united states, 30–45 iu/ 100 ml Milk in canada, and edible oil spreads (Margarine) in australia, HOWEVER, a large proportion of dietary intakes are STILL below RECOMMENDED levels [100,101].']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 210), ('IMPORTANT_CONSIDERATION', 261), ('FUTURE_WORK', 273)]	4	[('CHEBI_33290', 'food', 62, 'foods'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0001913', 'milk', 145, 'milk'), ('CHEBI_6784', 'mestranol', 185, 'margarine')]
PMC4934634	11/2015	S295-PMC4934634	['their conclusion: “through the use of a diet rich in seafood and fortified foods, ear, BUT NOT rda, levels of Vitamin D CAN be achieved.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 87), ('INCOMPLETE_EVIDENCE', 120)]	2	[('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC4934634	11/2015	S297-PMC4934634	['UNLIKE Folic Acid fortification of grain products, Vitamin D fortification has primarily focused on dairy products, POTENTIALLY missing certain populations DUE TO cultural practices or perceived or actual Lactose intolerance.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 116), ('PROBLEM_COMPLICATION', 156)]	3	[('CHEBI_30751', 'formic acid', 7, 'folic acid'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_17716', 'lactose', 205, 'lactose')]
PMC4934634	11/2015	S303-PMC4934634	['Vitamin D supplementation/fortification HAS also BEEN met with OPPOSITION [107] DUE TO CONCERNS that Vitamin D is a hormone and SHOULD BE treated as such including addressing efficacy, dose and side effects.']	[('INCOMPLETE_EVIDENCE', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63), ('PROBLEM_COMPLICATION', 80), ('PROBLEM_COMPLICATION', 87), ('FUTURE_WORK', 128)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC4934634	11/2015	S304-PMC4934634	['HOWEVER, Vitamin D is NOT a hormone BUT RATHER a pro-hormone.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 40)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
PMC4934634	11/2015	S305-PMC4934634	['OTHER CONCERNS are the INSUFFICIENT EVIDENCE to determine the EFFECTS of Vitamin D supplementation/fortification on bone health and fracture incidence and that fda RECOMMENDATIONS to include Vitamin D on Food labels MAY ENCOURAGE fortification of Vitamin D in products that would not otherwise necessarily be RECOMMENDED, and lastly, that there is SOME EVIDENCE for POSSIBLE adverse consequences to Vitamin D fortification [107].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 6), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 62), ('FUTURE_WORK', 164), ('INCOMPLETE_EVIDENCE', 216), ('FUTURE_WORK', 220), ('FUTURE_WORK', 309), ('INCOMPLETE_EVIDENCE', 348), ('INCOMPLETE_EVIDENCE', 366)]	10	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('CHEBI_33290', 'food', 204, 'food'), ('CHEBI_27300', 'vitamin D', 247, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 399, 'vitamin D')]
PMC4934634	11/2015	S306-PMC4934634	['WHILE the ESSENTIALITY of adequate Vitamin D during Pregnancy is not DISPUTED, CONTROVERSY exists over the RECOMMENDED dietary intake levels, the mathematical approaches to calculating that level, and the endpoints used to determine REQUIREMENTS; the concentrations of circulating 25(Oh)D that denote deficiency, insufficiency and adequacy status; and WHETHER race, body weight or OTHER factors SHOULD BE TAKEN into account when making dietary RECOMMENDATIONS, similarly, it is NOT CLEAR WHAT Vitamin D supplementation regimens are most EFFECTIVE during Pregnancy; WHETHER mother, child OR both SHOULD BE supplemented; and WHETHER there are long-term CONSEQUENCES of supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 79), ('FUTURE_WORK', 107), ('IMPORTANT_CONSIDERATION', 233), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 352), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 381), ('FUTURE_WORK', 395), ('IMPORTANT_CONSIDERATION', 405), ('FUTURE_WORK', 444), ('FULL_UNKNOWN', 478), ('EXPLICIT_QUESTION', 488), ('SUPERFICIAL_RELATIONSHIP', 537), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 565), ('FUTURE_WORK', 595), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 623), ('PROBLEM_COMPLICATION', 651)]	18	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 281, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 281, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 493, 'vitamin D'), ('GO_0007565', 'female pregnancy', 554, 'pregnancy')]
PMC4944244	7/2016	S0-PMC4944244	['risk factors for Antenatal hypovitaminosis d in an urban district in malaysia\n\nabstract\n\nbackground\nPregnant women form one of the HIGH RISK groups facing hypovitaminosis d. low level of Vitamin D will AFFECT directly OR indirectly both mother and fetus.']	[('IMPORTANT_CONSIDERATION', 131), ('SUPERFICIAL_RELATIONSHIP', 202), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 218)]	3	[('GO_0007567', 'parturition', 17, 'antenatal'), ('GO_0007565', 'female pregnancy', 100, 'Pregnant'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin D')]
PMC4944244	7/2016	S10-PMC4944244	['FURTHER STUDIES NEED TO BE conducted among health care workers to determine their level of knowledge RELATED to Vitamin D, AS they are front liner in detecting the hypovitaminosis d.\n\nbackground\nmalaysia is rich with sunshine, a MAJOR source of Vitamin D. HOWEVER, a study by moy [1] among a cohort of malays SHOWED that 67.9\xa0% had insufficient Vitamin D especially in women, with Serum mean concentration of 25(Oh)D of 36.2\u2009±\u200913.4\xa0nmol/l in women and 56.2\u2009±\u200918.9\xa0nmol/l in men.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 16), ('SUPERFICIAL_RELATIONSHIP', 101), ('PROBABLE_UNDERSTANDING', 123), ('IMPORTANT_CONSIDERATION', 229), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 256), ('INCOMPLETE_EVIDENCE', 309)]	7	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 345, 'vitamin D'), ('UBERON_0001977', 'blood serum', 381, 'serum'), ('CHEBI_71657', 'versiconol acetate', 409, '25(OH)D')]
PMC4944244	7/2016	S27-PMC4944244	['healthcare workers USUALLY ENCOURAGE Pregnant women to increase calcium intake BUT they are LESS AWARE that without sufficient Vitamin D, calcium intake will not have much EFFECT ESPECIALLY during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 19), ('FUTURE_WORK', 27), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 79), ('ANOMALY_CURIOUS_FINDING', 79), ('INCOMPLETE_EVIDENCE', 92), ('IMPORTANT_CONSIDERATION', 97), ('SUPERFICIAL_RELATIONSHIP', 172), ('ANOMALY_CURIOUS_FINDING', 179)]	8	[('GO_0007565', 'female pregnancy', 37, 'pregnant'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('GO_0007565', 'female pregnancy', 197, 'pregnancy')]
PMC4944244	7/2016	S79-PMC4944244	['HOWEVER, in order to prevent the occurrence of multicollinearity, Melanin index, Vitamin D intake from Food and supplements, and the level of Vitamin D in foods and Supplements (iu/day) were not included in the multivariable analysis.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('CHEBI_25179', 'melanins', 66, 'melanin'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('CHEBI_33290', 'food', 103, 'food'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 165, 'supplements')]
PMC4944244	7/2016	S106-PMC4944244	['ethnic chinese in THIS STUDY had better Vitamin D results COMPARED TO malays and indians which CONTRIBUTE to the decrease of the overall measure.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 58), ('SUPERFICIAL_RELATIONSHIP', 95)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC4944244	7/2016	S119-PMC4944244	['HOWEVER, 20 Pregnant women who consumed Antenatal Vitamins with Vitamin D at least 400\xa0iu/day still had INADEQUATE Vitamin D levels in the third trimester [22].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 104)]	3	[('GO_0007565', 'female pregnancy', 12, 'pregnant'), ('GO_0007567', 'parturition', 40, 'antenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 50, 'vitamins'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC4944244	7/2016	S130-PMC4944244	['the laboratory measurement techniques for measuring Vitamin D are also DIFFERENT.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 71)]	1	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D')]
PMC4944244	7/2016	S132-PMC4944244	['this concentration has been used in OTHER Vitamin D studies in malaysia [1,2,24].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 36)]	1	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
PMC4944244	7/2016	S142-PMC4944244	['the significant predictive factors after multivariable analysis in OUR STUDY were ethnic group, educational status and dietary intake of Vitamin D. HOWEVER, the study by chailurkit et al.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 67), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 148)]	2	[('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC4944244	7/2016	S171-PMC4944244	['HOWEVER, this ASSUMPTION would not be EFFECTIVE for countries with less exposure to the sun, where low education was ASSOCIATED with lower Serum 25(Oh)D, PERHAPS AS a result of less dietary intake of Vitamin D and less opportunity for sunbathing leisure and vacation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 117), ('INCOMPLETE_EVIDENCE', 154), ('PROBABLE_UNDERSTANDING', 162)]	6	[('UBERON_0001977', 'blood serum', 139, 'serum'), ('CHEBI_71657', 'versiconol acetate', 145, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 145, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D')]
PMC4944244	7/2016	S173-PMC4944244	['[10] CLAIMED that work status (farmer versus non farmer) have significant IMPACT on Vitamin D levels, where farmers had higher levels of Serum 25(Oh)D COMPARED TO non-farmers.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 151)]	3	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('UBERON_0001977', 'blood serum', 137, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 146, 'OH)D')]
PMC4949006	7/2016	S136-PMC4949006	['Vitamin B6Supplementation HAS BEEN shown in 3 SMALL STUDIES to give a modest gain in Birth weight.99Vitamin C supplementation has not been shown to be of value in improving Pregnancy outcomes,99but HAS SHOWN value for PREVENTION of wheezing and asthma in the children of smokers.100\n\nVitamin E\nONE STUDY CORRELATED risk of wheeze inversely to the level of Vitamin E as well as a linear RELATIONSHIP between the level and the forced Expiratory volume at 1 minute.101NO OTHER STUDIES APPEAR to support OR REFUTE this.']	[('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 46), ('INCOMPLETE_EVIDENCE', 198), ('SUPERFICIAL_RELATIONSHIP', 218), ('INCOMPLETE_EVIDENCE', 294), ('SUPERFICIAL_RELATIONSHIP', 304), ('SUPERFICIAL_RELATIONSHIP', 386), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 462), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 468), ('INCOMPLETE_EVIDENCE', 468), ('ANOMALY_CURIOUS_FINDING', 482), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 500), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 503)]	13	[('CHEBI_10122', 'Zizyphine F', 0, 'Vitamin B6supplementation'), ('PR_000017279', 'testis-specific basic protein Y 1', 0, 'Vitamin B6supplementation'), ('GO_0007567', 'parturition', 85, 'birth'), ('CHEBI_65430', 'ardisiphenol A', 98, '99Vitamin C'), ('PR_000004900', 'complement C3', 108, 'C'), ('GO_0007565', 'female pregnancy', 173, 'pregnancy'), ('CHEBI_28384', 'vitamin K', 284, 'Vitamin E'), ('CHEBI_27300', 'vitamin D', 356, 'vitamin E'), ('GO_0010467', 'gene expression', 432, 'expiratory')]
PMC4949006	7/2016	S145-PMC4949006	['HOWEVER, when Vitamin D deficiency is identified during Pregnancy, supplementation with up to 1000 to 2000 iu/d is CONSIDERED SAFE by MOST EXPERTS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 115), ('IMPORTANT_CONSIDERATION', 126), ('PROBABLE_UNDERSTANDING', 134), ('PROBABLE_UNDERSTANDING', 139)]	5	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 56, 'pregnancy')]
PMC4949006	7/2016	S147-PMC4949006	['it HAS BEEN IDENTIFIED as a Nutrient of PUBLIC HEALTH CONCERN by the us department of health and Human services.104\nNUMEROUS STUDIES HAVE SHOWN a prevalence of vitamin d levels of less than 50 nmol/l in 30% to 96% of Pregnant women, increasing with latitude and with nonwhite race.105–111a study done using archived samples of Cord Blood in denmark SHOWED an increased risk of developing schizophrenia with either elevated or low levels of Vitamin D. it was HYPOTHESIZED that IF all the infants COULD have been Born with normal levels there would have been a reduction of 43% in the incidence of schizophrenia among the Adults.112there is also an ASSOCIATION of Vitamin D deficiency and Insulin resistance,113which was reversed with a single injection of the vitamin114(not approved in the united states).']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 40), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 133), ('INCOMPLETE_EVIDENCE', 349), ('INCOMPLETE_EVIDENCE', 458), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 476), ('INCOMPLETE_EVIDENCE', 495), ('SUPERFICIAL_RELATIONSHIP', 647)]	10	[('CHEBI_33284', 'nutrient', 28, 'nutrient'), ('NCBITaxon_10088', 'Mus <genus>', 97, 'Human'), ('GO_0007565', 'female pregnancy', 217, 'pregnant'), ('UBERON_0002240', 'spinal cord', 327, 'cord'), ('UBERON_0000178', 'blood', 332, 'blood'), ('CHEBI_28384', 'vitamin K', 440, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 440, 'Vitamin D'), ('GO_0007567', 'parturition', 511, 'born'), ('UBERON_0007023', 'adult organism', 620, 'adults'), ('CHEBI_27300', 'vitamin D', 662, 'vitamin D'), ('PR_000045358', 'insulin family protein', 687, 'insulin')]
PMC4949006	7/2016	S148-PMC4949006	['SOME STUDIES REPORT higher long-bone density in fetuses of women with adequate amounts of Vitamin D,115,116but the numbers are SMALL.117the general RECOMMENDATION is 1000 to 2000 mg/d of supplementation, BUT there are no AGREED-UPON levels for sufficiency or insufficiency in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 127), ('FUTURE_WORK', 148), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 204), ('INCOMPLETE_EVIDENCE', 221)]	6	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0007565', 'female pregnancy', 276, 'pregnancy')]
PMC4949006	7/2016	S149-PMC4949006	['THERE ARE NO STUDIES clearly SHOWING DIFFERENCES in maternal outcomes or fetal survival, Birth weight, or Gestational length relative to Vitamin D,118but studies on bone health (and Lung function and asthma at age 6 years119) SUPPORT a level of AT LEAST 50 nmol/l, which implies a need for some supplementation for all Pregnant women.120–123\n\nCalcium\nwomen lose 3% to 5% of their bone mass while Lactating but rapidly regain it within 6 months after weaning.']	[('FULL_UNKNOWN', 0), ('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 37), ('INCOMPLETE_EVIDENCE', 226), ('PROBABLE_UNDERSTANDING', 245)]	6	[('GO_0007567', 'parturition', 89, 'birth'), ('GO_0007565', 'female pregnancy', 106, 'gestational'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('UBERON_0002048', 'lung', 182, 'lung'), ('GO_0007565', 'female pregnancy', 319, 'pregnant'), ('CHEBI_31341', 'calcium dihydroxide', 343, 'Calcium'), ('GO_0007594', 'puparial adhesion', 396, 'lactating')]
PMC4969253	8/2016	S61-PMC4969253	['a meta-analysis of these data [21] SHOWED that at 36\xa0weeks of age, there was a significant reduction in oxygen use in the preterm infants treated with Vitamin A supplementation COMPARED TO the control (placebo) group, ALTHOUGH ONLY a TREND towards reduction of death or chronic Lung disease was observed.']	[('INCOMPLETE_EVIDENCE', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 177), ('ANOMALY_CURIOUS_FINDING', 218), ('ANOMALY_CURIOUS_FINDING', 227), ('INCOMPLETE_EVIDENCE', 234)]	5	[('CHEBI_27300', 'vitamin D', 151, 'vitamin A'), ('UBERON_0002048', 'lung', 278, 'lung')]
PMC4969253	8/2016	S82-PMC4969253	['REMARKABLY, IF returned to normal Vitamin A diet later in Gestation and throughout their Postnatal Life, Adult Mice show a markedly thick Airway Sm layer.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12)]	2	[('CHEBI_27300', 'vitamin D', 34, 'vitamin A'), ('GO_0007565', 'female pregnancy', 58, 'gestation'), ('GO_0007567', 'parturition', 89, 'postnatal'), ('UBERON_0000104', 'life cycle', 99, 'life'), ('UBERON_0007023', 'adult organism', 105, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 111, 'mice'), ('UBERON_0001005', 'respiratory airway', 138, 'airway'), ('UBERON_0001290', 'proximal straight tubule', 145, 'SM')]
PMC4971719	8/2016	S1-PMC4971719	['we performed THIS STUDY TO EVALUATE WHETHER low maternal Vitamin D levels are ASSOCIATED with depressive symptoms in Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 36), ('SUPERFICIAL_RELATIONSHIP', 78)]	4	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007565', 'female pregnancy', 117, 'pregnancy')]
PMC4971719	8/2016	S13-PMC4971719	['FUTURE INVESTIGATIONS SHOULD study WHETHER Vitamin D supplementation in early Pregnancy MAY PREVENT Perinatal depressive symptoms.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 92)]	5	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0007565', 'female pregnancy', 78, 'pregnancy'), ('GO_0036268', 'swimming', 100, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 100, 'perinatal')]
PMC4971719	8/2016	S38-PMC4971719	['we CONDUCTED THIS STUDY TO EVALUATE WHETHER Plasma Vitamin D levels, measured in early and late Pregnancy were ASSOCIATED with depression symptom scores at 3 time points during Pregnancy and at 6–8 weeks Postpartum.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 36), ('SUPERFICIAL_RELATIONSHIP', 111)]	5	[('UBERON_0001969', 'blood plasma', 44, 'plasma'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 96, 'pregnancy'), ('GO_0007565', 'female pregnancy', 177, 'pregnancy'), ('GO_0007565', 'female pregnancy', 204, 'postpartum')]
PMC4971719	8/2016	S39-PMC4971719	['this study DIFFERS from PREVIOUSLY-reported investigations in that our subjects were selected BASED ON predisposition to depression and both 25 [Oh] Vitamin D and depression scores were measured at several time points.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 94)]	3	[('CHEBI_74958', 'N-isovaleryl-L-homoserine lactone', 141, '25 [OH]'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC4971719	8/2016	S44-PMC4971719	['the primary AIM of this secondary analysis was TO DETERMINE WHETHER low Vitamin D during Pregnancy is ASSOCIATED with depressive symptoms as assessed by the beck depression inventory score at three time points during Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 47), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 60), ('SUPERFICIAL_RELATIONSHIP', 102)]	4	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy'), ('GO_0007565', 'female pregnancy', 217, 'pregnancy')]
PMC4971719	8/2016	S45-PMC4971719	['as a secondary AIM of THIS STUDY, we EVALUATED WHETHER Vitamin D levels were ASSOCIATED with mini international neuropsychiatric interview diagnoses of major depressive disorder (mdd), generalized anxiety disorder (gad), or anxiety symptoms (mini anxiety subtest, question 1a) [34].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('QUESTION_ANSWERED_BY_THIS_WORK', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('SUPERFICIAL_RELATIONSHIP', 77)]	5	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC4971719	8/2016	S80-PMC4971719	['ALTHOUGH 1, 25-Dihydroxyvitamin D (not 25-Oh-D) is the biologically active form of Vitamin D, circulating levels of 1, 25-dihydroxyvitamin d are not a good representation of Tissue levels, and Tissue levels are not easily measured.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0)]	2	[('CHEBI_67469', '15-hydroxyajubractin C', 9, '1, 25-Dihydroxyvitamin D'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 39, '25-OH-D'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('UBERON_0000479', 'tissue', 174, 'tissue'), ('UBERON_0000479', 'tissue', 193, 'tissue')]
PMC4971719	8/2016	S81-PMC4971719	['ON THE OTHER HAND, 25-Oh-D is the major form of circulating Vitamin D and is highly stable for analysis from stored Serum or Plasma.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('CHEBI_46744', 'DDT-2,3-dihydrodiol', 19, '25-OH-D'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0001977', 'blood serum', 116, 'serum'), ('UBERON_0001969', 'blood plasma', 125, 'plasma')]
PMC4971719	8/2016	S146-PMC4971719	['CONVERSELY, we FOUND that ALTHOUGH there was a TREND toward an ASSOCIATION of most recent Vitamin D levels with the bdi score in later Pregnancy and Postpartum, this trend was not significant and largely disappeared after adjustment for the baseline Bdi score.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 15), ('ANOMALY_CURIOUS_FINDING', 26), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 63)]	5	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0007565', 'female pregnancy', 135, 'pregnancy'), ('GO_0007565', 'female pregnancy', 149, 'postpartum'), ('PR_000004717', "transcription factor TFIIIB component B''", 250, 'BDI')]
PMC4971719	8/2016	S152-PMC4971719	['the LACK OF association OBSERVED between Vitamin D level in early or late Pregnancy and the 6–8 week Postpartum bdi score MAY BE EXPLAINED by the COMPLEXITY of the pathogenesis of Postpartum depression symptoms, OR it MAY represent a TRUE negative FINDING.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 122), ('ANOMALY_CURIOUS_FINDING', 126), ('PROBABLE_UNDERSTANDING', 129), ('DIFFICULT_TASK', 146), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 212), ('INCOMPLETE_EVIDENCE', 218), ('PROBABLE_UNDERSTANDING', 234), ('INCOMPLETE_EVIDENCE', 248)]	10	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 74, 'pregnancy'), ('GO_0007565', 'female pregnancy', 101, 'postpartum'), ('GO_0007565', 'female pregnancy', 180, 'postpartum')]
PMC4971719	8/2016	S161-PMC4971719	['OUR STUDY FOUND an ASSOCIATION between low Vitamin D levels in early Pregnancy and depressive symptoms during Pregnancy BUT NOT Postpartum.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 120)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0007565', 'female pregnancy', 69, 'pregnancy'), ('GO_0007565', 'female pregnancy', 110, 'pregnancy'), ('GO_0007565', 'female pregnancy', 128, 'postpartum')]
PMC4971719	8/2016	S167-PMC4971719	['IF randomized studies SHOW a benefit for Vitamin D for PREVENTION or treatment of Perinatal depression, supplementation MAY benefit maternal fetal and neonatal health [49,50].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 55), ('INCOMPLETE_EVIDENCE', 120)]	4	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0036268', 'swimming', 82, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 82, 'perinatal')]
PMC4971719	8/2016	S169-PMC4971719	['this ASSOCIATION MAY BE ATTRIBUTED to a true EFFECT of nutritional deficiency OR ALTERNATELY MIGHT be RELATED to DIFFERENCES in Vitamin D Metabolism between women who are predisposed to depression and those who are not.']	[('SUPERFICIAL_RELATIONSHIP', 5), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 24), ('SUPERFICIAL_RELATIONSHIP', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('INCOMPLETE_EVIDENCE', 93), ('SUPERFICIAL_RELATIONSHIP', 102), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113)]	9	[('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 128, 'vitamin D metabolism')]
PMC4973215	8/2016	S11-PMC4973215	['several large OBSERVATIONAL studies and meta-analyses have DESCRIBED the ASSOCIATION of maternal Vitamin D deficiency with Pregnancy COMPLICATIONS such as pre-eclampsia, Gestational diabetes and premature Birth.10,11,12,13racial DISPARITIES in maternal and neonatal Vitamin D deficiency HAVE BEEN DESCRIBED.1,14,15vitamin D deficiency is MORE COMMON and more SEVERE in black mothers.10,15,16,17,18,19racial DISPARITIES are also SEEN with Pregnancy COMPLICATIONS such as Preterm birth, pre-eclampsia and Gestational diabetes, as well as adverse neonatal outcomes including low Birth weight and small-for-Gestational-age (sga) status.15,17,20,21HOWEVER, the MAJORITY of studies EXAMINED maternal Vitamin D levels during the first and second Trimesters of Pregnancy7,8,22,23and CORRELATED these levels to neonatal outcomes.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 73), ('PROBLEM_COMPLICATION', 133), ('IMPORTANT_CONSIDERATION', 229), ('INCOMPLETE_EVIDENCE', 287), ('INCOMPLETE_EVIDENCE', 297), ('PROBABLE_UNDERSTANDING', 338), ('IMPORTANT_CONSIDERATION', 359), ('IMPORTANT_CONSIDERATION', 407), ('INCOMPLETE_EVIDENCE', 428), ('PROBLEM_COMPLICATION', 448), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 643), ('PROBABLE_UNDERSTANDING', 656), ('INCOMPLETE_EVIDENCE', 676), ('SUPERFICIAL_RELATIONSHIP', 775)]	16	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('GO_0007565', 'female pregnancy', 123, 'pregnancy'), ('GO_0007565', 'female pregnancy', 170, 'gestational'), ('GO_0007567', 'parturition', 205, 'birth'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 322, 'D'), ('GO_0007565', 'female pregnancy', 438, 'pregnancy'), ('GO_0007565', 'female pregnancy', 470, 'preterm'), ('GO_0007565', 'female pregnancy', 503, 'gestational'), ('GO_0007567', 'parturition', 576, 'birth'), ('GO_0007565', 'female pregnancy', 603, 'gestational'), ('CHEBI_27300', 'vitamin D', 694, 'vitamin D'), ('GO_0043033', 'isoamylase complex', 739, 'trimesters'), ('GO_0007565', 'female pregnancy', 753, 'pregnancy7')]
PMC4973215	8/2016	S13-PMC4973215	['ALTHOUGH studies HAVE SHOWN that supplementation increases maternal and Cord Blood Vitamin D levels, changes in clinical outcomes HAVE NOT yet BEEN WELL PROVEN.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 130)]	3	[('UBERON_0002240', 'spinal cord', 72, 'cord'), ('UBERON_0000178', 'blood', 77, 'blood'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
PMC4973215	8/2016	S14-PMC4973215	['THUS, sufficient EVIDENCE is LACKING at this time to RECOMMEND routine Vitamin D supplementation during Pregnancy.12HOWEVER, identification of specific RISK FACTORS for Vitamin D deficiency and the additive EFFECTS of these RISK FACTORS MAY LEAD TO OPPORTUNITIES for targeted supplementation with improved outcomes.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('FUTURE_WORK', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116), ('SUPERFICIAL_RELATIONSHIP', 152), ('SUPERFICIAL_RELATIONSHIP', 207), ('SUPERFICIAL_RELATIONSHIP', 224), ('INCOMPLETE_EVIDENCE', 237), ('SUPERFICIAL_RELATIONSHIP', 241), ('FUTURE_WORK', 249)]	10	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0007565', 'female pregnancy', 104, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC4973215	8/2016	S45-PMC4973215	['SIMILARLY, infants on medicaid, a MARKER of socioeconomic status, had higher odds of Vitamin D deficiency (odds ratio (or) 2.3, 95% ci: 1.4, 3.8), WHEREAS Prenatal Vitamin use SHOWED a PROTECTIVE EFFECT (or 0.24, 95% ci: 0.09, 0.62).']	[('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 147), ('INCOMPLETE_EVIDENCE', 176), ('SUPERFICIAL_RELATIONSHIP', 185), ('SUPERFICIAL_RELATIONSHIP', 196)]	6	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007565', 'female pregnancy', 155, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 164, 'vitamin')]
PMC4973215	8/2016	S48-PMC4973215	['for instance, at a mean maternal bmi of 32.3\u2009kg\u2009m−2, an infant who is black, on medicaid and no Prenatal vitamin use has an 86% (95% ci: 82, 97) PROBABILITY of Vitamin D deficiency, WHEREAS a black infant who is not on medicaid and with Prenatal vitamin use has a 66% (95% ci: 44, 67) PROBABILITY of Vitamin D deficiency.']	[('PROBABLE_UNDERSTANDING', 145), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182), ('PROBABLE_UNDERSTANDING', 285)]	3	[('GO_0007565', 'female pregnancy', 96, 'prenatal'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('GO_0007565', 'female pregnancy', 237, 'prenatal'), ('CHEBI_27300', 'vitamin D', 300, 'vitamin D')]
PMC4973215	8/2016	S50-PMC4973215	['AS Vitamin D levels also DIFFERED by race, we stratified the models predicting sga by race and EXAMINED Vitamin D deficiency, smoking, pre-eclampsia, maternal age, medicaid status and bmi at Delivery as covariates (table 3).']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('QUESTION_ANSWERED_BY_THIS_WORK', 95)]	3	[('CHEBI_27300', 'vitamin D', 3, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('GO_0007567', 'parturition', 191, 'delivery')]
PMC4973215	8/2016	S62-PMC4973215	['ALTHOUGH the prevalence of Vitamin D deficiency in black mothers and neonates is WELL KNOWN, DEBATE exists as to the RELATIONSHIP between race, Vitamin D deficiency and sga.12,14,15,17,18we EXAMINED this RELATIONSHIP in conjunction with additional maternal characteristics in order TO IDENTIFY groups of Pregnant women who could BENEFIT MOST from Vitamin D supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93), ('SUPERFICIAL_RELATIONSHIP', 117), ('QUESTION_ANSWERED_BY_THIS_WORK', 190), ('SUPERFICIAL_RELATIONSHIP', 204), ('QUESTION_ANSWERED_BY_THIS_WORK', 282), ('IMPORTANT_CONSIDERATION', 329), ('PROBABLE_UNDERSTANDING', 337)]	9	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('GO_0007565', 'female pregnancy', 304, 'pregnant'), ('CHEBI_27300', 'vitamin D', 347, 'vitamin D')]
PMC4973215	8/2016	S65-PMC4973215	['INTERESTINGLY HOWEVER, white race with Vitamin D deficiency was not significantly associated with increased odds of sga.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14)]	2	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC4973215	8/2016	S67-PMC4973215	['Vitamin D MAY AFFECT fetal growth through its EFFECT on Calcium Metabolism, bone growth and Placental Development.32ALTHOUGH INITIAL STUDIES SHOWED CONFLICTING results, more RECENT STUDIES SUGGEST that Vitamin D deficiency MAY adversely AFFECT growth and LEAD TO low Birth weight or sga infants.7,9,11,12,18,22,23,33BECAUSE of a KNOWN RELATIONSHIP between race and Vitamin D status, ATTENTION then turned to investigation of the RELATIONSHIP between race, Vitamin D deficiency and sga.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 14), ('SUPERFICIAL_RELATIONSHIP', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116), ('INCOMPLETE_EVIDENCE', 125), ('INCOMPLETE_EVIDENCE', 141), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 148), ('INCOMPLETE_EVIDENCE', 174), ('INCOMPLETE_EVIDENCE', 189), ('INCOMPLETE_EVIDENCE', 223), ('SUPERFICIAL_RELATIONSHIP', 237), ('SUPERFICIAL_RELATIONSHIP', 255), ('PROBABLE_UNDERSTANDING', 316), ('INCOMPLETE_EVIDENCE', 329), ('SUPERFICIAL_RELATIONSHIP', 335), ('IMPORTANT_CONSIDERATION', 383), ('SUPERFICIAL_RELATIONSHIP', 429)]	17	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0018884', 'carbazole metabolic process', 56, 'calcium metabolism'), ('GO_0001890', 'placenta development', 92, 'placental development'), ('UBERON_0001987', 'placenta', 92, 'placental'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('GO_0007567', 'parturition', 267, 'birth'), ('CHEBI_27300', 'vitamin D', 365, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 456, 'vitamin D')]
PMC4973215	8/2016	S71-PMC4973215	['HOWEVER, no relationship was seen between Vitamin D status and sga among black mothers.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
PMC4973215	8/2016	S74-PMC4973215	['they FOUND that Vitamin D status was ASSOCIATED with risk of sga in white and nonobese women, BUT that there was no association between Vitamin D and sga in black or obese mothers.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 94)]	3	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D')]
PMC4973215	8/2016	S75-PMC4973215	['IN CONTRAST TO the above-mentioned studies, our results SHOW that the combination of black race and Vitamin D deficiency was ASSOCIATED with increased odds of sga, BUT this RELATIONSHIP was not preserved for white infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 125), ('ANOMALY_CURIOUS_FINDING', 164), ('SUPERFICIAL_RELATIONSHIP', 173)]	5	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC4973215	8/2016	S78-PMC4973215	['furthermore, this study was CONDUCTED in hamilton county, ohio, an area with worse Perinatal outcomes THAN national averages, including higher infant mortality, Preterm Birth and low Birth weight rates, as well as CONSIDERABLE racial DISPARITIES in infant mortality and Perinatal outcomes.34all of Cord Blood samples were collected over one winter season, THUS negating seasonal variations in Vitamin D levels that MAY have been SEEN in OTHER STUDIES.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102), ('IMPORTANT_CONSIDERATION', 214), ('IMPORTANT_CONSIDERATION', 234), ('PROBABLE_UNDERSTANDING', 356), ('INCOMPLETE_EVIDENCE', 415), ('INCOMPLETE_EVIDENCE', 429), ('INCOMPLETE_EVIDENCE', 437)]	8	[('GO_0036268', 'swimming', 83, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 83, 'perinatal'), ('GO_0007565', 'female pregnancy', 161, 'preterm birth'), ('GO_0007567', 'parturition', 183, 'birth'), ('GO_0036268', 'swimming', 270, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 270, 'perinatal'), ('UBERON_0002240', 'spinal cord', 298, 'cord'), ('UBERON_0000178', 'blood', 303, 'blood'), ('CHEBI_27300', 'vitamin D', 393, 'vitamin D')]
PMC4973215	8/2016	S79-PMC4973215	['finally, we ANALYZED Cord Blood Vitamin D levels at the time of Delivery, RATHER THAN maternal Serum Vitamin D levels during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81)]	3	[('UBERON_0002240', 'spinal cord', 21, 'cord'), ('UBERON_0000178', 'blood', 26, 'blood'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007567', 'parturition', 64, 'delivery'), ('UBERON_0001977', 'blood serum', 95, 'serum'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('GO_0007565', 'female pregnancy', 125, 'pregnancy')]
PMC4973215	8/2016	S80-PMC4973215	['ALTHOUGH Cord Blood 25(Oh)D levels do CORRELATE to maternal levels, FACTORS that AFFECT fetal growth MAY not be uniform throughout Pregnancy and this DIFFERENCE in timing COULD AFFECT study FINDINGS.1,3,4,5,6in addition, maternal characteristics such as obesity or pre-eclampsia COULD also AFFECT results that MAY NOT HAVE BEEN SEEN IF Vitamin D samples were obtained during early Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 68), ('SUPERFICIAL_RELATIONSHIP', 81), ('INCOMPLETE_EVIDENCE', 101), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 150), ('INCOMPLETE_EVIDENCE', 171), ('SUPERFICIAL_RELATIONSHIP', 177), ('INCOMPLETE_EVIDENCE', 190), ('INCOMPLETE_EVIDENCE', 279), ('SUPERFICIAL_RELATIONSHIP', 290), ('INCOMPLETE_EVIDENCE', 310), ('INCOMPLETE_EVIDENCE', 314), ('INCOMPLETE_EVIDENCE', 318), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 333)]	15	[('UBERON_0002240', 'spinal cord', 9, 'cord'), ('UBERON_0000178', 'blood', 14, 'blood'), ('CHEBI_71657', 'versiconol acetate', 20, '25(OH)D'), ('PR_000011040', 'nuclear receptor coactivator 1', 22, '(OH'), ('PR_000006444', 'diacylglycerol kinase delta', 26, 'D'), ('GO_0007565', 'female pregnancy', 131, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 336, 'vitamin D'), ('GO_0007565', 'female pregnancy', 381, 'pregnancy')]
PMC4973215	8/2016	S85-PMC4973215	['furthermore, the PROTECTIVE EFFECT against Vitamin D deficiency was SEEN in both blacks and whites in our study, IN CONTRAST TO a RECENTLY PUBLISHED STUDY by burris et al.']	[('SUPERFICIAL_RELATIONSHIP', 17), ('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113), ('INCOMPLETE_EVIDENCE', 130)]	5	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D')]
PMC4973215	8/2016	S86-PMC4973215	[',39who FOUND that lack of Prenatal vitamin use was ASSOCIATED with Vitamin D deficiency in white BUT NOT black women.']	[('INCOMPLETE_EVIDENCE', 7), ('SUPERFICIAL_RELATIONSHIP', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 97)]	3	[('GO_0007565', 'female pregnancy', 26, 'prenatal'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC4973215	8/2016	S94-PMC4973215	['Vitamin D supplementation during Pregnancy HAS BEEN SHOWN to positively AFFECT Cord Blood Vitamin D levels at Birth.43,44studies of Vitamin D supplementation during Pregnancy THUS FAR HAVE SHOWN CONFLICTING results with respect to Birth weight and reduction of sga.43,45,46,47,48adequately powered and randomized controlled trials of vitamin d supplementation during Pregnancy ARE NEEDED TO ASSESS the IMPACT of supplementation on sga as well as the APPROPRIATE dose and timing of supplementation.']	[('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 72), ('INCOMPLETE_EVIDENCE', 175), ('INCOMPLETE_EVIDENCE', 184), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 195), ('FUTURE_WORK', 377), ('FUTURE_WORK', 388), ('SUPERFICIAL_RELATIONSHIP', 402), ('IMPORTANT_CONSIDERATION', 450)]	9	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 79, 'cord'), ('UBERON_0000178', 'blood', 84, 'blood'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0007567', 'parturition', 110, 'birth'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('GO_0007565', 'female pregnancy', 165, 'pregnancy'), ('GO_0007567', 'parturition', 231, 'birth'), ('GO_0007565', 'female pregnancy', 367, 'pregnancy')]
PMC4976416	7/2016	S10-PMC4976416	['[3]\nthere are eight types of Vitamin E (α-,β-,Γ-, and Σ-Tocopherols and their RELATED corresponding Tocotrienols), Γ-Tocopherol being the most abundant Tocopherol in diet, WHEREAS Α-Tocopherol (α-Toc) is the most abundant Vitamin E Derivative in Human Tissues and Sera.']	[('SUPERFICIAL_RELATIONSHIP', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 172)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin E'), ('CHEBI_66498', 'Ys-IV', 46, 'γ-,'), ('CHEBI_52029', 'dilC18(3) dye', 54, 'σ-'), ('CHEBI_27013', 'tocopherol', 56, 'tocopherols'), ('CHEBI_33257', 'secondary amide', 100, 'tocotrienols'), ('CHEBI_27725', 'butin', 115, 'γ-tocopherol'), ('CHEBI_27013', 'tocopherol', 152, 'tocopherol'), ('CHEBI_27725', 'butin', 180, 'α-tocopherol'), ('CHEBI_27021', 'toluate', 196, 'Toc'), ('CHEBI_84790', 'trans-3-hexenoyl-CoA(4-)', 222, 'vitamin E derivative'), ('NCBITaxon_9606', 'Homo sapiens', 246, 'human'), ('UBERON_0000479', 'tissue', 252, 'tissues'), ('UBERON_0001977', 'blood serum', 264, 'sera')]
PMC4976416	7/2016	S17-PMC4976416	['HOWEVER when a stable formulation delivers a high concentration of nonesterified, OPTIMAL isomer of the antioxidant, Vitamins C and E inhibit the acute uv damage as well as chronic uv photoaging and skin cancer.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 82)]	2	[('CHEBI_27300', 'vitamin D', 117, 'vitamins C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 132, 'E')]
PMC4976416	7/2016	S59-PMC4976416	['HOWEVER, studies have DEMONSTRATED that Vitamin E does not significantly ameliorate Retinoid side effects when combined with isotretinoin in the treatment of acne.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 22)]	2	[('CHEBI_27300', 'vitamin D', 40, 'vitamin E'), ('CHEBI_26537', 'retinoid', 84, 'retinoid')]
PMC4976416	7/2016	S73-PMC4976416	['HOWEVER, studies looking AT the efficacy of Vitamin E in the treatment of burns and scars HAVE BEEN DISAPPOINTING.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 25), ('INCOMPLETE_EVIDENCE', 90), ('ANOMALY_CURIOUS_FINDING', 100)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin E')]
PMC4976416	7/2016	S85-PMC4976416	['conclusion\nDESPITE development of new Formulations for use in cosmetics and skin care products, there is a LACK OF controlled clinical trials providing a rationale for well-defined dosages and clinical indications for oral and topical Vitamin E. after so MANY YEARS of RESEARCH on Vitamin E, it is STILL UNCLEAR as to WHETHER millions of dollars worth of Vitamin E products paid for by patients and consumers have been of any benefit.']	[('ANOMALY_CURIOUS_FINDING', 11), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 255), ('INCOMPLETE_EVIDENCE', 269), ('FULL_UNKNOWN', 298), ('IMPORTANT_CONSIDERATION', 298), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 318)]	7	[('CHEBI_38864', 'propetamphos', 38, 'formulations'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 281, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 355, 'vitamin E')]
PMC4979151	8/2016	S12-PMC4979151	['IN CONTRAST, no association [6,7] or negative EFFECTS of high Vitamin D intake in Pregnancy on the RISK of eczema, asthma and wheezing in the offspring HAVE also BEEN SHOWN [8].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 46), ('IMPORTANT_CONSIDERATION', 99), ('INCOMPLETE_EVIDENCE', 152)]	4	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'pregnancy')]
PMC4979151	8/2016	S13-PMC4979151	['there is NO CONSENSUS on the cutoff value for Vitamin D deficiency and the optimum dosage for supplementation during Pregnancy REMAINS CONTROVERSIAL.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('INCOMPLETE_EVIDENCE', 127), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0007565', 'female pregnancy', 117, 'pregnancy')]
PMC4982007	8/2016	S273-PMC4982007	['HOWEVER, the percentage with Language impairment was double in children of Vitamin D deficient mothers COMPARED TO normal mothers in ONE STUDY [21].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('INCOMPLETE_EVIDENCE', 133)]	4	[('GO_0006266', 'DNA ligation', 29, 'language'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC4982007	8/2016	S280-PMC4982007	['THUS, based ON a LIMITED NUMBER OF observational studies evidence LINKING maternal Vitamin D deficiency with reduced offspring Cognitive function is NOT CONCLUSIVE.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 12), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 66), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 149)]	6	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0050890', 'cognition', 127, 'cognitive')]
PMC4988030	8/2016	S111-PMC4988030	['IF the distribution passed the goodness of fit tests or failed the tests BUT APPEARED sufficiently normal for the underlying assumptions of normality to be reasonable for practical purposes of analysis, then the diet outcome (hei total and component scores; and total fat, Sodium, Folate, and Vitamin D intakes) was modeled using a gaussian distribution with an identity link function.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 73), ('ANOMALY_CURIOUS_FINDING', 77)]	3	[('CHEBI_52632', 'potassium-39 atom', 273, 'sodium'), ('CHEBI_30863', '5-azaorotic acid', 281, 'folate'), ('CHEBI_27300', 'vitamin D', 293, 'vitamin D')]
PMC4988030	8/2016	S139-PMC4988030	['WHEREAS, more than half of the women met intake recommendations for Cholesterol, Folate, iron, Vitamin C, and Vitamin D at baseline.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('CHEBI_16113', 'cholesterol', 68, 'cholesterol'), ('CHEBI_30863', '5-azaorotic acid', 81, 'folate'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC4989298	8/2016	S237-PMC4989298	['NUMEROUS STUDIES have also evaluated the Intake of Vitamins (vit a, e, c) and Minerals (Mg, zn, Ca, p) [please NOTE that except for this chapter the data on Vitamin D is treated in a special section], BUT these often include methodological ERRORS, starting with the DIFFICULTY of FINDING a correct quantification of dietary Intakes of various Foods.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 201), ('PROBLEM_COMPLICATION', 240), ('DIFFICULT_TASK', 266), ('INCOMPLETE_EVIDENCE', 280)]	6	[('GO_0007631', 'feeding behavior', 41, 'intake'), ('CHEBI_33277', 'gamma-tocotrienol', 51, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 78, 'minerals'), ('CHEBI_34829', 'Medrysone', 88, 'Mg'), ('CHEBI_32588', 'potassium chloride', 96, 'Ca'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('GO_0007631', 'feeding behavior', 324, 'intakes'), ('CHEBI_33290', 'food', 343, 'foods')]
PMC4989298	8/2016	S345-PMC4989298	['HOWEVER, SEVERAL STUDIES report SUBOPTIMAL Vitamin D status in large parts of the population of children and Adults.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 32)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('UBERON_0007023', 'adult organism', 109, 'adults')]
PMC4989298	8/2016	S373-PMC4989298	['the results REMAIN CONTROVERSIAL EVEN when CORRELATIONS between Vitamin D levels in maternal and Umbilical Cord Blood and allergic disease risk are measured directly.']	[('INCOMPLETE_EVIDENCE', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('ANOMALY_CURIOUS_FINDING', 33), ('SUPERFICIAL_RELATIONSHIP', 43)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0002331', 'umbilical cord', 97, 'umbilical cord'), ('UBERON_0000178', 'blood', 112, 'blood')]
PMC4989298	8/2016	S375-PMC4989298	['conclusions\nALTHOUGH the AVAILABLE literature data SUGGEST the existence of a RELATIONSHIP between latitude and its consequent degree of ultraviolet radiation exposure, Vitamin D levels and the prevalence and severity of allergic diseases, the data of OBSERVATIONAL studies are encouraging, BUT CONTROVERSIAL and the ONLY available rct FAILS to SHOW an EFFECT on allergic disease prevalence.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('ANOMALY_CURIOUS_FINDING', 12), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 78), ('INCOMPLETE_EVIDENCE', 252), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 291), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 295), ('INCOMPLETE_EVIDENCE', 317), ('PROBLEM_COMPLICATION', 336), ('INCOMPLETE_EVIDENCE', 345), ('SUPERFICIAL_RELATIONSHIP', 353)]	12	[('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC4989298	8/2016	S376-PMC4989298	['the use of Vitamin D supplementation for the primary PREVENTION of allergic diseases REMAINS an attractive TOPIC of study, BUT CURRENT KNOWLEDGE and AVAILABLE EVIDENCE does not warrant its RECOMMENDATION [129].']	[('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 85), ('IMPORTANT_CONSIDERATION', 107), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 123), ('INCOMPLETE_EVIDENCE', 127), ('INCOMPLETE_EVIDENCE', 149), ('FUTURE_WORK', 189)]	7	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D')]
PMC4990268	8/2016	S298-PMC4990268	['one additional ISSUE for Vitamin A supplementation in Pregnancy is that high doses of Retinol are a WELL-KNOWN Teratogen IF provided early in Gestation[102].']	[('PROBLEM_COMPLICATION', 15), ('PROBABLE_UNDERSTANDING', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin A'), ('GO_0007565', 'female pregnancy', 54, 'pregnancy'), ('CHEBI_26536', 'retinoic acid', 86, 'retinol'), ('CHEBI_50117', 'phenylglyoxylyl-CoA', 111, 'teratogen'), ('GO_0007565', 'female pregnancy', 142, 'gestation')]
PMC4990268	8/2016	S314-PMC4990268	['IN SUMMARY, there is CONFLICTING EVIDENCE for benefit of Vitamin A or Β-Carotene supplementation on maternal mortality.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 21), ('INCOMPLETE_EVIDENCE', 33)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin A'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 70, 'β-carotene')]
PMC4990268	8/2016	S315-PMC4990268	['meta-analyses do not SUPPORT this intervention as a Maternal survival strategy[101,108] HOWEVER the most RECENT such analysis NOTED significant heterogeneity in trial outcomes (i2 = 52%, p = 0.04) MOST LIKELY due TO VARIATIONS in underlying population levels of Vitamin A deficiency between studies[101].']	[('INCOMPLETE_EVIDENCE', 21), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 88), ('INCOMPLETE_EVIDENCE', 105), ('ANOMALY_CURIOUS_FINDING', 126), ('PROBABLE_UNDERSTANDING', 197), ('QUESTION_ANSWERED_BY_THIS_WORK', 213), ('DIFFICULT_TASK', 216)]	7	[('GO_0007618', 'mating', 52, 'maternal'), ('CHEBI_27300', 'vitamin D', 262, 'vitamin A')]
PMC4990268	8/2016	S319-PMC4990268	['overall, there is NO CONSISTENT EVIDENCE that Antenatal Vitamin A supplementation improves growth of infants through the first year of Life[101].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 18), ('INCOMPLETE_EVIDENCE', 21)]	2	[('GO_0007567', 'parturition', 46, 'antenatal'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin A'), ('UBERON_0000104', 'life cycle', 135, 'life')]
PMC4990268	8/2016	S326-PMC4990268	['maternal hiv infection: there is NO CONSISTENT EVIDENCE that Antenatal Vitamin A supplementation reduces RISK of Mother-To-child-Transmission Of Hiv (mtct) BUT there is significant heterogeneity in trial results [101].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 33), ('INCOMPLETE_EVIDENCE', 33), ('IMPORTANT_CONSIDERATION', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 156)]	4	[('GO_0007567', 'parturition', 61, 'antenatal'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin A'), ('GO_0007533', 'mating type switching', 113, 'mother-to ... transmission of HIV')]
PMC4990268	8/2016	S337-PMC4990268	['DESPITE this benefit, it was ASSUMED for many years that children younger than 6 months and breastfeeding either exclusively or for the majority of their intake were protected by the Vitamin A in Breastmilk.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 29)]	3	[('CHEBI_27300', 'vitamin D', 183, 'vitamin A'), ('UBERON_0001348', 'brown adipose tissue', 196, 'breastmilk')]
PMC4990268	8/2016	S343-PMC4990268	['evidence: the studies identified for this review FOUND VARYING results of Vitamin A supplementation on infant mortality.']	[('INCOMPLETE_EVIDENCE', 49), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 55)]	2	[('CHEBI_27300', 'vitamin D', 74, 'vitamin A')]
PMC4990268	8/2016	S359-PMC4990268	['WHILE those results are not yet published, they SHOW a DIFFERENCE between the results of trials conducted in settings with significant maternal Vitamin A deficiency (indonesia, south india, bangladesh, and north india) and those in settings with little to no maternal Vitamin A deficiency (zimbabwe, guinea-bissau, ghana, and tanzania).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 55)]	3	[('CHEBI_27300', 'vitamin D', 144, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 268, 'vitamin A')]
PMC4990268	8/2016	S360-PMC4990268	['in settings with endemic Vitamin A deficiency there is an overall BENEFIT to newborn dosing with regard to early infant mortality WHEREAS in settings without deficiency there is no evidence of benefit.']	[('IMPORTANT_CONSIDERATION', 66), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 130)]	2	[('CHEBI_27300', 'vitamin D', 25, 'vitamin A')]
PMC4990268	8/2016	S362-PMC4990268	['HOWEVER, there is significant heterogeneity in results with benefit EVIDENT in settings with significant maternal Vitamin A deficiency but no benefit when maternal Vitamin A deficiency is LACKING.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 68), ('FULL_UNKNOWN', 188)]	3	[('CHEBI_27300', 'vitamin D', 114, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin A')]
PMC4990268	8/2016	S364-PMC4990268	['the expected reduction in mortality BURDEN achievable with this intervention will vary DEPENDING ON the population BURDEN of Vitamin A deficiency among women of Reproductive age.']	[('IMPORTANT_CONSIDERATION', 36), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 87), ('IMPORTANT_CONSIDERATION', 115)]	3	[('CHEBI_27300', 'vitamin D', 125, 'vitamin A'), ('GO_0000003', 'reproduction', 161, 'reproductive')]
PMC4990268	8/2016	S1116-PMC4990268	['intable 6below, we have offered very brief comments on such implementation CONSIDERATIONS.10.1371/journal.pone.0160562.t006\n\ncaption (table-wrap): table 6\n“best buy” ratings for interventions reviewed.interventionpopulation impactease of Deliverycommentsbreastfeeding—early initiation ✓ ☺large magnitude EFFECT on newborn mortalityiron/ anemia ✓✓✓ ☺LIKELY a significant mortality EFFECT, BUT EVIDENCE is WEAK; clear benefit however for iugr multi-Micronutrient supplementation✓ ☺ ALTHOUGH iugr is reduced , in many low income settings there MAY BE no net benefit; under SOME conditions there MAY BE net harm Calcium ✓✓✓😐 large magnitude EFFECTS but significant logistical barriers at currently recommended dose antenatal Vitamin A ☺ no effects on our outcomes of interest Postnatal Vitamin A ✓ ☺EVIDENCE for IMPACT on early infant deaths in Vitamin-A deficient populationsiodine ✓ ☺major benefit in ↓’d burden of Cognitive disabilitybalanced protein-energy supplementation ✓✓✓😐 significant benefits, but cost & logistical challenges limit scalability deworming ☺ no effects on our outcomes of interest iptp/itns ✓✓✓✓ ☺large magnitude EFFECTS in malarious areastetanus Toxoid ✓ ☺in most settings, coverage is now relatively high; this NEEDS to be sustainedchlorhexidine advance distribution ✓ ☺large magnitude EFFECT on newborn mortality in high nmr populationssyphilis screening & treatment ✓✓✓ ☺relatively inexpensive and straightforward diagnostics and treatmentpmtct ✓😐 high population effective coverage REQUIRES robust services and systemsmisoprostol advance distribution ✓ ☺to ensure SAFETY, Delivery strategy NEEDS to reliably ensure counseling on correct timing of use (i.e.']	[('IMPORTANT_CONSIDERATION', 75), ('SUPERFICIAL_RELATIONSHIP', 304), ('PROBABLE_UNDERSTANDING', 349), ('SUPERFICIAL_RELATIONSHIP', 380), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 388), ('INCOMPLETE_EVIDENCE', 392), ('INCOMPLETE_EVIDENCE', 404), ('ANOMALY_CURIOUS_FINDING', 480), ('INCOMPLETE_EVIDENCE', 541), ('INCOMPLETE_EVIDENCE', 570), ('INCOMPLETE_EVIDENCE', 592), ('SUPERFICIAL_RELATIONSHIP', 637), ('INCOMPLETE_EVIDENCE', 795), ('SUPERFICIAL_RELATIONSHIP', 808), ('SUPERFICIAL_RELATIONSHIP', 1134), ('FUTURE_WORK', 1234), ('SUPERFICIAL_RELATIONSHIP', 1309), ('IMPORTANT_CONSIDERATION', 1508), ('IMPORTANT_CONSIDERATION', 1590), ('FUTURE_WORK', 1616), ('IMPORTANT_CONSIDERATION', 1616)]	21	[('GO_0031078', 'histone deacetylase activity (H3-K14 specific)', 238, 'DeliveryCommentsBreastfeeding'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 447, 'micronutrient'), ('CHEBI_31341', 'calcium dihydroxide', 608, 'Calcium'), ('CHEBI_77082', 'O-adipoylcarnitine(1-)', 616, '✓✓✓😐'), ('CHEBI_33233', 'fundamental particle', 721, 'vitamin A ☺'), ('PR_000021995', 'dual specificity mitogen-activated protein kinase kinase 4 phosphorylated form', 721, 'vitamin A ☺'), ('GO_0007567', 'parturition', 772, 'Postnatal'), ('CHEBI_27300', 'vitamin D', 782, 'vitamin A'), ('CHEBI_33229', 'vitamin (role)', 841, 'vitamin'), ('PR_000027594', 'histone H3', 841, 'vitamin-A'), ('GO_0050890', 'cognition', 913, 'cognitive'), ('CHEBI_29238', 'tritium atom', 1168, 'toxoid'), ('GO_0007567', 'parturition', 1598, 'delivery')]
PMC4990268	8/2016	S1153-PMC4990268	['DEPENDING ON the setting, this COULD BE supplemented by clinical preventive interventions that CAN be put into operation at the time of home Births, NOTABLY the use of Misoprostol for prevention of pph, application of Chlorhexidine to the Umbilical Cord Stump and newborn Vitamin A supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 95), ('IMPORTANT_CONSIDERATION', 149)]	4	[('GO_0007567', 'parturition', 141, 'births'), ('CHEBI_63610', 'misoprostol', 168, 'misoprostol'), ('CHEBI_3647', 'chlorpromazine', 218, 'chlorhexidine'), ('UBERON_0010270', 'filum terminale externum', 239, 'umbilical cord stump'), ('CHEBI_27300', 'vitamin D', 272, 'vitamin A')]
PMC4990268	8/2016	S1184-PMC4990268	['BUT current RECOMMENDED dose imposes IMPORTANT logistical DIFFICULTIES.antenatal vitamin aroutine supplementation not indicated BUT in Vitamin A deficient populations screening for night blindness and treating such cases with Vitamin A CAN be RECOMMENDED.Postnatal vitamin abenefit expected in Vitamin A deficient populations (e.g.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 12), ('IMPORTANT_CONSIDERATION', 37), ('DIFFICULT_TASK', 58), ('PROBLEM_COMPLICATION', 58), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 128), ('INCOMPLETE_EVIDENCE', 236), ('FUTURE_WORK', 243)]	8	[('CHEBI_27300', 'vitamin D', 135, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin A'), ('GO_0007567', 'parturition', 255, 'Postnatal'), ('CHEBI_27300', 'vitamin D', 294, 'vitamin A')]
PMC4990280	8/2016	S129-PMC4990280	['in the fe60f group BUT NOT others (fe30f and mm), hb was strongly positively ASSOCIATED with Plasma hepcidin and Vitamin A in all children.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('ANOMALY_CURIOUS_FINDING', 19), ('SUPERFICIAL_RELATIONSHIP', 77)]	3	[('UBERON_0001969', 'blood plasma', 93, 'plasma'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin A')]
PMC4992225	8/2016	S162-PMC4992225	['WHILE, the mean depression scores were significantly lower in the Vitamin D group than the control one at 38–40 weeks of Gestation ( p \u2009=\u20090.01) also, at 4 and 8 weeks after Birth ( p \u2009>\u20090.001) (table\xa03).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007565', 'female pregnancy', 121, 'gestation'), ('GO_0007567', 'parturition', 173, 'birth')]
PMC4992225	8/2016	S195-PMC4992225	['NONETHELESS, ONLY 9.7\xa0% in the Vitamin D group achieved Serum concentrations higher than 30\xa0ng/ml.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 13)]	2	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('UBERON_0001977', 'blood serum', 56, 'serum')]
PMC4992225	8/2016	S196-PMC4992225	['IN CONTRAST, in the PREVIOUS STUDIES 2000\xa0iu Vitamin D supplementation was more sufficient to increase Serum 25-Hydroxyvitamin D concentrations up to the adequate amount (≥32\xa0ng/ml) [18,57,58].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 20)]	2	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0001977', 'blood serum', 103, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 109, '25-hydroxyvitamin D')]
PMC4992225	8/2016	S197-PMC4992225	['in those studies, Vitamin D supplementations started at the end of the first trimester or at the beginning of the second Trimester and their participants had higher initial 25-hydroxyvitamin d concentrations COMPARED TO the participants in OUR STUDY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 208), ('QUESTION_ANSWERED_BY_THIS_WORK', 240)]	2	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 121, 'trimester')]
PMC4992225	8/2016	S232-PMC4992225	['the Vitamin D and control groups were SIMILAR regarding to general characteristics EXCEPT FOR two variables: unplanned Pregnancy and using other Supplements OUT OF THE STUDY’S PROTOCOL.']	[('SUPERFICIAL_RELATIONSHIP', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('PROBLEM_COMPLICATION', 157)]	3	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'pregnancy'), ('CHEBI_33341', 'titanium atom', 145, 'supplements')]
PMC4992225	8/2016	S235-PMC4992225	['NONETHELESS, in OUR STUDY, the Vitamin D group had significantly lower depression scores after intervention.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 16)]	2	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC4992225	8/2016	S237-PMC4992225	['the control group consumed extra supplements such as Calcium more frequently, NONETHELESS this group had significantly higher depression scores compared to Vitamin D group.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 78)]	1	[('CHEBI_22313', 'alkaline earth metal atom', 53, 'calcium'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D')]
PMC4992225	8/2016	S239-PMC4992225	['HOWEVER in a cross-sectional study in japan, higher dietary Vitamin D intake was INDEPENDENTLY ASSOCIATED with a lower prevalence of depressive symptoms during Pregnancy [66].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 81), ('SUPERFICIAL_RELATIONSHIP', 95)]	3	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 160, 'pregnancy')]
PMC4992225	8/2016	S240-PMC4992225	['ON THE OTHER HAND, the EFFECT of Vitamin D on depression in non-Pregnant People are NOT entirely CLEAR.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 23), ('FULL_UNKNOWN', 84)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'pregnant'), ('NCBITaxon_10088', 'Mus <genus>', 73, 'people')]
PMC4992225	8/2016	S245-PMC4992225	['IN CONTRAST, in ANOTHER STUDY 40,000\xa0iu Vitamin D per week was used for 6\xa0months, BUT Vitamin D was not EFFECTIVE in decreasing depression level compared to the control group [68].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('SUPERFICIAL_RELATIONSHIP', 104)]	4	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC4992225	8/2016	S281-PMC4992225	['also, SINCE more than 95\xa0% of the mothers had lower than 30\xa0ng/ml Serum 25-Hydroxyvitamin D concentration, it is NOT CLEAR IF the same results WOULD BE OBSERVED in mothers with higher levels of 25-Hydroxyvitamin D. THEREFORE, we SUGGEST FURTHER clinical TRIALS, using 2000\xa0iu Vitamin D on a larger population, mothers with high levels of depression, and high Serum 25-Hydroxyvitamin D concentrations.']	[('PROBLEM_COMPLICATION', 6), ('FULL_UNKNOWN', 113), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 123), ('FUTURE_PREDICTION', 143), ('INCOMPLETE_EVIDENCE', 152), ('PROBABLE_UNDERSTANDING', 215), ('INCOMPLETE_EVIDENCE', 229), ('FUTURE_WORK', 237)]	8	[('UBERON_0001977', 'blood serum', 66, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 72, '25-hydroxyvitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 194, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D'), ('UBERON_0001977', 'blood serum', 359, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 365, '25-hydroxyvitamin D')]
PMC4993554	8/2016	S102-PMC4993554	['the respondents were able to identify Food sources high in iron (63.7%, n=55), Iodine (65.2%, n=261), and Omega-3 Fatty Acids (90%, n=360) BUT less able to correctly identify Foods that were a high source of Vitamin A (38%, n=152).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 139)]	1	[('CHEBI_33290', 'food', 38, 'food'), ('CHEBI_24859', 'iodine atom', 79, 'iodine'), ('CHEBI_79370', 'ibho#10', 106, 'omega-3'), ('CHEBI_35366', 'fatty acid', 114, 'fatty acids'), ('CHEBI_33290', 'food', 175, 'foods'), ('CHEBI_27300', 'vitamin D', 208, 'vitamin A')]
PMC4997421	8/2016	S11-PMC4997421	['conclusion there APPEAR TO BE DISPARITIES in Serum Vitamin A levels in women of Childbearing age RELATED to income and race in the united states.']	[('ANOMALY_CURIOUS_FINDING', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('IMPORTANT_CONSIDERATION', 30), ('SUPERFICIAL_RELATIONSHIP', 97)]	4	[('UBERON_0001977', 'blood serum', 45, 'serum'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin A'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 80, 'childbearing')]
PMC4997421	8/2016	S13-PMC4997421	['introduction\nvitamin a is an ESSENTIAL Nutrient throughout the Lifecycle; HOWEVER, its INFLUENCE is PARTICULARLY CRITICAL during periods when cells Proliferate rapidly and differentiate, such as during Pregnancy.adequate Vitamin A status in the mother is CRITICAL for fetal growth, Morphogenesis, and maturation of multiple Organ Systems, including the Immune System, Lungs, and Eyes [1,2].']	[('IMPORTANT_CONSIDERATION', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 74), ('SUPERFICIAL_RELATIONSHIP', 87), ('IMPORTANT_CONSIDERATION', 100), ('IMPORTANT_CONSIDERATION', 113), ('IMPORTANT_CONSIDERATION', 255)]	6	[('CHEBI_33284', 'nutrient', 39, 'nutrient'), ('UBERON_0000104', 'life cycle', 63, 'lifecycle'), ('GO_0008283', 'cell proliferation', 148, 'proliferate'), ('GO_0007565', 'female pregnancy', 202, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin A'), ('GO_0009653', 'anatomical structure morphogenesis', 282, 'morphogenesis'), ('UBERON_0000467', 'anatomical system', 324, 'organ systems'), ('UBERON_0002405', 'immune system', 353, 'immune system'), ('UBERON_0002048', 'lung', 368, 'lungs'), ('UBERON_0000970', 'eye', 379, 'eyes')]
PMC4997421	8/2016	S23-PMC4997421	['THEREFORE, the OBJECTIVE of THIS STUDY was to use nhanes data to EXAMINE the Retinol status of women of Childbearing age in the united states, and TO ASSESS the IMPACT of poverty and race, as well as OTHER INDICATORS that have NOT previously BEEN EXAMINED in this population, including Food security and use of supplemental nutrition assistance programs (snap), on Vitamin A status.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('QUESTION_ANSWERED_BY_THIS_WORK', 65), ('QUESTION_ANSWERED_BY_THIS_WORK', 147), ('SUPERFICIAL_RELATIONSHIP', 161), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 200), ('SUPERFICIAL_RELATIONSHIP', 206), ('FULL_UNKNOWN', 227)]	9	[('CHEBI_26536', 'retinoic acid', 77, 'retinol'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 104, 'childbearing'), ('CHEBI_33290', 'food', 286, 'food'), ('CHEBI_27300', 'vitamin D', 365, 'vitamin A')]
PMC4997421	8/2016	S123-PMC4997421	['we also INVESTIGATED the IMPACT of OTHER socioeconomic indicators on Vitamin A status that have not been WELL explored, including Food insecurity and Snap use.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('SUPERFICIAL_RELATIONSHIP', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('FUTURE_WORK', 105)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin A'), ('CHEBI_33290', 'food', 130, 'food'), ('PR_000015329', 'stannin', 150, 'SNAP')]
PMC4997421	8/2016	S136-PMC4997421	['our use of the who Retinol classifications, HOWEVER, does provide us with INFORMATION about the Vitamin A status of this IMPORTANT population [44], women of Childbearing age.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 44), ('INCOMPLETE_EVIDENCE', 74), ('IMPORTANT_CONSIDERATION', 121)]	3	[('CHEBI_26536', 'retinoic acid', 19, 'retinol'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin A'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 157, 'childbearing')]
PMC4997567	8/2016	S91-PMC4997567	['(2008) [19], and bakeit and megeid (2012) [13], who REVEALED that most of the rickets children were Breast-Fed which may LEAD TO decreased Vitamin D 25-Hydroxy Vitamin D(25-Ohd) intake from OTHER sources and thereby causing rickets.']	[('INCOMPLETE_EVIDENCE', 52), ('PROBABLE_UNDERSTANDING', 121), ('SUPERFICIAL_RELATIONSHIP', 121), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 190)]	4	[('GO_0007567', 'parturition', 100, 'breast'), ('UBERON_0000310', 'breast', 100, 'breast'), ('GO_0007631', 'feeding behavior', 107, 'fed'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('CHEBI_43141', '3-hydroxypropoxy group', 149, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('CHEBI_72765', 'verruculogen', 170, '25-OHD')]
PMC4998950	4/2016	S0-PMC4998950	['maternal Vitamin D deficiency and the risk of autism spectrum disorders: population-based study\n\nabstract\n\nbackground\nmaternal Vitamin D deficiency MAY increase risk of autism spectrum disorder (asd), BUT DIRECT EVIDENCE IS LACKING.']	[('INCOMPLETE_EVIDENCE', 148), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 201), ('INCOMPLETE_EVIDENCE', 205), ('FULL_UNKNOWN', 224)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
PMC4998950	4/2016	S10-PMC4998950	['environmental and Genetic FACTORS APPEAR equally IMPORTANT,1ALTHOUGH asd with and without intellectual disability MAY IN PART have DIFFERENT origins.2,3\nin high-latitude countries such as sweden, children of mothers with dark complexion are at PARTICULARLY elevated RISK of asd with intellectual disability.3because such women OFTEN have very low Vitamin d levels due to Melanin absorption of uvb radiation, maternal Vitamin D deficiency HAS BEEN SUGGESTED to CONTRIBUTE to asd risk in offspring.4,5indeed, experimentally induced Vitamin D deficiency in Pregnant dams is REPORTED to AFFECT foetal Neurodevelopment and behaviour in Adult offspring in Rats,4AND a RECENT STUDY DEMONSTRATED lower neonatal Vitamin D levels in children with asd compared with their siblings.6\nearly Life Vitamin D deficiency is THUS a POSSIBLE RISK FACTOR for asd, BUT direct SUPPORT of an ASSOCIATION IS LACKING.4maternal hypovitaminosis d is treatable, THUS INVESTIGATION of the matter IS WARRANTED.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('ANOMALY_CURIOUS_FINDING', 34), ('IMPORTANT_CONSIDERATION', 49), ('ANOMALY_CURIOUS_FINDING', 59), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 118), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('ANOMALY_CURIOUS_FINDING', 244), ('IMPORTANT_CONSIDERATION', 244), ('IMPORTANT_CONSIDERATION', 266), ('PROBABLE_UNDERSTANDING', 327), ('INCOMPLETE_EVIDENCE', 438), ('SUPERFICIAL_RELATIONSHIP', 460), ('INCOMPLETE_EVIDENCE', 571), ('SUPERFICIAL_RELATIONSHIP', 583), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 655), ('INCOMPLETE_EVIDENCE', 662), ('INCOMPLETE_EVIDENCE', 675), ('PROBABLE_UNDERSTANDING', 807), ('INCOMPLETE_EVIDENCE', 814), ('SUPERFICIAL_RELATIONSHIP', 823), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 844), ('INCOMPLETE_EVIDENCE', 855), ('SUPERFICIAL_RELATIONSHIP', 869), ('INCOMPLETE_EVIDENCE', 881), ('FULL_UNKNOWN', 884), ('PROBABLE_UNDERSTANDING', 934), ('FUTURE_WORK', 939), ('FUTURE_WORK', 967)]	29	[('SO_0000704', 'gene', 18, 'genetic'), ('CHEBI_33229', 'vitamin (role)', 347, 'vitamin'), ('CHEBI_25179', 'melanins', 371, 'melanin'), ('CHEBI_27300', 'vitamin D', 417, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 530, 'vitamin D'), ('GO_0007565', 'female pregnancy', 554, 'pregnant'), ('GO_0007399', 'nervous system development', 597, 'neurodevelopment'), ('UBERON_0007023', 'adult organism', 631, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 650, 'rats'), ('CHEBI_27300', 'vitamin D', 703, 'vitamin D'), ('UBERON_0000104', 'life cycle', 778, 'life'), ('CHEBI_27300', 'vitamin D', 783, 'vitamin D')]
PMC4998950	4/2016	S23-PMC4998950	['lastly, we EVALUATED WHETHER lifetime maternal Vitamin D deficiency was DIFFERENTLY ASSOCIATED with asd among children with and without maternal histories of migration.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 21), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 72), ('SUPERFICIAL_RELATIONSHIP', 84)]	4	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC4998950	4/2016	S37-PMC4998950	['second, maternal Vitamin D status was IDENTIFIED from secondary care records, and THEREFORE under-ascertained and PERHAPS DIFFERENTIALLY so with regard to asd RISK FACTORS.']	[('INCOMPLETE_EVIDENCE', 38), ('PROBABLE_UNDERSTANDING', 82), ('INCOMPLETE_EVIDENCE', 114), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('SUPERFICIAL_RELATIONSHIP', 159)]	5	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D')]
PMC4998950	4/2016	S38-PMC4998950	['indeed, diagnosed maternal Vitamin D deficiency CO-OCCURRED with such FACTORS including parental psychiatric histories10(including depression, a PROXY also for in utero exposure to Antidepressants, shown to, RATHER than the underlying disorder, increase the risk of asd),11immigration status3and disadvantageous social position.8hence, residual CONFOUNDING CANNOT BE ruled out.']	[('SUPERFICIAL_RELATIONSHIP', 48), ('IMPORTANT_CONSIDERATION', 50), ('SUPERFICIAL_RELATIONSHIP', 51), ('SUPERFICIAL_RELATIONSHIP', 70), ('SUPERFICIAL_RELATIONSHIP', 145), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 208), ('PROBLEM_COMPLICATION', 345), ('DIFFICULT_TASK', 357)]	8	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_35475', 'non-steroidal anti-inflammatory drug', 181, 'antidepressants')]
PMC4998950	4/2016	S42-PMC4998950	['HOWEVER, given that Vitamin D deficiency among Pregnant women in sweden is detected ONLY when outright screened for,12many cases of deficiency are LIKELY to manifest well before any official diagnosis is recorded.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 84), ('PROBABLE_UNDERSTANDING', 147)]	3	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0007565', 'female pregnancy', 47, 'pregnant')]
PMC4998950	4/2016	S43-PMC4998950	['our finding of a stronger ASSOCIATION between maternal hypovitaminosis d and asd with intellectual disability than without intellectual disability is IN LINE WITH migrant STUDIES, DEMONSTRATING that offspring risk of severe forms of asd – BUT NOT asperger’s syndrome or asd without intellectual disability – is increased in migrant populations where Vitamin D deficiency is highly prevalent.3–6,8there is also MOUNTING EVIDENCE that environmental FACTORS are more RELEVANT (THAN Genetic factors) for the development of lower-functioning asd.2we, as well as others,6FURTHER OBSERVED heterogeneity in the ASSOCIATIONS between Vitamin D deficiency and asd between children with and without maternal migrant history.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 150), ('INCOMPLETE_EVIDENCE', 171), ('INCOMPLETE_EVIDENCE', 180), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 239), ('ANOMALY_CURIOUS_FINDING', 239), ('INCOMPLETE_EVIDENCE', 410), ('SUPERFICIAL_RELATIONSHIP', 447), ('IMPORTANT_CONSIDERATION', 464), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 474), ('INCOMPLETE_EVIDENCE', 564), ('INCOMPLETE_EVIDENCE', 573), ('SUPERFICIAL_RELATIONSHIP', 603)]	13	[('CHEBI_27300', 'vitamin D', 350, 'vitamin D'), ('SO_0000704', 'gene', 479, 'genetic'), ('CHEBI_27300', 'vitamin D', 624, 'vitamin D')]
PMC4998950	4/2016	S44-PMC4998950	['this DISCREPANCY MIGHT be DUE TO a limited range of exposure in children of immigrant mothers, AS the majority of children and Pregnant mothers with migrant background have neonatal/Gestational Vitamin D deficiency, ACCORDING TO RECENT swedish REPORTS.6,11\ncausality cannot be inferred from our study.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('INCOMPLETE_EVIDENCE', 17), ('PROBLEM_COMPLICATION', 26), ('PROBABLE_UNDERSTANDING', 95), ('INCOMPLETE_EVIDENCE', 216), ('INCOMPLETE_EVIDENCE', 229), ('INCOMPLETE_EVIDENCE', 244)]	7	[('GO_0007565', 'female pregnancy', 127, 'pregnant'), ('GO_0007565', 'female pregnancy', 182, 'gestational'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D')]
PMC4998950	4/2016	S45-PMC4998950	['there are, HOWEVER, biological UNDERPINNINGS of a TRUE ASSOCIATION AS experimental studies INDICATE CRITICAL ROLES of Vitamin D in the Development and functioning Of the Brain.4\nIN SUMMARY, our results SUPPORT, BUT DO NOT PROVE, the HYPOTHESIS that maternal Vitamin D status is IMPLICATED in the aetiology of asd with comorbid intellectual disability.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('SUPERFICIAL_RELATIONSHIP', 31), ('PROBABLE_UNDERSTANDING', 50), ('SUPERFICIAL_RELATIONSHIP', 55), ('PROBABLE_UNDERSTANDING', 67), ('INCOMPLETE_EVIDENCE', 91), ('IMPORTANT_CONSIDERATION', 100), ('SUPERFICIAL_RELATIONSHIP', 109), ('INCOMPLETE_EVIDENCE', 178), ('INCOMPLETE_EVIDENCE', 202), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 211), ('FULL_UNKNOWN', 215), ('INCOMPLETE_EVIDENCE', 233), ('SUPERFICIAL_RELATIONSHIP', 278)]	14	[('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0050887', 'determination of sensory modality', 135, 'development ... of ... brain'), ('UBERON_0000955', 'brain', 170, 'brain'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D')]
PMC5014971	8/2016	S1-PMC5014971	['RECOMMENDATIONS for adequate levels of circulating 25-Hydroxyvitamin D and appropriate Vitamin D supplementation during Pregnancy DIFFER between the institute of medicine and the Endocrine society.']	[('FUTURE_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 130)]	2	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 51, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0007565', 'female pregnancy', 120, 'pregnancy'), ('UBERON_0005063', 'left ventricular compact myocardium', 179, 'Endocrine')]
PMC5014971	8/2016	S12-PMC5014971	['our species evolved under circumstances of extensive sun exposure, so in the evolutionary sense Vitamin D was not a TRUE Vitamin but RATHER an endogenously Photosynthetically produced precursor to the active Steroid hormone (1,25-Dihydroxyvitamin D).']	[('PROBABLE_UNDERSTANDING', 116), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 133)]	2	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 121, 'vitamin'), ('GO_0007602', 'phototransduction', 156, 'photosynthetically'), ('CHEBI_35341', 'steroid', 208, 'steroid'), ('CHEBI_67472', '15-epi-lupulin B', 225, '1,25-dihydroxyvitamin D')]
PMC5014971	8/2016	S20-PMC5014971	['in SOME populations, especially during the winter months in higher latitudes, the proportion of Pregnant women with INADEQUATE Vitamin D status MAY exceed 50% [13], DEPENDING ON whose definition of INADEQUATE is used.']	[('INCOMPLETE_EVIDENCE', 3), ('IMPORTANT_CONSIDERATION', 116), ('INCOMPLETE_EVIDENCE', 144), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 165), ('PROBLEM_COMPLICATION', 198)]	5	[('GO_0007565', 'female pregnancy', 96, 'pregnant'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
PMC5014971	8/2016	S21-PMC5014971	['there is SOME uncertainty over the extent of the us population that has INADEQUATE Vitamin D status DUE TO DISAGREEMENTS between experts as to WHAT constitutes INADEQUATE status.']	[('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 72), ('PROBLEM_COMPLICATION', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 107), ('EXPLICIT_QUESTION', 143), ('IMPORTANT_CONSIDERATION', 160)]	6	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
PMC5014971	8/2016	S24-PMC5014971	['other researchers have QUESTIONED this FINDING, citing both a CONCERN that circulating levels of 25-Oh-D at 20\u2009ng/ml have not been shown to be sufficient for bone health for all populations and that OTHER nonskeletal functions of Vitamin D POTENTIALLY IMPORTANT for health, which the iom report DISCOUNTS BASED ON INADEQUATE evidence, MAY yet be shown to be IMPORTANT and REQUIRE higher circulating levels of 25-Oh-D [17,18].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 39), ('IMPORTANT_CONSIDERATION', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 199), ('INCOMPLETE_EVIDENCE', 240), ('IMPORTANT_CONSIDERATION', 252), ('INCOMPLETE_EVIDENCE', 295), ('PROBABLE_UNDERSTANDING', 305), ('ANOMALY_CURIOUS_FINDING', 311), ('IMPORTANT_CONSIDERATION', 314), ('PROBLEM_COMPLICATION', 314), ('INCOMPLETE_EVIDENCE', 335), ('IMPORTANT_CONSIDERATION', 358), ('IMPORTANT_CONSIDERATION', 372)]	15	[('CHEBI_46744', 'DDT-2,3-dihydrodiol', 97, '25-OH-D'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 409, '25-OH-D')]
PMC5014971	8/2016	S26-PMC5014971	['the two groups also RECOMMEND DIFFERENT levels of Vitamin D supplementation, IN LARGE PART DUE TO the DIFFERENT stable levels of circulating 25-Oh-D they are attempting to obtain.']	[('FUTURE_WORK', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('INCOMPLETE_EVIDENCE', 77), ('PROBABLE_UNDERSTANDING', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102)]	5	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 141, '25-OH-D')]
PMC5014971	8/2016	S32-PMC5014971	['screening for Vitamin D status is relatively easy and accurate [19], though there is a NONTRIVIAL cost.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 87)]	1	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D')]
PMC5014971	8/2016	S35-PMC5014971	['HOWEVER, CONSENSUS on WHAT constitutes adequate Vitamin D status during Pregnancy and the most efficacious means to prevent and treat Vitamin D deficiency/insufficiency in Pregnant women has yet to be reached, leading to DIFFERING assessments of this PUBLIC HEALTH ISSUE [14,19].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 9), ('EXPLICIT_QUESTION', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221), ('IMPORTANT_CONSIDERATION', 251), ('IMPORTANT_CONSIDERATION', 265)]	6	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007565', 'female pregnancy', 72, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0007565', 'female pregnancy', 172, 'pregnant')]
PMC5014971	8/2016	S63-PMC5014971	['less than half (45.5%) had read acog committee opinion 495 (co 495) on Vitamin D during Pregnancy, and opinion was split evenly among these physicians on WHETHER this committee opinion had changed their practice regarding Vitamin D screening and supplementation during Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 154)]	1	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0007565', 'female pregnancy', 88, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 222, 'vitamin D'), ('GO_0007565', 'female pregnancy', 269, 'pregnancy')]
PMC5014971	8/2016	S80-PMC5014971	['there was a LACK OF consensus of opinion among respondents regarding whether Pregnant women taking Prenatal Vitamins are at low RISK of Vitamin D deficiency, with equal proportions agreeing and disagreeing and the modal response being neutral.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('ANOMALY_CURIOUS_FINDING', 17), ('IMPORTANT_CONSIDERATION', 128)]	3	[('GO_0007565', 'female pregnancy', 77, 'pregnant'), ('GO_0007565', 'female pregnancy', 99, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 108, 'vitamins'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D')]
PMC5014971	8/2016	S81-PMC5014971	['most respondents were EITHER neutral (23.8%) OR DISAGREED (41.6%) with the following statement: most of my Pregnant patients will get enough Vitamin D through sun exposure and diet.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 48)]	2	[('GO_0007565', 'female pregnancy', 107, 'pregnant'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC5014971	8/2016	S98-PMC5014971	['there was a LACK OF CONSENSUS regarding the APPROPRIATE level of Vitamin D supplementation during Pregnancy and the value of circulating 25-Hydroxyvitamin D, below which there is CONCERN regarding Vitamin D insufficiency.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 44), ('IMPORTANT_CONSIDERATION', 179), ('PROBLEM_COMPLICATION', 179)]	5	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 98, 'pregnancy'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 137, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D')]
PMC5014971	8/2016	S100-PMC5014971	['there is CONTINUING CONTROVERSY over the APPROPRIATE levels of Vitamin D supplementation and of the levels of circulating 25-Hydroxyvitamin D that represent good health.']	[('FUTURE_WORK', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 20), ('IMPORTANT_CONSIDERATION', 41)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 122, '25-hydroxyvitamin D')]
PMC5014971	8/2016	S101-PMC5014971	['the result has been CONFLICTING RECOMMENDATIONS from the iom [14,15] and the Endocrine society [19], ESPECIALLY CONCERNING Vitamin D supplementation and APPROPRIATE levels of circulating 25-Oh-D during Pregnancy (table 4).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 20), ('FUTURE_WORK', 32), ('IMPORTANT_CONSIDERATION', 101), ('IMPORTANT_CONSIDERATION', 112), ('IMPORTANT_CONSIDERATION', 153)]	5	[('UBERON_0005063', 'left ventricular compact myocardium', 77, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 187, '25-OH-D'), ('GO_0007565', 'female pregnancy', 202, 'pregnancy')]
PMC5014971	8/2016	S108-PMC5014971	['EVEN researchers SKEPTICAL of the causality of Vitamin D EFFECTS on Pregnancy outcomes POINT to a knowledge deficit that NEEDS ADDRESSING, ESPECIALLY in areas such as maternal and neonatal infections (e.g., [21]).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 17), ('SUPERFICIAL_RELATIONSHIP', 57), ('INCOMPLETE_EVIDENCE', 87), ('FUTURE_WORK', 121), ('IMPORTANT_CONSIDERATION', 121), ('FUTURE_WORK', 127), ('IMPORTANT_CONSIDERATION', 139)]	8	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy')]
PMC5014971	8/2016	S111-PMC5014971	['a RECENT STUDY on a mother-offspring cohort in singapore FOUND NO EVIDENCE for an effect of Vitamin D status on Birth outcome, THOUGH the authors CAUTION that the population had a low prevalence of Vitamin D deficiency/insufficiency and THUS they MAY NOT HAVE BEEN able to detect small EFFECTS [29].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 63), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('ANOMALY_CURIOUS_FINDING', 127), ('INCOMPLETE_EVIDENCE', 146), ('PROBABLE_UNDERSTANDING', 237), ('INCOMPLETE_EVIDENCE', 247), ('INCOMPLETE_EVIDENCE', 255), ('SUPERFICIAL_RELATIONSHIP', 286)]	10	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007567', 'parturition', 112, 'birth'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D')]
PMC5014971	8/2016	S117-PMC5014971	['the CONFLICT between researchers and experts in Vitamin D Metabolism During Pregnancy APPEARS TO BE reflected in the clinical practice of obstetrician-gynecologists.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('ANOMALY_CURIOUS_FINDING', 86)]	2	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0044694', 'pore-mediated entry of viral genome into host cell', 48, 'vitamin D metabolism during'), ('GO_0007565', 'female pregnancy', 76, 'pregnancy')]
PMC5014971	8/2016	S124-PMC5014971	['dark skin pigmentation, AS OPPOSED TO african heritage per se, is a RISK FACTOR for poor Vitamin D status, especially in higher latitudes where sun intensity decreases outside of the summer months.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('SUPERFICIAL_RELATIONSHIP', 68)]	2	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC5024513	9/2016	S36-PMC5024513	['HOWEVER the author CONCLUDED that there was SOME consensus in the AVAILABLE LITERATURE that Pregnant adolescents had intakes of energy, iron, Folate, Calcium, Vitamin E and magnesium which were below the dietary RECOMMENDED intakes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 66), ('FUTURE_WORK', 212)]	5	[('GO_0007565', 'female pregnancy', 92, 'pregnant'), ('CHEBI_30863', '5-azaorotic acid', 142, 'folate'), ('CHEBI_22313', 'alkaline earth metal atom', 150, 'calcium'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin E')]
PMC5024513	9/2016	S106-PMC5024513	['results of the pooled analyses HOWEVER SHOWED that ONLY intake of Vitamin D remained significantly below both the uk rni and us rda, and intakes of potassium below the us rda.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('ANOMALY_CURIOUS_FINDING', 31), ('INCOMPLETE_EVIDENCE', 39), ('ANOMALY_CURIOUS_FINDING', 51)]	4	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC5024513	9/2016	S107-PMC5024513	['sub-group analysis SHOWED that Micronutrient intake was lower in uk based studies than those based in the usa for all Micronutrients with the EXCEPTION of Vitamin C, HOWEVER Vitamin D was the ONLY Micronutrient where the percentage of the Drv in uk based studies was below the uk rni (21.4\xa0%, ci 0–63.5\xa0%) and us rda (14.3\xa0%, ci 0–42.3\xa0%).']	[('INCOMPLETE_EVIDENCE', 19), ('ANOMALY_CURIOUS_FINDING', 142), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 166), ('INCOMPLETE_EVIDENCE', 192)]	4	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 31, 'micronutrient'), ('CHEBI_33839', 'macromolecule', 118, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 197, 'micronutrient'), ('UBERON_0004004', 'cerebellum lobule', 239, 'DRV')]
PMC5028238	10/2016	S83-PMC5028238	['in addition, BENEFITS from Prenatal Vitamin D supplementation are also Modulated by geographic location and OTHER FACTORS.47THEREFORE biological mechanisms that maximize Vitamin D production and absorption would be selected for in the north.']	[('IMPORTANT_CONSIDERATION', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 108), ('SUPERFICIAL_RELATIONSHIP', 114), ('ANOMALY_CURIOUS_FINDING', 122), ('ANOMALY_CURIOUS_FINDING', 122), ('ANOMALY_CURIOUS_FINDING', 122)]	6	[('GO_0007565', 'female pregnancy', 27, 'prenatal'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0065007', 'biological regulation', 71, 'modulated'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
PMC5028238	10/2016	S86-PMC5028238	['improved hip formation IS THOUGHT TO enable females to produce more offspring and thereby provide another carrier advantage.11,35in addition, Vitamin D HAS BEEN SHOWN to increase chances of Pregnancy for infertile women receiving in Vitro Fertilization.48vitamin d has many pleiotropic ROLES in Reproductive outcomes and CAN AFFECT both male and female Fertility.49THEREFORE, there COULD BE MULTIPLE mechanisms that COULD EXPLAIN WHY evolution favors Vitamin D Production in northern climates through mutations in Dhcr7 (and other Genes).']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 152), ('SUPERFICIAL_RELATIONSHIP', 286), ('INCOMPLETE_EVIDENCE', 321), ('SUPERFICIAL_RELATIONSHIP', 325), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 363), ('INCOMPLETE_EVIDENCE', 382), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 391), ('INCOMPLETE_EVIDENCE', 416), ('PROBABLE_UNDERSTANDING', 422), ('EXPLICIT_QUESTION', 430)]	12	[('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('GO_0007565', 'female pregnancy', 190, 'pregnancy'), ('GO_0007601', 'visual perception', 233, 'vitro'), ('GO_0009566', 'fertilization', 239, 'fertilization'), ('GO_0000003', 'reproduction', 295, 'reproductive'), ('GO_0009566', 'fertilization', 353, 'fertility'), ('CHEBI_27300', 'vitamin D', 451, 'vitamin D'), ('GO_0071611', 'granulocyte colony-stimulating factor production', 451, 'vitamin D production'), ('PR_000006474', 'ATP-dependent RNA helicase A', 514, 'DHCR7'), ('SO_0000704', 'gene', 531, 'genes')]
PMC5028238	10/2016	S89-PMC5028238	["the conversion Of 7-Dehydrocholesterol to Vitamin D occurs in the skin upon exposure to ultraviolet b light (290–320\u2009nm).50under normal sunlight conditions, ONLY around 15% of available 7-Dehydrocholesterol will be converted to Vitamin D, WHEREAS excess 7-Dehydrocholesterol in the skin will be converted to inert compounds for degradation.51,52dhcr7 is the sole enzyme used to convert 7-Dehydrocholesterol to Cholesterol.53a shortage of Dhcr7 would decrease the body's ability to convert 7-Dehydrocholesterol into Cholesterol thereby causing a build-up of 7-Dehydrocholesterol, which COULD BE converted into Vitamin D in the skin."]	[('ANOMALY_CURIOUS_FINDING', 157), ('INCOMPLETE_EVIDENCE', 157), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 239), ('INCOMPLETE_EVIDENCE', 585)]	4	[('GO_0007608', 'sensory perception of smell', 15, 'of ...'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 18, '7-dehydrocholesterol'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 186, '7-dehydrocholesterol'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 236, 'D'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 254, '7-dehydrocholesterol'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 386, '7-dehydrocholesterol'), ('CHEBI_16113', 'cholesterol', 410, 'cholesterol'), ('PR_000006474', 'ATP-dependent RNA helicase A', 438, 'DHCR7'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 489, '7-dehydrocholesterol'), ('CHEBI_16113', 'cholesterol', 515, 'cholesterol'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 557, '7-dehydrocholesterol'), ('CHEBI_27300', 'vitamin D', 609, 'vitamin D')]
PMC5028238	10/2016	S201-PMC5028238	["COMMENT on Vitamin D3's in-direct inhibition of Dhcr7\nOF NOTE, Vitamin D (Cholecalciferol) decreases the Dhcr7 activity through an indirect mechanism.54there HAS BEEN SOME SPECULATION on the POSSIBILITY of Teratogenic AFFECTS resulting from high doses of Vitamin D when taken as a Prenatal supplement.89HOWEVER, a RECENT REVIEW of Vitamin D supplementation among Pregnant women FOUND that Vitamin D supplementation MAY reduce the RISK of pre-eclampsia, low Birth weight, Preterm Birth90,91and adverse Kidney outcomes in offspring.92BECAUSE the mechanism of Vitamin D3's inhibition of Dhcr7 is indirect (UNLIKE our studied Pharmacological Dhcr7 Inhibitors) it is LIKELY to be MEDIATED through a COMPLEX pathway with many INTERACTING feedback loops."]	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 54), ('INCOMPLETE_EVIDENCE', 158), ('INCOMPLETE_EVIDENCE', 167), ('INCOMPLETE_EVIDENCE', 172), ('INCOMPLETE_EVIDENCE', 191), ('SUPERFICIAL_RELATIONSHIP', 218), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 301), ('INCOMPLETE_EVIDENCE', 314), ('INCOMPLETE_EVIDENCE', 378), ('INCOMPLETE_EVIDENCE', 415), ('IMPORTANT_CONSIDERATION', 430), ('PROBABLE_UNDERSTANDING', 530), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 603), ('PROBABLE_UNDERSTANDING', 662), ('SUPERFICIAL_RELATIONSHIP', 675), ('DIFFICULT_TASK', 694), ('SUPERFICIAL_RELATIONSHIP', 720)]	18	[('CHEBI_33279', 'vitamin D5', 11, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 11, 'vitamin D3'), ('PR_000006474', 'ATP-dependent RNA helicase A', 48, 'DHCR7'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_52550', 'theopalauamide', 74, 'cholecalciferol'), ('PR_000006474', 'ATP-dependent RNA helicase A', 105, 'DHCR7'), ('CHEBI_50905', 'teratogenic agent', 206, 'teratogenic'), ('GO_0031649', 'heat generation', 206, 'teratogenic'), ('CHEBI_27300', 'vitamin D', 255, 'vitamin D'), ('GO_0007565', 'female pregnancy', 281, 'prenatal'), ('CHEBI_27300', 'vitamin D', 331, 'vitamin D'), ('GO_0007565', 'female pregnancy', 363, 'pregnant'), ('CHEBI_27300', 'vitamin D', 389, 'vitamin D'), ('GO_0007567', 'parturition', 457, 'birth'), ('GO_0007565', 'female pregnancy', 471, 'preterm'), ('GO_0042633', 'hair cycle', 479, 'birth90'), ('UBERON_0002113', 'kidney', 501, 'kidney'), ('CHEBI_33279', 'vitamin D5', 557, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 557, 'vitamin D3'), ('PR_000006474', 'ATP-dependent RNA helicase A', 584, 'DHCR7'), ('CHEBI_52217', 'pharmaceutical', 622, 'pharmacological'), ('PR_000006474', 'ATP-dependent RNA helicase A', 638, 'DHCR7'), ('CHEBI_35222', 'inhibitor', 644, 'inhibitors')]
PMC5028238	10/2016	S202-PMC5028238	['studies involving moderate Prenatal Vitamin D supplementation HAVE REPORTED no adverse EFFECTS.89THEREFORE, we would not expect Vitamin D to result in slos-RELATED Teratogenic EFFECTS, ALTHOUGH ADDITIONAL STUDIES would BE NEEDED to ascertain the EFFECTS of large doses of Prenatal Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 62), ('SUPERFICIAL_RELATIONSHIP', 87), ('PROBABLE_UNDERSTANDING', 95), ('PROBABLE_UNDERSTANDING', 95), ('SUPERFICIAL_RELATIONSHIP', 156), ('SUPERFICIAL_RELATIONSHIP', 176), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 185), ('FUTURE_WORK', 194), ('FUTURE_WORK', 205), ('FUTURE_WORK', 219), ('SUPERFICIAL_RELATIONSHIP', 246)]	11	[('GO_0007565', 'female pregnancy', 27, 'prenatal'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('CHEBI_50905', 'teratogenic agent', 164, 'teratogenic'), ('GO_0007565', 'female pregnancy', 272, 'prenatal'), ('CHEBI_27300', 'vitamin D', 281, 'vitamin D')]
PMC5029041	9/2016	S112-PMC5029041	['multiple Micronutrient supplements decrease lbw, fgr and stillbirths [69]; HOWEVER, WHETHER deficiencies of Micronutrients such as zinc, Calcium and Vitamin A INTERACT with malaria in Pregnancy REMAINS UNCLEAR [70].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 84), ('SUPERFICIAL_RELATIONSHIP', 159), ('FULL_UNKNOWN', 194)]	4	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 9, 'micronutrient'), ('CHEBI_33839', 'macromolecule', 108, 'micronutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 137, 'calcium'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin A'), ('GO_0007565', 'female pregnancy', 184, 'pregnancy')]
PMC5030591	9/2016	S80-PMC5030591	["caption (table-wrap): table 4\n\nthemes and elements relating to specific Conception and Pregnancy information for women with rheumatoid arthritis and their familiessaying : information that should be discussed by health professionals doing : actions that SHOULD BE undertaken by health professionals review of current Medications in relation to safety during Conception and Pregnancy (100%) prior to Conception and Pregnancy, review current Medication(s) and discuss:\nmedications vary with respect to their SAFETY during Pregnancy and RISKS related to Fertility, Ovulation, Conception and Miscarriage\nSOME Medicines used in ra care MAY have EFFECTS on Fertility, Conception and Pregnancy process, for example, regular Nsaids MAY impair fertility and ASSOCIATED RISKS with fetus\nit is IMPORTANT to time Conceptionprovide GUIDANCE as to WHERE to obtain reliable information about SAFETY of Medicines in Pregnancywhere current Medication(s) is (are) contraindicated for Conception/Pregnancy the following SHOULD BE discussed with the patient:\nthere are SAFE Medication options pre, during (including Delivery) and Postpregnancy (including Breast feeding)\ntiming is IMPORTANT in RELATION to ceasing or switching of current Medications and allowing for washout periods prior to Conception\nthere is a need for close supervision/monitoring by a rheumatologist when discontinuing current Medications prior to Pregnancy, including CONSIDERING POTENTIAL NEED for disease stabilisation on new treatment prior to Conception and Pregnancydiscuss IMPACT of ra pathology on Pregnancy and Pregnancy on ra (100%) there are DIFFERENT SCENARIOS regarding ra disease activity during Pregnancy (eg, POSSIBLE remission/low disease activity)discuss: ra-related pain management options during Pregnancyconception MAY take longer compared with women who do not have rathere is a need to balance disease Control with maternal and fetal health and safetyra MAY AFFECT Pregnancy and Pregnancy MAY AFFECT ra, and there are POSSIBLE adverse outcomes where risks are identified (eg, Prematurity)there are significant risks ASSOCIATED with active or uncontrolled ra for the mother and baby, ESPECIALLY irreversible Joint damage and functional impairmentpregnancy MAY change a patient’s health outlook in the futurethe size of the baby MAY BE smaller than women without ra and MAY also be Delivered pre-term discuss IMPORTANT elements of Preconception care RELEVANT to patient (97.1%) it is IMPORTANT to achieve optimal disease control prior to considering Pregnancy—Planning Conception is preferable after patients achieve and maintain low disease activityencourage and facilitate early discussions with all health practitioners involved in care about family planning to allow for adequate preparationthere is a CRITICAL need for a planned Pregnancy RATHER than an unplanned Pregnancyreview Prenatal nutrition, including need for dietary/vitamin supplements (ie, Folic Acid, calcium, Vitamin D, Iodine, iron)history of previous Attempts To Conceive/Pregnancies or Pregnancy-related complications (eg, Miscarriage) and other relevant patient history (such as smoking/Illicit Drug use history, family history of hereditary issues) MAY AFFECT Pregnancyundertake RELEVANT health checks such as immunisation status (eg, rubella, varicella, pertussis), Sexually Transmitted disease screening, pap test, screening for other Autoimmune disorders that MAY IMPACT on Pregnancyweight management and appropriate exercise are very IMPORTANTCONSIDER the NEED for review of diabetes or impaired Glucose tolerance if RISK factors are present (eg, on Steroid medication or overweight/obese)it is IMPORTANT to manage comorbid conditions, such as diabetes and hypertensionsome women MAY NEED to avoid Conception during a flarera disease activity MAY or MAY not improve with Pregnancy and there is a LIKELIHOOD of Postpartum flares importance of maintaining optimistic outlook and providing positive messages (97.1%) Pregnancy and Breast feeding success rates are near normal in women with mild to moderate ra nowadays (where appropriate for the patient's clinical status)ra is not a BARRIER to Pregnancystrategies to address anxiety, stress and depression (if relevant) are IMPORTANT, such as mindfulness meditation need for close monitoring of a patient prior to and during Pregnancy, where indicated (94.1%) it is IMPORTANCE to have a healthcare team with expertise in Autoimmune disorders for SOME women with radetermine THE NEED for high-level obstetric care during a Pregnancy (where indicated), including the need for Anaesthetic inputsome women REQUIRE closer monitoring of their Pregnancy and this is USUALLY proportional to disease activity, comorbidities and maternal historyassess the REQUIREMENTS for any extra treatment or monitoring prior to, or during, Pregnancyit is IMPORTANT to develop a Pregnancy plan, which includes different options for management of ra and support for different scenariosvaginal Delivery MAY NOT always BE POSSIBLE, depending on condition of the patient's Hips."]	[('FUTURE_WORK', 254), ('IMPORTANT_CONSIDERATION', 506), ('IMPORTANT_CONSIDERATION', 534), ('INCOMPLETE_EVIDENCE', 600), ('INCOMPLETE_EVIDENCE', 631), ('SUPERFICIAL_RELATIONSHIP', 640), ('INCOMPLETE_EVIDENCE', 724), ('SUPERFICIAL_RELATIONSHIP', 749), ('IMPORTANT_CONSIDERATION', 760), ('IMPORTANT_CONSIDERATION', 783), ('FUTURE_WORK', 819), ('EXPLICIT_QUESTION', 834), ('IMPORTANT_CONSIDERATION', 877), ('FUTURE_WORK', 1001), ('IMPORTANT_CONSIDERATION', 1049), ('IMPORTANT_CONSIDERATION', 1161), ('SUPERFICIAL_RELATIONSHIP', 1174), ('FUTURE_WORK', 1421), ('IMPORTANT_CONSIDERATION', 1421), ('INCOMPLETE_EVIDENCE', 1433), ('SUPERFICIAL_RELATIONSHIP', 1532), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1605), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1615), ('INCOMPLETE_EVIDENCE', 1677), ('INCOMPLETE_EVIDENCE', 1788), ('INCOMPLETE_EVIDENCE', 1929), ('SUPERFICIAL_RELATIONSHIP', 1933), ('INCOMPLETE_EVIDENCE', 1964), ('SUPERFICIAL_RELATIONSHIP', 1968), ('INCOMPLETE_EVIDENCE', 1993), ('SUPERFICIAL_RELATIONSHIP', 2091), ('IMPORTANT_CONSIDERATION', 2158), ('INCOMPLETE_EVIDENCE', 2230), ('INCOMPLETE_EVIDENCE', 2302), ('INCOMPLETE_EVIDENCE', 2343), ('IMPORTANT_CONSIDERATION', 2382), ('SUPERFICIAL_RELATIONSHIP', 2423), ('IMPORTANT_CONSIDERATION', 2457), ('IMPORTANT_CONSIDERATION', 2779), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2817), ('INCOMPLETE_EVIDENCE', 3196), ('SUPERFICIAL_RELATIONSHIP', 3200), ('IMPORTANT_CONSIDERATION', 3226), ('INCOMPLETE_EVIDENCE', 3410), ('SUPERFICIAL_RELATIONSHIP', 3414), ('IMPORTANT_CONSIDERATION', 3485), ('INCOMPLETE_EVIDENCE', 3507), ('SUPERFICIAL_RELATIONSHIP', 3568), ('IMPORTANT_CONSIDERATION', 3646), ('INCOMPLETE_EVIDENCE', 3731), ('FUTURE_WORK', 3735), ('IMPORTANT_CONSIDERATION', 3735), ('INCOMPLETE_EVIDENCE', 3794), ('INCOMPLETE_EVIDENCE', 3801), ('PROBABLE_UNDERSTANDING', 3847), ('DIFFICULT_TASK', 4131), ('IMPORTANT_CONSIDERATION', 4222), ('IMPORTANT_CONSIDERATION', 4364), ('INCOMPLETE_EVIDENCE', 4444), ('INCOMPLETE_EVIDENCE', 4472), ('IMPORTANT_CONSIDERATION', 4600), ('INCOMPLETE_EVIDENCE', 4657), ('IMPORTANT_CONSIDERATION', 4744), ('IMPORTANT_CONSIDERATION', 4831), ('INCOMPLETE_EVIDENCE', 4976), ('DIFFICULT_TASK', 4980)]	66	[('GO_0007631', 'feeding behavior', 72, 'conception ...'), ('GO_0007565', 'female pregnancy', 87, 'pregnancy'), ('CHEBI_25441', 'mycothiols', 317, 'medications'), ('GO_0007620', 'copulation', 358, 'conception'), ('GO_0007565', 'female pregnancy', 373, 'pregnancy'), ('GO_0007620', 'copulation', 399, 'conception'), ('GO_0007565', 'female pregnancy', 414, 'pregnancy'), ('CHEBI_60211', 'compound Z', 440, 'medication'), ('GO_0007565', 'female pregnancy', 520, 'pregnancy'), ('GO_0009566', 'fertilization', 551, 'fertility'), ('GO_0030728', 'ovulation', 562, 'ovulation'), ('GO_0007620', 'copulation', 573, 'conception'), ('GO_0046660', 'female sex differentiation', 588, 'miscarriage'), ('CHEBI_25179', 'melanins', 605, 'medicines'), ('GO_0009566', 'fertilization', 651, 'fertility'), ('GO_0007620', 'copulation', 662, 'conception'), ('GO_0007565', 'female pregnancy', 677, 'pregnancy'), ('CHEBI_16039', 'ITP', 717, 'NSAIDs'), ('GO_0070268', 'cornification', 801, 'conceptionProvide'), ('CHEBI_25179', 'melanins', 887, 'medicines'), ('GO_0000712', 'resolution of meiotic recombination intermediates', 900, 'pregnancyWhere'), ('CHEBI_60211', 'compound Z', 923, 'medication'), ('GO_0007620', 'copulation', 966, 'conception'), ('GO_0007565', 'female pregnancy', 977, 'pregnancy'), ('CHEBI_60211', 'compound Z', 1054, 'medication'), ('GO_0007567', 'parturition', 1096, 'delivery'), ('GO_0007565', 'female pregnancy', 1110, 'postpregnancy'), ('UBERON_0000310', 'breast', 1135, 'breast'), ('CHEBI_25441', 'mycothiols', 1218, 'medications'), ('GO_0007620', 'copulation', 1272, 'conception'), ('CHEBI_25441', 'mycothiols', 1379, 'medications'), ('GO_0007565', 'female pregnancy', 1400, 'pregnancy'), ('GO_0007620', 'copulation', 1500, 'conception'), ('GO_0006915', 'apoptotic process', 1515, 'pregnancyDiscuss'), ('GO_0007565', 'female pregnancy', 1558, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1572, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1662, 'pregnancy'), ('GO_0007602', 'phototransduction', 1768, 'pregnancyConception'), ('GO_0065007', 'biological regulation', 1877, 'control'), ('GO_0007565', 'female pregnancy', 1940, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1954, 'pregnancy'), ('GO_0007565', 'female pregnancy', 2051, 'prematurity'), ('UBERON_0004905', 'articulation', 2182, 'joint'), ('GO_0007567', 'parturition', 2355, 'delivered'), ('GO_0007565', 'female pregnancy', 2404, 'preconception'), ('GO_0007565', 'female pregnancy', 2523, 'pregnancy'), ('GO_0006260', 'DNA replication', 2533, 'planning'), ('GO_0007620', 'copulation', 2542, 'conception'), ('GO_0007565', 'female pregnancy', 2807, 'pregnancy'), ('GO_0006412', 'translation', 2842, 'pregnancyReview'), ('GO_0007565', 'female pregnancy', 2858, 'prenatal'), ('CHEBI_30751', 'formic acid', 2930, 'folic acid'), ('CHEBI_27300', 'vitamin D', 2951, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 2962, 'iodine'), ('GO_0000380', 'alternative mRNA splicing, via spliceosome', 2995, 'attempts to conceive'), ('GO_0007565', 'female pregnancy', 3016, 'pregnancies'), ('GO_0007565', 'female pregnancy', 3031, 'pregnancy'), ('GO_0046660', 'female sex differentiation', 3068, 'miscarriage'), ('CHEBI_35704', 'N(2)-acetyl-L-lysine', 3133, 'illicit drug'), ('GO_0051610', 'serotonin uptake', 3207, 'pregnancyUndertake'), ('GO_0019095', 'pole plasm mitochondrial rRNA localization', 3314, 'sexually transmitted'), ('UBERON_0001442', 'skeleton of manus', 3384, 'autoimmune'), ('GO_0006412', 'translation', 3424, 'pregnancyWeight'), ('CHEBI_17234', 'glucose', 3547, 'glucose'), ('CHEBI_35341', 'steroid', 3601, 'steroid'), ('GO_0007620', 'copulation', 3749, 'conception'), ('GO_0007565', 'female pregnancy', 3822, 'pregnancy'), ('GO_0007565', 'female pregnancy', 3861, 'postpartum'), ('GO_0007565', 'female pregnancy', 3964, 'Pregnancy'), ('UBERON_0000310', 'breast', 3978, 'breast'), ('GO_0006915', 'apoptotic process', 4142, 'pregnancyStrategies'), ('GO_0007565', 'female pregnancy', 4323, 'pregnancy'), ('UBERON_0001442', 'skeleton of manus', 4419, 'autoimmune'), ('GO_0007565', 'female pregnancy', 4520, 'pregnancy'), ('CHEBI_38867', 'anaesthetic', 4572, 'anaesthetic'), ('GO_0007565', 'female pregnancy', 4635, 'pregnancy'), ('GO_0007565', 'female pregnancy', 4816, 'pregnancyIt'), ('GO_0007565', 'female pregnancy', 4854, 'pregnancy'), ('GO_0007567', 'parturition', 4967, 'delivery'), ('UBERON_0000988', 'pons', 5044, 'hips')]
PMC5035678	4/2016	S115-PMC5035678	['HOWEVER, there is SCARCE INFORMATION about the EFFECT of Vitamin D supplementation on Glucose Metabolism, especially during Pregnancy and after Delivery.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 47)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_17234', 'glucose', 86, 'glucose'), ('GO_0006006', 'glucose metabolic process', 86, 'glucose metabolism'), ('GO_0007565', 'female pregnancy', 124, 'pregnancy'), ('GO_0007567', 'parturition', 144, 'delivery')]
PMC5035678	4/2016	S129-PMC5035678	['IN CONTRAST WITH OUR STUDY, in which all patients were evaluated for basal Vitamin D insufficiency or deficiency, the proportion of the patients with initial hypovitaminosis was not clarified in the asemi study.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 17)]	2	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC5035678	4/2016	S132-PMC5035678	['they FOUND that high dose supplementation for a mean of 14 weeks during Pregnancy was not beneficial to the patients’ plasma Glucose level or Insulin resistance during Pregnancy, BUT that their babies BENEFITTED from the supplementation with decreased neonatal hypovitaminosis D. the authors CONCLUDED that the commencement of Vitamin D supplementation MAY HAVE been too late to cause any observable EFFECTS on Β-Cell function, and they SUGGESTED that earlier supplementation, EVEN before Pregnancy, MIGHT be EFFECTIVE.']	[('INCOMPLETE_EVIDENCE', 5), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 179), ('IMPORTANT_CONSIDERATION', 201), ('INCOMPLETE_EVIDENCE', 292), ('INCOMPLETE_EVIDENCE', 353), ('IMPORTANT_CONSIDERATION', 357), ('SUPERFICIAL_RELATIONSHIP', 400), ('INCOMPLETE_EVIDENCE', 437), ('ANOMALY_CURIOUS_FINDING', 477), ('INCOMPLETE_EVIDENCE', 500), ('SUPERFICIAL_RELATIONSHIP', 509)]	11	[('GO_0007565', 'female pregnancy', 72, 'pregnancy'), ('CHEBI_17234', 'glucose', 125, 'glucose'), ('PR_000045358', 'insulin family protein', 142, 'insulin'), ('GO_0007565', 'female pregnancy', 168, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 277, 'D'), ('CHEBI_27300', 'vitamin D', 327, 'vitamin D'), ('CL_0000623', 'natural killer cell', 411, 'β-cell'), ('GO_0007565', 'female pregnancy', 489, 'pregnancy')]
PMC5039809	10/2016	S0-PMC5039809	['maternal Serum Retinol and Β-Carotene concentrations and neonatal bone mineralization: results from the southampton women’s survey cohort\n\nabstract\nbackground: studies in older Adults and Animals have SUGGESTED CONTRASTING RELATIONS between bone health and DIFFERENT Vitamin A Compounds.']	[('INCOMPLETE_EVIDENCE', 201), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 211), ('SUPERFICIAL_RELATIONSHIP', 223), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 257)]	4	[('UBERON_0001977', 'blood serum', 9, 'serum'), ('CHEBI_26536', 'retinoic acid', 15, 'retinol'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 27, 'β-carotene'), ('UBERON_0007023', 'adult organism', 177, 'adults'), ('NCBITaxon_33208', 'Metazoa', 188, 'animals'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin A'), ('CHEBI_36357', 'polyatomic entity', 277, 'compounds')]
PMC5039809	10/2016	S17-PMC5039809	['THERE IS EVIDENCE in Adults that Vitamin A intake is ASSOCIATED with measures of bone health, BUT NOTABLY, the DIFFERENT forms of dietary Vitamin A HAVE BEEN demonstrated to have OPPOSING ASSOCIATIONS with fracture risk (6).']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 53), ('ANOMALY_CURIOUS_FINDING', 94), ('ANOMALY_CURIOUS_FINDING', 98), ('IMPORTANT_CONSIDERATION', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('INCOMPLETE_EVIDENCE', 148), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 179), ('SUPERFICIAL_RELATIONSHIP', 188)]	9	[('UBERON_0007023', 'adult organism', 21, 'adults'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin A')]
PMC5039809	10/2016	S103-PMC5039809	['in the final analyses, maternal Vitamin D status in late Pregnancy was included in the MODELS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 87)]	1	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007565', 'female pregnancy', 57, 'pregnancy')]
PMC5039809	10/2016	S109-PMC5039809	['PREVIOUS intervention STUDIES have NOT CONSISTENTLY DEMONSTRATED that Prenatal Vitamin A supplementation CAN increase Birth size.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('INCOMPLETE_EVIDENCE', 52), ('INCOMPLETE_EVIDENCE', 105)]	4	[('GO_0007565', 'female pregnancy', 70, 'prenatal'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin A'), ('GO_0007567', 'parturition', 118, 'birth')]
PMC5039809	10/2016	S110-PMC5039809	['HOWEVER, these STUDIES have TYPICALLY been performed in developing countries with a high prevalence of Vitamin A deficiency, and MANY have used an interventional product containing both Retinol and Β-Carotene (17).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 15), ('PROBABLE_UNDERSTANDING', 28), ('INCOMPLETE_EVIDENCE', 129)]	4	[('CHEBI_27300', 'vitamin D', 103, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 186, 'retinol'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 198, 'β-carotene')]
PMC5039809	10/2016	S115-PMC5039809	['the RELATIONS between Vitamin A nutrition, assessed by an ffq or Serum measurements, and fracture risk or bmd in Adults are INCONSISTENT (18), BUT in a RECENT meta-analysis wu et al.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 143), ('INCOMPLETE_EVIDENCE', 152)]	4	[('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('UBERON_0001977', 'blood serum', 65, 'serum'), ('UBERON_0007023', 'adult organism', 113, 'adults')]
PMC5045784	10/2016	S67-PMC5045784	['the ASSOCIATION between low Vitamin D levels and Respiratory morbidity as SEEN in older children and Adults MAY BE DUE TO DIFFERENT pathology than that SEEN in bpd, which is characterized by Alveolar simplification and impaired septation.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 108), ('PROBLEM_COMPLICATION', 115), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('INCOMPLETE_EVIDENCE', 152)]	6	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 49, 'respiratory'), ('UBERON_0007023', 'adult organism', 101, 'adults'), ('UBERON_0003215', 'alveolus', 191, 'alveolar')]
PMC5045784	10/2016	S79-PMC5045784	['HOWEVER, these studies DID NOT address the ROLE of Vitamin D status in bpd, wheezing and asthma among preterm infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 43)]	3	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC5045784	10/2016	S91-PMC5045784	['in CONCLUSION, we FOUND that low 25(Oh)D levels (<30\u2009ng\u2009ml−1) are frequent and MODIFIABLE among preterm infants at Birth, HOWEVER, in our study samples we did not detect any association between Vitamin D status and Pulmonary or other morbidities of prematurity.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 18), ('IMPORTANT_CONSIDERATION', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122)]	4	[('CHEBI_71657', 'versiconol acetate', 33, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 39, 'D'), ('GO_0007567', 'parturition', 115, 'birth'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('UBERON_0002048', 'lung', 215, 'pulmonary')]
PMC5051327	9/2016	S11-PMC5051327	['IF OUR FINDINGS are SUPPORTED by FURTHER STUDIES, PREFERABLY on SEVERE Birth asphyxia, Vitamin D supplementation/sun exposure in Pregnancy MAY lower the risk of subsequent Birth asphyxia.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 20), ('FUTURE_WORK', 33), ('PROBABLE_UNDERSTANDING', 50), ('IMPORTANT_CONSIDERATION', 64), ('INCOMPLETE_EVIDENCE', 139)]	7	[('GO_0007567', 'parturition', 71, 'birth'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy'), ('GO_0007567', 'parturition', 172, 'birth')]
PMC5051327	9/2016	S17-PMC5051327	['introduction\nVitamin D is NECESSARY for optimal Skeletal function and deficiency is RELATED to rachitis.1\nit is, HOWEVER, IMPORTANT for bone Metabolism, as well as for optimal function of Striated and Smooth Muscle strength including Heart Muscle, and is RELATED to Postnatal muscle strength.2vitamin D supplementation has a positive IMPACT on muscle strength on Individuals with Vitamin D deficiency.134THE institute of medicine (iom), usa RECOMMENDS daily nutritional intake of Vitamin D of 600\u2005u, BUT OTHERS RECOMMEND higher doses.56a RECENT swedish STUDY SHOWED that the mean nutritional intake of Vitamin D was <200\u2005u/day.7ALTHOUGH Vitamin D is found in low amounts in the diet, mainly in oily fish and egg, the primary source of Vitamin D for Humans is skin conversion to Vitamin D from solar ultraviolet radiation.1pregnant women residing at high latitudes are AT RISK of Vitamin D deficiency BECAUSE of low solar intensity, especially during the winter months.18vitamin D deficiency is common in the nordic countries, ESPECIALLY among those not exposing themselves to the sun.8since fetal Vitamin D levels are directly RELATED to that of their mothers there is also a high LIKELIHOOD of fetal Vitamin D deficiency in our population.9\nBirth asphyxia is ASSOCIATED with Cardiovascular dysfunction, including low Ventricular output, lower left Ventricular Ejection fraction and increased troponin levels.1011congestive Heart failure MAY occur in severe cases of asphyxia.12intrauterine fetal distress is RELATED to an increase in Blood pressure, redistribution and a change in fetal Heart rate pattern.']	[('IMPORTANT_CONSIDERATION', 26), ('SUPERFICIAL_RELATIONSHIP', 84), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113), ('IMPORTANT_CONSIDERATION', 122), ('SUPERFICIAL_RELATIONSHIP', 255), ('SUPERFICIAL_RELATIONSHIP', 334), ('INCOMPLETE_EVIDENCE', 401), ('FUTURE_WORK', 441), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 500), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 504), ('FUTURE_WORK', 511), ('INCOMPLETE_EVIDENCE', 538), ('INCOMPLETE_EVIDENCE', 559), ('ANOMALY_CURIOUS_FINDING', 627), ('IMPORTANT_CONSIDERATION', 868), ('PROBABLE_UNDERSTANDING', 900), ('ANOMALY_CURIOUS_FINDING', 1026), ('SUPERFICIAL_RELATIONSHIP', 1127), ('PROBABLE_UNDERSTANDING', 1181), ('SUPERFICIAL_RELATIONSHIP', 1260), ('INCOMPLETE_EVIDENCE', 1438), ('SUPERFICIAL_RELATIONSHIP', 1509)]	22	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('UBERON_0004288', 'skeleton', 48, 'skeletal'), ('GO_0008152', 'metabolic process', 141, 'metabolism'), ('UBERON_0002435', 'striatum', 188, 'striated'), ('UBERON_0001135', 'smooth muscle tissue', 201, 'smooth muscle'), ('UBERON_0001133', 'cardiac muscle tissue', 234, 'heart muscle'), ('GO_0007567', 'parturition', 266, 'postnatal'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 301, 'D'), ('NCBITaxon_1', 'root', 363, 'individuals'), ('CHEBI_27300', 'vitamin D', 380, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 480, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 602, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 637, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 735, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 749, 'humans'), ('CHEBI_27300', 'vitamin D', 778, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 879, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 978, 'D'), ('CHEBI_27300', 'vitamin D', 1097, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1201, 'vitamin D'), ('GO_0007567', 'parturition', 1242, 'Birth'), ('UBERON_0004535', 'cardiovascular system', 1276, 'cardiovascular'), ('UBERON_0002082', 'cardiac ventricle', 1318, 'ventricular'), ('UBERON_0002082', 'cardiac ventricle', 1349, 'ventricular'), ('UBERON_0000970', 'eye', 1361, 'ejection'), ('UBERON_0000948', 'heart', 1424, 'heart'), ('UBERON_0000178', 'blood', 1535, 'blood'), ('UBERON_0000948', 'heart', 1588, 'heart')]
PMC5051327	9/2016	S20-PMC5051327	['the primary AIM of this PILOT STUDY was TO INVESTIGATE 25-Oh Vitamin D, the main MARKER of Vitamin D status, in women who underwent caesarean section DUE to suspected fetal distress COMPARED TO those who did not.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 40), ('SUPERFICIAL_RELATIONSHIP', 81), ('IMPORTANT_CONSIDERATION', 150), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182)]	6	[('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 55, '25-OH'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
PMC5051327	9/2016	S52-PMC5051327	['discussion\nTHIS PILOT STUDY is the FIRST to SHOW that women who underwent emergency caesarean section due to suspected fetal asphyxia had lower Vitamin D levels in early Pregnancy as COMPARED TO a control group.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 183)]	5	[('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('GO_0007565', 'female pregnancy', 170, 'pregnancy')]
PMC5051327	9/2016	S55-PMC5051327	['beside the two STUDIES SHOWING increased caesarean Delivery rate with low Vitamin D levels,1415a large STUDY with Blood drawn in early Pregnancy SHOWED no difference between caesarean and Vaginal Delivery depending on Vitamin D levels after adjustments.22HOWEVER, in the subgroup of women with caesarean Delivery due to fetal distress (n=46), the median 25-Oh Vitamin D level was 32.9\u2005nmol/l, as compared to 46.6\u2005nmol/l among the control group (n=796).']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 145), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 253)]	5	[('GO_0007567', 'parturition', 51, 'delivery'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('UBERON_0000178', 'blood', 114, 'blood'), ('GO_0007565', 'female pregnancy', 135, 'pregnancy'), ('GO_0007601', 'visual perception', 188, 'vaginal'), ('UBERON_0001987', 'placenta', 188, 'vaginal'), ('GO_0007567', 'parturition', 196, 'delivery'), ('CHEBI_27300', 'vitamin D', 218, 'vitamin D'), ('GO_0007567', 'parturition', 304, 'delivery'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 354, '25-OH'), ('CHEBI_27300', 'vitamin D', 360, 'vitamin D')]
PMC5051327	9/2016	S56-PMC5051327	['Vitamin D deficiency was ASSOCIATED with a significantly shorter Gestational age at Delivery, which is IN LINE WITH OTHER DATA.23furthermore, there SEEMS TO be an inverse RELATION between low active Vitamin D (1,25-Dihydroxy Vitamin D) and meconium-stained Amniotic Fluid, a sign of fetal distress, in Pregnancies complicated by Intrahepatic cholestasis.24\nthe FINDINGS that more than two-third of mothers were Vitamin D deficient during winter/spring season and one-third at summer are CONSISTENT with PREVIOUS reports.2526in THIS STUDY, we used the LIMITS of 25-Oh Vitamin D SUGGESTED by the iom,17BUT the discussion of WHAT levels SHOULD BE CONSIDERED deficient is ONGOING.']	[('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 116), ('ANOMALY_CURIOUS_FINDING', 148), ('SUPERFICIAL_RELATIONSHIP', 171), ('INCOMPLETE_EVIDENCE', 361), ('INCOMPLETE_EVIDENCE', 487), ('INCOMPLETE_EVIDENCE', 503), ('QUESTION_ANSWERED_BY_THIS_WORK', 527), ('INCOMPLETE_EVIDENCE', 551), ('INCOMPLETE_EVIDENCE', 577), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 598), ('EXPLICIT_QUESTION', 622), ('FUTURE_WORK', 634), ('FUTURE_WORK', 644), ('IMPORTANT_CONSIDERATION', 668)]	16	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'gestational'), ('GO_0007567', 'parturition', 84, 'delivery'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('CHEBI_50341', '1-hydroxyethyl group', 210, '1,25-dihydroxy'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D'), ('UBERON_0000173', 'amniotic fluid', 257, 'amniotic fluid'), ('GO_0007565', 'female pregnancy', 302, 'pregnancies'), ('UBERON_0001226', 'major calyx', 329, 'intrahepatic'), ('CHEBI_27300', 'vitamin D', 411, 'vitamin D'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 561, '25-OH'), ('CHEBI_27300', 'vitamin D', 567, 'vitamin D')]
PMC5051327	9/2016	S83-PMC5051327	['IF OTHER groups REPRODUCE our FINDINGS and a causal RELATIONSHIP CAN be established, we MIGHT be in a position to lower the risk of fetal distress/Birth asphyxia with Vitamin D supplementation/sun exposure in Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 3), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 52), ('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 88)]	7	[('GO_0007567', 'parturition', 147, 'birth'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('GO_0007565', 'female pregnancy', 209, 'pregnancy')]
PMC5062906	10/2016	S15-PMC5062906	['differences in Vitamin D-dependent epigenetic state between cell types and generations INDICATE perturbation of the epigenetic landscape RATHER than a targeted, locus-specific EFFECT.']	[('INCOMPLETE_EVIDENCE', 87), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137), ('SUPERFICIAL_RELATIONSHIP', 176)]	3	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D')]
PMC5062906	10/2016	S16-PMC5062906	['WHILE the biological IMPORTANCE of these subtle changes REMAINS UNCLEAR, they WARRANT AN INVESTIGATION of epigenome-wide EFFECTS of maternal Vitamin D depletion.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 21), ('FULL_UNKNOWN', 56), ('FUTURE_WORK', 78), ('SUPERFICIAL_RELATIONSHIP', 121)]	6	[('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC5062906	10/2016	S39-PMC5062906	['HOWEVER, RECENT FINDINGS implicate Vitamin D in Regulating Histone Modifications [16,17] and Dna Methylation [18].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9)]	2	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0065007', 'biological regulation', 48, 'regulating'), ('CHEBI_15358', 'histone', 59, 'histone'), ('GO_0016570', 'histone modification', 59, 'histone modifications'), ('PR_000043452', 'core histone', 59, 'histone'), ('GO_0006306', 'DNA methylation', 93, 'DNA methylation')]
PMC5062906	10/2016	S48-PMC5062906	['to address the ROLE of maternal Vitamin D in determining offspring epigenetic state, we used a Mouse MODEL to characterize WHETHER depletion of maternal Vitamin D during Gestation and Lactation AFFECTS epigenetic and developmental outcomes of progeny.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 101), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 123), ('SUPERFICIAL_RELATIONSHIP', 194)]	4	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 95, 'mouse'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D'), ('GO_0007565', 'female pregnancy', 170, 'gestation'), ('GO_0007595', 'lactation', 184, 'lactation')]
PMC5062906	10/2016	S89-PMC5062906	['panel above the graph lists all statistically significant ( p value <0.05) comparisons determined by regression analysis for overall diet-dependent effects (diet) and diet\u2009×\u2009strain INTERACTIVE EFFECTS (diet\u2009×\u2009strain)\n\nmaternal Vitamin D depletion alters g1and g2offspring developmental outcomes in a parent and grandparent of origin-DEPENDENT manner\nwe next ASSESSED WHETHER maternal Vitamin D depletion AFFECTS offspring developmental outcomes in a parent and grandparent of origin-DEPENDENT manner across multiple generations.']	[('SUPERFICIAL_RELATIONSHIP', 181), ('SUPERFICIAL_RELATIONSHIP', 193), ('SUPERFICIAL_RELATIONSHIP', 333), ('QUESTION_ANSWERED_BY_THIS_WORK', 358), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 367), ('SUPERFICIAL_RELATIONSHIP', 404), ('SUPERFICIAL_RELATIONSHIP', 483)]	7	[('CHEBI_27300', 'vitamin D', 227, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 384, 'vitamin D')]
PMC5062906	10/2016	S153-PMC5062906	['maternal Vitamin D depletion alters Dna Methylation in Soma and germline of Adult g1and g2males in a parent and grandparent of origin-DEPENDENT manner\nwe INVESTIGATED WHETHER Vitamin D depletion AFFECTS Dna Methylation state at Imprinted Genes in g1and g2males and WHETHER these differences are LINKED to the developmental changes described above.']	[('SUPERFICIAL_RELATIONSHIP', 134), ('QUESTION_ANSWERED_BY_THIS_WORK', 154), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 167), ('SUPERFICIAL_RELATIONSHIP', 195), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 265), ('SUPERFICIAL_RELATIONSHIP', 295)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0006306', 'DNA methylation', 36, 'DNA methylation'), ('GO_0044297', 'cell body', 55, 'soma'), ('UBERON_0007023', 'adult organism', 76, 'adult'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('GO_0006306', 'DNA methylation', 203, 'DNA methylation'), ('GO_0071514', 'genetic imprinting', 228, 'imprinted'), ('SO_0000704', 'gene', 238, 'genes')]
PMC5062906	10/2016	S219-PMC5062906	['TO DETERMINE WHETHER the Vitamin D-dependent epigenetic perturbation REPORTED HERE results in transcriptional perturbation, we measured relative levels of igf2 , H19 , snrpn , and Grb10 in g2neonatal Liver.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('INCOMPLETE_EVIDENCE', 69), ('QUESTION_ANSWERED_BY_THIS_WORK', 78)]	4	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('PR_000008474', 'hematopoietic lineage cell-specific protein', 162, 'H19'), ('PR_000008210', 'glutathione peroxidase 1', 180, 'Grb10'), ('UBERON_0002107', 'liver', 200, 'liver')]
PMC5062906	10/2016	S232-PMC5062906	['ONE LIKELY EXPLANATION for the sporadic methylation changes OBSERVED in response to Vitamin D depletion is perturbation of global epigenetic Programming AS an indirect EFFECT of Dysregulation of master epigenetic REGULATORS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 4), ('PROBABLE_UNDERSTANDING', 11), ('INCOMPLETE_EVIDENCE', 60), ('PROBABLE_UNDERSTANDING', 153), ('SUPERFICIAL_RELATIONSHIP', 168), ('SUPERFICIAL_RELATIONSHIP', 213)]	7	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('GO_0007565', 'female pregnancy', 141, 'programming'), ('GO_0060233', 'oenocyte delamination', 178, 'dysregulation')]
PMC5062906	10/2016	S243-PMC5062906	['WHILE maternal Vitamin D deficiency resulted in both phenotypic and epigenetic changes in both generations, it REMAINS UNCLEAR WHETHER the Dna Methylation changes are causally LINKED to the phenotypic outcomes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('EXPLICIT_QUESTION', 127), ('SUPERFICIAL_RELATIONSHIP', 176)]	6	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0006306', 'DNA methylation', 139, 'DNA methylation')]
PMC5062906	10/2016	S251-PMC5062906	['our data HIGHLIGHT two mechanisms that CONTRIBUTE to interindividual DIFFERENCES in response to Vitamin D deficiency: the Genetic INFLUENCE on maternal Plasma depletion of 25(Oh)D and the INFLUENCE of parent and grandparent of origin in the extent of Vitamin D-DEPENDENT developmental and epigenetic outcomes.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 39), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 69), ('SUPERFICIAL_RELATIONSHIP', 130), ('SUPERFICIAL_RELATIONSHIP', 188), ('SUPERFICIAL_RELATIONSHIP', 261)]	6	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('SO_0000704', 'gene', 122, 'genetic'), ('UBERON_0001969', 'blood plasma', 152, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 172, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 251, 'vitamin D')]
PMC5062906	10/2016	S254-PMC5062906	['this is MOST LIKELY the result of Genetic DIFFERENCES in Vitamin D Metabolism and STUDIES are ONGOING to identify and characterize the loci responsible.']	[('PROBABLE_UNDERSTANDING', 8), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('INCOMPLETE_EVIDENCE', 82), ('IMPORTANT_CONSIDERATION', 94)]	4	[('SO_0000704', 'gene', 34, 'genetic'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 57, 'vitamin D metabolism')]
PMC5062906	10/2016	S256-PMC5062906	['Genetic INFLUENCES on adiposity MAY also indirectly explain DIFFERENCES in Vitamin D depletion SINCE adiposity HAS BEEN LINKED to Vitamin D levels [55].']	[('SUPERFICIAL_RELATIONSHIP', 8), ('INCOMPLETE_EVIDENCE', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 60), ('PROBABLE_UNDERSTANDING', 95), ('INCOMPLETE_EVIDENCE', 111), ('SUPERFICIAL_RELATIONSHIP', 120)]	6	[('SO_0000704', 'gene', 0, 'Genetic'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC5062906	10/2016	S264-PMC5062906	['THEREFORE, the Vitamin D-dependent parent of origin EFFECTS REPORTED HERE MAY BE INFLUENCED by EITHER epigenetic mechanisms OR Genetic DIFFERENCES in cis or trans .']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 52), ('INCOMPLETE_EVIDENCE', 60), ('QUESTION_ANSWERED_BY_THIS_WORK', 69), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135)]	8	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('SO_0000704', 'gene', 127, 'genetic')]
PMC5062906	10/2016	S268-PMC5062906	['HOWEVER, we CANNOT COMPLETELY RULE OUT the POSSIBILITY that cis -acting Allelic DIFFERENCES in g1and g2animals somehow INFLUENCES the Vitamin D-DEPENDENT parent of origin epigenetic EFFECTS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 43), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 80), ('SUPERFICIAL_RELATIONSHIP', 119), ('SUPERFICIAL_RELATIONSHIP', 144), ('SUPERFICIAL_RELATIONSHIP', 182)]	7	[('SO_0001023', 'allele', 72, 'allelic'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC5062906	10/2016	S305-PMC5062906	['7b) INDICATING that epigenetic changes in the Soma resulting from direct exposure to Vitamin D deficiency in utero are DIFFERENT than those resulting from indirect exposure in the next Generation (G2).']	[('INCOMPLETE_EVIDENCE', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 119)]	2	[('GO_0044297', 'cell body', 46, 'soma'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007281', 'germ cell development', 185, 'generation ... G2 ...')]
PMC5064894	10/2016	S28-PMC5064894	['DESPITE these SUGGESTIVE results from observational studies, there HAVE BEEN FEW prospective randomized controlled trials examining the IMPACT of Vitamin D supplementation on RISK of ari in children.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 136), ('IMPORTANT_CONSIDERATION', 175)]	7	[('CHEBI_27300', 'vitamin D', 146, 'vitamin D')]
PMC5064894	10/2016	S31-PMC5064894	['HOWEVER, a trial in afghanistan involving over 3000 children randomized to receive quarterly doses of 100,000\xa0iu of Vitamin D or placebo found no difference in the incidence of pneumonia [24].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC5064894	10/2016	S35-PMC5064894	['HOWEVER, the researchers identified multiple LIMITATIONS in their study including lack OF blinding of participants and subjective outcomes, SMALL sample size and LIMITED statistical power, and dosages of Vitamin D that lead to ONLY 13\xa0% of the daily group and 3\xa0% of the bolus group having Cord Serum 25 (Oh) D levels considered to be in a sufficient range.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 45), ('ANOMALY_CURIOUS_FINDING', 87), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 162), ('ANOMALY_CURIOUS_FINDING', 227)]	6	[('CHEBI_27300', 'vitamin D', 204, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 290, 'cord'), ('UBERON_0001977', 'blood serum', 295, 'serum'), ('CHEBI_71657', 'versiconol acetate', 301, '25 (OH) D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 305, 'OH ... D')]
PMC5064894	10/2016	S168-PMC5064894	['we thus maintain 80\xa0% power to address the QUESTION of WHETHER maternal Vitamin D supplementation CAN reduce the rate of microbiologically-confirmed acute Respiratory infections, while simultaneously being able to address WHETHER lower doses are also EFFECTIVE, and TO INVESTIGATE WHETHER a dose–response RELATIONSHIP exists, thereby SUPPORTING the biological PLAUSIBILITY and robustness of inferences.']	[('EXPLICIT_QUESTION', 43), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 55), ('EXPLICIT_QUESTION', 55), ('INCOMPLETE_EVIDENCE', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 222), ('SUPERFICIAL_RELATIONSHIP', 251), ('QUESTION_ANSWERED_BY_THIS_WORK', 266), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 281), ('SUPERFICIAL_RELATIONSHIP', 305), ('INCOMPLETE_EVIDENCE', 334), ('INCOMPLETE_EVIDENCE', 360)]	11	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 155, 'respiratory')]
PMC5064894	10/2016	S171-PMC5064894	['in secondary analyses, we will consider aggregation of multiple Vitamin D arms (e.g., group d and e), which will have the benefit of increasing the sample size; HOWEVER, for the a priori primary outcome analysis, we have decided to retain the separation of the groups (according to the design of the mdig trial) to LIMIT the POSSIBILITY of increasing a type ii ERROR IF a TRUE effect of the longer duration or higher-dose intervention were diluted by the lack OF effect of the other group(s).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 161), ('INCOMPLETE_EVIDENCE', 315), ('INCOMPLETE_EVIDENCE', 325), ('PROBLEM_COMPLICATION', 361), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 367), ('PROBABLE_UNDERSTANDING', 372), ('ANOMALY_CURIOUS_FINDING', 460)]	7	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC5064894	10/2016	S194-PMC5064894	['IF SHOWN to reduce the RISK of ari in infancy, integration of maternal Prenatal/Postpartum Vitamin D supplementation into Antenatal Care programs in south asia MAY BE a FEASIBLE primary preventive STRATEGY to reduce THE BURDEN of ari-associated morbidity and mortality in young infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 23), ('INCOMPLETE_EVIDENCE', 160), ('PROBABLE_UNDERSTANDING', 169), ('FUTURE_WORK', 197), ('IMPORTANT_CONSIDERATION', 216)]	7	[('GO_0007565', 'female pregnancy', 71, 'prenatal'), ('GO_0007565', 'female pregnancy', 80, 'postpartum'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0007608', 'sensory perception of smell', 122, 'antenatal care')]
PMC5084016	10/2016	S128-PMC5084016	['HOWEVER, Vitamin D deficiency is very common during Pregnancy EVEN in countries with sunny climates and is ASSOCIATED with an INCREASED RISK of developing pre-eclampsia and Gestational diabetes mellitus.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 62), ('SUPERFICIAL_RELATIONSHIP', 107), ('IMPORTANT_CONSIDERATION', 126)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'pregnancy'), ('GO_0007565', 'female pregnancy', 173, 'gestational')]
PMC5084016	10/2016	S132-PMC5084016	['DESPITE the LACK OF CONSENSUS on adequate intakes among DIFFERENT countries (table 3), supplementation with Vitamin D is RECOMMENDED for all Pregnant women at a dose of 600 iu/day (15 µg/day) [57].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 56), ('FUTURE_WORK', 121)]	6	[('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('GO_0007565', 'female pregnancy', 141, 'pregnant')]
PMC5084016	10/2016	S213-PMC5084016	['NOTABLY, the values recorded in italy [25,53] DIFFER from those RECOMMENDED by the italian GUIDELINES [7] from 40% (Iodine) to 85% (Vitamin D).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 46), ('FUTURE_WORK', 64), ('PROBABLE_UNDERSTANDING', 91)]	4	[('CHEBI_24859', 'iodine atom', 116, 'iodine'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC5084041	10/2016	S118-PMC5084041	['FEW STUDIES have PREVIOUSLY investigated changes in Vitamin D status during Pregnancy and results were CONFLICTING.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('GO_0007565', 'female pregnancy', 76, 'pregnancy')]
PMC5084041	10/2016	S145-PMC5084041	['HOWEVER, this was, IN PART, overcome by the season-correction of change in Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 19)]	2	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC5084734	5/2016	S28-PMC5084734	['gaps in Nutrient intake at this age are GENERALLY greatest for iron and zinc (vitta & dewey2013), BUT OTHER Nutrients MAY BE PROBLEMATIC (such as calcium, Vitamin A and certain b Vitamins) DEPENDING ON the types of foods consumed (dewey2013).']	[('PROBABLE_UNDERSTANDING', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102), ('INCOMPLETE_EVIDENCE', 118), ('PROBLEM_COMPLICATION', 125), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 189)]	6	[('CHEBI_33284', 'nutrient', 8, 'nutrient'), ('CHEBI_33284', 'nutrient', 108, 'nutrients'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin A'), ('CHEBI_33277', 'gamma-tocotrienol', 179, 'vitamins'), ('PR_000027594', 'histone H3', 179, 'vitamins')]
PMC5085625	9/2016	S16-PMC5085625	['the active form of Vitamin D, i.e., 1,25(Oh)2D, is now recognized as an IMPORTANT hormone playing a CRUCIAL role in Skeletal Homeostasis (classical effects) and exerting NON-CLASSICAL EFFECTS in various pathological and physiological conditions, such as cancer, Arterial hypertension, Cardiovascular diseases, Brain Development and Immunomodulation [3,4,5,6].']	[('IMPORTANT_CONSIDERATION', 72), ('IMPORTANT_CONSIDERATION', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('SUPERFICIAL_RELATIONSHIP', 184)]	4	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 38, '25(OH)2D'), ('GO_0043276', 'anoikis', 116, 'skeletal homeostasis'), ('UBERON_0004288', 'skeleton', 116, 'skeletal'), ('UBERON_0001637', 'artery', 262, 'arterial'), ('UBERON_0004535', 'cardiovascular system', 285, 'cardiovascular'), ('GO_0007420', 'brain development', 310, 'brain development'), ('UBERON_0000955', 'brain', 310, 'brain'), ('GO_0050900', 'leukocyte migration', 332, 'immunomodulation')]
PMC5085625	9/2016	S38-PMC5085625	['ALTHOUGH the biological ROLE of Vitamin D HAS BEEN studied extensively, the consequences of its deficiency for maternal, fetal and neonatal health are STILL UNCLEAR [4,22,24].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 24), ('INCOMPLETE_EVIDENCE', 42), ('FULL_UNKNOWN', 151)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D')]
PMC5085625	9/2016	S44-PMC5085625	['HOWEVER, deficiency of Vitamin D (concentration 25(Oh)D <20 ng/ml) was RECOGNIZED in as many as 45.6% patients participating in the study.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 71)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 48, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 51, 'OH ... D')]
PMC5085625	9/2016	S68-PMC5085625	['taking into account INCONCLUSIVE results of cross-sectional and cohort studies analyzing the ASSOCIATION between Vitamin D status and occurrence of Pregnancy pathologies [28,29], the AIM of OUR STUDY was to asses 25(Oh)D status in women with Gestational hypertension (gh).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 20), ('SUPERFICIAL_RELATIONSHIP', 93), ('QUESTION_ANSWERED_BY_THIS_WORK', 183), ('QUESTION_ANSWERED_BY_THIS_WORK', 190)]	4	[('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('GO_0007565', 'female pregnancy', 148, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 213, '25(OH)D'), ('GO_0007565', 'female pregnancy', 242, 'gestational')]
PMC5085625	9/2016	S72-PMC5085625	['the RELATIONSHIP between Vitamin D status and gh HAS also BEEN a subject of OTHER STUDIES.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 49), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 76), ('INCOMPLETE_EVIDENCE', 76)]	4	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D')]
PMC5085625	9/2016	S82-PMC5085625	['in our opinion, SOME DISCREPANCIES between the results of PREVIOUS STUDIES MAY result from LACK OF adjustment for Vitamin D supplementation and season of the Blood sampling.']	[('INCOMPLETE_EVIDENCE', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 21), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 75), ('PROBLEM_COMPLICATION', 91)]	5	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('UBERON_0000178', 'blood', 158, 'blood')]
PMC5085625	9/2016	S119-PMC5085625	['DID NOT observe significant differences in Vitamin D levels among Pregnant women and healthy controls; NEVERTHELESS, the prevalence of a Vitamin D deficiency in both groups was quite high [23].']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103)]	2	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0007565', 'female pregnancy', 66, 'pregnant'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC5085625	9/2016	S120-PMC5085625	['HOWEVER, PUBLISHED EVIDENCE regarding the RELATIONSHIP between Vitamin D level and occurrence of gdm is INCONCLUSIVE.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 42), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 104)]	5	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC5095257	11/2016	S86-PMC5095257	['verifying Vitamin D deficiency and aad risk by ascertaining 25 (Oh)D status in infancy, HOWEVER, will be difficult given the RARITY of the condition and the fact that diagnosis is USUALLY made in Individuals in their third to fifth decade.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 88), ('DIFFICULT_TASK', 125), ('INCOMPLETE_EVIDENCE', 180)]	3	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 60, '25 (OH)D'), ('NCBITaxon_1', 'root', 196, 'individuals')]
PMC5115165	1/2016	S14-PMC5115165	['introduction\npotatoes are the third most commonly Consumed Food crop in the world, after rice and wheat.1in the united states, about 35% of women of Reproductive Age (that is, aged 19-50) Consume potatoes daily, accounting FOR 8% of daily total energy intake.2the health EFFECTS of potatoes are INCONCLUSIVE,13and there HAVE BEEN longstanding DEBATES on the appropriate placement of potatoes in dietary guidance.456nonetheless, the dietary guidelines for americans continue to include potatoes in the vegetable Food group and encourage Consumption.7THOUGH potatoes are rich in Vitamin C, Potassium, dietary fiber, and some Phytochemicals,6unlike other vegetables they CAN have DETRIMENTAL EFFECTS on Glucose Metabolism because they contain large amounts of rapidly absorbable Starch.3indeed, SEVERAL epidemiologic STUDIES have LINKED higher potato Consumption to increased concentrations of fasting Plasma Glucose,8insulin resistance,8and an increased risk of type 2 diabetes mellitus.910\nGestational diabetes mellitus (gdm) is a common COMPLICATION of Pregnancy characterized by Glucose intolerance with onset or first recognition during Pregnancy.11gdm is not only ASSOCIATED with adverse Perinatal outcomes,12it is also RELATED to increased long term Cardiometabolic risk in both mothers and their offspring.1113it is THEREFORE CRUCIAL to identify modifiable RISK FACTORS that COULD CONTRIBUTE to the PREVENTION of gdm.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 223), ('SUPERFICIAL_RELATIONSHIP', 271), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 295), ('INCOMPLETE_EVIDENCE', 320), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 343), ('ANOMALY_CURIOUS_FINDING', 548), ('INCOMPLETE_EVIDENCE', 668), ('IMPORTANT_CONSIDERATION', 677), ('SUPERFICIAL_RELATIONSHIP', 689), ('INCOMPLETE_EVIDENCE', 792), ('SUPERFICIAL_RELATIONSHIP', 827), ('PROBLEM_COMPLICATION', 1037), ('SUPERFICIAL_RELATIONSHIP', 1167), ('SUPERFICIAL_RELATIONSHIP', 1223), ('PROBABLE_UNDERSTANDING', 1321), ('IMPORTANT_CONSIDERATION', 1331), ('SUPERFICIAL_RELATIONSHIP', 1362), ('INCOMPLETE_EVIDENCE', 1380), ('SUPERFICIAL_RELATIONSHIP', 1386), ('SUPERFICIAL_RELATIONSHIP', 1404)]	20	[('GO_0007631', 'feeding behavior', 50, 'consumed'), ('CHEBI_33290', 'food', 59, 'food'), ('GO_0000003', 'reproduction', 149, 'reproductive age'), ('GO_0007631', 'feeding behavior', 188, 'consume'), ('CHEBI_33290', 'food', 511, 'food'), ('GO_0007631', 'feeding behavior', 536, 'consumption'), ('CHEBI_27300', 'vitamin D', 577, 'vitamin C'), ('CHEBI_22314', 'alkali metal atom', 588, 'potassium'), ('CHEBI_26254', 'prenylnaphthoquinone', 623, 'phytochemicals'), ('CHEBI_17234', 'glucose', 700, 'glucose'), ('GO_0006006', 'glucose metabolic process', 700, 'glucose metabolism'), ('CHEBI_28017', 'starch', 776, 'starch'), ('GO_0007631', 'feeding behavior', 848, 'consumption'), ('UBERON_0001969', 'blood plasma', 899, 'plasma'), ('CHEBI_17234', 'glucose', 906, 'glucose'), ('GO_0007565', 'female pregnancy', 989, 'Gestational'), ('GO_0007565', 'female pregnancy', 1053, 'pregnancy'), ('CHEBI_17234', 'glucose', 1080, 'glucose'), ('GO_0007565', 'female pregnancy', 1139, 'pregnancy'), ('GO_0036268', 'swimming', 1191, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1191, 'perinatal'), ('GO_0007599', 'hemostasis', 1254, 'cardiometabolic')]
PMC5118763	12/2016	S22-PMC5118763	['ALTHOUGH PREVIOUS reports from this trial SHOWED a high prevalence of anemia, zinc, and Vitamin B-12 deficiencies in early Pregnancy among the women in the trial (14), there was no differential effect of using the mmn regimen on women’s hemoglobin concentration compared with standard Iron–Folic Acid supplementation regimens (11).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 42)]	4	[('CHEBI_27300', 'vitamin D', 88, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 88, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 123, 'pregnancy'), ('CHEBI_24870', 'ion', 285, 'iron'), ('CHEBI_30751', 'formic acid', 290, 'folic acid')]
PMC5118763	12/2016	S158-PMC5118763	['HOWEVER, there was no dose-response relation between the number of mmn capsules taken and Plasma Vitamin B-12 that COULD EXPLAIN the higher Plasma concentrations of Vitamin B-12 at week 30 in the mmn group.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 115), ('PROBABLE_UNDERSTANDING', 121)]	4	[('UBERON_0001969', 'blood plasma', 90, 'plasma'), ('CHEBI_85855', 'diacylglycerol 46:7', 97, 'vitamin B-12'), ('PR_000017269', 'ventral anterior homeobox 2', 97, 'vitamin B-12'), ('UBERON_0001969', 'blood plasma', 140, 'plasma'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 165, 'vitamin B-12')]
PMC5118763	12/2016	S184-PMC5118763	['the presence of OTHER Micronutrients in Mmns such as Vitamins C and a, which CAN improve the absorption of iron (26), MAY EXPLAIN this equivalence DESPITE the lower content of iron in the Mmn.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 118), ('PROBABLE_UNDERSTANDING', 122), ('ANOMALY_CURIOUS_FINDING', 147)]	5	[('CHEBI_33839', 'macromolecule', 22, 'micronutrients'), ('UBERON_0002544', 'digit', 40, 'MMNs'), ('CHEBI_27300', 'vitamin D', 53, 'vitamins C'), ('PR_000004900', 'complement C3', 62, 'C'), ('UBERON_0003109', 'parapophysis', 188, 'MMN')]
PMC5129897	10/2016	S6-PMC5129897	['HOWEVER, the EFFECTS on disease incidence, economic BURDEN, and mortality rate would be phased in gradually over several years PRIMARILY because once a chronic disease is established, Vitamin D AFFECTS its progression ONLY modestly.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('IMPORTANT_CONSIDERATION', 52), ('PROBABLE_UNDERSTANDING', 127), ('SUPERFICIAL_RELATIONSHIP', 194), ('ANOMALY_CURIOUS_FINDING', 218), ('INCOMPLETE_EVIDENCE', 218)]	7	[('CHEBI_27300', 'vitamin D', 184, 'vitamin D')]
PMC5129897	10/2016	S7-PMC5129897	['NEVERTHELESS, national policy changes are JUSTIFIED to improve Vitamin D status of canadians through promotion of SAFE sun exposure messages, Vitamin D supplement use, and/or facilitation of Food fortification.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 42), ('IMPORTANT_CONSIDERATION', 42), ('IMPORTANT_CONSIDERATION', 114)]	4	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('CHEBI_33290', 'food', 191, 'food')]
PMC5129897	10/2016	S16-PMC5129897	['NEITHER ASSUMPTION holds for Vitamin D. robert heaney OUTLINED the GUIDELINES for Nutrient studies including Vitamin D. the most RELEVANT features are that one SHOULD start with an understanding of the 25(Oh)D concentration–health outcome RELATION, 25(Oh)D concentrations SHOULD BE measured in prospective participants, ONLY those with low concentrations SHOULD BE enrolled, sufficient Vitamin D SHOULD BE given to raise 25(Oh)D concentrations to where a significant beneficial EFFECT is expected, and achieved 25(Oh)D concentrations SHOULD BE measured.2until those steps are followed routinely, FEW Vitamin D clinical TRIALS will report beneficial EFFECTS.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 8), ('INCOMPLETE_EVIDENCE', 54), ('IMPORTANT_CONSIDERATION', 67), ('PROBABLE_UNDERSTANDING', 67), ('IMPORTANT_CONSIDERATION', 129), ('FUTURE_WORK', 160), ('SUPERFICIAL_RELATIONSHIP', 239), ('FUTURE_WORK', 272), ('INCOMPLETE_EVIDENCE', 320), ('FUTURE_WORK', 355), ('FUTURE_WORK', 396), ('SUPERFICIAL_RELATIONSHIP', 478), ('FUTURE_WORK', 534), ('INCOMPLETE_EVIDENCE', 596), ('FUTURE_WORK', 619), ('SUPERFICIAL_RELATIONSHIP', 649)]	17	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_33284', 'nutrient', 82, 'nutrient'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 202, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 249, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 386, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 421, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 427, 'D'), ('CHEBI_71657', 'versiconol acetate', 511, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 517, 'D'), ('CHEBI_27300', 'vitamin D', 600, 'vitamin D')]
PMC5129897	10/2016	S20-PMC5129897	['the criteria most RELEVANT for Vitamin D are strength of ASSOCIATION, CONSISTENT findings in DIFFERENT populations, temporality, biological gradient, plausibility (e.g., mechanisms), coherence with known facts, and experiments (e.g., clinical trials).5not all criteria NEED be satisfied, BUT the more that are, the stronger the case.']	[('IMPORTANT_CONSIDERATION', 18), ('SUPERFICIAL_RELATIONSHIP', 57), ('INCOMPLETE_EVIDENCE', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93), ('IMPORTANT_CONSIDERATION', 269), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 288)]	6	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC5129897	10/2016	S117-PMC5129897	["the annual economic BURDEN of crohn's disease in canada is $1.7\xa0billion, WHEREAS that of ulcerative colitis is $1.2\xa0billion.78several papers HAVE REPORTED inverse CORRELATIONS between Vitamin D status and incidence, prevalence, and/or severity of Inflammatory Bowel disease.79,80\nEVIDENCE is mounting that higher 25(Oh)D concentrations are ASSOCIATED with BETTER Pregnancy and Birth outcomes."]	[('IMPORTANT_CONSIDERATION', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 73), ('INCOMPLETE_EVIDENCE', 141), ('SUPERFICIAL_RELATIONSHIP', 163), ('INCOMPLETE_EVIDENCE', 280), ('SUPERFICIAL_RELATIONSHIP', 340), ('IMPORTANT_CONSIDERATION', 356)]	7	[('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('UBERON_0001782', 'pigmented layer of retina', 247, 'inflammatory bowel'), ('CHEBI_71657', 'versiconol acetate', 313, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 319, 'D'), ('GO_0007565', 'female pregnancy', 363, 'pregnancy'), ('GO_0007567', 'parturition', 377, 'birth')]
PMC5129897	10/2016	S168-PMC5129897	['for some intermediate situations, such as cancer, survival rates are better with higher 25(Oh)D concentrations.12,93thus, EVEN IF all canadians achieved concentrations of > 100\xa0nmol/l immediately, the beneficial EFFECTS would accrue slowly, PERHAPS over 10–20\xa0y because for many health outcomes, the beneficial EFFECTS of Vitamin D are much stronger for PREVENTION than for treatment.']	[('ANOMALY_CURIOUS_FINDING', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('SUPERFICIAL_RELATIONSHIP', 212), ('INCOMPLETE_EVIDENCE', 241), ('SUPERFICIAL_RELATIONSHIP', 311), ('SUPERFICIAL_RELATIONSHIP', 354)]	6	[('CHEBI_71657', 'versiconol acetate', 88, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 94, 'D'), ('CHEBI_27300', 'vitamin D', 322, 'vitamin D')]
PMC5129897	10/2016	S176-PMC5129897	['the results of observational studies are GENERALLY not well-SUPPORTED by clinical trials of Vitamin D supplementation.94the primary REASON for that lack OF support SEEMS TO be that the trials were NOT WELL DESIGNED, being based LARGELY on the guidelines for Pharmaceutical Drugs RATHER than for Nutrients.2another WORRISOME POINT is that clinical trials have BEEN much more successful when baseline 25(Oh)D concentrations were low.']	[('PROBABLE_UNDERSTANDING', 41), ('INCOMPLETE_EVIDENCE', 60), ('PROBABLE_UNDERSTANDING', 132), ('ANOMALY_CURIOUS_FINDING', 153), ('ANOMALY_CURIOUS_FINDING', 164), ('INCOMPLETE_EVIDENCE', 197), ('INCOMPLETE_EVIDENCE', 228), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 279), ('IMPORTANT_CONSIDERATION', 314), ('IMPORTANT_CONSIDERATION', 324), ('ANOMALY_CURIOUS_FINDING', 359)]	11	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_52217', 'pharmaceutical', 258, 'pharmaceutical'), ('CHEBI_23888', 'drug', 273, 'drugs'), ('CHEBI_33284', 'nutrient', 295, 'nutrients'), ('CHEBI_71657', 'versiconol acetate', 399, '25(OH)D')]
PMC5129897	10/2016	S177-PMC5129897	['for example, 50% of the clinical trials with baseline 25(Oh)D concentration <50\xa0nmol/l FOUND beneficial EFFECTS of Vitamin D on BIOMARKERS of inflammation, WHEREAS ONLY 26% of those with higher baseline 25(Oh)D concentrations did.3the DIFFERENT results with respect to baseline 25(Oh)D concentration MAY BE DUE TO the LIMITED accuracy of clinical trials but COULD also be DUE TO CONSIDERABLY less BENEFIT for those with 25(Oh)D concentrations above 50\xa0nmol/l.']	[('INCOMPLETE_EVIDENCE', 87), ('SUPERFICIAL_RELATIONSHIP', 104), ('SUPERFICIAL_RELATIONSHIP', 128), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 156), ('ANOMALY_CURIOUS_FINDING', 156), ('ANOMALY_CURIOUS_FINDING', 164), ('INCOMPLETE_EVIDENCE', 164), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 235), ('INCOMPLETE_EVIDENCE', 300), ('PROBLEM_COMPLICATION', 307), ('INCOMPLETE_EVIDENCE', 318), ('INCOMPLETE_EVIDENCE', 358), ('PROBLEM_COMPLICATION', 372), ('ANOMALY_CURIOUS_FINDING', 379), ('IMPORTANT_CONSIDERATION', 397)]	15	[('CHEBI_71657', 'versiconol acetate', 54, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 54, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 203, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 203, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 278, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 284, 'D'), ('CHEBI_71657', 'versiconol acetate', 420, '25(OH)D')]
PMC5129897	10/2016	S178-PMC5129897	['ANOTHER LIMITATION of clinical trials is that they are of short duration—GENERALLY a few months to a few years—YET chronic diseases MAY develop slowly over decades, and the half-life of Vitamin D is about 3\xa0weeks, requiring several months of supplementation to show benefit.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('PROBABLE_UNDERSTANDING', 73), ('ANOMALY_CURIOUS_FINDING', 111), ('INCOMPLETE_EVIDENCE', 132)]	5	[('CHEBI_27300', 'vitamin D', 186, 'vitamin D')]
PMC5129897	10/2016	S180-PMC5129897	['BUT SOME STUDIES FOUND that Vitamin D AFFECTS mortality rates more than incidence rates.94our ESTIMATES also do NOT take into account prevalence rates for the various diseases.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 94), ('ANOMALY_CURIOUS_FINDING', 112)]	6	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D')]
PMC5129897	10/2016	S188-PMC5129897	['according to a consensus Vitamin D position statement published by 7 joint health organizations in the uk, enjoying the sun safely, while taking care not to burn, CAN HELP to provide the benefits of Vitamin D without unduly raising the risk of skin cancer.99HOWEVER, sun exposure in the uk as well as in canada is a RECOMMENDATION for ONLY 5–7\xa0months of the year(except for People traveling to sun destinations during winter months).']	[('INCOMPLETE_EVIDENCE', 163), ('FUTURE_WORK', 167), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 256), ('FUTURE_WORK', 316), ('INCOMPLETE_EVIDENCE', 335)]	5	[('CHEBI_28384', 'vitamin K', 25, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 25, 'Vitamin'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 374, 'people')]
PMC5129897	10/2016	S192-PMC5129897	['one was a meta-analysis of observational studies.104the OTHER was a study of cancer incidence by occupation in nordic countries.49\n\nconclusions\nmany People living in canada do not have OPTIMAL 25(Oh)D concentrations AS a result of limited solar uvb exposure and/or not obtaining enough Vitamin D from Food or supplements.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 56), ('IMPORTANT_CONSIDERATION', 185), ('PROBABLE_UNDERSTANDING', 216)]	3	[('NCBITaxon_10088', 'Mus <genus>', 149, 'people'), ('CHEBI_71657', 'versiconol acetate', 193, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 193, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 286, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 294, 'D'), ('CHEBI_33290', 'food', 301, 'food')]
PMC5133057	10/2016	S17-PMC5133057	['its occurrence is classically ASSOCIATED with low Intake of Vitamin A from Food sources [5,12], BUT it MAY also be ASSOCIATED with OTHER FACTORS such as socioeconomic status, and inadequate sanitation and the presence of infection [13,14,15].']	[('SUPERFICIAL_RELATIONSHIP', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 96), ('INCOMPLETE_EVIDENCE', 103), ('SUPERFICIAL_RELATIONSHIP', 115), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('SUPERFICIAL_RELATIONSHIP', 137)]	6	[('GO_0007631', 'feeding behavior', 50, 'intake'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin A'), ('CHEBI_33290', 'food', 75, 'food')]
PMC5133057	10/2016	S18-PMC5133057	['in brazil, vad HAS BEEN DOCUMENTED in the northeast and in SOME parts of the southeast [16]; HOWEVER, there are STILL ONLY a FEW STUDIES that evaluate the Consumption of Vitamin A by Pregnant women [17], and there are EVEN FEWER STUDIES investigating the occurrence of vad among Pregnant teenagers.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 59), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93), ('IMPORTANT_CONSIDERATION', 112), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 125), ('ANOMALY_CURIOUS_FINDING', 218), ('INCOMPLETE_EVIDENCE', 223)]	9	[('GO_0007631', 'feeding behavior', 155, 'consumption'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin A'), ('GO_0007565', 'female pregnancy', 183, 'pregnant'), ('GO_0007565', 'female pregnancy', 279, 'pregnant')]
PMC5133057	10/2016	S108-PMC5133057	['it is IMPORTANT TO NOTE that EVEN IF the reduction occurs with more intensity in the second and third quarter due to Plasma volume expansion and increased Vitamin A transfer from the mother to the fetus, special ATTENTION throughout Pregnancy is NECESSARY, PARTICULARLY in the first trimester, when the major changes in the Fetal Development occur.']	[('IMPORTANT_CONSIDERATION', 6), ('ANOMALY_CURIOUS_FINDING', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('FUTURE_WORK', 212), ('IMPORTANT_CONSIDERATION', 212), ('IMPORTANT_CONSIDERATION', 246), ('IMPORTANT_CONSIDERATION', 257)]	7	[('UBERON_0001969', 'blood plasma', 117, 'plasma'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin A'), ('GO_0007565', 'female pregnancy', 233, 'pregnancy'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 324, 'fetal development')]
PMC5137891	12/2016	S138-PMC5137891	['other key FACTORS that MAY CONTRIBUTE to anemia include: OTHER Nutrient deficiencies (Folate, Vitamin B12, and Vitamin A), Genetic traits (including Sickle-Cell anemia and thalassaemia), malaria, schistosomiasis, hookworm and Trichuris infection, and hiv and some non-communicable diseases [1].']	[('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 27), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 57)]	4	[('CHEBI_33284', 'nutrient', 63, 'nutrient'), ('CHEBI_30863', '5-azaorotic acid', 86, 'folate'), ('CHEBI_33279', 'vitamin D5', 94, 'vitamin B12'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 102, 'B12'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin A'), ('SO_0000704', 'gene', 123, 'genetic'), ('CL_0000429', 'imaginal disc cell', 149, 'sickle-cell'), ('NCBITaxon_10088', 'Mus <genus>', 226, 'trichuris')]
PMC5137891	12/2016	S143-PMC5137891	['Retinol Binding protein (rbp- a marker of Vitamin A status) was also directly ASSOCIATED with hb (0.27 mg/dl) and with ferritin (0.09 mg/dl), WHEREAS hookworm infection was indirectly ASSOCIATED with hb (-0.11) through rbp and ferritin.']	[('SUPERFICIAL_RELATIONSHIP', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 142), ('SUPERFICIAL_RELATIONSHIP', 184)]	3	[('CHEBI_27810', 'resorcinol', 0, 'Retinol'), ('PR_000014379', 'ryanodine receptor 3', 0, 'Retinol Binding'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin A')]
PMC5137891	12/2016	S144-PMC5137891	['HOWEVER, SIMILAR TO the low levels of iron deficiency in our population ONLY 4% of women were Vitamin A deficient.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('ANOMALY_CURIOUS_FINDING', 72), ('INCOMPLETE_EVIDENCE', 72)]	5	[('CHEBI_27300', 'vitamin D', 94, 'vitamin A')]
PMC5146866	12/2016	S15-PMC5146866	['HOWEVER, the clinical practice guidelines published by the Endocrine society RECOMMENDS that 30\xa0ng/ml of Vitamin D in children and Adults SHOULD BE CONSIDERED sufficient and classifies levels below 20\xa0ng/ml (50\xa0nmol/l) and 21–29\xa0ng/ml (55–75\xa0nmol/l) as deficient and insufficient, respectively [10].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 77), ('FUTURE_WORK', 138), ('IMPORTANT_CONSIDERATION', 148)]	4	[('UBERON_0005063', 'left ventricular compact myocardium', 59, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('UBERON_0007023', 'adult organism', 131, 'adults')]
PMC5146866	12/2016	S23-PMC5146866	['DIFFERENCES in the classification [8–10] used to assess the infants’ Vitamin D status and strong DEPENDENCE of their Vitamin D pool on maternal Vitamin D levels [18] MAY BE RESPONSIBLE for the wide VARIABILITY in the REPORTED rates of Vitamin D deficiency/insufficiency in infants at Birth.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 97), ('INCOMPLETE_EVIDENCE', 166), ('PROBABLE_UNDERSTANDING', 173), ('DIFFICULT_TASK', 198), ('INCOMPLETE_EVIDENCE', 217)]	6	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin D'), ('GO_0007567', 'parturition', 284, 'birth')]
PMC5146866	12/2016	S24-PMC5146866	['DESPITE numerous publications that explored Vitamin D status in cb, FURTHER RESEARCH is REQUIRED to determine the LIKELIHOOD for detection of Vitamin D insufficiency in cb of infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 68), ('IMPORTANT_CONSIDERATION', 88), ('PROBABLE_UNDERSTANDING', 114)]	5	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D')]
PMC5146866	12/2016	S80-PMC5146866	['WHILE a Vitamin D level of 20\xa0ng/ml IS CONSIDERED sufficient, maintenance of 30\xa0ng/ml is RECOMMENDED for better health in children and Adults [24] DESPITE the LACK OF CLEAR EVIDENCE of an OPTIMAL concentration of Vitamin D for bone and general health.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 36), ('FUTURE_WORK', 89), ('ANOMALY_CURIOUS_FINDING', 147), ('INCOMPLETE_EVIDENCE', 159), ('IMPORTANT_CONSIDERATION', 188)]	6	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('UBERON_0007023', 'adult organism', 135, 'adults'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D')]
PMC5146866	12/2016	S96-PMC5146866	['HOWEVER, there was a TENDENCY for a higher use of phototherapy in infants Born with Vitamin D deficiency as compared to those with Vitamin D sufficiency (5.3 vs. 1.1%, one-sided p \u2009=\u20090.053).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 21)]	3	[('GO_0007567', 'parturition', 74, 'born'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC5146866	12/2016	S102-PMC5146866	['HOWEVER, it is UNLIKELY that these limitations will AFFECT the OBSERVED rate of Vitamin D deficiency and insufficiency SEEN at Birth in the studied infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 15), ('SUPERFICIAL_RELATIONSHIP', 52), ('INCOMPLETE_EVIDENCE', 63), ('INCOMPLETE_EVIDENCE', 119)]	5	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007567', 'parturition', 127, 'birth')]
PMC5155676	12/2016	S17-PMC5155676	['NONETHELESS, the institute of medicine (iom) has SUGGESTED that risk of Vitamin D insufficiency, DEFINED as a 25(Oh)D less than 50 nmol/l, SHOULD BE avoided during Pregnancy (5), and this is SUPPORTED by the RECENT global consensus on the prevention of rickets (6).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 49), ('PROBABLE_UNDERSTANDING', 97), ('FUTURE_WORK', 139), ('INCOMPLETE_EVIDENCE', 191), ('INCOMPLETE_EVIDENCE', 208)]	6	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 110, '25(OH)D'), ('GO_0007565', 'female pregnancy', 164, 'pregnancy')]
PMC5155676	12/2016	S22-PMC5155676	['during Pregnancy, maternal hemodilution is ACCOMPANIED by a number OF physiological changes to both Vitamin D Metabolism (15) and maternal body composition (16); such adaptations MIGHT lead to DIFFERENCES in the DETERMINANTS of response to Vitamin D supplementation between Pregnant and nonpregnant women.']	[('SUPERFICIAL_RELATIONSHIP', 43), ('ANOMALY_CURIOUS_FINDING', 67), ('INCOMPLETE_EVIDENCE', 179), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 193), ('SUPERFICIAL_RELATIONSHIP', 212)]	5	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('GO_0007601', 'visual perception', 100, 'vitamin D'), ('GO_0008152', 'metabolic process', 110, 'metabolism'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D'), ('GO_0007565', 'female pregnancy', 274, 'pregnant')]
PMC5155676	12/2016	S84-PMC5155676	['when achievement of Vitamin D replete status at 34 weeks of Gestation was considered INSTEAD of absolute 25(Oh)D concentration, in multivariate analyses, Delivery in summer (relative risk [rr] = 1.20; 95%ci 1.09, 1.33; p< .001), white ethnicity (rr = 1.27; 95%ci 1.17, 1.37; p< .001), greater compliance with Medication (%) (rr = 1.01; 95%ci 1.00, 1.02; p = .03), and greater early Pregnancy 25(Oh)D concentration (nmol/l) (rr = 1.003; 95%ci 1.001, 1.006; p = .007) were significantly ASSOCIATED with achieving 25(Oh)D >50 nmol/l in the women randomized to Cholecalciferol.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 85), ('SUPERFICIAL_RELATIONSHIP', 485)]	2	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0007565', 'female pregnancy', 60, 'gestation'), ('CHEBI_71657', 'versiconol acetate', 105, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 111, 'D'), ('GO_0007567', 'parturition', 154, 'delivery'), ('CHEBI_60211', 'compound Z', 309, 'medication'), ('GO_0007565', 'female pregnancy', 382, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 392, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 511, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 511, '25(OH)D'), ('CHEBI_52550', 'theopalauamide', 557, 'cholecalciferol')]
PMC5155676	12/2016	S100-PMC5155676	['HOWEVER, when Vitamin D replete status was considered as the outcome, ONLY non-white maternal ethnicity and Delivery in winter were significant PREDICTORS of Vitamin D nonreplete status after supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 70), ('SUPERFICIAL_RELATIONSHIP', 144)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007567', 'parturition', 108, 'delivery'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D')]
PMC5155676	12/2016	S109-PMC5155676	['HOWEVER, IMPORTANTLY, when using a 25(Oh)D more than 50 nmol/l as a cut-point for repletion, Pregnancy weight gain was not an independent predictor of achieving Vitamin D repletion.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 9)]	3	[('CHEBI_71657', 'versiconol acetate', 35, '25(OH)D'), ('GO_0007565', 'female pregnancy', 93, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D')]
PMC5155676	12/2016	S112-PMC5155676	['HOWEVER, it is NOTABLE that there were marked DIFFERENCES in baseline 25(Oh)D concentrations between these investigations, and we OBSERVED that initial 25(Oh)D status was positively ASSOCIATED with both the LIKELIHOOD of achieving Vitamin D replete status and absolute 25(Oh)D status at 34 weeks of Gestation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 46), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 182), ('PROBABLE_UNDERSTANDING', 207)]	7	[('CHEBI_71657', 'versiconol acetate', 70, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 76, 'D'), ('CHEBI_63056', 'zinc cation', 152, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 158, 'D'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 269, '25(OH)D'), ('GO_0007565', 'female pregnancy', 299, 'gestation')]
PMC5155676	12/2016	S115-PMC5155676	['this mechanism MIGHT be IMPORTANT in preventing hypervitaminosis D. HOWEVER, studies comparing the effectiveness of DIFFERING doses of Vitamin D in Pregnancy HAVE SHOWN that 4000 iu/d CAN achieve a higher 25(Oh)D than 400 iu/d (10,28), BUT WHETHER these higher doses are of clinical benefit is YET to be DEMONSTRATED (4,29) and at the general population level, lower doses would be compatible with keeping 25(Oh)D below a concentration which MIGHT be concerning.']	[('INCOMPLETE_EVIDENCE', 15), ('IMPORTANT_CONSIDERATION', 24), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116), ('INCOMPLETE_EVIDENCE', 158), ('INCOMPLETE_EVIDENCE', 184), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 236), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 240), ('ANOMALY_CURIOUS_FINDING', 294), ('INCOMPLETE_EVIDENCE', 304), ('INCOMPLETE_EVIDENCE', 442)]	11	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 65, 'D'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('GO_0007565', 'female pregnancy', 148, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 205, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 205, '25(OH'), ('PR_000006444', 'diacylglycerol kinase delta', 211, 'D'), ('CHEBI_71657', 'versiconol acetate', 406, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 412, 'D')]
PMC5155676	12/2016	S132-PMC5155676	['it HAS BEEN demonstrated PREVIOUSLY that the incremental rise in 25(Oh)D after supplementation DIFFERS by Single Nucleotide Polymorphisms in Vitamin D Binding Protein (33,34) and 25-hydroxylase Genes (33).']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95)]	3	[('CHEBI_71657', 'versiconol acetate', 65, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 65, '25(OH ... D'), ('SO_0000694', 'SNP', 106, 'single nucleotide polymorphisms'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 141, 'vitamin D binding protein'), ('SO_0000704', 'gene', 194, 'genes')]
PMC5155676	12/2016	S133-PMC5155676	['ALTHOUGH this Genetic information CAN enable a more COMPREHENSIVE understanding of the biochemical response to Vitamin D supplementation, the current inability to undertake genotyping on a widespread population basis means this additional information WOULD NOT ALLOW for alterations to current clinical PRACTICE regarding Vitamin D supplementation in Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 34), ('PROBABLE_UNDERSTANDING', 52), ('DIFFICULT_TASK', 251), ('INCOMPLETE_EVIDENCE', 303)]	6	[('SO_0000704', 'gene', 14, 'genetic'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 322, 'vitamin D'), ('GO_0007565', 'female pregnancy', 351, 'pregnancy')]
PMC5167470	12/2016	S44-PMC5167470	['HOWEVER, daily ingestion of multivitamin tablets that include around 6,000–8,000 u/d of Vitamin A do not SEEM to increase the rate of malformations RELATED to Isotretinoine (13-Cis Retinoic) exposure, and this result is from SEVERAL long-term case-control STUDIES.25,26for Vitamin D, exposure to high doses increased the rate of fetal Cardiac malformations, especially Aortic stenosis, which HAS BEEN ASSOCIATED with an intake of 4,000 iu/d.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 105), ('SUPERFICIAL_RELATIONSHIP', 148), ('INCOMPLETE_EVIDENCE', 225), ('INCOMPLETE_EVIDENCE', 256), ('INCOMPLETE_EVIDENCE', 392), ('SUPERFICIAL_RELATIONSHIP', 401)]	7	[('CHEBI_27300', 'vitamin D', 88, 'vitamin A'), ('CHEBI_31719', 'ipriflavone', 159, 'isotretinoine'), ('CHEBI_33804', 'gluconates', 174, '13-cis'), ('CHEBI_26537', 'retinoid', 181, 'retinoic'), ('CHEBI_27300', 'vitamin D', 273, 'vitamin D'), ('UBERON_0000948', 'heart', 335, 'cardiac'), ('UBERON_0000947', 'aorta', 369, 'aortic')]
PMC5223368	12/2016	S138-PMC5223368	['THUS, IF the third trimester is in spring OR in summer, the status of maternal Vitamin D would be better than in OTHER seasons.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113)]	4	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC5240436	1/2017	S115-PMC5240436	['CONTRARY to our expectation BASED ON these PREVIOUS STUDIES, sq-Lns and mmn which contained both Vitamin A and zinc were not associated with a lower risk of p. falciparum parasitaemia.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 28), ('INCOMPLETE_EVIDENCE', 43)]	4	[('UBERON_0000029', 'lymph node', 64, 'LNS'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin A')]
PMC5241768	1/2017	S324-PMC5241768	['management of ckd in diabetesegfr (ml/min/1.73 m2)recommended managementall patients• yearly measurement of uacr, serum creatinine, and potassium45–60• refer to a nephrologist IF POSSIBILITY for nondiabetic Kidney disease exists (duration of type 1 diabetes <10 years, persistent albuminuria, abnormal findings on Renal ultrasound, resistant hypertension, rapid fall in egfr, or active Urinary sediment on Urine microscopic examination)• consider the need for dose adjustment of Medications• monitor egfr every 6 months• monitor electrolytes, bicarbonate, hemoglobin, calcium, Phosphorus, and Parathyroid hormone at least yearly• assure Vitamin D sufficiency• vaccinate against hepatitis b Virus• consider bone density testing• refer for dietary counseling30–44• monitor egfr every 3 months• monitor electrolytes, bicarbonate, calcium, phosphorus, Parathyroid hormone, hemoglobin, albumin, and weight every 3–6 months• consider THE NEED for dose adjustment of Medications<30• refer to a nephrologist\n\ndiabetic retinopathy\nrecommendations\noptimize Glycemic Control to reduce the RISK or slow the progression of diabetic retinopathy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 176), ('INCOMPLETE_EVIDENCE', 179), ('INCOMPLETE_EVIDENCE', 928), ('IMPORTANT_CONSIDERATION', 1078)]	4	[('UBERON_0002113', 'kidney', 207, 'kidney'), ('UBERON_0002113', 'kidney', 314, 'renal'), ('UBERON_0001088', 'urine', 386, 'urinary'), ('UBERON_0001088', 'urine', 406, 'urine'), ('CHEBI_25441', 'mycothiols', 479, 'medications'), ('CHEBI_35885', 'secondary phosphine', 577, 'phosphorus'), ('UBERON_0001132', 'parathyroid gland', 593, 'parathyroid'), ('CHEBI_27300', 'vitamin D', 637, 'vitamin D'), ('NCBITaxon_1', 'root', 690, 'virus'), ('UBERON_0001132', 'parathyroid gland', 848, 'parathyroid'), ('CHEBI_25441', 'mycothiols', 960, 'medications'), ('GO_0006094', 'gluconeogenesis', 1047, 'glycemic control')]
PMC5264377	7/2016	S20-PMC5264377	['there is a direct ASSOCIATION between Vitamin D levels and Fertilization rates in DIFFERENT Animal MODELS (panda et al ., 2001;luk et al ., 2012).']	[('SUPERFICIAL_RELATIONSHIP', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('INCOMPLETE_EVIDENCE', 99)]	3	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0009566', 'fertilization', 59, 'fertilization'), ('NCBITaxon_33208', 'Metazoa', 92, 'animal')]
PMC5264377	7/2016	S21-PMC5264377	['in Humans, the ROLE of Vitamin D in Fertilization, Embryo quality and Implantation is STILL CONTROVERSIAL (terushkin et al ., 2010;aleyasin et al ., 2011;rudick et al ., 2012;aflatoonian et al ., 2014;paffoni et al ., 2014;polyzos et al ., 2014).']	[('SUPERFICIAL_RELATIONSHIP', 15), ('IMPORTANT_CONSIDERATION', 86), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92)]	3	[('NCBITaxon_9606', 'Homo sapiens', 3, 'humans'), ('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0009566', 'fertilization', 36, 'fertilization'), ('UBERON_0000922', 'embryo', 51, 'embryo'), ('GO_0007566', 'embryo implantation', 70, 'implantation')]
PMC5264377	7/2016	S85-PMC5264377	['first we checked WHETHER follicular Vitamin D levels REPRODUCED Serum Vitamin D levels.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 53)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0001977', 'blood serum', 64, 'serum'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC5264377	7/2016	S100-PMC5264377	['ANOTHER PLAUSIBLE EXPLANATION is the molecular abduction of Vitamin D by Adipose Tissue discussed above.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('PROBABLE_UNDERSTANDING', 18)]	3	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0001013', 'adipose tissue', 73, 'adipose tissue')]
PMC5318550	2/2017	S19-PMC5318550	['HOWEVER, an integral test of these POSSIBLE explanations for the RISK of POOR Neurodevelopmental outcomes is LACKING and newer HYPOTHESES, such as variation in Vitamin D levels, HAVE NOT BEEN INVESTIGATED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 35), ('IMPORTANT_CONSIDERATION', 65), ('IMPORTANT_CONSIDERATION', 73), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 109), ('FULL_UNKNOWN', 109), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('INCOMPLETE_EVIDENCE', 127), ('FULL_UNKNOWN', 178), ('IMPORTANT_CONSIDERATION', 178)]	10	[('GO_0007399', 'nervous system development', 78, 'neurodevelopmental'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D')]
PMC5318550	2/2017	S28-PMC5318550	['next, we determined in additional models WHETHER this ASSOCIATION COULD BE explained by specific variables—thereby testing DIFFERENT HYPOTHESES; (2) sociodemographic factors and maternal iq; (3) child Birth weight and Gestational duration; (4) Pregnancy Vitamin D plasma status; (5) maternal nutritional intake; (6) maternal exposure to fever during Pregnancy; and (7) child age relative to peers at school.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 41), ('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 66), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 123), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 133)]	5	[('GO_0007567', 'parturition', 201, 'birth'), ('GO_0007565', 'female pregnancy', 218, 'gestational'), ('GO_0007565', 'female pregnancy', 244, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D'), ('GO_0007565', 'female pregnancy', 350, 'pregnancy')]
PMC5322422	2/2017	S67-PMC5322422	['HOWEVER, authors SPECULATE these ESTIMATES are lower than the actual figures because the number of exclusively Breastfed infants who do not receive intramuscular Vitamin K are UNKNOWN.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 33), ('FULL_UNKNOWN', 176)]	4	[('GO_0007567', 'parturition', 111, 'breastfed'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin K')]
PMC5322422	2/2017	S87-PMC5322422	['WHILE the differential diagnosis included spontaneous hemorrhage into normal Thymic Tissue, malignancy or Vitamin K ASSOCIATED bleeding into benign or malignant Tissue could not be ruled out.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 116)]	2	[('UBERON_0002370', 'thymus', 77, 'thymic tissue'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin K'), ('UBERON_0000479', 'tissue', 161, 'tissue')]
PMC5332602	3/2017	S53-PMC5332602	['the normal ranges of the levels of these elements in the Plasma or Serum of conventional Suckling Piglets are 44 to 91\xa0mg/dl for Glucose, 5.8 to 8.1\xa0g/dl for protein, 3.2 to 4.2\xa0g/dl for Albumin, 100 to 350\xa0ng/ml for Vitamin A, 0.4 to 5\xa0μg/ml for Vitamin E, and 50 to 150\xa0ng/ml for Selenium; HOWEVER, the respective ranges in gn Pigs are NOT ESTABLISHED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 292), ('ANOMALY_CURIOUS_FINDING', 292), ('FULL_UNKNOWN', 338)]	3	[('UBERON_0001969', 'blood plasma', 57, 'plasma'), ('UBERON_0001977', 'blood serum', 67, 'serum'), ('GO_0001967', 'suckling behavior', 89, 'suckling'), ('NCBITaxon_33208', 'Metazoa', 98, 'piglets'), ('CHEBI_17234', 'glucose', 129, 'glucose'), ('PR_000005908', 'alpha-crystallin B chain', 187, 'albumin'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 247, 'vitamin E'), ('CHEBI_27568', 'selenium atom', 282, 'selenium'), ('NCBITaxon_10088', 'Mus <genus>', 329, 'pigs')]
PMC5332602	3/2017	S181-PMC5332602	['THUS, UNLIKE in our MODEL of Prenatal Vitamin A deficiency (single-Micronutrient deficiency) (31), protein deficiency AFFECTED the levels or Homeostatic Control of multiple Macro- and Micronutrients, limiting the ability of neonatal Pigs to adapt/maintain Homeostasis through compensatory mechanisms.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 118)]	4	[('GO_0007565', 'female pregnancy', 29, 'prenatal'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin A'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 67, 'micronutrient'), ('GO_0042592', 'homeostatic process', 141, 'homeostatic'), ('GO_0065007', 'biological regulation', 153, 'control'), ('CHEBI_34830', 'mefenacet', 173, 'macro'), ('CHEBI_33839', 'macromolecule', 184, 'micronutrients'), ('NCBITaxon_10088', 'Mus <genus>', 233, 'pigs'), ('GO_0042592', 'homeostatic process', 256, 'homeostasis')]
PMC5340372	3/2017	S10-PMC5340372	['conclusion\nalthough a high CORRELATION was FOUND between maternal and Cord Vitamin D levels, the EFFECT on Respiratory outcome was DIFFERENT.']	[('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 97), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131)]	4	[('UBERON_0002240', 'spinal cord', 70, 'cord'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 107, 'respiratory')]
PMC5340372	3/2017	S16-PMC5340372	['measurements of Vitamin D Serum level 25-Hydroxyvitamin D [25(Oh)D] have yielded CONFLICTING results regarding the RELATIONSHIP between maternal- or Cord-Blood levels and subsequent Asthma Development [6–15].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('SUPERFICIAL_RELATIONSHIP', 115)]	2	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('UBERON_0001977', 'blood serum', 26, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 38, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 59, '25(OH)D'), ('UBERON_0002240', 'spinal cord', 149, 'cord'), ('UBERON_0000178', 'blood', 154, 'blood'), ('GO_0035801', 'adrenal cortex development', 182, 'asthma development')]
PMC5340372	3/2017	S25-PMC5340372	['HOWEVER, the RELATIONSHIP between Vitamin D levels and Respiratory function during infancy has NOT YET been clarified.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('FULL_UNKNOWN', 95)]	3	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 55, 'respiratory')]
PMC5340372	3/2017	S93-PMC5340372	['ALTHOUGH a circulating level of 25(Oh)D less than 20 ng/ml is DEFINED AS Vitamin D deficiency [27,28], the mean levels MAY VARY among DIFFERENT populations [29].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 62), ('PROBABLE_UNDERSTANDING', 70), ('INCOMPLETE_EVIDENCE', 119), ('DIFFICULT_TASK', 123), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 134)]	6	[('CHEBI_71657', 'versiconol acetate', 32, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 38, 'D'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC5340372	3/2017	S103-PMC5340372	['HOWEVER, in CONTRARY to these REPORTS, a survey in canadian children SHOWED that both low and high Vitamin D levels were RELATED to INCREASED RISK of wheeze and reduced performance of Lung function [35].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 121), ('IMPORTANT_CONSIDERATION', 132)]	6	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('UBERON_0002048', 'lung', 184, 'lung')]
PMC5340372	3/2017	S144-PMC5340372	['ALTHOUGH poor Lung function performance and an INCREASED RISK of Respiratory Tract infection were RELATED to relatively low cord Serum Vitamin D levels, FURTHER extrapolating the EFFECTS of Vitamin d on the Respiratory function of the general infant population MIGHT STILL BE DIFFICULT.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 47), ('SUPERFICIAL_RELATIONSHIP', 98), ('FUTURE_WORK', 153), ('SUPERFICIAL_RELATIONSHIP', 179), ('INCOMPLETE_EVIDENCE', 261), ('FUTURE_WORK', 267), ('DIFFICULT_TASK', 276)]	8	[('UBERON_0002048', 'lung', 14, 'lung'), ('UBERON_0000065', 'respiratory tract', 65, 'respiratory tract'), ('UBERON_0001977', 'blood serum', 129, 'serum'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 190, 'vitamin'), ('UBERON_0001004', 'respiratory system', 207, 'respiratory')]
PMC5351212	3/2017	S4-PMC5351212	['in addition, given the KNOWN immunomodulatory and neuroprotective EFFECTS of Vitamin D, we also INVESTIGATED WHETHER the co-administration of Vitamin D COULD block mia-induced asd-related behaviors.']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 66), ('QUESTION_ANSWERED_BY_THIS_WORK', 96), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 109), ('INCOMPLETE_EVIDENCE', 152)]	5	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D')]
PMC5351212	3/2017	S9-PMC5351212	['HOWEVER, Prenatal administration of Vitamin D had no effect on pro-inflammatory cytokine levels in dams or in fetal Brains SUGGESTING the anti-inflammatory actions of Vitamin d are not the CRITICAL mechanism for its preventive actions in this asd Animal MODEL.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 123), ('IMPORTANT_CONSIDERATION', 189), ('INCOMPLETE_EVIDENCE', 254)]	5	[('GO_0007565', 'female pregnancy', 9, 'prenatal'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0000955', 'brain', 116, 'brains'), ('CHEBI_33229', 'vitamin (role)', 167, 'vitamin'), ('NCBITaxon_33208', 'Metazoa', 247, 'animal')]
PMC5351212	3/2017	S35-PMC5351212	['THEREFORE, inflammatory factors produced early in Brain Development EITHER directly, by inducing mia, OR indirectly, by the maternal absence of a potent anti-inflammatory factor such as Vitamin D MAY, REPRESENT a CONVERGENT pathway towards developmental Brain abnormalities and psychiatric conditions later in Life.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('INCOMPLETE_EVIDENCE', 196), ('PROBABLE_UNDERSTANDING', 201), ('SUPERFICIAL_RELATIONSHIP', 213)]	5	[('GO_0007420', 'brain development', 50, 'brain development'), ('UBERON_0000955', 'brain', 50, 'brain'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('UBERON_0000955', 'brain', 254, 'brain'), ('UBERON_0000104', 'life cycle', 310, 'life')]
PMC5351212	3/2017	S39-PMC5351212	['(b) GIVEN the anti-inflammatory properties of Vitamin D, the PRESENT STUDY was DESIGNED TO INVESTIGATE WHETHER use of Calcitriol, [1α, 25-Dihydroxy Vitamin D3 (1,25Ohd)], the hormonally active form of Vitamin D, COULD prevent Poly(I:C)-induced behavioral dysfunctions RELEVANT TO asd, including deficits in Social Interaction, stereotyped behavior, innate anxiety, and Emotional Learning.']	[('PROBABLE_UNDERSTANDING', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 61), ('QUESTION_ANSWERED_BY_THIS_WORK', 79), ('QUESTION_ANSWERED_BY_THIS_WORK', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('INCOMPLETE_EVIDENCE', 212), ('SUPERFICIAL_RELATIONSHIP', 268)]	7	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 118, 'calcitriol'), ('CHEBI_43176', 'hydroxy group', 138, 'dihydroxy'), ('CHEBI_33279', 'vitamin D5', 148, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 148, 'vitamin D3'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 162, '25OHD'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D'), ('CHEBI_77358', 'CDP-dipalmitoyl-sn-glycerol', 226, 'poly(I:C'), ('GO_0019417', 'sulfur oxidation', 307, 'social interaction'), ('GO_0050959', 'echolocation', 369, 'emotional learning')]
PMC5351212	3/2017	S262-PMC5351212	['HOWEVER, the fact that mia with poly(I:c) has induced abnormalities in Social Interaction and Cognition at a more translationally RELEVANT age, i.e., juveniles, together with the presence of behavioral abnormalities not normally associated with schizophrenia such as altered digging behavior SUGGEST to us that this Animal MODEL MAY have greater relevance to asd\n\nvitddoes not alter maternal or fetal inflammatory Cytokine Production\nin VIEW OF the KNOWN immunomodulatory EFFECTS of Vitamin D, an obvious neuroprotective mechanism explored HERE was the POSSIBILITY that vitdameliorates the inflammatory response induced by Poly(I:c).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 130), ('INCOMPLETE_EVIDENCE', 292), ('INCOMPLETE_EVIDENCE', 323), ('INCOMPLETE_EVIDENCE', 329), ('INCOMPLETE_EVIDENCE', 437), ('INCOMPLETE_EVIDENCE', 449), ('SUPERFICIAL_RELATIONSHIP', 472), ('QUESTION_ANSWERED_BY_THIS_WORK', 540), ('INCOMPLETE_EVIDENCE', 553)]	10	[('CHEBI_51686', 'haematoxylin', 37, 'I'), ('GO_0019417', 'sulfur oxidation', 71, 'social interaction'), ('GO_0050890', 'cognition', 94, 'cognition'), ('NCBITaxon_33208', 'Metazoa', 316, 'animal'), ('GO_0001814', 'negative regulation of antibody-dependent cellular cytotoxicity', 414, 'cytokine production'), ('CHEBI_27300', 'vitamin D', 483, 'vitamin D'), ('CHEBI_37311', 'einsteinium molecular entity', 623, 'poly'), ('CHEBI_51686', 'haematoxylin', 628, 'I')]
PMC5351212	3/2017	S304-PMC5351212	['finally, GIVEN that mia and maternal Vitamin D deficiency are both risk-modifying factors for autism and GIVEN that the distinct OVERLAP in behavioral phenotypes produced in the Animal MODELS of these environmental RISK FACTORS, we ADDRESSED the issue of WHETHER mia induces Vitamin D deficiency.']	[('PROBABLE_UNDERSTANDING', 9), ('PROBABLE_UNDERSTANDING', 105), ('SUPERFICIAL_RELATIONSHIP', 129), ('INCOMPLETE_EVIDENCE', 185), ('SUPERFICIAL_RELATIONSHIP', 215), ('QUESTION_ANSWERED_BY_THIS_WORK', 232), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 255)]	7	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 178, 'animal'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D')]
PMC5351212	3/2017	S305-PMC5351212	['OBVIOUSLY, IF this were the case then the corrective actions of the active Vitamin D hormone MAY SIMPLY be treating an mia-induced Vitamin D deficiency.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('INCOMPLETE_EVIDENCE', 93), ('ANOMALY_CURIOUS_FINDING', 97)]	4	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC5351212	3/2017	S306-PMC5351212	['HOWEVER, our results clearly SHOW no effect of Poly(I:C) on both major Circulatory measures of Vitamin D, RULING OUT this POSSIBILITY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 106), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 106), ('INCOMPLETE_EVIDENCE', 122)]	6	[('CHEBI_77358', 'CDP-dipalmitoyl-sn-glycerol', 47, 'poly(I:C'), ('UBERON_0001009', 'circulatory system', 71, 'circulatory'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC5368580	4/2017	S138-PMC5368580	['HOWEVER, when compared with their adequate intakes, ONLY 2.3–11.1% of Thiamin, 2.8–7.9% of riboflavin, and 8.6–22.3% of Vitamin A were transferred to the milk via maternal supplement, whereas 30.7–98.9% of the adequate intake was provided by maternal Vitamin B-6 supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 52)]	3	[('CHEBI_26948', 'vitamin B1', 70, 'thiamin'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 251, 'vitamin B'), ('PR_000017255', 'Vang-like protein 1', 251, 'vitamin B-6')]
PMC5368580	4/2017	S165-PMC5368580	['we found significant differences between the 3 aliquots (i, ii, and iii) collected within a Feeding for some of the Vitamins analyzed (Thiamin, riboflavin, niacin, Vitamin A, vitamin afat, vitamin efat, and fat), WHEREAS others (Vitamins B-6 and B-12) were not affected.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 213)]	1	[('GO_0007631', 'feeding behavior', 92, 'feeding'), ('CHEBI_33277', 'gamma-tocotrienol', 116, 'vitamins'), ('CHEBI_26948', 'vitamin B1', 135, 'thiamin'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin A'), ('CHEBI_33277', 'gamma-tocotrienol', 229, 'vitamins'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 229, 'vitamins B-6'), ('PR_000004770', 'Polycomb complex protein BMI-1', 246, 'B-12')]
PMC5368580	4/2017	S175-PMC5368580	['without supplementation, the morning hours (0900–0959) and early afternoon hours (1500–1559) were also acceptable for sample collection based on their lower variation in Vitamin concentrations, WHEREAS increases in the concentration of riboflavin and Vitamin B-6 in milk during the early afternoon on days 2 and 3 reflected acute EFFECTS of maternal supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 194), ('SUPERFICIAL_RELATIONSHIP', 330)]	2	[('CHEBI_33229', 'vitamin (role)', 170, 'vitamin'), ('CHEBI_27300', 'vitamin D', 251, 'vitamin B'), ('PR_000017255', 'Vang-like protein 1', 251, 'vitamin B-6')]
PMC5368580	4/2017	S187-PMC5368580	['NEVERTHELESS, in the case of Vitamin B-6, this limited secretion accounted for ∼30–100% of the value assumed to set the adequate intake for infants aged 0–6 mo.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('CHEBI_27300', 'vitamin D', 29, 'vitamin B'), ('PR_000017255', 'Vang-like protein 1', 29, 'vitamin B-6')]
PMC5368580	4/2017	S188-PMC5368580	['moreover, we FOUND that the acute EFFECTS of maternal supplementation REMAINED significant for riboflavin and Vitamin B-6 in the fasting Milk samples 24 h after supplementation compared with day 1, and that the Vitamins were not Secreted into Milk at the same rate throughout a day during maternal supplementation, resulting in a bolus dose of ≤35% of the adequate intake for Vitamin B-6 during a single Feeding, WHEREAS the bolus dose for riboflavin during a single Feeding only provided ∼11% of the adequate intake.']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 34), ('INCOMPLETE_EVIDENCE', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 413)]	4	[('CHEBI_27300', 'vitamin D', 110, 'vitamin B'), ('PR_000017255', 'Vang-like protein 1', 110, 'vitamin B-6'), ('UBERON_0001913', 'milk', 137, 'milk'), ('CHEBI_33277', 'gamma-tocotrienol', 211, 'vitamins'), ('GO_0046903', 'secretion', 229, 'secreted'), ('UBERON_0001913', 'milk', 243, 'milk'), ('CHEBI_27300', 'vitamin D', 376, 'vitamin B'), ('PR_000017255', 'Vang-like protein 1', 376, 'vitamin B-6'), ('GO_0007631', 'feeding behavior', 404, 'feeding'), ('GO_0007631', 'feeding behavior', 467, 'feeding')]
PMC5371920	3/2017	S135-PMC5371920	['IN CONTRAST, 25(Oh)D concentrations in mothers allocated to Vitamin D supplementation rose REGARDLESS OF season of Delivery.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 91)]	2	[('CHEBI_71657', 'versiconol acetate', 13, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 19, 'D'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007567', 'parturition', 115, 'delivery')]
PMC5372327	3/2017	S3-PMC5372327	['it REMAINS UNCLEAR WHETHER the RECOMMENDED doses are sufficient for the wide array of OTHER EFFECTS of Vitamin D. the vidi trial performed in finland is the FIRST large randomised controlled study for evaluation of the EFFECTS of different Vitamin D supplemental doses in infancy on:\nbone strength\ninfections and immunity\nallergy, atopy and asthma\nCognitive development\nGenetic Regulation Of Mineral Homeostasis\n\nmethods/design\nvidi, a randomised controlled double-blinded single-centre intervention study is conducted in infants from the age of 2\xa0weeks to 24\xa0months.']	[('FULL_UNKNOWN', 3), ('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('FUTURE_WORK', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 157), ('SUPERFICIAL_RELATIONSHIP', 219)]	8	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D'), ('GO_0050890', 'cognition', 348, 'cognitive'), ('SO_0000704', 'gene', 370, 'genetic'), ('GO_1900046', 'regulation of hemostasis', 378, 'regulation of ... homeostasis'), ('CHEBI_46662', 'mineral', 392, 'mineral')]
PMC5372327	3/2017	S29-PMC5372327	['HOWEVER, data on the RELATIONSHIP between Vitamin D and bmd in children are SOMEWHAT CONTRADICTORY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 21), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 76), ('INCOMPLETE_EVIDENCE', 76), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 85)]	5	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
PMC5372327	3/2017	S30-PMC5372327	['in healthy children aged 8–17 years with S-25-Ohd levels above 50\xa0nmol/l, no effect of Vitamin D supplementation on bmd is seen [14], and the RELATIONSHIP between bmd and s-25-Ohd is INCONSISTENT in infants and young children [15].']	[('SUPERFICIAL_RELATIONSHIP', 142), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 183)]	2	[('CHEBI_86929', 'S b G-5,5-G b S A CH2', 41, 'S-25-OHD'), ('PR_000000036', 'BMP receptor type-1B', 42, '-25'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('CHEBI_72765', 'verruculogen', 173, '25-OHD')]
PMC5372327	3/2017	S41-PMC5372327	['in Adults, Vitamin D insufficiency increases the RISK of SEVERE infections [28], BUT the results from intervention trials are CONFLICTING [29].']	[('IMPORTANT_CONSIDERATION', 49), ('IMPORTANT_CONSIDERATION', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 126)]	4	[('UBERON_0007023', 'adult organism', 3, 'adults'), ('CHEBI_27300', 'vitamin D', 11, 'vitamin D')]
PMC5372327	3/2017	S48-PMC5372327	['HOWEVER, findings have NOT been CONSISTENT [39] and RECENT STUDIES on Prenatal Vitamin D supplementation have not demonstrated an EFFECT on wheezing at 3\xa0years of age [40,41].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 130)]	5	[('GO_0007565', 'female pregnancy', 70, 'prenatal'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC5372327	3/2017	S123-PMC5372327	['to date, epidemiological studies and randomised intervention trials have DEMONSTRATED CONFLICTING results on, for example, the EFFECT of Vitamin D supplementation on childhood infections and on Neurocognitive functioning.']	[('INCOMPLETE_EVIDENCE', 73), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('SUPERFICIAL_RELATIONSHIP', 127)]	3	[('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('GO_0050905', 'neuromuscular process', 194, 'neurocognitive')]
PMC5372327	3/2017	S135-PMC5372327	['HOWEVER, DUE TO the randomised controlled study design our study will provide valuable data on the EFFECTS of Vitamin D substitution in populations with variable Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('SUPERFICIAL_RELATIONSHIP', 99)]	3	[('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D')]
PMC5372327	3/2017	S136-PMC5372327	['in addition, the study is designed to have control over the most common sources of Vitamin D.\nIF the results from the vidi-trial CONFIRM the connections between the increased dose of Vitamin D and the primary outcomes, the health benefits gained by a population-wide supplementation with higher Vitamin D dose — a simple and low-cost INTERVENTION — are obvious.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 94), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 334)]	3	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D')]
PMC5385921	4/2017	S40-PMC5385921	['ALTHOUGH there is SOME DEBATE about the definition of these strata,21there is no DEBATE that children with 25Ohd concentrations of <25 nmol/l have Vitamin D deficiency (AS defined by an increased risk of rickets and increased Parathyroid hormone).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('PROBABLE_UNDERSTANDING', 169)]	6	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 107, '25OHD'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('UBERON_0001132', 'parathyroid gland', 226, 'parathyroid')]
PMC5385921	4/2017	S120-PMC5385921	['ASSUMING that the variables of interest are causally RELATED and that other VARIABLES remain unchanged), optimising Vitamin D status of this sample COULD BE ASSOCIATED with a reduction in the prevalence of asd of APPROXIMATELY 10%.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 148), ('SUPERFICIAL_RELATIONSHIP', 157), ('INCOMPLETE_EVIDENCE', 213)]	6	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC5385921	4/2017	S123-PMC5385921	['Rodent MODELS BASED ON transient Prenatal exposure to Vitamin D deficiency have FOUND a range of persistent molecular, neurochemical and behavioural changes of interest to neuropsychiatry.32a number OF STUDIES have LINKED asd with Neuronal Migration.33migration-ASSOCIATED phenotypes such as changes in Neuronal density and volume, aberrant Minicolumns and heterotopias HAVE BEEN detected in patients with asd.34,35as Neuronal Migration starts at 6 weeks Gestation and USUALLY ends around 24 weeks Gestation, the OBSERVED ASSOCIATION between our mid-Gestation samples, which were drawn at ~20 weeks Gestation, and risk of asd CORROBORATES our PREVIOUS FINDINGS LINKING Vitamin D deficiency with abnormal Brain Development.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 7), ('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 14), ('PROBABLE_UNDERSTANDING', 14), ('INCOMPLETE_EVIDENCE', 80), ('INCOMPLETE_EVIDENCE', 199), ('SUPERFICIAL_RELATIONSHIP', 215), ('SUPERFICIAL_RELATIONSHIP', 262), ('INCOMPLETE_EVIDENCE', 370), ('INCOMPLETE_EVIDENCE', 469), ('INCOMPLETE_EVIDENCE', 513), ('SUPERFICIAL_RELATIONSHIP', 522), ('INCOMPLETE_EVIDENCE', 626), ('INCOMPLETE_EVIDENCE', 643), ('SUPERFICIAL_RELATIONSHIP', 661)]	15	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Rodent'), ('GO_0007565', 'female pregnancy', 33, 'prenatal'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CL_0000540', 'neuron', 231, 'neuronal'), ('GO_0001764', 'neuron migration', 231, 'neuronal migration'), ('CL_0000540', 'neuron', 303, 'neuronal'), ('UBERON_0016512', 'lumen of duodenum', 341, 'minicolumns'), ('CL_0000540', 'neuron', 418, 'neuronal'), ('GO_0001764', 'neuron migration', 418, 'neuronal migration'), ('GO_0007565', 'female pregnancy', 455, 'gestation'), ('GO_0007565', 'female pregnancy', 498, 'gestation'), ('GO_0007565', 'female pregnancy', 550, 'gestation'), ('GO_0007565', 'female pregnancy', 599, 'gestation'), ('CHEBI_27300', 'vitamin D', 669, 'vitamin D'), ('GO_0007420', 'brain development', 704, 'brain development'), ('UBERON_0000955', 'brain', 704, 'brain')]
PMC5405075	4/2017	S5-PMC5405075	['ALTHOUGH, the results of rcts SHOWED a POTENTIAL ASSOCIATION with asthma-RELATED phenotypes RATHER than asthma per se , the low toxicity of Vitamin D supplements make it TEMPTING to SPECULATE that Pregnant women at a high RISK of obtaining a child with asthma MAY BE benefited, ESPECIALLY if they are Vitamin D deficient.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 49), ('SUPERFICIAL_RELATIONSHIP', 73), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('INCOMPLETE_EVIDENCE', 170), ('INCOMPLETE_EVIDENCE', 182), ('IMPORTANT_CONSIDERATION', 222), ('INCOMPLETE_EVIDENCE', 260), ('ANOMALY_CURIOUS_FINDING', 278)]	12	[('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('GO_0007565', 'female pregnancy', 197, 'pregnant'), ('CHEBI_27300', 'vitamin D', 301, 'vitamin D')]
PMC5405075	4/2017	S13-PMC5405075	['HOWEVER, it REMAINS UNCLEAR WHETHER maternal Vitamin D deficiency MAY CONTRIBUTE to the development of childhood asthma OR it is the consequence of a GENERALLY altered biochemistry.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 70), ('PROBABLE_UNDERSTANDING', 150)]	7	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC5405075	4/2017	S16-PMC5405075	['it is, HOWEVER, INTERESTING that, during this period, Vitamin D Metabolism is shifted from the classical determinants of Calcium Homeostasis to OTHER Regulatory mechanisms.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 7), ('ANOMALY_CURIOUS_FINDING', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 144)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 54, 'vitamin D metabolism'), ('GO_0055073', 'cadmium ion homeostasis', 121, 'calcium homeostasis'), ('GO_0065007', 'biological regulation', 150, 'regulatory')]
PMC5405075	4/2017	S31-PMC5405075	['the most cited adverse outcome of maternal Vitamin D deficiency is neonatal rickets, WHILE mild hypovitaminosis D COULD BE more pronounced in exclusively Breast-Fed infants, on the BASIS that Breast Milk constitutes a POOR source of Vitamin D compared with formulas (34–36).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 85), ('ANOMALY_CURIOUS_FINDING', 85), ('INCOMPLETE_EVIDENCE', 114), ('PROBABLE_UNDERSTANDING', 181), ('IMPORTANT_CONSIDERATION', 218)]	5	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 112, 'D'), ('GO_0007567', 'parturition', 154, 'breast'), ('UBERON_0000310', 'breast', 154, 'breast'), ('GO_0007631', 'feeding behavior', 161, 'fed'), ('UBERON_0001348', 'brown adipose tissue', 192, 'breast milk'), ('CHEBI_27300', 'vitamin D', 233, 'vitamin D')]
PMC5405075	4/2017	S42-PMC5405075	['INCONSISTENCIES across studies HAVE BEEN ATTRIBUTED to a plethora of FACTORS such as diverse study designs, MISSING significant follow-up, lack OF a clear definition of vitamin d sufficiency in Pregnancy, REMARKABLE fluctuations in populations in different latitudes, Genetic heterogeneity, the diversity of assays employed (69), low repeatability of Serum 25(Oh)D values (37), variety of Vitamin D status DETERMINANTS, multifactorial nature and phenotypical diversity of asthma, as well as imprecision in diagnosing asthma in early Life.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 41), ('SUPERFICIAL_RELATIONSHIP', 69), ('PROBLEM_COMPLICATION', 108), ('ANOMALY_CURIOUS_FINDING', 144), ('ANOMALY_CURIOUS_FINDING', 205), ('SUPERFICIAL_RELATIONSHIP', 406)]	8	[('GO_0007565', 'female pregnancy', 194, 'pregnancy'), ('SO_0000704', 'gene', 268, 'genetic'), ('UBERON_0001977', 'blood serum', 351, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 360, 'OH)D'), ('CHEBI_27300', 'vitamin D', 389, 'vitamin D'), ('UBERON_0000104', 'life cycle', 533, 'life')]
PMC5405075	4/2017	S45-PMC5405075	['the INCONSISTENT body of EVIDENCE with glimmer of positivity from observational prospective cohorts, the RATHER low toxicity of Vitamin D, which is a relative inexpensive CANDIDATE in the attenuation of the asthma’s EPIDEMIC BURDEN on PUBLIC HEALTH, were clearly INDICATIVE of THE NEED to proceed to clinical trials.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 105), ('INCOMPLETE_EVIDENCE', 171), ('IMPORTANT_CONSIDERATION', 216), ('IMPORTANT_CONSIDERATION', 235), ('PROBABLE_UNDERSTANDING', 263), ('INCOMPLETE_EVIDENCE', 277)]	8	[('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC5405075	4/2017	S54-PMC5405075	['HOWEVER, these clinical trials were BIASED by many LIMITATIONS, such as SMALL SIZE, Vitamin D administration ONLY in the last Trimester of Pregnancy, POSSIBLY INADEQUATE maternal dose administration, WHILE authors also acknowledged that they were NOT PRIMARY designed to assess the specific outcome.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 36), ('PROBLEM_COMPLICATION', 36), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 109), ('INCOMPLETE_EVIDENCE', 150), ('IMPORTANT_CONSIDERATION', 159), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 200), ('INCOMPLETE_EVIDENCE', 247)]	10	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 126, 'trimester'), ('GO_0007565', 'female pregnancy', 139, 'pregnancy')]
PMC5405075	4/2017	S56-PMC5405075	['still, the ASSOCIATION of Vitamin D with asthma, AMBIGUOUSLY emerged from observational studies, COULD NOT be confirmed and established AS a causative FACTOR.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 49), ('DIFFICULT_TASK', 97), ('PROBABLE_UNDERSTANDING', 136), ('SUPERFICIAL_RELATIONSHIP', 151)]	5	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D')]
PMC5405075	4/2017	S82-PMC5405075	['taken all TOGETHER, Vitamin D SHOWS a POTENTIAL ASSOCIATION RATHER with asthma-RELATED phenotypes than with asthma per se .']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 60), ('SUPERFICIAL_RELATIONSHIP', 79)]	6	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D')]
PMC5405075	4/2017	S84-PMC5405075	['THEREFORE, it remains to be answered IF a real cause-effect RELATIONSHIP exists OR Vitamin D exerts a PROTECTIVE ROLE via OTHER UNDERLYING mechanisms of this MULTIFACTORIAL disease, such as Lung function or protection against Viral infections.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 37), ('SUPERFICIAL_RELATIONSHIP', 60), ('SUPERFICIAL_RELATIONSHIP', 102), ('SUPERFICIAL_RELATIONSHIP', 113), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('SUPERFICIAL_RELATIONSHIP', 128), ('DIFFICULT_TASK', 158)]	8	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('UBERON_0002048', 'lung', 190, 'lung'), ('NCBITaxon_1', 'root', 226, 'viral')]
PMC5405075	4/2017	S89-PMC5405075	['moreover, it HAS BEEN PROPOSED that studies SHOULD focus on Vitamin D status in early Pregnancy and supplementary administration SHOULD BE initiated from the first Trimester of Gestation in order to observe the OPTIMAL EFFECT on RISK of childhood asthma, THOUGH EVIDENCE from chawes et al.’s clinical trial DID NOT CONFIRM this NOTION (75).']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 22), ('FUTURE_WORK', 44), ('FUTURE_WORK', 129), ('IMPORTANT_CONSIDERATION', 211), ('SUPERFICIAL_RELATIONSHIP', 219), ('IMPORTANT_CONSIDERATION', 229), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 255), ('ANOMALY_CURIOUS_FINDING', 255), ('INCOMPLETE_EVIDENCE', 262), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 307), ('INCOMPLETE_EVIDENCE', 328)]	12	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 86, 'pregnancy'), ('GO_0009294', 'DNA mediated transformation', 164, 'trimester'), ('GO_0007565', 'female pregnancy', 177, 'gestation')]
PMC5405075	4/2017	S93-PMC5405075	['a plethora of environmental and Genetic/epigenetic FACTORS CONTRIBUTE in a COMPLEX manner to a PARTLY understood pathogenesis, WHILE the shifted Vitamin D Metabolism during Pregnancy is also NOT FULLY ELUCIDATED.']	[('SUPERFICIAL_RELATIONSHIP', 51), ('SUPERFICIAL_RELATIONSHIP', 59), ('DIFFICULT_TASK', 75), ('INCOMPLETE_EVIDENCE', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('INCOMPLETE_EVIDENCE', 191)]	6	[('SO_0000704', 'gene', 32, 'genetic'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 145, 'vitamin D metabolism'), ('GO_0007565', 'female pregnancy', 173, 'pregnancy')]
PMC5405075	4/2017	S96-PMC5405075	['SHIFTING the discussion to a clinical platform, Vitamin D administration during Pregnancy has NOT YET been justified.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FULL_UNKNOWN', 94)]	2	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy')]
PMC5405075	4/2017	S102-PMC5405075	['HOWEVER, given the RATHER low toxicity of such a Supplement, Pregnant women at a high risk of obtaining a child with asthma MAY BE benefited, especially IF they are Vitamin D deficient.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('INCOMPLETE_EVIDENCE', 124), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 153)]	4	[('CHEBI_16158', 'steroid sulfate', 49, 'supplement'), ('GO_0007565', 'female pregnancy', 61, 'pregnant'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D')]
PMC5410409	4/2017	S62-PMC5410409	['SOME REPORTED that high maternal Vitamin D intake during Pregnancy was ASSOCIATED with reduced RISK of wheezing in the child, WHILE SOME SHOWED no effect.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 71), ('IMPORTANT_CONSIDERATION', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 126), ('INCOMPLETE_EVIDENCE', 132), ('INCOMPLETE_EVIDENCE', 137)]	7	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007565', 'female pregnancy', 57, 'pregnancy')]
PMC5410409	4/2017	S64-PMC5410409	['the CONFLICTING results MAY reflect Genetic variability in the general population in the Metabolism and allergy preventive EFFECTS of Vitamin D supplementation in the child [67].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 123)]	3	[('SO_0000704', 'gene', 36, 'genetic'), ('GO_0008152', 'metabolic process', 89, 'metabolism'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC5410409	4/2017	S193-PMC5410409	['also, the 2 cohort studies on Vitamin D supplementation have CONFLICTING results.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 61)]	1	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D')]
PMC5418719	5/2017	S12-PMC5418719	['HOWEVER, NO CONSENSUS RECOMMENDATION for Vitamin D deficiency was made specifically for preterm infants, BECAUSE FEW DATA on bone mineralization rates in utero are reported.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('FUTURE_WORK', 22), ('PROBLEM_COMPLICATION', 105), ('INCOMPLETE_EVIDENCE', 113)]	5	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D')]
PMC5418719	5/2017	S13-PMC5418719	['the european GUIDELINE on daily Vitamin D supplementation RECOMMEND 800 to 1000\xa0iu/day for preterm infants, WHILE western countries RECOMMEND 400\xa0iu/day [3].']	[('PROBABLE_UNDERSTANDING', 13), ('FUTURE_WORK', 58), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 108), ('FUTURE_WORK', 132)]	4	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D')]
PMC5418719	5/2017	S14-PMC5418719	['ALTHOUGH the incidence of Vitamin D insufficiency in preterm infants varies according TO DIFFERENT geographical locations, mean Serum 25(Oh)D levels during 1–3 days after Birth in preterm infants ranges from 9.5 to 25\xa0ng/ml in both europe and western world [4–7].']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 86), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 89)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('UBERON_0001977', 'blood serum', 128, 'serum'), ('CHEBI_71657', 'versiconol acetate', 134, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 134, '25(OH ... D'), ('GO_0007567', 'parturition', 171, 'birth')]
PMC5418719	5/2017	S16-PMC5418719	['WHILE Breast Milk Feeding is currently RECOMMENDED as a source of early nutrition in full and preterm infants, an infant diet with Breast Milk alone does not contain enough Vitamin D. the definition of Vitamin D sufficiency in preterm infants is STILL CONTROVERSIAL; optimal Vitamin D status is BASED ON the Vitamin D concentrations for multiple health outcomes in Adults with a target value for 25(Oh)D levels >30\xa0ng/ml [8].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 39), ('IMPORTANT_CONSIDERATION', 246), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 252), ('QUESTION_ANSWERED_BY_THIS_WORK', 295), ('SUPERFICIAL_RELATIONSHIP', 295)]	6	[('UBERON_0001348', 'brown adipose tissue', 6, 'breast milk'), ('GO_0007614', 'short-term memory', 13, 'milk'), ('GO_0007631', 'feeding behavior', 18, 'feeding'), ('UBERON_0001348', 'brown adipose tissue', 131, 'breast milk'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 308, 'vitamin D'), ('UBERON_0007023', 'adult organism', 365, 'adults'), ('CHEBI_71657', 'versiconol acetate', 396, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 396, '25(OH ... D')]
PMC5418719	5/2017	S18-PMC5418719	['NEVERTHELESS, the APPROPRIATE amount of Vitamin D REQUIRED for optimal growth in vlbw is STILL IMPORTANT ISSUE to address.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 18), ('IMPORTANT_CONSIDERATION', 50), ('IMPORTANT_CONSIDERATION', 89), ('IMPORTANT_CONSIDERATION', 95), ('PROBLEM_COMPLICATION', 105)]	6	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC5418719	5/2017	S19-PMC5418719	['the AIM of THIS STUDY was TO DETERMINE WHETHER daily Vitamin D supplementation with a high dose of 800\xa0iu is SAFE and EFFECTIVE to increase the proportion of vlbw infants with 25(Oh)D\u2009>\u200930\xa0ng/ml, from 2\xa0weeks of age until hospital discharge.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 39), ('IMPORTANT_CONSIDERATION', 109), ('SUPERFICIAL_RELATIONSHIP', 118)]	6	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 176, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 176, '25(OH)D')]
PMC5418719	5/2017	S70-PMC5418719	['HOWEVER, neonates Born during the Vitamin D Synthesis period, from april to october (20 neonates, 69%), had higher 25(Oh)D concentrations in Cord Blood samples than those not Born during the Vitamin D Synthesis period (7 neonates, 35%; p \u2009=\u20090.023; table\xa01).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0)]	2	[('GO_0007567', 'parturition', 18, 'born'), ('CHEBI_28384', 'vitamin K', 34, 'Vitamin D'), ('GO_0042358', 'thiamine diphosphate catabolic process', 34, 'Vitamin D synthesis'), ('CHEBI_71657', 'versiconol acetate', 115, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 121, 'D'), ('UBERON_0002240', 'spinal cord', 141, 'cord'), ('UBERON_0000178', 'blood', 146, 'blood'), ('GO_0007567', 'parturition', 175, 'born'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 191, 'vitamin D synthesis')]
PMC5418719	5/2017	S89-PMC5418719	['discussion\nTHIS PROSPECTIVE STUDY was PLANNED TO DETERMINE WHETHER 800\xa0iu Vitamin D supplementation from 2\xa0weeks of age is SAFE and EFFECTIVE to reach sufficient Vitamin D levels at 36\xa0weeks pma in vlbw infants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 38), ('QUESTION_ANSWERED_BY_THIS_WORK', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 59), ('IMPORTANT_CONSIDERATION', 123), ('SUPERFICIAL_RELATIONSHIP', 132)]	6	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D')]
PMC5418719	5/2017	S92-PMC5418719	['WHILE the use of 800\xa0iu/d of Vitamin D achieved Serum 25(Oh)D concentrations to the ADEQUATE range of 30–80\xa0ng/ml without toxicity at 36\xa0weeks pma, this dose MAY STILL be too low to restore Vitamin D stores for the MAJORITY of infants with 25(Oh)D concentrations\u2009<\u200910\xa0ng/ml at Birth.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 84), ('INCOMPLETE_EVIDENCE', 158), ('IMPORTANT_CONSIDERATION', 162), ('PROBABLE_UNDERSTANDING', 215)]	5	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('UBERON_0001977', 'blood serum', 48, 'serum'), ('CHEBI_71657', 'versiconol acetate', 54, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 54, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 240, '25(OH)D'), ('GO_0007567', 'parturition', 277, 'birth')]
PMC5418719	5/2017	S100-PMC5418719	['HOWEVER, the exact and efficient timing of Vitamin D-dependent absorption of calcium REMAINS UNKNOWN in preterm infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FULL_UNKNOWN', 85)]	2	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D')]
PMC5418719	5/2017	S102-PMC5418719	['this LACK OF EVIDENCE has resulted in VARYING practices among neonatologists, and CONTROVERSY REMAINS about the thresholds and STRATEGIES for Vitamin D intake of 800\xa0iu among vlbw infants earlier in Life.']	[('INCOMPLETE_EVIDENCE', 5), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('INCOMPLETE_EVIDENCE', 94), ('FUTURE_WORK', 127)]	5	[('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('UBERON_0000104', 'life cycle', 199, 'life')]
PMC5418719	5/2017	S104-PMC5418719	['ALTHOUGH a number of Vitamin D deficiency was significantly lower after supplementation than before supplementation in the PRESENT STUDY, supplementation with 800\xa0iu MIGHT not be sufficient to achieve optimal Vitamin D levels in preterm infants with UNDERLYING level of Vitamin D deficiency from Birth.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 123), ('INCOMPLETE_EVIDENCE', 166), ('SUPERFICIAL_RELATIONSHIP', 250)]	5	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D'), ('GO_0007567', 'parturition', 296, 'birth')]
PMC5418719	5/2017	S105-PMC5418719	['the DIFFERENT response to Vitamin D supplementation COULD BE EXPLAINED by vdr Gene polymorphism INVOLVED in Vitamin D Receptor, which results in Vitamin D deficiency at 36 pma in SOME babies after supplementation [24].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 52), ('ANOMALY_CURIOUS_FINDING', 58), ('PROBABLE_UNDERSTANDING', 61), ('SUPERFICIAL_RELATIONSHIP', 96), ('INCOMPLETE_EVIDENCE', 179)]	6	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('SO_0000704', 'gene', 78, 'gene'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 108, 'vitamin D receptor'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
PMC5418719	5/2017	S107-PMC5418719	['HOWEVER, RECOMMENDED oral Vitamin D supplementation to attain adequate Serum 25(Oh)D concentrations has not been recognized in vlbw infants with underlying level of Vitamin D deficiency from Birth.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 9)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('UBERON_0001977', 'blood serum', 71, 'serum'), ('CHEBI_71657', 'versiconol acetate', 77, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 83, 'D'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D'), ('GO_0007567', 'parturition', 191, 'birth')]
PMC5426325	4/2017	S15-PMC5426325	['in denmark, the reintroduction of fortified Foods to improve the general population’s Vitamin D status is currently being CONSIDERED, and its justification is part of an ongoing international DEBATE.']	[('FUTURE_WORK', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 192)]	2	[('CHEBI_33290', 'food', 44, 'foods'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC5426325	4/2017	S16-PMC5426325	['until 1 june 1985, Vitamin D fortification of Margarine was MANDATORY in denmark, BUT fortification was abolished, RELATED to an UNSUPPORTED ASSUMPTION that the amounts added to Margarine were too small to IMPACT the dietary NEEDS of Vitamin D in the danish population(3).']	[('IMPORTANT_CONSIDERATION', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('SUPERFICIAL_RELATIONSHIP', 115), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 129), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('SUPERFICIAL_RELATIONSHIP', 206), ('IMPORTANT_CONSIDERATION', 225)]	7	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_6784', 'mestranol', 46, 'margarine'), ('CHEBI_6784', 'mestranol', 178, 'margarine'), ('CHEBI_27300', 'vitamin D', 234, 'vitamin D')]
PMC5426325	4/2017	S27-PMC5426325	['we DID NOT identify OTHER abrupt societal changes during 1983–1988 that POTENTIALLY COULD INFLUENCE our results, neither in relation to fortification practices in other Food products for Consumption(31,32), nor in relation to Margarine intake in the danish population(33)or in relation to national RECOMMENDATIONS for Vitamin D supplementation to Pregnant women or infants.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 20), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 84), ('SUPERFICIAL_RELATIONSHIP', 90), ('FUTURE_WORK', 298)]	6	[('CHEBI_33290', 'food', 169, 'food'), ('GO_0007631', 'feeding behavior', 187, 'consumption'), ('CHEBI_6784', 'mestranol', 226, 'margarine'), ('CHEBI_27300', 'vitamin D', 318, 'vitamin D'), ('GO_0007565', 'female pregnancy', 347, 'pregnant')]
PMC5426325	4/2017	S119-PMC5426325	['THUS, we CANNOT RULE OUT WHETHER the Birth cohort results REFLECT a TRUE adverse EFFECT of Vitamin D on bone; one PREVIOUS STUDY did indeed report borderline significant inverse ASSOCIATIONS between maternal late Pregnancy 25(Oh)D concentrations and offspring Forearm fractures(12).']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('SUPERFICIAL_RELATIONSHIP', 58), ('PROBABLE_UNDERSTANDING', 68), ('SUPERFICIAL_RELATIONSHIP', 81), ('INCOMPLETE_EVIDENCE', 114), ('SUPERFICIAL_RELATIONSHIP', 178)]	8	[('GO_0007567', 'parturition', 37, 'birth'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0007565', 'female pregnancy', 213, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 223, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 223, '25(OH)D'), ('UBERON_0002386', 'forelimb zeugopod', 260, 'forearm')]
PMC5426325	4/2017	S122-PMC5426325	['by comparing Individuals from entire adjacent Birth cohorts that were, or were not, exposed to extra Vitamin D from Margarine fortification Prenatally only, but all unexposed thereafter, we ASSUME that all POTENTIAL CONFOUNDERS are equally distributed in both groups, and HENCE that control for CONFOUNDING is not NEEDED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 190), ('INCOMPLETE_EVIDENCE', 206), ('PROBLEM_COMPLICATION', 216), ('PROBABLE_UNDERSTANDING', 272), ('PROBLEM_COMPLICATION', 295), ('FUTURE_WORK', 314)]	6	[('NCBITaxon_1', 'root', 13, 'individuals'), ('GO_0007567', 'parturition', 46, 'birth'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('CHEBI_6784', 'mestranol', 116, 'margarine'), ('GO_0019230', 'proprioception', 140, 'prenatally')]
PMC5426325	4/2017	S135-PMC5426325	['the RELATIONSHIP between Vitamin D status during fetal Life and long-term bone health has not previously been widely examined, and results from earlier observational studies SHOWED EITHER no association or a direct association.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 174), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('UBERON_0000104', 'life cycle', 55, 'life')]
PMC5426325	4/2017	S152-PMC5426325	['UNFORTUNATELY, we LACK INFORMATION on Vitamin D status among danish women in the Reproductive age during the fortification period, BUT for comparision, a study SHOWED that among 850 Pregnant women recruited from the second-largest city in denmark in 1988–1989 (the period without fortification), only 6·3 of the Pregnant women had a Serum 25(Oh)D concentration ≤25 nmol/l(12); the median concentrations of 76·2 (95 % ci 23·0, 152·1) nmol/l were also above the ‘OPTIMAL level’ as STATED by the us Endocrine society(62,63).']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('INCOMPLETE_EVIDENCE', 160), ('IMPORTANT_CONSIDERATION', 461), ('INCOMPLETE_EVIDENCE', 479)]	7	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0000003', 'reproduction', 81, 'reproductive'), ('GO_0007565', 'female pregnancy', 182, 'pregnant'), ('GO_0007565', 'female pregnancy', 312, 'pregnant'), ('UBERON_0001977', 'blood serum', 333, 'serum'), ('CHEBI_71657', 'versiconol acetate', 339, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 339, '25(OH)D'), ('UBERON_0005063', 'left ventricular compact myocardium', 496, 'Endocrine')]
PMC5473979	6/2017	S20-PMC5473979	['several Micronutrients such as iron, zinc, Folate, Vitamin B-6, B-12, Calcium, Selenium, and N-3 Fatty Acids have BEEN LINKED to maternal mental health and wellbeing [9,10] HOWEVER, much of the work to date has focused on the Postpartum period.']	[('ANOMALY_CURIOUS_FINDING', 114), ('SUPERFICIAL_RELATIONSHIP', 119), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 173)]	3	[('CHEBI_33839', 'macromolecule', 8, 'micronutrients'), ('CHEBI_30863', '5-azaorotic acid', 43, 'folate'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin B'), ('PR_000017255', 'Vang-like protein 1', 51, 'vitamin B-6'), ('PR_000004770', 'Polycomb complex protein BMI-1', 64, 'B-12'), ('CHEBI_22313', 'alkaline earth metal atom', 70, 'calcium'), ('CHEBI_27568', 'selenium atom', 79, 'selenium'), ('CHEBI_30256', 'thiocarbonyl group', 93, 'n-3'), ('CHEBI_35366', 'fatty acid', 97, 'fatty acids'), ('GO_0007565', 'female pregnancy', 226, 'postpartum')]
PMC5473979	6/2017	S118-PMC5473979	['various Micronutrients, such as Vitamin D, Selenium, zinc, Vitamin B12, Folates and OTHER b Vitamins, HAVE BEEN SUGGESTED as IMPORTANT for the PREVENTION of maternal depression [36].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 84), ('INCOMPLETE_EVIDENCE', 102), ('IMPORTANT_CONSIDERATION', 125), ('SUPERFICIAL_RELATIONSHIP', 143)]	4	[('CHEBI_33839', 'macromolecule', 8, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27568', 'selenium atom', 43, 'selenium'), ('CHEBI_33279', 'vitamin D5', 59, 'vitamin B12'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 67, 'B12'), ('CHEBI_72469', 'alpha-Neup5Gc-(2->6)-beta-D-Galp-(1->4)-beta-D-GlcpNAc', 72, 'folates'), ('CHEBI_33277', 'gamma-tocotrienol', 92, 'vitamins')]
PMC5474873	6/2017	S29-PMC5474873	['WHILE there are MANY STUDIES reporting the ASSOCIATION between Vitamin D levels in the Blood samples (18,19), there is STILL a LACK OF STUDIES on sun exposure, the main source of Vitamin D in most countries.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 43), ('IMPORTANT_CONSIDERATION', 119), ('INCOMPLETE_EVIDENCE', 127), ('INCOMPLETE_EVIDENCE', 127)]	6	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0000178', 'blood', 87, 'blood'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D')]
PMC5474873	6/2017	S32-PMC5474873	['THUS, the ASSOCIATION between Vitamin D, sun exposure, and psychosis REMAINS DEBATED.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D')]
PMC5474873	6/2017	S145-PMC5474873	['the CONFLICTING FINDING of the PRESENT STUDY COULD POSSIBLY BE ATTRIBUTED to any of the following: (1) DIFFERENT measures were used as PROXIES for Vitamin D—the present study ONLY CONSIDERED the sun exposure variables (and not diet) as a main source for Vitamin D levels (9,13,14); (2) the FOCUS of the PRESENT STUDY was detailed assessment of the entire distribution of the cape scale WHEREAS hedelin et al.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 63), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('SUPERFICIAL_RELATIONSHIP', 135), ('INCOMPLETE_EVIDENCE', 175), ('INCOMPLETE_EVIDENCE', 180), ('QUESTION_ANSWERED_BY_THIS_WORK', 290), ('QUESTION_ANSWERED_BY_THIS_WORK', 303), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 386)]	13	[('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D')]
PMC5474873	6/2017	S186-PMC5474873	['HOWEVER, there is a LACK OF PREVIOUS STUDIES on HOW sun exposure, the main source of Vitamin D, INFLUENCES psychotic experiences in the general population.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 28), ('EXPLICIT_QUESTION', 48), ('SUPERFICIAL_RELATIONSHIP', 96)]	5	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC5487839	3/2016	S131-PMC5487839	['an increased risk of malformations events has NOT been OBSERVED in Humans (LIMITED DATA) [360]cvitamin dthe ROLE for Vitamin D supplementation in Pregnancy is CONTROVERSIAL, BUT there is NO EVIDENCE of a reduction in adverse Pregnancy outcomes (e.g., Preeclampsia, Stillbirth, neonatal death) [361] or improvement in bone Mineral content in children in studies in which supplementation was given INDEPENDENTLY from Blood levels [362].']	[('FULL_UNKNOWN', 46), ('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 108), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 159), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 174), ('INCOMPLETE_EVIDENCE', 187), ('SUPERFICIAL_RELATIONSHIP', 396)]	7	[('NCBITaxon_9606', 'Homo sapiens', 67, 'humans'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('GO_0007565', 'female pregnancy', 146, 'pregnancy'), ('GO_0007565', 'female pregnancy', 225, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 251, 'preeclampsia'), ('GO_0001966', 'thigmotaxis', 265, 'stillbirth'), ('CHEBI_46662', 'mineral', 322, 'mineral'), ('UBERON_0000178', 'blood', 415, 'blood')]
PMC5489519	6/2017	S2-PMC5489519	['WHILE Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (Trail) HAS BEEN IMPLICATED in Cellular growth/Apoptosis, Immune Cell function and Bone-Resorbing Osteoclast formation, the Expression of Trail in Human milk as a function of Vitamin D status in mothers REMAINS UNKNOWN.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 79), ('FULL_UNKNOWN', 265)]	4	[('PR_000000035', 'BMP receptor type-1A', 6, 'tumor necrosis factor-related apoptosis inducing ligand'), ('GO_0006915', 'apoptotic process', 36, 'apoptosis'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 63, 'TRAIL'), ('GO_0006915', 'apoptotic process', 93, 'cellular ... apoptosis'), ('CL_0000738', 'leukocyte', 120, 'immune cell'), ('UBERON_0002405', 'immune system', 120, 'immune'), ('GO_0046849', 'bone remodeling', 145, 'bone-resorbing'), ('CL_0000092', 'osteoclast', 160, 'osteoclast'), ('GO_0010467', 'gene expression', 186, 'expression'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 200, 'TRAIL'), ('NCBITaxon_9606', 'Homo sapiens', 209, 'human'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D')]
PMC5489519	6/2017	S6-PMC5489519	['IN CONTRAST, Vitamin D at 20\u2009nm concentration SUPPRESSED the Expression of both Trail Α and β proteins.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 46)]	2	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0010467', 'gene expression', 61, 'expression'), ('PR_000001683', 'vasopressin V2 receptor', 80, 'TRAIL α')]
PMC5489519	6/2017	S20-PMC5489519	['HOWEVER, it is UNKNOWN WHETHER Vitamin D deficiency in Lactating mothers Modulates the Expression of cellular factor(s) in Human Milk that is ASSOCIATED with Immune health and Skeletal Development in breastfeeding infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('SUPERFICIAL_RELATIONSHIP', 142)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 55, 'lactating'), ('GO_0065007', 'biological regulation', 73, 'modulates'), ('GO_0010467', 'gene expression', 87, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 123, 'human'), ('UBERON_0001913', 'milk', 129, 'milk'), ('UBERON_0002405', 'immune system', 158, 'immune'), ('GO_0001501', 'skeletal system development', 176, 'skeletal development'), ('UBERON_0004288', 'skeleton', 176, 'skeletal')]
PMC5489519	6/2017	S27-PMC5489519	['HOWEVER, the ASSOCIATION between the levels of Vitamin D in the maternal Blood and Trail Expression in Human Milk has not been previously described.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13)]	2	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('UBERON_0000178', 'blood', 73, 'blood'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 83, 'TRAIL'), ('GO_0010467', 'gene expression', 89, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 103, 'human'), ('UBERON_0001913', 'milk', 109, 'milk')]
PMC5489519	6/2017	S113-PMC5489519	['high dose Vitamin D decreased Trail Expression COMPARED TO basal levels, SUGGESTING that low levels of Vitamin D MAY BE REQUIRED to stimulate Trail Expression in Mammary Epithelial Cells.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('INCOMPLETE_EVIDENCE', 73), ('INCOMPLETE_EVIDENCE', 113), ('IMPORTANT_CONSIDERATION', 120)]	4	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 30, 'TRAIL'), ('GO_0010467', 'gene expression', 36, 'expression'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 142, 'TRAIL'), ('GO_0010467', 'gene expression', 148, 'expression'), ('CL_0002327', 'mammary gland epithelial cell', 162, 'mammary epithelial cells'), ('UBERON_0006954', 'mammary gland myoepithelium', 162, 'mammary epithelial')]
PMC5510234	7/2017	S73-PMC5510234	['this finding SUGGESTS then a LINK between Vitamin A deficiency and an INCREASED RISK of infant exposure to hiv during Vaginal Delivery.48,57later on, this was NOT CONFIRMED by other studies from the developped countries.61,62a cochrane review on Vitamin A supplementation and mtct of hiv was published in 2011, by wiysonge et al .']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 29), ('IMPORTANT_CONSIDERATION', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 159)]	4	[('CHEBI_27300', 'vitamin D', 42, 'vitamin A'), ('UBERON_0001987', 'placenta', 118, 'vaginal'), ('GO_0007567', 'parturition', 126, 'delivery'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin A')]
PMC5510234	7/2017	S79-PMC5510234	['HOWEVER, another DID NOT FIND a benefit for Vitamin A in decreasing mtct rates.59\nlow maternal Vitamin D level (<32 ng/ml) HAS BEEN SHOWN to be ASSOCIATED with a 50% higher risk of mtct of hiv at 6 weeks in tanzanian women.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 123), ('INCOMPLETE_EVIDENCE', 132), ('SUPERFICIAL_RELATIONSHIP', 144)]	6	[('CHEBI_27300', 'vitamin D', 44, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC5513133	7/2017	S0-PMC5513133	['the ROLE of Vitamin D in pre-eclampsia: a systematic review\n\nabstract\n\nbackground\nthe etiology of pre-eclampsia (pe) is not YET FULLY UNDERSTOOD, THOUGH CURRENT LITERATURE INDICATES an upregulation of Inflammatory Mediators produced by the Placenta AS a POTENTIAL causal mechanism.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 124), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 146), ('INCOMPLETE_EVIDENCE', 153), ('INCOMPLETE_EVIDENCE', 172), ('PROBABLE_UNDERSTANDING', 249), ('INCOMPLETE_EVIDENCE', 254)]	7	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('CHEBI_64668', 'geranylgeranyl-chlorophyll a', 201, 'inflammatory mediators'), ('UBERON_0001987', 'placenta', 240, 'placenta')]
PMC5513133	7/2017	S4-PMC5513133	['these sources were retrieved, collected, indexed, and ASSESSED for availability of Pregnancy-related data on pe and Vitamin D.\n\nresults\nseveral case-control studies and cross-sectional studies HAVE SHOWN an ASSOCIATION between Vitamin D status and pe, ALTHOUGH EVIDENCE HAS BEEN INCONSISTENT.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 54), ('INCOMPLETE_EVIDENCE', 193), ('SUPERFICIAL_RELATIONSHIP', 207), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 252), ('INCOMPLETE_EVIDENCE', 261), ('INCOMPLETE_EVIDENCE', 270), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 279)]	7	[('GO_0007565', 'female pregnancy', 83, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D')]
PMC5513133	7/2017	S6-PMC5513133	['conclusions\nthe included clinical trials do not show an independent effect of Vitamin D supplementation in PREVENTING pe; HOWEVER, ISSUES with dose, timing, and duration of supplementation HAVE NOT BEEN COMPLETELY ADDRESSED.']	[('SUPERFICIAL_RELATIONSHIP', 107), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('PROBLEM_COMPLICATION', 131), ('IMPORTANT_CONSIDERATION', 189), ('INCOMPLETE_EVIDENCE', 194)]	5	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC5513133	7/2017	S30-PMC5513133	['WHILE the pathogenesis of pe INVOLVES a number of biological Processes, there are several HYPOTHESES to SUGGEST HOW Vitamin D levels MAY AFFECT these processes (table1).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90), ('INCOMPLETE_EVIDENCE', 104), ('EXPLICIT_QUESTION', 112), ('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 137)]	7	[('GO_0007565', 'female pregnancy', 61, 'processes'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC5513133	7/2017	S46-PMC5513133	['during the course of Pregnancy, EVIDENCE from observational studies SHOWS DIVERGENT data on the concentration of Serum 25(Oh)D levels in different Trimesters of Pregnancy, with EITHER decline [41], increase [42], or absence of change in Vitamin D levels with progression [43,44].']	[('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 177)]	4	[('GO_0007565', 'female pregnancy', 21, 'pregnancy'), ('UBERON_0001977', 'blood serum', 113, 'serum'), ('CHEBI_71657', 'versiconol acetate', 119, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 119, '25(OH)D'), ('GO_0043033', 'isoamylase complex', 147, 'trimesters'), ('GO_0007565', 'female pregnancy', 161, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D')]
PMC5513133	7/2017	S70-PMC5513133	['FOUND that the EFFECT of 1,25(Oh)2D on Vsmc Proliferation is MEDIATED by increased vegf Expression, WHILE others FIND no relation between Vitamin D and pro-Angiogenic factors [15].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 15), ('SUPERFICIAL_RELATIONSHIP', 61), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 100), ('INCOMPLETE_EVIDENCE', 113)]	5	[('CHEBI_82784', 'PVP38-Ag NP', 25, '1,25(OH)2D'), ('CL_0000359', 'vascular associated smooth muscle cell', 39, 'VSMC'), ('GO_0008283', 'cell proliferation', 44, 'proliferation'), ('GO_0010467', 'gene expression', 88, 'expression'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('GO_0001525', 'angiogenesis', 156, 'angiogenic')]
PMC5513133	7/2017	S102-PMC5513133	['studies were excluded IF they were reviews, commentaries, editorials, letters, non-Human studies, didn’t include maternal Vitamin D measured during Gestation as a primary or secondary variable, or did not include pe as a primary or secondary outcome.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 22)]	1	[('NCBITaxon_9606', 'Homo sapiens', 83, 'human'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('GO_0007565', 'female pregnancy', 148, 'gestation')]
PMC5513133	7/2017	S118-PMC5513133	['HOWEVER, when CONSIDERING total Vitamin D intake (diet + supplement) of 15–20\xa0μg/d compared to less than 5\xa0μg/d, there was an adjusted or of 0.76 (95% ci 0.60–0.95) for diagnosis with pe [77].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 14)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D')]
PMC5513133	7/2017	S121-PMC5513133	['another prospective cohort study of nulliparous women with singleton Pregnancies FOUND no significant association between Vitamin D deficiency in the 1st Trimester and risk for pe; HOWEVER, at 24–26\xa0weeks of Gestation mean maternal 25(Oh)D was significantly lower in women who developed pe COMPARED WITH those who did not ( p \xa0=\xa00.03) [60].']	[('INCOMPLETE_EVIDENCE', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('ANOMALY_CURIOUS_FINDING', 181), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 290)]	4	[('GO_0007565', 'female pregnancy', 69, 'pregnancies'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 154, 'trimester'), ('GO_0007565', 'female pregnancy', 208, 'gestation'), ('CHEBI_71657', 'versiconol acetate', 232, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 232, '25(OH ... D')]
PMC5513133	7/2017	S125-PMC5513133	['HOWEVER, there was no association in women with Vitamin D insufficiency who did not also have high pth.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0)]	2	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
PMC5513133	7/2017	S132-PMC5513133	['germany, 2–14 [85]↓ 25(Oh)D levels in pe in summer compared to controls, 1,25(Oh)2D ↓ only in winter25(Oh)D: pe:18.2\xa0±\xa017.1; control: 49.2\xa0±\xa029.2\xa0ng/ml, ( p \xa0<\xa00.001); 1,25(Oh)2D: 291\xa0±\xa0217 vs 612.3\xa0±\xa0455\xa0pmol/ml ( p \xa0<\xa00.05)mohaghegh et al., iran, 2015 [89]↓ mean 25(Oh)D in pe compared to Pregnant controls without pe25(Oh)D:Pe: 37.9\xa0±\xa033.9\xa0nmol/lcontrols: 58.2\xa0±\xa038.2\xa0nmol/l( p \xa0=\xa00.001)powe, usa, 2010 [86]↔ women with pe and controls with 25(Oh)D\xa0<\xa015.0\xa0nmol/ladjusted or: 1.3595% ci: 0.40 to 4.50robinson et al., usa, 2010 [25]↑ eospe in women with maternal 25(Oh)D levels <=19.6\xa0nmol/l compared to levels >19.6\xa0nmol/lor: 3.6095% ci: 1.71–7.58( p \xa0<\xa00.001)schneuer et al., australia, 2014 [114]↔ pe or eospe and low 25(Oh)D (< 25\xa0nmol/l)adjusted or- all pe: 0.4695% ci: 0.19–1.10adjusted or- eospe: 1.4095% ci: 0.20 to 9.89singla et al., india, 2015 [87]↓ mean Serum Vitamin D in women with pe vs controlspe: 24.2\xa0±\xa012.4\xa0nmol/l controls: 36.9\xa0±\xa016.7\xa0nmol/l;( p \xa0=\xa00.0001)ullah et al., bangladesh, 2013 [82]↑ pe per 25\xa0nmol/l decrease in 25(Oh)D leveladjusted or: 1.6695% ci: 1.05–3.02wetta et al., uk, 2013 [96]↔ between pe and 25-Oh D\xa0<\xa030\xa0ng/ml and <37.4\xa0nmol/l<30\xa0ng/ml adjusted or: 1.195% ci: 0.6–2.0adjusted or: 1.4 (<37.4\xa0nmol/l)95% ci: 0.7–3.0woodham et al., usa, 2011 [15]↓ severe pe in women with 10\xa0nmol/l increase in maternal 25(Oh)D leveladjusted or: 0.6295% ci: 0.51–0.76xu et al., usa, 2014 [53]↑ pe in women with Vitamin D deficiency (<37.5\xa0nmol/l)or: 4.495% ci: 1.8–10.8yu et al., uk, 2012 [115]↔ Serum Vitamin D raw values in pe and controls25(Oh)D levels: controls: 46.8\xa0nmol/l (27.8–70.0;)early pe: 32.2\xa0nmol/l (22.7–50.4); late pe: 39.2\xa0nmol/l (22.1–63.0) ( p \xa0=\xa00.231)alvarez-fernandez et al., spain, 2014 [90]↑ pe in women with 25(Oh)D levels <50\xa0nmol/l compared TO levels >50\xa0nmol/l after 20\xa0weeks of Gestationor: 4.695% ci:1.4–15( p \xa0=\xa00.010)scholl et al., usa, 2013 [78]↑ pe in women with 25(Oh)D\xa0<\xa049.9\xa0nmol/l and hyperparathyroidismadjusted or: 2.8695% ci: 1.28–6.41burris et al., usa, 2014 [94]↔ Pe and 25(Oh)D levels compared at each 25\xa0nmol/l increase in 25 (Oh)Dadjusted or: 1.1495% ci: 0.77–1.67haugen et al., norway, 2000 [77]↓ pe in women taking 10–15 mcg/d as compared with no supplementsadjusted or: 0.7395% ci: 0.58–0.92shand et al., canada, 2010 [37]↔ pe and 25(Oh)D levels <37.5\xa0nmol/ladjusted or: 0.9195% ci: 0.31–2.62wei et al., canda 2012 [60]↔ Pe and 25(Oh)D\xa0<\xa050\xa0nmol/ladjusted or: 1.2495% ci: 0.58–2.67( p \xa0=\xa00.58)wei, canada, 2013 [14]↑ pe and women with ↓ pigf levels and maternal 25(Oh)d\xa0<\xa050\xa0nmol/ladjusted or: 2.9795% ci: 1.23–7.20zhou, china, 2014 [116]↔ pe and 25(Oh)D levels25(Oh)D levelsgroup a ( n \xa0=\xa013): 41.4\xa0±\xa06.5\xa0nmol/l; group b ( n \xa0=\xa036): 62.1\xa0±\xa07.0\xa0nmol/l; group c ( n \xa0=\xa025): 89.6\xa0±\xa013.0\xa0nmol/l; ( p \xa0=\xa00.900)\na case-cohort study of women from 12 different united states (us) sites whose vitamin D levels were measured at ≤26\xa0weeks of Gestation SHOWED that 25(Oh)D levels greater than 50\xa0nmol/l were ASSOCIATED with a 40% reduction in risk for severe pe (0.65 [95% ci 0.43 to 0.98]), although there was no reduction in absolute and relative risk for the milder clinical subtypes of pe when 25(Oh)D levels were greater than 50\xa0nmol/l [79].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 1791), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2293), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2609), ('INCOMPLETE_EVIDENCE', 2914), ('SUPERFICIAL_RELATIONSHIP', 2969)]	5	[('CHEBI_71657', 'versiconol acetate', 20, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 26, 'D'), ('CHEBI_73285', "3-iodo-4-aminobenzyl-5'-N-methylcarboxamidoadenosine", 75, '25(OH)2D ↓'), ('CHEBI_33010', 'chromide(1-)', 102, '(OH)D'), ('CHEBI_82784', 'PVP38-Ag NP', 168, '1,25(OH)2D'), ('CHEBI_71657', 'versiconol acetate', 265, '25(OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 265, '25'), ('PR_000011614', 'opioid growth factor receptor', 268, 'OH'), ('PR_000006444', 'diacylglycerol kinase delta', 271, 'D'), ('GO_0007565', 'female pregnancy', 291, 'pregnant'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 322, 'OH)D'), ('CHEBI_51383', 'hydridocarbon(3.)', 327, 'PE'), ('CHEBI_71657', 'versiconol acetate', 444, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 444, '25(OH)D'), ('CHEBI_33010', 'chromide(1-)', 566, '(OH)D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 725, 'OH)D'), ('UBERON_0001977', 'blood serum', 867, 'serum'), ('CHEBI_27300', 'vitamin D', 873, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 1043, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 1043, '25(OH ... D'), ('CHEBI_72765', 'verruculogen', 1134, '25-OH D'), ('CHEBI_71657', 'versiconol acetate', 1343, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1343, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 1434, 'vitamin D'), ('UBERON_0001977', 'blood serum', 1519, 'serum'), ('CHEBI_27300', 'vitamin D', 1525, 'vitamin D'), ('CHEBI_33010', 'chromide(1-)', 1566, '(OH)D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 1759, 'OH)D'), ('GO_0007565', 'female pregnancy', 1830, 'gestationOR'), ('CHEBI_71657', 'versiconol acetate', 1920, '25(OH)D'), ('CHEBI_51383', 'hydridocarbon(3.)', 2030, 'PE'), ('CHEBI_71657', 'versiconol acetate', 2037, '25(OH)D'), ('CHEBI_982', '2-Aceto-2-hydroxybutanoate', 2091, '25 (OH)DAdjusted'), ('CHEBI_71657', 'versiconol acetate', 2303, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 2303, '25(OH)D'), ('CHEBI_51383', 'hydridocarbon(3.)', 2393, 'PE'), ('CHEBI_71657', 'versiconol acetate', 2400, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 2534, '25(OH'), ('CHEBI_71657', 'versiconol acetate', 2619, '25(OH)D'), ('CHEBI_33010', 'chromide(1-)', 2635, '(OH)D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 2865, 'D'), ('GO_0007565', 'female pregnancy', 2904, 'gestation'), ('CHEBI_71657', 'versiconol acetate', 2926, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 3159, '25(OH)D')]
PMC5513133	7/2017	S145-PMC5513133	['ALTHOUGH these STUDIES FIND an inverse ASSOCIATION between Vitamin D levels and pe, this ASSOCIATION MAY BE CONFOUNDED by the Gestational age at Serum collection.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 89), ('INCOMPLETE_EVIDENCE', 101), ('DIFFICULT_TASK', 108)]	8	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007565', 'female pregnancy', 126, 'gestational'), ('UBERON_0001977', 'blood serum', 145, 'serum')]
PMC5513133	7/2017	S170-PMC5513133	['caption (table-wrap): table 4\n\nASSOCIATION of Vitamin D supplementation and Pregnancy-induced hypertension (pih) outcomes in clinical trialsauthor, location, yearstudy designsubjectsinterventionkey findingsresultsolsen and secher, denmark, 1990 [91]randomized controlled clinical trial5644 Pregnant women2500\xa0iu Vitamin D supplement versus no Supplement at week 20 of Pregnancy↓ pe31.5% reduction in the odds ( p \xa0<\xa00.005)olsen et al., europe, 2000 [98]randomized placebo controlled clinical trial386 women who previously experienced pih2.7\xa0g N-3 Fatty Acids/day given from 33\xa0weeks until Delivery vs Olive Oil placebo↔ pih recurrence riskor\xa0=\xa00.9895% ci: 0.63–1.53\n\nevidence that SUGGESTS no association between maternal Vitamin D deficiency and pe\nWHILE the PRECEDING STUDIES SUPPORT a LINK between Vitamin D deficiency during Pregnancy and risk of pe, SOME STUDIES present CONFLICTING EVIDENCE (tables2and3).']	[('SUPERFICIAL_RELATIONSHIP', 31), ('INCOMPLETE_EVIDENCE', 681), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 750), ('INCOMPLETE_EVIDENCE', 760), ('INCOMPLETE_EVIDENCE', 778), ('SUPERFICIAL_RELATIONSHIP', 788), ('INCOMPLETE_EVIDENCE', 855), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 876), ('INCOMPLETE_EVIDENCE', 888)]	9	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0007565', 'female pregnancy', 76, 'pregnancy'), ('GO_0007565', 'female pregnancy', 290, 'pregnant'), ('CHEBI_27300', 'vitamin D', 312, 'vitamin D'), ('CHEBI_16158', 'steroid sulfate', 343, 'supplement'), ('GO_0007565', 'female pregnancy', 368, 'pregnancy'), ('GO_0007567', 'parturition', 377, '↓'), ('CHEBI_30256', 'thiocarbonyl group', 543, 'n-3'), ('CHEBI_35366', 'fatty acid', 547, 'fatty acids'), ('GO_0007567', 'parturition', 589, 'delivery'), ('CHEBI_50695', 'monobactam', 601, 'olive oil'), ('CHEBI_27300', 'vitamin D', 722, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 801, 'vitamin D'), ('GO_0007565', 'female pregnancy', 829, 'pregnancy')]
PMC5513133	7/2017	S171-PMC5513133	['most of these studies were OBSERVATIONAL, and measured maternal Vitamin D concentration before the diagnosis of pe AS OPPOSED TO measuring at the time of diagnosis or Delivery.']	[('INCOMPLETE_EVIDENCE', 27), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115)]	2	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007567', 'parturition', 167, 'delivery')]
PMC5513133	7/2017	S199-PMC5513133	['discussion\nOBSERVATIONAL studies evaluating the ASSOCIATION between Vitamin D and pe HAVE SHOWN INCONSISTENT results and MUST BE interpreted CAUTIOUSLY.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 85), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 96), ('IMPORTANT_CONSIDERATION', 121), ('INCOMPLETE_EVIDENCE', 141)]	6	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC5513133	7/2017	S231-PMC5513133	['the ROLE of Fish Oils in pe REMAINS UNCERTAIN and SIMILARLY poses a CHALLENGE in determining an isolated EFFECT of Vitamin D supplementation, UNLESS studies are designed such that they CONSIDER this.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 28), ('FULL_UNKNOWN', 36), ('SUPERFICIAL_RELATIONSHIP', 50), ('DIFFICULT_TASK', 68), ('SUPERFICIAL_RELATIONSHIP', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 142), ('FUTURE_WORK', 142), ('INCOMPLETE_EVIDENCE', 185)]	9	[('CHEBI_39279', 'halomethane', 12, 'fish oils'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC5513133	7/2017	S240-PMC5513133	['DESPITE EVIDENCE that low Vitamin D levels increase RISK for pe early in Pregnancy, VERY FEW STUDIES have tried TO RELATE this EFFECT with the Regulation Of Angiogenic or anti-Angiogenic factors.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 52), ('INCOMPLETE_EVIDENCE', 84), ('QUESTION_ANSWERED_BY_THIS_WORK', 112), ('SUPERFICIAL_RELATIONSHIP', 115), ('SUPERFICIAL_RELATIONSHIP', 127), ('SUPERFICIAL_RELATIONSHIP', 143)]	9	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('GO_0006110', 'regulation of glycolytic process', 143, 'regulation of angiogenic'), ('GO_0001525', 'angiogenesis', 176, 'angiogenic')]
PMC5513133	7/2017	S241-PMC5513133	['ALTHOUGH CURRENT EVIDENCE SUPPORTS an ASSOCIATION between Angiogenic factors and pe, these STUDIES have NOT FOUND an ASSOCIATION between Vitamin D levels and Angiogenic factors [14,15].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 104), ('SUPERFICIAL_RELATIONSHIP', 117)]	9	[('GO_0001525', 'angiogenesis', 58, 'angiogenic'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('GO_0001525', 'angiogenesis', 158, 'angiogenic')]
PMC5513133	7/2017	S253-PMC5513133	['HOWEVER, women with a Serum Vitamin D status of ≥75\xa0nmol/l that was maintained from enrollment through late Pregnancy had a significantly lower RISK of pe versus women who had <75\xa0nmol/l ( p \xa0=\xa00.04).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 144)]	3	[('UBERON_0001977', 'blood serum', 22, 'serum'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007565', 'female pregnancy', 108, 'pregnancy')]
PMC5513133	7/2017	S254-PMC5513133	['BUT this Vitamin D level was maintained in ONLY 74% of Pregnancies in the supplementation group by weeks 32 to 38 of Gestation, SUGGESTING that supplementation at EVEN earlier time-points or before Pregnancy MAY BE NECESSARY to maintain sufficient Vitamin D levels that are PROTECTIVE against pe.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 43), ('INCOMPLETE_EVIDENCE', 128), ('ANOMALY_CURIOUS_FINDING', 163), ('INCOMPLETE_EVIDENCE', 208), ('IMPORTANT_CONSIDERATION', 215), ('SUPERFICIAL_RELATIONSHIP', 274)]	8	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 55, 'pregnancies'), ('GO_0007565', 'female pregnancy', 117, 'gestation'), ('GO_0007565', 'female pregnancy', 198, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin D')]
PMC5513133	7/2017	S264-PMC5513133	['WHILE SOME STUDIES HAVE BEEN able to capture an adequate representation of african american women [96], there is a NEED FOR FURTHER RESEARCH on populations with very low Vitamin D levels to understand THIS OBSERVATION and IDENTIFY FACTORS that PREDISPOSE high-risk groups to pe and its more THREATENING clinical subtypes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 19), ('FUTURE_WORK', 115), ('FUTURE_WORK', 124), ('QUESTION_ANSWERED_BY_THIS_WORK', 201), ('INCOMPLETE_EVIDENCE', 206), ('QUESTION_ANSWERED_BY_THIS_WORK', 222), ('SUPERFICIAL_RELATIONSHIP', 231), ('SUPERFICIAL_RELATIONSHIP', 244), ('IMPORTANT_CONSIDERATION', 291)]	11	[('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
PMC5521778	7/2017	S5-PMC5521778	['CONSEQUENTLY, we INVESTIGATED IF gcs counteract Retinoid EFFECTS in Alveolar Epithelial Cells by mechanisms involving Bco1-dependent local Vitamin A Metabolism.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('SUPERFICIAL_RELATIONSHIP', 57)]	4	[('CHEBI_26537', 'retinoid', 48, 'retinoid'), ('CL_0000322', 'pneumocyte', 68, 'alveolar epithelial cells'), ('UBERON_0004821', 'pulmonary alveolus epithelium', 68, 'alveolar epithelial'), ('PR_000004693', 'Bcl-2-like protein 10', 118, 'BCO1'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin A'), ('GO_0070639', 'vitamin D2 metabolic process', 139, 'vitamin A metabolism')]
PMC5521778	7/2017	S137-PMC5521778	['suppression of Bco1 Expression and activity by Glucocorticoids\nsince Retinoids (Vitamin A) and Gcs play INTERACTIVE ROLES in Lung Development and Regeneration [40], we ASKED WHETHER gcs alter Carotenoid-to-Retinoid Metabolism.']	[('SUPERFICIAL_RELATIONSHIP', 104), ('SUPERFICIAL_RELATIONSHIP', 116), ('EXPLICIT_QUESTION', 168), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 174)]	4	[('PR_000004693', 'Bcl-2-like protein 10', 15, 'BCO1'), ('GO_0010467', 'gene expression', 20, 'expression'), ('CHEBI_36597', 'phthalazine', 47, 'glucocorticoids'), ('CHEBI_26537', 'retinoid', 69, 'retinoids'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin A'), ('CL_0000740', 'retinal ganglion cell', 95, 'GCs'), ('GO_0060424', 'lung field specification', 125, 'lung development ... regeneration'), ('UBERON_0002048', 'lung', 125, 'lung'), ('CHEBI_23044', 'carotenoid', 192, 'carotenoid'), ('GO_0016116', 'carotenoid metabolic process', 192, 'carotenoid- ... metabolism'), ('CHEBI_26537', 'retinoid', 206, 'retinoid')]
PMC5524288	7/2017	S118-PMC5524288	['among women with initial 25(Oh)D concentrations <40 ng/ml, the significantly lower ptb rate (60%) for those who achieved ≥40 ng/ml COMPARED TO those who did not reach the target concentration on a follow-up test SUGGESTS that maternal Vitamin D status is a MODIFIABLE RISK FACTOR that CAN be addressed during the Prenatal period.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('INCOMPLETE_EVIDENCE', 212), ('IMPORTANT_CONSIDERATION', 257), ('SUPERFICIAL_RELATIONSHIP', 268), ('INCOMPLETE_EVIDENCE', 285)]	5	[('CHEBI_71657', 'versiconol acetate', 25, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 25, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin D'), ('GO_0007565', 'female pregnancy', 313, 'prenatal')]
PMC5537904	7/2017	S14-PMC5537904	['Prenatal Vitamin D deficiency HAS BEEN ASSOCIATED with pre-term Birth [4,5], low birthweight [5,6], and small for Gestational age offspring [5,6,7], WHILE Prenatal Vitamin D supplementation HAS BEEN SHOWN to increase offspring Birth weight and length [8].']	[('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 39), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 149), ('INCOMPLETE_EVIDENCE', 190)]	4	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007567', 'parturition', 64, 'birth'), ('GO_0007565', 'female pregnancy', 114, 'gestational'), ('GO_0007565', 'female pregnancy', 155, 'prenatal'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0007567', 'parturition', 227, 'birth')]
PMC5537904	7/2017	S16-PMC5537904	['current Human EVIDENCE SUPPORTING the ASSOCIATION between Prenatal Vitamin D intake, neonatal Vitamin D status, and offspring adiposity is MIXED.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139)]	4	[('NCBITaxon_9606', 'Homo sapiens', 8, 'human'), ('GO_0007565', 'female pregnancy', 58, 'prenatal'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC5537904	7/2017	S17-PMC5537904	['WHILE NUMEROUS STUDIES HAVE REPORTED that higher maternal Vitamin D intake (from Food and/or dietary supplements) is ASSOCIATED with increased Prenatal and/or cord Blood 25(Oh)D levels [14,15,16,17], it is NOT CLEAR WHETHER this TRANSLATES TO an EFFECT on neonatal adiposity.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 117), ('FULL_UNKNOWN', 206), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 216), ('SUPERFICIAL_RELATIONSHIP', 229), ('SUPERFICIAL_RELATIONSHIP', 246)]	8	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_33290', 'food', 81, 'food'), ('GO_0007565', 'female pregnancy', 143, 'prenatal'), ('UBERON_0000178', 'blood', 164, 'blood'), ('CHEBI_71657', 'versiconol acetate', 170, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 176, 'D')]
PMC5537904	7/2017	S21-PMC5537904	['PRIOR STUDIES VARY strongly in methodology, PARTICULARLY in regard to assessment of Prenatal Vitamin D intake, timing and source of 25(Oh)D measurements, a method for assessing neonatal adiposity, and CONSIDERATION of OTHER contributing factors such as maternal obesity.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('IMPORTANT_CONSIDERATION', 44), ('FUTURE_WORK', 201), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 218)]	5	[('GO_0007565', 'female pregnancy', 84, 'prenatal'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 132, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 138, 'D')]
PMC5537904	7/2017	S23-PMC5537904	['in addition, FEW STUDIES EXAMINED WHETHER Gestational weight gain OR body mass index (bmi) modify the ASSOCIATIONS between Prenatal Vitamin D intake, neonatal Vitamin D status, and offspring adiposity.']	[('INCOMPLETE_EVIDENCE', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('SUPERFICIAL_RELATIONSHIP', 102)]	4	[('GO_0007565', 'female pregnancy', 42, 'gestational'), ('GO_0007565', 'female pregnancy', 123, 'prenatal'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D')]
PMC5537904	7/2017	S150-PMC5537904	['IT IS POSSIBLE that the differential ASSOCIATIONS between 25(Oh)D and Birthweight according to maternal bmi we OBSERVED are DUE TO VARIATIONS in overall energy intake or OTHER nutritional factors that are concomitant with increased Vitamin D intake and THUS increased 25(Oh)D levels.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 111), ('PROBLEM_COMPLICATION', 124), ('DIFFICULT_TASK', 131), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('PROBABLE_UNDERSTANDING', 253)]	7	[('CHEBI_71657', 'versiconol acetate', 58, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 58, '25(OH)D'), ('GO_0007596', 'blood coagulation', 70, 'birthweight'), ('CHEBI_27300', 'vitamin D', 232, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 268, '25(OH)D')]
PMC5537904	7/2017	S151-PMC5537904	['OUR finding that the ASSOCIATION between Cord Blood 25(Oh)D and Birthweight varies according to maternal bmi MUST BE REPLICATED in OTHER studies, including intervention trials, TO DETERMINE IF Vitamin D supplementation RECOMMENDATIONS to modify Birthweight SHOULD BE bmi-specific.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 21), ('IMPORTANT_CONSIDERATION', 109), ('INCOMPLETE_EVIDENCE', 117), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('QUESTION_ANSWERED_BY_THIS_WORK', 177), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 190), ('FUTURE_WORK', 219), ('FUTURE_WORK', 257)]	9	[('UBERON_0009472', 'axilla', 41, 'cord blood'), ('CHEBI_71657', 'versiconol acetate', 52, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 52, '25(OH)D'), ('GO_0007596', 'blood coagulation', 64, 'birthweight'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('GO_0007596', 'blood coagulation', 245, 'birthweight')]
PMC5537904	7/2017	S170-PMC5537904	['HOWEVER, this dose also exceeds the united states national academy of sciences Food and nutrition board tolerable upper limit of 4000 iu/day of Vitamin D for pregnant women [63], and THEREFORE cannot be RECOMMENDED based SOLELY on the present results.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 183), ('FUTURE_WORK', 203), ('INCOMPLETE_EVIDENCE', 221)]	4	[('CHEBI_33290', 'food', 79, 'Food'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D')]
PMC5539754	8/2017	S0-PMC5539754	['season and Vitamin D status are INDEPENDENTLY ASSOCIATED with Glucose Homeostasis in Pregnancy\n\nabstract\n\nbackground\nVitamin D status and season are intrinsically LINKED, and both have been PROPOSED to be ASSOCIATED with Glucose Homeostasis in Pregnancy, with CONFLICTING results.']	[('SUPERFICIAL_RELATIONSHIP', 32), ('SUPERFICIAL_RELATIONSHIP', 46), ('SUPERFICIAL_RELATIONSHIP', 163), ('INCOMPLETE_EVIDENCE', 190), ('SUPERFICIAL_RELATIONSHIP', 205), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 260)]	6	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_17234', 'glucose', 62, 'glucose'), ('GO_0042593', 'glucose homeostasis', 62, 'glucose homeostasis'), ('GO_0007565', 'female pregnancy', 85, 'pregnancy'), ('CHEBI_28384', 'vitamin K', 117, 'Vitamin D'), ('CHEBI_17234', 'glucose', 221, 'glucose'), ('GO_0042593', 'glucose homeostasis', 221, 'glucose homeostasis'), ('GO_0007565', 'female pregnancy', 244, 'pregnancy')]
PMC5539754	8/2017	S17-PMC5539754	['in Pregnancy, the ASSOCIATION between low Vitamin D levels and abnormalities in Glucose tolerance is the subject of scientific DEBATE, with SOME STUDIES reporting that maternal Insulin sensitivity, fasting Glucose and Gestational diabetes are not associated with 25ohd [7], WHILE others have FOUND inverse ASSOCIATIONS between 25ohd, fasting Glucose [8] and risk of Gestational diabetes [9].']	[('SUPERFICIAL_RELATIONSHIP', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('INCOMPLETE_EVIDENCE', 140), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 274), ('INCOMPLETE_EVIDENCE', 292), ('SUPERFICIAL_RELATIONSHIP', 306)]	6	[('GO_0007565', 'female pregnancy', 3, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_17234', 'glucose', 80, 'glucose'), ('PR_000045358', 'insulin family protein', 177, 'insulin'), ('CHEBI_17234', 'glucose', 206, 'glucose'), ('GO_0007565', 'female pregnancy', 218, 'gestational'), ('CHEBI_17234', 'glucose', 342, 'glucose'), ('GO_0007565', 'female pregnancy', 366, 'gestational')]
PMC5539754	8/2017	S18-PMC5539754	['HOWEVER, the MAJORITY of Vitamin D supplementation intervention trials in Pregnancy have not had a SIGNIFICANT IMPACT on maternal and offspring health [10].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 13), ('IMPORTANT_CONSIDERATION', 99)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007565', 'female pregnancy', 74, 'pregnancy')]
PMC5539754	8/2017	S152-PMC5539754	['HOWEVER, UNLIKE the Hapo trial, we FOUND increased fasting Plasma Glucose in late Pregnancy among those at risk of Vitamin D deficiency.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('INCOMPLETE_EVIDENCE', 35)]	3	[('CHEBI_17883', 'hydrogen chloride', 20, 'HAPO'), ('UBERON_0001969', 'blood plasma', 59, 'plasma'), ('CHEBI_17234', 'glucose', 66, 'glucose'), ('GO_0007565', 'female pregnancy', 82, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC5539754	8/2017	S158-PMC5539754	['at present, there REMAINS a LACK OF CONSENSUS regarding RECOMMENDATIONS for uvb exposure for the Production Of Vitamin D for Pregnant Women [46].']	[('INCOMPLETE_EVIDENCE', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('FUTURE_WORK', 56)]	3	[('GO_0018240', 'protein S-linked glycosylation via cysteine', 97, 'production of vitamin D'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('GO_0007565', 'female pregnancy', 125, 'pregnant women')]
PMC5539754	8/2017	S159-PMC5539754	['OUR FINDINGS SUGGEST that women at risk of Vitamin D deficiency in early Pregnancy have altered Glucose Metabolism in later Gestation, BUT the evidence is NOT CONSISTENT for Insulin resistance.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 155)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('CHEBI_17234', 'glucose', 96, 'glucose'), ('GO_0006006', 'glucose metabolic process', 96, 'glucose metabolism'), ('GO_0007565', 'female pregnancy', 124, 'gestation'), ('PR_000045358', 'insulin family protein', 174, 'insulin')]
PMC5540678	7/2017	S49-PMC5540678	['IN ORDER TO ASSESS CONFOUNDING arising from OTHER dimensions of diet, we additionally adjusted separately for maternal Intake of Vitamin E, zinc, Selenium, n -3 Polyunsaturated Fatty Acids (Pufas), N -6 Pufas, and total fruits and vegetables in Pregnancy [1,29–31].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('PROBLEM_COMPLICATION', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 44)]	4	[('GO_0007631', 'feeding behavior', 119, 'intake'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin E'), ('CHEBI_27568', 'selenium atom', 146, 'selenium'), ('CHEBI_26203', 'polyprenol triphosphate', 161, 'polyunsaturated'), ('CHEBI_35366', 'fatty acid', 177, 'fatty acids'), ('CHEBI_86926', 'S a S b S', 190, 'PUFAs'), ('CHEBI_73643', 'Phe-Phe-Asp', 198, 'n -6 PUFAs'), ('GO_0007565', 'female pregnancy', 245, 'pregnancy')]
PMC5546866	8/2017	S0-PMC5546866	['response to antenatal Cholecalciferol supplementation is ASSOCIATED with common Vitamin D–related Genetic variants\n\nabstract\n\ncontext:\nSingle-Nucleotide Polymorphisms (Snps) in Genes RELATED to Vitamin D Metabolism HAVE BEEN ASSOCIATED with Serum 25-Hydroxyvitamin D [25(Oh)D] concentration, BUT these RELATIONSHIPS have NOT BEEN EXAMINED following Antenatal Cholecalciferol supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 57), ('SUPERFICIAL_RELATIONSHIP', 183), ('INCOMPLETE_EVIDENCE', 215), ('SUPERFICIAL_RELATIONSHIP', 225), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 292), ('SUPERFICIAL_RELATIONSHIP', 302), ('FULL_UNKNOWN', 321)]	7	[('CHEBI_16113', 'cholesterol', 22, 'Cholecalciferol'), ('CHEBI_28384', 'vitamin K', 80, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 80, 'Vitamin D'), ('SO_0000704', 'gene', 98, 'Genetic'), ('SO_0000694', 'SNP', 135, 'Single-nucleotide polymorphisms'), ('SO_0000694', 'SNP', 168, 'SNPs'), ('SO_0000704', 'gene', 177, 'genes'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('GO_0018977', '1,1,1-trichloro-2,2-bis-(4-chlorophenyl)ethane metabolic process', 202, 'D metabolism'), ('UBERON_0001977', 'blood serum', 241, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 247, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 268, '25(OH)D'), ('GO_0007567', 'parturition', 349, 'antenatal'), ('CHEBI_52550', 'theopalauamide', 359, 'cholecalciferol')]
PMC5546866	8/2017	S11-PMC5546866	['conclusions:\nGenetic variation in Dhcr7 , which encodes 7-Dehyrocholesterol reductase in the Epidermal Vitamin D Biosynthesis pathway, APPEARS to modify baseline 25(Oh)D. IN CONTRAST, the response to Antenatal Cholecalciferol supplementation was ASSOCIATED with Snps in Cyp2R1 , which MAY alter 25-hydroxylase activity, and gc , which MAY AFFECT Vitamin D binding Protein Synthesis or Metabolite affinity.']	[('ANOMALY_CURIOUS_FINDING', 135), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 171), ('SUPERFICIAL_RELATIONSHIP', 246), ('INCOMPLETE_EVIDENCE', 285), ('INCOMPLETE_EVIDENCE', 335), ('SUPERFICIAL_RELATIONSHIP', 339)]	6	[('SO_0000704', 'gene', 13, 'Genetic'), ('PR_000006474', 'ATP-dependent RNA helicase A', 34, 'DHCR7'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 56, '7-dehyrocholesterol'), ('UBERON_0007376', 'outer epithelium', 93, 'epidermal'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 103, 'vitamin D biosynthesis'), ('PR_000006444', 'diacylglycerol kinase delta', 111, 'D'), ('CHEBI_71657', 'versiconol acetate', 162, '25(OH)D'), ('GO_0007567', 'parturition', 200, 'antenatal'), ('CHEBI_52550', 'theopalauamide', 210, 'cholecalciferol'), ('SO_0000694', 'SNP', 262, 'SNPs'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 270, 'CYP2R1'), ('CHEBI_27300', 'vitamin D', 346, 'vitamin D'), ('GO_0006412', 'translation', 364, 'protein synthesis'), ('CHEBI_39382', 'flufenoxuron', 385, 'metabolite')]
PMC5546866	8/2017	S27-PMC5546866	['we THEREFORE undertook THIS STUDY TO DETERMINE WHETHER Snps within the Vitamin D Metabolism pathway KNOWN to modify Vitamin D status are also ASSOCIATED with the response to Antenatal Vitamin d supplementation.']	[('PROBABLE_UNDERSTANDING', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 142)]	6	[('SO_0000694', 'SNP', 55, 'SNPs'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 71, 'vitamin D metabolism'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007567', 'parturition', 174, 'antenatal'), ('CHEBI_33229', 'vitamin (role)', 184, 'vitamin')]
PMC5546866	8/2017	S118-PMC5546866	['discussion\nTHIS STUDY ASSESSED the RELATIONSHIPS between common Genetic variants and the response to Vitamin D supplementation in Pregnancy; rs12785878 in dhcr7 was ASSOCIATED with 25(Oh)D status in early Pregnancy prior to Vitamin D supplementation, WHEREAS rs10741657 in Cyp2R1 and rs2282679 in gc were ASSOCIATED with both the achieved and change in 25(Oh)D concentration following supplementation with 1000 iu/d Cholecalciferol.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('SUPERFICIAL_RELATIONSHIP', 35), ('SUPERFICIAL_RELATIONSHIP', 165), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 251), ('SUPERFICIAL_RELATIONSHIP', 305)]	6	[('SO_0000704', 'gene', 64, 'genetic'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('GO_0007565', 'female pregnancy', 130, 'pregnancy'), ('CHEBI_30778', 'gallic acid', 181, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 187, 'D'), ('GO_0007565', 'female pregnancy', 205, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 224, 'vitamin D'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 273, 'CYP2R1'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 356, 'OH)D'), ('CHEBI_52550', 'theopalauamide', 416, 'cholecalciferol')]
PMC5546866	8/2017	S125-PMC5546866	['(11) (15 to 18 nmol/l) than our cohort (9 to 10 nmol/l), BUT this COULD REFLECT the higher Cholecalciferol doses used in those studies and/or alterations in Vitamin D Metabolism and volume of distribution in Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 57), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 72)]	3	[('CHEBI_52550', 'theopalauamide', 91, 'cholecalciferol'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 157, 'vitamin D metabolism'), ('GO_0007565', 'female pregnancy', 208, 'pregnancy')]
PMC5546866	8/2017	S129-PMC5546866	['the Dhcr7 Gene encodes 7-Dhc reductase, which converts 7-Dhc back to Cholesterol, thereby reducing the availability of 7-Dhc for conversion to previtamin d. the ASSOCIATION of this Snp with only baseline 25(Oh)D is biologically CONSISTENT with the NOTION that the relative proportion of 25(Oh)D obtained from Vitamin D Biosynthesis in the skin AS OPPOSED TO dietary intake is lower following supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 161), ('INCOMPLETE_EVIDENCE', 228), ('INCOMPLETE_EVIDENCE', 248), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 344)]	4	[('PR_000006474', 'ATP-dependent RNA helicase A', 4, 'DHCR7'), ('SO_0000704', 'gene', 10, 'gene'), ('CHEBI_17759', 'cholesta-5,7-dien-3beta-ol', 23, '7-DHC'), ('CHEBI_17759', 'cholesta-5,7-dien-3beta-ol', 55, '7-DHC'), ('CHEBI_16113', 'cholesterol', 69, 'cholesterol'), ('CHEBI_17759', 'cholesta-5,7-dien-3beta-ol', 119, '7-DHC'), ('SO_0000694', 'SNP', 181, 'SNP'), ('CHEBI_71657', 'versiconol acetate', 204, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 287, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 293, 'D'), ('CHEBI_27300', 'vitamin D', 309, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 309, 'vitamin D biosynthesis')]
PMC5576167	8/2017	S87-PMC5576167	['with regards to OTHER Micronutrients, Vitamin D and Iodine deficiencies HAVE BEEN ASSOCIATED with various fetal and maternal abnormalities [29,30].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('INCOMPLETE_EVIDENCE', 72), ('SUPERFICIAL_RELATIONSHIP', 82)]	3	[('CHEBI_33839', 'macromolecule', 22, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 52, 'iodine')]
PMC5579643	8/2017	S57-PMC5579643	['HOWEVER, over the last decade, the EFFECTS of Vitamin D on the innate and Adaptive Immune System HAVE BEEN investigated and expanded [20].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 97)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0051866', 'general adaptation syndrome', 74, 'adaptive immune system'), ('UBERON_0002405', 'immune system', 83, 'immune system')]
PMC5579643	8/2017	S61-PMC5579643	['NEVERTHELESS, the POTENTIAL EFFECT of Vitamin D on Th1/Th2 Adaptive Immune Response is of INTEREST and RELATED to Food allergy [21,22,23].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 28), ('ANOMALY_CURIOUS_FINDING', 90), ('SUPERFICIAL_RELATIONSHIP', 103)]	5	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0042639', 'telogen', 51, 'Th1 ...'), ('GO_0002290', 'gamma-delta T cell activation involved in immune response', 55, 'Th2 adaptive immune response'), ('UBERON_0002405', 'immune system', 68, 'immune'), ('CHEBI_33290', 'food', 114, 'food')]
PMC5579643	8/2017	S64-PMC5579643	['HOWEVER, clinical trials on Vitamin D supplementation in children and the POSSIBLE ROLE in preventing Food allergy are LACKING.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 83), ('FULL_UNKNOWN', 119)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_33290', 'food', 102, 'food')]
PMC5587553	9/2017	S66-PMC5587553	['ON THE OTHER HAND, Antenatal supplementation was FOUND EFFECTIVE when they had iron (n\u2009=\u200910, d 0.05, 95% ci 0.002–0.10, p\u2009=\u20090.04), Vitamins B1, B2, b3, B12(n\u2009=\u200910, d 0.05, 95% ci 0.01–0.10, p\u2009=\u20090.02), and Vitamin C (n\u2009=\u20099, d 0.07, 95% ci 0.02–0.12, p\u2009=\u20090.004).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 55)]	3	[('GO_0007567', 'parturition', 19, 'antenatal'), ('CHEBI_34993', 'talampicillin hydrochloride', 131, 'vitamins B1'), ('PR_000004693', 'Bcl-2-like protein 10', 140, 'B1'), ('PR_000004693', 'Bcl-2-like protein 10', 144, 'B2'), ('CHEBI_27778', 'abequose', 152, 'B12'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin C')]
PMC5623264	9/2017	S108-PMC5623264	['vitamin a supplementation with other Micronutrients (Iron\xa0+\xa0Folate) compared with Micronutrient supplementation without Vitamin A had a positive EFFECT and reduced the risk of lbw by 33%.24HOWEVER, THESE FINDINGS are from a study involving only hiv-positive women and when comparing Vitamin A supplementation alone versus placebo or no treatment, a reduction of lbw could NOT be OBSERVED.']	[('SUPERFICIAL_RELATIONSHIP', 145), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 187), ('INCOMPLETE_EVIDENCE', 198), ('FULL_UNKNOWN', 372)]	4	[('CHEBI_33839', 'macromolecule', 37, 'micronutrients'), ('CHEBI_24870', 'ion', 53, 'iron'), ('CHEBI_30863', '5-azaorotic acid', 60, 'folate'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 82, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin A')]
PMC5623264	9/2017	S121-PMC5623264	['piso et al FOUND that Vitamin C supplementation during Pregnancy increased the RISK of ptb and magnesium supplementation decreased the RISK of ptb, lbw and sga.15HOWEVER, the cochrane reviews from which data were extracted had previously been updated and new studies had been added resulting in changed conclusions.']	[('INCOMPLETE_EVIDENCE', 11), ('IMPORTANT_CONSIDERATION', 79), ('IMPORTANT_CONSIDERATION', 135), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 160)]	4	[('CHEBI_27300', 'vitamin D', 22, 'vitamin C'), ('GO_0007565', 'female pregnancy', 55, 'pregnancy')]
PMC5634602	10/2017	S0-PMC5634602	['randomized trial of two doses of Vitamin D3In preterm infants <32 weeks: dose IMPACT on achieving desired Serum 25(Oh)D3In a nicu population\n\nabstract\n\nbackground\nRECOMMENDATIONS for Vitamin D supplementation for preterm infants span a WIDE range of doses.']	[('SUPERFICIAL_RELATIONSHIP', 78), ('FUTURE_WORK', 163), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 236)]	3	[('CHEBI_33229', 'vitamin (role)', 33, 'vitamin D3in'), ('PR_000017209', 'utrophin', 33, 'vitamin D3in'), ('UBERON_0001977', 'blood serum', 106, 'serum'), ('PR_000001883', 'lysosome-associated membrane protein', 112, '25(OH)D3in'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D')]
PMC5634602	10/2017	S19-PMC5634602	['the authors of THIS PAPER HOWEVER, CONCLUDE that doses of supplementation of Vitamin D SHOULD ensure 25(Oh)D levels of 75 nmol/l to maintain Skeletal health.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 26), ('INCOMPLETE_EVIDENCE', 35), ('FUTURE_WORK', 87)]	4	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 101, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 107, 'D'), ('UBERON_0004288', 'skeleton', 141, 'skeletal')]
PMC5634602	10/2017	S25-PMC5634602	['*formula Fed infants taking <1 liter of formula2008[5]aap—committee on nutrition preterm infants vlbw200–400 iu>50 nmol/l (targeting bone health)discharge Vitamin D RECOMMENDED for breastfed infants 400 iu, for formula Fed 200–400 iu2013[6]aap—committee on nutrition preterm infants>1500g400–1000 iu>50 nmol/l (targeting bone health)tolerating full enteral feeds2013[6]world health organization Preterm infants400–1000 iulow and middle-income countrieswho[7]institute of medicine infants 0–6 months400 iu>50 nmol/l (targeting bone health)under assumption of minimal sunlight2011[8]esphagan preterm infants800–1000 iu>80 nmol/lstable Growing, 1000 to 1800 grams2010[4]pediatric Endocrine society breastfed infants, or those taking <1lformula/day400 iu>50 nmol/l (desire ADDITIONAL STUDIES to determine IF >80 nmol/l is OPTIMAL)800 iu for high risk populations i.e.']	[('FUTURE_WORK', 165), ('FUTURE_WORK', 769), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 801), ('IMPORTANT_CONSIDERATION', 818)]	4	[('GO_0007631', 'feeding behavior', 9, 'fed'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D'), ('GO_0007631', 'feeding behavior', 219, 'fed'), ('GO_0007128', 'meiotic prophase I', 395, 'Preterm'), ('GO_0001947', 'heart looping', 633, 'Growing'), ('UBERON_0005063', 'left ventricular compact myocardium', 677, 'Endocrine')]
PMC5634602	10/2017	S79-PMC5634602	['there were statistically BUT not clinically significant differences in the Intake of Vitamin D from diet favoring the 400 iu group during the 1stand 7thweeks of the study (table 4).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 25)]	1	[('GO_0007631', 'feeding behavior', 75, 'intake'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC5634602	10/2017	S89-PMC5634602	['a notable DIFFERENCE between THIS STUDY and ours is that in natarajan’s intervention the dose of Vitamin D supplementation was reduced to ACCOUNT FOR dietary intake of vitamin D and the total intake of Vitamin D was 400 iu or 800 iu.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('PROBABLE_UNDERSTANDING', 138)]	3	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 176, 'D'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D')]
PMC5634602	10/2017	S120-PMC5634602	['jones has OUTLINED a mechanism by which this toxicity MAY present ARGUING that 25(Oh)D3At these concentrations displaces 1-alpha,25(Oh)2D from Vitamin D binding protein leading to increased Gene transcription [48].']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 54), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 66)]	3	[('CHEBI_35047', 'xanthomicrol', 79, '25(OH)D3at'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 129, '25(OH)2D'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('SO_0000704', 'gene', 190, 'gene')]
PMC5634602	10/2017	S137-PMC5634602	['HOWEVER, given that the MAJORITY of Prenatal Vitamins have 400 iu of Vitamin D and this has not been shown to increase levels in Pregnancy this LIKELY does not have any IMPACT on our DESCRIBED results.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 24), ('PROBABLE_UNDERSTANDING', 144), ('SUPERFICIAL_RELATIONSHIP', 169), ('INCOMPLETE_EVIDENCE', 183)]	5	[('GO_0007565', 'female pregnancy', 36, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 45, 'vitamins'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy')]
PMC5634602	10/2017	S146-PMC5634602	['ALTERNATIVELY, the risks of RECOMMENDATION of too low a dose MAY have significant IMPACT on Individual and population health with disease outcomes ASSOCIATED with low Vitamin D status, including hypocalcemic seizures, growth restriction, fractures, and elevation of Serum Parathyroid hormone [53–55].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 28), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 82), ('SUPERFICIAL_RELATIONSHIP', 147)]	5	[('NCBITaxon_1', 'root', 92, 'individual'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('UBERON_0001977', 'blood serum', 266, 'serum'), ('UBERON_0001132', 'parathyroid gland', 272, 'parathyroid')]
PMC5634602	10/2017	S148-PMC5634602	['OTHER authors have RECOMMENDED loading doses to more quickly improve Vitamin D status in AT RISK populations, a STRATEGY that MERITS FURTHER INVESTIGATION [57].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 19), ('IMPORTANT_CONSIDERATION', 89), ('FUTURE_WORK', 112), ('IMPORTANT_CONSIDERATION', 126), ('FUTURE_WORK', 133)]	6	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC5638722	8/2017	S105-PMC5638722	['BUT we PROPOSE that, MORE prospective STUDIES regarding to the RELATIONSHIP of Vitamin D and sepsis in premature infants ARE NEEDED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 7), ('ANOMALY_CURIOUS_FINDING', 21), ('FUTURE_WORK', 38), ('SUPERFICIAL_RELATIONSHIP', 63), ('FUTURE_WORK', 121)]	6	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC5638722	8/2017	S108-PMC5638722	['BUT ON THE OTHER HAND, SOME STUDIES DID NOT FIND difference between the Vitamin D levels and preeclampsia.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 36)]	4	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC5638722	8/2017	S111-PMC5638722	['BUT with the results of OUR STUDY, no relation between the Cord-Blood Vitamin D levels and Gestational diabetes incidence is FOUND.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('INCOMPLETE_EVIDENCE', 125)]	3	[('UBERON_0002240', 'spinal cord', 59, 'cord'), ('UBERON_0000178', 'blood', 64, 'blood'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0007565', 'female pregnancy', 91, 'gestational')]
PMC5638722	8/2017	S116-PMC5638722	['in OUR STUDY which included only premature infants, the number of patients with <5 ng/dl Vitamin D levels was more than the OTHER 2 groups.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124)]	2	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC5638722	8/2017	S120-PMC5638722	['BUT, ON THE OTHER HAND, there are also studies which DID NOT FIND a RELATIONSHIP between the Pregnancy Vitamin D levels and Birth weight and length.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('INCOMPLETE_EVIDENCE', 53), ('SUPERFICIAL_RELATIONSHIP', 68)]	4	[('GO_0007565', 'female pregnancy', 93, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0007567', 'parturition', 124, 'birth')]
PMC5638722	8/2017	S125-PMC5638722	['secondly, we also DO NOT HAVE data related to OTHER dietary factors which COULD BE INTERFERING with Vitamin D level.']	[('FULL_UNKNOWN', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 46), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 83)]	4	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC5638722	8/2017	S128-PMC5638722	['due to this knowledge, we SUPPOSED that the Cord-Blood Vitamin D levels are proportional to the maternal Blood levels.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 26)]	1	[('UBERON_0002240', 'spinal cord', 44, 'cord'), ('UBERON_0000178', 'blood', 49, 'blood'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('UBERON_0000178', 'blood', 105, 'blood')]
PMC5640793	9/2017	S44-PMC5640793	["the lancet 's 2013 maternal and child nutrition series RECOMMENDS ten nutrition-specific INTERVENTIONS, including sufficient and diverse Foods for adolescent girls and women; iron, Folic Acid, and Calcium supplementation in Pregnancy; good infant and young child Feeding practices; Vitamin A, iron, and preventive zinc supplementation for children; and treatment for moderate and severe acute malnutrition.5strikingly HOWEVER, expanding the coverage of these nutrition-specific INTERVENTIONS to 90% of mothers and children would only reduce stunting by an ESTIMATED 20%.5larger reductions than these REQUIRE increasing access to family Planning, health services for Pregnant women and children, investments in Water and sanitation, social safety nets, girls' education, and women's empowerment.6a pragmatic approach to design community STRATEGIES for stunting reduction MIGHT THEREFORE be to prioritise action on immediate determinants (infection control, nutrition, and care in the first 1000 days) while providing an enabling social environment for changes in more distal determinants, for example by sharing information about health, nutrition, and sanitation entitlements, and bolstering women's agency."]	[('FUTURE_WORK', 55), ('SUPERFICIAL_RELATIONSHIP', 89), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 418), ('ANOMALY_CURIOUS_FINDING', 418), ('SUPERFICIAL_RELATIONSHIP', 478), ('INCOMPLETE_EVIDENCE', 556), ('FUTURE_WORK', 600), ('IMPORTANT_CONSIDERATION', 600), ('FUTURE_WORK', 836), ('INCOMPLETE_EVIDENCE', 870), ('PROBABLE_UNDERSTANDING', 876)]	11	[('CHEBI_33290', 'food', 137, 'foods'), ('CHEBI_30751', 'formic acid', 181, 'folic acid'), ('CHEBI_22313', 'alkaline earth metal atom', 197, 'calcium'), ('GO_0007565', 'female pregnancy', 224, 'pregnancy'), ('GO_0007631', 'feeding behavior', 263, 'feeding'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin A'), ('GO_0006260', 'DNA replication', 636, 'planning'), ('GO_0007565', 'female pregnancy', 666, 'pregnant'), ('CHEBI_15377', 'water', 710, 'water')]
PMC5659607	10/2017	S21-PMC5659607	['a recent meta-analysis SUGGESTED that INSUFFICIENT power DUE TO an OVERESTIMATION of the treatment effect MAY HAVE BEEN one of the ISSUES for the non-significance of the FINDINGS[11], BUT we HYPOTHESIZED that maternal 25(Oh)D level at trial entry MAY also have INFLUENCED the EFFECT of the Vitamin D supplementation[12].']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 38), ('PROBLEM_COMPLICATION', 38), ('PROBLEM_COMPLICATION', 57), ('PROBLEM_COMPLICATION', 67), ('INCOMPLETE_EVIDENCE', 106), ('INCOMPLETE_EVIDENCE', 110), ('PROBLEM_COMPLICATION', 131), ('INCOMPLETE_EVIDENCE', 170), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 184), ('INCOMPLETE_EVIDENCE', 191), ('INCOMPLETE_EVIDENCE', 247), ('SUPERFICIAL_RELATIONSHIP', 261), ('SUPERFICIAL_RELATIONSHIP', 276)]	14	[('CHEBI_71657', 'versiconol acetate', 218, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 224, 'D'), ('CHEBI_27300', 'vitamin D', 290, 'vitamin D')]
PMC5659607	10/2017	S22-PMC5659607	['we THEREFORE conducted a combined analysis of the two trials including the primary end-point asthma/recurrent wheeze by age 3 years as well as the secondary end-points specific Ige, total Ige, eczema and Lower Respiratory Tract infections (lrti) and did 25(Oh)D level-based analyses to determine WHETHER nutritional status at entry to the trials INFLUENCED the EFFECT of Vitamin D.\n\nmethods\nvdaart: monitored by nhlbi and copsac: approved by the ethics committee for copenhagen.']	[('PROBABLE_UNDERSTANDING', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 296), ('SUPERFICIAL_RELATIONSHIP', 346), ('SUPERFICIAL_RELATIONSHIP', 361)]	4	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 177, 'IgE'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 188, 'IgE'), ('UBERON_0004905', 'articulation', 204, 'lower respiratory tract'), ('CHEBI_71657', 'versiconol acetate', 254, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 254, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 371, 'vitamin D')]
PMC5659607	10/2017	S68-PMC5659607	['HOWEVER, a literature search REVEALED one additional trial of Vitamin D supplementation in Pregnancy and subsequent asthma/recurrent wheeze performed by goldring et al., which DIFFERED markedly from our trials by enrolling 180 women at Pregnancy week 27 and randomizing them to either no Vitamin D, 800 iu Ergocalciferol daily until Delivery or a single oral bolus of 200,000 iu Cholecalciferol[22].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 176)]	3	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 91, 'pregnancy'), ('GO_0007565', 'female pregnancy', 236, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 288, 'vitamin D'), ('CHEBI_4910', 'etomidate', 306, 'ergocalciferol'), ('GO_0007567', 'parturition', 333, 'delivery'), ('CHEBI_52550', 'theopalauamide', 379, 'cholecalciferol')]
PMC5659607	10/2017	S120-PMC5659607	['DESPITE these DIFFERENCES, the trials SIMILARLY SHOWED that the Vitamin D supplementation resulted in significantly increased post-interventional 25(Oh)D levels in the mothers.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 48)]	5	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 146, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 146, '25(OH ... D')]
PMC5659607	10/2017	S121-PMC5659607	['furthermore, taking advantage of these DIFFERENCES in the combined analysis by utilizing the measured 25(Oh)D levels at study entry, unmasked the most pronounced protective EFFECT of the Vitamin D intervention in women with 25(Oh)D level ≥ 30 ng/ml.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 39), ('SUPERFICIAL_RELATIONSHIP', 173)]	2	[('CHEBI_71657', 'versiconol acetate', 102, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 108, 'D'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 224, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 230, 'D')]
PMC5659607	10/2017	S125-PMC5659607	['finally, vdaart included a large group of african-american women in the trial, who are WELL-KNOWN to have a higher RISK of developing asthma and allergy[25] and had lower Vitamin D levels at randomization COMPARED to the OTHER ethnic groups[12].']	[('FUTURE_WORK', 87), ('PROBABLE_UNDERSTANDING', 92), ('IMPORTANT_CONSIDERATION', 115), ('ANOMALY_CURIOUS_FINDING', 205), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221)]	5	[('CHEBI_27300', 'vitamin D', 171, 'vitamin D')]
PMC5659607	10/2017	S131-PMC5659607	['INTERPRETATION\nthis combined analysis of our two Vitamin D rcts SHOWED a significant 26% reduced risk of the primary end-point asthma/recurrent wheeze during the first 3 years of Life, which SUGGESTS that the non-significant/borderline significant trial responses OBSERVED in the individual intent-to-treat analyses were PARTLY due to LACK OF power caused by an OVERESTIMATION of the treatment effect, RATHER than lack of an intervention effect.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 64), ('INCOMPLETE_EVIDENCE', 191), ('INCOMPLETE_EVIDENCE', 264), ('INCOMPLETE_EVIDENCE', 321), ('INCOMPLETE_EVIDENCE', 335), ('ANOMALY_CURIOUS_FINDING', 340), ('PROBLEM_COMPLICATION', 362), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 402)]	9	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000104', 'life cycle', 179, 'life')]
PMC5659607	10/2017	S135-PMC5659607	['to explore that ISSUE, we performed the combined analyses stratified for the women’s 25(Oh)D level at trial entry, which SHOWED that the Vitamin D supplement resulted in a significantly reduced RISK of asthma/recurrent wheeze in the offspring of women with 25(Oh)D ≥ 30 ng/ml, BUT a much SMALLER and statistically non-significant EFFECT among women with 25(Oh)D < 30 ng/ml.']	[('PROBLEM_COMPLICATION', 16), ('INCOMPLETE_EVIDENCE', 121), ('IMPORTANT_CONSIDERATION', 194), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 277), ('INCOMPLETE_EVIDENCE', 288), ('SUPERFICIAL_RELATIONSHIP', 330)]	6	[('CHEBI_71657', 'versiconol acetate', 85, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 91, 'D'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 257, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 257, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 354, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 354, '25(OH)D')]
PMC5659607	10/2017	S136-PMC5659607	['this FINDING is CONTRARY to what MANY have SUGGESTED that ONLY those who are deficient in Vitamin D would BENEFIT from supplementation.']	[('INCOMPLETE_EVIDENCE', 5), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 43), ('ANOMALY_CURIOUS_FINDING', 58), ('IMPORTANT_CONSIDERATION', 106)]	6	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC5659607	10/2017	S139-PMC5659607	['HOWEVER, EMERGING EVIDENCE arising from Lung Gene Expression data from our own lab have SUBSEQUENTLY SHOWN that Vitamin D already has EFFECTS at the stage of Branching Morphogenesis of the fetal Lung occurring in the first Trimester of Pregnancy prior to randomization in both these trials[2].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 134)]	4	[('UBERON_0002048', 'lung', 40, 'lung'), ('GO_0010467', 'gene expression', 45, 'gene expression'), ('SO_0000704', 'gene', 45, 'gene'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0001763', 'morphogenesis of a branching structure', 158, 'branching morphogenesis'), ('UBERON_0002048', 'lung', 195, 'lung'), ('GO_0009294', 'DNA mediated transformation', 223, 'trimester'), ('GO_0007565', 'female pregnancy', 236, 'pregnancy')]
PMC5659607	10/2017	S148-PMC5659607	['this is CONSISTENT with a RECENT rct SHOWING no effect on Cat specific Ige levels, WHEREAS decreased house-Dust Mite specific Ige was SHOWN in the offspring of mothers supplemented with Vitamin D during Pregnancy[31].']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('INCOMPLETE_EVIDENCE', 134)]	5	[('NCBITaxon_33208', 'Metazoa', 58, 'cat'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 71, 'IgE'), ('NCBITaxon_10088', 'Mus <genus>', 107, 'dust'), ('NCBITaxon_10088', 'Mus <genus>', 112, 'mite'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 126, 'IgE'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('GO_0007565', 'female pregnancy', 203, 'pregnancy')]
PMC5659607	10/2017	S150-PMC5659607	['it has already been shown that maternal Vitamin D status is ASSOCIATED with OTHER Immune-mediated diseases such as pre-eclampsia[34] and type i diabetes in the offspring[35].']	[('SUPERFICIAL_RELATIONSHIP', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 76)]	2	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('UBERON_0002405', 'immune system', 82, 'immune')]
PMC5664622	9/2017	S11-PMC5664622	['the literature offers NO CONSENSUS on the RECOMMENDED Vitamin D concentrations or unified diagnostic criteria.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('FUTURE_WORK', 42)]	2	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
PMC5664622	9/2017	S13-PMC5664622	['IN LIGHT OF the ONGOING DEBATE on the OPTIMAL Vitamin D concentration in Pregnant women, MOST EXPERTS are of the OPINION that the 25(Oh)D concentration in maternal Blood SHOULD exceed 30 ng/ml [2,8,9].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('IMPORTANT_CONSIDERATION', 38), ('PROBABLE_UNDERSTANDING', 89), ('PROBABLE_UNDERSTANDING', 94), ('INCOMPLETE_EVIDENCE', 113), ('FUTURE_WORK', 170), ('IMPORTANT_CONSIDERATION', 170)]	9	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0007565', 'female pregnancy', 73, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 130, '25(OH)D'), ('UBERON_0000178', 'blood', 164, 'blood')]
PMC5664622	9/2017	S14-PMC5664622	['HOWEVER, OTHER authors CLAIM that maternal concentration that fully normalizes Vitamin D Metabolism and Calcium Homeostasis is AT LEAST 40 ng/ml [10], and still others that >20 ng/ml is NECESSARY to prevent Vitamin D deficiency in the newborn [11].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('INCOMPLETE_EVIDENCE', 23), ('PROBABLE_UNDERSTANDING', 127), ('IMPORTANT_CONSIDERATION', 186)]	5	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 79, 'vitamin D metabolism'), ('GO_0055073', 'cadmium ion homeostasis', 104, 'calcium homeostasis'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D')]
PMC5664622	9/2017	S50-PMC5664622	['in the summer group, the number of subjects with Vitamin D deficiency was almost 50% lower, WHILE the recommended level was DETECTED in almost 3-times more subjects as compared to the winter group, BUT STILL in ONLY 16% of the group.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('ANOMALY_CURIOUS_FINDING', 92), ('ANOMALY_CURIOUS_FINDING', 124), ('ANOMALY_CURIOUS_FINDING', 198), ('ANOMALY_CURIOUS_FINDING', 202), ('ANOMALY_CURIOUS_FINDING', 211)]	6	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC5664622	9/2017	S77-PMC5664622	['our results are CONSISTENT with the FINDINGS of OTHER authors, who have also CONFIRMED Vitamin D deficiency among Pregnant women in poland [3,5,17,18,19], ALTHOUGH REPORTS in the polish literature on better Vitamin D saturation in the summer are LESS UNAMBIGUOUS.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 36), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 48), ('INCOMPLETE_EVIDENCE', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 155), ('ANOMALY_CURIOUS_FINDING', 155), ('INCOMPLETE_EVIDENCE', 164), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 246), ('INCOMPLETE_EVIDENCE', 246), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 251)]	10	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0007565', 'female pregnancy', 114, 'pregnant'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D')]
PMC5664622	9/2017	S83-PMC5664622	['reports from OTHER european countries also FOUND a TENDENCY for higher Vitamin D levels among Pregnant women during summer, e.g., in germany which is located at a similar latitude as poland [20], as well as countries with very DIFFERENT geographic location and sun exposure, such as greece [12], or norway [21].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 227)]	4	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'pregnant')]
PMC5664622	9/2017	S94-PMC5664622	['REGARDLESS, DESPITE Vitamin/Mineral supplementation in Pregnancy, maternal intake of Vitamin D REMAINS below the RECOMMENDED levels, MOSTLY BECAUSE 75% of the multi-component Supplements for Pregnant women which are available in poland contain small amount of Vitamin D (5–10 µg) [14], as compared to the recommended dose of 37.5–50 µg [8].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 12), ('INCOMPLETE_EVIDENCE', 95), ('FUTURE_WORK', 113), ('PROBABLE_UNDERSTANDING', 133), ('PROBABLE_UNDERSTANDING', 140)]	6	[('CHEBI_33229', 'vitamin (role)', 20, 'vitamin'), ('CHEBI_46662', 'mineral', 28, 'mineral'), ('GO_0007565', 'female pregnancy', 55, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 175, 'supplements'), ('GO_0007565', 'female pregnancy', 191, 'pregnant'), ('CHEBI_27300', 'vitamin D', 260, 'vitamin D')]
PMC5664622	9/2017	S103-PMC5664622	['in all mother-infant Blood sets, Umbilical Cord Blood Vitamin D concentration was higher by 7.7 ng/ml on average (APPROXIMATELY 40%), as COMPARED TO maternal levels, which is CONSISTENT with MOST studies worldwide, CLAIMING that Cord Blood level was higher than maternal Venous Blood level by 3.9–8.0 ng/ml [7,12,26,32].']	[('INCOMPLETE_EVIDENCE', 114), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137), ('INCOMPLETE_EVIDENCE', 175), ('PROBABLE_UNDERSTANDING', 191), ('PROBABLE_UNDERSTANDING', 215), ('PROBABLE_UNDERSTANDING', 215)]	6	[('UBERON_0000178', 'blood', 21, 'blood'), ('UBERON_0002331', 'umbilical cord', 33, 'umbilical cord'), ('UBERON_0000178', 'blood', 48, 'blood'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 229, 'cord'), ('UBERON_0000178', 'blood', 234, 'blood'), ('UBERON_0013756', 'venous blood', 271, 'venous blood')]
PMC5664622	9/2017	S118-PMC5664622	['it SEEMS that the ESTIMATED Vitamin D consumption is a RELIABLE result AS it is CONSISTENT with OTHER REPORTS, which for years have INDICATED a consistently low amount of Vitamin D in the diet of polish Pregnant women (2.6–2.8 µg/day) [13,35].']	[('ANOMALY_CURIOUS_FINDING', 3), ('INCOMPLETE_EVIDENCE', 18), ('IMPORTANT_CONSIDERATION', 55), ('PROBABLE_UNDERSTANDING', 71), ('INCOMPLETE_EVIDENCE', 80), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 96), ('INCOMPLETE_EVIDENCE', 102), ('INCOMPLETE_EVIDENCE', 132)]	8	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('GO_0007565', 'female pregnancy', 203, 'pregnant')]
PMC5664622	9/2017	S136-PMC5664622	['HOWEVER, that level does not apply to the overall EFFECT of Vitamin D on the course of Pregnancy and maternal health.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 50)]	2	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 87, 'pregnancy')]
PMC5679631	11/2017	S1-PMC5679631	['we INVESTIGATED WHETHER maternal Vitamin D supplemention, maternal Plasma 25-Hydroxyvitamin D concentration, OR direct supplementation of the infant INFLUENCES key bacterial taxa within microbiota of one month old infants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('SUPERFICIAL_RELATIONSHIP', 149)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 67, 'plasma'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 74, '25-hydroxyvitamin D')]
PMC5679631	11/2017	S26-PMC5679631	['GIVEN that Vitamin D status is a MODIFIABLE FACTOR which MAY INFLUENCE Intestinal Microbiotic Homeostasis, which in turn is INDICATED to be IMPORTANT in the prevention of Immune mediated diseases, we INVESTIGATED WHETHER maternal use of multivitamin supplements containing Vitamin D, maternal Vitamin D status (25 Hydroxyvitamin D (25(Oh)D), OR administration of Vitamin D supplement to the baby INFLUENCES the presence and abundance of several key bacterial taxa of the infant Gut microbiota.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 33), ('SUPERFICIAL_RELATIONSHIP', 44), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 61), ('INCOMPLETE_EVIDENCE', 124), ('IMPORTANT_CONSIDERATION', 140), ('QUESTION_ANSWERED_BY_THIS_WORK', 200), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 213), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 342), ('SUPERFICIAL_RELATIONSHIP', 396)]	11	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('UBERON_0000160', 'intestine', 71, 'intestinal'), ('CHEBI_75293', 'methyltrioctylammonium', 82, 'microbiotic'), ('GO_0055074', 'calcium ion homeostasis', 82, 'microbiotic homeostasis'), ('UBERON_0002405', 'immune system', 171, 'immune'), ('CHEBI_27300', 'vitamin D', 273, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 293, 'vitamin D'), ('CHEBI_67828', 'rel-(3aR,4S,6aS,7R,9aR,10aS)-10a-Hydroxy-7-isopropyl-1,4,9a-trimethyl-4,5,6,6a,7,8,9,9a,10,10a-decahydro-3aH-dicyclopenta[a,d]cycloocten-3-one', 311, '25 hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 332, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 363, 'vitamin D'), ('UBERON_0001555', 'digestive tract', 478, 'gut')]
PMC5679631	11/2017	S88-PMC5679631	['during seasons of both high and low cutaneous Production Of Vitamin D, the mean maternal Plasma 25(Oh)D concentrations were significantly greater in mothers who used Vitamin D containing supplements COMPARED TO those who did not.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 199)]	1	[('GO_0018240', 'protein S-linked glycosylation via cysteine', 46, 'production of vitamin D'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 89, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 96, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 96, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D')]
PMC5679631	11/2017	S130-PMC5679631	['ALTHOUGH Vitamin D promotes Immune tolerance, adequate Adaptive Immune Response, as measured by Igg Production in response to infection or vaccination, HAS BEEN observed in patients with relatively high Serum 25(Oh)D levels, SUGGESTING that Vitamin D maintains Immune stability by preventing excessive Immune Responses in EITHER direction [26].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 152), ('INCOMPLETE_EVIDENCE', 225), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 322)]	5	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0002405', 'immune system', 28, 'immune'), ('GO_0002250', 'adaptive immune response', 55, 'adaptive immune response'), ('UBERON_0002405', 'immune system', 64, 'immune'), ('GO_0032608', 'interferon-beta production', 96, 'IgG production'), ('GO_0071735', 'IgG immunoglobulin complex', 96, 'IgG'), ('UBERON_0001977', 'blood serum', 203, 'serum'), ('CHEBI_71657', 'versiconol acetate', 209, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 209, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 241, 'vitamin D'), ('UBERON_0002405', 'immune system', 261, 'immune'), ('GO_0006955', 'immune response', 302, 'immune responses'), ('UBERON_0002405', 'immune system', 302, 'immune')]
PMC5679631	11/2017	S134-PMC5679631	['in Humans, a study investigating variation in diet and microbial composition of the Intestinal Tract between 52 african americans and 46 caucasian americans FOUND DISCORDANT Vitamin D supplementation practices and differences between the counts of bacteroidetes in the Fecal samples between the two groups [28].']	[('INCOMPLETE_EVIDENCE', 157), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 163)]	2	[('NCBITaxon_9606', 'Homo sapiens', 3, 'humans'), ('UBERON_0001555', 'digestive tract', 84, 'intestinal tract'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('UBERON_0000922', 'embryo', 269, 'fecal')]
PMC5679631	11/2017	S138-PMC5679631	['the INFLUENCE of direct Vitamin D supplementation of the child DIFFERED between the two recruitment groups SUGGESTING that lifestyle factors are Modulating the ASSOCIATION between Vitamin D and the Intestinal bacterial Taxa.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63), ('INCOMPLETE_EVIDENCE', 107), ('SUPERFICIAL_RELATIONSHIP', 160)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0065007', 'biological regulation', 145, 'modulating'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('UBERON_0000160', 'intestine', 198, 'intestinal'), ('NCBITaxon_10088', 'Mus <genus>', 219, 'taxa')]
PMC5682869	11/2017	S46-PMC5682869	['HOWEVER, still a well-balanced ovo-lacto vegetarian diet USUALLY enables good Nutrient status in Pregnancy, when supplemented with Vitamin D, Folic Acid, Iodine, iron, Vitamin B12 and zinc, and, in cases of a fish-free diet, with Dha [19].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 57)]	2	[('CHEBI_33284', 'nutrient', 78, 'nutrient'), ('GO_0007565', 'female pregnancy', 97, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('CHEBI_30751', 'formic acid', 142, 'folic acid'), ('CHEBI_24859', 'iodine atom', 154, 'iodine'), ('CHEBI_33279', 'vitamin D5', 168, 'vitamin B12'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 176, 'B12'), ('CHEBI_17874', 'dihydrozeatin', 230, 'DHA')]
PMC5685050	10/2014	S10-PMC5685050	['HOWEVER, according to the RECENT STUDIES, Vitamin D deficiency is also common in these countries10,11.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 26)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
PMC5706533	11/2017	S18-PMC5706533	['beyond its established INFLUENCE on bone growth and Calcium Homeostasis,1vitamin D and its RELATED Metabolites have HYPOTHESISED EFFECTS on the risk of Cardiovascular diseases,2cancer,3respiratory infections,4asthma,5conditions RELATED to Pregnancy (such as pre-eclampsia, Gestational diabetes), and Birth outcomes.6concern that Vitamin D deficiency is a global PUBLIC HEALTH PROBLEM HAS BEEN sparked by numerous REPORTS of the high proportion of Individuals in studies throughout the world who have relatively low Serum/Plasma concentrations of 25-hydroxyvitamin d (25(Oh)D),7the conventional circulating BIOMARKER of Vitamin D status.8there HAS BEEN particular ATTENTION to the high prevalence of vitamin d deficiency in Pregnant women and newborns.7\nin 2010, dietary reference intakes for Vitamin D for canada and the us from the institute of medicine were based solely on bone health—particularly in young children (for instance, rickets) and older Adults (for instance, osteoporosis).1considerable SKEPTICISM was cast onto the LINK between Vitamin D and Extraskeletal health conditions or the POTENTIAL benefits (versus risks) of intakes larger than the recommended dietary allowance (600 iu/day for MOST children and Adults).1THE institute’s report DID NOT RECOMMEND higher intakes during Pregnancy and Lactation.1a 2016 update of the cochrane collaboration systematic review and meta-analysis of trials of Vitamin D in Pregnancy (versus placebo or no Supplement), HOWEVER, TENTATIVELY CONCLUDED that Prenatal Vitamin D supplementation “MAY reduce the risk of pre-eclampsia, low birthweight and Preterm Birth.”6other RECENT systematic reviews that included trials with active control arms (in which participants received Vitamin D) ACKNOWLEDGED the POTENTIAL EFFECT of Vitamin D on fetal growth910but DID NOT FIND evidence of EFFECTS on OTHER maternal, fetal, or infant outcomes.91011citing the 2016 cochrane review,6the world health organization guidelines for Antenatal care ADVISE against routine Vitamin D supplementation in Pregnancy.12dietary and supplementation RECOMMENDATIONS, HOWEVER, vary widely across other professional organisations (appendix 1), and there REMAINS a LACK OF CONSENSUS on target health outcomes, indications for Prenatal supplementation, or EVIDENCE BASED regimens for supplement dose (or fortification STRATEGIES).']	[('SUPERFICIAL_RELATIONSHIP', 23), ('SUPERFICIAL_RELATIONSHIP', 91), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 129), ('SUPERFICIAL_RELATIONSHIP', 228), ('IMPORTANT_CONSIDERATION', 362), ('IMPORTANT_CONSIDERATION', 376), ('PROBLEM_COMPLICATION', 376), ('INCOMPLETE_EVIDENCE', 384), ('INCOMPLETE_EVIDENCE', 413), ('SUPERFICIAL_RELATIONSHIP', 606), ('INCOMPLETE_EVIDENCE', 643), ('IMPORTANT_CONSIDERATION', 663), ('INCOMPLETE_EVIDENCE', 663), ('IMPORTANT_CONSIDERATION', 1003), ('SUPERFICIAL_RELATIONSHIP', 1032), ('INCOMPLETE_EVIDENCE', 1098), ('PROBABLE_UNDERSTANDING', 1205), ('INCOMPLETE_EVIDENCE', 1231), ('INCOMPLETE_EVIDENCE', 1255), ('FUTURE_WORK', 1263), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1471), ('INCOMPLETE_EVIDENCE', 1480), ('INCOMPLETE_EVIDENCE', 1492), ('INCOMPLETE_EVIDENCE', 1543), ('INCOMPLETE_EVIDENCE', 1623), ('INCOMPLETE_EVIDENCE', 1738), ('PROBABLE_UNDERSTANDING', 1738), ('INCOMPLETE_EVIDENCE', 1755), ('SUPERFICIAL_RELATIONSHIP', 1765), ('INCOMPLETE_EVIDENCE', 1807), ('SUPERFICIAL_RELATIONSHIP', 1832), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1843), ('FUTURE_WORK', 1983), ('FUTURE_WORK', 2075), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2092), ('ANOMALY_CURIOUS_FINDING', 2092), ('INCOMPLETE_EVIDENCE', 2177), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2187), ('INCOMPLETE_EVIDENCE', 2187), ('INCOMPLETE_EVIDENCE', 2277), ('FUTURE_WORK', 2339)]	42	[('GO_0055073', 'cadmium ion homeostasis', 52, 'calcium homeostasis'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 81, 'D'), ('CHEBI_25212', 'metabolite', 99, 'metabolites'), ('UBERON_0004535', 'cardiovascular system', 152, 'cardiovascular'), ('GO_0007565', 'female pregnancy', 239, 'pregnancy'), ('GO_0007565', 'female pregnancy', 273, 'gestational'), ('GO_0007567', 'parturition', 300, 'birth'), ('CHEBI_27300', 'vitamin D', 329, 'vitamin D'), ('NCBITaxon_1', 'root', 447, 'individuals'), ('UBERON_0001977', 'blood serum', 515, 'serum'), ('UBERON_0001969', 'blood plasma', 521, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 567, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 619, 'vitamin D'), ('GO_0007565', 'female pregnancy', 723, 'pregnant'), ('CHEBI_27300', 'vitamin D', 792, 'vitamin D'), ('UBERON_0007023', 'adult organism', 953, 'adults'), ('CHEBI_27300', 'vitamin D', 1045, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 1059, 'extraskeletal'), ('UBERON_0007023', 'adult organism', 1223, 'adults'), ('GO_0007565', 'female pregnancy', 1295, 'pregnancy'), ('GO_0007595', 'lactation', 1309, 'lactation'), ('CHEBI_27300', 'vitamin D', 1413, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1426, 'pregnancy'), ('CHEBI_16158', 'steroid sulfate', 1458, 'supplement'), ('GO_0007565', 'female pregnancy', 1507, 'prenatal'), ('CHEBI_27300', 'vitamin D', 1516, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1601, 'preterm birth'), ('CHEBI_27300', 'vitamin D', 1727, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1775, 'vitamin D'), ('GO_0007567', 'parturition', 1968, 'antenatal'), ('CHEBI_27300', 'vitamin D', 2006, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2035, 'pregnancy'), ('GO_0007565', 'female pregnancy', 2248, 'prenatal')]
PMC5706533	11/2017	S29-PMC5706533	['we EXCLUDED from the systematic review single arm Vitamin D trials (such as pharmacokinetic studies); trials in which the intervention was administered only before Conception or after Delivery; observational cohorts RATHER than parallel group trials (that is, intervention group assignment was based on review of medical records or participant Recall or there was a lack of sufficient evidence in the published report to INDICATE that participants were assigned prospectively to intervention groups); and trials in which differences in cointervention(s) across trial arms prevented inferences specifically about Vitamin D. two independent reviewers screened abstracts and full text articles for inclusion using a web based systematic review platform (covidence).']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 216), ('INCOMPLETE_EVIDENCE', 421)]	3	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007620', 'copulation', 164, 'conception'), ('GO_0007567', 'parturition', 184, 'delivery'), ('GO_0060033', 'anatomical structure regression', 344, 'recall'), ('CHEBI_27300', 'vitamin D', 612, 'vitamin D')]
PMC5706533	11/2017	S96-PMC5706533	['higher regular dose regimens (≥2000 iu/day) LED TO a greater average increment in Maternal Delivery and Cord 25(Oh)D than lower doses (tables s1 and s2 in appendix 10); HOWEVER, the linear dose-response curves for maternal and Cord Blood INDICATED modest EFFECTS of increasing Vitamin D doses on the increment in 25(Oh)D concentrations (fig s2 and s4 in Appendix 10).']	[('SUPERFICIAL_RELATIONSHIP', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 169), ('INCOMPLETE_EVIDENCE', 238), ('SUPERFICIAL_RELATIONSHIP', 255)]	4	[('GO_0007618', 'mating', 82, 'maternal'), ('GO_0007567', 'parturition', 91, 'delivery'), ('UBERON_0002240', 'spinal cord', 104, 'cord'), ('CHEBI_71657', 'versiconol acetate', 109, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 109, '25(OH)D'), ('UBERON_0002240', 'spinal cord', 227, 'cord'), ('UBERON_0000178', 'blood', 232, 'blood'), ('CHEBI_27300', 'vitamin D', 277, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 313, '25(OH)D'), ('UBERON_0001154', 'vermiform appendix', 354, 'appendix')]
PMC5706533	11/2017	S105-PMC5706533	['inclusion of all trials irrespective of these criteria, HOWEVER, SUGGESTED that Vitamin D COULD reduce the risk of Gestational diabetes (risk ratio 0.61, 95% confidence interval 0.45 to 0.83; 14 comparisons; 2643 participants) (table s5 and fig s10 in appendix 10).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 56), ('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 90)]	3	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'gestational')]
PMC5706533	11/2017	S148-PMC5706533	['THOUGH SOME OBSERVATIONAL STUDIES HAVE SHOWN ASSOCIATIONS between maternal Vitamin D deficiency and Gestational diabetes and pre-eclampsia,22we DID NOT FIND ROBUST corroborating evidence from randomised controlled trials.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 144), ('INCOMPLETE_EVIDENCE', 157)]	8	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0007565', 'female pregnancy', 100, 'gestational')]
PMC5706533	11/2017	S154-PMC5706533	['two trials INDICATED that Vitamin D COULD enhance Postnatal linear growth, an outcome RELATED to growth plates for which a HYPOTHESISED ROLE of Vitamin D is logical,26and which is the primary focus of our AS YET unpublished trial in bangladesh.27in the FEW STUDIES reporting EFFECTS on infant bone mass, results were MIXED; the largest of these trials—the mavidos study in the uk, which excluded women with 25(Oh)D concentrations <25 nmol/l28—has scheduled follow-up of children at age 4 years.29infant rickets was NOT REPORTED in any trials; THOUGH RARE, this is one of the MOST LIKELY paediatric conditions to be directly caused by poor maternal and early infant Vitamin D status.30adverse events were infrequently REPORTED, resulting in unreliable meta-analyses.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 136), ('INCOMPLETE_EVIDENCE', 205), ('ANOMALY_CURIOUS_FINDING', 208), ('INCOMPLETE_EVIDENCE', 253), ('SUPERFICIAL_RELATIONSHIP', 275), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 317), ('INCOMPLETE_EVIDENCE', 515), ('ANOMALY_CURIOUS_FINDING', 543), ('INCOMPLETE_EVIDENCE', 550), ('PROBABLE_UNDERSTANDING', 575), ('PROBABLE_UNDERSTANDING', 580), ('INCOMPLETE_EVIDENCE', 717)]	16	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007567', 'parturition', 50, 'postnatal'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 407, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 413, 'D'), ('CHEBI_27300', 'vitamin D', 665, 'vitamin D')]
PMC5706533	11/2017	S155-PMC5706533	['for example, Prenatal Vitamin D supplementation in deficient women modifies neonatal Calcium Homeostasis,31BUT clinical CORRELATES (such as symptomatic infant hypocalcaemia) were RARE and infrequently ascertained across trials.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 105), ('SUPERFICIAL_RELATIONSHIP', 120), ('INCOMPLETE_EVIDENCE', 179)]	3	[('GO_0007565', 'female pregnancy', 13, 'prenatal'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0055073', 'cadmium ion homeostasis', 85, 'calcium homeostasis')]
PMC5706533	11/2017	S156-PMC5706533	['NONETHELESS, there was no EVIDENCE of any specific harms to mothers or fetuses attributable to Vitamin D supplementation within the range of reported doses.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 26)]	2	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC5706533	11/2017	S157-PMC5706533	['one of the most ROBUST FINDINGS in our systematic review—which has been PREVIOUSLY REPORTED32—was the beneficial EFFECT of Prenatal Vitamin D on RISK of persistent/recurrent wheeze (or asthma) in offspring, BASED ON data from two large well conducted trials in which wheeze/asthma was the primary outcome.3334this is broadly CONSISTENT with the POSSIBLY positive EFFECT of Vitamin D on severity of illness in Adults with asthma.5before Prenatal Vitamin D CAN be RECOMMENDED as a routine preventive measure against childhood asthma, HOWEVER, FURTHER WORK IS REQUIRED to CLARIFY the minimum effective dose and longer term follow-up to determine IF OBSERVED early EFFECTS on symptoms TRANSLATE into reductions in the incidence of asthma and improvements in Pulmonary function.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 113), ('IMPORTANT_CONSIDERATION', 145), ('INCOMPLETE_EVIDENCE', 207), ('ANOMALY_CURIOUS_FINDING', 213), ('INCOMPLETE_EVIDENCE', 325), ('INCOMPLETE_EVIDENCE', 345), ('SUPERFICIAL_RELATIONSHIP', 363), ('INCOMPLETE_EVIDENCE', 455), ('FUTURE_WORK', 462), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 532), ('FUTURE_WORK', 541), ('IMPORTANT_CONSIDERATION', 557), ('FUTURE_WORK', 569), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 643), ('INCOMPLETE_EVIDENCE', 646), ('SUPERFICIAL_RELATIONSHIP', 661), ('SUPERFICIAL_RELATIONSHIP', 681)]	21	[('GO_0007565', 'female pregnancy', 123, 'prenatal'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 373, 'vitamin D'), ('UBERON_0007023', 'adult organism', 409, 'adults'), ('GO_0007565', 'female pregnancy', 436, 'prenatal'), ('CHEBI_27300', 'vitamin D', 445, 'vitamin D'), ('UBERON_0002048', 'lung', 754, 'pulmonary')]
PMC5706533	11/2017	S159-PMC5706533	['the INTERPRETATION of Micronutrient intervention trials, HOWEVER, is COMPLEX BECAUSE all Individuals have some Vitamin D intake or Endogenous production.35the EFFECT of a given dose depends on the difference between the intervention and control doses (or the difference in mean 25(Oh)D in the intervention versus control group at/near delivery) as well as baseline Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 57), ('DIFFICULT_TASK', 69), ('PROBABLE_UNDERSTANDING', 77), ('SUPERFICIAL_RELATIONSHIP', 159)]	6	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 22, 'micronutrient'), ('NCBITaxon_1', 'root', 89, 'individuals'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('GO_0009790', 'embryo development', 131, 'endogenous'), ('CHEBI_71657', 'versiconol acetate', 278, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 278, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 365, 'vitamin D')]
PMC5706533	11/2017	S160-PMC5706533	['populations without Vitamin D deficiency MIGHT have little to gain from any dose, BUT deficient populations MIGHT require relatively high doses to raise Vitamin D status to an optimal range ASSOCIATED with clinical BENEFITS.35in this FRAMEWORK, the DISTINCTION between placebo versus active control trials is ONLY INFORMATIVE insofar as an active control dose increases the baseline status to which the intervention dose is compared (as such, we considered a “modified” baseline status to be reflected by the mean 25(Oh)d at Delivery in the control group).']	[('INCOMPLETE_EVIDENCE', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 190), ('IMPORTANT_CONSIDERATION', 215), ('INCOMPLETE_EVIDENCE', 234), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 249), ('INCOMPLETE_EVIDENCE', 309), ('INCOMPLETE_EVIDENCE', 314)]	9	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 514, '25(OH)'), ('GO_0007567', 'parturition', 525, 'delivery')]
PMC5706533	11/2017	S161-PMC5706533	['IF a modest dose of Vitamin D (<600 iu/day) readily eliminates deficiency in EVEN the most deficient women, then we MIGHT expect to see benefits ONLY in Placebo control trials conducted in populations where deficiency is common.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 77), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 145)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_26130', 'biological pigment', 153, 'placebo')]
PMC5706533	11/2017	S163-PMC5706533	['MANY of the REPORTED doses, HOWEVER, DID NOT yield EFFECTS on maternal 25(Oh)D that would be expected BASED ON Vitamin D pharmacokinetics.3637the muted dose-25(Oh)D RELATION COULD BE ATTRIBUTED to high baseline 25(Oh)D, low precision of 25(Oh)D assays, low rates of adherence to supplementation regimens, or lower than labeled Vitamin D content of the Supplements.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 51), ('QUESTION_ANSWERED_BY_THIS_WORK', 102), ('ANOMALY_CURIOUS_FINDING', 108), ('SUPERFICIAL_RELATIONSHIP', 165), ('INCOMPLETE_EVIDENCE', 174), ('SUPERFICIAL_RELATIONSHIP', 183)]	10	[('CHEBI_71657', 'versiconol acetate', 71, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 73, '(OH ... D'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 157, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 211, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 237, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 327, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 352, 'supplements')]
PMC5706533	11/2017	S164-PMC5706533	['we CONSIDERED the weak ASSOCIATION between dose and 25(Oh)D to reflect the overall low quality of many of the trials, which TEMPERED expectations of finding dose DEPENDENT EFFECTS of Vitamin D on clinical outcomes.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124), ('SUPERFICIAL_RELATIONSHIP', 162), ('SUPERFICIAL_RELATIONSHIP', 172)]	5	[('CHEBI_71657', 'versiconol acetate', 52, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 52, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D')]
PMC5706533	11/2017	S167-PMC5706533	['for example, for the EFFECT of Vitamin D on pre-eclampsia, de-regil and colleagues REPORTED a pooled risk ratio of 0.52 (95% confidence interval 0.25 to 1.05) based on two trials that we included in our review, but neither of which met our minimum criteria for case definitions and methods of ascertainment: one trial ONLY mentioned the exclusion of a participant for “severe pre-eclampsia,”38AND the other REPORTED frequencies of pre-eclampsia but DID NOT mention any screening or diagnostic procedures.39de-regil and colleagues also REPORTED that Vitamin D reduced the RISK of Preterm Birth based on thee trials,6but the current meta-analysis based on 15 comparisons produced REASONABLY strong evidence of a null effect.']	[('SUPERFICIAL_RELATIONSHIP', 21), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 318), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 391), ('INCOMPLETE_EVIDENCE', 407), ('INCOMPLETE_EVIDENCE', 449), ('INCOMPLETE_EVIDENCE', 535), ('IMPORTANT_CONSIDERATION', 571), ('PROBABLE_UNDERSTANDING', 678)]	9	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 549, 'vitamin D'), ('GO_0007565', 'female pregnancy', 579, 'preterm birth')]
PMC5706533	11/2017	S176-PMC5706533	['in the meantime, we ENDORSE the NOTION that WHENEVER feasible, investigators SHOULD report all clinically IMPORTANT outcomes, EVEN in SMALL trials that are individually UNDERPOWERED to detect EFFECTS on such outcomes.45\njohn ioannidis RECENTLY REMARKED that “systematic reviews MAY SOMETIMES be most helpful IF, INSTEAD of focusing on the summary of the evidence, HIGHLIGHT the BIASES that are INVOLVED and what NEEDS to be done to remedy the state-of-the-EVIDENCE in the given field.”46we conclude that there is currently INSUFFICIENT EVIDENCE to guide RECOMMENDATIONS for Prenatal Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 44), ('FUTURE_WORK', 77), ('IMPORTANT_CONSIDERATION', 106), ('ANOMALY_CURIOUS_FINDING', 126), ('INCOMPLETE_EVIDENCE', 134), ('PROBLEM_COMPLICATION', 169), ('SUPERFICIAL_RELATIONSHIP', 192), ('INCOMPLETE_EVIDENCE', 235), ('ANOMALY_CURIOUS_FINDING', 244), ('ANOMALY_CURIOUS_FINDING', 244), ('INCOMPLETE_EVIDENCE', 278), ('INCOMPLETE_EVIDENCE', 282), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 308), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 312), ('INCOMPLETE_EVIDENCE', 364), ('PROBLEM_COMPLICATION', 378), ('SUPERFICIAL_RELATIONSHIP', 394), ('FUTURE_WORK', 412), ('INCOMPLETE_EVIDENCE', 456), ('INCOMPLETE_EVIDENCE', 523), ('FUTURE_WORK', 554)]	23	[('GO_0007565', 'female pregnancy', 574, 'prenatal'), ('CHEBI_27300', 'vitamin D', 583, 'vitamin D')]
PMC5706533	11/2017	S177-PMC5706533	['cautious PROJECTIONS for the next decade SUGGEST that we will eventually know more about Vitamin D in Pregnancy THAN we do now, BUT in the absence of a coordinated effort and funding to conduct large new trials, SOME of the most CRITICAL QUESTIONS about the effectiveness of Prenatal Vitamin D supplementation will PROBABLY REMAIN unanswered in the foreseeable FUTURE.']	[('FUTURE_WORK', 9), ('FUTURE_WORK', 9), ('INCOMPLETE_EVIDENCE', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 128), ('INCOMPLETE_EVIDENCE', 212), ('IMPORTANT_CONSIDERATION', 229), ('EXPLICIT_QUESTION', 238), ('PROBABLE_UNDERSTANDING', 315), ('INCOMPLETE_EVIDENCE', 324), ('FUTURE_WORK', 361)]	11	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 102, 'pregnancy'), ('GO_0007565', 'female pregnancy', 275, 'prenatal'), ('CHEBI_27300', 'vitamin D', 284, 'vitamin D')]
PMC5706533	11/2017	S178-PMC5706533	['what is already known on THIS topic\nnumerous randomised trials and systematic reviews of Vitamin D supplementation during Pregnancy HAVE BEEN published, with CONFLICTING results and conclusions\nrecommendations regarding Vitamin D supplementation vary widely among medical and professional organisations, and who currently RECOMMENDS against routine Prenatal Vitamin D supplementation\n\nwhat THIS STUDY adds\nsystematic review and meta-analyses of 43 trials including 8406 participants SHOWED that Prenatal Vitamin D supplementation was ASSOCIATED with increased maternal and cord Serum 25-Hydroxyvitamin D concentrations, increased mean birth weight, reduced the risk of small for Gestational age, reduced the risk of wheeze in offspring, and increased infant length at one year of age\nthere was a LACK OF EVIDENCE OF benefits of Prenatal Vitamin D supplementation for maternal health conditions RELATED to Pregnancy, no effect on other Birth outcomes of PUBLIC HEALTH IMPORTANCE such as Preterm Birth, and SCANT EVIDENCE on safety outcomes\nFEW of the trials were designed to test the EFFECT of Vitamin D on clinical or functional outcomes, and most trials were SMALL and at overall high or UNCERTAIN risk of bias\nthirty five planned or ongoing Prenatal Vitamin D trials COULD contribute an additional 12\u2009530 participants to FUTURE systematic reviews\n\npubmed central:']	[('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('INCOMPLETE_EVIDENCE', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158), ('FUTURE_WORK', 322), ('QUESTION_ANSWERED_BY_THIS_WORK', 390), ('INCOMPLETE_EVIDENCE', 483), ('SUPERFICIAL_RELATIONSHIP', 534), ('INCOMPLETE_EVIDENCE', 796), ('SUPERFICIAL_RELATIONSHIP', 894), ('IMPORTANT_CONSIDERATION', 953), ('IMPORTANT_CONSIDERATION', 967), ('INCOMPLETE_EVIDENCE', 1005), ('INCOMPLETE_EVIDENCE', 1039), ('SUPERFICIAL_RELATIONSHIP', 1083), ('INCOMPLETE_EVIDENCE', 1160), ('FULL_UNKNOWN', 1189), ('INCOMPLETE_EVIDENCE', 1269), ('FUTURE_WORK', 1323)]	18	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 122, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 228, 'D'), ('GO_0007565', 'female pregnancy', 349, 'prenatal'), ('CHEBI_27300', 'vitamin D', 358, 'vitamin D'), ('GO_0007565', 'female pregnancy', 495, 'prenatal'), ('CHEBI_27300', 'vitamin D', 504, 'vitamin D'), ('UBERON_0001977', 'blood serum', 578, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 584, '25-hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 679, 'gestational'), ('GO_0007565', 'female pregnancy', 828, 'prenatal'), ('CHEBI_27300', 'vitamin D', 837, 'vitamin D'), ('GO_0007565', 'female pregnancy', 905, 'pregnancy'), ('GO_0007567', 'parturition', 935, 'birth'), ('GO_0007565', 'female pregnancy', 986, 'preterm'), ('GO_0007567', 'parturition', 994, 'birth'), ('CHEBI_27300', 'vitamin D', 1093, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1243, 'prenatal'), ('CHEBI_27300', 'vitamin D', 1252, 'vitamin D')]
PMC5707701	11/2017	S13-PMC5707701	['since infants are Born with very low reserves of Vitamin A in the Liver REGARDLESS of the mother’s nutritional status [3], they rely entirely on Breast Milk to support growth and build up Liver storage.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 72)]	1	[('GO_0007567', 'parturition', 18, 'born'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin A'), ('UBERON_0002107', 'liver', 66, 'liver'), ('UBERON_0000310', 'breast', 145, 'breast'), ('UBERON_0001913', 'milk', 152, 'milk'), ('UBERON_0002107', 'liver', 188, 'liver')]
PMC5707701	11/2017	S177-PMC5707701	['HOWEVER, our results INDICATED that neither Vitamin A nor E intakes from one 24-h dietary Recall was associated with Vitamin A and E in Human milk, which MAY BE DUE TO the inherent Intake variability of one single 24-h dietary Recall questionnaire, which DID NOT ALLOW for estimations of an Individual’s usual diet, and THEREFORE, it is LIKELY to under- OR overestimate some Nutrient intakes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 154), ('PROBLEM_COMPLICATION', 161), ('DIFFICULT_TASK', 255), ('ANOMALY_CURIOUS_FINDING', 259), ('PROBABLE_UNDERSTANDING', 320), ('PROBABLE_UNDERSTANDING', 337), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 354)]	9	[('CHEBI_27300', 'vitamin D', 44, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 58, 'E'), ('GO_0060033', 'anatomical structure regression', 90, 'recall'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 131, 'E'), ('NCBITaxon_9606', 'Homo sapiens', 136, 'human'), ('GO_0007631', 'feeding behavior', 181, 'intake'), ('GO_0060033', 'anatomical structure regression', 227, 'recall'), ('NCBITaxon_1', 'root', 291, 'individual'), ('CHEBI_33284', 'nutrient', 375, 'nutrient')]
PMC5707701	11/2017	S187-PMC5707701	['indeed, our results SHOWED that all of these milks, except for colostrum, did not meet an infant’s nutritional REQUIREMENT of Vitamin E. HOWEVER, we COULD NOT ESTIMATE the POSSIBLE supply of Vitamin A to the infant in the present study, DUE TO the LACKING detection of Retinol in Human milk.']	[('INCOMPLETE_EVIDENCE', 20), ('IMPORTANT_CONSIDERATION', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137), ('DIFFICULT_TASK', 149), ('INCOMPLETE_EVIDENCE', 155), ('INCOMPLETE_EVIDENCE', 172), ('PROBLEM_COMPLICATION', 237), ('FULL_UNKNOWN', 248)]	8	[('CHEBI_27300', 'vitamin D', 126, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 269, 'retinol'), ('NCBITaxon_9606', 'Homo sapiens', 280, 'human')]
PMC5732505	12/2017	S0-PMC5732505	['maternal Vitamin D status, Gestational diabetes and infant Birth size\n\nabstract\n\nbackground\nmaternal Vitamin D status HAS BEEN ASSOCIATED with both Gestational diabetes mellitus (gdm) and fetal growth restriction, HOWEVER, the EVIDENCE is INCONSISTENT.']	[('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 127), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 214), ('INCOMPLETE_EVIDENCE', 227), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 239)]	5	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 27, 'gestational'), ('GO_0007567', 'parturition', 59, 'birth'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('GO_0007565', 'female pregnancy', 148, 'gestational')]
PMC5732505	12/2017	S2-PMC5732505	['our OBJECTIVE was to compare maternal 25-Hydroxy Vitamin D concentrations [25(Oh)D] between mothers with and without gdm, and TO INVESTIGATE IF an ASSOCIATION existed between maternal Vitamin D concentration and infant Birth size.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 126), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('SUPERFICIAL_RELATIONSHIP', 147)]	4	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 38, '25-hydroxy vitamin D'), ('CHEBI_71657', 'versiconol acetate', 75, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('GO_0007567', 'parturition', 219, 'birth')]
PMC5732505	12/2017	S14-PMC5732505	['ASSOCIATIONS between maternal Vitamin D status and Birth size were INCONSISTENT.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 67)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007567', 'parturition', 51, 'birth')]
PMC5732505	12/2017	S19-PMC5732505	['HOWEVER, DUE TO recent changes in national health policies, intake of Vitamin D has increased RESULTING IN decreasing rates of Vitamin D deficiency [2–5].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 9), ('SUPERFICIAL_RELATIONSHIP', 94)]	3	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
PMC5732505	12/2017	S132-PMC5732505	['abbreviations: gwg, Gestational weight gain; gdm, Gestational diabetes mellitus; 25(Oh)D, 25-Hydroxy Vitamin D; suboptimal, ucb, Umbilical Cord Blood; 25(Oh)D\u2009<\u200980\xa0nmol/l; optimal 25(Oh)D\u2009≥\u200980\xa0nmol/l\n\ndiscussion\nthe primary FOCUS of this work was TO DETERMINE WHETHER 25(Oh)D concentration differs between mothers with AND without gdm, and WHETHER Vitamin D status AFFECTS Birth size in normal-Birth-weight infants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 224), ('QUESTION_ANSWERED_BY_THIS_WORK', 247), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 260), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 340), ('SUPERFICIAL_RELATIONSHIP', 365)]	5	[('GO_0007565', 'female pregnancy', 20, 'gestational'), ('GO_0007565', 'female pregnancy', 50, 'gestational'), ('CHEBI_71657', 'versiconol acetate', 81, '25(OH)D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 90, '25-hydroxy vitamin D'), ('UBERON_0002331', 'umbilical cord', 129, 'umbilical cord'), ('UBERON_0000178', 'blood', 144, 'blood'), ('CHEBI_71657', 'versiconol acetate', 151, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 180, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 268, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 348, 'vitamin D'), ('GO_0007567', 'parturition', 373, 'birth'), ('GO_0007567', 'parturition', 394, 'birth')]
PMC5732505	12/2017	S151-PMC5732505	['ALTHOUGH a biological mechanism between low Vitamin D status and diabetes is PLAUSIBLE [29], ONLY a FEW INTERVENTIONS have been conducted, and these HAVE NOT proved an EFFECT of Vitamin D supplementation on RISK of gdm [30].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 93), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 104), ('INCOMPLETE_EVIDENCE', 149), ('SUPERFICIAL_RELATIONSHIP', 168), ('IMPORTANT_CONSIDERATION', 207)]	8	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
PMC5732505	12/2017	S155-PMC5732505	['SOME earlier STUDIES HAVE SHOWN that SEVERE maternal Vitamin D deficiency ASSOCIATES with smaller Head circumference at Birth [32,33], YET SOME HAVE NOT [34,35].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('IMPORTANT_CONSIDERATION', 37), ('SUPERFICIAL_RELATIONSHIP', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135), ('INCOMPLETE_EVIDENCE', 139), ('INCOMPLETE_EVIDENCE', 144)]	7	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('UBERON_0000033', 'head', 98, 'head'), ('GO_0007567', 'parturition', 120, 'birth')]
PMC5732505	12/2017	S178-PMC5732505	['HOWEVER, randomised controlled TRIALS ARE REQUIRED in specific RISK groups of Vitamin D deficiency TO CLARIFY if Vitamin D supplementation AFFECTS the RISK of gdm.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 31), ('IMPORTANT_CONSIDERATION', 63), ('FUTURE_WORK', 99), ('SUPERFICIAL_RELATIONSHIP', 139), ('IMPORTANT_CONSIDERATION', 151)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D')]
PMC5758521	1/2018	S1-PMC5758521	['we ASSESSED WHETHER Vitamin A and Vitamin E nutritional status MAY AFFECT circulating leptin, adiponectin, Insulin-Like Growth Factor (Igf)-I and Igf-Ii levels in early Life in Humans.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 67)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin E'), ('PR_000008929', 'interferon-related developmental regulator 1', 107, 'insulin-like growth factor ...'), ('PR_000008954', 'insulin-like growth factor-binding protein-like 1', 135, 'IGF)-I'), ('PR_000002046', 'interferon regulatory factor 4', 146, 'IGF-II'), ('UBERON_0000104', 'life cycle', 169, 'life'), ('NCBITaxon_9606', 'Homo sapiens', 177, 'humans')]
PMC5758521	1/2018	S20-PMC5758521	['HOWEVER, there is a LACK OF DATA on WHETHER Vitamin A and E nutritional status MAY BE ASSOCIATED with Metabolic health BIOMARKERS in early Life in Humans.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 36), ('INCOMPLETE_EVIDENCE', 79), ('SUPERFICIAL_RELATIONSHIP', 86), ('SUPERFICIAL_RELATIONSHIP', 119)]	7	[('CHEBI_27300', 'vitamin D', 44, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 58, 'E'), ('GO_0008152', 'metabolic process', 102, 'metabolic'), ('UBERON_0000104', 'life cycle', 139, 'life'), ('NCBITaxon_9606', 'Homo sapiens', 147, 'humans')]
PMC5758521	1/2018	S21-PMC5758521	['to fill this IMPORTANT research data gap, we SOUGHT TO EVALUATE WHETHER Vitamin A and e nutritional status in neonates are ASSOCIATED with circulating concentrations of leptin, adiponectin, Igf-I and Igf-Ii which are IMPORTANT BIOMARKERS of fetal growth and Metabolic health15,16.']	[('IMPORTANT_CONSIDERATION', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 45), ('QUESTION_ANSWERED_BY_THIS_WORK', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 64), ('SUPERFICIAL_RELATIONSHIP', 123), ('IMPORTANT_CONSIDERATION', 217), ('SUPERFICIAL_RELATIONSHIP', 227)]	7	[('CHEBI_27300', 'vitamin D', 72, 'vitamin A'), ('PR_000008919', 'interferon alpha-6', 190, 'IGF-I'), ('PR_000002046', 'interferon regulatory factor 4', 200, 'IGF-II'), ('GO_0008152', 'metabolic process', 258, 'metabolic')]
PMC5758521	1/2018	S140-PMC5758521	['MOST STUDIES on Vitamins A and E in Pregnancy HAVE BEEN focused on the ASSOCIATION with fetal growth, and the FINDINGS HAVE BEEN INCONSISTENT33–35.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 71), ('INCOMPLETE_EVIDENCE', 110), ('INCOMPLETE_EVIDENCE', 119), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 129)]	6	[('CHEBI_27300', 'vitamin D', 16, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 25, 'A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 31, 'E'), ('GO_0007565', 'female pregnancy', 36, 'pregnancy')]
PMC5758521	1/2018	S144-PMC5758521	['REPORTED that maternal Α-Tocopherol concentrations were positively ASSOCIATED with Birth weight, BUT poston and colleagues FOUND that Prenatal supplementation with Α-Tocopherol and Vitamin C was ASSOCIATED with elevated risk of low Birth weight8.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 67), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 97), ('ANOMALY_CURIOUS_FINDING', 97), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 195)]	6	[('CHEBI_27725', 'butin', 23, 'α-tocopherol'), ('GO_0007567', 'parturition', 83, 'birth'), ('GO_0007565', 'female pregnancy', 134, 'prenatal'), ('CHEBI_27725', 'butin', 164, 'α-tocopherol'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin C'), ('GO_0007567', 'parturition', 232, 'birth')]
PMC5784894	1/2018	S108-PMC5784894	['trabecular spacing (fig 3j) increased in the offspring of Vitamin D-deplete AS OPPOSED TO replete dams without loading.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 76)]	1	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC5784894	1/2018	S142-PMC5784894	['we HAVE SHOWN through multiple means that the Bones of the offspring of Vitamin D replete AS OPPOSED TO deplete Mice are intrinsically stronger and better able to respond effectively to mechanical stimulation.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90)]	2	[('UBERON_0001474', 'bone element', 46, 'bones'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 112, 'mice')]
PMC5784894	1/2018	S144-PMC5784894	['that these changes are present in Mice that, following weaning, are Vitamin D replete throughout Life INDICATES that early Life, AS OPPOSED TO current, Vitamin D status is the cause of these differences.']	[('INCOMPLETE_EVIDENCE', 102), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 129)]	2	[('NCBITaxon_10088', 'Mus <genus>', 34, 'mice'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0000104', 'life cycle', 97, 'life'), ('UBERON_0000104', 'life cycle', 123, 'life'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D')]
PMC5784894	1/2018	S184-PMC5784894	['INSTEAD it SHOWS the EFFECT of Vitamin D response before or after Birth on the bone stiffness.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 21)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0007567', 'parturition', 66, 'birth')]
PMC5812027	2/2018	S65-PMC5812027	['these groups were chosen to study WHETHER Vitamin D insufficiency (30–50\xa0nmol/l), sufficiency (≥\u200950\xa0nmol/l) or high status (≥\u200975 or ≥\u2009100\xa0nmol/l) was ASSOCIATED with the outcomes studied, COMPARED to Vitamin D deficiency (<\u200930\xa0nmol/l).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('SUPERFICIAL_RELATIONSHIP', 150)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D')]
PMC5812027	2/2018	S73-PMC5812027	['tobacco use and Vitamin D supplement use were also INVESTIGATED as POTENTIAL CONFOUNDERS BUT did not show any confounding effect and were THUS not included in the final MODELS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 51), ('INCOMPLETE_EVIDENCE', 67), ('PROBLEM_COMPLICATION', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 89), ('PROBABLE_UNDERSTANDING', 138), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 169)]	6	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D')]
PMC5812027	2/2018	S108-PMC5812027	['discussion\nwe FOUND that higher Vitamin D status among women in late, BUT NOT early, Pregnancy was ASSOCIATED with lower probability of sga and lbw.']	[('INCOMPLETE_EVIDENCE', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 70), ('SUPERFICIAL_RELATIONSHIP', 99)]	3	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007565', 'female pregnancy', 85, 'pregnancy')]
PMC5812027	2/2018	S122-PMC5812027	['WHETHER Vitamin D Metabolism is altered in Placental dysfunction in UNCLEAR and WARRANTS FURTHER INVESTIGATION.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FULL_UNKNOWN', 68), ('FUTURE_WORK', 80)]	3	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 8, 'vitamin D metabolism'), ('UBERON_0001987', 'placenta', 43, 'placental')]
PMC5812027	2/2018	S127-PMC5812027	['this COULD BE INTERPRETED AS SUPPORT of our finding that late RATHER than early Pregnancy Vitamin D status is the stronger PREDICTOR of fetal growth restriction.']	[('INCOMPLETE_EVIDENCE', 5), ('PROBABLE_UNDERSTANDING', 14), ('INCOMPLETE_EVIDENCE', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 62), ('SUPERFICIAL_RELATIONSHIP', 123)]	5	[('GO_0007565', 'female pregnancy', 80, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC5812027	2/2018	S131-PMC5812027	['we DID NOT SEE a u-shaped ASSOCIATION between early Pregnancy Vitamin D status and sga, as PREVIOUSLY INDICATED [9].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 3), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 102)]	4	[('GO_0007565', 'female pregnancy', 52, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC5812027	2/2018	S136-PMC5812027	['supplementation CAN THEREFORE ONLY PARTLY EXPLAIN the large proportion with high Vitamin D status, and OTHER LIKELY CONTRIBUTORS are Pregnancy associated Endocrine changes and POSSIBLY lifestyle FACTORS.']	[('INCOMPLETE_EVIDENCE', 16), ('PROBABLE_UNDERSTANDING', 20), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 35), ('PROBABLE_UNDERSTANDING', 42), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('PROBABLE_UNDERSTANDING', 109), ('SUPERFICIAL_RELATIONSHIP', 116), ('INCOMPLETE_EVIDENCE', 176), ('SUPERFICIAL_RELATIONSHIP', 195)]	10	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007565', 'female pregnancy', 133, 'pregnancy'), ('GO_0006397', 'mRNA processing', 154, 'endocrine')]
PMC5812027	2/2018	S162-PMC5812027	['high Vitamin D status in late, BUT NOT early, Pregnancy was ASSOCIATED with lower odds of sga and lbw.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('SUPERFICIAL_RELATIONSHIP', 60)]	2	[('CHEBI_27300', 'vitamin D', 5, 'vitamin D'), ('GO_0007565', 'female pregnancy', 46, 'pregnancy')]
PMC5827025	2/2018	S15-PMC5827025	['ALTHOUGH SOME POTENTIAL INFLUENT FACTORS for Vitamin D status, such as seasonality, age, smoking, race and ethnicity HAVE BEEN IDENTIFIED in SEVERAL case-control STUDIES6–8, research REPORTS on the INFLUENT FACTORS for Gestational Vitamin D status in a population-based cohort are LACKING.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 24), ('SUPERFICIAL_RELATIONSHIP', 33), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 127), ('INCOMPLETE_EVIDENCE', 141), ('INCOMPLETE_EVIDENCE', 162), ('INCOMPLETE_EVIDENCE', 183), ('SUPERFICIAL_RELATIONSHIP', 198), ('SUPERFICIAL_RELATIONSHIP', 207), ('FULL_UNKNOWN', 281), ('INCOMPLETE_EVIDENCE', 281)]	15	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007565', 'female pregnancy', 219, 'gestational'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D')]
PMC5827025	2/2018	S17-PMC5827025	['IN CONTRAST, the reports from randomized controlled trials INDICATE that Gestational Vitamin D supplementation CAN markedly decrease Pregnancy COMPLICATIONS including Preeclampsia and Pregnancy induced hypertension11.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 111), ('PROBLEM_COMPLICATION', 143)]	4	[('GO_0007565', 'female pregnancy', 73, 'gestational'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007565', 'female pregnancy', 133, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 167, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 184, 'pregnancy')]
PMC5827025	2/2018	S101-PMC5827025	['follow-up, SEVERAL randomized TRIAL of Vitamin D supplementation FOUND that the rate of Preterm Delivery is significant more lower in Pregnant women with Serum 25(Oh)D ≥40\u2009ng/ml COMPARED TO those with Serum 25(Oh)D ≤20\u2009ng/ml, SUGGESTING higher 25(Oh)D concentration was ASSOCIATED with an decreased risk of Preterm Delivery35–38.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 65), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 178), ('INCOMPLETE_EVIDENCE', 226), ('SUPERFICIAL_RELATIONSHIP', 270)]	5	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0007565', 'female pregnancy', 88, 'preterm'), ('GO_0007567', 'parturition', 96, 'delivery'), ('GO_0007565', 'female pregnancy', 134, 'pregnant'), ('UBERON_0001977', 'blood serum', 154, 'serum'), ('CHEBI_63056', 'zinc cation', 160, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 166, 'D'), ('UBERON_0001977', 'blood serum', 201, 'serum'), ('CHEBI_71657', 'versiconol acetate', 207, '25(OH)D'), ('PR_000011614', 'opioid growth factor receptor', 210, 'OH'), ('PR_000006444', 'diacylglycerol kinase delta', 213, 'D'), ('CHEBI_71657', 'versiconol acetate', 244, '25(OH)D'), ('GO_0007565', 'female pregnancy', 307, 'preterm'), ('GO_0008219', 'cell death', 315, 'delivery35')]
PMC5827025	2/2018	S102-PMC5827025	['the INCONSISTENCY of PAST FINDINGS MAY BE RELATED to following REASONS: first, cohort among Pregnant women with relatively Vitamin D replete, with a history of Preterm Delivery or at high risk for Preeclampsia; second, Gestational Vitamin D status is a LINK to ethnic DISPARITIES in adverse Birth outcomes24.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 42), ('PROBABLE_UNDERSTANDING', 63), ('SUPERFICIAL_RELATIONSHIP', 253), ('IMPORTANT_CONSIDERATION', 268)]	9	[('GO_0007565', 'female pregnancy', 92, 'pregnant'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('GO_0007565', 'female pregnancy', 160, 'preterm'), ('GO_0007567', 'parturition', 168, 'delivery'), ('GO_0007128', 'meiotic prophase I', 197, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 219, 'gestational'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('GO_0007567', 'parturition', 291, 'birth')]
PMC5827025	2/2018	S103-PMC5827025	['ALTHOUGH a RECENT STUDY in northeast china DEMONSTRATED that vdd was more PREVALENT in the SEVERE preterm group than in the mildly preterm group and the in-term group, they DID NOT analyze the ASSOCIATION between vdd and an INCREASED RISK of Preterm Delivery BECAUSE Vitamin D status at prior to labor cannot be used to assess risk of Preterm Delivery39.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 43), ('IMPORTANT_CONSIDERATION', 74), ('IMPORTANT_CONSIDERATION', 91), ('INCOMPLETE_EVIDENCE', 173), ('SUPERFICIAL_RELATIONSHIP', 193), ('IMPORTANT_CONSIDERATION', 224), ('PROBLEM_COMPLICATION', 259)]	10	[('GO_0007565', 'female pregnancy', 242, 'preterm'), ('GO_0007567', 'parturition', 250, 'delivery'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D'), ('GO_0007565', 'female pregnancy', 335, 'preterm'), ('GO_0007567', 'parturition', 343, 'delivery39')]
PMC5838372	3/2018	S84-PMC5838372	['HOWEVER, the levels of Vitamin D insufficiency and deficiency are NOT CLEARLY defined and the discussion about the prevalence Vitamin D deficiency is ONGOING (22,23).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FULL_UNKNOWN', 66), ('IMPORTANT_CONSIDERATION', 150)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
PMC5838372	3/2018	S104-PMC5838372	['Vitamin D levels were significantly lower in mothers who used low dose Vitamin D supplements COMPARED TO those who used recommended doses.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 93)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC5838372	3/2018	S114-PMC5838372	['HOWEVER, the infants of mothers in the sufficient group had significantly higher Vitamin D level than OTHER infants.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102)]	2	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC5838372	3/2018	S120-PMC5838372	['HOWEVER, mothers’ low Vitamin intake was FOUND AS a RISK FACTOR for the infants’ Vitamin D level.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 41), ('PROBABLE_UNDERSTANDING', 47), ('SUPERFICIAL_RELATIONSHIP', 52)]	4	[('CHEBI_33229', 'vitamin (role)', 22, 'vitamin'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC5841533	2/2018	S17-PMC5841533	['introduction\nan ESTIMATED 250\u2009million children GLOBALLY are denied the opportunity to reach their full developmental potential DUE TO the combined EFFECTS of poverty and undernutrition.1poor nutrition during Pregnancy CONTRIBUTES to maternal morbidity and mortality, increases the risks of low Birth weight and poor development, and exacerbates the risk of chronic disease in Adulthood.2 3many Pregnant women face Micronutrient deficiencies: an ESTIMATED 15.3% globally lack Vitamin A, 28.5% lack Iodine and 38% have iron-deficiency anaemia.1 4nutritional deprivation in Pregnancy CAN alter neural growth in the fetus and AFFECT Cognitive functioning, hindering children’s chances in school and CONTRIBUTING to the intergenerational transmission of poverty.5–9\nthe world health organisation (who) currently RECOMMENDS Iron and Folic Acid (ifa) supplementation in Pregnancy to improve maternal and Perinatal outcomes, BUT NOT multiple Micronutrient (mmn)supplementation.10–12could Antenatal Micronutrient supplementation improve children’s long-term Cognitive functioning?']	[('INCOMPLETE_EVIDENCE', 16), ('IMPORTANT_CONSIDERATION', 47), ('PROBLEM_COMPLICATION', 127), ('SUPERFICIAL_RELATIONSHIP', 147), ('SUPERFICIAL_RELATIONSHIP', 218), ('INCOMPLETE_EVIDENCE', 445), ('INCOMPLETE_EVIDENCE', 581), ('SUPERFICIAL_RELATIONSHIP', 622), ('SUPERFICIAL_RELATIONSHIP', 695), ('FUTURE_WORK', 807), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 917), ('ANOMALY_CURIOUS_FINDING', 917), ('EXPLICIT_QUESTION', 1070)]	13	[('GO_0007565', 'female pregnancy', 208, 'pregnancy'), ('GO_0007567', 'parturition', 294, 'birth'), ('UBERON_0000113', 'post-juvenile adult stage', 376, 'adulthood'), ('GO_0007565', 'female pregnancy', 394, 'pregnant'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 414, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 475, 'vitamin A'), ('CHEBI_24859', 'iodine atom', 497, 'iodine'), ('GO_0007565', 'female pregnancy', 571, 'pregnancy'), ('GO_0050890', 'cognition', 629, 'cognitive'), ('CHEBI_24870', 'ion', 818, 'Iron'), ('CHEBI_30751', 'formic acid', 827, 'Folic Acid'), ('GO_0007565', 'female pregnancy', 863, 'pregnancy'), ('GO_0036268', 'swimming', 897, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 897, 'perinatal'), ('CHEBI_6956', 'Mitragynine', 934, 'Micronutrient'), ('GO_0007567', 'parturition', 980, 'antenatal'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 990, 'micronutrient'), ('GO_0050890', 'cognition', 1049, 'cognitive')]
PMC5941617	5/2018	S1-PMC5941617	['besides its historical Skeletal functions, in the last years it HAS BEEN DEMONSTRATED that Vitamin D directly OR indirectly Regulates up to 1250 Genes, playing so-called Extraskeletal actions.']	[('INCOMPLETE_EVIDENCE', 64), ('INCOMPLETE_EVIDENCE', 73), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 110)]	3	[('UBERON_0004288', 'skeleton', 23, 'skeletal'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0065007', 'biological regulation', 124, 'regulates'), ('SO_0000704', 'gene', 145, 'genes'), ('UBERON_0001431', 'distal carpal bone 2', 170, 'extraskeletal')]
PMC5941617	5/2018	S3-PMC5941617	['THUS, Vitamin D deficiency MAY AFFECT NOT ONLY Musculoskeletal health BUT ALSO a POTENTIALLY WIDE range of acute and chronic conditions.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 31), ('ANOMALY_CURIOUS_FINDING', 38), ('INCOMPLETE_EVIDENCE', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93)]	6	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('UBERON_0002204', 'musculoskeletal system', 47, 'musculoskeletal')]
PMC5941617	5/2018	S7-PMC5941617	['besides these classic Skeletal actions, RECENT STUDIES have DEMONSTRATED that Vitamin D exerts OTHER significant Extraskeletal actions, with a POSSIBLE ROLE in the pathogenesis of several pathological conditions, including infectious and Autoimmune diseases [1].']	[('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('INCOMPLETE_EVIDENCE', 143), ('SUPERFICIAL_RELATIONSHIP', 152)]	5	[('UBERON_0004288', 'skeleton', 22, 'skeletal'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 113, 'extraskeletal'), ('UBERON_0001442', 'skeleton of manus', 238, 'autoimmune')]
PMC5941617	5/2018	S8-PMC5941617	['the term ‘Vitamin D’ is used for two DIFFERENT forms which are found in nature: Vitamin D3(Cholecalciferol) from Animal sources and Vitamin D2(Ergocalciferol) from Plants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 37)]	1	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 80, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 80, 'vitamin D3'), ('CHEBI_52550', 'theopalauamide', 91, 'cholecalciferol'), ('NCBITaxon_33208', 'Metazoa', 113, 'animal'), ('CHEBI_28934', 'vitamin D2', 132, 'vitamin D2'), ('PR_000017299', 'VIP peptides', 132, 'vitamin D2'), ('CHEBI_4910', 'etomidate', 143, 'ergocalciferol'), ('NCBITaxon_10088', 'Mus <genus>', 164, 'plants')]
PMC5941617	5/2018	S32-PMC5941617	['caption (table-wrap): table 2\n\ndefinition of Vitamin D status according to several societies and organizations in the last 10\xa0yearssociety/organizationyearsevere deficiencydeficiencyinsufficiencysufficiency/adequacycanadian pediatric society [8]2007–<\u2009 10\xa0ng/ml10–29\xa0ng/ml≥ 30\xa0ng/mllawson wilkins pediatric Endocrine society [9]2008<\u2009 5\xa0ng/ml5–14\xa0ng/ml15–19\xa0ng/ml≥ 20\xa0ng/mlinstitute of medicine [10]2011–<\u2009 12\xa0ng/ml12–20\xa0ng/mla≥ 20\xa0ng/mlthe Endocrine society [11]2011–<\u2009 20\xa0ng/ml21–29\xa0ng/ml≥ 30\xa0ng/mlbritish paediatric and adolescent bone group [12]2012–<\u200910\xa0ng/ml10–19\xa0ng/ml≥ 20\xa0ng/mlfrench society of paediatrics [13]2012–<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mlasociación espanola de pediatría (spain) [14]2012–<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mlfederal commission for nutrition (switzerland) [15]2012<\u200910\xa0ng/ml<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mlnordic nutrition recommendations [16]2012–<\u2009 12\xa0ng/ml12–20\xa0ng/ml≥ 20\xa0ng/mlgerman nutrition society [17]2012–––≥ 20\xa0ng/mlhealth council of the netherlands [18]2012–––≥ 12\xa0ng/mleuropean society for paediatric gastroenterology hepatology and nutrition [19]2013<\u200910\xa0ng/ml<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mlcentral europe [20]2013–< 20\xa0ng/ml20–29\xa0ng/ml≥ 30\xa0ng/mlsociety for adolescent health and medicine [21]2013–<\u2009 20\xa0ng/ml20–29\xa0ng/ml≥ 30\xa0ng/mlaustralia/new zealand [22]2013<\u2009 5\xa0ng/ml5–11\xa0ng/ml12–19\xa0ng/ml≥ 20\xa0ng/mlamerican academy of pediatrics [23]2014–<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mljapanese society for bone and Mineral research, japan Endocrine societyb[24]2015–<\u2009 20\xa0ng/ml––scientific advisory committee on nutrition [25]2016–––≥ 10\xa0ng/mleuropean Food safety authority [26]2016–––≥ 20\xa0ng/mlunited arab emirates [27]2016–<\u2009 20\xa0ng/ml20–29\xa0ng/ml≥ 30\xa0ng/mlglobal consensus for rickets [28]2016–<\u2009 12\xa0ng/ml12–19\xa0ng/ml≥ 20\xa0ng/mljapanese society for bone and Mineral research, japan Endocrine societyc[29]2017–<\u2009 20\xa0ng/ml20–29\xa0ng/ml≥ 30\xa0ng/mleuropean academy of pediatrics [30]2017definition of Vitamin D status is UNCLEAR DUE TO a lack OF consensus\navitamin D inadequacy\nbdiagnostic criteria for rickets\ncassessment criteria for Vitamin D deficiency/insufficiency (authors REPORTED that DIFFERENT criteria MAY BE needed for children)\nsevere Vitamin D deficiency is DEFINED as 25(Oh)d levels <\u200910\xa0ng/ml by SEVERAL authors and societies BECAUSE the risk of rickets is high below this cut-off also in presence of an adequate Calcium intake [31–33] (see chapter “nutritional rickets”).']	[('FULL_UNKNOWN', 1894), ('PROBLEM_COMPLICATION', 1902), ('ANOMALY_CURIOUS_FINDING', 1916), ('ANOMALY_CURIOUS_FINDING', 1916), ('INCOMPLETE_EVIDENCE', 2053), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2067), ('INCOMPLETE_EVIDENCE', 2086), ('PROBABLE_UNDERSTANDING', 2145), ('INCOMPLETE_EVIDENCE', 2185), ('PROBABLE_UNDERSTANDING', 2215)]	10	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0005063', 'left ventricular compact myocardium', 307, 'Endocrine'), ('UBERON_0005063', 'left ventricular compact myocardium', 441, 'Endocrine'), ('CHEBI_46662', 'mineral', 1396, 'Mineral'), ('GO_0009790', 'embryo development', 1420, 'Endocrine'), ('UBERON_0005063', 'left ventricular compact myocardium', 1420, 'Endocrine'), ('CHEBI_33290', 'food', 1533, 'Food'), ('CHEBI_46662', 'mineral', 1738, 'Mineral'), ('GO_0009790', 'embryo development', 1762, 'Endocrine'), ('UBERON_0005063', 'left ventricular compact myocardium', 1762, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 1874, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1938, 'D'), ('CHEBI_27300', 'vitamin D', 2009, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 2121, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 2156, '25(OH)'), ('CHEBI_22313', 'alkaline earth metal atom', 2302, 'calcium')]
PMC5941617	5/2018	S49-PMC5941617	['the measurement of 25(Oh)D is DIFFICULT DUE TO its lipophilic nature, the binding to Vitamin D binding protein, the DIFFERENT circulating forms that also include epimers and isobars, and the standardization.']	[('DIFFICULT_TASK', 30), ('PROBLEM_COMPLICATION', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116)]	3	[('CHEBI_71657', 'versiconol acetate', 19, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC5941617	5/2018	S106-PMC5941617	['WHILE there is sufficient global agreement in considering 400\xa0iu/day as dietary reference value for Vitamin D during the first year of Life, RECOMMENDED reference values for children and adolescents (1–18\xa0years) slightly differ between organizations and societies, reflecting DIFFERENT approaches and methods applied to calculate them.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 141), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 276)]	3	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('UBERON_0000104', 'life cycle', 135, 'life')]
PMC5941617	5/2018	S107-PMC5941617	['HOWEVER, various dietary reference values for Vitamin D are useful to guide local STRATEGIES for Vitamin D supplementation, but are not directly comparable.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 82)]	2	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D')]
PMC5941617	5/2018	S117-PMC5941617	['ON THE CONTRARY, Vitamin D supplementation at higher dosages SEEMED TO BE ASSOCIATED with increased RISK of hypervitaminosis D with hypercalciuria and hypercalcemia [62].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 7), ('ANOMALY_CURIOUS_FINDING', 7), ('ANOMALY_CURIOUS_FINDING', 61), ('SUPERFICIAL_RELATIONSHIP', 74), ('IMPORTANT_CONSIDERATION', 100)]	6	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 125, 'D')]
PMC5941617	5/2018	S125-PMC5941617	['regarding the PREFERRED form of Vitamin D for supplementation, the national institute for health and care excellence GUIDELINE RECOMMENDED Vitamin D drops in infants and young children [114], WHILE other international scientific societies DID NOT make any SPECIFIC RECOMMENDATION.']	[('PROBABLE_UNDERSTANDING', 14), ('PROBABLE_UNDERSTANDING', 117), ('FUTURE_WORK', 127), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 192), ('INCOMPLETE_EVIDENCE', 239), ('FUTURE_WORK', 256), ('FUTURE_WORK', 265)]	7	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC5941617	5/2018	S126-PMC5941617	['DESPITE this GLOBAL agreement on Vitamin D supplementation in the first year of Life, several barriers to adherence STILL exist, such as reluctance of mothers to give their children daily supplementation, lack OF knowledge about Vitamin D actions and the RISK of nutritional rickets, lack of awareness by health care professionals, ASSUMPTION that both breast milk and formula milk provide sufficient Vitamin D intake [116,117].']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 13), ('IMPORTANT_CONSIDERATION', 116), ('ANOMALY_CURIOUS_FINDING', 210), ('IMPORTANT_CONSIDERATION', 255), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 332)]	6	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0000104', 'life cycle', 80, 'life'), ('CHEBI_27300', 'vitamin D', 229, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 401, 'vitamin D')]
PMC5941617	5/2018	S143-PMC5941617	['DIFFERENTLY, CONSIDERING the high prevalence of Vitamin D deficiency during Pregnancy, the espghan RECOMMENDED for preterm infants a Vitamin D intake of 800–1000\xa0iu/day during the first months of Life to rapidly correct fetal low Serum 25(Oh)D levels [125].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 13), ('FUTURE_WORK', 99)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007565', 'female pregnancy', 76, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('UBERON_0000104', 'life cycle', 196, 'life'), ('UBERON_0001977', 'blood serum', 230, 'serum'), ('CHEBI_71657', 'versiconol acetate', 236, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 236, '25(OH ... D')]
PMC5941617	5/2018	S144-PMC5941617	['OTHER authors and GUIDELINES for central europe RECOMMENDED Vitamin D supplementation in preterm infants at higher dosages (400–1000\xa0iu/day) THAN those SUGGESTED for healthy term newborns [1,9,20,126], BUT such an intake SHOULD NOT BE prolonged over the THEORETICAL term (40\xa0weeks of post-Conceptional age) due to the POTENTIAL risk of Vitamin D intoxication [126].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 18), ('FUTURE_WORK', 48), ('INCOMPLETE_EVIDENCE', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('INCOMPLETE_EVIDENCE', 152), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 202), ('FUTURE_WORK', 221), ('INCOMPLETE_EVIDENCE', 254), ('INCOMPLETE_EVIDENCE', 318)]	10	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007620', 'copulation', 289, 'conceptional'), ('CHEBI_27300', 'vitamin D', 336, 'vitamin D')]
PMC5941617	5/2018	S146-PMC5941617	['HOWEVER, total Vitamin D intake from supplementation and Feeding SHOULD BE assessed to avoid excess, particularly in vlbw infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 65)]	2	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0007631', 'feeding behavior', 57, 'feeding')]
PMC5941617	5/2018	S147-PMC5941617	['SOME STUDIES evaluated the EFFECT of Vitamin D supplementation at DIFFERENT doses in preterm infants of various Gestational age and Birth weight [124,128–146].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 27), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 66)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 112, 'gestational'), ('GO_0007567', 'parturition', 132, 'birth')]
PMC5941617	5/2018	S149-PMC5941617	['studies that evaluated Vitamin D supplementation at 200\xa0iu/day gave CONFLICTING results [128,129,134].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 68)]	1	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D')]
PMC5941617	5/2018	S160-PMC5941617	['VARIOUS STUDIES evaluated DIFFERENT regimens of Vitamin D supplementation, BUT comparison of results is COMPLEX DUE TO HETEROGENEITY in Vitamin D administration (dose, interval, and length of supplementation) and population enrolled (age, gender, ethnicity, body mass index, latitude of the country of residence, season of enrolment, and basal Vitamin D status).']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 26), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 75), ('PROBLEM_COMPLICATION', 75), ('DIFFICULT_TASK', 104), ('PROBLEM_COMPLICATION', 112), ('DIFFICULT_TASK', 119)]	7	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 344, 'vitamin D')]
PMC5941617	5/2018	S168-PMC5941617	['intermittent Vitamin D administration MAY BE CONSIDERED in case of reduced compliance with daily supplementation, BUT ACTUAL EVIDENCE IS INSUFFICIENT to RECOMMEND a PREFERRED doses and interval.']	[('INCOMPLETE_EVIDENCE', 38), ('FUTURE_WORK', 45), ('INCOMPLETE_EVIDENCE', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114), ('INCOMPLETE_EVIDENCE', 118), ('PROBLEM_COMPLICATION', 137), ('FUTURE_WORK', 153), ('PROBABLE_UNDERSTANDING', 165)]	8	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D')]
PMC5941617	5/2018	S173-PMC5941617	['ON THE CONTRARY, OTHER societies systematically RECOMMENDED Vitamin D supplementation in children and adolescents during winter months [13,20,115] or throughout the whole year IF reduced sun exposure during summer [20,115].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 7), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 17), ('FUTURE_WORK', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 176)]	5	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC5941617	5/2018	S177-PMC5941617	['variation of sunlight efficacy in promoting skin Vitamin D Synthesis (DEPENDING ON season and latitude) and local factors RELATED to sunlight exposure (i.e.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 70), ('SUPERFICIAL_RELATIONSHIP', 122)]	2	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 49, 'vitamin D synthesis')]
PMC5941617	5/2018	S181-PMC5941617	['subsequent italian cross sectional studies enrolling children and adolescents living in the north-western area of tuscany, central italy (latitude between 43°n and 44°n) not receiving Vitamin D supplementation CONFIRMED seasonal variability in Serum 25(Oh)D levels, with lower concentrations during late winter-early spring months (february–april), with negligible amount of Vitamin D obtained from diet [50,79], ACCORDING TO OTHER italian pediatric studies [70,76–78,83].']	[('INCOMPLETE_EVIDENCE', 210), ('INCOMPLETE_EVIDENCE', 413), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 426)]	3	[('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('UBERON_0001977', 'blood serum', 244, 'serum'), ('CHEBI_71657', 'versiconol acetate', 250, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 250, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 375, 'vitamin D')]
PMC5941617	5/2018	S197-PMC5941617	['indeed, Serum 25(Oh)D evaluation SHOULD BE reserved to subjects AT RISK for Vitamin D deficiency, BUT INDICATIONS for 25(Oh)D measurement significantly VARY among different societies (table\xa08) [9,11,13,15,20–23,27,30].']	[('FUTURE_WORK', 33), ('IMPORTANT_CONSIDERATION', 64), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('INCOMPLETE_EVIDENCE', 102), ('DIFFICULT_TASK', 152)]	5	[('UBERON_0001977', 'blood serum', 8, 'serum'), ('CHEBI_71657', 'versiconol acetate', 14, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 118, '25(OH)D')]
PMC5941617	5/2018	S205-PMC5941617	['tuberculosis)xxxxamenorrheaxcancer (DIFFERENT types)xfxxxhepatitis cgxxrecurrent acute Lower Respiratory Tract infectionsgxxatopic dermatitisgxxatopic asthmagxxautoimmune diseaseshxxixcardiovascular diseases (especially hypertension)xxmetabolic syndrome, type 2 diabetesx\npes pediatric endocrine society, Es endocrine society, fcn federal commission for nutrition (switzerland), sahm society for adolescent health and medicine, aap american academy of pediatrics, eap european academy of pediatrics\nasuggested to guide Vitamin D prescription in Individuals with underlying RISKS requiring continuing supplementation all year long, if NECESSARY\nbgenetic conditions (Osteogenesis imperfecta, idiopathic juvenile osteoporosis, turner syndrome), Endocrine conditions (cushing syndrome, hypogonadism, hyperthyroidism, hyperparathyroidism, growth hormone deficiency, diabetes mellitus) ASSOCIATED with reduced bone mass\ncliving at higher latitudes in the winter and spring months\ndafrican-american and hispanic children\neobese children with additional RISK factors/symptoms for Vitamin D deficiency\nfsome lymphomas\ngpatients admitted to hospital\nhmultiple sclerosis, psoriasis, rheumatoid arthritis, dermatomyositis, systemic lupus erythematosus\nisystemic lupus erythematosus, juvenile idiopathic arthritis, juvenile dermatomyositis as associated with reduced bone mass\n\nSkeletal actions of Vitamin D\n\nnutritional rickets\nrickets is characterized by defective Mineralization Of developing Bone Tissue and reduced or absent Endochondral Ossification of the growth plate, with subsequent deformation [183,184].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 36), ('IMPORTANT_CONSIDERATION', 573), ('IMPORTANT_CONSIDERATION', 634), ('SUPERFICIAL_RELATIONSHIP', 880), ('SUPERFICIAL_RELATIONSHIP', 1046)]	5	[('UBERON_0004905', 'articulation', 87, 'lower respiratory tract'), ('CL_0002322', 'embryonic stem cell', 305, 'ES'), ('CHEBI_27300', 'vitamin D', 519, 'vitamin D'), ('NCBITaxon_1', 'root', 545, 'individuals'), ('GO_0001503', 'ossification', 665, 'osteogenesis'), ('GO_0006397', 'mRNA processing', 742, 'endocrine'), ('CHEBI_27300', 'vitamin D', 1072, 'vitamin D'), ('UBERON_0004288', 'skeleton', 1365, 'Skeletal'), ('CHEBI_27300', 'vitamin D', 1385, 'vitamin D'), ('GO_0051217', 'molybdenum incorporation via L-aspartyl molybdenum bis(molybdopterin guanine dinucleotide)', 1454, 'mineralization of ...'), ('UBERON_0002481', 'bone tissue', 1483, 'bone tissue'), ('GO_0042695', 'thelarche', 1488, 'tissue'), ('GO_0001958', 'endochondral ossification', 1517, 'endochondral ossification'), ('UBERON_0010363', 'endochondral element', 1517, 'endochondral')]
PMC5941617	5/2018	S226-PMC5941617	['the global CONSENSUS on nutritional rickets RECOMMENDED the administration of 2000\xa0iu/day of Vitamin D in patients aged less than 1\xa0year, 3000–6000\xa0iu/day in patients aged 1 to 12\xa0years and 6000\xa0iu/day in patients older than 12\xa0years for a minimum of 3\xa0months, EVEN IF some children MAY require a longer treatment duration [28].']	[('PROBABLE_UNDERSTANDING', 11), ('FUTURE_WORK', 44), ('ANOMALY_CURIOUS_FINDING', 261), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 266), ('INCOMPLETE_EVIDENCE', 283)]	5	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC5941617	5/2018	S227-PMC5941617	['intermittent administration of Vitamin D MAY BE a reliable ALTERNATIVE to daily administration, PARTICULARLY in cases with low compliance.']	[('INCOMPLETE_EVIDENCE', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 59), ('ANOMALY_CURIOUS_FINDING', 96)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC5941617	5/2018	S236-PMC5941617	['RECOMMENDED oral Calcium administration of 500\xa0mg/day in conjunction with Vitamin D REGARDLESS OF age or weight [28], WHILE misra et al.']	[('FUTURE_WORK', 0), ('INCOMPLETE_EVIDENCE', 84), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 118)]	3	[('CHEBI_22313', 'alkaline earth metal atom', 17, 'calcium'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC5941617	5/2018	S257-PMC5941617	['results of these studies are HETEROGENEOUS, because SOME DEMONSTRATED that Vitamin D status was significantly RELATED to bone mass [41,42,54,206–208] WHILE others DID NOT FIND any association [44,209–211].']	[('DIFFICULT_TASK', 29), ('INCOMPLETE_EVIDENCE', 52), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 110), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 150), ('INCOMPLETE_EVIDENCE', 163)]	6	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC5941617	5/2018	S269-PMC5941617	['in 2016, sacn and efsa revised dietary reference values for Vitamin D reporting an INCREASED RISK of adverse Musculoskeletal health outcomes at Serum 25(Oh)D levels in the range of deficiency, BUT with DIFFERENT THRESHOLDS (<\u200910\xa0ng/ml and\u2009<\u2009\xa020\xa0ng/ml, respectively) [25,26].']	[('IMPORTANT_CONSIDERATION', 83), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 193), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 202), ('PROBABLE_UNDERSTANDING', 212)]	4	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0002204', 'musculoskeletal system', 109, 'musculoskeletal'), ('UBERON_0001977', 'blood serum', 144, 'serum'), ('CHEBI_71657', 'versiconol acetate', 150, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 150, '25 ... OH ... D')]
PMC5941617	5/2018	S282-PMC5941617	['several variables MAY justify this DISCREPANCY, such as DIFFERENT enrolled populations, various regimens of Vitamin D supplementation, and age at bone mass assessment.']	[('INCOMPLETE_EVIDENCE', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 56)]	3	[('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC5941617	5/2018	S283-PMC5941617	['HOWEVER, the most RECENT STUDY SUGGESTED that Vitamin D status during childhood MIGHT be more RELEVANT for bone health that maternal 25(Oh)D levels during fetal Life [237].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 80), ('IMPORTANT_CONSIDERATION', 94), ('SUPERFICIAL_RELATIONSHIP', 94)]	6	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 133, '25(OH)D'), ('UBERON_0000104', 'life cycle', 161, 'life')]
PMC5941617	5/2018	S289-PMC5941617	['OTHER than pneumonia, SOME data also INDICATE that Vitamin D deficiency MIGHT be a risk factor also for undifferentiated Viral infections [246], recurrent pharyngotonsillitis [247], otitis media [248], bronchiolitis [249] and viral wheezing [250].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 72)]	4	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('NCBITaxon_1', 'root', 121, 'viral')]
PMC5941617	5/2018	S291-PMC5941617	['OBVIOUSLY, the more ROBUST EVIDENCES on the ASSOCIATION between Vitamin D deficiency and Respiratory infections stem from prospective studies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 44)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 89, 'respiratory')]
PMC5941617	5/2018	S292-PMC5941617	['camargo et al., after adjusting for season of Birth, FOUND that newborns with Vitamin D Cord Blood levels <\u200910\xa0ng/ml had a two-fold (odds ratio: 2.16; 95% ci 1.35–3.46) increased risk of Respiratory infections by 3\xa0months of age as COMPARED TO newborns with 25(Oh)D concentrations >\u200930\xa0ng/ml [252].']	[('INCOMPLETE_EVIDENCE', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 232)]	2	[('GO_0007567', 'parturition', 46, 'birth'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 88, 'cord'), ('UBERON_0000178', 'blood', 93, 'blood'), ('UBERON_0001004', 'respiratory system', 187, 'respiratory'), ('CHEBI_71657', 'versiconol acetate', 258, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 258, '25(OH)D')]
PMC5941617	5/2018	S302-PMC5941617	['furthermore, SOME ROLE from vdr polymorphisms or OTHER Genetic factors MIGHT play a ROLE in determining the INFLUENCE of Vitamin D status on Respiratory morbidity [257,258].']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 49), ('INCOMPLETE_EVIDENCE', 71), ('SUPERFICIAL_RELATIONSHIP', 84), ('SUPERFICIAL_RELATIONSHIP', 108)]	6	[('SO_0000704', 'gene', 55, 'genetic'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 141, 'respiratory')]
PMC5941617	5/2018	S303-PMC5941617	['SEVERAL STUDIES, mostly in Adults, have also addressed the QUESTION WHETHER Vitamin D supplementation CAN PREVENT OR reduce the severity of upper or lower Respiratory infections.']	[('INCOMPLETE_EVIDENCE', 0), ('EXPLICIT_QUESTION', 59), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('EXPLICIT_QUESTION', 68), ('INCOMPLETE_EVIDENCE', 102), ('SUPERFICIAL_RELATIONSHIP', 106), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114)]	7	[('UBERON_0007023', 'adult organism', 27, 'adults'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 155, 'respiratory')]
PMC5941617	5/2018	S306-PMC5941617	['all BUT two [259,261] of the aforementioned reviews concluded that published studies do not INDICATE a PROTECTIVE EFFECT of Vitamin D supplementation on the PREVENTION of acute Respiratory infections in healthy Individuals.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 103), ('SUPERFICIAL_RELATIONSHIP', 114), ('SUPERFICIAL_RELATIONSHIP', 157)]	5	[('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 177, 'respiratory'), ('NCBITaxon_1', 'root', 211, 'individuals')]
PMC5941617	5/2018	S308-PMC5941617	['HOWEVER, a well conducted study, not included in the above cited meta-analysis, on a selected population of otitis prone children, FOUND that Vitamin D administration (1000\xa0iu/day) reduces the RISK of uncomplicated acute otitis [267].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 131), ('IMPORTANT_CONSIDERATION', 193)]	3	[('CHEBI_27300', 'vitamin D', 142, 'vitamin D')]
PMC5941617	5/2018	S319-PMC5941617	['HOWEVER, it is UNCLEAR WHETHER the OBSERVED Vitamin D deficiency/insufficiency is TO BE CONSIDERED a consequence of the infection itself OR IF it plays a ROLE in determining susceptibility to infections or the severity of the disease.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FULL_UNKNOWN', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 82), ('INCOMPLETE_EVIDENCE', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 140), ('SUPERFICIAL_RELATIONSHIP', 154)]	8	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC5941617	5/2018	S333-PMC5941617	['an italian rct was performed TO TEST WHETHER Vitamin D3Supplementation (oral 100000\xa0iu every 3\xa0months for 4 doses) COULD improve Vitamin D status and AFFECT the t-Cell phenotype in hiv-infected patients aged 8 to 26\xa0years with Serum 25(Oh) D\u2009<\u200930\xa0ng/ml.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 37), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 150)]	4	[('CHEBI_52915', 'phosphatediyl group', 45, 'vitamin D3supplementation'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('CL_0000622', 'acinar cell', 162, '-cell'), ('UBERON_0001977', 'blood serum', 227, 'serum'), ('CHEBI_71657', 'versiconol acetate', 233, '25(OH) D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 233, '25(OH) D')]
PMC5941617	5/2018	S340-PMC5941617	['SEVERAL STUDIES investigated a POSSIBLE RELATIONSHIP between Vitamin D deficiency and tuberculosis infection in children [295], BUT literature results are DISCORDANT.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 128), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 155)]	5	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC5941617	5/2018	S386-PMC5941617	['two STUDIES in vitro SHOWED the IMPORTANCE of Vitamin D supplementation in patients affected by Corticosteroid-resistant asthma [315,343] BUT two other STUDIES DEMONSTRATED in vivo that lower 25(Oh)D levels were ASSOCIATED with an increase in Corticosteroids use and an IMPAIRED Lung function [344,345].']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 21), ('IMPORTANT_CONSIDERATION', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 138), ('INCOMPLETE_EVIDENCE', 152), ('INCOMPLETE_EVIDENCE', 160), ('SUPERFICIAL_RELATIONSHIP', 212), ('IMPORTANT_CONSIDERATION', 270)]	8	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_36916', 'cation', 96, 'corticosteroid'), ('CHEBI_71657', 'versiconol acetate', 192, '25(OH)D'), ('CHEBI_50850', 'etabonate ester', 243, 'corticosteroids'), ('UBERON_0002048', 'lung', 279, 'lung')]
PMC5941617	5/2018	S389-PMC5941617	['being Vitamin D INVOLVED in Innate Immunity and in skin barrier integrity, and BECAUSE both FACTORS are dysfunctional in ad, the ASSOCIATION is actively DEBATED.']	[('SUPERFICIAL_RELATIONSHIP', 16), ('PROBABLE_UNDERSTANDING', 79), ('SUPERFICIAL_RELATIONSHIP', 92), ('SUPERFICIAL_RELATIONSHIP', 129), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 153)]	5	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('GO_0045087', 'innate immune response', 28, 'innate immunity')]
PMC5941617	5/2018	S390-PMC5941617	['the EVIDENCES for a pathogenetic ROLE for Vitamin D in ad are STILL CONFLICTING EVEN THOUGH data in favour of such CORRELATION are increasingly stronger with MORE STUDIES in favour BUT OTHERS OPPOSING THIS HYPOTHESIS.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 33), ('IMPORTANT_CONSIDERATION', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('ANOMALY_CURIOUS_FINDING', 80), ('SUPERFICIAL_RELATIONSHIP', 115), ('FUTURE_WORK', 158), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 192), ('QUESTION_ANSWERED_BY_THIS_WORK', 201), ('INCOMPLETE_EVIDENCE', 206)]	11	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
PMC5941617	5/2018	S391-PMC5941617	['HOWEVER, at LEAST two longitudinal STUDIES have CORRELATED the Vitamin D Cord Blood low levels to the development of ad in the offsprings, FINDING that low levels in the Cord Blood significantly increased the risk to develop the disease [347,348].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 139)]	5	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 73, 'cord'), ('UBERON_0000178', 'blood', 78, 'blood'), ('UBERON_0009472', 'axilla', 170, 'cord blood')]
PMC5941617	5/2018	S393-PMC5941617	['it is STILL a matter for full DEBATE WHETHER supplementation with Vitamin D in pediatric ad is WORTH, PARTICULARLY in deficient patients.']	[('IMPORTANT_CONSIDERATION', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 37), ('ANOMALY_CURIOUS_FINDING', 95), ('IMPORTANT_CONSIDERATION', 102)]	5	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC5941617	5/2018	S395-PMC5941617	['HOWEVER, there are also two reviews and meta-analyses, considering ad patients of all ages, SHOWING that Vitamin D supplementation is capable of a higher mean difference in severity of ad symptoms [350,351].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 92)]	2	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC5941617	5/2018	S397-PMC5941617	['in pediatric population there is SOME EVIDENCE about a favourable EFFECT of administration of Vitamin D on several aspects of ad, but results are STILL CONFLICTING.']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 146), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 152)]	4	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC5941617	5/2018	S400-PMC5941617	['HOWEVER, it HAS BEEN SUGGESTED that in patients with a more SEVERE ad, unresponsive to common therapy and with low Serum 25(Oh)D levels, a trial of Vitamin D supplementation CAN BE CONSIDERED [352].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 60), ('FUTURE_WORK', 174), ('FUTURE_WORK', 181)]	5	[('UBERON_0001977', 'blood serum', 115, 'serum'), ('CHEBI_71657', 'versiconol acetate', 121, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 127, 'D'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
PMC5941617	5/2018	S402-PMC5941617	['again, we NEED clinical data SHOWING that restoring normal levels of Vitamin D one CAN obtain significant variation in severity especially IF evaluated by standardized methods (symptom score, scoring atopic dermatitis or equivalent).']	[('FUTURE_WORK', 10), ('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 83), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC5941617	5/2018	S405-PMC5941617	['furthermore, the use of Vitamin D supplementation for primary PREVENTION of allergic diseases REMAINS an attractive AREA OF STUDY, BUT CURRENT KNOWLEDGE and EVIDENCE DOES NOT ALLOW to RECOMMEND it in routine use.']	[('SUPERFICIAL_RELATIONSHIP', 62), ('INCOMPLETE_EVIDENCE', 94), ('FUTURE_WORK', 116), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('INCOMPLETE_EVIDENCE', 135), ('INCOMPLETE_EVIDENCE', 157), ('DIFFICULT_TASK', 166), ('FUTURE_WORK', 184)]	8	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC5941617	5/2018	S407-PMC5941617	['also in Food allergies the ROLE of Vitamin D REMAINS CONTROVERSIAL.']	[('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 53)]	3	[('CHEBI_33290', 'food', 8, 'food'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
PMC5941617	5/2018	S412-PMC5941617	['there is THE NEED for rcts to validate these HYPOTHESES and to evaluate the POSSIBILITY of primary prevention and treatment of Food allergies with Vitamin D [355–357].']	[('INCOMPLETE_EVIDENCE', 9), ('FUTURE_WORK', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 45), ('INCOMPLETE_EVIDENCE', 76)]	4	[('CHEBI_33290', 'food', 127, 'food'), ('GO_0007631', 'feeding behavior', 127, 'food'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 155, 'D')]
PMC5941617	5/2018	S419-PMC5941617	['data on polymorphisms of OTHER Genes INVOLVED in Vitamin D Metabolism are still CONFLICTING or RELATED to small populations [373–376].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('SUPERFICIAL_RELATIONSHIP', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 80), ('SUPERFICIAL_RELATIONSHIP', 95)]	4	[('SO_0000704', 'gene', 31, 'genes'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 49, 'vitamin D metabolism')]
PMC5941617	5/2018	S422-PMC5941617	['IF data of OBSERVATIONAL studies in general population in infancy are ENCOURAGING, in the daisy study, conducted in subjects at higher RISK, the Vitamin D nutritional intake in the first years of Life as well as the Serum 25(Oh)D levels at 9\xa0months of age were not associated with the development of Autoantibodies or with the progression to t1dm [381].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 11), ('FUTURE_WORK', 70), ('IMPORTANT_CONSIDERATION', 135)]	4	[('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('UBERON_0000104', 'life cycle', 196, 'life'), ('UBERON_0001977', 'blood serum', 216, 'serum'), ('CHEBI_71657', 'versiconol acetate', 222, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 222, '25 ... OH ... D'), ('GO_0044308', 'axonal spine', 300, 'autoantibodies')]
PMC5941617	5/2018	S423-PMC5941617	['CONVERSELY, neonatal Vitamin D status SEEMS TO BE ASSOCIATED to the RISK of t1dm in some [382] BUT NOT all the populations [383].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 38), ('SUPERFICIAL_RELATIONSHIP', 50), ('IMPORTANT_CONSIDERATION', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95)]	5	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D')]
PMC5941617	5/2018	S431-PMC5941617	['ALTHOUGH SOME SUGGESTIVE and encouraging data on epidemiological observational studies and pilot clinical studies of intervention, the LACK OF EVIDENCE deriving by rcts DOES NOT ALLOW to ENCOURAGE treatment with Cholecalciferol or other Vitamin D Metabolites in patients with t1dm or subjects at higher RISK.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 135), ('DIFFICULT_TASK', 169), ('FUTURE_WORK', 187), ('IMPORTANT_CONSIDERATION', 303)]	8	[('CHEBI_52550', 'theopalauamide', 212, 'cholecalciferol'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D'), ('CHEBI_25212', 'metabolite', 247, 'metabolites')]
PMC5941617	5/2018	S432-PMC5941617	['HOWEVER, Vitamin D deficiency SHOULD BE avoided in these populations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 30)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
PMC5941617	5/2018	S444-PMC5941617	['AT PRESENT the IDEAL dosing regimen to treat Vitamin D deficiency and to maintain sufficiency in ibd patients is STILL DEBATED [406].']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 15), ('IMPORTANT_CONSIDERATION', 113), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 119)]	4	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC5941617	5/2018	S470-PMC5941617	['spontaneous recovery of Vitamin D status following gluten free diet HAS BEEN SUGGESTED [417], BUT it is still DEBATED.']	[('INCOMPLETE_EVIDENCE', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 94), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 110)]	3	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC5941617	5/2018	S481-PMC5941617	['CONVERSELY, Vitamin D deficiency does not lead to obesity [441].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D')]
PMC5941617	5/2018	S494-PMC5941617	['further, CONTRASTING results came from the studies investigating the ASSOCIATION between Vitamin D deficiency and non-alcoholic fatty Liver disease [451–453].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('SUPERFICIAL_RELATIONSHIP', 69)]	2	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0002107', 'liver', 134, 'liver')]
PMC5941617	5/2018	S499-PMC5941617	['more RECENT FINDINGS have reported no influence of DIFFERENT Vitamin D supplementation schedules on Serum Lipid levels, Glucose Homeostasis, glycated hemoglobin and Pancreatic Insulin secretion [457–459].']	[('INCOMPLETE_EVIDENCE', 5), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 51)]	2	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('UBERON_0001977', 'blood serum', 100, 'serum'), ('CHEBI_18059', 'lipid', 106, 'lipid'), ('CHEBI_17234', 'glucose', 120, 'glucose'), ('GO_0042593', 'glucose homeostasis', 120, 'glucose homeostasis'), ('UBERON_0001264', 'pancreas', 165, 'pancreatic'), ('PR_000045358', 'insulin family protein', 176, 'insulin')]
PMC5941617	5/2018	S505-PMC5941617	['DIFFERENT Vitamin D dose regimens HAVE BEEN PROPOSED in obese children and adolescents for both Vitamin D supplementation and treatment of deficiency [463–467].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 44)]	3	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D')]
PMC5941617	5/2018	S508-PMC5941617	['similarly, guidelines for central europe RECOMMENDED in obese children Vitamin D supplementation (1200–2000\xa0iu/day depending on severity of obesity) between september and april, or throughout the whole year IF sufficient Skin Synthesis Of Vitamin D is not ensured in the summer [20].']	[('FUTURE_WORK', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 207)]	2	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0034205', 'amyloid-beta formation', 221, 'skin synthesis of'), ('CHEBI_27300', 'vitamin D', 239, 'vitamin D')]
PMC5941617	5/2018	S510-PMC5941617	['more RECENTLY, united arab emirates GUIDELINES also RECOMMENDED Vitamin D supplementation in obese children and adolescents (1200–2000\xa0iu/day DEPENDING ON severity of obesity, season and sun exposure) throughout the year IF sufficient Skin Synthesis if Vitamin D is not ensured during winter [27].']	[('INCOMPLETE_EVIDENCE', 5), ('PROBABLE_UNDERSTANDING', 36), ('FUTURE_WORK', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 142), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221)]	5	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0009697', 'salicylic acid biosynthetic process', 235, 'skin synthesis'), ('CHEBI_27300', 'vitamin D', 253, 'vitamin D')]
PMC5941617	5/2018	S511-PMC5941617	['DIFFERENTLY, sacn CONFIRMED that obese People are AT RISK of low Serum 25(Oh)D concentrations, but HIGHLIGHTED that CURRENTLY EVIDENCE is INSUFFICIENT to RECOMMEND for obese Individuals different reference Nutrient intake of Vitamin D from that PROPOSED for the general uk population [25].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 18), ('IMPORTANT_CONSIDERATION', 50), ('INCOMPLETE_EVIDENCE', 99), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 126), ('INCOMPLETE_EVIDENCE', 138), ('FUTURE_WORK', 154), ('INCOMPLETE_EVIDENCE', 245)]	9	[('NCBITaxon_10088', 'Mus <genus>', 39, 'people'), ('UBERON_0001977', 'blood serum', 65, 'serum'), ('CHEBI_71657', 'versiconol acetate', 71, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 71, '25(OH ... D'), ('NCBITaxon_1', 'root', 174, 'individuals'), ('CHEBI_33284', 'nutrient', 206, 'nutrient'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D')]
PMC5941617	5/2018	S517-PMC5941617	['AT PRESENT, CONSIDERING that obese italian children have higher prevalence of Vitamin D deficiency and insufficiency then normal weight Individuals, we SUGGEST in obese children and adolescents vitamin D supplementation at higher doses THAN those RECOMMENDED for age (1000–1500\xa0iu/day) from the end of fall to the beginning of spring (november–april) to ensure an adequate Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 152), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 236), ('FUTURE_WORK', 247)]	5	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('NCBITaxon_1', 'root', 136, 'individuals'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 202, 'D'), ('CHEBI_27300', 'vitamin D', 373, 'vitamin D')]
PMC5941617	5/2018	S525-PMC5941617	['NEVERTHELESS, a RECENT rct enrolled 42 children with autism spectrum disorders showing that Vitamin D supplementation (2000\xa0iu/day of Vitamin D3For 20\xa0weeks) had no EFFECT on the primary outcome (the stereotypic behaviour subscale from the aberrant behaviour checklist) in comparison with placebo [485].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 165)]	3	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_27364', 'zinc molecular entity', 134, 'vitamin D3for')]
PMC5941617	5/2018	S536-PMC5941617	['meta-analyses assessing the EFFECT of Vitamin D supplementation in depressed Adults FOUNDED CONFLICTING results [495–497].']	[('SUPERFICIAL_RELATIONSHIP', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 84), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92)]	3	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0007023', 'adult organism', 77, 'adults')]
PMC5941617	5/2018	S537-PMC5941617	['AS literature SHOWS CONTRASTING results because of DIFFERENT methods and study designs, MORE STUDIES ARE NEEDED to define the ROLE of Vitamin D in pathogenesis and severity of depression, particularly in the pediatric age.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 51), ('ANOMALY_CURIOUS_FINDING', 88), ('FUTURE_WORK', 93), ('SUPERFICIAL_RELATIONSHIP', 126)]	7	[('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC5941617	5/2018	S545-PMC5941617	['during Pregnancy Vitamin D Metabolism changes so that maternal Serum 1,25(Oh)2D levels significantly rise to meet increased calcium REQUIREMENTS for Fetal Skeleton mineralization, WHEREAS fetal Vitamin D stores are exclusively DEPENDENT on maternal Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 180), ('SUPERFICIAL_RELATIONSHIP', 227)]	3	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 17, 'vitamin D metabolism'), ('UBERON_0001977', 'blood serum', 63, 'serum'), ('CHEBI_37958', 'dye', 69, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 71, '25(OH)2D'), ('UBERON_0000922', 'embryo', 149, 'fetal'), ('UBERON_0004288', 'skeleton', 155, 'skeleton'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D')]
PMC5941617	5/2018	S561-PMC5941617	['screening for Vitamin D deficiency during Pregnancy is STILL DEBATED.']	[('IMPORTANT_CONSIDERATION', 55), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 61)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 42, 'pregnancy')]
PMC5941617	5/2018	S568-PMC5941617	['we do not RECOMMEND routine screening of Serum 25(Oh)D levels in all Pregnant and breastfeeding women, BUT we SUGGEST to CONSIDER Vitamin D testing in women with multiple RISK FACTORS for Vitamin D deficiency, PARTICULARLY if not receiving Vitamin D supplementation.']	[('FUTURE_WORK', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('INCOMPLETE_EVIDENCE', 110), ('FUTURE_WORK', 121), ('SUPERFICIAL_RELATIONSHIP', 171), ('ANOMALY_CURIOUS_FINDING', 210), ('IMPORTANT_CONSIDERATION', 210)]	7	[('UBERON_0001977', 'blood serum', 41, 'serum'), ('CHEBI_71657', 'versiconol acetate', 47, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 47, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 69, 'pregnant'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D')]
PMC5941617	5/2018	S574-PMC5941617	['relatively FEW STUDIES evaluated the efficacy of DIFFERENT regimens with Vitamin D2Or Vitamin D3For the treatment of Vitamin D deficiency in otherwise healthy children.']	[('INCOMPLETE_EVIDENCE', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 49)]	2	[('CHEBI_27329', 'xanthosine phosphate', 73, 'vitamin D2or'), ('PR_000017209', 'utrophin', 73, 'vitamin D2or'), ('CHEBI_27364', 'zinc molecular entity', 86, 'vitamin D3for'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 94, 'D3for'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC5941617	5/2018	S588-PMC5941617	['two studies evaluated the efficacy of administering a bolus dose of Vitamin D2, 150000\xa0iu [225] or 300000\xa0iu [224], every 3\xa0months for 12\xa0months in adolescent females with SEVERE Vitamin D deficiency, with CONFLICTING results.']	[('IMPORTANT_CONSIDERATION', 172), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 206)]	2	[('CHEBI_28934', 'vitamin D2', 68, 'vitamin D2'), ('PR_000017299', 'VIP peptides', 68, 'vitamin D2'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D')]
PMC5941617	5/2018	S592-PMC5941617	['both 300000 and 600000\xa0iu single oral Vitamin-D bolus were effecting in treating Vitamin D deficiency in young children (3\xa0months-3\xa0years) BUT a significant percentage developed hypercalcemia and/or hypercalciuria [195].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 139)]	1	[('CHEBI_83326', 'tedizolid phosphate', 38, 'vitamin-D'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC5941617	5/2018	S593-PMC5941617	['on the CONTRARY a stoss therapy (Oral single-dose of 10000\xa0iu/kg or 300000\xa0iu of Vitamin D3) HAS BEEN DEMONSTRATED EFFECTIVE and SAFE in the treatment of Vitamin D deficiency in older children (mean age 10.6\u2009±\u20094.4\xa0years) without rickets [523].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 7), ('INCOMPLETE_EVIDENCE', 93), ('SUPERFICIAL_RELATIONSHIP', 115), ('IMPORTANT_CONSIDERATION', 129)]	4	[('UBERON_0000165', 'mouth', 33, 'oral'), ('CHEBI_33279', 'vitamin D5', 81, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 81, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC5941617	5/2018	S594-PMC5941617	['HOWEVER, at PRESENT safety data in both the short- and the long-term of monthly or OTHER Vitamin D regimens LACK DUE TO the nature of the studies, especially in young children.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('INCOMPLETE_EVIDENCE', 108), ('PROBLEM_COMPLICATION', 113)]	5	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC5941617	5/2018	S604-PMC5941617	['AT PRESENT there is NO STRONG EVIDENCE about WHETHER to treat asymptomatic children with Vitamin D insufficiency [23].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 45)]	3	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC5941617	5/2018	S615-PMC5941617	['DEPENDING ON 25(Oh)D levels, Vitamin D status can be defined as follows:\nsufficiency ≥30\xa0ng/ml\ninsufficiency 20–29\xa0ng/ml\ndeficiency <\u200920\xa0ng/ml\nsevere deficiency <\u200910\xa0ng/ml\nthe term hypovitaminosis D refers to Serum 25(Oh)D levels <\u200930\xa0ng/ml.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('CHEBI_71657', 'versiconol acetate', 13, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 197, 'D'), ('UBERON_0001977', 'blood serum', 209, 'serum'), ('CHEBI_71657', 'versiconol acetate', 215, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 215, '25(OH)D')]
PMC5941617	5/2018	S664-PMC5941617	['HOWEVER, BECAUSE CURRENT EVIDENCE IS WEAK, we SUGGEST against Vitamin D administration as a therapy for Respiratory infections, beyond the correction of a DOCUMENTED Vitamin D deficiency.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 46), ('INCOMPLETE_EVIDENCE', 155)]	6	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 104, 'respiratory'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D')]
PMC5941617	5/2018	S674-PMC5941617	['HOWEVER, as FEW STUDIES SHOWED that Vitamin D supplementation improves clinical parameters in patients with active tuberculosis or hiv infection, MORE rigorous and extensive STUDIES ARE NEEDED to EVALUATE the ROLE of Vitamin D supplementation in infectious diseases, CONSIDERING also the setting of care, children’s age and nutritional status, POTENTIAL co-infections and compliance with Anti-infective therapy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 24), ('ANOMALY_CURIOUS_FINDING', 146), ('FUTURE_WORK', 174), ('QUESTION_ANSWERED_BY_THIS_WORK', 196), ('SUPERFICIAL_RELATIONSHIP', 209), ('IMPORTANT_CONSIDERATION', 267), ('INCOMPLETE_EVIDENCE', 344)]	9	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D'), ('CHEBI_59132', 'antigen', 388, 'anti')]
PMC5941617	5/2018	S692-PMC5941617	['HOWEVER, we RECOMMEND to maintain Vitamin D intake for age and to treat Vitamin D deficiency IF FOUND.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93), ('INCOMPLETE_EVIDENCE', 96)]	4	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC5941617	5/2018	S695-PMC5941617	['we RECOMMEND continuous Vitamin D supplementation at higher doses THAN those RECOMMENDED for age (AT LEAST 1000–1500\xa0iu/day).']	[('FUTURE_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 66), ('FUTURE_WORK', 77), ('PROBABLE_UNDERSTANDING', 98)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC5941617	5/2018	S696-PMC5941617	['we RECOMMEND to treat Vitamin D deficiency with daily Vitamin D at higher doses THAN those RECOMMENDED for otherwise healthy pediatric population (AT LEAST 2000–4000\xa0iu/day), for a minimum of 6–8\xa0weeks.']	[('FUTURE_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 80), ('FUTURE_WORK', 91), ('PROBABLE_UNDERSTANDING', 147)]	4	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
PMC5941617	5/2018	S705-PMC5941617	['it is UNCERTAIN IF Vitamin D deficiency MAY worsen Metabolic profile of obese children and adolescents.']	[('FULL_UNKNOWN', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('INCOMPLETE_EVIDENCE', 40)]	3	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0008152', 'metabolic process', 51, 'metabolic')]
PMC5941617	5/2018	S706-PMC5941617	['we SUGGEST against Vitamin D administration to improve obesity-related COMPLICATIONS, given INCONSISTENT results and the SMALL NUMBER OF STUDIES.']	[('INCOMPLETE_EVIDENCE', 3), ('IMPORTANT_CONSIDERATION', 71), ('PROBLEM_COMPLICATION', 71), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('INCOMPLETE_EVIDENCE', 121)]	5	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D')]
PMC5941617	5/2018	S707-PMC5941617	['we SUGGEST Vitamin D supplementation at higher doses THAN those RECOMMENDED for age (1000–1500\xa0iu/day) from the end of fall to the beginning of spring (november–april) in obese children and adolescents to ensure an adequate Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 53), ('FUTURE_WORK', 64)]	3	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 224, 'vitamin D')]
PMC5941617	5/2018	S712-PMC5941617	['in obese subjects with Vitamin D deficiency we RECOMMEND Vitamin D treatment at higher doses THAN those RECOMMENDED for otherwise healthy pediatric population (AT LEAST 2000–4000\xa0iu/day), for a minimum of 6–8\xa0weeks.']	[('FUTURE_WORK', 47), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93), ('FUTURE_WORK', 104), ('PROBABLE_UNDERSTANDING', 160)]	4	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC5941617	5/2018	S715-PMC5941617	['we RECOMMEND against Vitamin D treatment to improve patient’s performance CONSIDERING the LIMITED and CONFLICTING AVAILABLE EVIDENCE.']	[('FUTURE_WORK', 3), ('PROBABLE_UNDERSTANDING', 74), ('INCOMPLETE_EVIDENCE', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102), ('INCOMPLETE_EVIDENCE', 114)]	5	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D')]
PMC5941617	5/2018	S728-PMC5941617	['in subjects with asymptomatic Vitamin D deficiency assuming Drugs interfering with Vitamin D Metabolism (Anticonvulsants, oral Corticosteroids, antifungals like Ketoconazole, Anti-retroviral Drugs) we RECOMMEND Vitamin D treatment at higher doses THAN those RECOMMENDED for otherwise healthy pediatric population (AT LEAST 2000–4000\xa0iu/day), for a minimum of 6–8\xa0weeks.']	[('FUTURE_WORK', 201), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 247), ('FUTURE_WORK', 258), ('PROBABLE_UNDERSTANDING', 314)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_23888', 'drug', 60, 'drugs'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 83, 'vitamin D metabolism'), ('CHEBI_37540', 'arabinarate(2-)', 105, 'anticonvulsants'), ('CHEBI_50850', 'etabonate ester', 127, 'corticosteroids'), ('CHEBI_47519', 'ketoconazole', 161, 'ketoconazole'), ('CHEBI_59132', 'antigen', 175, 'anti'), ('CHEBI_23888', 'drug', 191, 'drugs'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D')]
PMC5941617	5/2018	S729-PMC5941617	['CONSIDERING AVAILABLE EVIDENCE, PARTICULARLY the LACK OF italian studies, at PRESENT we DO NOT RECOMMEND OTHER modalities DIFFERENT from daily or weekly administration of Vitamin D to treat asymptomatic Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 32), ('INCOMPLETE_EVIDENCE', 49), ('QUESTION_ANSWERED_BY_THIS_WORK', 77), ('FULL_UNKNOWN', 88), ('FUTURE_WORK', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122)]	10	[('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 211, 'D')]
PMC5952272	5/2018	S14-PMC5952272	['approximately 1 in 68 children aged 8\u2009years living in sites participating in the addm network surveillance areas (usa) met the asd case criteria for the 2012 surveillance year.1some HYPOTHESES were SUGGESTED to explain this increase, such as an increased awareness, improved detection, expanding definition, or an actual increase in incidence or a combination of these FACTORS.2ALTHOUGH both Genetic and multiple environmental RISK FACTORS HAVE BEEN studied extensively, many POTENTIALLY modifiable RISK factors including nutritional and Immune function–RELATED RISK FACTORS such as Vitamin D, Folic Acid, and Metabolic syndrome have NOT RECEIVED SUFFICIENT ATTENTION.3SEVERAL RECENT STUDIES have put FORWARD hypotheses to explain the mechanism of ASSOCIATION between both Folic Acid and Vitamin D and autism.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 182), ('INCOMPLETE_EVIDENCE', 198), ('SUPERFICIAL_RELATIONSHIP', 369), ('ANOMALY_CURIOUS_FINDING', 377), ('SUPERFICIAL_RELATIONSHIP', 427), ('INCOMPLETE_EVIDENCE', 440), ('INCOMPLETE_EVIDENCE', 476), ('SUPERFICIAL_RELATIONSHIP', 499), ('SUPERFICIAL_RELATIONSHIP', 554), ('SUPERFICIAL_RELATIONSHIP', 562), ('INCOMPLETE_EVIDENCE', 634), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 668), ('INCOMPLETE_EVIDENCE', 677), ('FUTURE_WORK', 701), ('SUPERFICIAL_RELATIONSHIP', 748)]	15	[('SO_0000704', 'gene', 392, 'genetic'), ('UBERON_0002405', 'immune system', 538, 'immune'), ('CHEBI_27300', 'vitamin D', 583, 'vitamin D'), ('CHEBI_30751', 'formic acid', 594, 'folic acid'), ('GO_0008152', 'metabolic process', 610, 'metabolic'), ('CHEBI_30751', 'formic acid', 773, 'folic acid'), ('CHEBI_27300', 'vitamin D', 788, 'vitamin D')]
PMC5952272	5/2018	S16-PMC5952272	['there is also a GROWING body of RESEARCH that SUGGESTS that Vitamin D status EITHER in utero OR early in Life MAY BE a RISK for autism.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('INCOMPLETE_EVIDENCE', 110), ('IMPORTANT_CONSIDERATION', 119)]	6	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0000104', 'life cycle', 105, 'life')]
PMC5952272	5/2018	S100-PMC5952272	['more than 40% of girls from the west bank and boys from both provinces had sufficient Serum levels of Vitamin D (>50\u2009nmol/l 25-Oh-d3), BUT this was only true for 21.9% of girls from gaza strip.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 135)]	1	[('UBERON_0001977', 'blood serum', 86, 'serum'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 124, '25-OH')]
PMC5952272	5/2018	S141-PMC5952272	['methionine MAY then be activated by methionine adenosyltransferase to form S-Adenosylmethionine (sam), the primary Methyl Donor for most cellular methyltransferase reactions, including the methylation of dna, rna, proteins, Phospholipids, and Neurotransmitters.34\n\nVitamin D status as a risk factor for autism\nthe main source of Vitamin D is the solar uv-b radiation–RELATED Conversion Of 7-Dehydrocholesterol to Previtamin D3 in the skin and a lesser amount of Vitamin D from Food.35there is a GROWING BODY of RESEARCH that SUGGESTS that Vitamin D status EITHER in utero OR early in Life MAY BE a risk of autism.36moreover, epidemiologic EVIDENCE SUPPORTS the ROLE of maternal Vitamin D deficiency AS a RISK FACTOR for the development of infantile autism.37maternal status of Vitamin D IS CONSIDERED INSUFFICIENT not ONLY in countries where solar radiation is low but also in very sunny places such saudi arabia, uae, iran, and jordan.38\nVitamin D functions in the body have been extensively studied by researchers.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 367), ('INCOMPLETE_EVIDENCE', 495), ('INCOMPLETE_EVIDENCE', 525), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 556), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 572), ('INCOMPLETE_EVIDENCE', 589), ('INCOMPLETE_EVIDENCE', 639), ('INCOMPLETE_EVIDENCE', 648), ('SUPERFICIAL_RELATIONSHIP', 661), ('PROBABLE_UNDERSTANDING', 699), ('SUPERFICIAL_RELATIONSHIP', 704), ('INCOMPLETE_EVIDENCE', 787), ('PROBLEM_COMPLICATION', 801), ('INCOMPLETE_EVIDENCE', 818)]	15	[('CHEBI_50770', 'N,N-dihydroxypentahomomethionine', 75, 'S-adenosylmethionine'), ('CHEBI_81933', 'methasulfocarb', 115, 'methyl donor'), ('CHEBI_16247', 'phospholipid', 224, 'phospholipids'), ('CHEBI_25512', 'neurotransmitter', 243, 'neurotransmitters'), ('CHEBI_28384', 'vitamin K', 265, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 329, 'vitamin D'), ('GO_0048669', 'collateral sprouting in absence of injury', 375, 'conversion of ... dehydrocholesterol'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 389, '7-dehydrocholesterol'), ('PR_000014709', 'neuroserpin', 413, 'previtamin D3'), ('CHEBI_29238', 'tritium atom', 424, 'D3'), ('CHEBI_27300', 'vitamin D', 462, 'vitamin D'), ('CHEBI_33290', 'food', 477, 'food'), ('CHEBI_27300', 'vitamin D', 539, 'vitamin D'), ('UBERON_0000104', 'life cycle', 584, 'life'), ('CHEBI_27300', 'vitamin D', 678, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 777, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 939, 'Vitamin D')]
PMC5952272	5/2018	S143-PMC5952272	['IN fact, it is the most potent Steroid Hormone in the Human body INTERACTING with 2.5% of the Human Genome or some 1000 Genes (a large NUMBER of which AFFECT Brain Development and function) and working like a master on-off switch.35\nthe LINK between Vitamin D and autism are based on 4 observational data:\nthe low concentrations of Serotonin in the Brain and its elevated concentrations in Tissues outside the Blood-Brain Barrier;\nlow Plasma concentrations of the Vitamin D hormone precursor 25-Hydroxyvitamin D (25(Oh) D3);\nhigh male incidence;\npresence of maternal Antibodies to foetal Brain Tissue.35,36\nthe level of Serotonin in the Brain DEPENDS ON the Blood levels of tryptophan, which, UNLIKE Serotonin, crosses the Blood-Brain Barrier.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 135), ('SUPERFICIAL_RELATIONSHIP', 151), ('SUPERFICIAL_RELATIONSHIP', 237), ('SUPERFICIAL_RELATIONSHIP', 643), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 693)]	7	[('CHEBI_26764', 'steroid hormone', 31, 'steroid hormone'), ('NCBITaxon_9606', 'Homo sapiens', 54, 'human'), ('NCBITaxon_9606', 'Homo sapiens', 94, 'human'), ('SO_0001026', 'genome', 100, 'genome'), ('SO_0000704', 'gene', 120, 'genes'), ('GO_0007420', 'brain development', 158, 'brain development'), ('UBERON_0000955', 'brain', 158, 'brain'), ('CHEBI_27300', 'vitamin D', 250, 'vitamin D'), ('CHEBI_28790', 'serotonin', 332, 'serotonin'), ('UBERON_0000955', 'brain', 349, 'brain'), ('UBERON_0000479', 'tissue', 390, 'tissues'), ('UBERON_0000120', 'blood brain barrier', 410, 'blood-brain barrier'), ('UBERON_0001969', 'blood plasma', 435, 'plasma'), ('CHEBI_27300', 'vitamin D', 464, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 492, '25-hydroxyvitamin D'), ('CHEBI_62946', 'ammonium sulfate', 513, '25(OH) D3'), ('GO_0042571', 'immunoglobulin complex, circulating', 567, 'antibodies'), ('UBERON_0000955', 'brain', 588, 'brain'), ('UBERON_0000479', 'tissue', 594, 'tissue'), ('CHEBI_28790', 'serotonin', 620, 'serotonin'), ('UBERON_0000955', 'brain', 637, 'brain'), ('UBERON_0000178', 'blood', 658, 'blood'), ('CHEBI_28790', 'serotonin', 700, 'serotonin'), ('UBERON_0000178', 'blood', 723, 'blood'), ('UBERON_0000052', 'fornix of brain', 729, 'brain barrier')]
PMC5952272	5/2018	S146-PMC5952272	['it is IMPORTANT TO MENTION in this context that the PREVALENCE of autism in somali children Born in sweden was FOUND TO BE 3 to 4 times higher than in the non-somali group (0.7% vs 0.19%).39as somalis have high levels of Melanin, during migration to northern latitudes, such as sweden, they would REQUIRE 5 to 10 times more uv-b exposure than light-skinned Individuals OR an ALTERNATIVE Vitamin D source, such as from the diet or supplementation.40moreover, saad et al41reported that 57% Vitamin D deficient and 30% insufficient patients who received Vitamin D3 (300\u2009iu/kg/day not to exceed 5000\u2009iu/day) for 3\u2009months SHOWED significant improved outcomes (80.72 %), which were MAINLY in the sections of the childhood autism rating scale (cars) and aberrant behaviour checklist subscales that measure behaviour, stereotypy, Eye contact, and attention span.']	[('IMPORTANT_CONSIDERATION', 6), ('IMPORTANT_CONSIDERATION', 52), ('ANOMALY_CURIOUS_FINDING', 111), ('FUTURE_WORK', 297), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 369), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 375), ('INCOMPLETE_EVIDENCE', 617), ('PROBABLE_UNDERSTANDING', 676)]	8	[('GO_0007567', 'parturition', 92, 'born'), ('CHEBI_25179', 'melanins', 221, 'melanin'), ('NCBITaxon_1', 'root', 357, 'individuals'), ('CHEBI_27300', 'vitamin D', 387, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 488, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 551, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 551, 'vitamin D3'), ('UBERON_0000970', 'eye', 822, 'eye')]
PMC5952272	5/2018	S147-PMC5952272	['experiment on Animal models SHOWED that 1,25 Dihydroxyvitamin D3 Prenatal supplementations were PROTECTIVE for offsprings against induced Maternal Immune Activation (mia).42maternal Immune Activation in experimental Animals Reproduces asd-like symptoms via significant increase of proinflammatory cytokines; however, administration of Vitamin D has blocked the emergence of asd-relevant deficits in social INTERACTION, stereotyped behaviour, and emotional Learning and Memory.42RECENTLY, sotodehasl et al43have reviewed 80 articles LINKING autism and Vitamin D. the authors found no significant DIFFERENCES between children with asd and neurotypical developed children.43this was also SUPPORTED by a canadian prospective cohort study that included 3852 children.44forty-one children were diagnosed with asd, who have no difference in the level of Vitamin D in their Serum compared with non-asd children.']	[('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 96), ('SUPERFICIAL_RELATIONSHIP', 406), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 476), ('SUPERFICIAL_RELATIONSHIP', 532), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 595), ('INCOMPLETE_EVIDENCE', 685)]	7	[('NCBITaxon_33208', 'Metazoa', 14, 'animal'), ('CHEBI_63912', '19-hydroxyprostaglandin H2', 40, '1,25 dihydroxyvitamin D3'), ('PR_000001177', 'D(2) dopamine receptor', 62, 'D3'), ('GO_0007565', 'female pregnancy', 65, 'prenatal'), ('GO_0007618', 'mating', 138, 'maternal'), ('GO_0060819', 'inactivation of X chromosome by genetic imprinting', 147, 'immune activation'), ('UBERON_0002405', 'immune system', 147, 'immune'), ('GO_0060819', 'inactivation of X chromosome by genetic imprinting', 182, 'immune activation'), ('UBERON_0002405', 'immune system', 182, 'immune'), ('NCBITaxon_33208', 'Metazoa', 216, 'animals'), ('GO_0000003', 'reproduction', 224, 'reproduces'), ('CHEBI_27300', 'vitamin D', 335, 'vitamin D'), ('GO_0007612', 'learning', 456, 'learning'), ('GO_0007613', 'memory', 469, 'memory'), ('CHEBI_27300', 'vitamin D', 551, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 847, 'vitamin D'), ('UBERON_0001977', 'blood serum', 866, 'serum')]
PMC5952272	5/2018	S151-PMC5952272	['on the community level, it was NOTICED that diet plays a MAJOR ROLE in the manifestation of anaemia and Vitamin E and D deficiency; HOWEVER, OTHER factors MAY interfere to make such a deficiency multifactorial.']	[('ANOMALY_CURIOUS_FINDING', 31), ('IMPORTANT_CONSIDERATION', 57), ('SUPERFICIAL_RELATIONSHIP', 63), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('INCOMPLETE_EVIDENCE', 155)]	6	[('CHEBI_27300', 'vitamin D', 104, 'vitamin E'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 118, 'D')]
PMC5956785	5/2018	S1-PMC5956785	['WHILE the ROLES of Vitamin D in OTHER Autoimmune diseases HAVE BEEN investigated, less is known about the ROLE of Vitamin D in chronic childhood arthritis.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 106)]	5	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 38, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC5956785	5/2018	S22-PMC5956785	['reports of RELATIONSHIPS between Vitamin D and chronic childhood arthritis are derived from studies having DIFFERENT methodologic approaches, originating from multiple geographic regions, and comprising demographically disparate populations.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 107)]	2	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC5956785	5/2018	S64-PMC5956785	['in the most RECENT review of Vitamin D REQUIREMENTS, the iom CONCLUDED that there was INADEQUATE INFORMATION to make intake RECOMMENDATIONS in RELATION to OTHER biologic ROLES of vitamin d [19].']	[('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 39), ('INCOMPLETE_EVIDENCE', 61), ('IMPORTANT_CONSIDERATION', 86), ('PROBLEM_COMPLICATION', 86), ('INCOMPLETE_EVIDENCE', 97), ('FUTURE_WORK', 124), ('SUPERFICIAL_RELATIONSHIP', 143), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 155), ('SUPERFICIAL_RELATIONSHIP', 170)]	10	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D')]
PMC5956785	5/2018	S183-PMC5956785	['ONE STUDY (26.3%) SHOWED the OPPOSITE RELATIONSHIP; those with active disease had higher Vitamin D concentrations than those with inactive disease [34].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 29), ('SUPERFICIAL_RELATIONSHIP', 38)]	4	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC5956785	5/2018	S188-PMC5956785	['active disease or frequent relapse was ASSOCIATED with reduced Vitamin D status COMPARED TO patients with no active disease or frequent flare-ups.']	[('SUPERFICIAL_RELATIONSHIP', 39), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 80)]	2	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC5956785	5/2018	S189-PMC5956785	['the authors QUESTIONED WHETHER jia patients with more SEVERE disease REQUIRE higher supplementation of Vitamin D to maintain normal 25(Oh) D concentrations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('IMPORTANT_CONSIDERATION', 54), ('IMPORTANT_CONSIDERATION', 69)]	5	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 132, '25(OH) D')]
PMC5956785	5/2018	S207-PMC5956785	['it HAS BEEN THEORIZED that there MAY BE an increased utilization of Vitamin D during active inflammation, POSSIBLY caused by \\the presence of Vitamin D receptor polymorphisms in patients with Autoimmune diseases [6,72].']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 12), ('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 106)]	6	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 192, 'autoimmune')]
PMC5956785	5/2018	S208-PMC5956785	['ADDITIONAL STUDIES investigating Vitamin D intake from all sources (both Food and supplements) are REQUIRED to determine IF children with chronic arthritis REQUIRE additional Vitamin D to maintain Serum concentrations in comparison to healthy children.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 99), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('IMPORTANT_CONSIDERATION', 156)]	4	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_33290', 'food', 73, 'food'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('UBERON_0001977', 'blood serum', 197, 'serum')]
PMC5956785	5/2018	S238-PMC5956785	['WHILE THIS REVIEW FOCUSED on Vitamin D status in children with jia, Vitamin D MAY BE INVOLVED in both disease development and subsequent disease activity status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 78), ('SUPERFICIAL_RELATIONSHIP', 85)]	5	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC5956785	5/2018	S244-PMC5956785	['season of Birth MAY BE a MARKER for Vitamin D status in utero with children Born in the non-Vitamin D synthesizing periods being exposed to less Vitamin D during their time in utero THAN those who are Born during the Vitamin D synthesizing seasons.']	[('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182)]	3	[('GO_0007567', 'parturition', 10, 'birth'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0007567', 'parturition', 76, 'born'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('GO_0007567', 'parturition', 201, 'born'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D')]
PMC5956785	5/2018	S250-PMC5956785	['certain vdr Gene polymorphisms MAY BE ASSOCIATED with different biologic response to Vitamin D. the cdx2 polymorphism of the Vdr Gene specifically the gg genotype, HAVE BEEN SUGGESTED to be more represented in patients with jia COMPARED TO healthy controls who more OFTEN have the ga genotype [82].']	[('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 164), ('INCOMPLETE_EVIDENCE', 174), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 228), ('PROBABLE_UNDERSTANDING', 266)]	6	[('SO_0000704', 'gene', 12, 'gene'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 125, 'VDR'), ('SO_0000704', 'gene', 129, 'gene')]
PMC5956785	5/2018	S258-PMC5956785	['UNDERSTANDING IF Genetic variants increase the risk of disease development will HELP tailor Vitamin D management in individual patients and CONTRIBUTE to improving Control of disease activity and improve outcomes.']	[('FUTURE_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('FUTURE_WORK', 80), ('SUPERFICIAL_RELATIONSHIP', 140)]	4	[('SO_0000704', 'gene', 17, 'genetic'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0065007', 'biological regulation', 164, 'control')]
PMC5956785	5/2018	S271-PMC5956785	['this review was UNABLE TO explore the RELATIONSHIP between Vitamin D status and ethnicity, Vitamin D receptor Genes or OTHER Genes that INFLUENCE Vitamin D Metabolism.']	[('DIFFICULT_TASK', 16), ('SUPERFICIAL_RELATIONSHIP', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 119), ('SUPERFICIAL_RELATIONSHIP', 136)]	4	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('SO_0000704', 'gene', 110, 'genes'), ('SO_0000704', 'gene', 125, 'genes'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 146, 'vitamin D metabolism')]
PMC5956785	5/2018	S280-PMC5956785	['we do not, HOWEVER, know the optimal Vitamin D status for children with jia, WHETHER reduced Vitamin D is caused by increased utilization OR reduced Vitamin D status in children with jia, the IMPACT of Vitamin D in disease activity or the ROLE of Vdr polymorphisms with jia.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('EXPLICIT_QUESTION', 77), ('SUPERFICIAL_RELATIONSHIP', 192), ('SUPERFICIAL_RELATIONSHIP', 239)]	5	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 247, 'VDR')]
PMC5958072	5/2018	S21-PMC5958072	['several HYPOTHESES HAVE BEEN PROPOSED in the literature, including increased Perinatal influenza infection for those Born in the winter in new york city or decreased Perinatal Vitamin D exposure10,11.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 8), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 29)]	3	[('GO_0036268', 'swimming', 77, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 77, 'perinatal'), ('GO_0007567', 'parturition', 117, 'born'), ('GO_0036268', 'swimming', 166, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 166, 'perinatal'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin D')]
PMC5995352	6/2018	S22-PMC5995352	['hypovitaminosis D MAY BE defined as Vitamin D deficiency or insufficiency (Serum-25-Hydroxyvitamin D (25Ohd) < 25 nmol/l and 25–50 nmol/l, respectively) [3], ALTHOUGH the most APPROPRIATE cut points are STILL UNDER DEBATE [4,5].']	[('INCOMPLETE_EVIDENCE', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158), ('IMPORTANT_CONSIDERATION', 176), ('IMPORTANT_CONSIDERATION', 203), ('IMPORTANT_CONSIDERATION', 209), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 215)]	6	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 16, 'D'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0001977', 'blood serum', 75, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 81, '25-hydroxyvitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 102, '25OHD')]
PMC5995352	6/2018	S34-PMC5995352	['ALTHOUGH maternal Vitamin D status during Pregnancy has no impact on foetal Bone mineralisation IF Calcium supply is adequate, observational studies have LINKED low maternal Vitamin D levels with smaller child bone mass and impaired linear growth in the first 12 months of Life [18–20].']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 96), ('SUPERFICIAL_RELATIONSHIP', 154)]	3	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0007565', 'female pregnancy', 42, 'pregnancy'), ('GO_0007567', 'parturition', 76, 'bone'), ('CHEBI_22313', 'alkaline earth metal atom', 99, 'calcium'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('UBERON_0000104', 'life cycle', 273, 'life')]
PMC5995352	6/2018	S38-PMC5995352	['IF low maternal or Cord 25Ohd is LINKED to diminished infant growth, especially of the Long Bones, DESPITE Vitamin D supplementation RECOMMENDATIONS, an IMPORTANT POTENTIAL for enforced PREVENTION STRATEGIES is SUGGESTED, EVEN in populations with low incidence of Vitamin D deficiency rickets.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 33), ('ANOMALY_CURIOUS_FINDING', 99), ('FUTURE_WORK', 133), ('IMPORTANT_CONSIDERATION', 153), ('INCOMPLETE_EVIDENCE', 163), ('SUPERFICIAL_RELATIONSHIP', 186), ('FUTURE_WORK', 197), ('INCOMPLETE_EVIDENCE', 211), ('ANOMALY_CURIOUS_FINDING', 222)]	10	[('UBERON_0002240', 'spinal cord', 19, 'cord'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 24, '25OHD'), ('UBERON_0002495', 'long bone', 87, 'long bones'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 264, 'vitamin D')]
PMC5995352	6/2018	S147-PMC5995352	['Breastfed infants MAY BE at a higher RISK of rickets [36], BUT this DID NOT apply to our cohort with a general high Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 18), ('IMPORTANT_CONSIDERATION', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 59), ('INCOMPLETE_EVIDENCE', 68)]	4	[('UBERON_0001224', 'renal pelvis', 0, 'Breastfed'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC5995352	6/2018	S162-PMC5995352	['AS s-Igf-I, promoting growth by Proliferation of the Growth Plate, is inhibited by active Vitamin D as DEMONSTRATED in Animal and in vitro studies [39–43], we SPECULATE IF higher Vitamin D levels MAY restrict infant linear growth through inhibition of Igf-I, which has higher Serum concentrations in boys than in girls.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 159), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 169), ('INCOMPLETE_EVIDENCE', 196)]	5	[('PR_000008919', 'interferon alpha-6', 5, 'IGF-I'), ('GO_0008283', 'cell proliferation', 32, 'proliferation'), ('UBERON_0002516', 'epiphyseal plate', 53, 'growth plate'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 119, 'animal'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D'), ('PR_000008919', 'interferon alpha-6', 252, 'IGF-I'), ('UBERON_0001977', 'blood serum', 276, 'serum')]
PMC5995352	6/2018	S163-PMC5995352	['ALTERNATIVE explanations MAY BE searched in the Expression of Genes encoding for the inactive c3-epimer Vitamin D, vdr, Vitamin D binding protein, etc.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 25)]	2	[('GO_0010467', 'gene expression', 48, 'expression'), ('SO_0000704', 'gene', 62, 'genes'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC6011374	6/2018	S14-PMC6011374	['HOWEVER, INCONSISTENCIES between studies reflect UNCERTAINTY about the true EFFECT of Vitamin D deficiency on Pregnancy outcome [5,6].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('FULL_UNKNOWN', 49), ('SUPERFICIAL_RELATIONSHIP', 76)]	4	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('GO_0007565', 'female pregnancy', 110, 'pregnancy')]
PMC6011374	6/2018	S24-PMC6011374	['PREVIOUS STUDIES on Pregnant australian and new zealand women have reported that WHILE circulating 25(Oh)D was significantly lower in women with pe, Sptb, gdm and those who Delivered a small-for Gestational age (sga) infant, no association between Vitamin D deficiency and these Pregnancy complications was found after adjusting for covariates [18–20].']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81)]	2	[('GO_0007565', 'female pregnancy', 20, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 99, '25(OH)D'), ('PR_000015390', 'sterol O-acyltransferase 2', 149, 'sPTB'), ('GO_0007567', 'parturition', 173, 'delivered'), ('GO_0007565', 'female pregnancy', 195, 'gestational'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin D'), ('GO_0007565', 'female pregnancy', 279, 'pregnancy')]
PMC6011374	6/2018	S29-PMC6011374	['using a robust, validated chemiluminescent-based assay to measure Serum 25(Oh)D [27], we AIMED TO INVESTIGATE the DIFFERENCES between Vitamin D status in early Pregnancy in two distinct populations of Nulliparous women from australia and new zealand.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 89), ('QUESTION_ANSWERED_BY_THIS_WORK', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114)]	3	[('UBERON_0001977', 'blood serum', 66, 'serum'), ('CHEBI_71657', 'versiconol acetate', 72, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 72, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0007565', 'female pregnancy', 160, 'pregnancy'), ('GO_0046662', 'regulation of oviposition', 201, 'nulliparous')]
PMC6011374	6/2018	S45-PMC6011374	['UNLIKE the PREVIOUSLY published data on Vitamin D in the auckland cohort [20], Serum 25(Oh)D was measured using the ids-isys chemiluminescent-based assay (abacus, als) as per the manufacturer’s instructions.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 11)]	2	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('UBERON_0001977', 'blood serum', 79, 'serum'), ('CHEBI_71657', 'versiconol acetate', 85, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 85, '25(OH ... D')]
PMC6011374	6/2018	S63-PMC6011374	['HOWEVER, after adjusting for maternal age, bmi, sei, smoking status and Alcohol consumption at 15\u2009±\u20091\xa0weeks’ Gestation, ethnicity, recreational walking and season, the women recruited in adelaide STILL had significantly lower Serum 25(Oh)D when compared with those in auckland (adelaide: 58.4\u2009±\u200950.3 vs. auckland: 70.2\u2009±\u200954.5\xa0nmol/l, p\u2009<\u20090.001) INDICATING the INFLUENCE of OTHER CONFOUNDERS not measured as part of the study on Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 196), ('INCOMPLETE_EVIDENCE', 345), ('SUPERFICIAL_RELATIONSHIP', 360), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 373), ('PROBLEM_COMPLICATION', 379)]	6	[('CHEBI_30879', 'alcohol', 72, 'alcohol'), ('GO_0007565', 'female pregnancy', 109, 'gestation'), ('UBERON_0001977', 'blood serum', 226, 'serum'), ('CHEBI_71657', 'versiconol acetate', 232, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 232, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 428, 'vitamin D')]
PMC6011374	6/2018	S80-PMC6011374	['caption (table-wrap): table 2\n\nadjusted relative risks (arr) of Pregnancy complications from any complication, Preeclampsia (pe), Gestational hypertension (gh), Gestational diabetes mellitus (gdm), spontaneous Preterm Birth (sptb) and small-for-Gestational age (sga) according to Vitamin D status categorised based on standardised quartiles and clinical definitions of Vitamin D statuspregnancy complicationsall womenany complicationpeghgdmsptbsga n (%) n (%)arr*(95% ci) n (%)arr*(95% ci) n (%)arr*(95% ci) n (%)arr*(95% ci) n (%)arr*(95% ci) n (%)arr*(95% ci)standardised quartiles**\u2003low711 (25)328 (46)0.95 (0.85, 1.07)46 (6)1.02 (0.66, 1.57))57 (8)0.97 (0.67, 1.42)28 (4)0.79 (0.47, 1.30)36 (5)0.83 (0.54, 1.29)84 (12)1.02 (0.75, 1.39)\u2003low-moderate755 (27)318 (42)1.00 (0.90, 1.12)42 (6)1.07 (0.69, 1.64)65 (9)1.06 (0.74, 1.52)25 (3)0.67 (0.39, 1.16)33 (4)0.87 (0.56, 1.3572 (10)0.98 (0.73, 1.32)\u2003moderate-high702 (25)309 (44)1.0†37 (5)1.0†50 (7)1.0†28 (4)1.0†39 (6)1.0†81 (12)1.0†\u2003high630 (23)258 (41)0.93 (0.82, 1.06)†35 (6)1.24 (0.78, 1.96)40 (6)0.87 (0.58, 1.30)10 (2) 0.47(0.23, 0.96) 30 (5)0.77 (0.48, 1.25)60 (10)0.80 (0.57, 1.11)Vitamin d status\u2003<25 nmol/l99 (4)51 (52)1.10 (0.89, 1.36)8 (8)1.44 (0.68, 3.03))6 (6)0.70 (0.32, 1.52)5 (5)0.98 (0.38, 2.52)7 (7)1.44 (0.68, 3.04)13 (13)1.15 (0.66, 2.01)\u200325-50 nmol/l673 (24)301 (45)0.93 (0.83, 1.03)45 (7)1.18 (0.80, 1.75)59 (9)0.97 (0.71, 1.34)26 (4)0.89 (0.54, 1.47)29 (4)0.75 (0.48, 1.16)74 (11)0.93 (0.69, 1.24)\u2003>50-75 nmol/l928 (33)428 (46)1.0†48 (5)1.0†80 (9)1.0†35 (4)1.0†52 (6)1.0†107 (12)1.0†\u2003>75 nmol/l1098 (39)435 (40)0.95 (0.86, 1.04)60 (5)1.28 (0.87, 1.87)67 (6)0.82 (0.59, 1.12)†26 (2)0.78 (0.48, 1.28)51 (5)0.86 (0.59, 1.26)104 (9)0.86 (0.67, 1.12)\n*relative risks compared to all women were adjusted for age, maternal body mass index, ethnicity (non caucasian vs. caucasian), smoking status at 15\u2009±\u20091\xa0weeks’ Gestation (no vs. yes), Alcohol consumption at 15\u2009±\u20091\xa0weeks’ (no vs yes), recreational walking (1-3×/week and\u2009≥\u20094×/week vs. never) and recruitment site (auckland vs. adelaide)\n**Serum 25(Oh)D was standardised for month that Serum was sampled based as previously described [34]\n†reference category\n\nSerum 25(Oh)D, Pregnancy outcome and fetal sex\nas THERE IS EVIDENCE to SUGGEST that Vitamin D Metabolism within the Placenta MAY DIFFER with respect to fetal sex [35] THUS, we ASSESSED the EFFECT of “standardised” Vitamin D status on Pregnancy outcome stratified by fetal sex (table\xa03).']	[('INCOMPLETE_EVIDENCE', 2230), ('INCOMPLETE_EVIDENCE', 2251), ('INCOMPLETE_EVIDENCE', 2305), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2309), ('PROBABLE_UNDERSTANDING', 2347), ('QUESTION_ANSWERED_BY_THIS_WORK', 2356), ('SUPERFICIAL_RELATIONSHIP', 2369)]	7	[('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 111, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 130, 'gestational'), ('GO_0007565', 'female pregnancy', 161, 'gestational'), ('GO_0007565', 'female pregnancy', 210, 'preterm birth'), ('GO_0007565', 'female pregnancy', 245, 'gestational'), ('CHEBI_27300', 'vitamin D', 280, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 369, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 1141, 'Vitamin'), ('GO_0007565', 'female pregnancy', 1882, 'gestation'), ('CHEBI_30879', 'alcohol', 1906, 'alcohol'), ('UBERON_0001977', 'blood serum', 2060, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 2066, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 2066, '25(OH)D'), ('UBERON_0001977', 'blood serum', 2106, 'serum'), ('UBERON_0001977', 'blood serum', 2180, 'Serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 2189, 'OH)D'), ('GO_0007565', 'female pregnancy', 2195, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 2264, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 2264, 'vitamin D metabolism'), ('UBERON_0001987', 'placenta', 2296, 'placenta'), ('CHEBI_27300', 'vitamin D', 2394, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2414, 'pregnancy')]
PMC6011374	6/2018	S90-PMC6011374	['HOWEVER, there was a protective ASSOCIATION of having high Vitamin D at 15\u2009±\u20091\xa0weeks’ Gestation and gdm once standardised based on month Serum was sampled.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 32)]	2	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007565', 'female pregnancy', 86, 'gestation'), ('UBERON_0001977', 'blood serum', 137, 'serum')]
PMC6011374	6/2018	S91-PMC6011374	['furthermore, there MAY BE POSSIBLE fetal sex specific DIFFERENCES in Vitamin D status WORTH CONSIDERING in FUTURE STUDIES.']	[('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 26), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 54), ('IMPORTANT_CONSIDERATION', 86), ('FUTURE_WORK', 107)]	5	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC6011374	6/2018	S97-PMC6011374	['HOWEVER, after adjusting for factors shown to be ASSOCIATED with Vitamin D status including bmi and recreational walking, serum 25(Oh)D remained significantly lower in the women recruited in adelaide SUGGESTING the INFLUENCE of OTHER factors not measured as part of scope for example, hours spent outside in the sun.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 200), ('SUPERFICIAL_RELATIONSHIP', 215), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 228)]	5	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 128, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 130, '(OH ... D')]
PMC6011374	6/2018	S98-PMC6011374	['as INDICATED by the seasonal variation in Serum 25(Oh)D, amongst women recruited in adelaide, Vitamin D status declined significantly from february to april WHILST in the women recruited in auckland, Serum 25(Oh)D in march and april remained elevated before declining.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 157)]	2	[('UBERON_0001977', 'blood serum', 42, 'serum'), ('CHEBI_71657', 'versiconol acetate', 48, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 48, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('UBERON_0001977', 'blood serum', 200, 'serum'), ('CHEBI_71657', 'versiconol acetate', 206, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 206, '25(OH)D')]
PMC6011374	6/2018	S107-PMC6011374	['in THIS STUDY, we observed marginal sex-specific DIFFERENCES between early Pregnancy Vitamin D status and Pregnancy outcome where by high Vitamin D status and carrying a male fetus was moderately ASSOCIATED with decreasing the risk of having any Pregnancy complication.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 49), ('SUPERFICIAL_RELATIONSHIP', 196)]	3	[('GO_0007565', 'female pregnancy', 75, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007565', 'female pregnancy', 106, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('GO_0007565', 'female pregnancy', 246, 'pregnancy')]
PMC6011374	6/2018	S108-PMC6011374	['CONVERSELY, high Vitamin D status and carrying a female fetus was not associated with changing the risk of having any Pregnancy complication.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0007565', 'female pregnancy', 118, 'pregnancy')]
PMC6011374	6/2018	S109-PMC6011374	['indeed, for the risk of gdm an OPPOSITE EFFECT of Vitamin D status in early Pregnancy was observed DEPENDING ON fetal sex.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('SUPERFICIAL_RELATIONSHIP', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99)]	3	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007565', 'female pregnancy', 76, 'pregnancy')]
PMC6011374	6/2018	S116-PMC6011374	['INCONSISTENCIES in the literature MAY also reflect OTHER causative factors in which Vitamin D is a mediator.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 51)]	3	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D')]
PMC6011374	6/2018	S121-PMC6011374	['HOWEVER, DIFFERENCES in Vitamin D status between the women recruited in adelaide and those recruited in auckland reflect obvious DIFFICULTIES in studying HOW Vitamin D MAY support healthy Pregnancies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('DIFFICULT_TASK', 129), ('EXPLICIT_QUESTION', 154), ('INCOMPLETE_EVIDENCE', 168)]	5	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('GO_0007565', 'female pregnancy', 188, 'pregnancies')]
PMC6039335	7/2018	S265-PMC6039335	['a continuous supply of normal levels of dietary Vitamin A during the entire growth period MAY also result in poor marbling and qg, EVEN IF the growth rate were normal and no health PROBLEMS occurred.']	[('INCOMPLETE_EVIDENCE', 90), ('ANOMALY_CURIOUS_FINDING', 131), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 136), ('PROBLEM_COMPLICATION', 181)]	4	[('CHEBI_27300', 'vitamin D', 48, 'vitamin A')]
PMC6043562	7/2018	S15-PMC6043562	['OTHER STUDIES have FOUND PROTECTIVE ASSOCIATIONS of maternal Antenatal Vitamin D or antioxidant Nutrient intake with later allergic or Respiratory outcomes8–12, THOUGH their findings have NOT always been reproducible13–16.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 25), ('SUPERFICIAL_RELATIONSHIP', 36), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 161), ('ANOMALY_CURIOUS_FINDING', 161), ('ANOMALY_CURIOUS_FINDING', 188)]	8	[('GO_0007567', 'parturition', 61, 'antenatal'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CHEBI_33284', 'nutrient', 96, 'nutrient'), ('UBERON_0001004', 'respiratory system', 135, 'respiratory')]
PMC6043562	7/2018	S93-PMC6043562	['IN CONTRAST, no interaction between black carbon and Vitamin E was observed in bkmr models for the Feno outcome, and a test of the interaction term in linear regression models was not statistically significant (p\u2009=\u20090.75).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('CHEBI_27300', 'vitamin D', 53, 'vitamin E'), ('CHEBI_32035', 'potassium hydroxide', 99, 'FeNO')]
PMC6043562	7/2018	S107-PMC6043562	['IN CONTRAST with OTHER Nutrients, total Vitamin E intake in Pregnancy APPEARED TO amplify the adverse EFFECT of Prenatal exposure to Pm2.5on Feno measured in adolescence, SUGGESTING a synergy between these two exposures.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 17), ('ANOMALY_CURIOUS_FINDING', 70), ('SUPERFICIAL_RELATIONSHIP', 102), ('INCOMPLETE_EVIDENCE', 171)]	6	[('CHEBI_33284', 'nutrient', 23, 'nutrients'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin E'), ('GO_0007565', 'female pregnancy', 60, 'pregnancy'), ('GO_0007565', 'female pregnancy', 112, 'prenatal'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 133, 'PM2'), ('CHEBI_32035', 'potassium hydroxide', 141, 'FeNO')]
PMC6043562	7/2018	S160-PMC6043562	['IN SUMMARY, we FOUND that greater maternal intakes of Vitamin D, Folate, and N-3 Fatty Acids were ASSOCIATED with less Airway inflammation in adolescence, WHILE other Nutrients (Vitamin E), and air Pollutants were ASSOCIATED with higher inflammation.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 155), ('SUPERFICIAL_RELATIONSHIP', 214)]	5	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 65, 'folate'), ('CHEBI_35418', 'N-acetylneuraminate', 77, 'n-3 fatty acids'), ('UBERON_0001005', 'respiratory airway', 119, 'airway'), ('CHEBI_33284', 'nutrient', 167, 'nutrients'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin E'), ('CHEBI_26199', 'polyprenol', 198, 'pollutants')]
PMC6043562	7/2018	S225-PMC6043562	['we MODELLED all Nutrients in the same exposure group except Vitamin E and Β-Carotene, which DEMONSTRATED ASSOCIATIONS with Feno in the direction OPPOSITE to that observed for other Nutrients.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 145)]	4	[('CHEBI_33284', 'nutrient', 16, 'nutrients'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin E'), ('CHEBI_28660', '(-)-alpha-pinene', 74, 'β-Carotene'), ('CHEBI_32035', 'potassium hydroxide', 123, 'FeNO'), ('CHEBI_33284', 'nutrient', 181, 'nutrients')]
PMC6056931	7/2018	S22-PMC6056931	['HOWEVER, adequate maternal intakes of zinc and Vitamin A MAY also be IMPORTANT for optimal Pregnancy outcomes, as well as for maternal and offspring health [11–13].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 57), ('IMPORTANT_CONSIDERATION', 69)]	3	[('CHEBI_27300', 'vitamin D', 47, 'vitamin A'), ('GO_0007565', 'female pregnancy', 91, 'pregnancy')]
